data_1fa3_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1fa3 _Structure_validation_residue.Date_analyzed 2016-10-06 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.4 mm -84.28 143.32 12.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 pt -104.99 154.84 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.637 0.775 . . . . 0.0 110.825 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.48 118.58 12.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.849 0.86 . . . . 0.0 109.388 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.45 129.13 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 172.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.01 -167.15 39.53 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -50.97 -41.73 55.1 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.711 2.941 . . . . 0.0 112.857 -174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -53.85 -60.75 2.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.648 0.779 . . . . 0.0 111.64 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -63.09 -43.55 98.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.617 -0.677 . . . . 0.0 110.082 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -51.03 -53.46 33.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -53.13 -49.71 65.99 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.451 0.7 . . . . 0.0 111.34 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 mt -63.98 -45.08 90.63 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.644 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.63 -43.47 96.19 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -57.23 -53.4 58.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.034 0.934 . . . . 0.0 108.872 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -53.6 -45.04 69.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.881 1.272 . . . . 0.0 110.829 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.87 -51.88 67.33 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.908 0.385 . . . . 0.0 110.585 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.12 -39.48 84.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.468 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.01 -47.58 84.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.955 0.902 . . . . 0.0 110.195 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -58.71 -53.98 52.23 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.048 0.939 . . . . 0.0 109.095 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -54.08 -48.18 70.92 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.987 0.515 . . . . 0.0 110.116 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -60.95 -44.24 97.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.343 1.457 . . . . 0.0 110.246 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.82 -42.02 96.89 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.678 0.391 . . . . 0.0 110.108 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.3 -43.51 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.58 17.78 59.65 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.983 1.278 . . . . 0.0 111.749 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -57.93 -38.45 75.96 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.7 0.75 . . . . 0.0 111.329 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -118.81 41.72 2.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.812 1.245 . . . . 0.0 109.421 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.51 -141.9 48.03 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -118.51 106.12 12.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.611 1.165 . . . . 0.0 109.2 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.49 151.92 18.88 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.177 0.444 . . . . 0.0 110.854 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.2 m -93.27 96.13 9.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -45.27 130.85 8.14 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 122.465 0.306 . . . . 0.0 110.474 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -105.82 -66.23 1.01 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.928 0.891 . . . . 0.0 109.141 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -165.56 -175.01 3.34 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -124.62 143.02 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.45 167.05 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.097 0.559 . . . . 0.0 110.057 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.04 152.12 72.31 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 122.875 0.47 . . . . 0.0 112.088 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.33 152.01 97.69 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 CA-C-N 119.074 0.705 . . . . 0.0 111.064 -3.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.8 m -138.85 81.07 1.82 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.5 ttm -105.77 138.53 41.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.047 0.539 . . . . 0.0 110.684 -167.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -122.29 144.84 48.75 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.76 1.624 . . . . 0.0 109.69 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -141.11 141.75 34.18 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.061 0.944 . . . . 0.0 109.7 169.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.5 t -63.86 142.39 58.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.625 0.37 . . . . 0.0 110.311 168.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.05 126.11 72.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.005 1.322 . . . . 0.0 110.27 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.452 -0.356 0 C-N-CA 124.931 1.292 . . . . 0.0 110.08 177.418 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -117.92 -33.72 4.39 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.502 0.592 . . . . 0.0 111.655 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.93 -154.02 11.09 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.206 -170.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.67 161.24 39.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.087 1.355 . . . . 0.0 108.185 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -125.0 151.1 45.98 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.482 1.113 . . . . 0.0 109.28 169.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -134.76 118.32 16.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.616 1.566 . . . . 0.0 107.58 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.58 111.65 24.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.775 1.23 . . . . 0.0 107.842 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 pp -138.52 154.29 48.77 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 122.791 0.437 . . . . 0.0 111.516 -172.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -103.07 104.55 14.73 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.214 1.006 . . . . 0.0 109.312 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.55 133.56 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.558 1.543 . . . . 0.0 110.102 -175.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.78 123.28 41.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.433 1.493 . . . . 0.0 108.476 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.51 130.63 26.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.4 m 50.45 40.28 22.74 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.419 1.088 . . . . 0.0 111.584 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t0 50.11 32.66 6.1 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.884 1.274 . . . . 0.0 112.972 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -119.07 129.79 55.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.3 tp -94.66 125.65 39.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -124.62 149.5 47.02 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 125.313 1.445 . . . . 0.0 108.17 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -92.15 123.64 35.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.65 133.08 54.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -107.4 122.01 45.75 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mm -113.27 146.19 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.098 1.759 . . . . 0.0 106.82 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 154.47 25.5 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -130.95 115.47 16.56 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.643 1.977 . . . . 0.0 106.669 169.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.93 124.42 33.12 Favored 'General case' 0 CA--C 1.526 0.03 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -58.34 -49.26 77.82 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.659 0.784 . . . . 0.0 111.063 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -68.89 -51.73 37.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.535 0.734 . . . . 0.0 110.777 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -62.86 -34.0 76.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 64.04 34.69 11.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.202 1.401 . . . . 0.0 109.933 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.33 143.71 14.68 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.11 165.31 12.89 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 122.795 0.438 . . . . 0.0 110.654 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.13 152.87 19.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.176 0.59 . . . . 0.0 111.299 170.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -71.67 118.64 14.76 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 mt -75.57 -50.87 14.29 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 167.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -156.73 160.67 39.52 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.897 0.317 . . . . 0.0 111.145 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -135.75 101.22 4.69 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.142 1.777 . . . . 0.0 107.074 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -105.8 152.29 23.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.928 0.891 . . . . 0.0 109.086 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 134.59 -168.03 23.69 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 N--CA 1.457 -0.673 0 CA-C-N 118.24 1.02 . . . . 0.0 111.167 2.966 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -78.72 138.57 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 pt -106.46 154.32 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.322 1.049 . . . . 0.0 109.833 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.66 145.41 55.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.207 0.603 . . . . 0.0 109.814 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.2 pt -83.3 122.43 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.14 -165.23 31.6 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.41 -41.77 72.79 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.942 2.428 . . . . 0.0 112.282 -172.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -58.87 -49.29 78.31 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.809 0.814 . . . . 0.0 110.91 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -47.54 82.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.859 1.264 . . . . 0.0 109.688 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -54.52 -49.28 70.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.107 0.563 . . . . 0.0 110.054 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -55.92 -48.58 75.44 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.715 0.806 . . . . 0.0 110.499 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -56.15 -46.54 79.21 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.992 -0.442 . . . . 0.0 110.949 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.76 -56.32 25.77 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -51.71 -50.45 60.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.668 1.587 . . . . 0.0 109.822 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -55.08 -50.34 69.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.884 1.273 . . . . 0.0 110.75 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.29 -50.37 71.61 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.85 -39.83 86.84 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.478 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.93 -49.78 73.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.28 1.032 . . . . 0.0 109.544 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.43 -53.84 52.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.033 0.933 . . . . 0.0 108.897 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.4 -41.05 84.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.474 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -70.46 -39.46 74.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.459 1.503 . . . . 0.0 110.136 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -60.52 -45.99 91.81 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.279 0.632 . . . . 0.0 109.363 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.66 -40.47 89.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 171.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.05 19.88 58.47 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.44 1.495 . . . . 0.0 110.896 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -61.49 -35.7 78.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.858 0.829 . . . . 0.0 111.152 -170.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -118.87 39.97 3.39 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.804 0.842 . . . . 0.0 109.337 171.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.51 -141.29 44.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -101.92 93.72 5.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.58 1.152 . . . . 0.0 109.629 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.2 mt -80.72 139.99 35.81 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.197 0.453 . . . . 0.0 110.02 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.2 m -94.0 90.13 6.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.508 1.123 . . . . 0.0 108.49 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -51.42 132.7 29.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 122.188 -0.32 . . . . 0.0 111.458 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -104.07 -66.09 0.98 Allowed 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 123.544 0.738 . . . . 0.0 109.193 169.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -164.93 -168.59 1.48 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.151 0.58 . . . . 0.0 109.593 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.9 145.45 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.7 pt -133.62 173.42 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.351 0.66 . . . . 0.0 110.22 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 152.6 82.47 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 123.893 0.877 . . . . 0.0 110.795 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.07 151.83 96.34 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 N-CA-C 110.452 -0.634 . . . . 0.0 110.452 -5.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.4 m -138.9 90.36 2.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.1 ttt -111.31 138.43 47.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.406 0.682 . . . . 0.0 110.57 -169.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -116.23 149.78 38.59 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.642 1.177 . . . . 0.0 108.492 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.49 151.29 33.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.599 0.76 . . . . 0.0 111.205 166.964 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 m -85.43 127.94 34.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.243 1.817 . . . . 0.0 111.586 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -99.44 136.29 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.486 1.515 . . . . 0.0 109.369 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 . . . . . 0 CA--C 1.529 0.148 0 C-N-CA 126.061 1.744 . . . . 0.0 109.985 -179.408 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -115.61 -31.85 5.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.677 1.191 . . . . 0.0 110.592 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.01 -158.91 20.79 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -144.73 158.65 43.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.83 1.252 . . . . 0.0 108.217 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -114.19 153.54 29.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.211 1.404 . . . . 0.0 108.631 168.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -136.42 117.21 14.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -110.47 113.88 26.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 pp -146.2 146.03 30.66 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.153 0.433 . . . . 0.0 111.726 -170.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -89.18 99.74 12.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.516 0.726 . . . . 0.0 109.242 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.7 t -81.65 132.4 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.941 1.696 . . . . 0.0 109.013 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.34 114.63 29.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.489 1.516 . . . . 0.0 107.617 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.06 130.95 26.05 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.103 0.961 . . . . 0.0 108.676 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.0 t 50.67 39.23 21.17 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.461 1.104 . . . . 0.0 111.861 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.3 t0 53.25 33.93 16.55 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.316 1.046 . . . . 0.0 112.523 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -122.68 138.63 54.55 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 168.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.0 tp -105.32 127.08 52.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -132.76 143.93 49.92 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 125.137 1.375 . . . . 0.0 108.636 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -82.35 116.16 21.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.6 132.76 43.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -110.47 125.28 53.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.98 152.91 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 125.372 1.469 . . . . 0.0 107.28 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.7 m -119.08 149.83 41.02 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.15 0.98 . . . . 0.0 109.151 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.04 122.4 37.16 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 168.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.46 120.63 38.19 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.02 -53.0 62.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.203 1.001 . . . . 0.0 110.767 -170.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -58.62 -48.02 82.38 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.124 0.569 . . . . 0.0 110.111 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 m -71.92 -20.24 61.8 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.629 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 43.14 45.59 4.77 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 125.969 1.707 . . . . 0.0 111.091 -171.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -140.8 155.33 24.84 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.8 mtt85 -114.95 171.28 7.75 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.306 0.642 . . . . 0.0 110.841 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -155.35 146.95 23.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.298 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.4 tp -71.58 119.09 15.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.83 -50.91 18.17 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -168.95 156.83 7.62 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -171.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -133.53 89.11 2.55 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.641 1.576 . . . . 0.0 107.476 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -98.4 138.27 35.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -170.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.43 -167.07 32.4 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.254 -0.748 . . . . 0.0 111.473 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.457 -0.637 0 CA-C-N 118.05 0.925 . . . . 0.0 111.113 2.123 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.6 144.19 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.6 pt -119.5 164.81 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.745 0.702 . . . . 0.0 110.377 169.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.61 141.85 51.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 110.461 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -88.54 120.52 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.2 -165.37 25.49 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -54.98 -44.56 48.51 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.196 2.597 . . . . 0.0 112.516 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -48.96 -58.44 4.87 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.232 1.015 . . . . 0.0 110.913 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -43.52 92.48 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.31 1.044 . . . . 0.0 109.808 -172.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -56.5 -49.84 73.55 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.354 1.062 . . . . 0.0 109.801 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -53.92 -52.18 61.4 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.395 0.543 . . . . 0.0 110.44 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -59.98 -44.58 94.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.729 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.33 -44.49 93.43 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -64.29 -50.53 67.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -50.46 -47.57 56.85 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.508 1.123 . . . . 0.0 110.914 173.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -52.83 63.78 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 110.152 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.5 -39.08 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.464 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.0 -49.65 75.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.349 0.66 . . . . 0.0 110.162 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -57.12 -50.26 73.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.84 0.856 . . . . 0.0 109.022 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -55.24 -51.23 67.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.45 0.7 . . . . 0.0 109.472 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -60.49 -40.36 91.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.536 1.135 . . . . 0.0 110.591 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -59.52 -42.65 92.71 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.6 mt -67.45 -44.22 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.91 22.74 57.23 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.041 1.305 . . . . 0.0 111.295 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.8 -38.87 86.83 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.79 0.795 . . . . 0.0 110.715 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -108.35 34.76 3.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.73 1.212 . . . . 0.0 109.978 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.52 -141.04 44.79 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -100.17 91.83 4.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.398 1.079 . . . . 0.0 109.783 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.28 173.21 10.51 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 168.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 m -138.25 102.49 4.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -51.94 134.26 31.79 Favored 'General case' 0 CA--C 1.524 -0.046 0 C-N-CA 122.838 0.455 . . . . 0.0 110.377 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -103.2 -63.18 1.2 Allowed 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -173.43 174.58 3.24 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.141 1.376 . . . . 0.0 108.711 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.66 150.12 14.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 124.489 1.116 . . . . 0.0 108.779 173.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.9 pt -138.26 168.37 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.067 0.547 . . . . 0.0 110.439 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.17 154.43 70.21 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 170.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.28 150.15 95.23 Favored 'Cis proline' 0 N--CA 1.458 -0.581 0 CA-C-N 119.193 0.748 . . . . 0.0 111.012 -3.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.1 t -140.87 102.2 4.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -121.33 141.56 50.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.708 1.203 . . . . 0.0 109.682 -166.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -126.56 158.77 35.34 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.792 0.837 . . . . 0.0 111.269 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -147.35 152.74 38.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.31 1.444 . . . . 0.0 108.334 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.3 m -85.04 137.69 32.9 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.709 0.803 . . . . 0.0 109.954 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.88 129.72 64.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.942 1.297 . . . . 0.0 110.196 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 . . . . . 0 N--CA 1.448 -0.528 0 C-N-CA 125.697 1.599 . . . . 0.0 108.863 -177.049 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.529 0.159 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -109.18 -25.8 10.44 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.992 0.36 . . . . 0.0 110.825 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.16 -163.51 28.84 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.638 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -142.45 156.16 45.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -120.83 142.4 49.66 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.006 1.322 . . . . 0.0 107.45 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -131.02 108.35 9.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.385 1.874 . . . . 0.0 106.745 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -105.08 123.11 47.25 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.116 1.767 . . . . 0.0 108.747 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.71 164.84 36.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -104.69 113.69 27.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.165 0.986 . . . . 0.0 110.898 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.44 130.1 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.558 1.543 . . . . 0.0 108.223 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -92.77 120.44 33.15 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.28 131.95 24.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.398 1.079 . . . . 0.0 108.119 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 t 49.76 45.45 24.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.219 1.008 . . . . 0.0 110.129 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 p30 53.34 17.76 1.14 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.361 1.864 . . . . 0.0 115.459 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -116.29 151.7 35.31 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.36 127.24 42.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -127.8 136.68 51.8 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.347 1.459 . . . . 0.0 108.444 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -85.3 137.37 33.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.03 139.53 53.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -115.83 114.99 25.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 168.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.88 145.0 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 m -119.38 144.25 47.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -113.04 129.43 56.5 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.8 2.04 . . . . 0.0 107.014 170.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -92.49 125.56 37.18 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -58.54 -43.55 89.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.373 1.069 . . . . 0.0 111.372 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -70.66 -48.65 53.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.1 m -67.74 -31.48 71.42 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.364 0.266 . . . . 0.0 111.263 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 55.41 41.01 31.44 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.235 1.014 . . . . 0.0 109.602 -169.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.1 155.62 25.62 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 -114.95 171.46 7.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.407 0.683 . . . . 0.0 112.28 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -162.56 148.7 12.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.107 1.763 . . . . 0.0 110.594 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.5 tp -68.1 134.87 51.28 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.7 tp -106.33 -64.54 1.16 Allowed 'General case' 0 C--N 1.338 0.076 0 C-N-CA 123.238 0.615 . . . . 0.0 109.779 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.14 146.47 45.94 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -136.71 130.94 32.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -145.03 155.21 43.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 126.89 -164.59 20.41 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 N--CA 1.454 -0.81 0 CA-C-N 118.797 1.299 . . . . 0.0 109.91 -6.755 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.226 -0.156 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mp -86.73 139.37 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.5 pt -101.04 151.35 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.403 0.681 . . . . 0.0 110.221 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -71.96 128.22 35.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.75 132.39 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 168.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.85 -172.34 44.58 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -53.65 -44.87 45.35 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.701 2.934 . . . . 0.0 112.677 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -50.16 -57.35 7.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.269 1.033 . . . . 0.0 110.853 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.02 -41.11 95.58 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.533 1.133 . . . . 0.0 109.81 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -58.12 -45.98 86.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.085 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -58.11 -46.8 84.94 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.6 0.637 . . . . 0.0 110.748 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.7 mt -58.22 -41.89 85.09 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.942 -0.474 . . . . 0.0 111.17 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.31 -58.31 15.23 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -44.12 -52.57 7.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.888 0.875 . . . . 0.0 111.616 172.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -55.59 -49.71 72.03 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.047 0.939 . . . . 0.0 110.808 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.92 69.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.73 -40.49 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.423 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.62 -50.29 71.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.09 0.956 . . . . 0.0 110.225 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -61.66 -47.49 85.13 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.138 0.975 . . . . 0.0 109.318 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -56.98 -49.8 74.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.497 0.319 . . . . 0.0 110.24 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -56.88 -43.42 81.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.464 1.106 . . . . 0.0 110.143 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -59.7 -39.92 86.17 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.2 mt -67.71 -45.53 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.48 18.03 57.65 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.174 1.369 . . . . 0.0 111.584 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -57.95 -39.88 79.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.702 0.751 . . . . 0.0 111.251 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.24 41.48 2.12 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.172 0.989 . . . . 0.0 109.62 172.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.17 -142.11 45.64 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -122.76 93.35 3.94 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.955 0.902 . . . . 0.0 109.079 -170.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp -85.53 -169.96 2.89 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.773 0.797 . . . . 0.0 109.392 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.9 m -145.23 124.74 13.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 172.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.57 140.07 42.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.626 0.371 . . . . 0.0 111.164 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -111.4 -64.29 1.3 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.648 0.779 . . . . 0.0 109.504 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.37 -179.92 4.16 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.097 0.959 . . . . 0.0 109.595 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.84 143.32 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.6 165.44 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.809 0.444 . . . . 0.0 110.236 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 158.53 79.54 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.113 0.965 . . . . 0.0 111.697 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.21 152.84 91.31 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 CA-C-N 119.468 0.846 . . . . 0.0 111.756 -9.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 76.4 m -138.79 100.25 4.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.8 ttt -118.27 142.44 47.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.321 0.648 . . . . 0.0 111.432 -167.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -120.97 143.12 49.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.409 2.284 . . . . 0.0 109.067 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -144.92 147.94 33.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.726 1.61 . . . . 0.0 110.123 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.49 134.66 35.56 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.778 1.631 . . . . 0.0 110.508 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -112.79 127.5 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.73 1.212 . . . . 0.0 110.816 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 125.197 1.399 . . . . 0.0 111.759 -176.942 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.3 mt . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -96.13 -27.91 14.83 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.59 -158.89 21.6 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -145.9 159.48 43.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.007 1.323 . . . . 0.0 107.699 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -124.57 135.58 53.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 125.599 1.559 . . . . 0.0 108.773 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.97 106.33 9.55 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.866 1.666 . . . . 0.0 107.519 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -94.53 124.11 38.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.303 1.041 . . . . 0.0 108.716 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.0 153.33 39.92 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.282 0.492 . . . . 0.0 111.023 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -95.28 105.04 16.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 123.983 0.913 . . . . 0.0 109.542 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.81 124.99 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.357 1.063 . . . . 0.0 109.729 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -79.8 117.21 20.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.28 122.86 40.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.032 1.333 . . . . 0.0 108.418 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t 72.37 -60.85 0.52 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 130.041 3.336 . . . . 0.0 108.327 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -177.1 0.23 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.757 2.823 . . . . 0.0 111.798 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -111.31 144.16 40.95 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.31 122.64 34.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.568 0.747 . . . . 0.0 109.147 -173.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -118.43 141.74 48.25 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 124.301 1.041 . . . . 0.0 109.179 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -86.53 104.24 15.8 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.778 1.231 . . . . 0.0 107.707 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.41 127.07 49.59 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -103.3 106.75 17.34 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.54 122.63 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.0 m -96.18 156.65 16.25 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 170.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -128.72 123.47 33.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.869 1.268 . . . . 0.0 107.796 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -96.08 113.02 24.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.513 1.125 . . . . 0.0 107.984 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -60.7 -27.17 67.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.172 0.589 . . . . 0.0 111.167 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -58.89 -24.66 62.55 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.607 0.763 . . . . 0.0 112.411 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.2 m -144.95 16.29 1.57 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.62 -0.675 . . . . 0.0 111.415 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 52.4 38.9 26.42 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.368 1.067 . . . . 0.0 111.021 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.58 138.31 14.88 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -102.75 167.64 9.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.724 0.762 . . . . 0.0 112.477 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.77 130.83 1.05 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.282 -168.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.5 tp -71.12 116.27 11.22 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.5 -56.74 3.01 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 123.352 0.661 . . . . 0.0 110.258 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -127.5 141.76 51.57 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -138.0 91.08 2.54 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -107.33 160.75 15.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -173.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.18 -163.97 12.13 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.454 -0.817 0 CA-C-N 118.807 1.303 . . . . 0.0 110.479 3.138 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.312 0.101 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mt -76.55 139.87 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.8 pt -110.06 156.78 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 123.178 0.591 . . . . 0.0 110.074 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.51 131.35 48.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.916 0.887 . . . . 0.0 109.777 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.29 120.99 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.15 -165.88 29.13 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -172.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -54.12 -45.65 39.41 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.806 3.004 . . . . 0.0 112.649 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -47.24 -56.84 5.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.654 1.181 . . . . 0.0 110.909 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -39.94 82.46 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.153 1.381 . . . . 0.0 110.005 -174.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -50.76 -53.21 33.61 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.779 1.631 . . . . 0.0 109.956 170.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -54.61 -48.86 71.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.666 0.387 . . . . 0.0 111.092 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.8 mt -63.87 -41.49 97.74 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.406 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.17 -51.24 55.4 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -54.13 -59.36 4.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.768 0.827 . . . . 0.0 110.708 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -49.84 -44.28 49.36 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.265 0.626 . . . . 0.0 111.624 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.36 70.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.896 0.379 . . . . 0.0 110.229 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.41 -43.4 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.145 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.18 -46.08 89.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.881 0.872 . . . . 0.0 109.971 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -63.98 -49.72 71.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.076 0.95 . . . . 0.0 109.376 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -57.44 -43.44 83.88 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.751 -0.593 . . . . 0.0 110.954 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -63.85 -39.51 94.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.871 1.268 . . . . 0.0 110.684 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -61.48 -43.77 98.27 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.395 0.678 . . . . 0.0 109.239 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.61 -40.17 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.1 20.62 58.84 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.336 1.446 . . . . 0.0 110.167 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.79 -35.95 75.7 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 117.404 0.602 . . . . 0.0 111.105 -168.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.46 33.87 5.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.084 0.953 . . . . 0.0 109.815 175.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.25 -145.37 49.57 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -171.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -106.46 88.5 2.79 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.525 1.13 . . . . 0.0 108.975 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -70.13 153.86 42.63 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.3 m -109.07 102.26 11.26 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -52.29 144.72 12.26 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.655 0.382 . . . . 0.0 110.446 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -120.84 -66.19 1.08 Allowed 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.901 0.48 . . . . 0.0 110.205 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 166.82 27.14 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 117.812 0.278 . . . . 0.0 110.452 175.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -91.62 150.23 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.194 0.998 . . . . 0.0 108.591 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -144.55 174.96 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.832 0.853 . . . . 0.0 109.195 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.49 154.79 85.77 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.632 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.02 157.32 97.28 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 119.67 0.918 . . . . 0.0 111.246 -4.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.3 t -153.98 93.88 1.69 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.716 0.806 . . . . 0.0 109.395 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -102.92 154.76 18.89 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.467 1.507 . . . . 0.0 110.546 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -133.79 143.49 48.43 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.42 1.488 . . . . 0.0 109.271 170.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -147.1 144.98 29.44 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.608 0.763 . . . . 0.0 111.598 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -65.34 139.04 58.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.862 1.265 . . . . 0.0 111.684 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.81 127.21 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.193 1.397 . . . . 0.0 108.443 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.7 p90 . . . . . 0 N--CA 1.455 -0.2 0 O-C-N 121.505 -0.747 . . . . 0.0 110.878 -163.813 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.8 mt . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -117.3 -21.14 8.87 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.153 0.581 . . . . 0.0 111.663 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.79 -167.71 33.82 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -130.03 164.9 23.31 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.17 144.79 50.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.64 1.576 . . . . 0.0 107.193 168.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -130.52 133.9 46.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -130.62 112.57 13.26 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -148.64 160.08 43.48 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.205 0.457 . . . . 0.0 112.203 -166.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.28 140.31 37.57 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 123.643 0.777 . . . . 0.0 110.528 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.17 133.09 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.819 1.647 . . . . 0.0 109.147 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.75 119.2 25.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.15 130.69 37.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t 51.27 41.41 27.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.461 1.105 . . . . 0.0 111.526 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 t0 49.3 35.74 8.24 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.87 1.668 . . . . 0.0 112.499 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -127.97 142.03 51.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 tp -87.37 117.0 25.85 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -113.96 155.12 26.41 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.735 0.814 . . . . 0.0 108.862 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -108.88 138.47 45.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.461 1.104 . . . . 0.0 108.223 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.04 137.81 46.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.977 0.911 . . . . 0.0 109.343 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -114.04 116.78 29.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 mm -109.26 155.11 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 126.373 1.869 . . . . 0.0 106.406 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.84 164.57 22.78 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 118.516 0.598 . . . . 0.0 109.517 167.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.65 138.89 52.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.152 2.181 . . . . 0.0 106.557 170.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.04 114.59 28.62 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.209 1.403 . . . . 0.0 107.298 174.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -56.44 -36.29 68.84 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.194 0.998 . . . . 0.0 111.452 -171.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -53.58 -23.6 11.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.62 1.568 . . . . 0.0 113.339 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -143.14 15.35 1.88 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.643 -0.661 . . . . 0.0 110.844 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 48.28 32.47 3.17 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.626 0.77 . . . . 0.0 111.023 -170.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.63 129.66 9.99 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -171.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -100.19 166.64 10.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.699 0.75 . . . . 0.0 112.694 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.35 140.09 4.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.405 -169.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.03 121.73 14.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 168.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mt -85.56 -60.2 2.09 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -145.03 154.96 43.07 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.329 0.652 . . . . 0.0 109.25 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -131.32 150.47 52.14 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -156.01 163.91 39.12 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.63 0.772 . . . . 0.0 109.288 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.93 -162.91 12.27 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 N--CA 1.453 -0.89 0 CA-C-N 118.75 1.275 . . . . 0.0 110.027 -2.801 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.3 mm -81.87 138.15 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.5 pt -101.4 155.66 4.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.178 0.591 . . . . 0.0 110.553 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.06 148.82 50.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.79 132.34 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 C-N-CA 125.017 1.327 . . . . 0.0 108.224 169.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.89 -168.97 39.6 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 108.269 -1.933 . . . . 0.0 108.269 -174.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.5 -43.29 59.56 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.446 2.764 . . . . 0.0 112.153 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -51.88 -57.42 9.42 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 122.004 0.907 . . . . 0.0 111.286 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -45.49 89.76 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.269 1.028 . . . . 0.0 109.964 -173.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -49.99 -58.31 5.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 118.36 -0.829 . . . . 0.0 108.923 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -49.34 -46.18 46.54 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.73 0.812 . . . . 0.0 111.013 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.32 -51.64 65.19 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.605 -0.684 . . . . 0.0 111.751 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.23 83.32 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 122.396 0.998 . . . . 0.0 112.414 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.73 -57.93 6.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.473 1.909 . . . . 0.0 106.808 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -47.45 -44.85 25.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.852 1.661 . . . . 0.0 110.417 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.54 -54.14 49.3 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.909 0.385 . . . . 0.0 110.495 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.75 -38.54 76.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 122.817 0.447 . . . . 0.0 111.31 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.86 -46.82 83.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.029 0.931 . . . . 0.0 109.99 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -60.89 -47.32 86.95 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.801 0.84 . . . . 0.0 108.977 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -55.99 -50.81 69.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.017 0.527 . . . . 0.0 109.67 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -57.94 -42.68 85.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.796 1.638 . . . . 0.0 110.209 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.5 -45.95 87.7 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.098 0.559 . . . . 0.0 110.19 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.6 mt -64.68 -42.96 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.53 18.55 65.96 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.988 1.28 . . . . 0.0 111.018 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -55.23 -41.61 72.32 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 117.762 0.781 . . . . 0.0 111.0 -173.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.54 25.95 11.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.397 1.079 . . . . 0.0 110.44 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.06 -152.91 46.11 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -117.25 120.68 38.99 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.953 1.301 . . . . 0.0 108.148 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.87 156.95 30.87 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.446 0.698 . . . . 0.0 111.805 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 m -97.56 95.89 7.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -45.3 132.14 7.75 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -101.02 -68.5 0.81 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -168.61 165.11 12.33 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -171.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -102.58 141.59 18.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 124.67 1.188 . . . . 0.0 108.109 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.54 172.3 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.488 0.715 . . . . 0.0 110.012 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.73 154.99 83.88 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.722 0.809 . . . . 0.0 111.405 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.56 158.23 98.66 Favored 'Cis proline' 0 N--CA 1.455 -0.755 0 N-CA-C 110.373 -0.664 . . . . 0.0 110.373 -4.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 77.0 m -141.79 91.31 2.35 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.26 127.84 53.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.306 1.042 . . . . 0.0 110.28 -168.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -102.68 145.31 29.87 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.705 0.802 . . . . 0.0 110.018 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -148.34 141.74 25.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.184 0.594 . . . . 0.0 110.237 166.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.5 m -58.49 134.61 56.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.577 0.751 . . . . 0.0 110.453 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 tp -115.61 127.68 73.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.632 1.173 . . . . 0.0 108.614 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.1 p90 . . . . . 0 N--CA 1.447 -0.596 0 C-N-CA 123.3 0.64 . . . . 0.0 110.115 -169.74 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.1 mt . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.16 -39.62 14.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.58 -152.11 9.78 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -172.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.16 152.95 42.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.966 1.306 . . . . 0.0 107.662 174.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.9 155.98 21.01 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.763 1.225 . . . . 0.0 108.875 170.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -138.27 102.72 4.73 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.511 1.924 . . . . 0.0 106.239 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 126.62 38.56 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 pp -152.24 153.55 33.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.308 0.503 . . . . 0.0 112.078 -172.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -85.88 118.19 25.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.51 125.84 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.009 1.324 . . . . 0.0 108.793 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -92.17 123.03 35.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.58 130.15 21.36 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t 51.85 37.04 19.63 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.766 0.826 . . . . 0.0 111.201 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.0 t70 64.25 12.79 7.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.774 1.23 . . . . 0.0 113.249 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -109.82 147.35 33.46 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.52 1.128 . . . . 0.0 107.995 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.53 112.74 24.7 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.983 1.313 . . . . 0.0 107.609 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.49 162.5 17.49 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.282 1.033 . . . . 0.0 108.324 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -112.56 128.22 56.3 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.26 134.95 54.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -112.21 107.86 16.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mp -97.6 151.6 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.6 m -128.98 152.71 48.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 169.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -117.35 125.48 51.09 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -87.97 125.36 34.48 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -66.98 -45.59 77.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.818 0.847 . . . . 0.0 110.625 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.78 -43.55 88.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.098 0.559 . . . . 0.0 110.416 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.0 m -69.42 -37.28 77.37 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 60.52 49.43 6.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.457 1.503 . . . . 0.0 108.777 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.87 154.79 26.03 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.94 168.48 9.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.609 0.764 . . . . 0.0 111.928 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -163.72 139.46 6.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.772 1.229 . . . . 0.0 110.869 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 34.7 tp -63.16 122.76 16.92 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 tp -83.27 -57.45 3.26 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.12 152.25 37.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.29 0.636 . . . . 0.0 109.472 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -117.05 134.85 54.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 168.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -134.67 149.36 50.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 130.7 -166.52 22.47 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.35 -0.695 . . . . 0.0 112.061 171.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 0 N--CA 1.456 -0.73 0 C-N-CA 124.752 -0.937 . . . . 0.0 110.045 -1.939 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 mp -88.82 139.12 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.95 161.1 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 123.811 0.845 . . . . 0.0 110.517 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.01 135.63 41.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.667 0.787 . . . . 0.0 110.357 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.59 124.87 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 167.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.05 -167.5 30.6 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -56.76 -44.02 49.12 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.933 2.422 . . . . 0.0 111.602 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -53.94 -52.76 59.59 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.167 0.984 . . . . 0.0 111.043 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -45.37 93.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.19 0.996 . . . . 0.0 109.767 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -60.42 -41.33 93.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.306 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -56.7 -49.86 73.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.012 0.824 . . . . 0.0 110.42 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 mt -57.48 -45.55 84.74 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.805 175.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.11 -46.55 62.01 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -60.0 -51.77 68.23 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -51.85 -47.16 64.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.054 0.541 . . . . 0.0 111.06 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.03 -50.16 74.38 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.317 0.58 . . . . 0.0 110.326 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.7 -40.75 90.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.098 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.49 -46.87 85.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.219 0.608 . . . . 0.0 110.058 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.91 -54.02 51.32 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.264 1.026 . . . . 0.0 109.041 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -57.29 -48.0 80.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.637 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -57.6 -45.12 85.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.35 1.06 . . . . 0.0 110.094 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.76 -41.37 86.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.569 0.348 . . . . 0.0 110.37 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.3 mt -72.24 -45.38 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.89 15.56 48.53 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.976 1.274 . . . . 0.0 112.838 174.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -53.79 -42.94 68.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.351 1.076 . . . . 0.0 111.963 -175.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.77 33.0 4.46 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.955 0.902 . . . . 0.0 109.707 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.44 -142.07 47.58 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -106.47 120.09 41.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.517 1.127 . . . . 0.0 109.213 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mt -106.73 168.78 8.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.364 1.065 . . . . 0.0 108.546 170.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.2 m -120.67 103.83 9.43 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -46.23 130.09 10.34 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.713 0.233 . . . . 0.0 110.989 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -106.49 -66.87 0.97 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -167.4 -169.39 1.22 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.293 0.637 . . . . 0.0 109.996 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.51 146.4 34.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 125.594 1.557 . . . . 0.0 106.809 174.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.55 166.57 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.358 0.599 . . . . 0.0 110.631 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.33 158.58 81.46 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 125.48 1.512 . . . . 0.0 111.94 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -67.63 148.33 80.79 Favored 'Cis proline' 0 N--CA 1.456 -0.688 0 CA-C-N 118.861 0.629 . . . . 0.0 111.168 -8.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 71.6 m -131.41 94.32 3.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.86 128.55 55.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.721 0.808 . . . . 0.0 109.809 -168.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -104.85 140.8 37.59 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.642 1.177 . . . . 0.0 109.186 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -133.83 152.02 51.73 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.453 1.101 . . . . 0.0 108.969 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 m -82.86 136.93 34.46 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.505 1.122 . . . . 0.0 109.844 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.16 131.87 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.262 1.425 . . . . 0.0 108.771 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.4 p90 . . . . . 0 N--CA 1.448 -0.554 0 C-N-CA 123.33 0.652 . . . . 0.0 109.857 -167.932 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.1 mt . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -81.56 -33.43 31.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.049 0.54 . . . . 0.0 110.792 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.23 -161.74 24.05 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.201 -1.0 . . . . 0.0 112.116 -170.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -147.68 159.6 43.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -121.87 149.19 43.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.978 1.311 . . . . 0.0 108.459 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -132.61 107.76 8.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -97.27 118.18 33.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -146.37 158.71 43.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.808 0.443 . . . . 0.0 111.133 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.99 112.55 24.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.524 0.73 . . . . 0.0 109.579 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -99.88 133.0 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 109.617 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.08 122.36 35.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.441 1.496 . . . . 0.0 107.521 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.6 127.15 28.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.812 0.845 . . . . 0.0 109.395 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t 70.74 -64.17 0.38 Allowed 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 129.593 3.157 . . . . 0.0 108.432 -169.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 179.72 11.09 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.518 3.127 . . . . 0.0 111.207 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -119.55 149.29 42.17 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.923 1.289 . . . . 0.0 107.832 -174.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 tp -106.79 120.98 43.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.45 0.7 . . . . 0.0 109.759 -169.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.4 137.93 54.7 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.738 1.215 . . . . 0.0 108.364 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -94.69 115.82 28.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.25 135.5 54.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.188 0.995 . . . . 0.0 109.559 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.58 103.67 14.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.531 1.132 . . . . 0.0 108.208 169.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 mm -91.26 161.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.86 1.664 . . . . 0.0 106.9 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.6 p -145.6 167.57 22.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.65 0.659 . . . . 0.0 111.438 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -136.52 131.24 33.65 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.553 1.941 . . . . 0.0 108.277 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -98.37 107.86 20.42 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 169.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -53.03 -37.48 61.58 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 124.439 1.096 . . . . 0.0 111.194 -173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -43.07 -40.55 3.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.414 1.886 . . . . 0.0 112.464 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 m -121.54 0.52 9.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.798 0.439 . . . . 0.0 110.99 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 52.77 28.78 6.71 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.686 0.795 . . . . 0.0 109.126 -165.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.99 128.13 9.3 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -168.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -105.88 170.04 8.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.567 0.699 . . . . 0.0 112.36 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -177.58 161.57 1.71 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.044 1.737 . . . . 0.0 112.35 -166.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.1 tp -89.84 138.18 31.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.3 1.44 . . . . 0.0 108.88 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.9 mt -104.47 -58.24 1.91 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.628 0.649 . . . . 0.0 110.245 169.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -136.2 150.56 49.06 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -143.77 106.33 4.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -115.39 147.84 40.05 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.68 -167.5 27.09 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.504 -0.609 . . . . 0.0 111.925 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 N--CA 1.455 -0.739 0 C-N-CA 124.373 -1.095 . . . . 0.0 110.002 -2.573 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mp -99.2 139.38 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.3 pt -103.02 154.23 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 123.842 0.857 . . . . 0.0 109.66 171.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.46 134.21 42.33 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.8 pt -62.27 141.36 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 165.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.66 -169.35 34.5 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -168.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.41 -48.77 17.48 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.427 2.751 . . . . 0.0 112.769 -169.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.37 -55.0 24.54 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.124 0.964 . . . . 0.0 111.066 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -67.37 -44.27 79.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.215 1.006 . . . . 0.0 110.018 -172.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -56.4 -49.25 75.04 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 118.93 -0.557 . . . . 0.0 109.882 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -56.31 -46.47 79.82 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.624 0.647 . . . . 0.0 110.928 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 mt -55.95 -51.87 66.13 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 117.894 0.315 . . . . 0.0 110.515 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.58 -45.07 90.63 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -59.81 -52.12 66.82 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -49.94 -48.48 51.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.731 1.212 . . . . 0.0 110.201 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.58 72.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.49 -39.95 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.776 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.94 -48.75 80.38 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.378 0.671 . . . . 0.0 109.938 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.74 -52.82 63.88 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.077 0.951 . . . . 0.0 109.152 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -54.08 -46.65 72.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.485 1.114 . . . . 0.0 110.315 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -69.65 -42.02 74.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.554 1.542 . . . . 0.0 110.518 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.55 -47.77 84.24 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.321 0.648 . . . . 0.0 109.718 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.32 -41.74 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.8 18.43 51.27 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.633 1.111 . . . . 0.0 112.26 173.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -55.6 -40.81 72.54 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.974 0.887 . . . . 0.0 111.091 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -111.75 33.29 4.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.208 1.003 . . . . 0.0 109.976 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.03 -140.09 45.23 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.91 108.3 19.89 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.538 0.735 . . . . 0.0 109.65 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.8 mt -93.85 141.66 28.26 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 167.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 m -100.74 95.34 6.59 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.227 1.011 . . . . 0.0 108.346 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -51.21 133.82 27.99 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.179 0.592 . . . . 0.0 111.448 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -100.27 -67.41 0.85 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -169.57 -159.5 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.444 1.098 . . . . 0.0 108.533 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.12 141.68 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.15 174.7 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.023 0.529 . . . . 0.0 110.884 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -63.49 153.57 82.36 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.095 1.358 . . . . 0.0 112.889 -170.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.11 159.14 97.18 Favored 'Cis proline' 0 N--CA 1.449 -1.094 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 -7.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -133.91 87.24 2.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.49 140.15 48.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.896 0.878 . . . . 0.0 109.421 -167.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -122.12 162.13 21.84 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.197 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -138.45 147.52 43.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.852 1.661 . . . . 0.0 108.488 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -83.6 130.49 34.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.226 1.01 . . . . 0.0 110.089 172.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.44 120.87 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.665 1.186 . . . . 0.0 108.856 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 p90 . . . . . 0 N--CA 1.455 -0.214 0 O-C-N 121.394 -0.816 . . . . 0.0 111.272 -173.78 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 -20.68 12.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 123.496 0.497 . . . . 0.0 111.069 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.94 -168.59 32.04 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.817 0.735 . . . . 0.0 112.59 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -142.9 157.8 44.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -130.72 145.26 51.9 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.973 1.309 . . . . 0.0 108.353 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -136.86 119.38 15.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.4 1.48 . . . . 0.0 107.878 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -107.86 126.1 52.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.866 1.267 . . . . 0.0 108.291 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pp -145.99 147.96 32.23 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.421 0.288 . . . . 0.0 110.269 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.2 99.48 11.97 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -83.17 134.07 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -102.22 122.78 44.85 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.39 136.04 25.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.77 37.66 24.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.457 1.103 . . . . 0.0 110.89 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 t70 56.63 28.84 14.66 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.987 1.315 . . . . 0.0 112.335 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -130.2 149.17 52.02 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.75 1.22 . . . . 0.0 108.218 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.7 tp -101.9 127.0 48.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.789 0.836 . . . . 0.0 109.637 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.24 136.9 50.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.861 1.264 . . . . 0.0 108.765 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -83.81 115.15 22.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.47 135.24 40.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -116.02 115.11 25.55 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.81 151.44 14.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.41 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.8 t -133.07 156.08 48.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.59 0.632 . . . . 0.0 109.574 169.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.05 131.34 52.18 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.322 1.849 . . . . 0.0 106.867 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -97.6 115.7 28.39 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -50.94 -48.33 60.85 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.647 1.579 . . . . 0.0 111.813 -168.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.26 -30.41 71.28 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.703 0.801 . . . . 0.0 110.972 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.4 m -84.13 -33.59 24.25 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 49.36 44.33 23.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.5 1.12 . . . . 0.0 109.759 -167.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.11 150.8 22.66 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.1 mtt85 -111.39 169.31 8.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.395 0.617 . . . . 0.0 112.271 -170.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.07 145.82 23.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.189 174.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.4 tp -71.83 138.05 48.01 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.755 0.822 . . . . 0.0 108.904 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.63 -57.05 2.4 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.934 0.894 . . . . 0.0 108.75 168.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.39 160.1 43.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.835 0.35 . . . . 0.0 110.959 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -136.25 92.24 2.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.63 1.972 . . . . 0.0 106.494 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.88 145.56 25.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.51 -167.88 24.35 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo . . . . . 0 N--CA 1.456 -0.701 0 CA-C-N 118.644 1.222 . . . . 0.0 110.588 0.096 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.27 143.57 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.9 pt -120.91 158.49 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.718 0.807 . . . . 0.0 110.373 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.16 140.78 58.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.919 0.888 . . . . 0.0 109.856 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -92.7 121.45 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.426 1.09 . . . . 0.0 108.425 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.48 -169.54 33.71 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -51.16 -45.97 33.77 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.723 2.948 . . . . 0.0 112.75 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -49.22 -55.28 13.06 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.114 0.959 . . . . 0.0 111.043 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -41.3 90.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.663 1.185 . . . . 0.0 110.591 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -56.67 -44.71 81.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.979 0.912 . . . . 0.0 109.55 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -51.8 -52.76 46.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.889 0.768 . . . . 0.0 110.75 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.47 -46.19 89.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 110.537 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.97 -42.2 86.23 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -64.7 -50.13 68.16 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -50.91 -46.15 60.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.12 0.968 . . . . 0.0 110.996 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.06 -53.05 62.68 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.793 0.806 . . . . 0.0 110.398 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.9 t -63.78 -36.57 77.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.678 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.02 -47.16 84.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.201 1.0 . . . . 0.0 110.091 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.97 -50.87 67.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.69 -41.71 95.67 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 121.635 -0.665 . . . . 0.0 111.383 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -56.42 -42.85 78.7 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.34 -39.97 96.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.312 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.7 mm -62.54 -46.27 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.16 0.891 . . . . 0.0 109.376 174.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.13 3.91 85.65 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.137 1.351 . . . . 0.0 112.78 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -29.12 70.04 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.071 1.436 . . . . 0.0 113.061 -171.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -110.44 27.03 10.04 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.584 0.753 . . . . 0.0 110.024 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.27 -164.07 52.44 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -95.34 107.45 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.199 1.0 . . . . 0.0 108.547 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.9 140.23 35.48 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.145 0.429 . . . . 0.0 110.776 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.6 m -85.48 103.78 14.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -49.03 128.86 16.87 Favored 'General case' 0 N--CA 1.457 -0.079 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -102.82 -64.51 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -167.8 170.64 10.63 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.341 1.056 . . . . 0.0 109.998 172.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.5 p -98.48 149.5 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.318 1.047 . . . . 0.0 108.745 169.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -138.8 170.8 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 123.374 0.67 . . . . 0.0 110.258 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -61.84 152.46 76.18 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.967 0.907 . . . . 0.0 110.421 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.35 152.31 97.49 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 CA-C-N 119.184 0.744 . . . . 0.0 110.453 -4.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 46.9 t -143.72 101.65 3.79 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 ttp -128.47 136.19 50.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.877 0.871 . . . . 0.0 110.271 -166.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -119.84 157.3 28.96 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.195 0.998 . . . . 0.0 110.846 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -146.69 146.28 30.3 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.375 1.07 . . . . 0.0 109.635 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -76.06 132.52 40.15 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.98 0.912 . . . . 0.0 109.955 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.48 116.54 51.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.281 1.433 . . . . 0.0 108.476 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.7 p90 . . . . . 0 N--CA 1.448 -0.543 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.668 -174.766 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -101.53 -34.83 9.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.33 -161.85 24.98 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -139.93 158.83 43.45 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -123.9 147.25 47.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.137 1.375 . . . . 0.0 108.363 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -135.67 111.23 9.22 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.195 1.398 . . . . 0.0 107.641 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.27 112.55 25.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.596 1.558 . . . . 0.0 107.83 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -139.81 146.42 39.4 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.689 0.796 . . . . 0.0 111.267 -171.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -99.44 115.97 30.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.064 0.945 . . . . 0.0 109.62 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 p -113.53 129.17 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.193 1.397 . . . . 0.0 110.866 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.33 118.55 26.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.749 1.22 . . . . 0.0 107.997 173.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.76 128.99 43.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 t 52.25 41.17 30.22 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.683 0.793 . . . . 0.0 111.401 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t0 51.54 32.83 9.47 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.067 1.347 . . . . 0.0 112.938 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -125.34 131.22 53.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 169.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.4 tp -89.3 128.79 35.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -125.34 152.37 44.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.001 1.321 . . . . 0.0 108.294 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -92.49 129.44 38.43 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 132.54 56.65 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.563 1.145 . . . . 0.0 108.506 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -112.01 107.47 16.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.1 mm -100.45 153.91 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 125.976 1.71 . . . . 0.0 107.961 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 t -132.34 159.96 37.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.167 0.508 . . . . 0.0 109.928 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -130.16 122.08 27.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.9 1.68 . . . . 0.0 106.483 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -83.89 119.06 24.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.403 1.081 . . . . 0.0 108.096 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -58.26 -58.3 9.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.643 0.777 . . . . 0.0 111.476 -170.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -68.94 -43.47 75.0 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.859 0.361 . . . . 0.0 110.039 -171.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.38 -30.29 70.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.565 0.746 . . . . 0.0 110.895 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 54.6 47.88 21.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.496 1.119 . . . . 0.0 110.069 -168.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -126.77 139.63 11.4 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -92.14 172.72 8.24 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.547 0.739 . . . . 0.0 110.689 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -174.94 143.18 0.7 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.853 2.061 . . . . 0.0 110.743 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.29 124.51 28.46 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 166.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.6 -59.92 2.36 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 169.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -142.75 150.42 40.04 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.178 0.591 . . . . 0.0 109.573 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -132.13 122.32 25.17 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -132.69 146.4 51.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -173.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 141.74 -165.23 26.55 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 123.578 0.609 . . . . 0.0 111.606 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 CA-C-N 118.045 0.923 . . . . 0.0 111.307 2.597 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 C--O 1.231 0.083 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 mt -77.44 138.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 125.094 1.357 . . . . 0.0 107.58 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 pt -103.2 155.98 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 123.273 0.629 . . . . 0.0 110.422 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.75 131.38 45.08 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.7 pt -73.32 154.35 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 164.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.9 -175.68 29.77 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -166.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -58.95 -45.22 29.68 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.681 2.921 . . . . 0.0 112.667 -171.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -54.29 -53.12 58.07 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 122.144 0.973 . . . . 0.0 110.943 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 m -68.31 -39.28 82.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.219 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -52.98 -56.61 14.78 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.063 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -46.71 -50.32 18.12 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.337 0.971 . . . . 0.0 110.805 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.01 -50.43 72.08 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.915 -0.491 . . . . 0.0 111.567 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.34 -25.11 62.23 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 121.661 -0.649 . . . . 0.0 112.851 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -80.59 -54.85 5.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -45.03 -45.52 10.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.757 1.623 . . . . 0.0 110.47 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.56 -53.84 51.4 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.93 0.395 . . . . 0.0 110.738 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.31 -38.97 82.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.243 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.68 -48.96 79.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.472 0.709 . . . . 0.0 109.693 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.07 -50.05 74.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.18 0.992 . . . . 0.0 108.967 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -56.29 -49.66 73.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -59.86 -41.42 91.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.285 1.434 . . . . 0.0 110.069 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -61.47 -37.72 84.63 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 119.637 -0.221 . . . . 0.0 110.676 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.73 -47.33 80.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.42 19.0 61.14 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.624 1.583 . . . . 0.0 111.719 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -56.74 -41.63 77.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.964 0.882 . . . . 0.0 110.808 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -110.82 35.21 3.59 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.951 0.901 . . . . 0.0 110.179 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.85 -154.59 43.13 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.432 0.539 . . . . 0.0 112.051 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.4 ptt85 -93.44 84.91 4.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.084 1.354 . . . . 0.0 109.834 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.11 144.04 38.77 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.932 -0.48 . . . . 0.0 110.169 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 m -100.69 96.98 7.69 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -45.9 125.57 6.38 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.879 0.471 . . . . 0.0 110.473 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.27 -64.96 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.97 169.84 3.33 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 125.005 1.322 . . . . 0.0 108.418 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 p -110.78 141.09 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 124.74 1.216 . . . . 0.0 109.297 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.79 178.72 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 123.587 0.554 . . . . 0.0 110.411 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -60.7 154.99 54.04 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.162 0.985 . . . . 0.0 111.663 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.92 155.61 93.6 Favored 'Cis proline' 0 N--CA 1.458 -0.569 0 CA-C-N 119.414 0.827 . . . . 0.0 110.717 -9.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 17.1 p -161.29 79.0 0.59 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -166.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -99.16 160.46 14.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.37 1.068 . . . . 0.0 110.936 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -140.78 149.4 42.03 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.055 1.342 . . . . 0.0 108.608 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -147.61 143.58 27.82 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.84 0.856 . . . . 0.0 110.693 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -59.76 141.39 55.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.533 1.533 . . . . 0.0 111.969 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.07 124.76 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.645 1.578 . . . . 0.0 109.23 173.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 . . . . . 0 CA--C 1.529 0.138 0 C-N-CA 125.79 1.636 . . . . 0.0 108.784 176.139 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -89.91 -37.6 14.29 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.13 -157.36 17.97 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.01 151.86 39.24 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -104.89 144.85 31.21 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.834 1.654 . . . . 0.0 107.309 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.07 139.12 51.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -141.05 99.9 3.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -170.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -122.06 138.6 54.38 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.574 1.149 . . . . 0.0 111.328 -164.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -87.34 102.27 14.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.728 0.775 . . . . 0.0 109.013 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.77 131.08 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.401 1.48 . . . . 0.0 109.378 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -98.65 124.25 43.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.227 1.411 . . . . 0.0 108.181 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.03 134.98 21.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.077 0.951 . . . . 0.0 108.897 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 t 52.46 32.62 11.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.173 0.989 . . . . 0.0 111.211 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.7 23.22 12.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.046 1.338 . . . . 0.0 113.45 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -116.75 143.66 45.39 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.434 1.494 . . . . 0.0 107.743 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.8 tp -103.5 129.15 50.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.493 0.717 . . . . 0.0 109.882 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -134.61 148.08 50.34 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 125.206 1.403 . . . . 0.0 109.902 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -94.15 110.59 22.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.711 1.204 . . . . 0.0 108.695 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.35 121.82 42.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.855 1.262 . . . . 0.0 107.903 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -108.63 121.62 45.4 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.86 153.58 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 126.448 1.899 . . . . 0.0 107.607 -175.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.1 p -123.77 146.28 48.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 126.64 51.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 168.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -96.86 119.37 35.21 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -63.92 -28.86 70.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.142 0.577 . . . . 0.0 111.047 -174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -63.56 -18.14 63.56 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.5 0.72 . . . . 0.0 112.656 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -143.75 8.57 1.51 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.307 -0.871 . . . . 0.0 111.721 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 44.8 ttt85 50.98 40.41 25.26 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.407 0.683 . . . . 0.0 110.156 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -110.21 137.85 14.52 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -109.79 164.02 12.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 117.503 0.652 . . . . 0.0 111.276 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -157.34 148.7 21.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.551 1.141 . . . . 0.0 110.963 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.19 135.04 39.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.718 1.207 . . . . 0.0 109.264 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.61 -67.11 0.8 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.31 160.27 43.84 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.255 1.022 . . . . 0.0 109.22 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -126.08 83.83 2.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.688 1.995 . . . . 0.0 106.657 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.6 145.69 26.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.87 -165.04 27.75 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.081 172.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.458 -0.586 0 CA-C-N 117.966 0.883 . . . . 0.0 111.318 2.976 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.6 mm -78.04 140.69 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -106.14 154.3 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.257 0.623 . . . . 0.0 109.961 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -73.89 124.46 26.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.5 pt -65.53 122.24 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 123.056 0.542 . . . . 0.0 109.626 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.82 -167.16 21.86 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -175.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -56.13 -41.64 74.66 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.239 2.626 . . . . 0.0 111.464 -175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -51.81 -50.01 61.66 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.889 0.875 . . . . 0.0 110.729 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.23 -49.51 71.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.948 0.899 . . . . 0.0 110.62 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -51.97 -53.26 43.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -54.91 -47.83 73.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.999 0.92 . . . . 0.0 111.423 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 mt -59.97 -48.27 82.38 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.979 0.354 . . . . 0.0 110.93 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.11 -48.61 85.27 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -54.9 -49.43 71.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.104 1.361 . . . . 0.0 110.25 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -55.87 -48.21 75.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.106 1.362 . . . . 0.0 110.52 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -49.55 74.86 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.34 -42.63 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.406 0.682 . . . . 0.0 110.783 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.25 -51.58 68.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.961 0.904 . . . . 0.0 109.664 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -58.22 -46.79 85.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.693 1.197 . . . . 0.0 109.746 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -56.16 -56.94 14.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -56.97 -38.72 73.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.578 1.151 . . . . 0.0 110.955 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -56.77 -39.21 73.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.853 0.461 . . . . 0.0 110.608 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.6 mt -83.1 -47.6 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.081 0.552 . . . . 0.0 110.235 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.25 10.83 58.02 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.556 1.55 . . . . 0.0 113.921 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -54.73 -42.64 71.8 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.035 1.417 . . . . 0.0 112.053 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -107.12 37.83 2.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.696 0.798 . . . . 0.0 110.076 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.11 -138.42 47.82 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -115.24 93.39 4.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.134 1.373 . . . . 0.0 108.837 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.3 mt -79.0 142.16 36.84 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.164 0.585 . . . . 0.0 109.575 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 t -103.84 106.92 17.58 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -59.04 133.73 56.36 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.458 0.703 . . . . 0.0 109.916 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -100.48 -64.69 1.02 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 168.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -167.61 179.03 5.06 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.356 1.062 . . . . 0.0 108.915 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.06 134.21 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.41 167.2 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 122.741 0.416 . . . . 0.0 110.335 -173.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -53.71 150.97 12.17 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.482 1.113 . . . . 0.0 111.831 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.38 142.76 72.72 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 CA-C-N 119.018 0.685 . . . . 0.0 110.701 -1.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.6 m -133.68 101.73 5.22 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 33.2 ttm -118.37 138.82 52.16 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.242 0.617 . . . . 0.0 110.491 -169.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -121.48 144.57 48.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.956 1.302 . . . . 0.0 110.132 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -146.38 149.8 34.46 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.456 0.702 . . . . 0.0 110.885 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -80.63 137.62 36.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.414 1.485 . . . . 0.0 111.365 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.53 120.74 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.79 1.236 . . . . 0.0 108.303 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.0 p90 . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 123.865 0.866 . . . . 0.0 109.275 179.291 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -119.59 -22.29 7.0 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 123.547 0.529 . . . . 0.0 111.166 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.95 -168.01 31.24 Favored Glycine 0 N--CA 1.448 -0.543 0 O-C-N 121.432 -0.792 . . . . 0.0 111.445 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -148.82 163.69 36.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.328 1.451 . . . . 0.0 107.693 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.84 148.83 52.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.688 1.195 . . . . 0.0 108.97 169.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -134.32 115.66 14.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -107.68 129.74 54.99 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.201 0.91 . . . . 0.0 109.263 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 pp -149.27 152.3 35.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.568 0.699 . . . . 0.0 111.568 -172.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CD1' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -89.02 111.34 22.03 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.537 1.535 . . . . 0.0 107.036 177.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.1 t -93.35 124.23 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 169.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.29 116.55 23.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 169.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 132.51 36.95 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.8 t 53.8 34.72 19.8 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.968 0.907 . . . . 0.0 111.708 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 t0 46.94 42.85 12.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.098 1.359 . . . . 0.0 111.064 -169.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -137.96 155.15 49.18 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.255 1.422 . . . . 0.0 107.953 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -81.74 118.11 22.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -173.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -130.07 112.63 13.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.451 1.1 . . . . 0.0 108.69 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -97.13 131.12 44.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.3 142.73 50.16 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.202 0.91 . . . . 0.0 110.204 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.9 120.68 42.25 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.226 1.01 . . . . 0.0 108.363 168.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.74 140.08 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.9 p -111.38 147.65 34.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.581 1.152 . . . . 0.0 108.108 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -126.78 134.35 50.61 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.907 1.683 . . . . 0.0 107.798 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -107.31 114.49 28.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.519 1.128 . . . . 0.0 108.846 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.28 -27.9 67.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.728 1.211 . . . . 0.0 111.365 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -58.04 -23.22 53.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.88 0.872 . . . . 0.0 112.407 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -141.14 6.07 1.93 Allowed 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.468 -0.77 . . . . 0.0 111.328 174.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 49.94 40.55 21.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.826 0.851 . . . . 0.0 110.028 -171.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.69 140.74 15.35 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 107.699 -2.161 . . . . 0.0 107.699 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -116.85 164.99 13.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.986 0.893 . . . . 0.0 110.787 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -161.2 150.69 16.79 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.842 0.857 . . . . 0.0 110.326 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.57 110.98 0.98 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.346 1.059 . . . . 0.0 108.677 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.7 tp -71.89 -48.26 46.96 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -162.56 155.57 19.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -119.32 141.5 48.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.4 131.7 40.31 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.93 -176.17 27.84 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.455 -0.761 0 CA-C-N 118.223 1.012 . . . . 0.0 110.508 -3.516 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--O 1.233 0.209 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.88 138.48 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.11 157.35 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.1 0.96 . . . . 0.0 110.475 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.52 125.39 29.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.503 0.721 . . . . 0.0 109.387 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 pt -65.13 136.32 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 165.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.11 -175.07 41.04 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -169.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.37 -46.78 31.35 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.745 2.963 . . . . 0.0 113.195 -170.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -52.13 -55.01 23.61 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.918 1.342 . . . . 0.0 110.871 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.9 m -66.73 -42.42 86.32 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.28 1.032 . . . . 0.0 110.198 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -57.03 -48.66 77.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.405 0.682 . . . . 0.0 110.078 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -54.02 -47.62 71.34 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 123.131 0.572 . . . . 0.0 110.839 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.06 -41.05 95.5 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.208 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.28 -51.63 40.95 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -51.3 -55.27 19.19 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.353 1.061 . . . . 0.0 110.185 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -51.26 -47.6 62.4 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.826 0.851 . . . . 0.0 110.447 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.35 -50.84 68.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.9 -40.87 90.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.39 -48.31 82.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.465 0.706 . . . . 0.0 110.076 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -63.09 -49.23 75.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.086 0.955 . . . . 0.0 109.698 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -54.74 -46.64 74.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -63.46 -44.94 93.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.635 1.574 . . . . 0.0 110.12 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -56.03 -46.0 78.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.55 0.74 . . . . 0.0 110.022 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -68.9 -47.56 75.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.98 14.9 55.65 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.219 1.39 . . . . 0.0 113.211 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -50.87 -44.46 59.65 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.621 1.21 . . . . 0.0 111.44 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -113.34 38.07 2.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.881 0.873 . . . . 0.0 109.984 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.4 -141.23 47.5 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -111.83 114.93 28.19 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.776 1.231 . . . . 0.0 109.344 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.3 152.25 21.76 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.351 0.66 . . . . 0.0 111.005 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.4 m -92.87 100.1 12.63 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -49.53 130.61 20.54 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -101.53 -63.63 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -171.58 -166.67 0.46 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.007 0.923 . . . . 0.0 109.122 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.53 144.81 35.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.11 165.34 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.544 0.611 . . . . 0.0 110.417 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -63.96 151.18 90.18 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.078 0.951 . . . . 0.0 111.4 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.1 151.47 96.82 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 119.268 0.774 . . . . 0.0 111.572 0.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.4 m -139.89 94.81 2.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.4 mtt -108.33 157.81 18.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.998 0.919 . . . . 0.0 110.673 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -131.96 154.44 49.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.031 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -130.04 151.9 50.08 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.148 2.179 . . . . 0.0 107.815 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.2 m -98.74 133.64 42.78 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.039 0.936 . . . . 0.0 109.319 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.58 128.19 62.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 125.006 1.323 . . . . 0.0 110.501 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.8 p90 . . . . . 0 N--CA 1.443 -0.783 0 C-N-CA 125.553 1.541 . . . . 0.0 107.607 -179.987 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -127.94 -34.71 2.12 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.207 0.603 . . . . 0.0 112.09 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.91 -164.43 28.99 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.02 -1.086 . . . . 0.0 111.862 -170.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -145.02 160.71 40.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.613 1.165 . . . . 0.0 108.027 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -126.41 144.1 50.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.532 1.533 . . . . 0.0 107.579 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -129.95 124.15 32.38 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -113.33 117.75 32.68 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.782 1.633 . . . . 0.0 106.723 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 pp -152.18 153.99 34.93 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.272 0.487 . . . . 0.0 111.535 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -96.1 104.58 16.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.232 1.013 . . . . 0.0 109.348 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.39 130.72 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.374 1.869 . . . . 0.0 108.571 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.57 120.12 39.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.809 1.244 . . . . 0.0 107.674 173.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.7 131.12 20.99 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.275 1.03 . . . . 0.0 108.81 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.43 39.22 29.62 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.18 0.992 . . . . 0.0 110.974 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.9 t0 45.95 37.5 3.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.081 1.352 . . . . 0.0 113.005 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -125.72 139.01 53.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 168.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.4 tp -98.54 126.9 44.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -124.89 140.4 52.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.679 1.592 . . . . 0.0 107.965 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -88.8 123.59 33.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.27 146.82 44.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.662 0.785 . . . . 0.0 109.158 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.58 124.5 43.64 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 mm -112.34 150.17 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 127.006 2.123 . . . . 0.0 107.05 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -120.86 148.91 43.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.599 1.16 . . . . 0.0 108.403 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -122.24 127.25 49.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.393 1.877 . . . . 0.0 106.63 169.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -102.78 119.22 38.45 Favored 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -66.45 -23.07 66.22 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -63.85 -55.56 21.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.103 0.865 . . . . 0.0 110.495 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.4 p -79.84 -26.84 40.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 68.31 13.96 9.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.053 1.341 . . . . 0.0 109.023 -164.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.02 155.09 34.43 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -115.51 171.92 7.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.948 0.499 . . . . 0.0 110.626 176.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.26 157.53 30.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.698 174.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 tp -78.5 119.2 21.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.1 tp -82.67 -59.78 2.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -144.84 154.35 42.57 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.065 0.946 . . . . 0.0 109.563 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -144.73 102.33 3.78 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.926 1.69 . . . . 0.0 106.838 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -117.11 142.27 47.21 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -172.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.74 -165.96 27.92 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.614 -0.548 . . . . 0.0 112.158 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.458 -0.588 0 CA-C-N 118.006 0.903 . . . . 0.0 111.237 2.137 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 C--O 1.232 0.167 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.53 139.99 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.043 1.337 . . . . 0.0 108.662 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.5 pt -104.25 156.74 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.481 1.113 . . . . 0.0 109.865 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.51 118.13 18.86 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.4 pt -55.56 133.47 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 166.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.4 -169.32 42.44 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -52.17 -44.08 48.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.628 2.885 . . . . 0.0 112.676 -172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -53.15 -57.13 11.52 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.554 0.692 . . . . 0.0 111.463 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.97 -45.07 94.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.507 0.723 . . . . 0.0 109.974 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -55.85 -48.83 74.83 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.492 0.717 . . . . 0.0 109.22 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -55.08 -51.81 65.2 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.322 0.649 . . . . 0.0 110.608 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.23 -45.23 91.69 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.675 -0.64 . . . . 0.0 111.642 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.98 -39.93 92.58 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -64.74 -52.33 57.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -50.98 -45.29 60.93 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.582 1.153 . . . . 0.0 110.849 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.1 70.67 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.0 -41.68 93.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.019 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.0 -48.81 77.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.236 0.614 . . . . 0.0 109.458 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.24 -52.77 63.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.575 1.15 . . . . 0.0 109.36 175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -57.71 -45.01 86.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 122.997 0.519 . . . . 0.0 110.365 -174.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -67.57 -43.77 79.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.786 1.634 . . . . 0.0 110.633 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.35 -44.48 96.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.9 0.48 . . . . 0.0 110.048 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.2 -43.67 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.47 12.94 57.82 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.444 1.021 . . . . 0.0 112.741 173.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -47.99 -46.08 32.34 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.246 1.023 . . . . 0.0 111.868 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -111.16 24.02 13.39 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.524 1.13 . . . . 0.0 110.798 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.33 -158.44 26.75 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -81.11 89.86 6.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.4 0.68 . . . . 0.0 110.796 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.6 140.52 48.09 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 169.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.5 m -95.56 93.84 7.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -48.67 129.37 16.5 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.689 0.222 . . . . 0.0 110.71 177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -102.82 -62.05 1.32 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -174.16 -161.36 0.12 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.057 1.343 . . . . 0.0 108.741 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.37 145.19 34.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.43 162.7 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 118.353 0.524 . . . . 0.0 110.388 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 151.32 67.38 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.77 1.228 . . . . 0.0 111.22 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.8 130.99 21.9 Favored 'Cis proline' 0 C--N 1.348 0.545 0 CA-C-N 120.035 1.048 . . . . 0.0 112.353 4.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 96.3 m -125.39 99.93 6.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 96.5 mtp -115.28 160.05 20.26 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.689 0.796 . . . . 0.0 110.902 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -133.94 158.48 43.37 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 167.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -150.58 173.16 14.43 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.9 m -98.27 135.18 40.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.531 1.132 . . . . 0.0 112.041 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.19 136.71 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.286 1.834 . . . . 0.0 108.705 171.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.5 p90 . . . . . 0 N--CA 1.436 -1.14 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -170.825 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -108.56 -22.37 12.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.749 0.82 . . . . 0.0 110.539 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.54 -162.39 28.55 Favored Glycine 0 C--N 1.336 0.566 0 O-C-N 121.408 -0.807 . . . . 0.0 111.479 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -142.59 155.14 44.94 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.118 1.367 . . . . 0.0 107.679 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -108.59 150.16 27.88 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -129.2 120.95 26.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -104.05 128.51 51.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 pp -151.88 153.02 33.34 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.814 0.734 . . . . 0.0 111.519 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -96.73 99.81 11.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.264 1.026 . . . . 0.0 108.7 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.77 135.46 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.9 113.09 26.43 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.01 132.48 23.55 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 123.568 0.747 . . . . 0.0 109.31 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 m 51.08 36.3 15.1 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.759 1.223 . . . . 0.0 111.185 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 56.12 30.87 17.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.272 1.029 . . . . 0.0 112.726 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.5 150.32 42.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 168.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mp -92.59 128.53 38.48 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.939 1.296 . . . . 0.0 108.452 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -127.05 132.04 50.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.27 1.028 . . . . 0.0 108.283 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 112.31 21.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.41 139.55 42.98 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -114.15 123.6 50.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mm -112.46 149.88 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.501 1.92 . . . . 0.0 105.907 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.9 t -117.7 150.37 39.18 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.94 113.47 15.24 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 127.363 2.265 . . . . 0.0 105.585 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -82.28 118.76 23.37 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -58.28 -52.3 66.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.302 1.441 . . . . 0.0 111.502 -171.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.17 -45.02 71.03 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 m -72.19 -29.78 64.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.45 0.3 . . . . 0.0 110.591 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 55.35 49.01 17.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.405 1.082 . . . . 0.0 109.53 -168.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -133.58 140.61 11.95 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.78 172.8 6.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.583 0.753 . . . . 0.0 111.187 -174.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -167.63 142.51 3.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.226 1.011 . . . . 0.0 111.056 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.63 121.84 17.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.7 tp -84.6 -45.43 12.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -162.49 143.93 10.42 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.069 0.547 . . . . 0.0 110.24 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -125.82 111.9 15.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.838 1.655 . . . . 0.0 107.197 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -116.9 151.23 37.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.0 -170.79 22.72 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.622 1.106 . . . . 0.0 110.491 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 N--CA 1.455 -0.762 0 CA-C-N 118.324 1.062 . . . . 0.0 110.702 1.826 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.233 0.215 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.46 138.46 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.9 pt -106.35 155.41 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.014 0.926 . . . . 0.0 110.18 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.56 140.78 58.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.32 120.61 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.01 -167.43 33.59 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -174.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -52.99 -43.78 54.17 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.515 2.81 . . . . 0.0 113.326 -172.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -51.12 -55.99 14.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.481 1.134 . . . . 0.0 111.159 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.33 -42.87 96.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.757 1.223 . . . . 0.0 109.797 -175.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -56.69 -48.22 78.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.888 0.875 . . . . 0.0 109.408 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -56.57 -49.24 75.46 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.03 0.532 . . . . 0.0 110.921 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.08 -45.9 82.96 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 117.846 0.293 . . . . 0.0 110.997 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.69 -53.84 40.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -52.66 -48.45 66.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.398 1.079 . . . . 0.0 110.86 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -56.4 -49.1 75.46 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.709 0.804 . . . . 0.0 110.713 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.59 78.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 110.258 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.93 -47.64 85.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.374 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.1 -48.55 81.14 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.727 1.211 . . . . 0.0 110.06 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -65.14 -43.61 91.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.659 0.783 . . . . 0.0 109.902 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -58.99 -48.66 80.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.419 171.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -54.52 -39.9 68.06 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.399 1.08 . . . . 0.0 110.276 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -49.43 -37.79 26.95 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.0 0.92 . . . . 0.0 111.141 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.14 -47.43 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.228 1.011 . . . . 0.0 109.355 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.0 28.35 23.57 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.32 0.962 . . . . 0.0 111.19 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -55.99 -38.26 70.2 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.502 0.651 . . . . 0.0 111.39 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -117.59 42.76 2.53 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.838 0.828 . . . . 0.0 109.825 170.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.72 -148.1 39.28 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -102.6 115.18 30.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.809 0.844 . . . . 0.0 109.623 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 mp -110.62 137.0 48.86 Favored 'General case' 0 N--CA 1.458 -0.046 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.2 m -86.07 131.47 34.26 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -60.04 135.51 57.73 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -105.76 -64.01 1.19 Allowed 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -165.41 161.32 18.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.19 0.596 . . . . 0.0 109.637 -173.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.93 144.41 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 125.429 1.491 . . . . 0.0 107.594 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.16 159.99 9.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 123.011 0.524 . . . . 0.0 110.187 -176.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -61.39 152.89 71.61 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.831 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.43 153.79 98.71 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 CA-C-N 119.294 0.783 . . . . 0.0 111.08 -4.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.9 m -141.13 100.6 3.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.3 mtt -113.24 155.0 25.85 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.28 1.032 . . . . 0.0 110.704 -174.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -138.38 154.7 48.92 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 167.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -150.15 160.05 43.96 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.396 1.079 . . . . 0.0 110.981 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.9 m -84.06 139.55 32.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.741 1.216 . . . . 0.0 112.851 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.07 137.05 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.756 1.622 . . . . 0.0 109.712 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.1 p90 . . . . . 0 CA--C 1.531 0.25 0 C-N-CA 123.23 0.612 . . . . 0.0 111.737 -167.246 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -112.69 -27.51 8.15 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.352 0.661 . . . . 0.0 111.458 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.11 -160.48 24.57 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.08 163.57 33.17 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.795 1.238 . . . . 0.0 108.356 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.57 145.76 48.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.492 1.517 . . . . 0.0 107.972 168.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -121.3 140.37 52.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -136.78 114.2 10.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.66 163.17 39.18 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.289 0.236 . . . . 0.0 110.711 -169.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -103.16 139.21 38.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 123.728 0.811 . . . . 0.0 110.345 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.48 137.4 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.421 1.488 . . . . 0.0 108.037 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.38 124.17 38.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 168.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.45 121.08 23.95 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.476 1.11 . . . . 0.0 109.554 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t 71.87 -63.31 0.43 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 129.318 3.047 . . . . 0.0 108.588 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -173.22 10.8 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.965 2.906 . . . . 0.0 111.064 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -113.77 130.75 56.4 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 119.432 1.014 . . . . 0.0 108.828 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 tt -87.96 123.49 32.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.775 1.23 . . . . 0.0 108.116 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -133.3 159.23 40.85 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.81 0.844 . . . . 0.0 110.035 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -91.35 136.59 33.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.692 0.797 . . . . 0.0 108.957 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.57 135.26 53.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.94 130.5 56.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 169.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.81 136.73 58.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 125.513 1.525 . . . . 0.0 106.89 -173.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.3 p -103.4 151.32 22.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.437 0.695 . . . . 0.0 109.295 171.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -126.62 119.6 27.45 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 126.802 2.041 . . . . 0.0 106.857 173.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.45 118.82 30.89 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -60.57 -46.47 90.1 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.081 0.953 . . . . 0.0 111.446 -171.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -63.74 -49.5 72.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.902 0.481 . . . . 0.0 111.542 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.8 m -71.27 -30.25 66.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.8 ttm-85 58.04 41.9 23.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.538 1.135 . . . . 0.0 109.056 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -131.23 150.76 19.5 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -120.35 167.72 12.03 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.539 0.735 . . . . 0.0 109.705 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.09 147.68 19.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 169.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.0 tp -57.33 109.9 0.76 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.295 1.438 . . . . 0.0 108.147 170.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.92 -54.53 8.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.78 156.78 42.42 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.598 0.759 . . . . 0.0 109.541 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -120.98 127.36 51.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 168.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -137.19 155.43 49.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.91 -159.57 21.5 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -169.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo . . . . . 0 N--CA 1.457 -0.674 0 CA-C-N 119.099 1.45 . . . . 0.0 112.07 2.99 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mp -78.26 140.26 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 pt -113.82 156.24 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.072 0.949 . . . . 0.0 109.673 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.3 167.44 18.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.807 0.813 . . . . 0.0 109.773 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pp -100.44 164.21 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 164.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.46 -174.12 23.54 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -169.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.05 -43.19 50.34 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.847 3.031 . . . . 0.0 112.382 -173.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -51.22 -58.11 7.02 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.019 0.914 . . . . 0.0 110.871 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.14 -41.18 86.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.665 -171.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -53.71 -53.79 47.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.643 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -51.68 -50.31 60.68 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.771 0.714 . . . . 0.0 110.712 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.22 -49.92 74.48 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.032 -0.418 . . . . 0.0 110.877 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.0 -34.23 71.7 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 122.142 -0.349 . . . . 0.0 112.257 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -73.06 -48.18 38.28 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -51.58 -47.19 63.6 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.279 1.031 . . . . 0.0 110.554 169.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.97 -53.33 59.3 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.093 0.473 . . . . 0.0 110.052 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.36 -40.08 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.771 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.72 -48.11 83.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.436 -0.79 . . . . 0.0 109.666 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -58.81 -50.27 74.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.282 1.033 . . . . 0.0 109.516 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -53.78 -44.94 70.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.278 0.631 . . . . 0.0 110.778 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -69.98 -39.69 75.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.554 1.542 . . . . 0.0 110.589 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -58.33 -46.03 86.99 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.86 -43.77 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.41 24.59 33.3 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.243 1.401 . . . . 0.0 110.282 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -57.85 -35.33 70.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.519 0.728 . . . . 0.0 111.47 -169.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -129.27 45.43 2.8 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.17 -140.11 46.44 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 86.33 2.97 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.066 1.346 . . . . 0.0 109.219 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.94 138.1 37.02 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.494 -0.754 . . . . 0.0 110.124 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 m -96.61 95.55 8.04 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -45.67 131.45 8.96 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 123.245 0.618 . . . . 0.0 110.234 173.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -102.0 -66.12 0.94 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -173.36 154.16 2.57 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.93 0.892 . . . . 0.0 110.546 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.79 144.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 168.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.97 156.92 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.815 0.846 . . . . 0.0 110.144 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.9 ptt85 -63.42 153.01 83.96 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.708 1.203 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.11 154.72 98.36 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 CA-C-N 119.443 0.837 . . . . 0.0 111.268 -5.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 89.9 m -137.66 131.04 30.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 mtp -135.82 158.08 45.26 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.44 0.696 . . . . 0.0 110.965 -169.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -145.07 154.58 42.64 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.251 0.621 . . . . 0.0 111.059 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -144.47 142.09 30.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.054 0.942 . . . . 0.0 111.381 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -73.95 123.36 24.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.753 2.421 . . . . 0.0 111.395 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.61 100.91 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 122.387 1.089 . . . . 0.0 108.17 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 124.517 1.127 . . . . 0.0 110.348 174.339 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -19.44 33.85 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.612 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.71 -167.1 30.61 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.464 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -142.29 164.63 29.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.313 1.445 . . . . 0.0 108.157 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -122.49 146.22 47.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 106.725 171.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -127.42 138.85 53.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 176.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -136.86 117.64 14.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 pp -150.87 146.27 26.22 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 118.438 0.563 . . . . 0.0 111.573 -169.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -89.98 130.62 36.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.022 0.929 . . . . 0.0 109.446 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.08 135.06 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 124.336 1.054 . . . . 0.0 110.424 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -89.22 128.81 35.85 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 125.49 25.56 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 t 52.34 40.0 28.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.961 0.905 . . . . 0.0 111.105 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.1 t70 57.54 23.0 8.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.012 1.325 . . . . 0.0 113.359 -176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.78 132.08 54.5 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 169.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -91.2 124.52 35.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.818 0.847 . . . . 0.0 108.725 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.05 159.29 37.98 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.176 1.39 . . . . 0.0 109.215 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -101.08 123.11 44.74 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 167.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.83 133.85 41.78 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -122.77 124.8 44.17 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.359 1.063 . . . . 0.0 108.37 172.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.46 155.02 41.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 126.557 1.943 . . . . 0.0 106.684 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.9 m -127.79 164.94 21.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.424 0.556 . . . . 0.0 109.813 168.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.97 133.37 44.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.431 1.892 . . . . 0.0 107.595 175.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -105.21 109.11 20.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.256 1.422 . . . . 0.0 107.911 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -56.89 -31.95 65.39 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.394 1.477 . . . . 0.0 111.092 -173.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -48.86 -26.91 2.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.416 1.486 . . . . 0.0 112.928 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.1 m -144.22 17.54 1.72 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.64 0.654 . . . . 0.0 111.151 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 49.07 30.86 3.08 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.896 0.878 . . . . 0.0 110.442 -169.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.36 125.8 8.17 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -168.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -98.03 167.14 11.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.855 0.836 . . . . 0.0 112.433 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -164.53 128.22 2.5 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.035 -170.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.28 121.97 16.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.5 mp -84.33 -50.58 7.7 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 170.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -161.88 161.42 28.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.724 0.297 . . . . 0.0 110.649 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -127.79 82.34 2.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -83.33 137.85 33.79 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.18 -166.61 25.69 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo . . . . . 0 N--CA 1.457 -0.649 0 CA-C-N 118.175 0.988 . . . . 0.0 110.726 1.643 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -76.08 131.34 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.1 153.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.54 0.736 . . . . 0.0 109.626 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.49 122.65 19.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.5 pt -64.44 146.34 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.2 -177.59 32.33 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -166.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.95 -47.27 27.53 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.041 3.161 . . . . 0.0 113.352 -169.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -54.22 -54.19 43.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 122.217 1.008 . . . . 0.0 111.101 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.3 m -65.92 -41.48 91.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.438 0.695 . . . . 0.0 110.239 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -54.15 -54.69 36.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.45 169.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -50.02 -49.39 50.97 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.898 0.772 . . . . 0.0 111.004 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.79 -49.42 76.4 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.074 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.78 -27.93 62.39 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.945 -0.472 . . . . 0.0 112.762 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -79.7 -52.82 7.47 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -46.26 -45.15 17.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.386 1.475 . . . . 0.0 110.802 172.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.46 -55.64 26.91 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.517 0.675 . . . . 0.0 110.523 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.32 -39.93 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.754 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.58 -48.9 78.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.615 0.766 . . . . 0.0 109.701 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -59.94 -49.55 77.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.216 1.007 . . . . 0.0 109.24 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -54.93 -47.0 75.01 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.96 0.504 . . . . 0.0 110.732 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -65.78 -40.53 92.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.315 1.446 . . . . 0.0 110.298 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -58.07 -45.16 87.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.4 mt -69.1 -42.72 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.29 37.75 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.276 1.417 . . . . 0.0 112.167 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.69 -39.45 80.75 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.978 0.889 . . . . 0.0 111.581 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -110.84 34.83 3.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.108 0.963 . . . . 0.0 109.794 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.08 -130.42 44.63 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -119.92 84.73 2.26 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.923 1.289 . . . . 0.0 109.305 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.01 139.82 40.19 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.95 -0.469 . . . . 0.0 109.946 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.4 m -97.39 94.57 7.13 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -48.33 135.31 13.86 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 122.756 0.422 . . . . 0.0 110.204 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.86 -62.47 1.47 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.089 0.956 . . . . 0.0 109.097 176.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.15 178.3 4.46 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.551 1.14 . . . . 0.0 108.959 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.48 142.88 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.838 1.255 . . . . 0.0 109.348 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.6 171.56 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.873 0.869 . . . . 0.0 109.37 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 151.4 94.1 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.532 -175.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.33 160.97 85.88 Favored 'Cis proline' 0 C--N 1.348 0.519 0 CA-C-N 120.098 1.071 . . . . 0.0 111.649 0.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.9 p -177.0 77.52 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 -163.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.5 ttt -122.01 134.25 54.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.42 1.088 . . . . 0.0 109.225 -165.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -103.47 138.44 40.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 117.991 -1.004 . . . . 0.0 111.027 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -134.62 145.59 48.77 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.944 0.793 . . . . 0.0 111.471 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.6 m -74.46 139.02 43.62 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.884 0.473 . . . . 0.0 109.925 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.62 126.06 71.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.905 1.282 . . . . 0.0 109.257 175.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.7 p90 . . . . . 0 N--CA 1.448 -0.573 0 C-N-CA 124.009 0.924 . . . . 0.0 109.946 -178.356 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -122.44 -34.19 3.31 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.235 0.614 . . . . 0.0 111.482 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -172.35 -160.1 20.21 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.507 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -135.67 163.9 29.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.675 1.19 . . . . 0.0 108.244 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -124.59 143.54 50.64 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.664 1.585 . . . . 0.0 108.043 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -124.13 111.91 16.47 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -106.62 110.72 22.99 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.87 141.72 34.6 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.028 0.831 . . . . 0.0 112.46 -172.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -87.91 101.99 14.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.896 0.879 . . . . 0.0 109.464 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.83 125.68 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.509 1.524 . . . . 0.0 109.301 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.8 117.79 24.89 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.889 1.276 . . . . 0.0 107.988 169.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.2 127.98 36.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.581 1.152 . . . . 0.0 108.17 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 t 51.27 39.4 23.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.104 0.962 . . . . 0.0 111.322 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.0 t0 55.26 22.79 5.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.087 1.355 . . . . 0.0 113.707 -176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -111.76 135.87 51.79 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.4 tp -100.11 126.39 46.34 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -131.63 142.8 49.95 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.604 1.162 . . . . 0.0 109.674 -176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -82.69 106.9 14.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.13 0.972 . . . . 0.0 108.707 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.43 124.64 34.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -110.62 108.9 18.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.0 mp -104.64 152.72 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.5 t -125.48 152.61 44.72 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.57 131.81 54.33 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.718 1.607 . . . . 0.0 107.779 173.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.04 124.03 35.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.768 0.827 . . . . 0.0 109.519 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -66.92 -29.41 69.28 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.197 -0.939 . . . . 0.0 111.979 -172.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -58.41 8.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.45 0.7 . . . . 0.0 111.329 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.24 -14.72 22.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.324 0.65 . . . . 0.0 110.827 -173.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.3 mtm-85 54.53 41.75 31.76 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.462 1.105 . . . . 0.0 110.737 -174.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.91 158.2 14.56 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 173.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.12 165.92 12.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.673 0.736 . . . . 0.0 111.548 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -157.92 148.74 20.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.875 1.27 . . . . 0.0 110.985 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 tp -69.57 127.4 32.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.936 0.894 . . . . 0.0 109.091 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.4 -51.43 6.22 Favored 'General case' 0 C--O 1.228 -0.039 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 167.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.3 167.55 25.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 117.909 0.322 . . . . 0.0 111.502 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -133.59 86.06 2.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.678 1.591 . . . . 0.0 107.264 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.7 146.65 25.59 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.25 -164.77 28.66 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.052 -0.86 . . . . 0.0 111.101 174.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.458 -0.599 0 CA-C-N 118.155 0.978 . . . . 0.0 110.744 -0.572 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--O 1.235 0.302 0 N-CA-C 110.694 -0.113 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.6 mm -64.93 148.34 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.906 1.282 . . . . 0.0 108.801 171.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 pt -114.08 152.06 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.145 1.378 . . . . 0.0 108.852 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -82.12 125.62 31.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 pt -60.19 132.79 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 166.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.61 -176.22 44.2 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -52.1 -49.04 18.68 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.71 2.94 . . . . 0.0 113.237 -169.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -54.31 -56.06 22.21 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.153 0.978 . . . . 0.0 110.849 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -64.94 -39.27 93.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.383 1.073 . . . . 0.0 110.497 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -59.28 -46.73 87.74 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.437 0.695 . . . . 0.0 109.813 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -57.0 -46.7 82.11 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 118.592 0.633 . . . . 0.0 110.633 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.27 -46.07 83.45 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.209 -0.307 . . . . 0.0 110.64 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.49 -51.84 53.89 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.596 -0.601 . . . . 0.0 111.596 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -57.4 -48.02 80.19 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.539 1.535 . . . . 0.0 109.063 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -55.21 -47.44 75.28 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.705 1.202 . . . . 0.0 110.702 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.19 -53.4 57.64 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.672 0.749 . . . . 0.0 110.274 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.55 -39.81 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.125 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.62 -48.86 75.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.817 1.247 . . . . 0.0 109.494 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -55.99 -51.73 66.72 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.71 -46.08 88.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.111 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -59.26 -45.63 90.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.182 0.993 . . . . 0.0 109.495 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.35 -45.29 95.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.446 0.698 . . . . 0.0 110.351 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.5 mt -70.39 -43.27 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.78 14.18 55.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.726 1.155 . . . . 0.0 112.863 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -50.32 -44.43 54.21 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.232 1.016 . . . . 0.0 111.995 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.09 34.79 4.25 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.75 0.786 . . . . 0.0 110.099 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.93 -143.43 48.64 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 -100.19 124.23 45.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.292 1.037 . . . . 0.0 108.961 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.53 134.9 50.76 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.111 0.964 . . . . 0.0 110.289 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.0 m -95.59 99.02 10.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.032 1.333 . . . . 0.0 108.994 -174.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -45.41 122.83 3.73 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 122.892 0.477 . . . . 0.0 110.712 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.15 -61.0 1.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -169.52 -165.63 0.53 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.19 149.85 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 126.342 1.857 . . . . 0.0 107.327 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -142.55 160.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -66.72 154.42 91.67 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.515 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.65 141.85 72.59 Favored 'Cis proline' 0 N--CA 1.455 -0.76 0 CA-C-N 118.89 0.639 . . . . 0.0 111.322 0.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -132.91 108.87 9.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.4 ttt -133.57 143.46 48.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 119.148 0.885 . . . . 0.0 109.529 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -119.48 144.44 46.99 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.057 0.39 . . . . 0.0 111.95 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -121.37 149.53 42.83 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.2 m -80.77 137.97 36.27 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.62 132.02 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.205 1.402 . . . . 0.0 108.211 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.0 p90 . . . . . 0 N--CA 1.45 -0.445 0 O-C-N 121.448 -0.782 . . . . 0.0 110.217 -167.58 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -100.44 -25.16 14.3 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.227 0.467 . . . . 0.0 111.431 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.73 -164.49 32.17 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 118.649 0.659 . . . . 0.0 111.461 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -144.22 164.77 29.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.038 1.335 . . . . 0.0 107.561 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -127.4 145.19 50.9 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.063 0.945 . . . . 0.0 108.816 167.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.2 119.12 32.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -114.84 105.36 12.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.12 143.41 47.95 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.819 0.848 . . . . 0.0 111.191 -168.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -87.71 110.12 20.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.1 p -95.24 139.43 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.502 1.121 . . . . 0.0 108.824 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -108.38 120.81 43.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.94 132.88 22.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m 46.81 45.08 14.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.117 0.967 . . . . 0.0 111.309 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t70 63.57 10.89 5.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.105 1.362 . . . . 0.0 113.656 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -110.52 140.22 45.02 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.227 1.411 . . . . 0.0 107.94 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.1 tp -98.69 120.47 39.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.135 0.974 . . . . 0.0 109.018 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -123.18 154.28 38.92 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.961 1.304 . . . . 0.0 108.638 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -96.45 128.79 43.71 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.11 126.92 55.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.809 1.244 . . . . 0.0 107.903 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -112.64 100.92 9.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.7 mm -96.21 147.34 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.727 1.611 . . . . 0.0 107.51 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -121.44 148.43 44.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 170.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.9 120.83 34.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 127.714 2.406 . . . . 0.0 106.194 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -97.27 115.72 28.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -63.48 -45.9 88.64 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.9 1.68 . . . . 0.0 110.701 -169.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -64.68 -50.21 67.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.83 0.452 . . . . 0.0 110.082 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 m -62.9 -35.18 79.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.063 0.945 . . . . 0.0 110.15 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 55.31 48.07 20.02 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.782 2.033 . . . . 0.0 110.141 -168.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.02 155.13 22.58 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -115.61 170.23 8.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.447 0.699 . . . . 0.0 111.124 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -165.29 149.08 8.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.544 1.138 . . . . 0.0 111.183 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.73 117.2 6.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 168.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.2 tp -85.0 -54.72 4.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -142.79 155.33 44.8 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -133.05 134.2 44.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 167.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -141.68 155.42 45.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -174.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.28 -164.99 16.08 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.455 -0.739 0 CA-C-N 118.249 1.025 . . . . 0.0 110.275 1.318 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.25 141.69 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.74 157.95 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 123.837 0.855 . . . . 0.0 109.902 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.99 148.56 48.73 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.385 0.674 . . . . 0.0 109.709 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.11 137.63 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 167.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.31 -171.24 44.33 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -170.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.03 -42.72 64.54 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.635 2.89 . . . . 0.0 113.006 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -58.25 -52.88 63.74 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.087 0.946 . . . . 0.0 111.053 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 -41.38 87.87 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.74 0.816 . . . . 0.0 109.63 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -57.38 -50.77 71.92 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.577 0.751 . . . . 0.0 109.875 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -48.96 -54.9 13.59 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.262 1.025 . . . . 0.0 109.828 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 mt -55.37 -44.34 75.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.517 0.144 . . . . 0.0 111.157 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.27 -53.63 44.21 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.283 0.468 . . . . 0.0 112.31 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -55.88 -47.84 76.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.457 1.103 . . . . 0.0 109.286 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -56.85 -48.32 78.37 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.604 0.762 . . . . 0.0 110.412 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.13 -51.19 70.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.99 -37.74 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.66 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.73 -49.7 75.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.238 1.015 . . . . 0.0 109.843 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.3 -49.52 77.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.471 0.708 . . . . 0.0 109.328 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -53.38 -50.32 65.37 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -57.65 -48.32 79.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.301 1.04 . . . . 0.0 109.945 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.95 -38.95 87.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.528 0.331 . . . . 0.0 110.632 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.7 mt -73.87 -52.83 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.07 13.18 46.91 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.46 1.505 . . . . 0.0 113.701 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -53.05 -43.68 66.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.594 1.197 . . . . 0.0 112.041 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -108.24 36.42 2.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.598 0.759 . . . . 0.0 110.005 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.97 -149.63 50.59 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -111.16 76.99 1.01 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.557 1.143 . . . . 0.0 108.802 -169.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.7 139.51 45.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.776 0.43 . . . . 0.0 111.448 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m -93.42 104.3 16.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -48.98 133.53 18.02 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -106.79 -65.39 1.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.57 0.748 . . . . 0.0 109.058 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -167.11 164.43 15.77 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.689 1.196 . . . . 0.0 109.017 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.43 141.42 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.354 1.062 . . . . 0.0 108.958 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -141.24 168.49 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.369 0.668 . . . . 0.0 110.67 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.59 154.66 79.11 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.11 0.964 . . . . 0.0 110.864 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.03 137.67 50.79 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 CA-C-N 119.539 0.871 . . . . 0.0 111.746 -3.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 68.9 m -126.77 121.18 31.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.2 ttm -138.77 138.71 37.86 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.199 0.6 . . . . 0.0 109.75 -167.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -121.29 142.95 49.46 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.999 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -132.14 141.55 49.17 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.927 0.891 . . . . 0.0 110.153 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.4 m -76.23 141.21 41.81 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.362 0.265 . . . . 0.0 110.989 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -110.56 123.72 66.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 125.772 1.629 . . . . 0.0 109.19 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 125.305 1.442 . . . . 0.0 110.693 -176.393 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -99.43 -34.62 10.2 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.354 0.661 . . . . 0.0 109.936 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.6 -157.64 19.61 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -172.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -142.96 160.0 41.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -123.14 150.28 43.47 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.354 1.461 . . . . 0.0 109.05 170.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -133.81 123.59 25.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -122.21 127.9 50.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.77 158.08 38.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.94 0.4 . . . . 0.0 110.839 -174.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -96.63 112.74 24.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.998 0.919 . . . . 0.0 109.355 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 p -103.28 132.45 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 124.091 0.956 . . . . 0.0 109.543 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.72 119.95 28.56 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.84 127.6 36.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 t 53.06 39.81 30.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.58 0.752 . . . . 0.0 111.001 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.8 t0 53.45 28.1 7.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.064 1.345 . . . . 0.0 113.245 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -118.61 134.88 54.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.2 tp -89.73 128.37 36.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -129.32 139.87 51.6 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.992 1.317 . . . . 0.0 109.711 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -88.19 108.2 19.16 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.868 1.267 . . . . 0.0 108.566 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.57 134.6 48.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -123.63 125.24 44.47 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.517 1.527 . . . . 0.0 107.608 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.09 146.74 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 126.004 1.721 . . . . 0.0 108.132 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.5 161.16 15.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.912 0.885 . . . . 0.0 108.744 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.66 119.33 11.1 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -97.32 122.06 39.92 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.729 1.212 . . . . 0.0 109.837 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -58.04 -39.38 78.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.27 0.628 . . . . 0.0 112.423 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -56.48 -51.62 67.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.153 0.581 . . . . 0.0 111.039 -171.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.6 p -107.31 4.81 26.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.547 1.139 . . . . 0.0 111.555 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.9 ptt85 46.78 40.72 9.28 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.809 1.244 . . . . 0.0 110.185 -168.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.88 125.31 8.36 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.6 -167.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -78.66 175.07 10.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.617 1.167 . . . . 0.0 109.952 171.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.67 118.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.994 2.117 . . . . 0.0 113.512 -167.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.1 tp -65.82 132.1 47.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.89 -62.58 1.46 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 167.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -145.65 151.95 38.87 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.322 0.649 . . . . 0.0 109.699 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -135.46 115.12 12.8 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.39 143.12 51.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.662 0.785 . . . . 0.0 108.893 -167.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.0 -157.69 25.49 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.457 -0.624 0 CA-C-N 118.757 1.279 . . . . 0.0 110.123 -1.973 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.232 0.183 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.0 mt -72.65 132.57 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 pt -99.14 153.79 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.299 0.64 . . . . 0.0 110.7 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.92 124.45 20.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.754 0.821 . . . . 0.0 108.791 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.29 122.12 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.79 -160.47 26.98 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.44 -46.24 25.6 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.865 2.377 . . . . 0.0 112.974 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -53.07 -54.72 31.3 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.31 1.052 . . . . 0.0 111.076 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -47.46 83.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.963 1.305 . . . . 0.0 109.416 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -53.74 -49.24 68.59 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.636 0.774 . . . . 0.0 110.025 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -55.94 -49.2 74.16 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.315 0.646 . . . . 0.0 110.859 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.27 -44.41 95.36 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.779 -0.576 . . . . 0.0 111.218 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.73 -47.53 87.98 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -52.84 -54.02 40.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.929 1.292 . . . . 0.0 109.793 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -55.95 -46.22 78.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.472 1.109 . . . . 0.0 110.623 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.02 -51.69 68.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.924 0.392 . . . . 0.0 110.467 177.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.91 -39.41 85.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.57 -50.86 70.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.976 0.91 . . . . 0.0 109.479 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -56.15 -51.04 69.42 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.13 0.972 . . . . 0.0 109.286 176.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -57.04 -51.24 70.05 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -55.32 -44.22 75.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.759 1.224 . . . . 0.0 109.999 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -58.07 -42.63 85.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.894 0.478 . . . . 0.0 110.414 -177.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.1 mt -73.41 -46.69 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.42 18.83 43.93 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.386 1.47 . . . . 0.0 112.716 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -54.42 -43.09 71.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.378 1.089 . . . . 0.0 111.256 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -107.74 30.69 6.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.938 0.895 . . . . 0.0 110.473 176.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.57 -152.15 52.49 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -100.01 118.24 35.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.118 0.967 . . . . 0.0 109.227 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.28 -171.89 1.93 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.0 m -141.36 125.4 17.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -55.03 132.6 47.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -107.66 -65.31 1.12 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -175.78 4.05 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.363 0.665 . . . . 0.0 110.842 173.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 t -120.72 141.19 42.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.43 168.25 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.477 0.581 . . . . 0.0 110.254 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 147.91 71.11 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.682 0.793 . . . . 0.0 111.658 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.31 153.31 91.93 Favored 'Cis proline' 0 N--CA 1.455 -0.787 0 CA-C-N 119.085 0.709 . . . . 0.0 111.058 -1.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.8 m -142.4 87.69 2.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.8 ttt -112.43 123.5 50.43 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.149 0.58 . . . . 0.0 110.938 -167.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -100.23 136.37 40.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.09 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -122.85 153.91 38.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.227 1.811 . . . . 0.0 109.379 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.1 m -89.65 138.99 30.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.417 1.087 . . . . 0.0 110.124 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.64 122.71 62.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.944 1.297 . . . . 0.0 109.31 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 123.848 0.859 . . . . 0.0 111.227 -177.764 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.5 mt . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -91.17 -33.03 15.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.54 -148.93 9.01 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -169.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -147.54 169.06 20.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.376 1.07 . . . . 0.0 109.531 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -136.89 155.22 50.05 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.126 0.97 . . . . 0.0 110.203 167.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -133.42 118.07 17.98 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -175.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.59 107.95 16.86 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -150.34 152.63 34.71 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -169.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -99.3 116.74 32.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.272 1.029 . . . . 0.0 110.552 -173.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.48 127.8 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 126.06 1.744 . . . . 0.0 109.123 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -84.66 114.97 22.4 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 170.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.42 121.81 40.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.9 1.28 . . . . 0.0 109.016 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 t 71.15 -67.93 0.24 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 128.969 2.907 . . . . 0.0 107.058 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -178.13 26.6 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.295 2.638 . . . . 0.0 110.047 170.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -111.71 135.75 51.89 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.4 tp -86.9 124.44 33.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -120.5 145.19 47.52 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -86.28 131.11 34.3 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.27 138.95 53.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -118.45 121.84 41.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 171.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.9 mm -120.84 150.44 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.487 1.915 . . . . 0.0 106.255 -173.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t -124.48 158.16 33.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.153 0.888 . . . . 0.0 109.612 168.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.77 133.55 46.09 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 170.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -103.15 118.98 38.0 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 124.155 0.909 . . . . 0.0 108.818 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -64.7 -24.02 67.44 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.965 0.906 . . . . 0.0 112.304 -171.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -56.97 -40.92 77.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.586 0.63 . . . . 0.0 111.018 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.0 m -103.87 -16.88 15.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.576 0.751 . . . . 0.0 110.652 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 55.2 36.25 26.61 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.944 1.298 . . . . 0.0 109.646 -167.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.53 137.99 14.59 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.54 164.69 13.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.296 0.638 . . . . 0.0 111.852 -176.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.77 140.09 16.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.004 1.321 . . . . 0.0 110.56 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.3 125.07 22.64 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 170.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.54 -56.76 3.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -148.12 157.78 43.7 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.926 1.29 . . . . 0.0 109.292 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -138.07 125.15 21.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -137.65 149.49 46.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.77 -166.25 24.62 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 N--CA 1.456 -0.685 0 CA-C-N 118.23 1.015 . . . . 0.0 110.954 2.493 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.457 -0.092 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.6 mm -76.1 135.22 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.44 163.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 123.92 0.888 . . . . 0.0 109.759 174.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.01 154.85 40.33 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.788 0.804 . . . . 0.0 110.446 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -94.41 138.24 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 167.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.58 -170.53 43.66 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -55.91 -45.5 38.25 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.298 2.666 . . . . 0.0 111.907 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -53.59 -52.33 60.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.043 0.925 . . . . 0.0 110.732 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -42.67 91.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.794 0.838 . . . . 0.0 110.083 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -54.1 -51.98 62.46 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.478 -0.773 . . . . 0.0 109.752 172.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -50.48 -50.96 51.18 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.915 0.779 . . . . 0.0 110.865 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.3 mt -58.42 -49.09 78.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.96 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.91 -37.01 75.92 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 122.108 -0.37 . . . . 0.0 112.238 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -73.96 -45.37 50.64 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.24 -48.32 65.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.03 0.932 . . . . 0.0 110.876 169.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.26 -53.44 58.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.574 0.702 . . . . 0.0 110.369 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.0 t -61.42 -38.47 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.632 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.55 -48.63 76.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.924 0.89 . . . . 0.0 109.974 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.77 -49.82 72.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.996 0.918 . . . . 0.0 108.727 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.22 -44.29 95.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.376 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -62.42 -44.7 95.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.228 1.011 . . . . 0.0 109.795 175.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -58.62 -47.81 83.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.486 0.714 . . . . 0.0 109.892 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.01 -39.53 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.58 22.83 61.39 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.73 1.157 . . . . 0.0 110.474 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -60.79 -33.64 73.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 117.651 0.726 . . . . 0.0 111.312 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -116.01 32.03 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.446 1.098 . . . . 0.0 109.591 174.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.7 -151.96 46.2 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -87.56 135.0 33.53 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.136 0.575 . . . . 0.0 109.636 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.6 mt -127.99 133.42 49.17 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.132 0.973 . . . . 0.0 109.319 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.2 m -99.68 97.6 8.54 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.523 1.129 . . . . 0.0 108.321 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -50.21 132.94 24.06 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 123.466 0.706 . . . . 0.0 111.074 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -98.94 -65.11 0.98 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 168.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -172.26 167.63 5.79 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 123.451 0.7 . . . . 0.0 110.11 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.24 142.48 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 124.432 1.093 . . . . 0.0 109.09 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.98 177.0 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.281 0.632 . . . . 0.0 110.251 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -63.13 153.26 81.96 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.654 0.782 . . . . 0.0 112.716 -172.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -83.12 169.63 57.53 Favored 'Cis proline' 0 N--CA 1.45 -1.047 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 -7.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.9 t -132.97 97.8 4.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 168.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 126.78 33.61 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.47 1.508 . . . . 0.0 107.765 -174.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -114.01 113.77 25.24 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 118.093 -0.956 . . . . 0.0 108.652 168.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -114.37 141.47 47.59 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.606 1.162 . . . . 0.0 111.158 173.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.5 142.25 46.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.69 120.18 62.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.392 1.091 . . . . 0.0 109.251 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 p90 . . . . . 0 N--CA 1.444 -0.764 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -176.362 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.16 -35.38 14.58 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.31 -152.25 9.21 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -148.42 159.72 43.75 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.584 1.554 . . . . 0.0 107.818 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -126.93 142.74 51.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.147 1.779 . . . . 0.0 108.358 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -126.9 105.63 8.76 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -106.16 117.77 34.88 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 pp -149.64 146.44 27.29 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.897 0.771 . . . . 0.0 111.974 -166.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -88.51 112.69 23.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 p -106.39 138.6 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.101 0.961 . . . . 0.0 109.523 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -103.54 123.12 46.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.133 1.773 . . . . 0.0 106.966 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.45 132.09 25.57 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t 46.77 41.48 10.4 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.447 1.099 . . . . 0.0 111.331 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.4 t70 62.45 19.47 11.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.11 1.364 . . . . 0.0 113.343 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -113.94 135.15 54.31 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.809 1.243 . . . . 0.0 107.873 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.51 126.81 37.76 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.4 143.39 50.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.934 1.294 . . . . 0.0 108.748 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -85.32 110.48 19.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.55 126.69 38.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -108.0 111.23 23.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -100.59 150.74 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.9 p -127.62 154.27 45.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.47 0.708 . . . . 0.0 109.198 176.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -123.33 135.97 54.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.92 120.98 40.95 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -67.31 -33.49 75.39 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.7 -0.625 . . . . 0.0 110.703 -172.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.062 0.945 . . . . 0.0 111.209 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -90.61 -22.95 20.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.084 0.554 . . . . 0.0 110.243 175.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 65.17 33.73 9.13 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.782 1.233 . . . . 0.0 110.233 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.18 155.74 15.95 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.3 mtt85 -115.13 163.74 15.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 117.446 0.623 . . . . 0.0 111.285 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 152.39 16.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.275 1.43 . . . . 0.0 111.331 177.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 tp -69.63 127.56 33.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.634 1.174 . . . . 0.0 109.845 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.69 -54.78 5.33 Favored 'General case' 0 C--N 1.337 0.041 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -170.44 169.05 7.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 111.197 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -131.87 88.44 2.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.288 1.835 . . . . 0.0 108.166 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.65 145.7 27.86 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.65 -159.85 24.63 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 N--CA 1.458 -0.559 0 CA-C-N 118.808 1.304 . . . . 0.0 110.071 -1.993 . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.495 0 N-CA-C 112.072 -0.411 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -103.44 103.0 12.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 172.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 22.2 m95 32.34 72.8 0.07 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.007 1.723 . . . . 0.0 113.751 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -125.38 155.86 39.67 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.58 0.752 . . . . 0.0 109.536 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.4 mm -84.28 143.32 12.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 pt -104.99 154.84 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.637 0.775 . . . . 0.0 110.825 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.48 118.58 12.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.849 0.86 . . . . 0.0 109.388 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.45 129.13 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 172.41 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.01 -167.15 39.53 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -50.97 -41.73 55.1 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.711 2.941 . . . . 0.0 112.857 -174.044 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -53.85 -60.75 2.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.648 0.779 . . . . 0.0 111.64 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -63.09 -43.55 98.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.617 -0.677 . . . . 0.0 110.082 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -51.03 -53.46 33.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -53.13 -49.71 65.99 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.451 0.7 . . . . 0.0 111.34 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 mt -63.98 -45.08 90.63 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.644 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.63 -43.47 96.19 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -57.23 -53.4 58.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.034 0.934 . . . . 0.0 108.872 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -53.6 -45.04 69.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.881 1.272 . . . . 0.0 110.829 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.87 -51.88 67.33 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.908 0.385 . . . . 0.0 110.585 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.12 -39.48 84.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.468 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.01 -47.58 84.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.955 0.902 . . . . 0.0 110.195 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -58.71 -53.98 52.23 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.048 0.939 . . . . 0.0 109.095 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -54.08 -48.18 70.92 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.987 0.515 . . . . 0.0 110.116 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -60.95 -44.24 97.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.343 1.457 . . . . 0.0 110.246 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.82 -42.02 96.89 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.678 0.391 . . . . 0.0 110.108 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.3 -43.51 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.58 17.78 59.65 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.983 1.278 . . . . 0.0 111.749 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -57.93 -38.45 75.96 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.7 0.75 . . . . 0.0 111.329 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -118.81 41.72 2.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.812 1.245 . . . . 0.0 109.421 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.51 -141.9 48.03 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -118.51 106.12 12.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.611 1.165 . . . . 0.0 109.2 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.49 151.92 18.88 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.177 0.444 . . . . 0.0 110.854 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.2 m -93.27 96.13 9.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -45.27 130.85 8.14 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 122.465 0.306 . . . . 0.0 110.474 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -105.82 -66.23 1.01 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.928 0.891 . . . . 0.0 109.141 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -165.56 -175.01 3.34 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -124.62 143.02 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.45 167.05 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.097 0.559 . . . . 0.0 110.057 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.04 152.12 72.31 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 122.875 0.47 . . . . 0.0 112.088 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.33 152.01 97.69 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 CA-C-N 119.074 0.705 . . . . 0.0 111.064 -3.13 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.8 m -138.85 81.07 1.82 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.5 ttm -105.77 138.53 41.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.047 0.539 . . . . 0.0 110.684 -167.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -122.29 144.84 48.75 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.76 1.624 . . . . 0.0 109.69 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -141.11 141.75 34.18 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.061 0.944 . . . . 0.0 109.7 169.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.5 t -63.86 142.39 58.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.625 0.37 . . . . 0.0 110.311 168.323 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.05 126.11 72.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.005 1.322 . . . . 0.0 110.27 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.58 171.17 8.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.931 1.292 . . . . 0.0 110.08 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.9 -149.03 0.27 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 169.04 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.44 -46.25 0.61 Allowed 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 127.969 2.508 . . . . 0.0 112.484 -176.752 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 67.14 165.83 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.898 1.679 . . . . 0.0 110.142 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.43 -83.05 0.03 OUTLIER Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.077 1.322 . . . . 0.0 111.53 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -67.42 -36.29 80.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.393 1.077 . . . . 0.0 110.241 172.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 73.25 154.08 0.14 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.947 1.699 . . . . 0.0 110.74 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -159.6 149.65 18.73 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.662 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.3 mt -69.49 134.83 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -117.92 -33.72 4.39 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.502 0.592 . . . . 0.0 111.655 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.93 -154.02 11.09 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.206 -170.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.67 161.24 39.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.087 1.355 . . . . 0.0 108.185 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -125.0 151.1 45.98 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.482 1.113 . . . . 0.0 109.28 169.07 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -134.76 118.32 16.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.616 1.566 . . . . 0.0 107.58 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.58 111.65 24.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.775 1.23 . . . . 0.0 107.842 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 pp -138.52 154.29 48.77 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 122.791 0.437 . . . . 0.0 111.516 -172.68 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -103.07 104.55 14.73 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.214 1.006 . . . . 0.0 109.312 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.55 133.56 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.558 1.543 . . . . 0.0 110.102 -175.885 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.78 123.28 41.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.433 1.493 . . . . 0.0 108.476 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.51 130.63 26.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.4 m 50.45 40.28 22.74 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.419 1.088 . . . . 0.0 111.584 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t0 50.11 32.66 6.1 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.884 1.274 . . . . 0.0 112.972 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -119.07 129.79 55.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.3 tp -94.66 125.65 39.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -124.62 149.5 47.02 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 125.313 1.445 . . . . 0.0 108.17 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -92.15 123.64 35.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.65 133.08 54.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -107.4 122.01 45.75 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mm -113.27 146.19 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.098 1.759 . . . . 0.0 106.82 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 154.47 25.5 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -130.95 115.47 16.56 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.643 1.977 . . . . 0.0 106.669 169.221 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.93 124.42 33.12 Favored 'General case' 0 CA--C 1.526 0.03 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -58.34 -49.26 77.82 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.659 0.784 . . . . 0.0 111.063 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -68.89 -51.73 37.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.535 0.734 . . . . 0.0 110.777 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -62.86 -34.0 76.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 64.04 34.69 11.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.202 1.401 . . . . 0.0 109.933 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.33 143.71 14.68 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.11 165.31 12.89 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 122.795 0.438 . . . . 0.0 110.654 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.13 152.87 19.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.176 0.59 . . . . 0.0 111.299 170.528 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -71.67 118.64 14.76 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 mt -75.57 -50.87 14.29 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 167.869 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -156.73 160.67 39.52 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.897 0.317 . . . . 0.0 111.145 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -135.75 101.22 4.69 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.142 1.777 . . . . 0.0 107.074 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -105.8 152.29 23.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.928 0.891 . . . . 0.0 109.086 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 134.59 -168.03 23.69 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.6 149.34 79.42 Favored 'Cis proline' 0 N--CA 1.457 -0.673 0 CA-C-N 118.24 1.02 . . . . 0.0 111.167 2.966 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.99 131.92 15.78 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 124.738 1.215 . . . . 0.0 108.132 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.03 159.47 47.75 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.061 1.841 . . . . 0.0 109.99 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.01 157.14 63.09 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.156 1.904 . . . . 0.0 109.454 169.826 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 C--O 1.25 1.09 0 C-N-CA 122.534 2.156 . . . . 0.0 110.872 177.001 . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.299 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 62.43 -172.39 0.16 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -171.588 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . 0.407 ' CE3' ' HB2' ' A' ' 44' ' ' LYS . 5.0 m95 -61.41 104.48 0.41 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.39 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -153.07 155.12 36.24 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 4.7 mp -78.72 138.57 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 175.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 pt -106.46 154.32 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.322 1.049 . . . . 0.0 109.833 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.66 145.41 55.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.207 0.603 . . . . 0.0 109.814 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.2 pt -83.3 122.43 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.955 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.14 -165.23 31.6 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.41 -41.77 72.79 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.942 2.428 . . . . 0.0 112.282 -172.429 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -58.87 -49.29 78.31 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.809 0.814 . . . . 0.0 110.91 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -47.54 82.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.859 1.264 . . . . 0.0 109.688 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -54.52 -49.28 70.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.107 0.563 . . . . 0.0 110.054 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -55.92 -48.58 75.44 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.715 0.806 . . . . 0.0 110.499 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -56.15 -46.54 79.21 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.992 -0.442 . . . . 0.0 110.949 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.76 -56.32 25.77 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -51.71 -50.45 60.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.668 1.587 . . . . 0.0 109.822 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -55.08 -50.34 69.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.884 1.273 . . . . 0.0 110.75 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.29 -50.37 71.61 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.85 -39.83 86.84 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.478 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.93 -49.78 73.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.28 1.032 . . . . 0.0 109.544 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.43 -53.84 52.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.033 0.933 . . . . 0.0 108.897 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.4 -41.05 84.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.474 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -70.46 -39.46 74.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.459 1.503 . . . . 0.0 110.136 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -60.52 -45.99 91.81 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.279 0.632 . . . . 0.0 109.363 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.66 -40.47 89.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 171.683 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.05 19.88 58.47 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.44 1.495 . . . . 0.0 110.896 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -61.49 -35.7 78.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.858 0.829 . . . . 0.0 111.152 -170.225 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -118.87 39.97 3.39 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.804 0.842 . . . . 0.0 109.337 171.134 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.51 -141.29 44.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -101.92 93.72 5.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.58 1.152 . . . . 0.0 109.629 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.2 mt -80.72 139.99 35.81 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.197 0.453 . . . . 0.0 110.02 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.2 m -94.0 90.13 6.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.508 1.123 . . . . 0.0 108.49 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -51.42 132.7 29.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 122.188 -0.32 . . . . 0.0 111.458 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -104.07 -66.09 0.98 Allowed 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 123.544 0.738 . . . . 0.0 109.193 169.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -164.93 -168.59 1.48 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.151 0.58 . . . . 0.0 109.593 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.9 145.45 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.7 pt -133.62 173.42 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.351 0.66 . . . . 0.0 110.22 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 152.6 82.47 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 123.893 0.877 . . . . 0.0 110.795 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.07 151.83 96.34 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 N-CA-C 110.452 -0.634 . . . . 0.0 110.452 -5.788 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.4 m -138.9 90.36 2.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.1 ttt -111.31 138.43 47.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.406 0.682 . . . . 0.0 110.57 -169.59 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -116.23 149.78 38.59 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.642 1.177 . . . . 0.0 108.492 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . 0.407 ' HB2' ' CE3' ' A' ' 3' ' ' TRP . 1.5 tmtp? -149.49 151.29 33.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.599 0.76 . . . . 0.0 111.205 166.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 m -85.43 127.94 34.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.243 1.817 . . . . 0.0 111.586 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -99.44 136.29 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.486 1.515 . . . . 0.0 109.369 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -117.66 164.32 15.14 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.061 1.744 . . . . 0.0 109.985 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -102.51 -153.73 0.47 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.963 0.905 . . . . 0.0 109.302 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -178.43 -38.06 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.154 1.782 . . . . 0.0 110.395 -169.602 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -60.87 82.06 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.383 1.473 . . . . 0.0 110.947 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.35 63.15 1.13 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.0 t80 81.82 159.26 0.14 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.478 1.911 . . . . 0.0 110.886 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -99.01 129.67 45.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.079 0.952 . . . . 0.0 108.444 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.47 156.82 32.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.8 mt -58.3 133.64 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.63 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -115.61 -31.85 5.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.677 1.191 . . . . 0.0 110.592 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.01 -158.91 20.79 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -144.73 158.65 43.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.83 1.252 . . . . 0.0 108.217 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -114.19 153.54 29.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.211 1.404 . . . . 0.0 108.631 168.856 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -136.42 117.21 14.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -110.47 113.88 26.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 pp -146.2 146.03 30.66 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.153 0.433 . . . . 0.0 111.726 -170.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -89.18 99.74 12.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.516 0.726 . . . . 0.0 109.242 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.7 t -81.65 132.4 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.941 1.696 . . . . 0.0 109.013 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.34 114.63 29.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.489 1.516 . . . . 0.0 107.617 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.06 130.95 26.05 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.103 0.961 . . . . 0.0 108.676 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.0 t 50.67 39.23 21.17 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.461 1.104 . . . . 0.0 111.861 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.3 t0 53.25 33.93 16.55 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.316 1.046 . . . . 0.0 112.523 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -122.68 138.63 54.55 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 168.726 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.0 tp -105.32 127.08 52.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -132.76 143.93 49.92 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 125.137 1.375 . . . . 0.0 108.636 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -82.35 116.16 21.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.6 132.76 43.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -110.47 125.28 53.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.98 152.91 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 125.372 1.469 . . . . 0.0 107.28 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.7 m -119.08 149.83 41.02 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.15 0.98 . . . . 0.0 109.151 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.04 122.4 37.16 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 168.126 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.46 120.63 38.19 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.02 -53.0 62.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.203 1.001 . . . . 0.0 110.767 -170.079 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -58.62 -48.02 82.38 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.124 0.569 . . . . 0.0 110.111 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 m -71.92 -20.24 61.8 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.629 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 43.14 45.59 4.77 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 125.969 1.707 . . . . 0.0 111.091 -171.546 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -140.8 155.33 24.84 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.8 mtt85 -114.95 171.28 7.75 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.306 0.642 . . . . 0.0 110.841 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -155.35 146.95 23.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.298 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.4 tp -71.58 119.09 15.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.005 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.83 -50.91 18.17 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.632 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -168.95 156.83 7.62 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -171.346 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -133.53 89.11 2.55 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.641 1.576 . . . . 0.0 107.476 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -98.4 138.27 35.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -170.057 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.43 -167.07 32.4 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.254 -0.748 . . . . 0.0 111.473 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.55 145.9 63.92 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 CA-C-N 118.05 0.925 . . . . 0.0 111.113 2.123 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.08 127.77 15.0 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.04 164.01 36.71 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.471 2.114 . . . . 0.0 109.549 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -72.62 153.14 54.41 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.809 1.673 . . . . 0.0 109.231 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.338 2.025 . . . . 0.0 110.766 176.445 . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 54.27 49.33 18.8 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.412 1.085 . . . . 0.0 110.901 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -112.6 129.44 56.37 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -120.54 144.4 48.08 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.948 0.899 . . . . 0.0 108.868 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.6 144.19 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.6 pt -119.5 164.81 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.745 0.702 . . . . 0.0 110.377 169.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.61 141.85 51.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 110.461 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -88.54 120.52 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.2 -165.37 25.49 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -54.98 -44.56 48.51 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.196 2.597 . . . . 0.0 112.516 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -48.96 -58.44 4.87 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.232 1.015 . . . . 0.0 110.913 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -43.52 92.48 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.31 1.044 . . . . 0.0 109.808 -172.621 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -56.5 -49.84 73.55 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.354 1.062 . . . . 0.0 109.801 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -53.92 -52.18 61.4 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.395 0.543 . . . . 0.0 110.44 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -59.98 -44.58 94.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.729 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.33 -44.49 93.43 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -64.29 -50.53 67.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -50.46 -47.57 56.85 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.508 1.123 . . . . 0.0 110.914 173.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -52.83 63.78 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 110.152 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.5 -39.08 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.464 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.0 -49.65 75.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.349 0.66 . . . . 0.0 110.162 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -57.12 -50.26 73.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.84 0.856 . . . . 0.0 109.022 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -55.24 -51.23 67.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.45 0.7 . . . . 0.0 109.472 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -60.49 -40.36 91.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.536 1.135 . . . . 0.0 110.591 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -59.52 -42.65 92.71 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.6 mt -67.45 -44.22 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.57 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.91 22.74 57.23 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.041 1.305 . . . . 0.0 111.295 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.8 -38.87 86.83 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.79 0.795 . . . . 0.0 110.715 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -108.35 34.76 3.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.73 1.212 . . . . 0.0 109.978 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.52 -141.04 44.79 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -100.17 91.83 4.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.398 1.079 . . . . 0.0 109.783 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.28 173.21 10.51 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 168.957 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 m -138.25 102.49 4.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -51.94 134.26 31.79 Favored 'General case' 0 CA--C 1.524 -0.046 0 C-N-CA 122.838 0.455 . . . . 0.0 110.377 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -103.2 -63.18 1.2 Allowed 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -173.43 174.58 3.24 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.141 1.376 . . . . 0.0 108.711 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.66 150.12 14.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 124.489 1.116 . . . . 0.0 108.779 173.849 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.9 pt -138.26 168.37 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.067 0.547 . . . . 0.0 110.439 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.17 154.43 70.21 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 170.626 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.28 150.15 95.23 Favored 'Cis proline' 0 N--CA 1.458 -0.581 0 CA-C-N 119.193 0.748 . . . . 0.0 111.012 -3.36 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.1 t -140.87 102.2 4.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -121.33 141.56 50.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.708 1.203 . . . . 0.0 109.682 -166.922 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -126.56 158.77 35.34 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.792 0.837 . . . . 0.0 111.269 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -147.35 152.74 38.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.31 1.444 . . . . 0.0 108.334 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.3 m -85.04 137.69 32.9 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.709 0.803 . . . . 0.0 109.954 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.88 129.72 64.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.942 1.297 . . . . 0.0 110.196 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -115.23 168.44 9.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.697 1.599 . . . . 0.0 108.863 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -118.55 154.25 32.89 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 122.397 1.094 . . . . 0.0 108.301 166.486 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -89.06 -45.19 9.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.064 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.5 147.77 17.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.171 0.51 . . . . 0.0 110.545 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.56 -106.69 3.04 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 106.094 -2.803 . . . . 0.0 106.094 -168.744 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -170.61 73.24 0.06 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.256 1.022 . . . . 0.0 110.144 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 62.39 89.91 0.08 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.447 1.099 . . . . 0.0 111.69 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -141.89 143.7 33.44 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.423 -0.798 . . . . 0.0 110.755 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.13 129.8 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -109.18 -25.8 10.44 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.992 0.36 . . . . 0.0 110.825 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.16 -163.51 28.84 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.638 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -142.45 156.16 45.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -120.83 142.4 49.66 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.006 1.322 . . . . 0.0 107.45 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -131.02 108.35 9.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.385 1.874 . . . . 0.0 106.745 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -105.08 123.11 47.25 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.116 1.767 . . . . 0.0 108.747 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.71 164.84 36.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -104.69 113.69 27.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.165 0.986 . . . . 0.0 110.898 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.44 130.1 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.558 1.543 . . . . 0.0 108.223 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -92.77 120.44 33.15 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.28 131.95 24.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.398 1.079 . . . . 0.0 108.119 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 t 49.76 45.45 24.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.219 1.008 . . . . 0.0 110.129 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 p30 53.34 17.76 1.14 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.361 1.864 . . . . 0.0 115.459 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -116.29 151.7 35.31 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.36 127.24 42.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -127.8 136.68 51.8 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.347 1.459 . . . . 0.0 108.444 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -85.3 137.37 33.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.03 139.53 53.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -115.83 114.99 25.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 168.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.88 145.0 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 m -119.38 144.25 47.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -113.04 129.43 56.5 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.8 2.04 . . . . 0.0 107.014 170.235 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -92.49 125.56 37.18 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -58.54 -43.55 89.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.373 1.069 . . . . 0.0 111.372 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -70.66 -48.65 53.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.1 m -67.74 -31.48 71.42 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.364 0.266 . . . . 0.0 111.263 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 55.41 41.01 31.44 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.235 1.014 . . . . 0.0 109.602 -169.409 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.1 155.62 25.62 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 -114.95 171.46 7.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.407 0.683 . . . . 0.0 112.28 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -162.56 148.7 12.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.107 1.763 . . . . 0.0 110.594 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.5 tp -68.1 134.87 51.28 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.7 tp -106.33 -64.54 1.16 Allowed 'General case' 0 C--N 1.338 0.076 0 C-N-CA 123.238 0.615 . . . . 0.0 109.779 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.14 146.47 45.94 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -136.71 130.94 32.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -145.03 155.21 43.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 126.89 -164.59 20.41 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.11 155.38 84.73 Favored 'Cis proline' 0 N--CA 1.454 -0.81 0 CA-C-N 118.797 1.299 . . . . 0.0 109.91 -6.755 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.92 154.28 76.06 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 124.084 0.954 . . . . 0.0 108.752 172.284 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.21 158.36 45.23 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.312 2.008 . . . . 0.0 108.969 169.352 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.7 156.29 63.89 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.937 1.758 . . . . 0.0 109.202 169.493 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 C--O 1.251 1.127 0 C-N-CA 122.529 2.153 . . . . 0.0 110.775 175.817 . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.274 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -90.12 89.35 7.63 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.244 0.522 . . . . 0.0 111.166 -169.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -60.76 114.09 2.84 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 167.619 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -148.76 154.89 40.21 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 118.383 0.538 . . . . 0.0 109.562 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.3 mp -86.73 139.37 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.525 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.5 pt -101.04 151.35 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.403 0.681 . . . . 0.0 110.221 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -71.96 128.22 35.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.75 132.39 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 168.15 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.85 -172.34 44.58 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -53.65 -44.87 45.35 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.701 2.934 . . . . 0.0 112.677 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -50.16 -57.35 7.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.269 1.033 . . . . 0.0 110.853 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.02 -41.11 95.58 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.533 1.133 . . . . 0.0 109.81 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -58.12 -45.98 86.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.085 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -58.11 -46.8 84.94 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.6 0.637 . . . . 0.0 110.748 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.7 mt -58.22 -41.89 85.09 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.942 -0.474 . . . . 0.0 111.17 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.31 -58.31 15.23 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -44.12 -52.57 7.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.888 0.875 . . . . 0.0 111.616 172.446 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -55.59 -49.71 72.03 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.047 0.939 . . . . 0.0 110.808 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.92 69.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.73 -40.49 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.423 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.62 -50.29 71.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.09 0.956 . . . . 0.0 110.225 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -61.66 -47.49 85.13 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.138 0.975 . . . . 0.0 109.318 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -56.98 -49.8 74.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.497 0.319 . . . . 0.0 110.24 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -56.88 -43.42 81.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.464 1.106 . . . . 0.0 110.143 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -59.7 -39.92 86.17 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.2 mt -67.71 -45.53 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.48 18.03 57.65 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.174 1.369 . . . . 0.0 111.584 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -57.95 -39.88 79.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.702 0.751 . . . . 0.0 111.251 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.24 41.48 2.12 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.172 0.989 . . . . 0.0 109.62 172.656 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.17 -142.11 45.64 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -122.76 93.35 3.94 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.955 0.902 . . . . 0.0 109.079 -170.139 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp -85.53 -169.96 2.89 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.773 0.797 . . . . 0.0 109.392 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.9 m -145.23 124.74 13.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 172.161 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.57 140.07 42.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.626 0.371 . . . . 0.0 111.164 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -111.4 -64.29 1.3 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.648 0.779 . . . . 0.0 109.504 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.37 -179.92 4.16 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.097 0.959 . . . . 0.0 109.595 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.84 143.32 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.6 165.44 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.809 0.444 . . . . 0.0 110.236 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 158.53 79.54 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.113 0.965 . . . . 0.0 111.697 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.21 152.84 91.31 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 CA-C-N 119.468 0.846 . . . . 0.0 111.756 -9.197 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 76.4 m -138.79 100.25 4.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.8 ttt -118.27 142.44 47.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.321 0.648 . . . . 0.0 111.432 -167.981 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -120.97 143.12 49.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.409 2.284 . . . . 0.0 109.067 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -144.92 147.94 33.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.726 1.61 . . . . 0.0 110.123 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.49 134.66 35.56 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.778 1.631 . . . . 0.0 110.508 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -112.79 127.5 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.73 1.212 . . . . 0.0 110.816 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -106.58 163.65 12.71 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.197 1.399 . . . . 0.0 111.759 -176.942 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.81 -168.96 2.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.47 1.908 . . . . 0.0 108.717 169.236 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -168.13 -36.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.847 2.059 . . . . 0.0 110.469 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -70.88 75.17 0.63 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.515 1.126 . . . . 0.0 110.087 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.3 89.07 1.87 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 61.43 167.98 0.1 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.322 1.849 . . . . 0.0 112.075 -173.583 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -100.34 134.88 42.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 167.643 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.79 156.41 31.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.95 119.05 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -96.13 -27.91 14.83 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.59 -158.89 21.6 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -145.9 159.48 43.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.007 1.323 . . . . 0.0 107.699 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -124.57 135.58 53.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 125.599 1.559 . . . . 0.0 108.773 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.97 106.33 9.55 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.866 1.666 . . . . 0.0 107.519 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -94.53 124.11 38.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.303 1.041 . . . . 0.0 108.716 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.0 153.33 39.92 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.282 0.492 . . . . 0.0 111.023 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -95.28 105.04 16.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 123.983 0.913 . . . . 0.0 109.542 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.81 124.99 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.357 1.063 . . . . 0.0 109.729 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -79.8 117.21 20.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.28 122.86 40.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.032 1.333 . . . . 0.0 108.418 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t 72.37 -60.85 0.52 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 130.041 3.336 . . . . 0.0 108.327 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -177.1 0.23 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.757 2.823 . . . . 0.0 111.798 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -111.31 144.16 40.95 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.31 122.64 34.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.568 0.747 . . . . 0.0 109.147 -173.53 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -118.43 141.74 48.25 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 124.301 1.041 . . . . 0.0 109.179 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -86.53 104.24 15.8 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.778 1.231 . . . . 0.0 107.707 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.41 127.07 49.59 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -103.3 106.75 17.34 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.54 122.63 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.0 m -96.18 156.65 16.25 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 170.388 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -128.72 123.47 33.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.869 1.268 . . . . 0.0 107.796 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -96.08 113.02 24.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.513 1.125 . . . . 0.0 107.984 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -60.7 -27.17 67.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.172 0.589 . . . . 0.0 111.167 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -58.89 -24.66 62.55 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.607 0.763 . . . . 0.0 112.411 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.2 m -144.95 16.29 1.57 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.62 -0.675 . . . . 0.0 111.415 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 52.4 38.9 26.42 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.368 1.067 . . . . 0.0 111.021 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.58 138.31 14.88 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -102.75 167.64 9.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.724 0.762 . . . . 0.0 112.477 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.77 130.83 1.05 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.282 -168.899 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.5 tp -71.12 116.27 11.22 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.5 -56.74 3.01 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 123.352 0.661 . . . . 0.0 110.258 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -127.5 141.76 51.57 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -138.0 91.08 2.54 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -107.33 160.75 15.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -173.208 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.18 -163.97 12.13 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.63 145.69 72.03 Favored 'Cis proline' 0 N--CA 1.454 -0.817 0 CA-C-N 118.807 1.303 . . . . 0.0 110.479 3.138 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.1 m -103.26 130.19 24.08 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.11 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.78 162.25 29.87 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.993 1.796 . . . . 0.0 108.673 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.82 150.47 83.26 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.596 1.53 . . . . 0.0 109.16 169.741 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 C--O 1.251 1.144 0 C-N-CA 122.461 2.107 . . . . 0.0 110.828 178.142 . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.329 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -80.91 61.8 4.66 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.309 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 14.8 m95 53.27 98.42 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.858 2.063 . . . . 0.0 111.995 -169.664 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -143.25 154.42 43.8 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.61 -0.681 . . . . 0.0 110.733 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mt -76.55 139.87 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.8 pt -110.06 156.78 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 123.178 0.591 . . . . 0.0 110.074 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.51 131.35 48.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.916 0.887 . . . . 0.0 109.777 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.29 120.99 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.15 -165.88 29.13 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -172.623 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -54.12 -45.65 39.41 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.806 3.004 . . . . 0.0 112.649 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -47.24 -56.84 5.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.654 1.181 . . . . 0.0 110.909 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -39.94 82.46 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.153 1.381 . . . . 0.0 110.005 -174.267 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -50.76 -53.21 33.61 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.779 1.631 . . . . 0.0 109.956 170.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -54.61 -48.86 71.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.666 0.387 . . . . 0.0 111.092 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.8 mt -63.87 -41.49 97.74 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.406 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.17 -51.24 55.4 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -54.13 -59.36 4.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.768 0.827 . . . . 0.0 110.708 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -49.84 -44.28 49.36 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.265 0.626 . . . . 0.0 111.624 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.36 70.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.896 0.379 . . . . 0.0 110.229 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.41 -43.4 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.145 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.18 -46.08 89.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.881 0.872 . . . . 0.0 109.971 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -63.98 -49.72 71.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.076 0.95 . . . . 0.0 109.376 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -57.44 -43.44 83.88 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.751 -0.593 . . . . 0.0 110.954 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -63.85 -39.51 94.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.871 1.268 . . . . 0.0 110.684 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -61.48 -43.77 98.27 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.395 0.678 . . . . 0.0 109.239 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.61 -40.17 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.1 20.62 58.84 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.336 1.446 . . . . 0.0 110.167 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.79 -35.95 75.7 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 117.404 0.602 . . . . 0.0 111.105 -168.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.46 33.87 5.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.084 0.953 . . . . 0.0 109.815 175.677 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.25 -145.37 49.57 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -171.217 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -106.46 88.5 2.79 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.525 1.13 . . . . 0.0 108.975 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -70.13 153.86 42.63 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.3 m -109.07 102.26 11.26 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -52.29 144.72 12.26 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.655 0.382 . . . . 0.0 110.446 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -120.84 -66.19 1.08 Allowed 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.901 0.48 . . . . 0.0 110.205 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 166.82 27.14 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 117.812 0.278 . . . . 0.0 110.452 175.304 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -91.62 150.23 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.194 0.998 . . . . 0.0 108.591 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -144.55 174.96 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.832 0.853 . . . . 0.0 109.195 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.49 154.79 85.77 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.632 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.02 157.32 97.28 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 119.67 0.918 . . . . 0.0 111.246 -4.532 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.3 t -153.98 93.88 1.69 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.716 0.806 . . . . 0.0 109.395 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -102.92 154.76 18.89 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.467 1.507 . . . . 0.0 110.546 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -133.79 143.49 48.43 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.42 1.488 . . . . 0.0 109.271 170.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -147.1 144.98 29.44 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.608 0.763 . . . . 0.0 111.598 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -65.34 139.04 58.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.862 1.265 . . . . 0.0 111.684 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.81 127.21 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.193 1.397 . . . . 0.0 108.443 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -162.73 177.8 9.03 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.505 -0.747 . . . . 0.0 110.878 -163.813 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -138.22 162.87 33.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.452 1.101 . . . . 0.0 108.784 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -114.91 -41.28 3.38 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.165 2.186 . . . . 0.0 110.794 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.37 149.55 24.46 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.86 0.464 . . . . 0.0 110.073 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.2 -69.23 1.96 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -170.107 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -160.51 162.77 33.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.322 1.049 . . . . 0.0 109.598 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.7 ptt85 -63.55 110.49 2.0 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 171.111 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -153.33 125.55 8.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.649 0.659 . . . . 0.0 112.394 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.8 mt -68.25 135.06 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 125.359 1.464 . . . . 0.0 109.276 169.155 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -117.3 -21.14 8.87 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.153 0.581 . . . . 0.0 111.663 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.79 -167.71 33.82 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -130.03 164.9 23.31 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.17 144.79 50.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.64 1.576 . . . . 0.0 107.193 168.914 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -130.52 133.9 46.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -130.62 112.57 13.26 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -148.64 160.08 43.48 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.205 0.457 . . . . 0.0 112.203 -166.634 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.28 140.31 37.57 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 123.643 0.777 . . . . 0.0 110.528 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.17 133.09 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.819 1.647 . . . . 0.0 109.147 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.75 119.2 25.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.968 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.15 130.69 37.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t 51.27 41.41 27.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.461 1.105 . . . . 0.0 111.526 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 t0 49.3 35.74 8.24 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.87 1.668 . . . . 0.0 112.499 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -127.97 142.03 51.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 tp -87.37 117.0 25.85 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -113.96 155.12 26.41 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.735 0.814 . . . . 0.0 108.862 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -108.88 138.47 45.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.461 1.104 . . . . 0.0 108.223 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.04 137.81 46.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.977 0.911 . . . . 0.0 109.343 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -114.04 116.78 29.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.395 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 mm -109.26 155.11 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 126.373 1.869 . . . . 0.0 106.406 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.84 164.57 22.78 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 118.516 0.598 . . . . 0.0 109.517 167.902 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.65 138.89 52.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.152 2.181 . . . . 0.0 106.557 170.446 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.04 114.59 28.62 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.209 1.403 . . . . 0.0 107.298 174.289 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -56.44 -36.29 68.84 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.194 0.998 . . . . 0.0 111.452 -171.356 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -53.58 -23.6 11.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.62 1.568 . . . . 0.0 113.339 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -143.14 15.35 1.88 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.643 -0.661 . . . . 0.0 110.844 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 48.28 32.47 3.17 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.626 0.77 . . . . 0.0 111.023 -170.63 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.63 129.66 9.99 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -171.257 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -100.19 166.64 10.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.699 0.75 . . . . 0.0 112.694 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.35 140.09 4.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.405 -169.746 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.03 121.73 14.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 168.58 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mt -85.56 -60.2 2.09 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -145.03 154.96 43.07 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.329 0.652 . . . . 0.0 109.25 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -131.32 150.47 52.14 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -156.01 163.91 39.12 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.63 0.772 . . . . 0.0 109.288 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.93 -162.91 12.27 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -67.97 160.2 82.36 Favored 'Cis proline' 0 N--CA 1.453 -0.89 0 CA-C-N 118.75 1.275 . . . . 0.0 110.027 -2.801 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.11 149.41 66.53 Favored Pre-proline 0 C--O 1.235 0.29 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -69.84 156.44 63.12 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.86 1.706 . . . . 0.0 109.388 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -67.51 154.46 73.6 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.034 1.823 . . . . 0.0 109.371 171.253 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 C--O 1.25 1.076 0 C-N-CA 122.585 2.19 . . . . 0.0 110.718 177.506 . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.201 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.13 165.44 13.6 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 169.229 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -53.47 114.33 1.47 Allowed 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -154.28 154.65 33.76 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.3 mm -81.87 138.15 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.5 pt -101.4 155.66 4.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.178 0.591 . . . . 0.0 110.553 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.06 148.82 50.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.79 132.34 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 C-N-CA 125.017 1.327 . . . . 0.0 108.224 169.347 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.89 -168.97 39.6 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 108.269 -1.933 . . . . 0.0 108.269 -174.911 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.5 -43.29 59.56 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.446 2.764 . . . . 0.0 112.153 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -51.88 -57.42 9.42 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 122.004 0.907 . . . . 0.0 111.286 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -45.49 89.76 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.269 1.028 . . . . 0.0 109.964 -173.92 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -49.99 -58.31 5.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 118.36 -0.829 . . . . 0.0 108.923 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -49.34 -46.18 46.54 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.73 0.812 . . . . 0.0 111.013 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.32 -51.64 65.19 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.605 -0.684 . . . . 0.0 111.751 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.23 83.32 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 122.396 0.998 . . . . 0.0 112.414 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.73 -57.93 6.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.473 1.909 . . . . 0.0 106.808 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -47.45 -44.85 25.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.852 1.661 . . . . 0.0 110.417 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.54 -54.14 49.3 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.909 0.385 . . . . 0.0 110.495 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.75 -38.54 76.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 122.817 0.447 . . . . 0.0 111.31 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.86 -46.82 83.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.029 0.931 . . . . 0.0 109.99 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -60.89 -47.32 86.95 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.801 0.84 . . . . 0.0 108.977 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -55.99 -50.81 69.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.017 0.527 . . . . 0.0 109.67 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -57.94 -42.68 85.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.796 1.638 . . . . 0.0 110.209 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.5 -45.95 87.7 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.098 0.559 . . . . 0.0 110.19 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.6 mt -64.68 -42.96 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.53 18.55 65.96 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.988 1.28 . . . . 0.0 111.018 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -55.23 -41.61 72.32 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 117.762 0.781 . . . . 0.0 111.0 -173.67 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.54 25.95 11.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.397 1.079 . . . . 0.0 110.44 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.06 -152.91 46.11 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -117.25 120.68 38.99 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.953 1.301 . . . . 0.0 108.148 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.87 156.95 30.87 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.446 0.698 . . . . 0.0 111.805 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 m -97.56 95.89 7.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -45.3 132.14 7.75 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -101.02 -68.5 0.81 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -168.61 165.11 12.33 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -171.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -102.58 141.59 18.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 124.67 1.188 . . . . 0.0 108.109 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.54 172.3 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.488 0.715 . . . . 0.0 110.012 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.73 154.99 83.88 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.722 0.809 . . . . 0.0 111.405 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.56 158.23 98.66 Favored 'Cis proline' 0 N--CA 1.455 -0.755 0 N-CA-C 110.373 -0.664 . . . . 0.0 110.373 -4.538 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 77.0 m -141.79 91.31 2.35 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.26 127.84 53.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.306 1.042 . . . . 0.0 110.28 -168.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -102.68 145.31 29.87 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.705 0.802 . . . . 0.0 110.018 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -148.34 141.74 25.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.184 0.594 . . . . 0.0 110.237 166.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.5 m -58.49 134.61 56.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.577 0.751 . . . . 0.0 110.453 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 tp -115.61 127.68 73.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.632 1.173 . . . . 0.0 108.614 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -161.57 -179.92 7.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.3 0.64 . . . . 0.0 110.115 -169.74 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -82.49 -143.97 0.06 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.934 0.772 . . . . 0.0 109.474 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -166.26 -48.03 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.299 1.04 . . . . 0.0 109.299 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -53.94 157.14 2.57 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.1 0.56 . . . . 0.0 109.939 170.539 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -46.43 -13.9 0.09 OUTLIER Glycine 0 CA--C 1.533 1.176 0 C-N-CA 127.524 2.488 . . . . 0.0 117.604 -169.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -54.51 -40.87 69.0 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.124 1.462 . . . . 0.0 109.209 168.988 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 36.64 68.53 0.25 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.932 2.093 . . . . 0.0 112.943 166.679 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -143.11 147.15 34.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.1 mt -79.97 125.11 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 123.786 0.834 . . . . 0.0 109.092 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.16 -39.62 14.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.58 -152.11 9.78 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -172.374 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.16 152.95 42.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.966 1.306 . . . . 0.0 107.662 174.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.9 155.98 21.01 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.763 1.225 . . . . 0.0 108.875 170.536 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -138.27 102.72 4.73 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.511 1.924 . . . . 0.0 106.239 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 126.62 38.56 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 pp -152.24 153.55 33.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.308 0.503 . . . . 0.0 112.078 -172.264 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -85.88 118.19 25.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.51 125.84 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.009 1.324 . . . . 0.0 108.793 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -92.17 123.03 35.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.58 130.15 21.36 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t 51.85 37.04 19.63 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.766 0.826 . . . . 0.0 111.201 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.0 t70 64.25 12.79 7.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.774 1.23 . . . . 0.0 113.249 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -109.82 147.35 33.46 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.52 1.128 . . . . 0.0 107.995 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.53 112.74 24.7 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.983 1.313 . . . . 0.0 107.609 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.49 162.5 17.49 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.282 1.033 . . . . 0.0 108.324 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -112.56 128.22 56.3 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.26 134.95 54.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -112.21 107.86 16.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mp -97.6 151.6 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.6 m -128.98 152.71 48.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 169.384 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -117.35 125.48 51.09 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -87.97 125.36 34.48 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -66.98 -45.59 77.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.818 0.847 . . . . 0.0 110.625 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.78 -43.55 88.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.098 0.559 . . . . 0.0 110.416 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.0 m -69.42 -37.28 77.37 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 60.52 49.43 6.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.457 1.503 . . . . 0.0 108.777 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.87 154.79 26.03 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.94 168.48 9.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.609 0.764 . . . . 0.0 111.928 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -163.72 139.46 6.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.772 1.229 . . . . 0.0 110.869 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 34.7 tp -63.16 122.76 16.92 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 tp -83.27 -57.45 3.26 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.12 152.25 37.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.29 0.636 . . . . 0.0 109.472 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -117.05 134.85 54.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 168.281 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -134.67 149.36 50.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 130.7 -166.52 22.47 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.35 -0.695 . . . . 0.0 112.061 171.431 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.57 151.69 78.14 Favored 'Cis proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.752 -0.937 . . . . 0.0 110.045 -1.939 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.46 130.12 18.89 Favored Pre-proline 0 N--CA 1.462 0.144 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.16 153.31 75.02 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.271 1.314 . . . . 0.0 109.302 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.35 153.67 76.24 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.071 1.847 . . . . 0.0 109.659 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 0 C--O 1.252 1.197 0 C-N-CA 122.707 2.271 . . . . 0.0 110.807 177.35 . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.328 0 N-CA-C 112.135 -0.386 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 48.4 48.06 19.48 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.921 1.288 . . . . 0.0 112.402 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -141.66 135.52 30.0 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 172.039 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -157.12 158.83 37.09 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.5 mp -88.82 139.12 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.924 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.95 161.1 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 123.811 0.845 . . . . 0.0 110.517 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.01 135.63 41.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.667 0.787 . . . . 0.0 110.357 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.59 124.87 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 167.49 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.05 -167.5 30.6 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -56.76 -44.02 49.12 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.933 2.422 . . . . 0.0 111.602 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -53.94 -52.76 59.59 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.167 0.984 . . . . 0.0 111.043 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -45.37 93.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.19 0.996 . . . . 0.0 109.767 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -60.42 -41.33 93.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.306 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -56.7 -49.86 73.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.012 0.824 . . . . 0.0 110.42 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.9 mt -57.48 -45.55 84.74 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.805 175.757 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.11 -46.55 62.01 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -60.0 -51.77 68.23 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -51.85 -47.16 64.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.054 0.541 . . . . 0.0 111.06 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.03 -50.16 74.38 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.317 0.58 . . . . 0.0 110.326 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.7 -40.75 90.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.098 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.49 -46.87 85.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.219 0.608 . . . . 0.0 110.058 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.91 -54.02 51.32 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.264 1.026 . . . . 0.0 109.041 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -57.29 -48.0 80.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.637 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -57.6 -45.12 85.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.35 1.06 . . . . 0.0 110.094 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.76 -41.37 86.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.569 0.348 . . . . 0.0 110.37 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.3 mt -72.24 -45.38 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.89 15.56 48.53 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.976 1.274 . . . . 0.0 112.838 174.251 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -53.79 -42.94 68.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.351 1.076 . . . . 0.0 111.963 -175.631 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.77 33.0 4.46 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.955 0.902 . . . . 0.0 109.707 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.44 -142.07 47.58 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -106.47 120.09 41.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.517 1.127 . . . . 0.0 109.213 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mt -106.73 168.78 8.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.364 1.065 . . . . 0.0 108.546 170.23 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.2 m -120.67 103.83 9.43 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -46.23 130.09 10.34 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.713 0.233 . . . . 0.0 110.989 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -106.49 -66.87 0.97 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -167.4 -169.39 1.22 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.293 0.637 . . . . 0.0 109.996 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.51 146.4 34.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 125.594 1.557 . . . . 0.0 106.809 174.716 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.55 166.57 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.358 0.599 . . . . 0.0 110.631 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.33 158.58 81.46 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 125.48 1.512 . . . . 0.0 111.94 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -67.63 148.33 80.79 Favored 'Cis proline' 0 N--CA 1.456 -0.688 0 CA-C-N 118.861 0.629 . . . . 0.0 111.168 -8.54 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 71.6 m -131.41 94.32 3.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.86 128.55 55.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.721 0.808 . . . . 0.0 109.809 -168.287 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -104.85 140.8 37.59 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.642 1.177 . . . . 0.0 109.186 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -133.83 152.02 51.73 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.453 1.101 . . . . 0.0 108.969 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 m -82.86 136.93 34.46 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.505 1.122 . . . . 0.0 109.844 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.16 131.87 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.262 1.425 . . . . 0.0 108.771 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -166.16 176.5 7.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.33 0.652 . . . . 0.0 109.857 -167.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -134.57 162.96 30.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -50.97 -58.77 5.19 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.016 1.327 . . . . 0.0 110.692 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 59.7 -176.07 0.1 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.016 0.927 . . . . 0.0 109.924 -174.034 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.88 -39.47 56.18 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.338 -0.851 . . . . 0.0 112.04 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -140.02 -55.43 0.54 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.274 1.03 . . . . 0.0 110.203 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -172.48 148.48 2.02 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -165.77 96.0 0.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.301 1.44 . . . . 0.0 107.174 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.5 110.18 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.066 0.546 . . . . 0.0 110.193 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -81.56 -33.43 31.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.049 0.54 . . . . 0.0 110.792 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.23 -161.74 24.05 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.201 -1.0 . . . . 0.0 112.116 -170.823 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -147.68 159.6 43.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -121.87 149.19 43.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.978 1.311 . . . . 0.0 108.459 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -132.61 107.76 8.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -97.27 118.18 33.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -146.37 158.71 43.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.808 0.443 . . . . 0.0 111.133 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.99 112.55 24.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.524 0.73 . . . . 0.0 109.579 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -99.88 133.0 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 109.617 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.08 122.36 35.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.441 1.496 . . . . 0.0 107.521 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.6 127.15 28.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.812 0.845 . . . . 0.0 109.395 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t 70.74 -64.17 0.38 Allowed 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 129.593 3.157 . . . . 0.0 108.432 -169.264 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 179.72 11.09 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.518 3.127 . . . . 0.0 111.207 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -119.55 149.29 42.17 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.923 1.289 . . . . 0.0 107.832 -174.555 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 tp -106.79 120.98 43.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.45 0.7 . . . . 0.0 109.759 -169.817 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.4 137.93 54.7 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.738 1.215 . . . . 0.0 108.364 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -94.69 115.82 28.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.25 135.5 54.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.188 0.995 . . . . 0.0 109.559 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.58 103.67 14.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.531 1.132 . . . . 0.0 108.208 169.893 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.9 mm -91.26 161.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.86 1.664 . . . . 0.0 106.9 176.298 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.6 p -145.6 167.57 22.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.65 0.659 . . . . 0.0 111.438 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -136.52 131.24 33.65 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.553 1.941 . . . . 0.0 108.277 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -98.37 107.86 20.42 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 169.47 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -53.03 -37.48 61.58 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 124.439 1.096 . . . . 0.0 111.194 -173.478 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -43.07 -40.55 3.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.414 1.886 . . . . 0.0 112.464 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 m -121.54 0.52 9.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.798 0.439 . . . . 0.0 110.99 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 52.77 28.78 6.71 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.686 0.795 . . . . 0.0 109.126 -165.711 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.99 128.13 9.3 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -168.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -105.88 170.04 8.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.567 0.699 . . . . 0.0 112.36 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -177.58 161.57 1.71 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.044 1.737 . . . . 0.0 112.35 -166.648 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.1 tp -89.84 138.18 31.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.3 1.44 . . . . 0.0 108.88 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.9 mt -104.47 -58.24 1.91 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.628 0.649 . . . . 0.0 110.245 169.447 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -136.2 150.56 49.06 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -143.77 106.33 4.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -115.39 147.84 40.05 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.68 -167.5 27.09 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.504 -0.609 . . . . 0.0 111.925 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.4 143.27 62.56 Favored 'Cis proline' 0 N--CA 1.455 -0.739 0 C-N-CA 124.373 -1.095 . . . . 0.0 110.002 -2.573 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.72 120.17 8.53 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -70.04 157.33 60.18 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.898 1.732 . . . . 0.0 108.583 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.21 150.72 76.99 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.936 1.757 . . . . 0.0 109.78 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo . . . . . 0 C--O 1.25 1.109 0 C-N-CA 122.59 2.193 . . . . 0.0 110.76 178.052 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.236 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -62.25 141.58 58.16 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -133.45 141.89 48.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -163.09 155.45 18.44 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mp -99.2 139.38 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.3 pt -103.02 154.23 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 123.842 0.857 . . . . 0.0 109.66 171.932 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.46 134.21 42.33 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.8 pt -62.27 141.36 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 165.543 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.66 -169.35 34.5 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -168.584 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.41 -48.77 17.48 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.427 2.751 . . . . 0.0 112.769 -169.816 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.37 -55.0 24.54 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.124 0.964 . . . . 0.0 111.066 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -67.37 -44.27 79.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.215 1.006 . . . . 0.0 110.018 -172.567 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -56.4 -49.25 75.04 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 118.93 -0.557 . . . . 0.0 109.882 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -56.31 -46.47 79.82 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.624 0.647 . . . . 0.0 110.928 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 mt -55.95 -51.87 66.13 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 117.894 0.315 . . . . 0.0 110.515 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.58 -45.07 90.63 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -59.81 -52.12 66.82 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -49.94 -48.48 51.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.731 1.212 . . . . 0.0 110.201 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.58 72.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.49 -39.95 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.776 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.94 -48.75 80.38 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.378 0.671 . . . . 0.0 109.938 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.74 -52.82 63.88 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.077 0.951 . . . . 0.0 109.152 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -54.08 -46.65 72.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.485 1.114 . . . . 0.0 110.315 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -69.65 -42.02 74.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.554 1.542 . . . . 0.0 110.518 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.55 -47.77 84.24 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.321 0.648 . . . . 0.0 109.718 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.32 -41.74 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.8 18.43 51.27 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.633 1.111 . . . . 0.0 112.26 173.713 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -55.6 -40.81 72.54 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.974 0.887 . . . . 0.0 111.091 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -111.75 33.29 4.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.208 1.003 . . . . 0.0 109.976 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.03 -140.09 45.23 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.91 108.3 19.89 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.538 0.735 . . . . 0.0 109.65 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.8 mt -93.85 141.66 28.26 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 167.402 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 m -100.74 95.34 6.59 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.227 1.011 . . . . 0.0 108.346 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -51.21 133.82 27.99 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.179 0.592 . . . . 0.0 111.448 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -100.27 -67.41 0.85 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -169.57 -159.5 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.444 1.098 . . . . 0.0 108.533 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.12 141.68 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.15 174.7 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.023 0.529 . . . . 0.0 110.884 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -63.49 153.57 82.36 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.095 1.358 . . . . 0.0 112.889 -170.844 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.11 159.14 97.18 Favored 'Cis proline' 0 N--CA 1.449 -1.094 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 -7.573 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -133.91 87.24 2.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.49 140.15 48.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.896 0.878 . . . . 0.0 109.421 -167.592 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -122.12 162.13 21.84 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.197 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -138.45 147.52 43.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.852 1.661 . . . . 0.0 108.488 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -83.6 130.49 34.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.226 1.01 . . . . 0.0 110.089 172.305 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.44 120.87 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.665 1.186 . . . . 0.0 108.856 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -144.84 162.23 37.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.394 -0.816 . . . . 0.0 111.272 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -98.39 -166.63 1.39 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -158.69 -51.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.485 0.714 . . . . 0.0 111.763 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.66 105.2 0.14 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.826 0.85 . . . . 0.0 110.501 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.76 78.67 0.56 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.1 t80 74.16 84.46 0.11 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.36 1.464 . . . . 0.0 110.254 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.2 ppt_? -58.23 135.39 57.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.288 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -158.83 151.43 21.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt -71.71 124.23 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 -20.68 12.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 123.496 0.497 . . . . 0.0 111.069 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.94 -168.59 32.04 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.817 0.735 . . . . 0.0 112.59 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -142.9 157.8 44.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -130.72 145.26 51.9 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.973 1.309 . . . . 0.0 108.353 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -136.86 119.38 15.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.4 1.48 . . . . 0.0 107.878 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -107.86 126.1 52.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.866 1.267 . . . . 0.0 108.291 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pp -145.99 147.96 32.23 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.421 0.288 . . . . 0.0 110.269 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.2 99.48 11.97 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.817 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -83.17 134.07 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -102.22 122.78 44.85 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.39 136.04 25.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.77 37.66 24.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.457 1.103 . . . . 0.0 110.89 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 t70 56.63 28.84 14.66 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.987 1.315 . . . . 0.0 112.335 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -130.2 149.17 52.02 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.75 1.22 . . . . 0.0 108.218 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.7 tp -101.9 127.0 48.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.789 0.836 . . . . 0.0 109.637 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.24 136.9 50.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.861 1.264 . . . . 0.0 108.765 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -83.81 115.15 22.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.47 135.24 40.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -116.02 115.11 25.55 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.81 151.44 14.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.41 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.8 t -133.07 156.08 48.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.59 0.632 . . . . 0.0 109.574 169.281 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.05 131.34 52.18 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.322 1.849 . . . . 0.0 106.867 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -97.6 115.7 28.39 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -50.94 -48.33 60.85 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.647 1.579 . . . . 0.0 111.813 -168.946 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.26 -30.41 71.28 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.703 0.801 . . . . 0.0 110.972 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.4 m -84.13 -33.59 24.25 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 49.36 44.33 23.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.5 1.12 . . . . 0.0 109.759 -167.562 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.11 150.8 22.66 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.1 mtt85 -111.39 169.31 8.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.395 0.617 . . . . 0.0 112.271 -170.847 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.07 145.82 23.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.189 174.44 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.4 tp -71.83 138.05 48.01 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.755 0.822 . . . . 0.0 108.904 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.63 -57.05 2.4 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.934 0.894 . . . . 0.0 108.75 168.637 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.39 160.1 43.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.835 0.35 . . . . 0.0 110.959 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -136.25 92.24 2.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.63 1.972 . . . . 0.0 106.494 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.88 145.56 25.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.51 -167.88 24.35 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -71.12 157.74 95.51 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 118.644 1.222 . . . . 0.0 110.588 0.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 m -132.23 140.34 37.72 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.345 0.658 . . . . 0.0 109.595 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.05 122.74 4.87 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.577 2.185 . . . . 0.0 108.787 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.26 154.52 56.53 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.48 1.453 . . . . 0.0 109.618 174.096 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.25 1.123 0 C-N-CA 122.546 2.164 . . . . 0.0 110.688 175.805 . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.294 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.19 115.19 21.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.555 1.542 . . . . 0.0 108.884 -171.786 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -73.64 99.29 3.05 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -115.31 139.01 50.35 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.642 0.777 . . . . 0.0 109.677 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -79.27 143.57 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.427 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.9 pt -120.91 158.49 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.718 0.807 . . . . 0.0 110.373 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.16 140.78 58.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.919 0.888 . . . . 0.0 109.856 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -92.7 121.45 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.426 1.09 . . . . 0.0 108.425 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.48 -169.54 33.71 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -51.16 -45.97 33.77 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.723 2.948 . . . . 0.0 112.75 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -49.22 -55.28 13.06 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.114 0.959 . . . . 0.0 111.043 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -41.3 90.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.663 1.185 . . . . 0.0 110.591 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -56.67 -44.71 81.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.979 0.912 . . . . 0.0 109.55 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -51.8 -52.76 46.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.889 0.768 . . . . 0.0 110.75 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.47 -46.19 89.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 110.537 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.97 -42.2 86.23 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -64.7 -50.13 68.16 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -50.91 -46.15 60.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.12 0.968 . . . . 0.0 110.996 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.06 -53.05 62.68 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.793 0.806 . . . . 0.0 110.398 179.473 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.9 t -63.78 -36.57 77.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.678 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.02 -47.16 84.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.201 1.0 . . . . 0.0 110.091 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.97 -50.87 67.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.69 -41.71 95.67 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 121.635 -0.665 . . . . 0.0 111.383 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -56.42 -42.85 78.7 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.235 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.34 -39.97 96.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.312 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.7 mm -62.54 -46.27 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.16 0.891 . . . . 0.0 109.376 174.095 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.13 3.91 85.65 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.137 1.351 . . . . 0.0 112.78 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -29.12 70.04 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.071 1.436 . . . . 0.0 113.061 -171.676 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -110.44 27.03 10.04 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.584 0.753 . . . . 0.0 110.024 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.27 -164.07 52.44 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -95.34 107.45 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.199 1.0 . . . . 0.0 108.547 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.9 140.23 35.48 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.145 0.429 . . . . 0.0 110.776 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.6 m -85.48 103.78 14.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -49.03 128.86 16.87 Favored 'General case' 0 N--CA 1.457 -0.079 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -102.82 -64.51 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -167.8 170.64 10.63 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.341 1.056 . . . . 0.0 109.998 172.954 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.5 p -98.48 149.5 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.318 1.047 . . . . 0.0 108.745 169.352 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -138.8 170.8 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 123.374 0.67 . . . . 0.0 110.258 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -61.84 152.46 76.18 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.967 0.907 . . . . 0.0 110.421 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.35 152.31 97.49 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 CA-C-N 119.184 0.744 . . . . 0.0 110.453 -4.791 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 46.9 t -143.72 101.65 3.79 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 ttp -128.47 136.19 50.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.877 0.871 . . . . 0.0 110.271 -166.019 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -119.84 157.3 28.96 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.195 0.998 . . . . 0.0 110.846 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -146.69 146.28 30.3 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.375 1.07 . . . . 0.0 109.635 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -76.06 132.52 40.15 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.98 0.912 . . . . 0.0 109.955 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.48 116.54 51.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.281 1.433 . . . . 0.0 108.476 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -148.91 174.07 12.64 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.668 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -131.56 154.57 48.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -89.38 -64.84 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.348 1.859 . . . . 0.0 107.556 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -7.42 84.57 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 129.6 3.16 . . . . 0.0 113.598 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.29 -75.81 0.42 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 -171.972 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -156.67 -66.18 0.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.247 1.419 . . . . 0.0 108.279 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -170.79 145.99 2.52 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.205 1.402 . . . . 0.0 107.794 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -162.36 114.34 1.65 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.495 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 87.6 mt -71.28 123.08 24.69 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -101.53 -34.83 9.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.33 -161.85 24.98 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -139.93 158.83 43.45 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -123.9 147.25 47.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.137 1.375 . . . . 0.0 108.363 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -135.67 111.23 9.22 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.195 1.398 . . . . 0.0 107.641 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.27 112.55 25.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.596 1.558 . . . . 0.0 107.83 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -139.81 146.42 39.4 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.689 0.796 . . . . 0.0 111.267 -171.016 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -99.44 115.97 30.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.064 0.945 . . . . 0.0 109.62 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 p -113.53 129.17 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.193 1.397 . . . . 0.0 110.866 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.33 118.55 26.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.749 1.22 . . . . 0.0 107.997 173.111 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.76 128.99 43.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 t 52.25 41.17 30.22 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.683 0.793 . . . . 0.0 111.401 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t0 51.54 32.83 9.47 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.067 1.347 . . . . 0.0 112.938 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -125.34 131.22 53.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 169.753 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.4 tp -89.3 128.79 35.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -125.34 152.37 44.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.001 1.321 . . . . 0.0 108.294 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -92.49 129.44 38.43 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 132.54 56.65 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.563 1.145 . . . . 0.0 108.506 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -112.01 107.47 16.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 13.1 mm -100.45 153.91 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 125.976 1.71 . . . . 0.0 107.961 -179.659 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 t -132.34 159.96 37.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.167 0.508 . . . . 0.0 109.928 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -130.16 122.08 27.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.9 1.68 . . . . 0.0 106.483 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -83.89 119.06 24.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.403 1.081 . . . . 0.0 108.096 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -58.26 -58.3 9.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.643 0.777 . . . . 0.0 111.476 -170.643 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -68.94 -43.47 75.0 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.859 0.361 . . . . 0.0 110.039 -171.346 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.38 -30.29 70.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.565 0.746 . . . . 0.0 110.895 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 54.6 47.88 21.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.496 1.119 . . . . 0.0 110.069 -168.777 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -126.77 139.63 11.4 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -92.14 172.72 8.24 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.547 0.739 . . . . 0.0 110.689 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -174.94 143.18 0.7 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.853 2.061 . . . . 0.0 110.743 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.29 124.51 28.46 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 166.679 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.6 -59.92 2.36 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 169.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -142.75 150.42 40.04 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.178 0.591 . . . . 0.0 109.573 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -132.13 122.32 25.17 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -132.69 146.4 51.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -173.922 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 141.74 -165.23 26.55 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 123.578 0.609 . . . . 0.0 111.606 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.35 147.68 67.9 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 CA-C-N 118.045 0.923 . . . . 0.0 111.307 2.597 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.53 136.0 15.24 Favored Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 124.853 1.261 . . . . 0.0 108.05 177.465 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -70.35 164.26 35.76 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.046 1.831 . . . . 0.0 109.511 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -69.08 153.44 72.06 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.839 1.693 . . . . 0.0 109.244 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.536 2.157 . . . . 0.0 110.734 177.197 . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.115 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 179.9 71.96 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.412 1.885 . . . . 0.0 107.454 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -69.53 121.23 16.63 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.49 152.86 37.61 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.368 0.531 . . . . 0.0 109.658 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 mt -77.44 138.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 125.094 1.357 . . . . 0.0 107.58 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 pt -103.2 155.98 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 123.273 0.629 . . . . 0.0 110.422 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.75 131.38 45.08 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.7 pt -73.32 154.35 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 164.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.9 -175.68 29.77 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -166.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -58.95 -45.22 29.68 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.681 2.921 . . . . 0.0 112.667 -171.182 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -54.29 -53.12 58.07 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 122.144 0.973 . . . . 0.0 110.943 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 m -68.31 -39.28 82.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.219 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -52.98 -56.61 14.78 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.063 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -46.71 -50.32 18.12 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.337 0.971 . . . . 0.0 110.805 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.01 -50.43 72.08 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.915 -0.491 . . . . 0.0 111.567 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.34 -25.11 62.23 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 121.661 -0.649 . . . . 0.0 112.851 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -80.59 -54.85 5.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -45.03 -45.52 10.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.757 1.623 . . . . 0.0 110.47 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.56 -53.84 51.4 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.93 0.395 . . . . 0.0 110.738 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.31 -38.97 82.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.243 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.68 -48.96 79.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.472 0.709 . . . . 0.0 109.693 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.07 -50.05 74.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.18 0.992 . . . . 0.0 108.967 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -56.29 -49.66 73.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -59.86 -41.42 91.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.285 1.434 . . . . 0.0 110.069 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -61.47 -37.72 84.63 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 119.637 -0.221 . . . . 0.0 110.676 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.73 -47.33 80.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.42 19.0 61.14 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.624 1.583 . . . . 0.0 111.719 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -56.74 -41.63 77.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.964 0.882 . . . . 0.0 110.808 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -110.82 35.21 3.59 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.951 0.901 . . . . 0.0 110.179 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.85 -154.59 43.13 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.432 0.539 . . . . 0.0 112.051 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.4 ptt85 -93.44 84.91 4.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.084 1.354 . . . . 0.0 109.834 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.11 144.04 38.77 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.932 -0.48 . . . . 0.0 110.169 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 m -100.69 96.98 7.69 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -45.9 125.57 6.38 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.879 0.471 . . . . 0.0 110.473 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.27 -64.96 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.97 169.84 3.33 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 125.005 1.322 . . . . 0.0 108.418 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 p -110.78 141.09 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 124.74 1.216 . . . . 0.0 109.297 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.79 178.72 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 123.587 0.554 . . . . 0.0 110.411 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -60.7 154.99 54.04 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.162 0.985 . . . . 0.0 111.663 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.92 155.61 93.6 Favored 'Cis proline' 0 N--CA 1.458 -0.569 0 CA-C-N 119.414 0.827 . . . . 0.0 110.717 -9.616 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 17.1 p -161.29 79.0 0.59 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -166.218 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -99.16 160.46 14.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.37 1.068 . . . . 0.0 110.936 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -140.78 149.4 42.03 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.055 1.342 . . . . 0.0 108.608 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -147.61 143.58 27.82 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.84 0.856 . . . . 0.0 110.693 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -59.76 141.39 55.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.533 1.533 . . . . 0.0 111.969 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.07 124.76 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.645 1.578 . . . . 0.0 109.23 173.428 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -101.83 165.73 11.04 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.79 1.636 . . . . 0.0 108.784 176.139 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -100.71 -146.42 0.35 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -164.28 -43.78 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 124.686 1.194 . . . . 0.0 110.473 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -73.29 62.68 0.7 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.762 0.825 . . . . 0.0 111.296 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.51 -165.33 37.83 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 106.695 -2.562 . . . . 0.0 106.695 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -75.61 168.94 19.07 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 168.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -56.52 113.21 1.51 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -144.35 147.54 33.58 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.31 1.444 . . . . 0.0 108.458 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.1 mt -74.85 127.02 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -89.91 -37.6 14.29 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.13 -157.36 17.97 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.01 151.86 39.24 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -104.89 144.85 31.21 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.834 1.654 . . . . 0.0 107.309 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.07 139.12 51.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -141.05 99.9 3.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -170.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -122.06 138.6 54.38 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.574 1.149 . . . . 0.0 111.328 -164.037 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -87.34 102.27 14.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.728 0.775 . . . . 0.0 109.013 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.77 131.08 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.401 1.48 . . . . 0.0 109.378 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -98.65 124.25 43.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.227 1.411 . . . . 0.0 108.181 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.03 134.98 21.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.077 0.951 . . . . 0.0 108.897 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 t 52.46 32.62 11.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.173 0.989 . . . . 0.0 111.211 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.7 23.22 12.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.046 1.338 . . . . 0.0 113.45 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -116.75 143.66 45.39 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.434 1.494 . . . . 0.0 107.743 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.8 tp -103.5 129.15 50.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.493 0.717 . . . . 0.0 109.882 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -134.61 148.08 50.34 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 125.206 1.403 . . . . 0.0 109.902 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -94.15 110.59 22.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.711 1.204 . . . . 0.0 108.695 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.35 121.82 42.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.855 1.262 . . . . 0.0 107.903 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -108.63 121.62 45.4 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.86 153.58 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 126.448 1.899 . . . . 0.0 107.607 -175.142 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.1 p -123.77 146.28 48.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 126.64 51.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 168.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -96.86 119.37 35.21 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -63.92 -28.86 70.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.142 0.577 . . . . 0.0 111.047 -174.245 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -63.56 -18.14 63.56 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.5 0.72 . . . . 0.0 112.656 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -143.75 8.57 1.51 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.307 -0.871 . . . . 0.0 111.721 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 44.8 ttt85 50.98 40.41 25.26 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.407 0.683 . . . . 0.0 110.156 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -110.21 137.85 14.52 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -109.79 164.02 12.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 117.503 0.652 . . . . 0.0 111.276 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -157.34 148.7 21.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.551 1.141 . . . . 0.0 110.963 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.19 135.04 39.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.718 1.207 . . . . 0.0 109.264 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.61 -67.11 0.8 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.542 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.31 160.27 43.84 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.255 1.022 . . . . 0.0 109.22 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -126.08 83.83 2.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.688 1.995 . . . . 0.0 106.657 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.6 145.69 26.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.87 -165.04 27.75 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.081 172.93 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.96 148.57 72.76 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 CA-C-N 117.966 0.883 . . . . 0.0 111.318 2.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.02 127.97 18.42 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 125.012 1.325 . . . . 0.0 108.145 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.9 163.3 37.33 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.408 2.072 . . . . 0.0 109.786 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -69.66 154.38 68.22 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.965 1.777 . . . . 0.0 109.35 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.458 2.106 . . . . 0.0 110.812 176.651 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.336 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -145.69 163.09 35.98 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.871 1.668 . . . . 0.0 106.645 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.3 m95 48.59 68.85 0.63 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.475 0.71 . . . . 0.0 111.277 -173.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -122.81 154.99 37.49 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.568 0.747 . . . . 0.0 109.133 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.6 mm -78.04 140.69 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -106.14 154.3 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.257 0.623 . . . . 0.0 109.961 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -73.89 124.46 26.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.5 pt -65.53 122.24 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 123.056 0.542 . . . . 0.0 109.626 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.82 -167.16 21.86 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -175.648 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -56.13 -41.64 74.66 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.239 2.626 . . . . 0.0 111.464 -175.832 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -51.81 -50.01 61.66 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.889 0.875 . . . . 0.0 110.729 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.23 -49.51 71.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.948 0.899 . . . . 0.0 110.62 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -51.97 -53.26 43.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -54.91 -47.83 73.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.999 0.92 . . . . 0.0 111.423 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 mt -59.97 -48.27 82.38 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.979 0.354 . . . . 0.0 110.93 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.11 -48.61 85.27 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -54.9 -49.43 71.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.104 1.361 . . . . 0.0 110.25 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -55.87 -48.21 75.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.106 1.362 . . . . 0.0 110.52 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -49.55 74.86 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.34 -42.63 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.406 0.682 . . . . 0.0 110.783 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.25 -51.58 68.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.961 0.904 . . . . 0.0 109.664 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -58.22 -46.79 85.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.693 1.197 . . . . 0.0 109.746 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -56.16 -56.94 14.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -56.97 -38.72 73.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.578 1.151 . . . . 0.0 110.955 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -56.77 -39.21 73.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.853 0.461 . . . . 0.0 110.608 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.6 mt -83.1 -47.6 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.081 0.552 . . . . 0.0 110.235 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.25 10.83 58.02 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.556 1.55 . . . . 0.0 113.921 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -54.73 -42.64 71.8 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.035 1.417 . . . . 0.0 112.053 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -107.12 37.83 2.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.696 0.798 . . . . 0.0 110.076 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.11 -138.42 47.82 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -115.24 93.39 4.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.134 1.373 . . . . 0.0 108.837 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.3 mt -79.0 142.16 36.84 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.164 0.585 . . . . 0.0 109.575 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 t -103.84 106.92 17.58 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -59.04 133.73 56.36 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.458 0.703 . . . . 0.0 109.916 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -100.48 -64.69 1.02 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 168.661 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -167.61 179.03 5.06 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.356 1.062 . . . . 0.0 108.915 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.06 134.21 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -176.488 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -146.41 167.2 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 122.741 0.416 . . . . 0.0 110.335 -173.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -53.71 150.97 12.17 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.482 1.113 . . . . 0.0 111.831 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.38 142.76 72.72 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 CA-C-N 119.018 0.685 . . . . 0.0 110.701 -1.495 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.6 m -133.68 101.73 5.22 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 33.2 ttm -118.37 138.82 52.16 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.242 0.617 . . . . 0.0 110.491 -169.204 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -121.48 144.57 48.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.956 1.302 . . . . 0.0 110.132 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -146.38 149.8 34.46 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.456 0.702 . . . . 0.0 110.885 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -80.63 137.62 36.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.414 1.485 . . . . 0.0 111.365 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.53 120.74 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.79 1.236 . . . . 0.0 108.303 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -146.94 165.27 30.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.865 0.866 . . . . 0.0 109.275 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -98.44 -151.04 0.37 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -169.1 -52.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.32 1.048 . . . . 0.0 109.245 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -53.85 144.29 18.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.652 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.89 -81.28 1.16 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -150.36 150.82 31.93 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.594 1.157 . . . . 0.0 108.984 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.88 126.64 29.14 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.686 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -164.38 140.13 6.01 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.649 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -74.63 133.37 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 123.779 0.831 . . . . 0.0 108.853 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -119.59 -22.29 7.0 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 123.547 0.529 . . . . 0.0 111.166 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.95 -168.01 31.24 Favored Glycine 0 N--CA 1.448 -0.543 0 O-C-N 121.432 -0.792 . . . . 0.0 111.445 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -148.82 163.69 36.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.328 1.451 . . . . 0.0 107.693 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.84 148.83 52.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.688 1.195 . . . . 0.0 108.97 169.026 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -134.32 115.66 14.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -107.68 129.74 54.99 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.201 0.91 . . . . 0.0 109.263 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 pp -149.27 152.3 35.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.568 0.699 . . . . 0.0 111.568 -172.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . 0.404 ' CD1' HD12 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -89.02 111.34 22.03 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.537 1.535 . . . . 0.0 107.036 177.479 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.1 t -93.35 124.23 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 169.296 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.29 116.55 23.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 169.66 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 132.51 36.95 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.8 t 53.8 34.72 19.8 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.968 0.907 . . . . 0.0 111.708 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 t0 46.94 42.85 12.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.098 1.359 . . . . 0.0 111.064 -169.434 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -137.96 155.15 49.18 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.255 1.422 . . . . 0.0 107.953 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . 0.404 HD12 ' CD1' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -81.74 118.11 22.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -173.898 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -130.07 112.63 13.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.451 1.1 . . . . 0.0 108.69 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -97.13 131.12 44.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.3 142.73 50.16 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.202 0.91 . . . . 0.0 110.204 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.9 120.68 42.25 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.226 1.01 . . . . 0.0 108.363 168.727 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.74 140.08 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.9 p -111.38 147.65 34.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.581 1.152 . . . . 0.0 108.108 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -126.78 134.35 50.61 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.907 1.683 . . . . 0.0 107.798 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -107.31 114.49 28.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.519 1.128 . . . . 0.0 108.846 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.28 -27.9 67.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.728 1.211 . . . . 0.0 111.365 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -58.04 -23.22 53.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.88 0.872 . . . . 0.0 112.407 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -141.14 6.07 1.93 Allowed 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.468 -0.77 . . . . 0.0 111.328 174.001 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 49.94 40.55 21.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.826 0.851 . . . . 0.0 110.028 -171.294 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.69 140.74 15.35 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 107.699 -2.161 . . . . 0.0 107.699 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -116.85 164.99 13.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.986 0.893 . . . . 0.0 110.787 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -161.2 150.69 16.79 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.842 0.857 . . . . 0.0 110.326 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.57 110.98 0.98 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.346 1.059 . . . . 0.0 108.677 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.7 tp -71.89 -48.26 46.96 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -162.56 155.57 19.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -119.32 141.5 48.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.85 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.4 131.7 40.31 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.93 -176.17 27.84 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.86 162.03 85.26 Favored 'Cis proline' 0 N--CA 1.455 -0.761 0 CA-C-N 118.223 1.012 . . . . 0.0 110.508 -3.516 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.09 162.79 47.94 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 171.171 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.27 158.95 37.08 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.0 1.8 . . . . 0.0 109.323 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.52 152.02 75.16 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.093 1.862 . . . . 0.0 109.335 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--O 1.252 1.21 0 C-N-CA 122.689 2.26 . . . . 0.0 110.5 178.493 . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -169.84 179.69 3.58 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.579 1.551 . . . . 0.0 107.246 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -56.55 109.84 0.68 Allowed 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.472 0.483 . . . . 0.0 109.971 170.643 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -153.76 158.26 40.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.88 138.48 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.11 157.35 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.1 0.96 . . . . 0.0 110.475 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.52 125.39 29.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.503 0.721 . . . . 0.0 109.387 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 pt -65.13 136.32 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 165.851 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.11 -175.07 41.04 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -169.841 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.37 -46.78 31.35 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.745 2.963 . . . . 0.0 113.195 -170.354 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -52.13 -55.01 23.61 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.918 1.342 . . . . 0.0 110.871 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.9 m -66.73 -42.42 86.32 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.28 1.032 . . . . 0.0 110.198 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -57.03 -48.66 77.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.405 0.682 . . . . 0.0 110.078 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -54.02 -47.62 71.34 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 123.131 0.572 . . . . 0.0 110.839 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.06 -41.05 95.5 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.208 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.28 -51.63 40.95 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -51.3 -55.27 19.19 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.353 1.061 . . . . 0.0 110.185 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -51.26 -47.6 62.4 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.826 0.851 . . . . 0.0 110.447 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.35 -50.84 68.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.9 -40.87 90.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.39 -48.31 82.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.465 0.706 . . . . 0.0 110.076 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -63.09 -49.23 75.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.086 0.955 . . . . 0.0 109.698 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -54.74 -46.64 74.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -63.46 -44.94 93.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.635 1.574 . . . . 0.0 110.12 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -56.03 -46.0 78.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.55 0.74 . . . . 0.0 110.022 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -68.9 -47.56 75.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.98 14.9 55.65 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.219 1.39 . . . . 0.0 113.211 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -50.87 -44.46 59.65 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.621 1.21 . . . . 0.0 111.44 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -113.34 38.07 2.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.881 0.873 . . . . 0.0 109.984 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.4 -141.23 47.5 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -111.83 114.93 28.19 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.776 1.231 . . . . 0.0 109.344 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.3 152.25 21.76 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.351 0.66 . . . . 0.0 111.005 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.4 m -92.87 100.1 12.63 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.442 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -49.53 130.61 20.54 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -101.53 -63.63 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -171.58 -166.67 0.46 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.007 0.923 . . . . 0.0 109.122 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.53 144.81 35.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.11 165.34 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.544 0.611 . . . . 0.0 110.417 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -63.96 151.18 90.18 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.078 0.951 . . . . 0.0 111.4 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.1 151.47 96.82 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 119.268 0.774 . . . . 0.0 111.572 0.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.4 m -139.89 94.81 2.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.4 mtt -108.33 157.81 18.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.998 0.919 . . . . 0.0 110.673 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -131.96 154.44 49.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.031 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -130.04 151.9 50.08 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.148 2.179 . . . . 0.0 107.815 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.2 m -98.74 133.64 42.78 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.039 0.936 . . . . 0.0 109.319 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.58 128.19 62.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 125.006 1.323 . . . . 0.0 110.501 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -146.7 175.7 10.41 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.553 1.541 . . . . 0.0 107.607 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 76.94 145.96 0.09 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 127.657 2.383 . . . . 0.0 111.925 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -169.72 -67.1 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.529 1.532 . . . . 0.0 109.521 170.349 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -80.44 173.54 12.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.93 -43.22 61.13 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -76.64 72.68 3.31 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 172.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -42.34 127.43 3.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.282 1.833 . . . . 0.0 109.668 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -149.42 150.79 32.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.863 0.865 . . . . 0.0 110.686 -173.35 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.16 136.73 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 124.233 1.013 . . . . 0.0 109.821 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -127.94 -34.71 2.12 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.207 0.603 . . . . 0.0 112.09 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.91 -164.43 28.99 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.02 -1.086 . . . . 0.0 111.862 -170.522 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -145.02 160.71 40.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.613 1.165 . . . . 0.0 108.027 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -126.41 144.1 50.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.532 1.533 . . . . 0.0 107.579 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -129.95 124.15 32.38 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -113.33 117.75 32.68 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.782 1.633 . . . . 0.0 106.723 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 pp -152.18 153.99 34.93 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.272 0.487 . . . . 0.0 111.535 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -96.1 104.58 16.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.232 1.013 . . . . 0.0 109.348 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.39 130.72 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.374 1.869 . . . . 0.0 108.571 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.57 120.12 39.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.809 1.244 . . . . 0.0 107.674 173.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.7 131.12 20.99 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.275 1.03 . . . . 0.0 108.81 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.43 39.22 29.62 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.18 0.992 . . . . 0.0 110.974 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.9 t0 45.95 37.5 3.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.081 1.352 . . . . 0.0 113.005 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -125.72 139.01 53.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 168.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.4 tp -98.54 126.9 44.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -124.89 140.4 52.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.679 1.592 . . . . 0.0 107.965 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -88.8 123.59 33.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.27 146.82 44.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.662 0.785 . . . . 0.0 109.158 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.58 124.5 43.64 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 mm -112.34 150.17 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 127.006 2.123 . . . . 0.0 107.05 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -120.86 148.91 43.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.599 1.16 . . . . 0.0 108.403 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -122.24 127.25 49.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.393 1.877 . . . . 0.0 106.63 169.207 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -102.78 119.22 38.45 Favored 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.379 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -66.45 -23.07 66.22 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.659 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -63.85 -55.56 21.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.103 0.865 . . . . 0.0 110.495 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.4 p -79.84 -26.84 40.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 68.31 13.96 9.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.053 1.341 . . . . 0.0 109.023 -164.044 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.02 155.09 34.43 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -115.51 171.92 7.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.948 0.499 . . . . 0.0 110.626 176.415 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.26 157.53 30.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.698 174.642 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 tp -78.5 119.2 21.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.1 tp -82.67 -59.78 2.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -144.84 154.35 42.57 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.065 0.946 . . . . 0.0 109.563 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -144.73 102.33 3.78 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.926 1.69 . . . . 0.0 106.838 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -117.11 142.27 47.21 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -172.291 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.74 -165.96 27.92 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.614 -0.548 . . . . 0.0 112.158 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.58 148.03 73.85 Favored 'Cis proline' 0 N--CA 1.458 -0.588 0 CA-C-N 118.006 0.903 . . . . 0.0 111.237 2.137 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.02 130.94 14.23 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 124.776 1.23 . . . . 0.0 108.243 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.56 161.51 43.89 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.1 1.866 . . . . 0.0 109.942 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -69.76 157.89 58.82 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.247 1.964 . . . . 0.0 109.303 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 C--O 1.251 1.173 0 C-N-CA 122.454 2.103 . . . . 0.0 110.763 176.115 . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.076 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.51 171.81 10.69 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.741 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -55.43 103.7 0.1 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.485 0.714 . . . . 0.0 110.373 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -142.9 154.09 43.76 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.803 0.841 . . . . 0.0 109.09 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.53 139.99 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.043 1.337 . . . . 0.0 108.662 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.5 pt -104.25 156.74 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.481 1.113 . . . . 0.0 109.865 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.51 118.13 18.86 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.4 pt -55.56 133.47 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 166.192 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.4 -169.32 42.44 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -52.17 -44.08 48.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.628 2.885 . . . . 0.0 112.676 -172.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -53.15 -57.13 11.52 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.554 0.692 . . . . 0.0 111.463 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.97 -45.07 94.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.507 0.723 . . . . 0.0 109.974 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -55.85 -48.83 74.83 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.492 0.717 . . . . 0.0 109.22 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -55.08 -51.81 65.2 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.322 0.649 . . . . 0.0 110.608 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 19.6 mt -59.23 -45.23 91.69 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.675 -0.64 . . . . 0.0 111.642 178.279 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.98 -39.93 92.58 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -64.74 -52.33 57.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -50.98 -45.29 60.93 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.582 1.153 . . . . 0.0 110.849 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.1 70.67 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.0 -41.68 93.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.019 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.0 -48.81 77.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.236 0.614 . . . . 0.0 109.458 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.24 -52.77 63.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.575 1.15 . . . . 0.0 109.36 175.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -57.71 -45.01 86.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 122.997 0.519 . . . . 0.0 110.365 -174.919 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -67.57 -43.77 79.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.786 1.634 . . . . 0.0 110.633 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.35 -44.48 96.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.9 0.48 . . . . 0.0 110.048 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.2 -43.67 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.47 12.94 57.82 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.444 1.021 . . . . 0.0 112.741 173.412 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -47.99 -46.08 32.34 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.246 1.023 . . . . 0.0 111.868 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -111.16 24.02 13.39 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.524 1.13 . . . . 0.0 110.798 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.33 -158.44 26.75 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -81.11 89.86 6.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.4 0.68 . . . . 0.0 110.796 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.6 140.52 48.09 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 169.465 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.5 m -95.56 93.84 7.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -48.67 129.37 16.5 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.689 0.222 . . . . 0.0 110.71 177.165 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -102.82 -62.05 1.32 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -174.16 -161.36 0.12 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.057 1.343 . . . . 0.0 108.741 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.37 145.19 34.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.43 162.7 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 118.353 0.524 . . . . 0.0 110.388 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 151.32 67.38 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.77 1.228 . . . . 0.0 111.22 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.8 130.99 21.9 Favored 'Cis proline' 0 C--N 1.348 0.545 0 CA-C-N 120.035 1.048 . . . . 0.0 112.353 4.765 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 96.3 m -125.39 99.93 6.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 96.5 mtp -115.28 160.05 20.26 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.689 0.796 . . . . 0.0 110.902 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -133.94 158.48 43.37 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 167.617 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -150.58 173.16 14.43 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.9 m -98.27 135.18 40.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.531 1.132 . . . . 0.0 112.041 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.19 136.71 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.286 1.834 . . . . 0.0 108.705 171.156 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -161.91 174.86 12.52 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -170.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.38 172.59 15.17 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 172.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -78.54 -28.26 46.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.582 2.353 . . . . 0.0 111.758 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -15.64 89.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.178 2.591 . . . . 0.0 114.133 -174.644 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.22 -62.44 3.0 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -142.68 158.46 43.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.001 1.32 . . . . 0.0 107.781 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -54.87 129.42 37.33 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 119.416 -0.326 . . . . 0.0 110.153 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -154.11 134.84 13.65 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.073 0.397 . . . . 0.0 110.81 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.51 127.99 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.998 1.319 . . . . 0.0 109.625 171.766 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -108.56 -22.37 12.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.749 0.82 . . . . 0.0 110.539 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.54 -162.39 28.55 Favored Glycine 0 C--N 1.336 0.566 0 O-C-N 121.408 -0.807 . . . . 0.0 111.479 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -142.59 155.14 44.94 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.118 1.367 . . . . 0.0 107.679 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -108.59 150.16 27.88 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.835 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -129.2 120.95 26.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -104.05 128.51 51.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 pp -151.88 153.02 33.34 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.814 0.734 . . . . 0.0 111.519 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -96.73 99.81 11.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.264 1.026 . . . . 0.0 108.7 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.77 135.46 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.9 113.09 26.43 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.462 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.01 132.48 23.55 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 123.568 0.747 . . . . 0.0 109.31 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 m 51.08 36.3 15.1 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.759 1.223 . . . . 0.0 111.185 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 56.12 30.87 17.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.272 1.029 . . . . 0.0 112.726 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.5 150.32 42.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 168.737 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mp -92.59 128.53 38.48 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.939 1.296 . . . . 0.0 108.452 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -127.05 132.04 50.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.27 1.028 . . . . 0.0 108.283 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 112.31 21.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.41 139.55 42.98 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -114.15 123.6 50.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.501 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mm -112.46 149.88 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.501 1.92 . . . . 0.0 105.907 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.9 t -117.7 150.37 39.18 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.94 113.47 15.24 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 127.363 2.265 . . . . 0.0 105.585 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -82.28 118.76 23.37 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -58.28 -52.3 66.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.302 1.441 . . . . 0.0 111.502 -171.218 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.17 -45.02 71.03 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 m -72.19 -29.78 64.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.45 0.3 . . . . 0.0 110.591 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 55.35 49.01 17.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.405 1.082 . . . . 0.0 109.53 -168.469 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -133.58 140.61 11.95 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.78 172.8 6.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.583 0.753 . . . . 0.0 111.187 -174.215 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -167.63 142.51 3.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.226 1.011 . . . . 0.0 111.056 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.63 121.84 17.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.7 tp -84.6 -45.43 12.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -162.49 143.93 10.42 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.069 0.547 . . . . 0.0 110.24 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -125.82 111.9 15.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.838 1.655 . . . . 0.0 107.197 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -116.9 151.23 37.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.0 -170.79 22.72 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.622 1.106 . . . . 0.0 110.491 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.39 152.13 88.13 Favored 'Cis proline' 0 N--CA 1.455 -0.762 0 CA-C-N 118.324 1.062 . . . . 0.0 110.702 1.826 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.48 143.69 39.46 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.878 0.871 . . . . 0.0 108.851 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.24 158.24 37.38 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.302 2.002 . . . . 0.0 109.299 173.119 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -70.75 154.26 63.9 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.918 1.745 . . . . 0.0 108.927 169.347 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.25 1.104 0 C-N-CA 122.323 2.015 . . . . 0.0 110.639 175.671 . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.173 0 N-CA-C 111.677 -0.569 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.32 87.35 2.69 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.411 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.4 m95 29.73 73.03 0.05 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.506 1.922 . . . . 0.0 113.578 -174.614 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -122.41 148.86 44.58 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.109 0.563 . . . . 0.0 109.597 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.46 138.46 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.9 pt -106.35 155.41 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.014 0.926 . . . . 0.0 110.18 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.56 140.78 58.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.32 120.61 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.01 -167.43 33.59 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -174.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -52.99 -43.78 54.17 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.515 2.81 . . . . 0.0 113.326 -172.527 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -51.12 -55.99 14.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.481 1.134 . . . . 0.0 111.159 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.33 -42.87 96.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.757 1.223 . . . . 0.0 109.797 -175.761 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -56.69 -48.22 78.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.888 0.875 . . . . 0.0 109.408 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -56.57 -49.24 75.46 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.03 0.532 . . . . 0.0 110.921 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.08 -45.9 82.96 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 117.846 0.293 . . . . 0.0 110.997 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.69 -53.84 40.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -52.66 -48.45 66.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.398 1.079 . . . . 0.0 110.86 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -56.4 -49.1 75.46 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.709 0.804 . . . . 0.0 110.713 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.59 78.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 110.258 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.93 -47.64 85.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.374 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.1 -48.55 81.14 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.727 1.211 . . . . 0.0 110.06 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -65.14 -43.61 91.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.659 0.783 . . . . 0.0 109.902 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -58.99 -48.66 80.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.419 171.33 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -54.52 -39.9 68.06 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.399 1.08 . . . . 0.0 110.276 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -49.43 -37.79 26.95 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.0 0.92 . . . . 0.0 111.141 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.14 -47.43 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.228 1.011 . . . . 0.0 109.355 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.0 28.35 23.57 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.32 0.962 . . . . 0.0 111.19 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -55.99 -38.26 70.2 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.502 0.651 . . . . 0.0 111.39 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -117.59 42.76 2.53 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.838 0.828 . . . . 0.0 109.825 170.852 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.72 -148.1 39.28 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -102.6 115.18 30.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.809 0.844 . . . . 0.0 109.623 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 mp -110.62 137.0 48.86 Favored 'General case' 0 N--CA 1.458 -0.046 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.2 m -86.07 131.47 34.26 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -60.04 135.51 57.73 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -105.76 -64.01 1.19 Allowed 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -165.41 161.32 18.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.19 0.596 . . . . 0.0 109.637 -173.474 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.93 144.41 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 125.429 1.491 . . . . 0.0 107.594 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.16 159.99 9.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 123.011 0.524 . . . . 0.0 110.187 -176.26 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -61.39 152.89 71.61 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.831 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.43 153.79 98.71 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 CA-C-N 119.294 0.783 . . . . 0.0 111.08 -4.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.9 m -141.13 100.6 3.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.3 mtt -113.24 155.0 25.85 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.28 1.032 . . . . 0.0 110.704 -174.709 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -138.38 154.7 48.92 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 167.998 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -150.15 160.05 43.96 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.396 1.079 . . . . 0.0 110.981 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.9 m -84.06 139.55 32.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.741 1.216 . . . . 0.0 112.851 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.07 137.05 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.756 1.622 . . . . 0.0 109.712 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -169.54 174.48 5.87 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.23 0.612 . . . . 0.0 111.737 -167.246 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -110.59 -159.38 0.68 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.96 1.304 . . . . 0.0 110.564 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -164.06 -46.94 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.625 1.57 . . . . 0.0 109.812 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.47 72.83 0.22 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.031 1.332 . . . . 0.0 111.84 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.57 -82.57 0.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 107.604 -2.199 . . . . 0.0 107.604 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -141.07 140.37 34.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -64.82 100.61 0.41 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -138.81 125.38 20.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.489 1.115 . . . . 0.0 108.581 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.84 132.67 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 170.276 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -112.69 -27.51 8.15 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.352 0.661 . . . . 0.0 111.458 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.11 -160.48 24.57 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.08 163.57 33.17 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.795 1.238 . . . . 0.0 108.356 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.57 145.76 48.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.492 1.517 . . . . 0.0 107.972 168.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -121.3 140.37 52.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -136.78 114.2 10.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.66 163.17 39.18 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.289 0.236 . . . . 0.0 110.711 -169.378 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -103.16 139.21 38.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 123.728 0.811 . . . . 0.0 110.345 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.48 137.4 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.421 1.488 . . . . 0.0 108.037 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.38 124.17 38.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 168.325 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.45 121.08 23.95 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.476 1.11 . . . . 0.0 109.554 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t 71.87 -63.31 0.43 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 129.318 3.047 . . . . 0.0 108.588 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -173.22 10.8 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.965 2.906 . . . . 0.0 111.064 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -113.77 130.75 56.4 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 119.432 1.014 . . . . 0.0 108.828 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 tt -87.96 123.49 32.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.775 1.23 . . . . 0.0 108.116 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -133.3 159.23 40.85 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.81 0.844 . . . . 0.0 110.035 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -91.35 136.59 33.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.692 0.797 . . . . 0.0 108.957 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.57 135.26 53.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.94 130.5 56.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 169.785 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.81 136.73 58.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 125.513 1.525 . . . . 0.0 106.89 -173.558 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.3 p -103.4 151.32 22.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.437 0.695 . . . . 0.0 109.295 171.676 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -126.62 119.6 27.45 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 126.802 2.041 . . . . 0.0 106.857 173.861 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.45 118.82 30.89 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -60.57 -46.47 90.1 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.081 0.953 . . . . 0.0 111.446 -171.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -63.74 -49.5 72.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.902 0.481 . . . . 0.0 111.542 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.8 m -71.27 -30.25 66.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.8 ttm-85 58.04 41.9 23.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.538 1.135 . . . . 0.0 109.056 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -131.23 150.76 19.5 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -120.35 167.72 12.03 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.539 0.735 . . . . 0.0 109.705 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.09 147.68 19.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 169.999 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.0 tp -57.33 109.9 0.76 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.295 1.438 . . . . 0.0 108.147 170.96 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.92 -54.53 8.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.188 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.78 156.78 42.42 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.598 0.759 . . . . 0.0 109.541 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -120.98 127.36 51.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 168.737 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -137.19 155.43 49.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.91 -159.57 21.5 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -169.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -66.09 159.62 76.66 Favored 'Cis proline' 0 N--CA 1.457 -0.674 0 CA-C-N 119.099 1.45 . . . . 0.0 112.07 2.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.13 136.99 23.67 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.4 157.55 41.03 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.998 1.798 . . . . 0.0 109.646 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -67.92 154.14 73.6 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.827 1.685 . . . . 0.0 109.229 169.36 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--O 1.251 1.173 0 C-N-CA 122.493 2.129 . . . . 0.0 110.839 177.822 . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.295 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -163.28 157.35 20.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 m95 37.37 56.64 1.37 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.103 1.361 . . . . 0.0 111.748 -169.369 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.72 143.22 33.08 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.455 -178.307 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mp -78.26 140.26 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 pt -113.82 156.24 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.072 0.949 . . . . 0.0 109.673 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.3 167.44 18.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.807 0.813 . . . . 0.0 109.773 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pp -100.44 164.21 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 164.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.46 -174.12 23.54 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -169.109 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.05 -43.19 50.34 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.847 3.031 . . . . 0.0 112.382 -173.097 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -51.22 -58.11 7.02 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.019 0.914 . . . . 0.0 110.871 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.14 -41.18 86.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.665 -171.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -53.71 -53.79 47.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.643 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -51.68 -50.31 60.68 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.771 0.714 . . . . 0.0 110.712 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.22 -49.92 74.48 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.032 -0.418 . . . . 0.0 110.877 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.0 -34.23 71.7 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 122.142 -0.349 . . . . 0.0 112.257 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -73.06 -48.18 38.28 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -51.58 -47.19 63.6 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.279 1.031 . . . . 0.0 110.554 169.569 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.97 -53.33 59.3 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.093 0.473 . . . . 0.0 110.052 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.36 -40.08 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.771 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.72 -48.11 83.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.436 -0.79 . . . . 0.0 109.666 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -58.81 -50.27 74.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.282 1.033 . . . . 0.0 109.516 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -53.78 -44.94 70.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.278 0.631 . . . . 0.0 110.778 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -69.98 -39.69 75.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.554 1.542 . . . . 0.0 110.589 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -58.33 -46.03 86.99 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.86 -43.77 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.41 24.59 33.3 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.243 1.401 . . . . 0.0 110.282 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -57.85 -35.33 70.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.519 0.728 . . . . 0.0 111.47 -169.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -129.27 45.43 2.8 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.013 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.17 -140.11 46.44 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 86.33 2.97 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.066 1.346 . . . . 0.0 109.219 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.94 138.1 37.02 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.494 -0.754 . . . . 0.0 110.124 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 m -96.61 95.55 8.04 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -45.67 131.45 8.96 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 123.245 0.618 . . . . 0.0 110.234 173.113 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -102.0 -66.12 0.94 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -173.36 154.16 2.57 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.93 0.892 . . . . 0.0 110.546 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.79 144.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 168.439 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.97 156.92 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.815 0.846 . . . . 0.0 110.144 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.9 ptt85 -63.42 153.01 83.96 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.708 1.203 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.11 154.72 98.36 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 CA-C-N 119.443 0.837 . . . . 0.0 111.268 -5.335 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 89.9 m -137.66 131.04 30.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 mtp -135.82 158.08 45.26 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.44 0.696 . . . . 0.0 110.965 -169.965 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -145.07 154.58 42.64 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.251 0.621 . . . . 0.0 111.059 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -144.47 142.09 30.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.054 0.942 . . . . 0.0 111.381 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -73.95 123.36 24.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.753 2.421 . . . . 0.0 111.395 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.61 100.91 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 122.387 1.089 . . . . 0.0 108.17 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -81.09 166.48 20.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.517 1.127 . . . . 0.0 110.348 174.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -148.04 162.23 39.78 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 166.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -58.12 -52.99 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.794 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 45.86 -151.36 0.07 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.957 1.703 . . . . 0.0 112.366 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.15 64.34 3.75 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 169.306 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.4 t80 73.01 163.24 0.27 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.165 1.786 . . . . 0.0 110.43 -167.532 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -33.2 112.29 0.12 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.107 1.763 . . . . 0.0 112.338 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -142.92 145.63 33.23 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.935 0.494 . . . . 0.0 109.742 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.9 mt -80.64 101.95 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 172.432 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -19.44 33.85 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.612 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.71 -167.1 30.61 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.464 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -142.29 164.63 29.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.313 1.445 . . . . 0.0 108.157 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -122.49 146.22 47.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 106.725 171.025 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -127.42 138.85 53.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 176.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -136.86 117.64 14.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 pp -150.87 146.27 26.22 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 118.438 0.563 . . . . 0.0 111.573 -169.15 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -89.98 130.62 36.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.022 0.929 . . . . 0.0 109.446 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.08 135.06 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 124.336 1.054 . . . . 0.0 110.424 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -89.22 128.81 35.85 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.592 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 125.49 25.56 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 t 52.34 40.0 28.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.961 0.905 . . . . 0.0 111.105 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.1 t70 57.54 23.0 8.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.012 1.325 . . . . 0.0 113.359 -176.873 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.78 132.08 54.5 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 169.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -91.2 124.52 35.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.818 0.847 . . . . 0.0 108.725 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.05 159.29 37.98 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.176 1.39 . . . . 0.0 109.215 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -101.08 123.11 44.74 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 167.623 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.83 133.85 41.78 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -122.77 124.8 44.17 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.359 1.063 . . . . 0.0 108.37 172.121 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.46 155.02 41.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 126.557 1.943 . . . . 0.0 106.684 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.9 m -127.79 164.94 21.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.424 0.556 . . . . 0.0 109.813 168.645 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.97 133.37 44.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.431 1.892 . . . . 0.0 107.595 175.877 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -105.21 109.11 20.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.256 1.422 . . . . 0.0 107.911 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -56.89 -31.95 65.39 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.394 1.477 . . . . 0.0 111.092 -173.327 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -48.86 -26.91 2.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.416 1.486 . . . . 0.0 112.928 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.1 m -144.22 17.54 1.72 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.64 0.654 . . . . 0.0 111.151 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 49.07 30.86 3.08 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.896 0.878 . . . . 0.0 110.442 -169.841 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.36 125.8 8.17 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -168.554 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -98.03 167.14 11.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.855 0.836 . . . . 0.0 112.433 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -164.53 128.22 2.5 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.035 -170.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.28 121.97 16.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.5 mp -84.33 -50.58 7.7 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 170.096 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -161.88 161.42 28.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.724 0.297 . . . . 0.0 110.649 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -127.79 82.34 2.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -83.33 137.85 33.79 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.18 -166.61 25.69 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -68.68 154.32 90.16 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 118.175 0.988 . . . . 0.0 110.726 1.643 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.6 149.21 49.75 Favored Pre-proline 0 C--O 1.227 -0.108 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.1 155.88 52.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.505 1.47 . . . . 0.0 109.076 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.03 145.29 73.17 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.632 1.555 . . . . 0.0 108.782 169.56 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.25 1.11 0 C-N-CA 122.465 2.11 . . . . 0.0 110.763 179.101 . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.216 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.79 70.08 1.87 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.97 0.508 . . . . 0.0 111.621 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -163.88 82.87 0.44 Allowed 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 125.225 1.41 . . . . 0.0 107.783 168.358 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -147.13 156.71 43.22 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.4 mp -76.08 131.34 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.666 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.1 153.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.54 0.736 . . . . 0.0 109.626 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.49 122.65 19.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.5 pt -64.44 146.34 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.222 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.2 -177.59 32.33 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -166.936 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.95 -47.27 27.53 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.041 3.161 . . . . 0.0 113.352 -169.089 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -54.22 -54.19 43.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 122.217 1.008 . . . . 0.0 111.101 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.3 m -65.92 -41.48 91.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.438 0.695 . . . . 0.0 110.239 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -54.15 -54.69 36.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.45 169.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -50.02 -49.39 50.97 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.898 0.772 . . . . 0.0 111.004 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.79 -49.42 76.4 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.074 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.78 -27.93 62.39 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.945 -0.472 . . . . 0.0 112.762 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -79.7 -52.82 7.47 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -46.26 -45.15 17.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.386 1.475 . . . . 0.0 110.802 172.165 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.46 -55.64 26.91 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.517 0.675 . . . . 0.0 110.523 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.32 -39.93 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.754 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.58 -48.9 78.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.615 0.766 . . . . 0.0 109.701 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -59.94 -49.55 77.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.216 1.007 . . . . 0.0 109.24 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -54.93 -47.0 75.01 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.96 0.504 . . . . 0.0 110.732 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -65.78 -40.53 92.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.315 1.446 . . . . 0.0 110.298 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -58.07 -45.16 87.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.4 mt -69.1 -42.72 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.29 37.75 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.276 1.417 . . . . 0.0 112.167 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.69 -39.45 80.75 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.978 0.889 . . . . 0.0 111.581 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -110.84 34.83 3.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.108 0.963 . . . . 0.0 109.794 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.08 -130.42 44.63 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -119.92 84.73 2.26 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.923 1.289 . . . . 0.0 109.305 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.01 139.82 40.19 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.95 -0.469 . . . . 0.0 109.946 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.4 m -97.39 94.57 7.13 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -48.33 135.31 13.86 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 122.756 0.422 . . . . 0.0 110.204 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.86 -62.47 1.47 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.089 0.956 . . . . 0.0 109.097 176.668 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.15 178.3 4.46 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.551 1.14 . . . . 0.0 108.959 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.48 142.88 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.838 1.255 . . . . 0.0 109.348 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.6 171.56 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.873 0.869 . . . . 0.0 109.37 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 151.4 94.1 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.532 -175.225 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.33 160.97 85.88 Favored 'Cis proline' 0 C--N 1.348 0.519 0 CA-C-N 120.098 1.071 . . . . 0.0 111.649 0.049 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.9 p -177.0 77.52 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 -163.935 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.5 ttt -122.01 134.25 54.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.42 1.088 . . . . 0.0 109.225 -165.596 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -103.47 138.44 40.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 117.991 -1.004 . . . . 0.0 111.027 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -134.62 145.59 48.77 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.944 0.793 . . . . 0.0 111.471 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.6 m -74.46 139.02 43.62 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.884 0.473 . . . . 0.0 109.925 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.62 126.06 71.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.905 1.282 . . . . 0.0 109.257 175.296 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -139.65 150.72 45.27 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.009 0.924 . . . . 0.0 109.946 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -176.51 173.24 2.07 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.996 1.718 . . . . 0.0 107.23 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -150.05 -65.23 0.21 Allowed 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 125.048 1.339 . . . . 0.0 108.663 169.336 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -175.07 77.21 0.03 OUTLIER 'General case' 0 C--O 1.247 0.966 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.38 -60.58 2.36 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -165.434 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -57.57 165.5 1.58 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.331 1.452 . . . . 0.0 110.843 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.2 ptt-85 -109.31 160.48 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.45 1.9 . . . . 0.0 110.609 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.47 139.19 0.56 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.16 2.184 . . . . 0.0 105.898 167.555 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.28 125.48 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 119.427 1.012 . . . . 0.0 109.158 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -122.44 -34.19 3.31 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.235 0.614 . . . . 0.0 111.482 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -172.35 -160.1 20.21 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.507 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -135.67 163.9 29.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.675 1.19 . . . . 0.0 108.244 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -124.59 143.54 50.64 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.664 1.585 . . . . 0.0 108.043 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -124.13 111.91 16.47 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -106.62 110.72 22.99 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.87 141.72 34.6 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.028 0.831 . . . . 0.0 112.46 -172.432 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -87.91 101.99 14.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.896 0.879 . . . . 0.0 109.464 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.83 125.68 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.509 1.524 . . . . 0.0 109.301 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.8 117.79 24.89 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.889 1.276 . . . . 0.0 107.988 169.982 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.2 127.98 36.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.581 1.152 . . . . 0.0 108.17 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 t 51.27 39.4 23.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.104 0.962 . . . . 0.0 111.322 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.0 t0 55.26 22.79 5.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.087 1.355 . . . . 0.0 113.707 -176.242 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -111.76 135.87 51.79 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.4 tp -100.11 126.39 46.34 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -131.63 142.8 49.95 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.604 1.162 . . . . 0.0 109.674 -176.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -82.69 106.9 14.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.13 0.972 . . . . 0.0 108.707 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.43 124.64 34.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -110.62 108.9 18.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.27 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.0 mp -104.64 152.72 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.5 t -125.48 152.61 44.72 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.796 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.57 131.81 54.33 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.718 1.607 . . . . 0.0 107.779 173.538 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.04 124.03 35.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.768 0.827 . . . . 0.0 109.519 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -66.92 -29.41 69.28 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.197 -0.939 . . . . 0.0 111.979 -172.861 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -58.41 8.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.45 0.7 . . . . 0.0 111.329 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.24 -14.72 22.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.324 0.65 . . . . 0.0 110.827 -173.567 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.3 mtm-85 54.53 41.75 31.76 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.462 1.105 . . . . 0.0 110.737 -174.26 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.91 158.2 14.56 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 173.774 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.12 165.92 12.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.673 0.736 . . . . 0.0 111.548 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -157.92 148.74 20.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.875 1.27 . . . . 0.0 110.985 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 tp -69.57 127.4 32.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.936 0.894 . . . . 0.0 109.091 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.4 -51.43 6.22 Favored 'General case' 0 C--O 1.228 -0.039 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 167.288 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.3 167.55 25.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 117.909 0.322 . . . . 0.0 111.502 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -133.59 86.06 2.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.678 1.591 . . . . 0.0 107.264 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.7 146.65 25.59 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.25 -164.77 28.66 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.052 -0.86 . . . . 0.0 111.101 174.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.09 146.85 64.48 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 CA-C-N 118.155 0.978 . . . . 0.0 110.744 -0.572 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.5 126.46 17.17 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 124.91 1.284 . . . . 0.0 108.168 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.66 162.6 40.83 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.426 2.084 . . . . 0.0 108.936 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.55 119.0 6.01 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.634 1.556 . . . . 0.0 108.575 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--O 1.251 1.138 0 C-N-CA 121.969 1.78 . . . . 0.0 110.874 -176.587 . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.274 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.88 139.34 33.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 87.08 115.52 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 129.443 3.097 . . . . 0.0 108.384 167.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.99 158.78 28.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.761 0.71 . . . . 0.0 110.694 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.6 mm -64.93 148.34 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.906 1.282 . . . . 0.0 108.801 171.435 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 pt -114.08 152.06 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.145 1.378 . . . . 0.0 108.852 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -82.12 125.62 31.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 pt -60.19 132.79 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 166.871 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.61 -176.22 44.2 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -52.1 -49.04 18.68 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.71 2.94 . . . . 0.0 113.237 -169.773 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -54.31 -56.06 22.21 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.153 0.978 . . . . 0.0 110.849 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -64.94 -39.27 93.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.383 1.073 . . . . 0.0 110.497 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -59.28 -46.73 87.74 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.437 0.695 . . . . 0.0 109.813 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -57.0 -46.7 82.11 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 118.592 0.633 . . . . 0.0 110.633 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.27 -46.07 83.45 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.209 -0.307 . . . . 0.0 110.64 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.49 -51.84 53.89 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.596 -0.601 . . . . 0.0 111.596 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -57.4 -48.02 80.19 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.539 1.535 . . . . 0.0 109.063 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -55.21 -47.44 75.28 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.705 1.202 . . . . 0.0 110.702 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.19 -53.4 57.64 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.672 0.749 . . . . 0.0 110.274 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.55 -39.81 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.125 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.62 -48.86 75.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.817 1.247 . . . . 0.0 109.494 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -55.99 -51.73 66.72 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.105 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.71 -46.08 88.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.111 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -59.26 -45.63 90.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.182 0.993 . . . . 0.0 109.495 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.35 -45.29 95.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.446 0.698 . . . . 0.0 110.351 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.5 mt -70.39 -43.27 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.78 14.18 55.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.726 1.155 . . . . 0.0 112.863 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -50.32 -44.43 54.21 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.232 1.016 . . . . 0.0 111.995 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.09 34.79 4.25 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.75 0.786 . . . . 0.0 110.099 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.93 -143.43 48.64 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 -100.19 124.23 45.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.292 1.037 . . . . 0.0 108.961 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.53 134.9 50.76 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.111 0.964 . . . . 0.0 110.289 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.0 m -95.59 99.02 10.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.032 1.333 . . . . 0.0 108.994 -174.901 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -45.41 122.83 3.73 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 122.892 0.477 . . . . 0.0 110.712 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.15 -61.0 1.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.309 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -169.52 -165.63 0.53 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.19 149.85 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 126.342 1.857 . . . . 0.0 107.327 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -142.55 160.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -66.72 154.42 91.67 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.515 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.65 141.85 72.59 Favored 'Cis proline' 0 N--CA 1.455 -0.76 0 CA-C-N 118.89 0.639 . . . . 0.0 111.322 0.176 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -132.91 108.87 9.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.4 ttt -133.57 143.46 48.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 119.148 0.885 . . . . 0.0 109.529 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -119.48 144.44 46.99 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.057 0.39 . . . . 0.0 111.95 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -121.37 149.53 42.83 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.2 m -80.77 137.97 36.27 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.62 132.02 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.205 1.402 . . . . 0.0 108.211 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -168.2 176.78 5.8 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.448 -0.782 . . . . 0.0 110.217 -167.58 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -159.53 170.92 20.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -79.08 -59.3 2.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.152 0.981 . . . . 0.0 109.384 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 45.72 55.51 6.75 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.594 1.158 . . . . 0.0 109.796 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.96 -71.33 1.42 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -115.47 103.18 10.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.205 1.002 . . . . 0.0 110.414 -174.668 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -28.72 126.24 0.1 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.283 2.233 . . . . 0.0 114.238 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.95 134.63 15.48 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.4 mm -64.5 127.14 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -100.44 -25.16 14.3 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.227 0.467 . . . . 0.0 111.431 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.73 -164.49 32.17 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 118.649 0.659 . . . . 0.0 111.461 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -144.22 164.77 29.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.038 1.335 . . . . 0.0 107.561 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -127.4 145.19 50.9 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.063 0.945 . . . . 0.0 108.816 167.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.2 119.12 32.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -114.84 105.36 12.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.12 143.41 47.95 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.819 0.848 . . . . 0.0 111.191 -168.974 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -87.71 110.12 20.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.1 p -95.24 139.43 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.502 1.121 . . . . 0.0 108.824 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -108.38 120.81 43.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.94 132.88 22.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m 46.81 45.08 14.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.117 0.967 . . . . 0.0 111.309 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t70 63.57 10.89 5.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.105 1.362 . . . . 0.0 113.656 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -110.52 140.22 45.02 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.227 1.411 . . . . 0.0 107.94 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.1 tp -98.69 120.47 39.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.135 0.974 . . . . 0.0 109.018 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -123.18 154.28 38.92 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.961 1.304 . . . . 0.0 108.638 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -96.45 128.79 43.71 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.647 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.11 126.92 55.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.809 1.244 . . . . 0.0 107.903 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -112.64 100.92 9.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.7 mm -96.21 147.34 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.727 1.611 . . . . 0.0 107.51 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -121.44 148.43 44.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 170.244 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.9 120.83 34.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 127.714 2.406 . . . . 0.0 106.194 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -97.27 115.72 28.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -63.48 -45.9 88.64 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.9 1.68 . . . . 0.0 110.701 -169.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -64.68 -50.21 67.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.83 0.452 . . . . 0.0 110.082 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 m -62.9 -35.18 79.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.063 0.945 . . . . 0.0 110.15 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 55.31 48.07 20.02 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.782 2.033 . . . . 0.0 110.141 -168.702 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.02 155.13 22.58 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -115.61 170.23 8.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.447 0.699 . . . . 0.0 111.124 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -165.29 149.08 8.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.544 1.138 . . . . 0.0 111.183 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.73 117.2 6.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 168.567 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.2 tp -85.0 -54.72 4.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -142.79 155.33 44.8 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -133.05 134.2 44.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 167.43 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -141.68 155.42 45.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -174.748 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.28 -164.99 16.08 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.11 154.68 91.6 Favored 'Cis proline' 0 N--CA 1.455 -0.739 0 CA-C-N 118.249 1.025 . . . . 0.0 110.275 1.318 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.61 133.47 16.84 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.69 154.18 54.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.696 1.597 . . . . 0.0 109.355 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.81 155.21 69.41 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.097 1.865 . . . . 0.0 109.374 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo . . . . . 0 C--O 1.25 1.087 0 C-N-CA 122.566 2.177 . . . . 0.0 110.736 176.901 . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.117 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -138.29 90.49 2.47 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.155 0.982 . . . . 0.0 109.153 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -159.32 110.7 2.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.94 1.696 . . . . 0.0 107.034 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -164.37 166.67 20.5 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.25 141.69 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.833 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.74 157.95 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 123.837 0.855 . . . . 0.0 109.902 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.99 148.56 48.73 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.385 0.674 . . . . 0.0 109.709 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.11 137.63 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 167.061 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.31 -171.24 44.33 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -170.18 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.03 -42.72 64.54 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.635 2.89 . . . . 0.0 113.006 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -58.25 -52.88 63.74 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.087 0.946 . . . . 0.0 111.053 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 -41.38 87.87 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.74 0.816 . . . . 0.0 109.63 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -57.38 -50.77 71.92 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.577 0.751 . . . . 0.0 109.875 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -48.96 -54.9 13.59 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.262 1.025 . . . . 0.0 109.828 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 mt -55.37 -44.34 75.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.517 0.144 . . . . 0.0 111.157 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.27 -53.63 44.21 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.283 0.468 . . . . 0.0 112.31 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -55.88 -47.84 76.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.457 1.103 . . . . 0.0 109.286 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -56.85 -48.32 78.37 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.604 0.762 . . . . 0.0 110.412 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.13 -51.19 70.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.99 -37.74 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.66 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.73 -49.7 75.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.238 1.015 . . . . 0.0 109.843 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.3 -49.52 77.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.471 0.708 . . . . 0.0 109.328 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -53.38 -50.32 65.37 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -57.65 -48.32 79.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.301 1.04 . . . . 0.0 109.945 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.95 -38.95 87.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.528 0.331 . . . . 0.0 110.632 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.7 mt -73.87 -52.83 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.07 13.18 46.91 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.46 1.505 . . . . 0.0 113.701 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -53.05 -43.68 66.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.594 1.197 . . . . 0.0 112.041 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -108.24 36.42 2.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.598 0.759 . . . . 0.0 110.005 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.97 -149.63 50.59 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -111.16 76.99 1.01 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.557 1.143 . . . . 0.0 108.802 -169.317 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.7 139.51 45.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.776 0.43 . . . . 0.0 111.448 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m -93.42 104.3 16.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -48.98 133.53 18.02 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -106.79 -65.39 1.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.57 0.748 . . . . 0.0 109.058 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -167.11 164.43 15.77 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.689 1.196 . . . . 0.0 109.017 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.43 141.42 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.354 1.062 . . . . 0.0 108.958 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -141.24 168.49 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.369 0.668 . . . . 0.0 110.67 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.59 154.66 79.11 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.11 0.964 . . . . 0.0 110.864 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.03 137.67 50.79 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 CA-C-N 119.539 0.871 . . . . 0.0 111.746 -3.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 68.9 m -126.77 121.18 31.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.2 ttm -138.77 138.71 37.86 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.199 0.6 . . . . 0.0 109.75 -167.577 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -121.29 142.95 49.46 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.999 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -132.14 141.55 49.17 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.927 0.891 . . . . 0.0 110.153 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.4 m -76.23 141.21 41.81 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.362 0.265 . . . . 0.0 110.989 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -110.56 123.72 66.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 125.772 1.629 . . . . 0.0 109.19 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -103.82 168.03 9.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.305 1.442 . . . . 0.0 110.693 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -123.19 155.86 36.26 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.147 1.379 . . . . 0.0 108.233 168.027 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -113.44 -36.6 4.91 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 128.949 2.9 . . . . 0.0 109.094 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -68.55 77.29 0.28 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.082 0.953 . . . . 0.0 110.58 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.67 -69.07 0.18 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -167.03 -59.14 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.684 1.193 . . . . 0.0 108.597 173.551 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -179.82 121.61 0.07 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.782 2.033 . . . . 0.0 105.594 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -163.97 161.53 22.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.203 0.91 . . . . 0.0 110.079 171.506 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.56 131.27 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -99.43 -34.62 10.2 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.354 0.661 . . . . 0.0 109.936 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.6 -157.64 19.61 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -172.452 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -142.96 160.0 41.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -123.14 150.28 43.47 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.354 1.461 . . . . 0.0 109.05 170.739 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -133.81 123.59 25.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -122.21 127.9 50.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.77 158.08 38.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.94 0.4 . . . . 0.0 110.839 -174.415 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -96.63 112.74 24.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.998 0.919 . . . . 0.0 109.355 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 p -103.28 132.45 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 124.091 0.956 . . . . 0.0 109.543 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.72 119.95 28.56 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.655 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.84 127.6 36.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 t 53.06 39.81 30.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.58 0.752 . . . . 0.0 111.001 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.8 t0 53.45 28.1 7.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.064 1.345 . . . . 0.0 113.245 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -118.61 134.88 54.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.2 tp -89.73 128.37 36.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -129.32 139.87 51.6 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.992 1.317 . . . . 0.0 109.711 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -88.19 108.2 19.16 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.868 1.267 . . . . 0.0 108.566 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.57 134.6 48.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -123.63 125.24 44.47 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.517 1.527 . . . . 0.0 107.608 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.09 146.74 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 126.004 1.721 . . . . 0.0 108.132 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.5 161.16 15.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.912 0.885 . . . . 0.0 108.744 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.66 119.33 11.1 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -97.32 122.06 39.92 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.729 1.212 . . . . 0.0 109.837 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -58.04 -39.38 78.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.27 0.628 . . . . 0.0 112.423 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -56.48 -51.62 67.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.153 0.581 . . . . 0.0 111.039 -171.187 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.6 p -107.31 4.81 26.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.547 1.139 . . . . 0.0 111.555 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.9 ptt85 46.78 40.72 9.28 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.809 1.244 . . . . 0.0 110.185 -168.618 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.88 125.31 8.36 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.6 -167.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -78.66 175.07 10.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.617 1.167 . . . . 0.0 109.952 171.555 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.67 118.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.994 2.117 . . . . 0.0 113.512 -167.891 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.1 tp -65.82 132.1 47.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.89 -62.58 1.46 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 167.751 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -145.65 151.95 38.87 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.322 0.649 . . . . 0.0 109.699 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -135.46 115.12 12.8 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 176.345 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.39 143.12 51.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.662 0.785 . . . . 0.0 108.893 -167.809 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.0 -157.69 25.49 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.79 156.75 82.75 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 CA-C-N 118.757 1.279 . . . . 0.0 110.123 -1.973 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 m -120.46 135.98 24.94 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.16 152.85 31.47 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.034 1.823 . . . . 0.0 108.772 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.51 151.08 64.55 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.824 1.682 . . . . 0.0 109.171 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.479 2.119 . . . . 0.0 110.674 176.398 . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.356 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.01 59.38 1.74 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 172.519 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER 61.35 96.91 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.351 1.46 . . . . 0.0 110.737 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -149.38 154.92 39.66 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.377 -0.827 . . . . 0.0 110.367 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.0 mt -72.65 132.57 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 pt -99.14 153.79 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.299 0.64 . . . . 0.0 110.7 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.92 124.45 20.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.754 0.821 . . . . 0.0 108.791 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.29 122.12 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.653 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.79 -160.47 26.98 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.44 -46.24 25.6 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.865 2.377 . . . . 0.0 112.974 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -53.07 -54.72 31.3 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.31 1.052 . . . . 0.0 111.076 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -47.46 83.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.963 1.305 . . . . 0.0 109.416 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -53.74 -49.24 68.59 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.636 0.774 . . . . 0.0 110.025 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -55.94 -49.2 74.16 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.315 0.646 . . . . 0.0 110.859 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.27 -44.41 95.36 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.779 -0.576 . . . . 0.0 111.218 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.73 -47.53 87.98 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -52.84 -54.02 40.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.929 1.292 . . . . 0.0 109.793 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -55.95 -46.22 78.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.472 1.109 . . . . 0.0 110.623 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.02 -51.69 68.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.924 0.392 . . . . 0.0 110.467 177.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.91 -39.41 85.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.57 -50.86 70.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.976 0.91 . . . . 0.0 109.479 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -56.15 -51.04 69.42 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.13 0.972 . . . . 0.0 109.286 176.907 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -57.04 -51.24 70.05 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -55.32 -44.22 75.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.759 1.224 . . . . 0.0 109.999 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -58.07 -42.63 85.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.894 0.478 . . . . 0.0 110.414 -177.18 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.1 mt -73.41 -46.69 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.42 18.83 43.93 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.386 1.47 . . . . 0.0 112.716 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -54.42 -43.09 71.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.378 1.089 . . . . 0.0 111.256 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -107.74 30.69 6.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.938 0.895 . . . . 0.0 110.473 176.076 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.57 -152.15 52.49 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -100.01 118.24 35.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.118 0.967 . . . . 0.0 109.227 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.28 -171.89 1.93 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.721 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.0 m -141.36 125.4 17.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -55.03 132.6 47.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -107.66 -65.31 1.12 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -175.78 4.05 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.363 0.665 . . . . 0.0 110.842 173.107 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 t -120.72 141.19 42.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.43 168.25 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.477 0.581 . . . . 0.0 110.254 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 147.91 71.11 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.682 0.793 . . . . 0.0 111.658 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.31 153.31 91.93 Favored 'Cis proline' 0 N--CA 1.455 -0.787 0 CA-C-N 119.085 0.709 . . . . 0.0 111.058 -1.317 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.8 m -142.4 87.69 2.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.8 ttt -112.43 123.5 50.43 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.149 0.58 . . . . 0.0 110.938 -167.606 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -100.23 136.37 40.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.09 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -122.85 153.91 38.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.227 1.811 . . . . 0.0 109.379 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.1 m -89.65 138.99 30.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.417 1.087 . . . . 0.0 110.124 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.64 122.71 62.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.944 1.297 . . . . 0.0 109.31 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -140.16 161.44 37.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.848 0.859 . . . . 0.0 111.227 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -106.19 162.24 13.82 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.675 1.59 . . . . 0.0 106.799 169.885 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -55.68 -69.57 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.326 1.45 . . . . 0.0 111.761 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 57.15 -171.19 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.972 0.509 . . . . 0.0 109.758 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.27 9.28 20.89 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 120.86 -1.15 . . . . 0.0 113.454 174.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -163.69 -72.44 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.985 1.392 . . . . 0.0 108.126 174.343 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -163.0 138.74 6.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.703 2.001 . . . . 0.0 106.334 171.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -114.33 95.37 5.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.061 1.744 . . . . 0.0 106.839 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.5 mt -64.47 115.08 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -91.17 -33.03 15.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.54 -148.93 9.01 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -169.232 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -147.54 169.06 20.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.376 1.07 . . . . 0.0 109.531 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -136.89 155.22 50.05 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.126 0.97 . . . . 0.0 110.203 167.381 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -133.42 118.07 17.98 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -175.395 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.59 107.95 16.86 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -150.34 152.63 34.71 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -169.286 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -99.3 116.74 32.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.272 1.029 . . . . 0.0 110.552 -173.561 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.48 127.8 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 126.06 1.744 . . . . 0.0 109.123 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -84.66 114.97 22.4 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 170.278 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.42 121.81 40.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.9 1.28 . . . . 0.0 109.016 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 t 71.15 -67.93 0.24 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 128.969 2.907 . . . . 0.0 107.058 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -178.13 26.6 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.295 2.638 . . . . 0.0 110.047 170.72 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -111.71 135.75 51.89 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.4 tp -86.9 124.44 33.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -120.5 145.19 47.52 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -86.28 131.11 34.3 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.27 138.95 53.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -118.45 121.84 41.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 171.643 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.9 mm -120.84 150.44 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.487 1.915 . . . . 0.0 106.255 -173.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t -124.48 158.16 33.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.153 0.888 . . . . 0.0 109.612 168.045 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.77 133.55 46.09 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 170.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -103.15 118.98 38.0 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 124.155 0.909 . . . . 0.0 108.818 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -64.7 -24.02 67.44 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.965 0.906 . . . . 0.0 112.304 -171.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -56.97 -40.92 77.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.586 0.63 . . . . 0.0 111.018 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.0 m -103.87 -16.88 15.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.576 0.751 . . . . 0.0 110.652 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 55.2 36.25 26.61 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.944 1.298 . . . . 0.0 109.646 -167.313 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.53 137.99 14.59 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.54 164.69 13.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.296 0.638 . . . . 0.0 111.852 -176.089 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.77 140.09 16.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.004 1.321 . . . . 0.0 110.56 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.3 125.07 22.64 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 170.03 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.54 -56.76 3.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.878 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -148.12 157.78 43.7 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.926 1.29 . . . . 0.0 109.292 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -138.07 125.15 21.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -137.65 149.49 46.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.77 -166.25 24.62 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.45 146.11 64.08 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 CA-C-N 118.23 1.015 . . . . 0.0 110.954 2.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.31 130.64 11.7 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 124.396 1.078 . . . . 0.0 108.585 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.68 161.91 43.74 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.867 1.711 . . . . 0.0 108.799 173.356 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.75 147.27 68.91 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.553 1.502 . . . . 0.0 108.969 172.451 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 122.403 2.069 . . . . 0.0 110.797 178.131 . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.272 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -75.61 66.56 1.98 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.169 0.987 . . . . 0.0 111.83 -172.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -59.68 123.82 18.15 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 169.359 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -169.02 163.5 11.3 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.6 mm -76.1 135.22 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.44 163.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 123.92 0.888 . . . . 0.0 109.759 174.126 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.01 154.85 40.33 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.788 0.804 . . . . 0.0 110.446 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -94.41 138.24 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 167.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.58 -170.53 43.66 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -55.91 -45.5 38.25 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.298 2.666 . . . . 0.0 111.907 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -53.59 -52.33 60.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.043 0.925 . . . . 0.0 110.732 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -42.67 91.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.794 0.838 . . . . 0.0 110.083 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -54.1 -51.98 62.46 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.478 -0.773 . . . . 0.0 109.752 172.686 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -50.48 -50.96 51.18 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.915 0.779 . . . . 0.0 110.865 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.3 mt -58.42 -49.09 78.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.96 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.91 -37.01 75.92 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 122.108 -0.37 . . . . 0.0 112.238 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -73.96 -45.37 50.64 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.24 -48.32 65.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.03 0.932 . . . . 0.0 110.876 169.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.26 -53.44 58.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.574 0.702 . . . . 0.0 110.369 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.0 t -61.42 -38.47 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.632 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.55 -48.63 76.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.924 0.89 . . . . 0.0 109.974 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.77 -49.82 72.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.996 0.918 . . . . 0.0 108.727 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.22 -44.29 95.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.376 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -62.42 -44.7 95.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.228 1.011 . . . . 0.0 109.795 175.232 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -58.62 -47.81 83.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.486 0.714 . . . . 0.0 109.892 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.01 -39.53 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.58 22.83 61.39 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.73 1.157 . . . . 0.0 110.474 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -60.79 -33.64 73.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 117.651 0.726 . . . . 0.0 111.312 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -116.01 32.03 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.446 1.098 . . . . 0.0 109.591 174.427 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.7 -151.96 46.2 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -87.56 135.0 33.53 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.136 0.575 . . . . 0.0 109.636 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.6 mt -127.99 133.42 49.17 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.132 0.973 . . . . 0.0 109.319 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.2 m -99.68 97.6 8.54 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.523 1.129 . . . . 0.0 108.321 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -50.21 132.94 24.06 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 123.466 0.706 . . . . 0.0 111.074 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -98.94 -65.11 0.98 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 168.701 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -172.26 167.63 5.79 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 123.451 0.7 . . . . 0.0 110.11 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.24 142.48 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 124.432 1.093 . . . . 0.0 109.09 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.98 177.0 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.281 0.632 . . . . 0.0 110.251 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -63.13 153.26 81.96 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.654 0.782 . . . . 0.0 112.716 -172.374 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -83.12 169.63 57.53 Favored 'Cis proline' 0 N--CA 1.45 -1.047 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 -7.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.9 t -132.97 97.8 4.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 168.179 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 126.78 33.61 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.47 1.508 . . . . 0.0 107.765 -174.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -114.01 113.77 25.24 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 118.093 -0.956 . . . . 0.0 108.652 168.539 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -114.37 141.47 47.59 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.606 1.162 . . . . 0.0 111.158 173.864 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.5 142.25 46.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.778 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.69 120.18 62.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.392 1.091 . . . . 0.0 109.251 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -151.59 178.04 9.73 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -87.99 -128.12 0.06 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -159.68 -41.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.708 0.686 . . . . 0.0 112.254 168.801 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -23.57 97.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.755 2.422 . . . . 0.0 113.884 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.41 43.21 84.97 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.355 0.502 . . . . 0.0 113.221 175.87 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.8 t80 73.04 60.18 0.1 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.663 1.585 . . . . 0.0 109.904 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -59.9 149.55 31.3 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.582 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.31 148.12 52.32 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.138 0.975 . . . . 0.0 110.063 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.41 128.73 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.16 -35.38 14.58 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.31 -152.25 9.21 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -148.42 159.72 43.75 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.584 1.554 . . . . 0.0 107.818 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -126.93 142.74 51.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.147 1.779 . . . . 0.0 108.358 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -126.9 105.63 8.76 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -106.16 117.77 34.88 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -175.384 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 pp -149.64 146.44 27.29 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.897 0.771 . . . . 0.0 111.974 -166.818 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -88.51 112.69 23.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 p -106.39 138.6 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.101 0.961 . . . . 0.0 109.523 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -103.54 123.12 46.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.133 1.773 . . . . 0.0 106.966 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.45 132.09 25.57 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t 46.77 41.48 10.4 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.447 1.099 . . . . 0.0 111.331 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.4 t70 62.45 19.47 11.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.11 1.364 . . . . 0.0 113.343 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -113.94 135.15 54.31 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.809 1.243 . . . . 0.0 107.873 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.51 126.81 37.76 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.4 143.39 50.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.934 1.294 . . . . 0.0 108.748 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -85.32 110.48 19.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.55 126.69 38.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -108.0 111.23 23.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.973 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -100.59 150.74 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.9 p -127.62 154.27 45.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.47 0.708 . . . . 0.0 109.198 176.83 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -123.33 135.97 54.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.92 120.98 40.95 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.161 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -67.31 -33.49 75.39 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.7 -0.625 . . . . 0.0 110.703 -172.947 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.062 0.945 . . . . 0.0 111.209 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -90.61 -22.95 20.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.084 0.554 . . . . 0.0 110.243 175.783 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 65.17 33.73 9.13 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.782 1.233 . . . . 0.0 110.233 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.18 155.74 15.95 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.3 mtt85 -115.13 163.74 15.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 117.446 0.623 . . . . 0.0 111.285 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 152.39 16.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.275 1.43 . . . . 0.0 111.331 177.528 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 tp -69.63 127.56 33.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.634 1.174 . . . . 0.0 109.845 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.69 -54.78 5.33 Favored 'General case' 0 C--N 1.337 0.041 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -170.44 169.05 7.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 111.197 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -131.87 88.44 2.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.288 1.835 . . . . 0.0 108.166 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.65 145.7 27.86 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.65 -159.85 24.63 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -65.42 157.05 77.35 Favored 'Cis proline' 0 N--CA 1.458 -0.559 0 CA-C-N 118.808 1.304 . . . . 0.0 110.071 -1.993 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.97 148.72 68.5 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.459 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.74 162.95 36.72 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.361 2.041 . . . . 0.0 108.722 168.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.4 153.96 75.29 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.689 1.593 . . . . 0.0 109.181 169.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.529 2.153 . . . . 0.0 110.851 177.205 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.4 mm -84.28 143.32 12.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 pt -104.99 154.84 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.637 0.775 . . . . 0.0 110.825 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.48 118.58 12.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.849 0.86 . . . . 0.0 109.388 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.45 129.13 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 172.41 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.01 -167.15 39.53 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -50.97 -41.73 55.1 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.711 2.941 . . . . 0.0 112.857 -174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -53.85 -60.75 2.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.648 0.779 . . . . 0.0 111.64 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -63.09 -43.55 98.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.617 -0.677 . . . . 0.0 110.082 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -51.03 -53.46 33.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -53.13 -49.71 65.99 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.451 0.7 . . . . 0.0 111.34 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 mt -63.98 -45.08 90.63 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.644 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.63 -43.47 96.19 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -57.23 -53.4 58.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.034 0.934 . . . . 0.0 108.872 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -53.6 -45.04 69.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.881 1.272 . . . . 0.0 110.829 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.87 -51.88 67.33 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.908 0.385 . . . . 0.0 110.585 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.12 -39.48 84.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.468 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.01 -47.58 84.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.955 0.902 . . . . 0.0 110.195 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -58.71 -53.98 52.23 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.048 0.939 . . . . 0.0 109.095 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -54.08 -48.18 70.92 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.987 0.515 . . . . 0.0 110.116 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -60.95 -44.24 97.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.343 1.457 . . . . 0.0 110.246 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.82 -42.02 96.89 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.678 0.391 . . . . 0.0 110.108 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.3 -43.51 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.58 17.78 59.65 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.983 1.278 . . . . 0.0 111.749 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -57.93 -38.45 75.96 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.7 0.75 . . . . 0.0 111.329 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -118.81 41.72 2.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.812 1.245 . . . . 0.0 109.421 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.51 -141.9 48.03 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -118.51 106.12 12.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.611 1.165 . . . . 0.0 109.2 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.49 151.92 18.88 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.177 0.444 . . . . 0.0 110.854 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.2 m -93.27 96.13 9.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -45.27 130.85 8.14 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 122.465 0.306 . . . . 0.0 110.474 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -105.82 -66.23 1.01 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.928 0.891 . . . . 0.0 109.141 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -165.56 -175.01 3.34 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -124.62 143.02 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.45 167.05 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.097 0.559 . . . . 0.0 110.057 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.04 152.12 72.31 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 122.875 0.47 . . . . 0.0 112.088 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.33 152.01 97.69 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 CA-C-N 119.074 0.705 . . . . 0.0 111.064 -3.13 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.8 m -138.85 81.07 1.82 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.5 ttm -105.77 138.53 41.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.047 0.539 . . . . 0.0 110.684 -167.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -122.29 144.84 48.75 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.76 1.624 . . . . 0.0 109.69 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -141.11 141.75 34.18 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.061 0.944 . . . . 0.0 109.7 169.919 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.5 t -63.86 142.39 58.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.625 0.37 . . . . 0.0 110.311 168.323 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.05 126.11 72.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.005 1.322 . . . . 0.0 110.27 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.452 -0.356 0 C-N-CA 124.931 1.292 . . . . 0.0 110.08 177.418 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -117.92 -33.72 4.39 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.502 0.592 . . . . 0.0 111.655 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.93 -154.02 11.09 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.206 -170.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.67 161.24 39.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.087 1.355 . . . . 0.0 108.185 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -125.0 151.1 45.98 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.482 1.113 . . . . 0.0 109.28 169.07 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -134.76 118.32 16.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.616 1.566 . . . . 0.0 107.58 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.58 111.65 24.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.775 1.23 . . . . 0.0 107.842 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 pp -138.52 154.29 48.77 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 122.791 0.437 . . . . 0.0 111.516 -172.68 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -103.07 104.55 14.73 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.214 1.006 . . . . 0.0 109.312 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.55 133.56 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.558 1.543 . . . . 0.0 110.102 -175.885 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.78 123.28 41.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.433 1.493 . . . . 0.0 108.476 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.51 130.63 26.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.4 m 50.45 40.28 22.74 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.419 1.088 . . . . 0.0 111.584 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t0 50.11 32.66 6.1 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.884 1.274 . . . . 0.0 112.972 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -119.07 129.79 55.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.3 tp -94.66 125.65 39.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -124.62 149.5 47.02 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 125.313 1.445 . . . . 0.0 108.17 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -92.15 123.64 35.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.65 133.08 54.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -107.4 122.01 45.75 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mm -113.27 146.19 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.098 1.759 . . . . 0.0 106.82 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 154.47 25.5 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -130.95 115.47 16.56 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.643 1.977 . . . . 0.0 106.669 169.221 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.93 124.42 33.12 Favored 'General case' 0 CA--C 1.526 0.03 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -58.34 -49.26 77.82 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.659 0.784 . . . . 0.0 111.063 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -68.89 -51.73 37.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.535 0.734 . . . . 0.0 110.777 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -62.86 -34.0 76.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 64.04 34.69 11.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.202 1.401 . . . . 0.0 109.933 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.33 143.71 14.68 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.11 165.31 12.89 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 122.795 0.438 . . . . 0.0 110.654 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.13 152.87 19.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.176 0.59 . . . . 0.0 111.299 170.528 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -71.67 118.64 14.76 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 mt -75.57 -50.87 14.29 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 167.869 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -156.73 160.67 39.52 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.897 0.317 . . . . 0.0 111.145 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -135.75 101.22 4.69 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.142 1.777 . . . . 0.0 107.074 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -105.8 152.29 23.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.928 0.891 . . . . 0.0 109.086 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 134.59 -168.03 23.69 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 N--CA 1.457 -0.673 0 CA-C-N 118.24 1.02 . . . . 0.0 111.167 2.966 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.42 HD12 ' H ' ' A' ' 5' ' ' ILE . 4.7 mp -78.72 138.57 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 pt -106.46 154.32 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.322 1.049 . . . . 0.0 109.833 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.66 145.41 55.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.207 0.603 . . . . 0.0 109.814 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.2 pt -83.3 122.43 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.955 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.14 -165.23 31.6 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.41 -41.77 72.79 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.942 2.428 . . . . 0.0 112.282 -172.429 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -58.87 -49.29 78.31 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.809 0.814 . . . . 0.0 110.91 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -47.54 82.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.859 1.264 . . . . 0.0 109.688 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -54.52 -49.28 70.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.107 0.563 . . . . 0.0 110.054 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -55.92 -48.58 75.44 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.715 0.806 . . . . 0.0 110.499 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -56.15 -46.54 79.21 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.992 -0.442 . . . . 0.0 110.949 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.76 -56.32 25.77 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -51.71 -50.45 60.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.668 1.587 . . . . 0.0 109.822 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -55.08 -50.34 69.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.884 1.273 . . . . 0.0 110.75 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.29 -50.37 71.61 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.85 -39.83 86.84 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.478 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.93 -49.78 73.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.28 1.032 . . . . 0.0 109.544 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.43 -53.84 52.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.033 0.933 . . . . 0.0 108.897 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.4 -41.05 84.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.474 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -70.46 -39.46 74.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.459 1.503 . . . . 0.0 110.136 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -60.52 -45.99 91.81 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.279 0.632 . . . . 0.0 109.363 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.66 -40.47 89.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 171.683 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.05 19.88 58.47 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.44 1.495 . . . . 0.0 110.896 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -61.49 -35.7 78.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.858 0.829 . . . . 0.0 111.152 -170.225 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -118.87 39.97 3.39 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.804 0.842 . . . . 0.0 109.337 171.134 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.51 -141.29 44.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -101.92 93.72 5.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.58 1.152 . . . . 0.0 109.629 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.2 mt -80.72 139.99 35.81 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.197 0.453 . . . . 0.0 110.02 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.2 m -94.0 90.13 6.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.508 1.123 . . . . 0.0 108.49 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -51.42 132.7 29.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 122.188 -0.32 . . . . 0.0 111.458 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -104.07 -66.09 0.98 Allowed 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 123.544 0.738 . . . . 0.0 109.193 169.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -164.93 -168.59 1.48 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.151 0.58 . . . . 0.0 109.593 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.9 145.45 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.7 pt -133.62 173.42 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.351 0.66 . . . . 0.0 110.22 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 152.6 82.47 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 123.893 0.877 . . . . 0.0 110.795 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.07 151.83 96.34 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 N-CA-C 110.452 -0.634 . . . . 0.0 110.452 -5.788 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.4 m -138.9 90.36 2.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.1 ttt -111.31 138.43 47.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.406 0.682 . . . . 0.0 110.57 -169.59 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -116.23 149.78 38.59 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.642 1.177 . . . . 0.0 108.492 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.49 151.29 33.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.599 0.76 . . . . 0.0 111.205 166.964 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 m -85.43 127.94 34.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.243 1.817 . . . . 0.0 111.586 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -99.44 136.29 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.486 1.515 . . . . 0.0 109.369 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 . . . . . 0 CA--C 1.529 0.148 0 C-N-CA 126.061 1.744 . . . . 0.0 109.985 -179.408 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -115.61 -31.85 5.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.677 1.191 . . . . 0.0 110.592 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.01 -158.91 20.79 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -144.73 158.65 43.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.83 1.252 . . . . 0.0 108.217 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -114.19 153.54 29.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.211 1.404 . . . . 0.0 108.631 168.856 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -136.42 117.21 14.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -110.47 113.88 26.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 pp -146.2 146.03 30.66 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.153 0.433 . . . . 0.0 111.726 -170.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -89.18 99.74 12.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.516 0.726 . . . . 0.0 109.242 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.7 t -81.65 132.4 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.941 1.696 . . . . 0.0 109.013 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.34 114.63 29.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.489 1.516 . . . . 0.0 107.617 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.06 130.95 26.05 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.103 0.961 . . . . 0.0 108.676 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.0 t 50.67 39.23 21.17 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.461 1.104 . . . . 0.0 111.861 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.3 t0 53.25 33.93 16.55 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.316 1.046 . . . . 0.0 112.523 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -122.68 138.63 54.55 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 168.726 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.0 tp -105.32 127.08 52.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -132.76 143.93 49.92 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 125.137 1.375 . . . . 0.0 108.636 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -82.35 116.16 21.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.6 132.76 43.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -110.47 125.28 53.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.98 152.91 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 125.372 1.469 . . . . 0.0 107.28 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.7 m -119.08 149.83 41.02 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.15 0.98 . . . . 0.0 109.151 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.04 122.4 37.16 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 168.126 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.46 120.63 38.19 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.02 -53.0 62.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.203 1.001 . . . . 0.0 110.767 -170.079 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -58.62 -48.02 82.38 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.124 0.569 . . . . 0.0 110.111 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 m -71.92 -20.24 61.8 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.629 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 43.14 45.59 4.77 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 125.969 1.707 . . . . 0.0 111.091 -171.546 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -140.8 155.33 24.84 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.8 mtt85 -114.95 171.28 7.75 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.306 0.642 . . . . 0.0 110.841 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -155.35 146.95 23.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.298 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.4 tp -71.58 119.09 15.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.005 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.83 -50.91 18.17 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.632 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -168.95 156.83 7.62 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -171.346 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -133.53 89.11 2.55 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.641 1.576 . . . . 0.0 107.476 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -98.4 138.27 35.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -170.057 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.43 -167.07 32.4 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.254 -0.748 . . . . 0.0 111.473 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.457 -0.637 0 CA-C-N 118.05 0.925 . . . . 0.0 111.113 2.123 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.6 144.19 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.6 pt -119.5 164.81 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.745 0.702 . . . . 0.0 110.377 169.811 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.61 141.85 51.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 110.461 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -88.54 120.52 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.2 -165.37 25.49 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -54.98 -44.56 48.51 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.196 2.597 . . . . 0.0 112.516 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -48.96 -58.44 4.87 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.232 1.015 . . . . 0.0 110.913 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -43.52 92.48 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.31 1.044 . . . . 0.0 109.808 -172.621 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -56.5 -49.84 73.55 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.354 1.062 . . . . 0.0 109.801 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -53.92 -52.18 61.4 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.395 0.543 . . . . 0.0 110.44 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -59.98 -44.58 94.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.729 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.33 -44.49 93.43 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -64.29 -50.53 67.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -50.46 -47.57 56.85 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.508 1.123 . . . . 0.0 110.914 173.974 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -52.83 63.78 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 110.152 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.5 -39.08 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.464 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.0 -49.65 75.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.349 0.66 . . . . 0.0 110.162 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -57.12 -50.26 73.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.84 0.856 . . . . 0.0 109.022 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -55.24 -51.23 67.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.45 0.7 . . . . 0.0 109.472 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -60.49 -40.36 91.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.536 1.135 . . . . 0.0 110.591 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -59.52 -42.65 92.71 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.6 mt -67.45 -44.22 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.57 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.91 22.74 57.23 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.041 1.305 . . . . 0.0 111.295 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.8 -38.87 86.83 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.79 0.795 . . . . 0.0 110.715 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -108.35 34.76 3.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.73 1.212 . . . . 0.0 109.978 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.52 -141.04 44.79 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -100.17 91.83 4.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.398 1.079 . . . . 0.0 109.783 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.28 173.21 10.51 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 168.957 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 m -138.25 102.49 4.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -51.94 134.26 31.79 Favored 'General case' 0 CA--C 1.524 -0.046 0 C-N-CA 122.838 0.455 . . . . 0.0 110.377 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -103.2 -63.18 1.2 Allowed 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -173.43 174.58 3.24 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.141 1.376 . . . . 0.0 108.711 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.66 150.12 14.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 124.489 1.116 . . . . 0.0 108.779 173.849 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.9 pt -138.26 168.37 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.067 0.547 . . . . 0.0 110.439 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' ARG . . . . . 0.426 ' CD ' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -62.17 154.43 70.21 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 170.626 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.28 150.15 95.23 Favored 'Cis proline' 0 N--CA 1.458 -0.581 0 CA-C-N 119.193 0.748 . . . . 0.0 111.012 -3.36 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.1 t -140.87 102.2 4.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -121.33 141.56 50.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.708 1.203 . . . . 0.0 109.682 -166.922 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -126.56 158.77 35.34 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.792 0.837 . . . . 0.0 111.269 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -147.35 152.74 38.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.31 1.444 . . . . 0.0 108.334 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.3 m -85.04 137.69 32.9 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.709 0.803 . . . . 0.0 109.954 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.88 129.72 64.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.942 1.297 . . . . 0.0 110.196 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 . . . . . 0 N--CA 1.448 -0.528 0 C-N-CA 125.697 1.599 . . . . 0.0 108.863 -177.049 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.529 0.159 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -109.18 -25.8 10.44 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.992 0.36 . . . . 0.0 110.825 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.16 -163.51 28.84 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.638 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -142.45 156.16 45.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -120.83 142.4 49.66 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.006 1.322 . . . . 0.0 107.45 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -131.02 108.35 9.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.385 1.874 . . . . 0.0 106.745 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -105.08 123.11 47.25 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.116 1.767 . . . . 0.0 108.747 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.71 164.84 36.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -104.69 113.69 27.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.165 0.986 . . . . 0.0 110.898 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.44 130.1 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.558 1.543 . . . . 0.0 108.223 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -92.77 120.44 33.15 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.28 131.95 24.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.398 1.079 . . . . 0.0 108.119 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 t 49.76 45.45 24.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.219 1.008 . . . . 0.0 110.129 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 p30 53.34 17.76 1.14 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.361 1.864 . . . . 0.0 115.459 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -116.29 151.7 35.31 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.36 127.24 42.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -127.8 136.68 51.8 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.347 1.459 . . . . 0.0 108.444 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -85.3 137.37 33.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.03 139.53 53.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -115.83 114.99 25.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 168.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.88 145.0 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 m -119.38 144.25 47.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -113.04 129.43 56.5 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.8 2.04 . . . . 0.0 107.014 170.235 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -92.49 125.56 37.18 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -58.54 -43.55 89.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.373 1.069 . . . . 0.0 111.372 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -70.66 -48.65 53.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.1 m -67.74 -31.48 71.42 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.364 0.266 . . . . 0.0 111.263 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 55.41 41.01 31.44 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.235 1.014 . . . . 0.0 109.602 -169.409 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.1 155.62 25.62 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 -114.95 171.46 7.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.407 0.683 . . . . 0.0 112.28 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -162.56 148.7 12.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.107 1.763 . . . . 0.0 110.594 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.5 tp -68.1 134.87 51.28 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.7 tp -106.33 -64.54 1.16 Allowed 'General case' 0 C--N 1.338 0.076 0 C-N-CA 123.238 0.615 . . . . 0.0 109.779 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.14 146.47 45.94 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -136.71 130.94 32.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -145.03 155.21 43.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 126.89 -164.59 20.41 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 N--CA 1.454 -0.81 0 CA-C-N 118.797 1.299 . . . . 0.0 109.91 -6.755 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.226 -0.156 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.418 HD12 ' H ' ' A' ' 5' ' ' ILE . 3.3 mp -86.73 139.37 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.5 pt -101.04 151.35 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.403 0.681 . . . . 0.0 110.221 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -71.96 128.22 35.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.75 132.39 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 168.15 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.85 -172.34 44.58 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -53.65 -44.87 45.35 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.701 2.934 . . . . 0.0 112.677 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -50.16 -57.35 7.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.269 1.033 . . . . 0.0 110.853 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.02 -41.11 95.58 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.533 1.133 . . . . 0.0 109.81 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -58.12 -45.98 86.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.085 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -58.11 -46.8 84.94 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.6 0.637 . . . . 0.0 110.748 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.7 mt -58.22 -41.89 85.09 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.942 -0.474 . . . . 0.0 111.17 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.31 -58.31 15.23 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -44.12 -52.57 7.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.888 0.875 . . . . 0.0 111.616 172.446 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -55.59 -49.71 72.03 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.047 0.939 . . . . 0.0 110.808 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.92 69.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.73 -40.49 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.423 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.62 -50.29 71.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.09 0.956 . . . . 0.0 110.225 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -61.66 -47.49 85.13 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.138 0.975 . . . . 0.0 109.318 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -56.98 -49.8 74.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.497 0.319 . . . . 0.0 110.24 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -56.88 -43.42 81.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.464 1.106 . . . . 0.0 110.143 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -59.7 -39.92 86.17 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.2 mt -67.71 -45.53 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.48 18.03 57.65 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.174 1.369 . . . . 0.0 111.584 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -57.95 -39.88 79.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.702 0.751 . . . . 0.0 111.251 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.24 41.48 2.12 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.172 0.989 . . . . 0.0 109.62 172.656 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.17 -142.11 45.64 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -122.76 93.35 3.94 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.955 0.902 . . . . 0.0 109.079 -170.139 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp -85.53 -169.96 2.89 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.773 0.797 . . . . 0.0 109.392 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.9 m -145.23 124.74 13.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 172.161 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.57 140.07 42.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.626 0.371 . . . . 0.0 111.164 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -111.4 -64.29 1.3 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.648 0.779 . . . . 0.0 109.504 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.37 -179.92 4.16 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.097 0.959 . . . . 0.0 109.595 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.84 143.32 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.6 165.44 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.809 0.444 . . . . 0.0 110.236 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 158.53 79.54 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.113 0.965 . . . . 0.0 111.697 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.21 152.84 91.31 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 CA-C-N 119.468 0.846 . . . . 0.0 111.756 -9.197 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 76.4 m -138.79 100.25 4.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.8 ttt -118.27 142.44 47.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.321 0.648 . . . . 0.0 111.432 -167.981 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -120.97 143.12 49.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.409 2.284 . . . . 0.0 109.067 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -144.92 147.94 33.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.726 1.61 . . . . 0.0 110.123 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.49 134.66 35.56 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.778 1.631 . . . . 0.0 110.508 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -112.79 127.5 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.73 1.212 . . . . 0.0 110.816 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 125.197 1.399 . . . . 0.0 111.759 -176.942 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.3 mt . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -96.13 -27.91 14.83 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.59 -158.89 21.6 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -145.9 159.48 43.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.007 1.323 . . . . 0.0 107.699 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -124.57 135.58 53.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 125.599 1.559 . . . . 0.0 108.773 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.97 106.33 9.55 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.866 1.666 . . . . 0.0 107.519 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -94.53 124.11 38.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.303 1.041 . . . . 0.0 108.716 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.0 153.33 39.92 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.282 0.492 . . . . 0.0 111.023 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -95.28 105.04 16.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 123.983 0.913 . . . . 0.0 109.542 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.81 124.99 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.357 1.063 . . . . 0.0 109.729 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -79.8 117.21 20.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.28 122.86 40.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.032 1.333 . . . . 0.0 108.418 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t 72.37 -60.85 0.52 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 130.041 3.336 . . . . 0.0 108.327 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -177.1 0.23 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.757 2.823 . . . . 0.0 111.798 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -111.31 144.16 40.95 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.31 122.64 34.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.568 0.747 . . . . 0.0 109.147 -173.53 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -118.43 141.74 48.25 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 124.301 1.041 . . . . 0.0 109.179 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -86.53 104.24 15.8 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.778 1.231 . . . . 0.0 107.707 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.41 127.07 49.59 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -103.3 106.75 17.34 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.54 122.63 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.0 m -96.18 156.65 16.25 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 170.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -128.72 123.47 33.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.869 1.268 . . . . 0.0 107.796 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -96.08 113.02 24.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.513 1.125 . . . . 0.0 107.984 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -60.7 -27.17 67.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.172 0.589 . . . . 0.0 111.167 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -58.89 -24.66 62.55 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.607 0.763 . . . . 0.0 112.411 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.2 m -144.95 16.29 1.57 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.62 -0.675 . . . . 0.0 111.415 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 52.4 38.9 26.42 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.368 1.067 . . . . 0.0 111.021 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.58 138.31 14.88 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -102.75 167.64 9.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.724 0.762 . . . . 0.0 112.477 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.77 130.83 1.05 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.282 -168.899 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.5 tp -71.12 116.27 11.22 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.5 -56.74 3.01 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 123.352 0.661 . . . . 0.0 110.258 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -127.5 141.76 51.57 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -138.0 91.08 2.54 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -107.33 160.75 15.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -173.208 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.18 -163.97 12.13 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.454 -0.817 0 CA-C-N 118.807 1.303 . . . . 0.0 110.479 3.138 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.312 0.101 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mt -76.55 139.87 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.8 pt -110.06 156.78 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 123.178 0.591 . . . . 0.0 110.074 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.51 131.35 48.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.916 0.887 . . . . 0.0 109.777 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.29 120.99 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.15 -165.88 29.13 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -172.623 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -54.12 -45.65 39.41 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.806 3.004 . . . . 0.0 112.649 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -47.24 -56.84 5.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.654 1.181 . . . . 0.0 110.909 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -39.94 82.46 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.153 1.381 . . . . 0.0 110.005 -174.267 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -50.76 -53.21 33.61 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.779 1.631 . . . . 0.0 109.956 170.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -54.61 -48.86 71.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.666 0.387 . . . . 0.0 111.092 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.8 mt -63.87 -41.49 97.74 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.406 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.17 -51.24 55.4 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -54.13 -59.36 4.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.768 0.827 . . . . 0.0 110.708 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -49.84 -44.28 49.36 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.265 0.626 . . . . 0.0 111.624 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.36 70.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.896 0.379 . . . . 0.0 110.229 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.41 -43.4 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.145 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.18 -46.08 89.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.881 0.872 . . . . 0.0 109.971 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -63.98 -49.72 71.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.076 0.95 . . . . 0.0 109.376 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -57.44 -43.44 83.88 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.751 -0.593 . . . . 0.0 110.954 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -63.85 -39.51 94.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.871 1.268 . . . . 0.0 110.684 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -61.48 -43.77 98.27 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.395 0.678 . . . . 0.0 109.239 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.61 -40.17 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.1 20.62 58.84 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.336 1.446 . . . . 0.0 110.167 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.79 -35.95 75.7 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 117.404 0.602 . . . . 0.0 111.105 -168.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.46 33.87 5.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.084 0.953 . . . . 0.0 109.815 175.677 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.25 -145.37 49.57 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -171.217 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -106.46 88.5 2.79 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.525 1.13 . . . . 0.0 108.975 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -70.13 153.86 42.63 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.3 m -109.07 102.26 11.26 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -52.29 144.72 12.26 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.655 0.382 . . . . 0.0 110.446 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -120.84 -66.19 1.08 Allowed 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.901 0.48 . . . . 0.0 110.205 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 166.82 27.14 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 117.812 0.278 . . . . 0.0 110.452 175.304 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -91.62 150.23 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.194 0.998 . . . . 0.0 108.591 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -144.55 174.96 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.832 0.853 . . . . 0.0 109.195 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.49 154.79 85.77 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.632 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.02 157.32 97.28 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 119.67 0.918 . . . . 0.0 111.246 -4.532 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.3 t -153.98 93.88 1.69 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.716 0.806 . . . . 0.0 109.395 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -102.92 154.76 18.89 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.467 1.507 . . . . 0.0 110.546 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -133.79 143.49 48.43 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.42 1.488 . . . . 0.0 109.271 170.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -147.1 144.98 29.44 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.608 0.763 . . . . 0.0 111.598 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -65.34 139.04 58.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.862 1.265 . . . . 0.0 111.684 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.81 127.21 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.193 1.397 . . . . 0.0 108.443 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.7 p90 . . . . . 0 N--CA 1.455 -0.2 0 O-C-N 121.505 -0.747 . . . . 0.0 110.878 -163.813 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.8 mt . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -117.3 -21.14 8.87 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.153 0.581 . . . . 0.0 111.663 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.79 -167.71 33.82 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -130.03 164.9 23.31 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.17 144.79 50.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.64 1.576 . . . . 0.0 107.193 168.914 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -130.52 133.9 46.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -130.62 112.57 13.26 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -148.64 160.08 43.48 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.205 0.457 . . . . 0.0 112.203 -166.634 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.28 140.31 37.57 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 123.643 0.777 . . . . 0.0 110.528 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.17 133.09 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.819 1.647 . . . . 0.0 109.147 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.75 119.2 25.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.968 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.15 130.69 37.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t 51.27 41.41 27.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.461 1.105 . . . . 0.0 111.526 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 t0 49.3 35.74 8.24 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.87 1.668 . . . . 0.0 112.499 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -127.97 142.03 51.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 tp -87.37 117.0 25.85 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -113.96 155.12 26.41 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.735 0.814 . . . . 0.0 108.862 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -108.88 138.47 45.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.461 1.104 . . . . 0.0 108.223 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.04 137.81 46.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.977 0.911 . . . . 0.0 109.343 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -114.04 116.78 29.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.395 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 mm -109.26 155.11 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 126.373 1.869 . . . . 0.0 106.406 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.84 164.57 22.78 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 118.516 0.598 . . . . 0.0 109.517 167.902 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.65 138.89 52.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.152 2.181 . . . . 0.0 106.557 170.446 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.04 114.59 28.62 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.209 1.403 . . . . 0.0 107.298 174.289 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -56.44 -36.29 68.84 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.194 0.998 . . . . 0.0 111.452 -171.356 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -53.58 -23.6 11.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.62 1.568 . . . . 0.0 113.339 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -143.14 15.35 1.88 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.643 -0.661 . . . . 0.0 110.844 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 48.28 32.47 3.17 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.626 0.77 . . . . 0.0 111.023 -170.63 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.63 129.66 9.99 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -171.257 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -100.19 166.64 10.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.699 0.75 . . . . 0.0 112.694 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.35 140.09 4.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.405 -169.746 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.03 121.73 14.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 168.58 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mt -85.56 -60.2 2.09 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -145.03 154.96 43.07 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.329 0.652 . . . . 0.0 109.25 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -131.32 150.47 52.14 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -156.01 163.91 39.12 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.63 0.772 . . . . 0.0 109.288 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.93 -162.91 12.27 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 N--CA 1.453 -0.89 0 CA-C-N 118.75 1.275 . . . . 0.0 110.027 -2.801 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.3 mm -81.87 138.15 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.5 pt -101.4 155.66 4.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.178 0.591 . . . . 0.0 110.553 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.06 148.82 50.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.79 132.34 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 C-N-CA 125.017 1.327 . . . . 0.0 108.224 169.347 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.89 -168.97 39.6 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 108.269 -1.933 . . . . 0.0 108.269 -174.911 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.5 -43.29 59.56 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.446 2.764 . . . . 0.0 112.153 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -51.88 -57.42 9.42 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 122.004 0.907 . . . . 0.0 111.286 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -45.49 89.76 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.269 1.028 . . . . 0.0 109.964 -173.92 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -49.99 -58.31 5.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 118.36 -0.829 . . . . 0.0 108.923 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -49.34 -46.18 46.54 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.73 0.812 . . . . 0.0 111.013 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.32 -51.64 65.19 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.605 -0.684 . . . . 0.0 111.751 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.23 83.32 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 122.396 0.998 . . . . 0.0 112.414 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.73 -57.93 6.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.473 1.909 . . . . 0.0 106.808 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -47.45 -44.85 25.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.852 1.661 . . . . 0.0 110.417 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.54 -54.14 49.3 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.909 0.385 . . . . 0.0 110.495 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.75 -38.54 76.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 122.817 0.447 . . . . 0.0 111.31 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.86 -46.82 83.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.029 0.931 . . . . 0.0 109.99 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -60.89 -47.32 86.95 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.801 0.84 . . . . 0.0 108.977 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -55.99 -50.81 69.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.017 0.527 . . . . 0.0 109.67 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -57.94 -42.68 85.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.796 1.638 . . . . 0.0 110.209 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.5 -45.95 87.7 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.098 0.559 . . . . 0.0 110.19 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.6 mt -64.68 -42.96 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.53 18.55 65.96 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.988 1.28 . . . . 0.0 111.018 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -55.23 -41.61 72.32 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 117.762 0.781 . . . . 0.0 111.0 -173.67 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.54 25.95 11.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.397 1.079 . . . . 0.0 110.44 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.06 -152.91 46.11 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -117.25 120.68 38.99 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.953 1.301 . . . . 0.0 108.148 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.87 156.95 30.87 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.446 0.698 . . . . 0.0 111.805 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 m -97.56 95.89 7.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -45.3 132.14 7.75 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -101.02 -68.5 0.81 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -168.61 165.11 12.33 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -171.953 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -102.58 141.59 18.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 124.67 1.188 . . . . 0.0 108.109 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.54 172.3 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.488 0.715 . . . . 0.0 110.012 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.73 154.99 83.88 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.722 0.809 . . . . 0.0 111.405 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.56 158.23 98.66 Favored 'Cis proline' 0 N--CA 1.455 -0.755 0 N-CA-C 110.373 -0.664 . . . . 0.0 110.373 -4.538 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 77.0 m -141.79 91.31 2.35 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.26 127.84 53.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.306 1.042 . . . . 0.0 110.28 -168.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -102.68 145.31 29.87 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.705 0.802 . . . . 0.0 110.018 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -148.34 141.74 25.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.184 0.594 . . . . 0.0 110.237 166.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.5 m -58.49 134.61 56.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.577 0.751 . . . . 0.0 110.453 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 tp -115.61 127.68 73.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.632 1.173 . . . . 0.0 108.614 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.1 p90 . . . . . 0 N--CA 1.447 -0.596 0 C-N-CA 123.3 0.64 . . . . 0.0 110.115 -169.74 . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.1 mt . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.16 -39.62 14.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.58 -152.11 9.78 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -172.374 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.16 152.95 42.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.966 1.306 . . . . 0.0 107.662 174.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.9 155.98 21.01 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.763 1.225 . . . . 0.0 108.875 170.536 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -138.27 102.72 4.73 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.511 1.924 . . . . 0.0 106.239 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 126.62 38.56 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 pp -152.24 153.55 33.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.308 0.503 . . . . 0.0 112.078 -172.264 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -85.88 118.19 25.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.51 125.84 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.009 1.324 . . . . 0.0 108.793 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -92.17 123.03 35.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.58 130.15 21.36 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t 51.85 37.04 19.63 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.766 0.826 . . . . 0.0 111.201 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.0 t70 64.25 12.79 7.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.774 1.23 . . . . 0.0 113.249 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -109.82 147.35 33.46 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.52 1.128 . . . . 0.0 107.995 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.53 112.74 24.7 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.983 1.313 . . . . 0.0 107.609 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.49 162.5 17.49 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.282 1.033 . . . . 0.0 108.324 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -112.56 128.22 56.3 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.26 134.95 54.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -112.21 107.86 16.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mp -97.6 151.6 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.6 m -128.98 152.71 48.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 169.384 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -117.35 125.48 51.09 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -87.97 125.36 34.48 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -66.98 -45.59 77.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.818 0.847 . . . . 0.0 110.625 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.78 -43.55 88.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.098 0.559 . . . . 0.0 110.416 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.0 m -69.42 -37.28 77.37 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 60.52 49.43 6.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.457 1.503 . . . . 0.0 108.777 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.87 154.79 26.03 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.94 168.48 9.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.609 0.764 . . . . 0.0 111.928 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -163.72 139.46 6.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.772 1.229 . . . . 0.0 110.869 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 34.7 tp -63.16 122.76 16.92 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.929 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 tp -83.27 -57.45 3.26 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.12 152.25 37.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.29 0.636 . . . . 0.0 109.472 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -117.05 134.85 54.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 168.281 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -134.67 149.36 50.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 130.7 -166.52 22.47 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.35 -0.695 . . . . 0.0 112.061 171.431 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 0 N--CA 1.456 -0.73 0 C-N-CA 124.752 -0.937 . . . . 0.0 110.045 -1.939 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 5' ' ' ILE . 3.5 mp -88.82 139.12 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.95 161.1 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 123.811 0.845 . . . . 0.0 110.517 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.01 135.63 41.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.667 0.787 . . . . 0.0 110.357 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.59 124.87 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 167.49 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.05 -167.5 30.6 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -56.76 -44.02 49.12 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.933 2.422 . . . . 0.0 111.602 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -53.94 -52.76 59.59 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.167 0.984 . . . . 0.0 111.043 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -45.37 93.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.19 0.996 . . . . 0.0 109.767 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -60.42 -41.33 93.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.306 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -56.7 -49.86 73.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.012 0.824 . . . . 0.0 110.42 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 15' ' ' LEU . 12.9 mt -57.48 -45.55 84.74 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.805 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.11 -46.55 62.01 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -60.0 -51.77 68.23 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -51.85 -47.16 64.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.054 0.541 . . . . 0.0 111.06 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.03 -50.16 74.38 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.317 0.58 . . . . 0.0 110.326 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.7 -40.75 90.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.098 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.49 -46.87 85.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.219 0.608 . . . . 0.0 110.058 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.91 -54.02 51.32 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.264 1.026 . . . . 0.0 109.041 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -57.29 -48.0 80.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.637 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -57.6 -45.12 85.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.35 1.06 . . . . 0.0 110.094 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.76 -41.37 86.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.569 0.348 . . . . 0.0 110.37 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.3 mt -72.24 -45.38 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.89 15.56 48.53 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.976 1.274 . . . . 0.0 112.838 174.251 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -53.79 -42.94 68.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.351 1.076 . . . . 0.0 111.963 -175.631 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.77 33.0 4.46 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.955 0.902 . . . . 0.0 109.707 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.44 -142.07 47.58 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -106.47 120.09 41.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.517 1.127 . . . . 0.0 109.213 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mt -106.73 168.78 8.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.364 1.065 . . . . 0.0 108.546 170.23 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.2 m -120.67 103.83 9.43 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -46.23 130.09 10.34 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.713 0.233 . . . . 0.0 110.989 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -106.49 -66.87 0.97 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -167.4 -169.39 1.22 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.293 0.637 . . . . 0.0 109.996 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.51 146.4 34.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 125.594 1.557 . . . . 0.0 106.809 174.716 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.55 166.57 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.358 0.599 . . . . 0.0 110.631 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.33 158.58 81.46 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 125.48 1.512 . . . . 0.0 111.94 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -67.63 148.33 80.79 Favored 'Cis proline' 0 N--CA 1.456 -0.688 0 CA-C-N 118.861 0.629 . . . . 0.0 111.168 -8.54 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 71.6 m -131.41 94.32 3.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.86 128.55 55.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.721 0.808 . . . . 0.0 109.809 -168.287 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -104.85 140.8 37.59 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.642 1.177 . . . . 0.0 109.186 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -133.83 152.02 51.73 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.453 1.101 . . . . 0.0 108.969 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 m -82.86 136.93 34.46 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.505 1.122 . . . . 0.0 109.844 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.16 131.87 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.262 1.425 . . . . 0.0 108.771 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.4 p90 . . . . . 0 N--CA 1.448 -0.554 0 C-N-CA 123.33 0.652 . . . . 0.0 109.857 -167.932 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.1 mt . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -81.56 -33.43 31.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.049 0.54 . . . . 0.0 110.792 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.23 -161.74 24.05 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.201 -1.0 . . . . 0.0 112.116 -170.823 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -147.68 159.6 43.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -121.87 149.19 43.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.978 1.311 . . . . 0.0 108.459 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -132.61 107.76 8.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -97.27 118.18 33.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -146.37 158.71 43.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.808 0.443 . . . . 0.0 111.133 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.99 112.55 24.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.524 0.73 . . . . 0.0 109.579 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -99.88 133.0 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 109.617 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.08 122.36 35.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.441 1.496 . . . . 0.0 107.521 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.6 127.15 28.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.812 0.845 . . . . 0.0 109.395 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t 70.74 -64.17 0.38 Allowed 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 129.593 3.157 . . . . 0.0 108.432 -169.264 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 179.72 11.09 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.518 3.127 . . . . 0.0 111.207 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -119.55 149.29 42.17 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.923 1.289 . . . . 0.0 107.832 -174.555 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 tp -106.79 120.98 43.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.45 0.7 . . . . 0.0 109.759 -169.817 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.4 137.93 54.7 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.738 1.215 . . . . 0.0 108.364 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -94.69 115.82 28.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.25 135.5 54.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.188 0.995 . . . . 0.0 109.559 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.58 103.67 14.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.531 1.132 . . . . 0.0 108.208 169.893 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.455 HG21 HD22 ' A' ' 15' ' ' LEU . 10.9 mm -91.26 161.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.86 1.664 . . . . 0.0 106.9 176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.6 p -145.6 167.57 22.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.65 0.659 . . . . 0.0 111.438 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -136.52 131.24 33.65 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.553 1.941 . . . . 0.0 108.277 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -98.37 107.86 20.42 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 169.47 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -53.03 -37.48 61.58 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 124.439 1.096 . . . . 0.0 111.194 -173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -43.07 -40.55 3.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.414 1.886 . . . . 0.0 112.464 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 m -121.54 0.52 9.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.798 0.439 . . . . 0.0 110.99 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 52.77 28.78 6.71 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.686 0.795 . . . . 0.0 109.126 -165.711 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.99 128.13 9.3 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -168.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -105.88 170.04 8.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.567 0.699 . . . . 0.0 112.36 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -177.58 161.57 1.71 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.044 1.737 . . . . 0.0 112.35 -166.648 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.1 tp -89.84 138.18 31.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.3 1.44 . . . . 0.0 108.88 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.9 mt -104.47 -58.24 1.91 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.628 0.649 . . . . 0.0 110.245 169.447 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -136.2 150.56 49.06 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -143.77 106.33 4.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -115.39 147.84 40.05 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.68 -167.5 27.09 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.504 -0.609 . . . . 0.0 111.925 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 N--CA 1.455 -0.739 0 C-N-CA 124.373 -1.095 . . . . 0.0 110.002 -2.573 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mp -99.2 139.38 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.3 pt -103.02 154.23 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 123.842 0.857 . . . . 0.0 109.66 171.932 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.46 134.21 42.33 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.8 pt -62.27 141.36 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 165.543 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.66 -169.35 34.5 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -168.584 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.41 -48.77 17.48 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.427 2.751 . . . . 0.0 112.769 -169.816 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.37 -55.0 24.54 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.124 0.964 . . . . 0.0 111.066 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -67.37 -44.27 79.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.215 1.006 . . . . 0.0 110.018 -172.567 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -56.4 -49.25 75.04 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 118.93 -0.557 . . . . 0.0 109.882 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -56.31 -46.47 79.82 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.624 0.647 . . . . 0.0 110.928 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 mt -55.95 -51.87 66.13 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 117.894 0.315 . . . . 0.0 110.515 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.58 -45.07 90.63 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -59.81 -52.12 66.82 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -49.94 -48.48 51.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.731 1.212 . . . . 0.0 110.201 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.58 72.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.49 -39.95 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.776 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.94 -48.75 80.38 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.378 0.671 . . . . 0.0 109.938 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.74 -52.82 63.88 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.077 0.951 . . . . 0.0 109.152 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -54.08 -46.65 72.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.485 1.114 . . . . 0.0 110.315 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -69.65 -42.02 74.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.554 1.542 . . . . 0.0 110.518 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.55 -47.77 84.24 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.321 0.648 . . . . 0.0 109.718 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.32 -41.74 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.8 18.43 51.27 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.633 1.111 . . . . 0.0 112.26 173.713 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -55.6 -40.81 72.54 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.974 0.887 . . . . 0.0 111.091 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -111.75 33.29 4.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.208 1.003 . . . . 0.0 109.976 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.03 -140.09 45.23 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.91 108.3 19.89 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.538 0.735 . . . . 0.0 109.65 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.8 mt -93.85 141.66 28.26 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 167.402 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 m -100.74 95.34 6.59 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.227 1.011 . . . . 0.0 108.346 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -51.21 133.82 27.99 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.179 0.592 . . . . 0.0 111.448 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -100.27 -67.41 0.85 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -169.57 -159.5 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.444 1.098 . . . . 0.0 108.533 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.12 141.68 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.15 174.7 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.023 0.529 . . . . 0.0 110.884 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -63.49 153.57 82.36 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.095 1.358 . . . . 0.0 112.889 -170.844 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.11 159.14 97.18 Favored 'Cis proline' 0 N--CA 1.449 -1.094 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 -7.573 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -133.91 87.24 2.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.49 140.15 48.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.896 0.878 . . . . 0.0 109.421 -167.592 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -122.12 162.13 21.84 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.197 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -138.45 147.52 43.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.852 1.661 . . . . 0.0 108.488 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -83.6 130.49 34.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.226 1.01 . . . . 0.0 110.089 172.305 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.44 120.87 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.665 1.186 . . . . 0.0 108.856 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 p90 . . . . . 0 N--CA 1.455 -0.214 0 O-C-N 121.394 -0.816 . . . . 0.0 111.272 -173.78 . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 . . . . . . . . . 0 0 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 -20.68 12.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 123.496 0.497 . . . . 0.0 111.069 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.94 -168.59 32.04 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.817 0.735 . . . . 0.0 112.59 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -142.9 157.8 44.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -130.72 145.26 51.9 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.973 1.309 . . . . 0.0 108.353 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -136.86 119.38 15.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.4 1.48 . . . . 0.0 107.878 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -107.86 126.1 52.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.866 1.267 . . . . 0.0 108.291 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pp -145.99 147.96 32.23 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.421 0.288 . . . . 0.0 110.269 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.2 99.48 11.97 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -83.17 134.07 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -102.22 122.78 44.85 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.39 136.04 25.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.77 37.66 24.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.457 1.103 . . . . 0.0 110.89 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 t70 56.63 28.84 14.66 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.987 1.315 . . . . 0.0 112.335 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -130.2 149.17 52.02 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.75 1.22 . . . . 0.0 108.218 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.7 tp -101.9 127.0 48.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.789 0.836 . . . . 0.0 109.637 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.24 136.9 50.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.861 1.264 . . . . 0.0 108.765 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -83.81 115.15 22.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.47 135.24 40.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -116.02 115.11 25.55 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.81 151.44 14.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.41 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.8 t -133.07 156.08 48.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.59 0.632 . . . . 0.0 109.574 169.281 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.05 131.34 52.18 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.322 1.849 . . . . 0.0 106.867 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -97.6 115.7 28.39 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -50.94 -48.33 60.85 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.647 1.579 . . . . 0.0 111.813 -168.946 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.26 -30.41 71.28 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.703 0.801 . . . . 0.0 110.972 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.4 m -84.13 -33.59 24.25 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 49.36 44.33 23.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.5 1.12 . . . . 0.0 109.759 -167.562 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.11 150.8 22.66 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.1 mtt85 -111.39 169.31 8.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.395 0.617 . . . . 0.0 112.271 -170.847 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.07 145.82 23.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.189 174.44 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.4 tp -71.83 138.05 48.01 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.755 0.822 . . . . 0.0 108.904 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.63 -57.05 2.4 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.934 0.894 . . . . 0.0 108.75 168.637 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.39 160.1 43.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.835 0.35 . . . . 0.0 110.959 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -136.25 92.24 2.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.63 1.972 . . . . 0.0 106.494 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.88 145.56 25.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.51 -167.88 24.35 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo . . . . . 0 N--CA 1.456 -0.701 0 CA-C-N 118.644 1.222 . . . . 0.0 110.588 0.096 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.557 HD12 ' H ' ' A' ' 5' ' ' ILE . 3.4 mp -79.27 143.57 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.9 pt -120.91 158.49 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.718 0.807 . . . . 0.0 110.373 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.16 140.78 58.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.919 0.888 . . . . 0.0 109.856 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -92.7 121.45 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.426 1.09 . . . . 0.0 108.425 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.48 -169.54 33.71 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -51.16 -45.97 33.77 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.723 2.948 . . . . 0.0 112.75 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -49.22 -55.28 13.06 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.114 0.959 . . . . 0.0 111.043 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -41.3 90.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.663 1.185 . . . . 0.0 110.591 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -56.67 -44.71 81.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.979 0.912 . . . . 0.0 109.55 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -51.8 -52.76 46.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.889 0.768 . . . . 0.0 110.75 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.47 -46.19 89.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 110.537 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.97 -42.2 86.23 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -64.7 -50.13 68.16 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -50.91 -46.15 60.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.12 0.968 . . . . 0.0 110.996 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 75' ' ' ILE . . . -58.06 -53.05 62.68 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.793 0.806 . . . . 0.0 110.398 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.9 t -63.78 -36.57 77.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.678 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.02 -47.16 84.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.201 1.0 . . . . 0.0 110.091 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.97 -50.87 67.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.69 -41.71 95.67 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 121.635 -0.665 . . . . 0.0 111.383 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -56.42 -42.85 78.7 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.235 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.34 -39.97 96.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.312 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.7 mm -62.54 -46.27 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.16 0.891 . . . . 0.0 109.376 174.095 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.13 3.91 85.65 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.137 1.351 . . . . 0.0 112.78 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -29.12 70.04 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.071 1.436 . . . . 0.0 113.061 -171.676 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -110.44 27.03 10.04 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.584 0.753 . . . . 0.0 110.024 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.27 -164.07 52.44 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -95.34 107.45 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.199 1.0 . . . . 0.0 108.547 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.9 140.23 35.48 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.145 0.429 . . . . 0.0 110.776 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.6 m -85.48 103.78 14.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -49.03 128.86 16.87 Favored 'General case' 0 N--CA 1.457 -0.079 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -102.82 -64.51 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -167.8 170.64 10.63 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.341 1.056 . . . . 0.0 109.998 172.954 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.5 p -98.48 149.5 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.318 1.047 . . . . 0.0 108.745 169.352 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -138.8 170.8 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 123.374 0.67 . . . . 0.0 110.258 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -61.84 152.46 76.18 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.967 0.907 . . . . 0.0 110.421 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.35 152.31 97.49 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 CA-C-N 119.184 0.744 . . . . 0.0 110.453 -4.791 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 46.9 t -143.72 101.65 3.79 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 ttp -128.47 136.19 50.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.877 0.871 . . . . 0.0 110.271 -166.019 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -119.84 157.3 28.96 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.195 0.998 . . . . 0.0 110.846 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -146.69 146.28 30.3 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.375 1.07 . . . . 0.0 109.635 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -76.06 132.52 40.15 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.98 0.912 . . . . 0.0 109.955 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.48 116.54 51.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.281 1.433 . . . . 0.0 108.476 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.7 p90 . . . . . 0 N--CA 1.448 -0.543 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.668 -174.766 . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -101.53 -34.83 9.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.33 -161.85 24.98 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -139.93 158.83 43.45 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -123.9 147.25 47.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.137 1.375 . . . . 0.0 108.363 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -135.67 111.23 9.22 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.195 1.398 . . . . 0.0 107.641 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.27 112.55 25.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.596 1.558 . . . . 0.0 107.83 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -139.81 146.42 39.4 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.689 0.796 . . . . 0.0 111.267 -171.016 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -99.44 115.97 30.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.064 0.945 . . . . 0.0 109.62 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 p -113.53 129.17 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.193 1.397 . . . . 0.0 110.866 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.33 118.55 26.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.749 1.22 . . . . 0.0 107.997 173.111 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.76 128.99 43.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 t 52.25 41.17 30.22 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.683 0.793 . . . . 0.0 111.401 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t0 51.54 32.83 9.47 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.067 1.347 . . . . 0.0 112.938 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -125.34 131.22 53.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 169.753 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.4 tp -89.3 128.79 35.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -125.34 152.37 44.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.001 1.321 . . . . 0.0 108.294 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -92.49 129.44 38.43 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 132.54 56.65 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.563 1.145 . . . . 0.0 108.506 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -112.01 107.47 16.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 19' ' ' ALA . 13.1 mm -100.45 153.91 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 125.976 1.71 . . . . 0.0 107.961 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 t -132.34 159.96 37.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.167 0.508 . . . . 0.0 109.928 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -130.16 122.08 27.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.9 1.68 . . . . 0.0 106.483 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -83.89 119.06 24.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.403 1.081 . . . . 0.0 108.096 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -58.26 -58.3 9.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.643 0.777 . . . . 0.0 111.476 -170.643 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -68.94 -43.47 75.0 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.859 0.361 . . . . 0.0 110.039 -171.346 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.38 -30.29 70.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.565 0.746 . . . . 0.0 110.895 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 54.6 47.88 21.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.496 1.119 . . . . 0.0 110.069 -168.777 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -126.77 139.63 11.4 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -92.14 172.72 8.24 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.547 0.739 . . . . 0.0 110.689 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -174.94 143.18 0.7 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.853 2.061 . . . . 0.0 110.743 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.29 124.51 28.46 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 166.679 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.6 -59.92 2.36 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 169.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -142.75 150.42 40.04 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.178 0.591 . . . . 0.0 109.573 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -132.13 122.32 25.17 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -132.69 146.4 51.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -173.922 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 141.74 -165.23 26.55 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 123.578 0.609 . . . . 0.0 111.606 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 CA-C-N 118.045 0.923 . . . . 0.0 111.307 2.597 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 C--O 1.231 0.083 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 mt -77.44 138.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 125.094 1.357 . . . . 0.0 107.58 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 pt -103.2 155.98 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 123.273 0.629 . . . . 0.0 110.422 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.75 131.38 45.08 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.7 pt -73.32 154.35 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 164.885 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.9 -175.68 29.77 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -166.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -58.95 -45.22 29.68 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.681 2.921 . . . . 0.0 112.667 -171.182 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -54.29 -53.12 58.07 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 122.144 0.973 . . . . 0.0 110.943 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 m -68.31 -39.28 82.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.219 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -52.98 -56.61 14.78 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.063 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -46.71 -50.32 18.12 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.337 0.971 . . . . 0.0 110.805 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.01 -50.43 72.08 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.915 -0.491 . . . . 0.0 111.567 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.34 -25.11 62.23 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 121.661 -0.649 . . . . 0.0 112.851 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -80.59 -54.85 5.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -45.03 -45.52 10.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.757 1.623 . . . . 0.0 110.47 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.56 -53.84 51.4 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.93 0.395 . . . . 0.0 110.738 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.31 -38.97 82.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.243 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.68 -48.96 79.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.472 0.709 . . . . 0.0 109.693 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.07 -50.05 74.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.18 0.992 . . . . 0.0 108.967 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -56.29 -49.66 73.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -59.86 -41.42 91.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.285 1.434 . . . . 0.0 110.069 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -61.47 -37.72 84.63 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 119.637 -0.221 . . . . 0.0 110.676 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.73 -47.33 80.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.42 19.0 61.14 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.624 1.583 . . . . 0.0 111.719 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -56.74 -41.63 77.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.964 0.882 . . . . 0.0 110.808 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -110.82 35.21 3.59 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.951 0.901 . . . . 0.0 110.179 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.85 -154.59 43.13 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.432 0.539 . . . . 0.0 112.051 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.4 ptt85 -93.44 84.91 4.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.084 1.354 . . . . 0.0 109.834 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.11 144.04 38.77 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.932 -0.48 . . . . 0.0 110.169 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 m -100.69 96.98 7.69 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -45.9 125.57 6.38 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.879 0.471 . . . . 0.0 110.473 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.27 -64.96 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.97 169.84 3.33 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 125.005 1.322 . . . . 0.0 108.418 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 p -110.78 141.09 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 124.74 1.216 . . . . 0.0 109.297 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.79 178.72 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 123.587 0.554 . . . . 0.0 110.411 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -60.7 154.99 54.04 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.162 0.985 . . . . 0.0 111.663 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.92 155.61 93.6 Favored 'Cis proline' 0 N--CA 1.458 -0.569 0 CA-C-N 119.414 0.827 . . . . 0.0 110.717 -9.616 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 17.1 p -161.29 79.0 0.59 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -166.218 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -99.16 160.46 14.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.37 1.068 . . . . 0.0 110.936 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -140.78 149.4 42.03 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.055 1.342 . . . . 0.0 108.608 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -147.61 143.58 27.82 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.84 0.856 . . . . 0.0 110.693 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -59.76 141.39 55.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.533 1.533 . . . . 0.0 111.969 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.07 124.76 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.645 1.578 . . . . 0.0 109.23 173.428 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 . . . . . 0 CA--C 1.529 0.138 0 C-N-CA 125.79 1.636 . . . . 0.0 108.784 176.139 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -89.91 -37.6 14.29 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.13 -157.36 17.97 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.01 151.86 39.24 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -104.89 144.85 31.21 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.834 1.654 . . . . 0.0 107.309 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.07 139.12 51.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -141.05 99.9 3.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -170.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -122.06 138.6 54.38 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.574 1.149 . . . . 0.0 111.328 -164.037 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -87.34 102.27 14.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.728 0.775 . . . . 0.0 109.013 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.77 131.08 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.401 1.48 . . . . 0.0 109.378 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -98.65 124.25 43.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.227 1.411 . . . . 0.0 108.181 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.03 134.98 21.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.077 0.951 . . . . 0.0 108.897 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 t 52.46 32.62 11.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.173 0.989 . . . . 0.0 111.211 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.7 23.22 12.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.046 1.338 . . . . 0.0 113.45 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -116.75 143.66 45.39 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.434 1.494 . . . . 0.0 107.743 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.8 tp -103.5 129.15 50.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.493 0.717 . . . . 0.0 109.882 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -134.61 148.08 50.34 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 125.206 1.403 . . . . 0.0 109.902 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -94.15 110.59 22.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.711 1.204 . . . . 0.0 108.695 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.35 121.82 42.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.855 1.262 . . . . 0.0 107.903 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -108.63 121.62 45.4 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.86 153.58 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 126.448 1.899 . . . . 0.0 107.607 -175.142 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.1 p -123.77 146.28 48.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 126.64 51.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 168.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -96.86 119.37 35.21 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -63.92 -28.86 70.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.142 0.577 . . . . 0.0 111.047 -174.245 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -63.56 -18.14 63.56 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.5 0.72 . . . . 0.0 112.656 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -143.75 8.57 1.51 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.307 -0.871 . . . . 0.0 111.721 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 44.8 ttt85 50.98 40.41 25.26 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.407 0.683 . . . . 0.0 110.156 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -110.21 137.85 14.52 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -109.79 164.02 12.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 117.503 0.652 . . . . 0.0 111.276 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -157.34 148.7 21.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.551 1.141 . . . . 0.0 110.963 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.19 135.04 39.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.718 1.207 . . . . 0.0 109.264 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.61 -67.11 0.8 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.542 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.31 160.27 43.84 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.255 1.022 . . . . 0.0 109.22 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -126.08 83.83 2.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.688 1.995 . . . . 0.0 106.657 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.6 145.69 26.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.87 -165.04 27.75 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.081 172.93 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.458 -0.586 0 CA-C-N 117.966 0.883 . . . . 0.0 111.318 2.976 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.6 mm -78.04 140.69 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -106.14 154.3 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.257 0.623 . . . . 0.0 109.961 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -73.89 124.46 26.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.5 pt -65.53 122.24 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 123.056 0.542 . . . . 0.0 109.626 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.82 -167.16 21.86 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -175.648 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -56.13 -41.64 74.66 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.239 2.626 . . . . 0.0 111.464 -175.832 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -51.81 -50.01 61.66 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.889 0.875 . . . . 0.0 110.729 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.23 -49.51 71.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.948 0.899 . . . . 0.0 110.62 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -51.97 -53.26 43.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -54.91 -47.83 73.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.999 0.92 . . . . 0.0 111.423 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 mt -59.97 -48.27 82.38 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.979 0.354 . . . . 0.0 110.93 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.11 -48.61 85.27 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -54.9 -49.43 71.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.104 1.361 . . . . 0.0 110.25 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -55.87 -48.21 75.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.106 1.362 . . . . 0.0 110.52 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -49.55 74.86 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.34 -42.63 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.406 0.682 . . . . 0.0 110.783 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.25 -51.58 68.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.961 0.904 . . . . 0.0 109.664 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -58.22 -46.79 85.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.693 1.197 . . . . 0.0 109.746 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -56.16 -56.94 14.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -56.97 -38.72 73.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.578 1.151 . . . . 0.0 110.955 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -56.77 -39.21 73.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.853 0.461 . . . . 0.0 110.608 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.6 mt -83.1 -47.6 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.081 0.552 . . . . 0.0 110.235 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.25 10.83 58.02 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.556 1.55 . . . . 0.0 113.921 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -54.73 -42.64 71.8 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.035 1.417 . . . . 0.0 112.053 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -107.12 37.83 2.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.696 0.798 . . . . 0.0 110.076 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.11 -138.42 47.82 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -115.24 93.39 4.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.134 1.373 . . . . 0.0 108.837 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.3 mt -79.0 142.16 36.84 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.164 0.585 . . . . 0.0 109.575 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 t -103.84 106.92 17.58 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -59.04 133.73 56.36 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.458 0.703 . . . . 0.0 109.916 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -100.48 -64.69 1.02 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 168.661 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -167.61 179.03 5.06 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.356 1.062 . . . . 0.0 108.915 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.06 134.21 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -176.488 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 38' ' ' ILE . . . . . 0.492 HD11 ' CZ ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -146.41 167.2 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 122.741 0.416 . . . . 0.0 110.335 -173.842 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -53.71 150.97 12.17 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.482 1.113 . . . . 0.0 111.831 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.38 142.76 72.72 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 CA-C-N 119.018 0.685 . . . . 0.0 110.701 -1.495 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.6 m -133.68 101.73 5.22 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 33.2 ttm -118.37 138.82 52.16 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.242 0.617 . . . . 0.0 110.491 -169.204 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -121.48 144.57 48.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.956 1.302 . . . . 0.0 110.132 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -146.38 149.8 34.46 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.456 0.702 . . . . 0.0 110.885 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -80.63 137.62 36.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.414 1.485 . . . . 0.0 111.365 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.53 120.74 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.79 1.236 . . . . 0.0 108.303 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.0 p90 . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 123.865 0.866 . . . . 0.0 109.275 179.291 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -119.59 -22.29 7.0 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 123.547 0.529 . . . . 0.0 111.166 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.95 -168.01 31.24 Favored Glycine 0 N--CA 1.448 -0.543 0 O-C-N 121.432 -0.792 . . . . 0.0 111.445 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -148.82 163.69 36.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.328 1.451 . . . . 0.0 107.693 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.84 148.83 52.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.688 1.195 . . . . 0.0 108.97 169.026 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -134.32 115.66 14.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -107.68 129.74 54.99 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.201 0.91 . . . . 0.0 109.263 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 pp -149.27 152.3 35.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.568 0.699 . . . . 0.0 111.568 -172.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 63' ' ' TYR . . . . . 0.612 ' CZ ' HD22 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -89.02 111.34 22.03 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.537 1.535 . . . . 0.0 107.036 177.479 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.1 t -93.35 124.23 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 169.296 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.29 116.55 23.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 169.66 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 132.51 36.95 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.8 t 53.8 34.72 19.8 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.968 0.907 . . . . 0.0 111.708 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 t0 46.94 42.85 12.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.098 1.359 . . . . 0.0 111.064 -169.434 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -137.96 155.15 49.18 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.255 1.422 . . . . 0.0 107.953 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LEU . . . . . 0.612 HD22 ' CZ ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -81.74 118.11 22.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -173.898 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -130.07 112.63 13.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.451 1.1 . . . . 0.0 108.69 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -97.13 131.12 44.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.3 142.73 50.16 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.202 0.91 . . . . 0.0 110.204 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.9 120.68 42.25 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.226 1.01 . . . . 0.0 108.363 168.727 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.74 140.08 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.9 p -111.38 147.65 34.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.581 1.152 . . . . 0.0 108.108 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -126.78 134.35 50.61 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.907 1.683 . . . . 0.0 107.798 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -107.31 114.49 28.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.519 1.128 . . . . 0.0 108.846 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.28 -27.9 67.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.728 1.211 . . . . 0.0 111.365 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -58.04 -23.22 53.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.88 0.872 . . . . 0.0 112.407 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -141.14 6.07 1.93 Allowed 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.468 -0.77 . . . . 0.0 111.328 174.001 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 49.94 40.55 21.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.826 0.851 . . . . 0.0 110.028 -171.294 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.69 140.74 15.35 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 107.699 -2.161 . . . . 0.0 107.699 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -116.85 164.99 13.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.986 0.893 . . . . 0.0 110.787 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -161.2 150.69 16.79 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.842 0.857 . . . . 0.0 110.326 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.57 110.98 0.98 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.346 1.059 . . . . 0.0 108.677 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.7 tp -71.89 -48.26 46.96 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -162.56 155.57 19.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -119.32 141.5 48.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.85 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.4 131.7 40.31 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.93 -176.17 27.84 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.455 -0.761 0 CA-C-N 118.223 1.012 . . . . 0.0 110.508 -3.516 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--O 1.233 0.209 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.88 138.48 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.11 157.35 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.1 0.96 . . . . 0.0 110.475 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.52 125.39 29.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.503 0.721 . . . . 0.0 109.387 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 pt -65.13 136.32 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 165.851 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.11 -175.07 41.04 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -169.841 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.37 -46.78 31.35 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.745 2.963 . . . . 0.0 113.195 -170.354 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -52.13 -55.01 23.61 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.918 1.342 . . . . 0.0 110.871 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.9 m -66.73 -42.42 86.32 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.28 1.032 . . . . 0.0 110.198 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -57.03 -48.66 77.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.405 0.682 . . . . 0.0 110.078 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -54.02 -47.62 71.34 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 123.131 0.572 . . . . 0.0 110.839 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.06 -41.05 95.5 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.208 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.28 -51.63 40.95 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -51.3 -55.27 19.19 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.353 1.061 . . . . 0.0 110.185 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -51.26 -47.6 62.4 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.826 0.851 . . . . 0.0 110.447 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.35 -50.84 68.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.9 -40.87 90.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.39 -48.31 82.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.465 0.706 . . . . 0.0 110.076 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -63.09 -49.23 75.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.086 0.955 . . . . 0.0 109.698 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -54.74 -46.64 74.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -63.46 -44.94 93.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.635 1.574 . . . . 0.0 110.12 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -56.03 -46.0 78.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.55 0.74 . . . . 0.0 110.022 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -68.9 -47.56 75.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.98 14.9 55.65 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.219 1.39 . . . . 0.0 113.211 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -50.87 -44.46 59.65 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.621 1.21 . . . . 0.0 111.44 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -113.34 38.07 2.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.881 0.873 . . . . 0.0 109.984 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.4 -141.23 47.5 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -111.83 114.93 28.19 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.776 1.231 . . . . 0.0 109.344 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.3 152.25 21.76 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.351 0.66 . . . . 0.0 111.005 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.4 m -92.87 100.1 12.63 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -49.53 130.61 20.54 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -101.53 -63.63 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -171.58 -166.67 0.46 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.007 0.923 . . . . 0.0 109.122 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.53 144.81 35.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.11 165.34 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.544 0.611 . . . . 0.0 110.417 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -63.96 151.18 90.18 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.078 0.951 . . . . 0.0 111.4 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.1 151.47 96.82 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 119.268 0.774 . . . . 0.0 111.572 0.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.4 m -139.89 94.81 2.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.4 mtt -108.33 157.81 18.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.998 0.919 . . . . 0.0 110.673 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -131.96 154.44 49.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.031 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -130.04 151.9 50.08 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.148 2.179 . . . . 0.0 107.815 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.2 m -98.74 133.64 42.78 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.039 0.936 . . . . 0.0 109.319 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.58 128.19 62.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 125.006 1.323 . . . . 0.0 110.501 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.8 p90 . . . . . 0 N--CA 1.443 -0.783 0 C-N-CA 125.553 1.541 . . . . 0.0 107.607 -179.987 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -127.94 -34.71 2.12 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.207 0.603 . . . . 0.0 112.09 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.91 -164.43 28.99 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.02 -1.086 . . . . 0.0 111.862 -170.522 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -145.02 160.71 40.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.613 1.165 . . . . 0.0 108.027 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -126.41 144.1 50.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.532 1.533 . . . . 0.0 107.579 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -129.95 124.15 32.38 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -113.33 117.75 32.68 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.782 1.633 . . . . 0.0 106.723 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 pp -152.18 153.99 34.93 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.272 0.487 . . . . 0.0 111.535 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -96.1 104.58 16.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.232 1.013 . . . . 0.0 109.348 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.39 130.72 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.374 1.869 . . . . 0.0 108.571 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.57 120.12 39.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.809 1.244 . . . . 0.0 107.674 173.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.7 131.12 20.99 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.275 1.03 . . . . 0.0 108.81 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.43 39.22 29.62 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.18 0.992 . . . . 0.0 110.974 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.9 t0 45.95 37.5 3.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.081 1.352 . . . . 0.0 113.005 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -125.72 139.01 53.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 168.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.4 tp -98.54 126.9 44.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -124.89 140.4 52.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.679 1.592 . . . . 0.0 107.965 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -88.8 123.59 33.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.27 146.82 44.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.662 0.785 . . . . 0.0 109.158 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.58 124.5 43.64 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 mm -112.34 150.17 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 127.006 2.123 . . . . 0.0 107.05 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -120.86 148.91 43.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.599 1.16 . . . . 0.0 108.403 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -122.24 127.25 49.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.393 1.877 . . . . 0.0 106.63 169.207 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -102.78 119.22 38.45 Favored 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.379 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -66.45 -23.07 66.22 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.659 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -63.85 -55.56 21.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.103 0.865 . . . . 0.0 110.495 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.4 p -79.84 -26.84 40.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 68.31 13.96 9.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.053 1.341 . . . . 0.0 109.023 -164.044 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.02 155.09 34.43 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -115.51 171.92 7.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.948 0.499 . . . . 0.0 110.626 176.415 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.26 157.53 30.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.698 174.642 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 tp -78.5 119.2 21.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.1 tp -82.67 -59.78 2.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -144.84 154.35 42.57 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.065 0.946 . . . . 0.0 109.563 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -144.73 102.33 3.78 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.926 1.69 . . . . 0.0 106.838 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -117.11 142.27 47.21 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -172.291 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.74 -165.96 27.92 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.614 -0.548 . . . . 0.0 112.158 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.458 -0.588 0 CA-C-N 118.006 0.903 . . . . 0.0 111.237 2.137 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 C--O 1.232 0.167 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.53 139.99 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.043 1.337 . . . . 0.0 108.662 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.5 pt -104.25 156.74 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.481 1.113 . . . . 0.0 109.865 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.51 118.13 18.86 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.4 pt -55.56 133.47 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 166.192 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.4 -169.32 42.44 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -172.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -52.17 -44.08 48.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.628 2.885 . . . . 0.0 112.676 -172.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -53.15 -57.13 11.52 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.554 0.692 . . . . 0.0 111.463 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.97 -45.07 94.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.507 0.723 . . . . 0.0 109.974 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -55.85 -48.83 74.83 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.492 0.717 . . . . 0.0 109.22 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -55.08 -51.81 65.2 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.322 0.649 . . . . 0.0 110.608 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 15' ' ' LEU . 19.6 mt -59.23 -45.23 91.69 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.675 -0.64 . . . . 0.0 111.642 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.98 -39.93 92.58 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -64.74 -52.33 57.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -50.98 -45.29 60.93 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.582 1.153 . . . . 0.0 110.849 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.1 70.67 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.0 -41.68 93.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.019 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.0 -48.81 77.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.236 0.614 . . . . 0.0 109.458 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.24 -52.77 63.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.575 1.15 . . . . 0.0 109.36 175.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -57.71 -45.01 86.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 122.997 0.519 . . . . 0.0 110.365 -174.919 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -67.57 -43.77 79.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.786 1.634 . . . . 0.0 110.633 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.35 -44.48 96.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.9 0.48 . . . . 0.0 110.048 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.2 -43.67 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.47 12.94 57.82 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.444 1.021 . . . . 0.0 112.741 173.412 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -47.99 -46.08 32.34 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.246 1.023 . . . . 0.0 111.868 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -111.16 24.02 13.39 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.524 1.13 . . . . 0.0 110.798 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.33 -158.44 26.75 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -81.11 89.86 6.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.4 0.68 . . . . 0.0 110.796 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.6 140.52 48.09 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 169.465 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.5 m -95.56 93.84 7.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -48.67 129.37 16.5 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.689 0.222 . . . . 0.0 110.71 177.165 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -102.82 -62.05 1.32 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -174.16 -161.36 0.12 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.057 1.343 . . . . 0.0 108.741 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.37 145.19 34.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.43 162.7 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 118.353 0.524 . . . . 0.0 110.388 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 151.32 67.38 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.77 1.228 . . . . 0.0 111.22 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.8 130.99 21.9 Favored 'Cis proline' 0 C--N 1.348 0.545 0 CA-C-N 120.035 1.048 . . . . 0.0 112.353 4.765 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 96.3 m -125.39 99.93 6.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 96.5 mtp -115.28 160.05 20.26 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.689 0.796 . . . . 0.0 110.902 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -133.94 158.48 43.37 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 167.617 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -150.58 173.16 14.43 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.9 m -98.27 135.18 40.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.531 1.132 . . . . 0.0 112.041 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.19 136.71 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.286 1.834 . . . . 0.0 108.705 171.156 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.5 p90 . . . . . 0 N--CA 1.436 -1.14 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -170.825 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -108.56 -22.37 12.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.749 0.82 . . . . 0.0 110.539 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.54 -162.39 28.55 Favored Glycine 0 C--N 1.336 0.566 0 O-C-N 121.408 -0.807 . . . . 0.0 111.479 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -142.59 155.14 44.94 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.118 1.367 . . . . 0.0 107.679 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -108.59 150.16 27.88 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.835 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -129.2 120.95 26.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -104.05 128.51 51.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 pp -151.88 153.02 33.34 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.814 0.734 . . . . 0.0 111.519 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -96.73 99.81 11.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.264 1.026 . . . . 0.0 108.7 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.77 135.46 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.9 113.09 26.43 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.462 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.01 132.48 23.55 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 123.568 0.747 . . . . 0.0 109.31 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 m 51.08 36.3 15.1 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.759 1.223 . . . . 0.0 111.185 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 56.12 30.87 17.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.272 1.029 . . . . 0.0 112.726 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.5 150.32 42.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 168.737 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mp -92.59 128.53 38.48 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.939 1.296 . . . . 0.0 108.452 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -127.05 132.04 50.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.27 1.028 . . . . 0.0 108.283 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 112.31 21.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.41 139.55 42.98 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -114.15 123.6 50.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.501 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mm -112.46 149.88 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.501 1.92 . . . . 0.0 105.907 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.9 t -117.7 150.37 39.18 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.94 113.47 15.24 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 127.363 2.265 . . . . 0.0 105.585 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -82.28 118.76 23.37 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -58.28 -52.3 66.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.302 1.441 . . . . 0.0 111.502 -171.218 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.17 -45.02 71.03 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 m -72.19 -29.78 64.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.45 0.3 . . . . 0.0 110.591 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 55.35 49.01 17.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.405 1.082 . . . . 0.0 109.53 -168.469 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -133.58 140.61 11.95 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.78 172.8 6.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.583 0.753 . . . . 0.0 111.187 -174.215 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -167.63 142.51 3.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.226 1.011 . . . . 0.0 111.056 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.63 121.84 17.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.7 tp -84.6 -45.43 12.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -162.49 143.93 10.42 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.069 0.547 . . . . 0.0 110.24 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -125.82 111.9 15.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.838 1.655 . . . . 0.0 107.197 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -116.9 151.23 37.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.0 -170.79 22.72 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.622 1.106 . . . . 0.0 110.491 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 N--CA 1.455 -0.762 0 CA-C-N 118.324 1.062 . . . . 0.0 110.702 1.826 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.233 0.215 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.46 138.46 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.9 pt -106.35 155.41 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.014 0.926 . . . . 0.0 110.18 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.56 140.78 58.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.32 120.61 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.01 -167.43 33.59 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -174.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -52.99 -43.78 54.17 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.515 2.81 . . . . 0.0 113.326 -172.527 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -51.12 -55.99 14.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.481 1.134 . . . . 0.0 111.159 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.33 -42.87 96.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.757 1.223 . . . . 0.0 109.797 -175.761 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -56.69 -48.22 78.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.888 0.875 . . . . 0.0 109.408 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -56.57 -49.24 75.46 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.03 0.532 . . . . 0.0 110.921 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.08 -45.9 82.96 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 117.846 0.293 . . . . 0.0 110.997 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.69 -53.84 40.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -52.66 -48.45 66.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.398 1.079 . . . . 0.0 110.86 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -56.4 -49.1 75.46 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.709 0.804 . . . . 0.0 110.713 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.59 78.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 110.258 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.93 -47.64 85.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.374 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.1 -48.55 81.14 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.727 1.211 . . . . 0.0 110.06 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -65.14 -43.61 91.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.659 0.783 . . . . 0.0 109.902 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -58.99 -48.66 80.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.419 171.33 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -54.52 -39.9 68.06 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.399 1.08 . . . . 0.0 110.276 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -49.43 -37.79 26.95 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.0 0.92 . . . . 0.0 111.141 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.14 -47.43 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.228 1.011 . . . . 0.0 109.355 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.0 28.35 23.57 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.32 0.962 . . . . 0.0 111.19 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -55.99 -38.26 70.2 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.502 0.651 . . . . 0.0 111.39 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -117.59 42.76 2.53 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.838 0.828 . . . . 0.0 109.825 170.852 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.72 -148.1 39.28 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -102.6 115.18 30.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.809 0.844 . . . . 0.0 109.623 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 mp -110.62 137.0 48.86 Favored 'General case' 0 N--CA 1.458 -0.046 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.2 m -86.07 131.47 34.26 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -60.04 135.51 57.73 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -105.76 -64.01 1.19 Allowed 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -165.41 161.32 18.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.19 0.596 . . . . 0.0 109.637 -173.474 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.93 144.41 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 125.429 1.491 . . . . 0.0 107.594 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.16 159.99 9.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 123.011 0.524 . . . . 0.0 110.187 -176.26 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -61.39 152.89 71.61 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.831 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.43 153.79 98.71 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 CA-C-N 119.294 0.783 . . . . 0.0 111.08 -4.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.9 m -141.13 100.6 3.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.3 mtt -113.24 155.0 25.85 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.28 1.032 . . . . 0.0 110.704 -174.709 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -138.38 154.7 48.92 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 167.998 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -150.15 160.05 43.96 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.396 1.079 . . . . 0.0 110.981 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.9 m -84.06 139.55 32.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.741 1.216 . . . . 0.0 112.851 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.07 137.05 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.756 1.622 . . . . 0.0 109.712 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.1 p90 . . . . . 0 CA--C 1.531 0.25 0 C-N-CA 123.23 0.612 . . . . 0.0 111.737 -167.246 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -112.69 -27.51 8.15 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.352 0.661 . . . . 0.0 111.458 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.11 -160.48 24.57 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.08 163.57 33.17 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.795 1.238 . . . . 0.0 108.356 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.57 145.76 48.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.492 1.517 . . . . 0.0 107.972 168.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -121.3 140.37 52.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -136.78 114.2 10.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.66 163.17 39.18 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.289 0.236 . . . . 0.0 110.711 -169.378 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -103.16 139.21 38.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 123.728 0.811 . . . . 0.0 110.345 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.48 137.4 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.421 1.488 . . . . 0.0 108.037 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.38 124.17 38.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 168.325 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.45 121.08 23.95 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.476 1.11 . . . . 0.0 109.554 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t 71.87 -63.31 0.43 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 129.318 3.047 . . . . 0.0 108.588 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -173.22 10.8 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.965 2.906 . . . . 0.0 111.064 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -113.77 130.75 56.4 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 119.432 1.014 . . . . 0.0 108.828 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 tt -87.96 123.49 32.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.775 1.23 . . . . 0.0 108.116 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -133.3 159.23 40.85 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.81 0.844 . . . . 0.0 110.035 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -91.35 136.59 33.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.692 0.797 . . . . 0.0 108.957 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.57 135.26 53.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.94 130.5 56.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 169.785 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.81 136.73 58.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 125.513 1.525 . . . . 0.0 106.89 -173.558 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.3 p -103.4 151.32 22.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.437 0.695 . . . . 0.0 109.295 171.676 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -126.62 119.6 27.45 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 126.802 2.041 . . . . 0.0 106.857 173.861 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.45 118.82 30.89 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -60.57 -46.47 90.1 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.081 0.953 . . . . 0.0 111.446 -171.916 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -63.74 -49.5 72.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.902 0.481 . . . . 0.0 111.542 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.8 m -71.27 -30.25 66.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.8 ttm-85 58.04 41.9 23.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.538 1.135 . . . . 0.0 109.056 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -131.23 150.76 19.5 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -120.35 167.72 12.03 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.539 0.735 . . . . 0.0 109.705 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.09 147.68 19.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 169.999 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.0 tp -57.33 109.9 0.76 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.295 1.438 . . . . 0.0 108.147 170.96 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.92 -54.53 8.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.188 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.78 156.78 42.42 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.598 0.759 . . . . 0.0 109.541 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -120.98 127.36 51.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 168.737 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -137.19 155.43 49.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.91 -159.57 21.5 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -169.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo . . . . . 0 N--CA 1.457 -0.674 0 CA-C-N 119.099 1.45 . . . . 0.0 112.07 2.99 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mp -78.26 140.26 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 pt -113.82 156.24 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.072 0.949 . . . . 0.0 109.673 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.3 167.44 18.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.807 0.813 . . . . 0.0 109.773 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pp -100.44 164.21 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 164.89 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.46 -174.12 23.54 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -169.109 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.05 -43.19 50.34 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.847 3.031 . . . . 0.0 112.382 -173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -51.22 -58.11 7.02 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.019 0.914 . . . . 0.0 110.871 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.14 -41.18 86.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.665 -171.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -53.71 -53.79 47.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.643 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -51.68 -50.31 60.68 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.771 0.714 . . . . 0.0 110.712 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.22 -49.92 74.48 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.032 -0.418 . . . . 0.0 110.877 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.0 -34.23 71.7 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 122.142 -0.349 . . . . 0.0 112.257 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -73.06 -48.18 38.28 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -51.58 -47.19 63.6 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.279 1.031 . . . . 0.0 110.554 169.569 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.97 -53.33 59.3 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.093 0.473 . . . . 0.0 110.052 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.36 -40.08 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.771 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.72 -48.11 83.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.436 -0.79 . . . . 0.0 109.666 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -58.81 -50.27 74.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.282 1.033 . . . . 0.0 109.516 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -53.78 -44.94 70.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.278 0.631 . . . . 0.0 110.778 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -69.98 -39.69 75.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.554 1.542 . . . . 0.0 110.589 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -58.33 -46.03 86.99 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.86 -43.77 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.41 24.59 33.3 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.243 1.401 . . . . 0.0 110.282 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -57.85 -35.33 70.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.519 0.728 . . . . 0.0 111.47 -169.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -129.27 45.43 2.8 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.013 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.17 -140.11 46.44 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 86.33 2.97 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.066 1.346 . . . . 0.0 109.219 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.94 138.1 37.02 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.494 -0.754 . . . . 0.0 110.124 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 m -96.61 95.55 8.04 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -45.67 131.45 8.96 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 123.245 0.618 . . . . 0.0 110.234 173.113 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -102.0 -66.12 0.94 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -173.36 154.16 2.57 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.93 0.892 . . . . 0.0 110.546 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.79 144.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 168.439 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.97 156.92 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.815 0.846 . . . . 0.0 110.144 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.9 ptt85 -63.42 153.01 83.96 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.708 1.203 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.11 154.72 98.36 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 CA-C-N 119.443 0.837 . . . . 0.0 111.268 -5.335 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 89.9 m -137.66 131.04 30.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 mtp -135.82 158.08 45.26 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.44 0.696 . . . . 0.0 110.965 -169.965 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -145.07 154.58 42.64 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.251 0.621 . . . . 0.0 111.059 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -144.47 142.09 30.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.054 0.942 . . . . 0.0 111.381 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -73.95 123.36 24.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.753 2.421 . . . . 0.0 111.395 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.61 100.91 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 122.387 1.089 . . . . 0.0 108.17 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 124.517 1.127 . . . . 0.0 110.348 174.339 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -19.44 33.85 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.612 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.71 -167.1 30.61 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.464 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -142.29 164.63 29.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.313 1.445 . . . . 0.0 108.157 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -122.49 146.22 47.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 106.725 171.025 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -127.42 138.85 53.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 176.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -136.86 117.64 14.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 pp -150.87 146.27 26.22 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 118.438 0.563 . . . . 0.0 111.573 -169.15 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -89.98 130.62 36.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.022 0.929 . . . . 0.0 109.446 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.08 135.06 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 124.336 1.054 . . . . 0.0 110.424 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -89.22 128.81 35.85 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.592 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 125.49 25.56 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 t 52.34 40.0 28.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.961 0.905 . . . . 0.0 111.105 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.1 t70 57.54 23.0 8.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.012 1.325 . . . . 0.0 113.359 -176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.78 132.08 54.5 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 169.959 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -91.2 124.52 35.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.818 0.847 . . . . 0.0 108.725 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.05 159.29 37.98 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.176 1.39 . . . . 0.0 109.215 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -101.08 123.11 44.74 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 167.623 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.83 133.85 41.78 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -122.77 124.8 44.17 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.359 1.063 . . . . 0.0 108.37 172.121 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.46 155.02 41.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 126.557 1.943 . . . . 0.0 106.684 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.9 m -127.79 164.94 21.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.424 0.556 . . . . 0.0 109.813 168.645 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.97 133.37 44.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.431 1.892 . . . . 0.0 107.595 175.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -105.21 109.11 20.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.256 1.422 . . . . 0.0 107.911 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -56.89 -31.95 65.39 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.394 1.477 . . . . 0.0 111.092 -173.327 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -48.86 -26.91 2.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.416 1.486 . . . . 0.0 112.928 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.1 m -144.22 17.54 1.72 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.64 0.654 . . . . 0.0 111.151 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 49.07 30.86 3.08 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.896 0.878 . . . . 0.0 110.442 -169.841 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.36 125.8 8.17 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -168.554 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -98.03 167.14 11.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.855 0.836 . . . . 0.0 112.433 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -164.53 128.22 2.5 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.035 -170.877 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.28 121.97 16.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.5 mp -84.33 -50.58 7.7 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 170.096 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -161.88 161.42 28.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.724 0.297 . . . . 0.0 110.649 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -127.79 82.34 2.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -83.33 137.85 33.79 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.18 -166.61 25.69 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo . . . . . 0 N--CA 1.457 -0.649 0 CA-C-N 118.175 0.988 . . . . 0.0 110.726 1.643 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 5' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 5' ' ' ILE . 3.4 mp -76.08 131.34 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.1 153.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.54 0.736 . . . . 0.0 109.626 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.49 122.65 19.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.5 pt -64.44 146.34 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.222 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.2 -177.59 32.33 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -166.936 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.95 -47.27 27.53 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.041 3.161 . . . . 0.0 113.352 -169.089 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -54.22 -54.19 43.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 122.217 1.008 . . . . 0.0 111.101 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.3 m -65.92 -41.48 91.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.438 0.695 . . . . 0.0 110.239 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -54.15 -54.69 36.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.45 169.721 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -50.02 -49.39 50.97 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.898 0.772 . . . . 0.0 111.004 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.79 -49.42 76.4 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.074 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.78 -27.93 62.39 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.945 -0.472 . . . . 0.0 112.762 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -79.7 -52.82 7.47 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -46.26 -45.15 17.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.386 1.475 . . . . 0.0 110.802 172.165 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.46 -55.64 26.91 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.517 0.675 . . . . 0.0 110.523 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.32 -39.93 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.754 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.58 -48.9 78.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.615 0.766 . . . . 0.0 109.701 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -59.94 -49.55 77.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.216 1.007 . . . . 0.0 109.24 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -54.93 -47.0 75.01 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.96 0.504 . . . . 0.0 110.732 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -65.78 -40.53 92.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.315 1.446 . . . . 0.0 110.298 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -58.07 -45.16 87.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.4 mt -69.1 -42.72 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.29 37.75 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.276 1.417 . . . . 0.0 112.167 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.69 -39.45 80.75 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.978 0.889 . . . . 0.0 111.581 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -110.84 34.83 3.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.108 0.963 . . . . 0.0 109.794 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.08 -130.42 44.63 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -119.92 84.73 2.26 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.923 1.289 . . . . 0.0 109.305 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.01 139.82 40.19 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.95 -0.469 . . . . 0.0 109.946 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.4 m -97.39 94.57 7.13 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -48.33 135.31 13.86 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 122.756 0.422 . . . . 0.0 110.204 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.86 -62.47 1.47 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.089 0.956 . . . . 0.0 109.097 176.668 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.15 178.3 4.46 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.551 1.14 . . . . 0.0 108.959 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.48 142.88 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.838 1.255 . . . . 0.0 109.348 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.6 171.56 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.873 0.869 . . . . 0.0 109.37 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 151.4 94.1 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.532 -175.225 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.33 160.97 85.88 Favored 'Cis proline' 0 C--N 1.348 0.519 0 CA-C-N 120.098 1.071 . . . . 0.0 111.649 0.049 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.9 p -177.0 77.52 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 -163.935 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.5 ttt -122.01 134.25 54.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.42 1.088 . . . . 0.0 109.225 -165.596 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -103.47 138.44 40.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 117.991 -1.004 . . . . 0.0 111.027 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -134.62 145.59 48.77 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.944 0.793 . . . . 0.0 111.471 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.6 m -74.46 139.02 43.62 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.884 0.473 . . . . 0.0 109.925 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.62 126.06 71.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.905 1.282 . . . . 0.0 109.257 175.296 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.7 p90 . . . . . 0 N--CA 1.448 -0.573 0 C-N-CA 124.009 0.924 . . . . 0.0 109.946 -178.356 . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -122.44 -34.19 3.31 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.235 0.614 . . . . 0.0 111.482 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -172.35 -160.1 20.21 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.507 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -135.67 163.9 29.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.675 1.19 . . . . 0.0 108.244 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -124.59 143.54 50.64 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.664 1.585 . . . . 0.0 108.043 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -124.13 111.91 16.47 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -106.62 110.72 22.99 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.87 141.72 34.6 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.028 0.831 . . . . 0.0 112.46 -172.432 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -87.91 101.99 14.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.896 0.879 . . . . 0.0 109.464 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.83 125.68 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.509 1.524 . . . . 0.0 109.301 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.8 117.79 24.89 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.889 1.276 . . . . 0.0 107.988 169.982 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.2 127.98 36.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.581 1.152 . . . . 0.0 108.17 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 t 51.27 39.4 23.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.104 0.962 . . . . 0.0 111.322 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.0 t0 55.26 22.79 5.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.087 1.355 . . . . 0.0 113.707 -176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -111.76 135.87 51.79 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.4 tp -100.11 126.39 46.34 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -131.63 142.8 49.95 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.604 1.162 . . . . 0.0 109.674 -176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -82.69 106.9 14.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.13 0.972 . . . . 0.0 108.707 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.43 124.64 34.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -110.62 108.9 18.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.27 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.0 mp -104.64 152.72 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.5 t -125.48 152.61 44.72 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.796 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.57 131.81 54.33 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.718 1.607 . . . . 0.0 107.779 173.538 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.04 124.03 35.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.768 0.827 . . . . 0.0 109.519 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -66.92 -29.41 69.28 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.197 -0.939 . . . . 0.0 111.979 -172.861 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -58.41 8.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.45 0.7 . . . . 0.0 111.329 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.24 -14.72 22.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.324 0.65 . . . . 0.0 110.827 -173.567 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.3 mtm-85 54.53 41.75 31.76 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.462 1.105 . . . . 0.0 110.737 -174.26 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.91 158.2 14.56 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 173.774 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.12 165.92 12.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.673 0.736 . . . . 0.0 111.548 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -157.92 148.74 20.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.875 1.27 . . . . 0.0 110.985 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 tp -69.57 127.4 32.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.936 0.894 . . . . 0.0 109.091 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.4 -51.43 6.22 Favored 'General case' 0 C--O 1.228 -0.039 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 167.288 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.3 167.55 25.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 117.909 0.322 . . . . 0.0 111.502 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -133.59 86.06 2.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.678 1.591 . . . . 0.0 107.264 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.7 146.65 25.59 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.25 -164.77 28.66 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.052 -0.86 . . . . 0.0 111.101 174.873 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.458 -0.599 0 CA-C-N 118.155 0.978 . . . . 0.0 110.744 -0.572 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--O 1.235 0.302 0 N-CA-C 110.694 -0.113 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.6 mm -64.93 148.34 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.906 1.282 . . . . 0.0 108.801 171.435 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 pt -114.08 152.06 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.145 1.378 . . . . 0.0 108.852 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -82.12 125.62 31.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 pt -60.19 132.79 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 166.871 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.61 -176.22 44.2 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -52.1 -49.04 18.68 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.71 2.94 . . . . 0.0 113.237 -169.773 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -54.31 -56.06 22.21 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.153 0.978 . . . . 0.0 110.849 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -64.94 -39.27 93.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.383 1.073 . . . . 0.0 110.497 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -59.28 -46.73 87.74 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.437 0.695 . . . . 0.0 109.813 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -57.0 -46.7 82.11 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 118.592 0.633 . . . . 0.0 110.633 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.27 -46.07 83.45 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.209 -0.307 . . . . 0.0 110.64 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.49 -51.84 53.89 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.596 -0.601 . . . . 0.0 111.596 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -57.4 -48.02 80.19 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.539 1.535 . . . . 0.0 109.063 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -55.21 -47.44 75.28 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.705 1.202 . . . . 0.0 110.702 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.19 -53.4 57.64 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.672 0.749 . . . . 0.0 110.274 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.55 -39.81 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.125 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.62 -48.86 75.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.817 1.247 . . . . 0.0 109.494 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -55.99 -51.73 66.72 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.105 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.71 -46.08 88.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.111 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -59.26 -45.63 90.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.182 0.993 . . . . 0.0 109.495 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.35 -45.29 95.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.446 0.698 . . . . 0.0 110.351 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.5 mt -70.39 -43.27 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.78 14.18 55.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.726 1.155 . . . . 0.0 112.863 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -50.32 -44.43 54.21 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.232 1.016 . . . . 0.0 111.995 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.09 34.79 4.25 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.75 0.786 . . . . 0.0 110.099 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.93 -143.43 48.64 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 -100.19 124.23 45.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.292 1.037 . . . . 0.0 108.961 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.53 134.9 50.76 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.111 0.964 . . . . 0.0 110.289 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.0 m -95.59 99.02 10.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.032 1.333 . . . . 0.0 108.994 -174.901 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -45.41 122.83 3.73 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 122.892 0.477 . . . . 0.0 110.712 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.15 -61.0 1.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.309 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -169.52 -165.63 0.53 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.19 149.85 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 126.342 1.857 . . . . 0.0 107.327 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -142.55 160.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -66.72 154.42 91.67 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.515 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.65 141.85 72.59 Favored 'Cis proline' 0 N--CA 1.455 -0.76 0 CA-C-N 118.89 0.639 . . . . 0.0 111.322 0.176 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -132.91 108.87 9.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.4 ttt -133.57 143.46 48.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 119.148 0.885 . . . . 0.0 109.529 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -119.48 144.44 46.99 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.057 0.39 . . . . 0.0 111.95 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -121.37 149.53 42.83 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.2 m -80.77 137.97 36.27 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.62 132.02 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.205 1.402 . . . . 0.0 108.211 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.0 p90 . . . . . 0 N--CA 1.45 -0.445 0 O-C-N 121.448 -0.782 . . . . 0.0 110.217 -167.58 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -100.44 -25.16 14.3 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.227 0.467 . . . . 0.0 111.431 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.73 -164.49 32.17 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 118.649 0.659 . . . . 0.0 111.461 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -144.22 164.77 29.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.038 1.335 . . . . 0.0 107.561 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -127.4 145.19 50.9 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.063 0.945 . . . . 0.0 108.816 167.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.2 119.12 32.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -114.84 105.36 12.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.12 143.41 47.95 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.819 0.848 . . . . 0.0 111.191 -168.974 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -87.71 110.12 20.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.1 p -95.24 139.43 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.502 1.121 . . . . 0.0 108.824 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -108.38 120.81 43.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.94 132.88 22.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m 46.81 45.08 14.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.117 0.967 . . . . 0.0 111.309 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t70 63.57 10.89 5.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.105 1.362 . . . . 0.0 113.656 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -110.52 140.22 45.02 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.227 1.411 . . . . 0.0 107.94 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.1 tp -98.69 120.47 39.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.135 0.974 . . . . 0.0 109.018 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -123.18 154.28 38.92 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.961 1.304 . . . . 0.0 108.638 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -96.45 128.79 43.71 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.647 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.11 126.92 55.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.809 1.244 . . . . 0.0 107.903 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -112.64 100.92 9.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.7 mm -96.21 147.34 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.727 1.611 . . . . 0.0 107.51 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -121.44 148.43 44.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 170.244 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.9 120.83 34.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 127.714 2.406 . . . . 0.0 106.194 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -97.27 115.72 28.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -63.48 -45.9 88.64 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.9 1.68 . . . . 0.0 110.701 -169.861 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -64.68 -50.21 67.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.83 0.452 . . . . 0.0 110.082 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 m -62.9 -35.18 79.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.063 0.945 . . . . 0.0 110.15 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 55.31 48.07 20.02 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.782 2.033 . . . . 0.0 110.141 -168.702 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.02 155.13 22.58 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -115.61 170.23 8.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.447 0.699 . . . . 0.0 111.124 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -165.29 149.08 8.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.544 1.138 . . . . 0.0 111.183 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.73 117.2 6.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 168.567 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.2 tp -85.0 -54.72 4.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -142.79 155.33 44.8 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -133.05 134.2 44.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 167.43 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -141.68 155.42 45.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -174.748 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.28 -164.99 16.08 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.455 -0.739 0 CA-C-N 118.249 1.025 . . . . 0.0 110.275 1.318 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.25 141.69 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.833 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.74 157.95 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 123.837 0.855 . . . . 0.0 109.902 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.99 148.56 48.73 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.385 0.674 . . . . 0.0 109.709 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.11 137.63 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 167.061 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.31 -171.24 44.33 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -170.18 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.03 -42.72 64.54 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.635 2.89 . . . . 0.0 113.006 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -58.25 -52.88 63.74 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.087 0.946 . . . . 0.0 111.053 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 -41.38 87.87 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.74 0.816 . . . . 0.0 109.63 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -57.38 -50.77 71.92 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.577 0.751 . . . . 0.0 109.875 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -48.96 -54.9 13.59 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.262 1.025 . . . . 0.0 109.828 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 mt -55.37 -44.34 75.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.517 0.144 . . . . 0.0 111.157 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.27 -53.63 44.21 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.283 0.468 . . . . 0.0 112.31 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -55.88 -47.84 76.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.457 1.103 . . . . 0.0 109.286 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -56.85 -48.32 78.37 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.604 0.762 . . . . 0.0 110.412 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.13 -51.19 70.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.99 -37.74 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.66 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.73 -49.7 75.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.238 1.015 . . . . 0.0 109.843 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.3 -49.52 77.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.471 0.708 . . . . 0.0 109.328 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -53.38 -50.32 65.37 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -57.65 -48.32 79.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.301 1.04 . . . . 0.0 109.945 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.95 -38.95 87.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.528 0.331 . . . . 0.0 110.632 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.7 mt -73.87 -52.83 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.07 13.18 46.91 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.46 1.505 . . . . 0.0 113.701 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -53.05 -43.68 66.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.594 1.197 . . . . 0.0 112.041 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -108.24 36.42 2.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.598 0.759 . . . . 0.0 110.005 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.97 -149.63 50.59 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -111.16 76.99 1.01 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.557 1.143 . . . . 0.0 108.802 -169.317 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.7 139.51 45.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.776 0.43 . . . . 0.0 111.448 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m -93.42 104.3 16.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -48.98 133.53 18.02 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -106.79 -65.39 1.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.57 0.748 . . . . 0.0 109.058 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -167.11 164.43 15.77 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.689 1.196 . . . . 0.0 109.017 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.43 141.42 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.354 1.062 . . . . 0.0 108.958 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -141.24 168.49 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.369 0.668 . . . . 0.0 110.67 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.59 154.66 79.11 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.11 0.964 . . . . 0.0 110.864 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.03 137.67 50.79 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 CA-C-N 119.539 0.871 . . . . 0.0 111.746 -3.256 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 68.9 m -126.77 121.18 31.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.2 ttm -138.77 138.71 37.86 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.199 0.6 . . . . 0.0 109.75 -167.577 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -121.29 142.95 49.46 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.999 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -132.14 141.55 49.17 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.927 0.891 . . . . 0.0 110.153 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.4 m -76.23 141.21 41.81 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.362 0.265 . . . . 0.0 110.989 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -110.56 123.72 66.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 125.772 1.629 . . . . 0.0 109.19 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 125.305 1.442 . . . . 0.0 110.693 -176.393 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -99.43 -34.62 10.2 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.354 0.661 . . . . 0.0 109.936 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.6 -157.64 19.61 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -172.452 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -142.96 160.0 41.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -123.14 150.28 43.47 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.354 1.461 . . . . 0.0 109.05 170.739 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -133.81 123.59 25.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -122.21 127.9 50.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.77 158.08 38.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.94 0.4 . . . . 0.0 110.839 -174.415 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -96.63 112.74 24.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.998 0.919 . . . . 0.0 109.355 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 p -103.28 132.45 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 124.091 0.956 . . . . 0.0 109.543 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.72 119.95 28.56 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.655 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.84 127.6 36.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 t 53.06 39.81 30.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.58 0.752 . . . . 0.0 111.001 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.8 t0 53.45 28.1 7.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.064 1.345 . . . . 0.0 113.245 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -118.61 134.88 54.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.2 tp -89.73 128.37 36.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -129.32 139.87 51.6 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.992 1.317 . . . . 0.0 109.711 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -88.19 108.2 19.16 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.868 1.267 . . . . 0.0 108.566 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.57 134.6 48.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -123.63 125.24 44.47 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.517 1.527 . . . . 0.0 107.608 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.09 146.74 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 126.004 1.721 . . . . 0.0 108.132 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.5 161.16 15.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.912 0.885 . . . . 0.0 108.744 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.66 119.33 11.1 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -97.32 122.06 39.92 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.729 1.212 . . . . 0.0 109.837 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -58.04 -39.38 78.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.27 0.628 . . . . 0.0 112.423 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -56.48 -51.62 67.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.153 0.581 . . . . 0.0 111.039 -171.187 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.6 p -107.31 4.81 26.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.547 1.139 . . . . 0.0 111.555 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.9 ptt85 46.78 40.72 9.28 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.809 1.244 . . . . 0.0 110.185 -168.618 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.88 125.31 8.36 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.6 -167.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -78.66 175.07 10.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.617 1.167 . . . . 0.0 109.952 171.555 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.67 118.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.994 2.117 . . . . 0.0 113.512 -167.891 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.1 tp -65.82 132.1 47.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.89 -62.58 1.46 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 167.751 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -145.65 151.95 38.87 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.322 0.649 . . . . 0.0 109.699 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -135.46 115.12 12.8 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.39 143.12 51.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.662 0.785 . . . . 0.0 108.893 -167.809 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.0 -157.69 25.49 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.457 -0.624 0 CA-C-N 118.757 1.279 . . . . 0.0 110.123 -1.973 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.232 0.183 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.0 mt -72.65 132.57 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 pt -99.14 153.79 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.299 0.64 . . . . 0.0 110.7 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.92 124.45 20.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.754 0.821 . . . . 0.0 108.791 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.29 122.12 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.653 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.79 -160.47 26.98 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.44 -46.24 25.6 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.865 2.377 . . . . 0.0 112.974 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -53.07 -54.72 31.3 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.31 1.052 . . . . 0.0 111.076 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -47.46 83.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.963 1.305 . . . . 0.0 109.416 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -53.74 -49.24 68.59 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.636 0.774 . . . . 0.0 110.025 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -55.94 -49.2 74.16 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.315 0.646 . . . . 0.0 110.859 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.27 -44.41 95.36 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.779 -0.576 . . . . 0.0 111.218 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.73 -47.53 87.98 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -52.84 -54.02 40.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.929 1.292 . . . . 0.0 109.793 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -55.95 -46.22 78.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.472 1.109 . . . . 0.0 110.623 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.02 -51.69 68.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.924 0.392 . . . . 0.0 110.467 177.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.91 -39.41 85.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.57 -50.86 70.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.976 0.91 . . . . 0.0 109.479 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -56.15 -51.04 69.42 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.13 0.972 . . . . 0.0 109.286 176.907 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -57.04 -51.24 70.05 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -55.32 -44.22 75.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.759 1.224 . . . . 0.0 109.999 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -58.07 -42.63 85.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.894 0.478 . . . . 0.0 110.414 -177.18 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.1 mt -73.41 -46.69 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.42 18.83 43.93 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.386 1.47 . . . . 0.0 112.716 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -54.42 -43.09 71.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.378 1.089 . . . . 0.0 111.256 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -107.74 30.69 6.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.938 0.895 . . . . 0.0 110.473 176.076 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.57 -152.15 52.49 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -100.01 118.24 35.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.118 0.967 . . . . 0.0 109.227 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.28 -171.89 1.93 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.721 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.0 m -141.36 125.4 17.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -55.03 132.6 47.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -107.66 -65.31 1.12 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -175.78 4.05 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.363 0.665 . . . . 0.0 110.842 173.107 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 t -120.72 141.19 42.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.43 168.25 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.477 0.581 . . . . 0.0 110.254 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 147.91 71.11 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.682 0.793 . . . . 0.0 111.658 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.31 153.31 91.93 Favored 'Cis proline' 0 N--CA 1.455 -0.787 0 CA-C-N 119.085 0.709 . . . . 0.0 111.058 -1.317 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.8 m -142.4 87.69 2.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.8 ttt -112.43 123.5 50.43 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.149 0.58 . . . . 0.0 110.938 -167.606 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -100.23 136.37 40.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.09 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -122.85 153.91 38.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.227 1.811 . . . . 0.0 109.379 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.1 m -89.65 138.99 30.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.417 1.087 . . . . 0.0 110.124 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.64 122.71 62.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.944 1.297 . . . . 0.0 109.31 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 123.848 0.859 . . . . 0.0 111.227 -177.764 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.5 mt . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -91.17 -33.03 15.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.54 -148.93 9.01 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -169.232 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -147.54 169.06 20.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.376 1.07 . . . . 0.0 109.531 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -136.89 155.22 50.05 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.126 0.97 . . . . 0.0 110.203 167.381 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -133.42 118.07 17.98 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -175.395 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.59 107.95 16.86 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -150.34 152.63 34.71 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -169.286 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -99.3 116.74 32.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.272 1.029 . . . . 0.0 110.552 -173.561 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.48 127.8 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 126.06 1.744 . . . . 0.0 109.123 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -84.66 114.97 22.4 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 170.278 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.42 121.81 40.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.9 1.28 . . . . 0.0 109.016 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 t 71.15 -67.93 0.24 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 128.969 2.907 . . . . 0.0 107.058 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -178.13 26.6 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.295 2.638 . . . . 0.0 110.047 170.72 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -111.71 135.75 51.89 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.4 tp -86.9 124.44 33.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -120.5 145.19 47.52 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -86.28 131.11 34.3 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.27 138.95 53.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -118.45 121.84 41.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 171.643 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.9 mm -120.84 150.44 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.487 1.915 . . . . 0.0 106.255 -173.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t -124.48 158.16 33.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.153 0.888 . . . . 0.0 109.612 168.045 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.77 133.55 46.09 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 170.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -103.15 118.98 38.0 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 124.155 0.909 . . . . 0.0 108.818 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -64.7 -24.02 67.44 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.965 0.906 . . . . 0.0 112.304 -171.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -56.97 -40.92 77.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.586 0.63 . . . . 0.0 111.018 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.0 m -103.87 -16.88 15.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.576 0.751 . . . . 0.0 110.652 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 55.2 36.25 26.61 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.944 1.298 . . . . 0.0 109.646 -167.313 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.53 137.99 14.59 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.54 164.69 13.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.296 0.638 . . . . 0.0 111.852 -176.089 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.77 140.09 16.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.004 1.321 . . . . 0.0 110.56 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.3 125.07 22.64 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 170.03 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.54 -56.76 3.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.878 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -148.12 157.78 43.7 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.926 1.29 . . . . 0.0 109.292 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -138.07 125.15 21.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -137.65 149.49 46.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.77 -166.25 24.62 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 N--CA 1.456 -0.685 0 CA-C-N 118.23 1.015 . . . . 0.0 110.954 2.493 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.457 -0.092 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.6 mm -76.1 135.22 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.44 163.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 123.92 0.888 . . . . 0.0 109.759 174.126 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.01 154.85 40.33 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.788 0.804 . . . . 0.0 110.446 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -94.41 138.24 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 167.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.58 -170.53 43.66 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -55.91 -45.5 38.25 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.298 2.666 . . . . 0.0 111.907 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -53.59 -52.33 60.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.043 0.925 . . . . 0.0 110.732 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -42.67 91.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.794 0.838 . . . . 0.0 110.083 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -54.1 -51.98 62.46 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.478 -0.773 . . . . 0.0 109.752 172.686 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -50.48 -50.96 51.18 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.915 0.779 . . . . 0.0 110.865 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.3 mt -58.42 -49.09 78.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.96 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.91 -37.01 75.92 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 122.108 -0.37 . . . . 0.0 112.238 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -73.96 -45.37 50.64 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.24 -48.32 65.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.03 0.932 . . . . 0.0 110.876 169.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.26 -53.44 58.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.574 0.702 . . . . 0.0 110.369 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.0 t -61.42 -38.47 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.632 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.55 -48.63 76.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.924 0.89 . . . . 0.0 109.974 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.77 -49.82 72.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.996 0.918 . . . . 0.0 108.727 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.22 -44.29 95.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.376 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -62.42 -44.7 95.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.228 1.011 . . . . 0.0 109.795 175.232 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -58.62 -47.81 83.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.486 0.714 . . . . 0.0 109.892 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.01 -39.53 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.58 22.83 61.39 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.73 1.157 . . . . 0.0 110.474 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -60.79 -33.64 73.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 117.651 0.726 . . . . 0.0 111.312 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -116.01 32.03 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.446 1.098 . . . . 0.0 109.591 174.427 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.7 -151.96 46.2 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -87.56 135.0 33.53 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.136 0.575 . . . . 0.0 109.636 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.6 mt -127.99 133.42 49.17 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.132 0.973 . . . . 0.0 109.319 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.2 m -99.68 97.6 8.54 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.523 1.129 . . . . 0.0 108.321 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -50.21 132.94 24.06 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 123.466 0.706 . . . . 0.0 111.074 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -98.94 -65.11 0.98 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 168.701 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -172.26 167.63 5.79 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 123.451 0.7 . . . . 0.0 110.11 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.24 142.48 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 124.432 1.093 . . . . 0.0 109.09 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.98 177.0 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.281 0.632 . . . . 0.0 110.251 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -63.13 153.26 81.96 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.654 0.782 . . . . 0.0 112.716 -172.374 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -83.12 169.63 57.53 Favored 'Cis proline' 0 N--CA 1.45 -1.047 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 -7.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.9 t -132.97 97.8 4.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 168.179 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 126.78 33.61 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.47 1.508 . . . . 0.0 107.765 -174.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -114.01 113.77 25.24 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 118.093 -0.956 . . . . 0.0 108.652 168.539 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -114.37 141.47 47.59 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.606 1.162 . . . . 0.0 111.158 173.864 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.5 142.25 46.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.778 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.69 120.18 62.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.392 1.091 . . . . 0.0 109.251 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 p90 . . . . . 0 N--CA 1.444 -0.764 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -176.362 . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.16 -35.38 14.58 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.31 -152.25 9.21 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -148.42 159.72 43.75 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.584 1.554 . . . . 0.0 107.818 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -126.93 142.74 51.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.147 1.779 . . . . 0.0 108.358 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -126.9 105.63 8.76 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -106.16 117.77 34.88 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 pp -149.64 146.44 27.29 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.897 0.771 . . . . 0.0 111.974 -166.818 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -88.51 112.69 23.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 p -106.39 138.6 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.101 0.961 . . . . 0.0 109.523 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -103.54 123.12 46.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.133 1.773 . . . . 0.0 106.966 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.45 132.09 25.57 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t 46.77 41.48 10.4 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.447 1.099 . . . . 0.0 111.331 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.4 t70 62.45 19.47 11.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.11 1.364 . . . . 0.0 113.343 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -113.94 135.15 54.31 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.809 1.243 . . . . 0.0 107.873 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.51 126.81 37.76 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.4 143.39 50.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.934 1.294 . . . . 0.0 108.748 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -85.32 110.48 19.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.55 126.69 38.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -108.0 111.23 23.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.973 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -100.59 150.74 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.9 p -127.62 154.27 45.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.47 0.708 . . . . 0.0 109.198 176.83 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -123.33 135.97 54.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.92 120.98 40.95 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.161 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -67.31 -33.49 75.39 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.7 -0.625 . . . . 0.0 110.703 -172.947 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.062 0.945 . . . . 0.0 111.209 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -90.61 -22.95 20.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.084 0.554 . . . . 0.0 110.243 175.783 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 65.17 33.73 9.13 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.782 1.233 . . . . 0.0 110.233 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.18 155.74 15.95 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.3 mtt85 -115.13 163.74 15.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 117.446 0.623 . . . . 0.0 111.285 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 152.39 16.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.275 1.43 . . . . 0.0 111.331 177.528 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 tp -69.63 127.56 33.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.634 1.174 . . . . 0.0 109.845 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.69 -54.78 5.33 Favored 'General case' 0 C--N 1.337 0.041 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -170.44 169.05 7.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 111.197 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -131.87 88.44 2.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.288 1.835 . . . . 0.0 108.166 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.65 145.7 27.86 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.65 -159.85 24.63 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 N--CA 1.458 -0.559 0 CA-C-N 118.808 1.304 . . . . 0.0 110.071 -1.993 . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.495 0 N-CA-C 112.072 -0.411 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -103.44 103.0 12.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 172.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 22.2 m95 32.34 72.8 0.07 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.007 1.723 . . . . 0.0 113.751 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -125.38 155.86 39.67 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.58 0.752 . . . . 0.0 109.536 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.4 mm -84.28 143.32 12.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 pt -104.99 154.84 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.637 0.775 . . . . 0.0 110.825 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.48 118.58 12.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.849 0.86 . . . . 0.0 109.388 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.45 129.13 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 172.41 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.01 -167.15 39.53 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -50.97 -41.73 55.1 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.711 2.941 . . . . 0.0 112.857 -174.044 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -53.85 -60.75 2.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.648 0.779 . . . . 0.0 111.64 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -63.09 -43.55 98.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.617 -0.677 . . . . 0.0 110.082 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -51.03 -53.46 33.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -53.13 -49.71 65.99 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.451 0.7 . . . . 0.0 111.34 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 mt -63.98 -45.08 90.63 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.644 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.63 -43.47 96.19 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -57.23 -53.4 58.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.034 0.934 . . . . 0.0 108.872 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -53.6 -45.04 69.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.881 1.272 . . . . 0.0 110.829 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.87 -51.88 67.33 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.908 0.385 . . . . 0.0 110.585 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.12 -39.48 84.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.468 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.01 -47.58 84.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.955 0.902 . . . . 0.0 110.195 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -58.71 -53.98 52.23 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.048 0.939 . . . . 0.0 109.095 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -54.08 -48.18 70.92 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.987 0.515 . . . . 0.0 110.116 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -60.95 -44.24 97.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.343 1.457 . . . . 0.0 110.246 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.82 -42.02 96.89 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.678 0.391 . . . . 0.0 110.108 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.3 -43.51 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.58 17.78 59.65 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.983 1.278 . . . . 0.0 111.749 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -57.93 -38.45 75.96 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.7 0.75 . . . . 0.0 111.329 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -118.81 41.72 2.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.812 1.245 . . . . 0.0 109.421 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.51 -141.9 48.03 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -118.51 106.12 12.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.611 1.165 . . . . 0.0 109.2 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.49 151.92 18.88 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.177 0.444 . . . . 0.0 110.854 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.2 m -93.27 96.13 9.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -45.27 130.85 8.14 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 122.465 0.306 . . . . 0.0 110.474 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -105.82 -66.23 1.01 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.928 0.891 . . . . 0.0 109.141 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -165.56 -175.01 3.34 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -124.62 143.02 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.45 167.05 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.097 0.559 . . . . 0.0 110.057 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.04 152.12 72.31 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 122.875 0.47 . . . . 0.0 112.088 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.33 152.01 97.69 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 CA-C-N 119.074 0.705 . . . . 0.0 111.064 -3.13 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.8 m -138.85 81.07 1.82 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.5 ttm -105.77 138.53 41.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.047 0.539 . . . . 0.0 110.684 -167.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -122.29 144.84 48.75 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.76 1.624 . . . . 0.0 109.69 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -141.11 141.75 34.18 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.061 0.944 . . . . 0.0 109.7 169.919 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.5 t -63.86 142.39 58.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.625 0.37 . . . . 0.0 110.311 168.323 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.05 126.11 72.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.005 1.322 . . . . 0.0 110.27 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.58 171.17 8.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.931 1.292 . . . . 0.0 110.08 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.9 -149.03 0.27 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 169.04 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.44 -46.25 0.61 Allowed 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 127.969 2.508 . . . . 0.0 112.484 -176.752 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 67.14 165.83 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.898 1.679 . . . . 0.0 110.142 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.43 -83.05 0.03 OUTLIER Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.077 1.322 . . . . 0.0 111.53 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -67.42 -36.29 80.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.393 1.077 . . . . 0.0 110.241 172.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 73.25 154.08 0.14 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.947 1.699 . . . . 0.0 110.74 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -159.6 149.65 18.73 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.662 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.3 mt -69.49 134.83 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -117.92 -33.72 4.39 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.502 0.592 . . . . 0.0 111.655 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.93 -154.02 11.09 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.206 -170.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.67 161.24 39.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.087 1.355 . . . . 0.0 108.185 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -125.0 151.1 45.98 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.482 1.113 . . . . 0.0 109.28 169.07 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -134.76 118.32 16.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.616 1.566 . . . . 0.0 107.58 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.58 111.65 24.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.775 1.23 . . . . 0.0 107.842 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 pp -138.52 154.29 48.77 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 122.791 0.437 . . . . 0.0 111.516 -172.68 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -103.07 104.55 14.73 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.214 1.006 . . . . 0.0 109.312 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.55 133.56 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.558 1.543 . . . . 0.0 110.102 -175.885 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.78 123.28 41.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.433 1.493 . . . . 0.0 108.476 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.51 130.63 26.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.4 m 50.45 40.28 22.74 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.419 1.088 . . . . 0.0 111.584 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t0 50.11 32.66 6.1 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.884 1.274 . . . . 0.0 112.972 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -119.07 129.79 55.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.3 tp -94.66 125.65 39.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -124.62 149.5 47.02 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 125.313 1.445 . . . . 0.0 108.17 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -92.15 123.64 35.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.65 133.08 54.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -107.4 122.01 45.75 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mm -113.27 146.19 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.098 1.759 . . . . 0.0 106.82 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 154.47 25.5 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -130.95 115.47 16.56 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.643 1.977 . . . . 0.0 106.669 169.221 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.93 124.42 33.12 Favored 'General case' 0 CA--C 1.526 0.03 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -58.34 -49.26 77.82 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.659 0.784 . . . . 0.0 111.063 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -68.89 -51.73 37.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.535 0.734 . . . . 0.0 110.777 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -62.86 -34.0 76.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 64.04 34.69 11.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.202 1.401 . . . . 0.0 109.933 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.33 143.71 14.68 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.11 165.31 12.89 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 122.795 0.438 . . . . 0.0 110.654 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.13 152.87 19.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.176 0.59 . . . . 0.0 111.299 170.528 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -71.67 118.64 14.76 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 mt -75.57 -50.87 14.29 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 167.869 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -156.73 160.67 39.52 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.897 0.317 . . . . 0.0 111.145 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -135.75 101.22 4.69 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.142 1.777 . . . . 0.0 107.074 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -105.8 152.29 23.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.928 0.891 . . . . 0.0 109.086 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 134.59 -168.03 23.69 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.6 149.34 79.42 Favored 'Cis proline' 0 N--CA 1.457 -0.673 0 CA-C-N 118.24 1.02 . . . . 0.0 111.167 2.966 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.99 131.92 15.78 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 124.738 1.215 . . . . 0.0 108.132 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.03 159.47 47.75 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.061 1.841 . . . . 0.0 109.99 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.01 157.14 63.09 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.156 1.904 . . . . 0.0 109.454 169.826 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 C--O 1.25 1.09 0 C-N-CA 122.534 2.156 . . . . 0.0 110.872 177.001 . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.299 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 62.43 -172.39 0.16 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -171.588 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CE3' ' HB2' ' A' ' 44' ' ' LYS . 5.0 m95 -61.41 104.48 0.41 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.39 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -153.07 155.12 36.24 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.42 HD12 ' H ' ' A' ' 5' ' ' ILE . 4.7 mp -78.72 138.57 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 pt -106.46 154.32 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.322 1.049 . . . . 0.0 109.833 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.66 145.41 55.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.207 0.603 . . . . 0.0 109.814 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.2 pt -83.3 122.43 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.955 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.14 -165.23 31.6 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.41 -41.77 72.79 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.942 2.428 . . . . 0.0 112.282 -172.429 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -58.87 -49.29 78.31 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.809 0.814 . . . . 0.0 110.91 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -47.54 82.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.859 1.264 . . . . 0.0 109.688 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -54.52 -49.28 70.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.107 0.563 . . . . 0.0 110.054 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -55.92 -48.58 75.44 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.715 0.806 . . . . 0.0 110.499 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -56.15 -46.54 79.21 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.992 -0.442 . . . . 0.0 110.949 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.76 -56.32 25.77 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -51.71 -50.45 60.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.668 1.587 . . . . 0.0 109.822 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -55.08 -50.34 69.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.884 1.273 . . . . 0.0 110.75 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.29 -50.37 71.61 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.85 -39.83 86.84 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.478 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.93 -49.78 73.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.28 1.032 . . . . 0.0 109.544 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.43 -53.84 52.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.033 0.933 . . . . 0.0 108.897 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.4 -41.05 84.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.474 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -70.46 -39.46 74.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.459 1.503 . . . . 0.0 110.136 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -60.52 -45.99 91.81 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.279 0.632 . . . . 0.0 109.363 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.66 -40.47 89.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 171.683 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.05 19.88 58.47 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.44 1.495 . . . . 0.0 110.896 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -61.49 -35.7 78.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.858 0.829 . . . . 0.0 111.152 -170.225 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -118.87 39.97 3.39 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.804 0.842 . . . . 0.0 109.337 171.134 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.51 -141.29 44.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -101.92 93.72 5.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.58 1.152 . . . . 0.0 109.629 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.2 mt -80.72 139.99 35.81 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.197 0.453 . . . . 0.0 110.02 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.2 m -94.0 90.13 6.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.508 1.123 . . . . 0.0 108.49 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -51.42 132.7 29.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 122.188 -0.32 . . . . 0.0 111.458 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -104.07 -66.09 0.98 Allowed 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 123.544 0.738 . . . . 0.0 109.193 169.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -164.93 -168.59 1.48 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.151 0.58 . . . . 0.0 109.593 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.9 145.45 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.7 pt -133.62 173.42 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.351 0.66 . . . . 0.0 110.22 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 152.6 82.47 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 123.893 0.877 . . . . 0.0 110.795 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.07 151.83 96.34 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 N-CA-C 110.452 -0.634 . . . . 0.0 110.452 -5.788 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.4 m -138.9 90.36 2.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.1 ttt -111.31 138.43 47.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.406 0.682 . . . . 0.0 110.57 -169.59 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -116.23 149.78 38.59 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.642 1.177 . . . . 0.0 108.492 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HB2' ' CE3' ' A' ' 3' ' ' TRP . 1.5 tmtp? -149.49 151.29 33.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.599 0.76 . . . . 0.0 111.205 166.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 m -85.43 127.94 34.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.243 1.817 . . . . 0.0 111.586 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -99.44 136.29 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.486 1.515 . . . . 0.0 109.369 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -117.66 164.32 15.14 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.061 1.744 . . . . 0.0 109.985 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -102.51 -153.73 0.47 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.963 0.905 . . . . 0.0 109.302 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -178.43 -38.06 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.154 1.782 . . . . 0.0 110.395 -169.602 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -60.87 82.06 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.383 1.473 . . . . 0.0 110.947 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.35 63.15 1.13 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.0 t80 81.82 159.26 0.14 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.478 1.911 . . . . 0.0 110.886 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -99.01 129.67 45.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.079 0.952 . . . . 0.0 108.444 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.47 156.82 32.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.8 mt -58.3 133.64 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.63 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -115.61 -31.85 5.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.677 1.191 . . . . 0.0 110.592 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.01 -158.91 20.79 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -144.73 158.65 43.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.83 1.252 . . . . 0.0 108.217 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -114.19 153.54 29.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.211 1.404 . . . . 0.0 108.631 168.856 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -136.42 117.21 14.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -110.47 113.88 26.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 pp -146.2 146.03 30.66 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.153 0.433 . . . . 0.0 111.726 -170.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -89.18 99.74 12.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.516 0.726 . . . . 0.0 109.242 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.7 t -81.65 132.4 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.941 1.696 . . . . 0.0 109.013 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.34 114.63 29.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.489 1.516 . . . . 0.0 107.617 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.06 130.95 26.05 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.103 0.961 . . . . 0.0 108.676 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.0 t 50.67 39.23 21.17 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.461 1.104 . . . . 0.0 111.861 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.3 t0 53.25 33.93 16.55 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.316 1.046 . . . . 0.0 112.523 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -122.68 138.63 54.55 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 168.726 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.0 tp -105.32 127.08 52.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -132.76 143.93 49.92 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 125.137 1.375 . . . . 0.0 108.636 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -82.35 116.16 21.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.6 132.76 43.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -110.47 125.28 53.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.98 152.91 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 125.372 1.469 . . . . 0.0 107.28 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.7 m -119.08 149.83 41.02 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.15 0.98 . . . . 0.0 109.151 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.04 122.4 37.16 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 168.126 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.46 120.63 38.19 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.02 -53.0 62.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.203 1.001 . . . . 0.0 110.767 -170.079 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -58.62 -48.02 82.38 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.124 0.569 . . . . 0.0 110.111 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 m -71.92 -20.24 61.8 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.629 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 43.14 45.59 4.77 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 125.969 1.707 . . . . 0.0 111.091 -171.546 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -140.8 155.33 24.84 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.8 mtt85 -114.95 171.28 7.75 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.306 0.642 . . . . 0.0 110.841 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -155.35 146.95 23.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.298 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.4 tp -71.58 119.09 15.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.005 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.83 -50.91 18.17 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.632 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -168.95 156.83 7.62 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -171.346 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -133.53 89.11 2.55 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.641 1.576 . . . . 0.0 107.476 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -98.4 138.27 35.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -170.057 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.43 -167.07 32.4 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.254 -0.748 . . . . 0.0 111.473 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.55 145.9 63.92 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 CA-C-N 118.05 0.925 . . . . 0.0 111.113 2.123 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.08 127.77 15.0 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.04 164.01 36.71 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.471 2.114 . . . . 0.0 109.549 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -72.62 153.14 54.41 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.809 1.673 . . . . 0.0 109.231 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.338 2.025 . . . . 0.0 110.766 176.445 . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 54.27 49.33 18.8 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.412 1.085 . . . . 0.0 110.901 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -112.6 129.44 56.37 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -120.54 144.4 48.08 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.948 0.899 . . . . 0.0 108.868 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.6 144.19 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.6 pt -119.5 164.81 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.745 0.702 . . . . 0.0 110.377 169.811 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.61 141.85 51.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 110.461 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -88.54 120.52 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.2 -165.37 25.49 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -54.98 -44.56 48.51 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.196 2.597 . . . . 0.0 112.516 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -48.96 -58.44 4.87 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.232 1.015 . . . . 0.0 110.913 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -43.52 92.48 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.31 1.044 . . . . 0.0 109.808 -172.621 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -56.5 -49.84 73.55 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.354 1.062 . . . . 0.0 109.801 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -53.92 -52.18 61.4 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.395 0.543 . . . . 0.0 110.44 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -59.98 -44.58 94.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.729 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.33 -44.49 93.43 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -64.29 -50.53 67.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -50.46 -47.57 56.85 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.508 1.123 . . . . 0.0 110.914 173.974 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -52.83 63.78 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 110.152 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.5 -39.08 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.464 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.0 -49.65 75.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.349 0.66 . . . . 0.0 110.162 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -57.12 -50.26 73.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.84 0.856 . . . . 0.0 109.022 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -55.24 -51.23 67.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.45 0.7 . . . . 0.0 109.472 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -60.49 -40.36 91.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.536 1.135 . . . . 0.0 110.591 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -59.52 -42.65 92.71 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.6 mt -67.45 -44.22 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.57 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.91 22.74 57.23 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.041 1.305 . . . . 0.0 111.295 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.8 -38.87 86.83 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.79 0.795 . . . . 0.0 110.715 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -108.35 34.76 3.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.73 1.212 . . . . 0.0 109.978 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.52 -141.04 44.79 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -100.17 91.83 4.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.398 1.079 . . . . 0.0 109.783 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.28 173.21 10.51 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 168.957 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 m -138.25 102.49 4.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -51.94 134.26 31.79 Favored 'General case' 0 CA--C 1.524 -0.046 0 C-N-CA 122.838 0.455 . . . . 0.0 110.377 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -103.2 -63.18 1.2 Allowed 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -173.43 174.58 3.24 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.141 1.376 . . . . 0.0 108.711 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.66 150.12 14.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 124.489 1.116 . . . . 0.0 108.779 173.849 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.9 pt -138.26 168.37 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.067 0.547 . . . . 0.0 110.439 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' ARG . . . . . 0.426 ' CD ' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -62.17 154.43 70.21 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 170.626 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.28 150.15 95.23 Favored 'Cis proline' 0 N--CA 1.458 -0.581 0 CA-C-N 119.193 0.748 . . . . 0.0 111.012 -3.36 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.1 t -140.87 102.2 4.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -121.33 141.56 50.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.708 1.203 . . . . 0.0 109.682 -166.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -126.56 158.77 35.34 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.792 0.837 . . . . 0.0 111.269 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -147.35 152.74 38.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.31 1.444 . . . . 0.0 108.334 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.3 m -85.04 137.69 32.9 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.709 0.803 . . . . 0.0 109.954 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.88 129.72 64.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.942 1.297 . . . . 0.0 110.196 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -115.23 168.44 9.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.697 1.599 . . . . 0.0 108.863 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -118.55 154.25 32.89 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 122.397 1.094 . . . . 0.0 108.301 166.486 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -89.06 -45.19 9.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.064 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.5 147.77 17.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.171 0.51 . . . . 0.0 110.545 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.56 -106.69 3.04 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 106.094 -2.803 . . . . 0.0 106.094 -168.744 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -170.61 73.24 0.06 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.256 1.022 . . . . 0.0 110.144 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 62.39 89.91 0.08 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.447 1.099 . . . . 0.0 111.69 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -141.89 143.7 33.44 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.423 -0.798 . . . . 0.0 110.755 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.13 129.8 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -109.18 -25.8 10.44 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.992 0.36 . . . . 0.0 110.825 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.16 -163.51 28.84 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.638 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -142.45 156.16 45.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -120.83 142.4 49.66 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.006 1.322 . . . . 0.0 107.45 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -131.02 108.35 9.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.385 1.874 . . . . 0.0 106.745 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -105.08 123.11 47.25 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.116 1.767 . . . . 0.0 108.747 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.71 164.84 36.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -104.69 113.69 27.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.165 0.986 . . . . 0.0 110.898 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.44 130.1 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.558 1.543 . . . . 0.0 108.223 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -92.77 120.44 33.15 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.28 131.95 24.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.398 1.079 . . . . 0.0 108.119 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 t 49.76 45.45 24.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.219 1.008 . . . . 0.0 110.129 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 p30 53.34 17.76 1.14 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.361 1.864 . . . . 0.0 115.459 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -116.29 151.7 35.31 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.36 127.24 42.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -127.8 136.68 51.8 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.347 1.459 . . . . 0.0 108.444 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -85.3 137.37 33.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.03 139.53 53.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -115.83 114.99 25.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 168.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.88 145.0 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 m -119.38 144.25 47.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -113.04 129.43 56.5 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.8 2.04 . . . . 0.0 107.014 170.235 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -92.49 125.56 37.18 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -58.54 -43.55 89.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.373 1.069 . . . . 0.0 111.372 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -70.66 -48.65 53.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.1 m -67.74 -31.48 71.42 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.364 0.266 . . . . 0.0 111.263 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 55.41 41.01 31.44 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.235 1.014 . . . . 0.0 109.602 -169.409 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.1 155.62 25.62 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 -114.95 171.46 7.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.407 0.683 . . . . 0.0 112.28 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -162.56 148.7 12.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.107 1.763 . . . . 0.0 110.594 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.5 tp -68.1 134.87 51.28 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.7 tp -106.33 -64.54 1.16 Allowed 'General case' 0 C--N 1.338 0.076 0 C-N-CA 123.238 0.615 . . . . 0.0 109.779 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.14 146.47 45.94 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -136.71 130.94 32.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -145.03 155.21 43.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 126.89 -164.59 20.41 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.11 155.38 84.73 Favored 'Cis proline' 0 N--CA 1.454 -0.81 0 CA-C-N 118.797 1.299 . . . . 0.0 109.91 -6.755 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.92 154.28 76.06 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 124.084 0.954 . . . . 0.0 108.752 172.284 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.21 158.36 45.23 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.312 2.008 . . . . 0.0 108.969 169.352 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.7 156.29 63.89 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.937 1.758 . . . . 0.0 109.202 169.493 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 C--O 1.251 1.127 0 C-N-CA 122.529 2.153 . . . . 0.0 110.775 175.817 . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.274 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -90.12 89.35 7.63 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.244 0.522 . . . . 0.0 111.166 -169.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -60.76 114.09 2.84 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 167.619 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -148.76 154.89 40.21 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 118.383 0.538 . . . . 0.0 109.562 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.418 HD12 ' H ' ' A' ' 5' ' ' ILE . 3.3 mp -86.73 139.37 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.5 pt -101.04 151.35 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.403 0.681 . . . . 0.0 110.221 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -71.96 128.22 35.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.75 132.39 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 168.15 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.85 -172.34 44.58 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -53.65 -44.87 45.35 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.701 2.934 . . . . 0.0 112.677 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -50.16 -57.35 7.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.269 1.033 . . . . 0.0 110.853 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.02 -41.11 95.58 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.533 1.133 . . . . 0.0 109.81 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -58.12 -45.98 86.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.085 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -58.11 -46.8 84.94 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.6 0.637 . . . . 0.0 110.748 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.7 mt -58.22 -41.89 85.09 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.942 -0.474 . . . . 0.0 111.17 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.31 -58.31 15.23 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -44.12 -52.57 7.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.888 0.875 . . . . 0.0 111.616 172.446 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -55.59 -49.71 72.03 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.047 0.939 . . . . 0.0 110.808 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.92 69.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.73 -40.49 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.423 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.62 -50.29 71.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.09 0.956 . . . . 0.0 110.225 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -61.66 -47.49 85.13 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.138 0.975 . . . . 0.0 109.318 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -56.98 -49.8 74.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.497 0.319 . . . . 0.0 110.24 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -56.88 -43.42 81.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.464 1.106 . . . . 0.0 110.143 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -59.7 -39.92 86.17 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.2 mt -67.71 -45.53 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.48 18.03 57.65 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.174 1.369 . . . . 0.0 111.584 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -57.95 -39.88 79.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.702 0.751 . . . . 0.0 111.251 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.24 41.48 2.12 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.172 0.989 . . . . 0.0 109.62 172.656 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.17 -142.11 45.64 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -122.76 93.35 3.94 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.955 0.902 . . . . 0.0 109.079 -170.139 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp -85.53 -169.96 2.89 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.773 0.797 . . . . 0.0 109.392 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.9 m -145.23 124.74 13.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 172.161 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.57 140.07 42.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.626 0.371 . . . . 0.0 111.164 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -111.4 -64.29 1.3 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.648 0.779 . . . . 0.0 109.504 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.37 -179.92 4.16 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.097 0.959 . . . . 0.0 109.595 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.84 143.32 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.6 165.44 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.809 0.444 . . . . 0.0 110.236 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 158.53 79.54 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.113 0.965 . . . . 0.0 111.697 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.21 152.84 91.31 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 CA-C-N 119.468 0.846 . . . . 0.0 111.756 -9.197 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 76.4 m -138.79 100.25 4.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.8 ttt -118.27 142.44 47.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.321 0.648 . . . . 0.0 111.432 -167.981 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -120.97 143.12 49.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.409 2.284 . . . . 0.0 109.067 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -144.92 147.94 33.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.726 1.61 . . . . 0.0 110.123 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.49 134.66 35.56 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.778 1.631 . . . . 0.0 110.508 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -112.79 127.5 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.73 1.212 . . . . 0.0 110.816 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -106.58 163.65 12.71 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.197 1.399 . . . . 0.0 111.759 -176.942 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.81 -168.96 2.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.47 1.908 . . . . 0.0 108.717 169.236 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -168.13 -36.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.847 2.059 . . . . 0.0 110.469 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -70.88 75.17 0.63 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.515 1.126 . . . . 0.0 110.087 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.3 89.07 1.87 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 61.43 167.98 0.1 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.322 1.849 . . . . 0.0 112.075 -173.583 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -100.34 134.88 42.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 167.643 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.79 156.41 31.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.95 119.05 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -96.13 -27.91 14.83 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.59 -158.89 21.6 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -145.9 159.48 43.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.007 1.323 . . . . 0.0 107.699 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -124.57 135.58 53.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 125.599 1.559 . . . . 0.0 108.773 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.97 106.33 9.55 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.866 1.666 . . . . 0.0 107.519 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -94.53 124.11 38.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.303 1.041 . . . . 0.0 108.716 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.0 153.33 39.92 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.282 0.492 . . . . 0.0 111.023 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -95.28 105.04 16.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 123.983 0.913 . . . . 0.0 109.542 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.81 124.99 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.357 1.063 . . . . 0.0 109.729 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -79.8 117.21 20.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.28 122.86 40.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.032 1.333 . . . . 0.0 108.418 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t 72.37 -60.85 0.52 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 130.041 3.336 . . . . 0.0 108.327 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -177.1 0.23 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.757 2.823 . . . . 0.0 111.798 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -111.31 144.16 40.95 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.31 122.64 34.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.568 0.747 . . . . 0.0 109.147 -173.53 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -118.43 141.74 48.25 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 124.301 1.041 . . . . 0.0 109.179 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -86.53 104.24 15.8 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.778 1.231 . . . . 0.0 107.707 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.41 127.07 49.59 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -103.3 106.75 17.34 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.54 122.63 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.0 m -96.18 156.65 16.25 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 170.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -128.72 123.47 33.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.869 1.268 . . . . 0.0 107.796 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -96.08 113.02 24.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.513 1.125 . . . . 0.0 107.984 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -60.7 -27.17 67.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.172 0.589 . . . . 0.0 111.167 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -58.89 -24.66 62.55 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.607 0.763 . . . . 0.0 112.411 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.2 m -144.95 16.29 1.57 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.62 -0.675 . . . . 0.0 111.415 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 52.4 38.9 26.42 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.368 1.067 . . . . 0.0 111.021 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.58 138.31 14.88 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -102.75 167.64 9.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.724 0.762 . . . . 0.0 112.477 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.77 130.83 1.05 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.282 -168.899 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.5 tp -71.12 116.27 11.22 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.5 -56.74 3.01 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 123.352 0.661 . . . . 0.0 110.258 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -127.5 141.76 51.57 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -138.0 91.08 2.54 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -107.33 160.75 15.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -173.208 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.18 -163.97 12.13 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.63 145.69 72.03 Favored 'Cis proline' 0 N--CA 1.454 -0.817 0 CA-C-N 118.807 1.303 . . . . 0.0 110.479 3.138 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.1 m -103.26 130.19 24.08 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.11 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.78 162.25 29.87 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.993 1.796 . . . . 0.0 108.673 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.82 150.47 83.26 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.596 1.53 . . . . 0.0 109.16 169.741 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 C--O 1.251 1.144 0 C-N-CA 122.461 2.107 . . . . 0.0 110.828 178.142 . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.329 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -80.91 61.8 4.66 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.309 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.414 ' CE3' ' HB2' ' A' ' 44' ' ' LYS . 14.8 m95 53.27 98.42 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.858 2.063 . . . . 0.0 111.995 -169.664 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -143.25 154.42 43.8 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.61 -0.681 . . . . 0.0 110.733 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mt -76.55 139.87 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.8 pt -110.06 156.78 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 123.178 0.591 . . . . 0.0 110.074 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.51 131.35 48.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.916 0.887 . . . . 0.0 109.777 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.29 120.99 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.15 -165.88 29.13 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -172.623 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -54.12 -45.65 39.41 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.806 3.004 . . . . 0.0 112.649 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -47.24 -56.84 5.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.654 1.181 . . . . 0.0 110.909 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -39.94 82.46 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.153 1.381 . . . . 0.0 110.005 -174.267 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -50.76 -53.21 33.61 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.779 1.631 . . . . 0.0 109.956 170.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -54.61 -48.86 71.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.666 0.387 . . . . 0.0 111.092 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.8 mt -63.87 -41.49 97.74 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.406 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.17 -51.24 55.4 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -54.13 -59.36 4.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.768 0.827 . . . . 0.0 110.708 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -49.84 -44.28 49.36 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.265 0.626 . . . . 0.0 111.624 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.36 70.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.896 0.379 . . . . 0.0 110.229 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.41 -43.4 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.145 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.18 -46.08 89.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.881 0.872 . . . . 0.0 109.971 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -63.98 -49.72 71.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.076 0.95 . . . . 0.0 109.376 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -57.44 -43.44 83.88 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.751 -0.593 . . . . 0.0 110.954 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -63.85 -39.51 94.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.871 1.268 . . . . 0.0 110.684 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -61.48 -43.77 98.27 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.395 0.678 . . . . 0.0 109.239 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.61 -40.17 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.1 20.62 58.84 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.336 1.446 . . . . 0.0 110.167 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.79 -35.95 75.7 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 117.404 0.602 . . . . 0.0 111.105 -168.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.46 33.87 5.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.084 0.953 . . . . 0.0 109.815 175.677 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.25 -145.37 49.57 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -171.217 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -106.46 88.5 2.79 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.525 1.13 . . . . 0.0 108.975 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -70.13 153.86 42.63 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.3 m -109.07 102.26 11.26 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -52.29 144.72 12.26 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.655 0.382 . . . . 0.0 110.446 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -120.84 -66.19 1.08 Allowed 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.901 0.48 . . . . 0.0 110.205 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 166.82 27.14 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 117.812 0.278 . . . . 0.0 110.452 175.304 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -91.62 150.23 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.194 0.998 . . . . 0.0 108.591 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -144.55 174.96 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.832 0.853 . . . . 0.0 109.195 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.49 154.79 85.77 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.632 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.02 157.32 97.28 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 119.67 0.918 . . . . 0.0 111.246 -4.532 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.3 t -153.98 93.88 1.69 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.716 0.806 . . . . 0.0 109.395 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -102.92 154.76 18.89 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.467 1.507 . . . . 0.0 110.546 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -133.79 143.49 48.43 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.42 1.488 . . . . 0.0 109.271 170.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HB2' ' CE3' ' A' ' 3' ' ' TRP . 1.1 tmtp? -147.1 144.98 29.44 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.608 0.763 . . . . 0.0 111.598 169.09 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -65.34 139.04 58.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.862 1.265 . . . . 0.0 111.684 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.81 127.21 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.193 1.397 . . . . 0.0 108.443 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -162.73 177.8 9.03 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.505 -0.747 . . . . 0.0 110.878 -163.813 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -138.22 162.87 33.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.452 1.101 . . . . 0.0 108.784 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -114.91 -41.28 3.38 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.165 2.186 . . . . 0.0 110.794 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.37 149.55 24.46 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.86 0.464 . . . . 0.0 110.073 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.2 -69.23 1.96 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -170.107 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -160.51 162.77 33.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.322 1.049 . . . . 0.0 109.598 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.7 ptt85 -63.55 110.49 2.0 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 171.111 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -153.33 125.55 8.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.649 0.659 . . . . 0.0 112.394 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.8 mt -68.25 135.06 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 125.359 1.464 . . . . 0.0 109.276 169.155 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -117.3 -21.14 8.87 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.153 0.581 . . . . 0.0 111.663 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.79 -167.71 33.82 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -130.03 164.9 23.31 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.17 144.79 50.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.64 1.576 . . . . 0.0 107.193 168.914 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -130.52 133.9 46.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -130.62 112.57 13.26 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -148.64 160.08 43.48 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.205 0.457 . . . . 0.0 112.203 -166.634 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.28 140.31 37.57 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 123.643 0.777 . . . . 0.0 110.528 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.17 133.09 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.819 1.647 . . . . 0.0 109.147 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.75 119.2 25.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.15 130.69 37.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t 51.27 41.41 27.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.461 1.105 . . . . 0.0 111.526 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 t0 49.3 35.74 8.24 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.87 1.668 . . . . 0.0 112.499 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -127.97 142.03 51.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 tp -87.37 117.0 25.85 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -113.96 155.12 26.41 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.735 0.814 . . . . 0.0 108.862 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -108.88 138.47 45.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.461 1.104 . . . . 0.0 108.223 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.04 137.81 46.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.977 0.911 . . . . 0.0 109.343 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -114.04 116.78 29.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.395 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 mm -109.26 155.11 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 126.373 1.869 . . . . 0.0 106.406 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.84 164.57 22.78 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 118.516 0.598 . . . . 0.0 109.517 167.902 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.65 138.89 52.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.152 2.181 . . . . 0.0 106.557 170.446 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.04 114.59 28.62 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.209 1.403 . . . . 0.0 107.298 174.289 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -56.44 -36.29 68.84 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.194 0.998 . . . . 0.0 111.452 -171.356 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -53.58 -23.6 11.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.62 1.568 . . . . 0.0 113.339 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -143.14 15.35 1.88 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.643 -0.661 . . . . 0.0 110.844 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 48.28 32.47 3.17 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.626 0.77 . . . . 0.0 111.023 -170.63 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.63 129.66 9.99 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -171.257 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -100.19 166.64 10.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.699 0.75 . . . . 0.0 112.694 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.35 140.09 4.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.405 -169.746 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.03 121.73 14.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 168.58 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mt -85.56 -60.2 2.09 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -145.03 154.96 43.07 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.329 0.652 . . . . 0.0 109.25 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -131.32 150.47 52.14 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -156.01 163.91 39.12 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.63 0.772 . . . . 0.0 109.288 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.93 -162.91 12.27 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -67.97 160.2 82.36 Favored 'Cis proline' 0 N--CA 1.453 -0.89 0 CA-C-N 118.75 1.275 . . . . 0.0 110.027 -2.801 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.11 149.41 66.53 Favored Pre-proline 0 C--O 1.235 0.29 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -69.84 156.44 63.12 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.86 1.706 . . . . 0.0 109.388 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -67.51 154.46 73.6 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.034 1.823 . . . . 0.0 109.371 171.253 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 C--O 1.25 1.076 0 C-N-CA 122.585 2.19 . . . . 0.0 110.718 177.506 . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.201 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.13 165.44 13.6 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 169.229 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -53.47 114.33 1.47 Allowed 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -154.28 154.65 33.76 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.3 mm -81.87 138.15 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.5 pt -101.4 155.66 4.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.178 0.591 . . . . 0.0 110.553 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.06 148.82 50.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.79 132.34 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 C-N-CA 125.017 1.327 . . . . 0.0 108.224 169.347 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.89 -168.97 39.6 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 108.269 -1.933 . . . . 0.0 108.269 -174.911 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.5 -43.29 59.56 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.446 2.764 . . . . 0.0 112.153 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -51.88 -57.42 9.42 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 122.004 0.907 . . . . 0.0 111.286 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -45.49 89.76 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.269 1.028 . . . . 0.0 109.964 -173.92 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -49.99 -58.31 5.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 118.36 -0.829 . . . . 0.0 108.923 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -49.34 -46.18 46.54 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.73 0.812 . . . . 0.0 111.013 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.32 -51.64 65.19 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.605 -0.684 . . . . 0.0 111.751 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.23 83.32 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 122.396 0.998 . . . . 0.0 112.414 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.73 -57.93 6.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.473 1.909 . . . . 0.0 106.808 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -47.45 -44.85 25.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.852 1.661 . . . . 0.0 110.417 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.54 -54.14 49.3 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.909 0.385 . . . . 0.0 110.495 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.75 -38.54 76.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 122.817 0.447 . . . . 0.0 111.31 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.86 -46.82 83.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.029 0.931 . . . . 0.0 109.99 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -60.89 -47.32 86.95 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.801 0.84 . . . . 0.0 108.977 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -55.99 -50.81 69.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.017 0.527 . . . . 0.0 109.67 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -57.94 -42.68 85.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.796 1.638 . . . . 0.0 110.209 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.5 -45.95 87.7 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.098 0.559 . . . . 0.0 110.19 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.6 mt -64.68 -42.96 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.53 18.55 65.96 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.988 1.28 . . . . 0.0 111.018 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -55.23 -41.61 72.32 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 117.762 0.781 . . . . 0.0 111.0 -173.67 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.54 25.95 11.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.397 1.079 . . . . 0.0 110.44 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.06 -152.91 46.11 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -117.25 120.68 38.99 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.953 1.301 . . . . 0.0 108.148 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.87 156.95 30.87 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.446 0.698 . . . . 0.0 111.805 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 m -97.56 95.89 7.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -45.3 132.14 7.75 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -101.02 -68.5 0.81 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -168.61 165.11 12.33 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -171.953 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -102.58 141.59 18.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 124.67 1.188 . . . . 0.0 108.109 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.54 172.3 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.488 0.715 . . . . 0.0 110.012 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.73 154.99 83.88 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.722 0.809 . . . . 0.0 111.405 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.56 158.23 98.66 Favored 'Cis proline' 0 N--CA 1.455 -0.755 0 N-CA-C 110.373 -0.664 . . . . 0.0 110.373 -4.538 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 77.0 m -141.79 91.31 2.35 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.26 127.84 53.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.306 1.042 . . . . 0.0 110.28 -168.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -102.68 145.31 29.87 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.705 0.802 . . . . 0.0 110.018 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -148.34 141.74 25.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.184 0.594 . . . . 0.0 110.237 166.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.5 m -58.49 134.61 56.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.577 0.751 . . . . 0.0 110.453 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 tp -115.61 127.68 73.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.632 1.173 . . . . 0.0 108.614 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -161.57 -179.92 7.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.3 0.64 . . . . 0.0 110.115 -169.74 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -82.49 -143.97 0.06 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.934 0.772 . . . . 0.0 109.474 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -166.26 -48.03 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.299 1.04 . . . . 0.0 109.299 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -53.94 157.14 2.57 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.1 0.56 . . . . 0.0 109.939 170.539 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -46.43 -13.9 0.09 OUTLIER Glycine 0 CA--C 1.533 1.176 0 C-N-CA 127.524 2.488 . . . . 0.0 117.604 -169.935 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -54.51 -40.87 69.0 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.124 1.462 . . . . 0.0 109.209 168.988 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 36.64 68.53 0.25 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.932 2.093 . . . . 0.0 112.943 166.679 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -143.11 147.15 34.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.1 mt -79.97 125.11 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 123.786 0.834 . . . . 0.0 109.092 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.16 -39.62 14.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.58 -152.11 9.78 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -172.374 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.16 152.95 42.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.966 1.306 . . . . 0.0 107.662 174.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.9 155.98 21.01 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.763 1.225 . . . . 0.0 108.875 170.536 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -138.27 102.72 4.73 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.511 1.924 . . . . 0.0 106.239 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 126.62 38.56 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 pp -152.24 153.55 33.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.308 0.503 . . . . 0.0 112.078 -172.264 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -85.88 118.19 25.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.51 125.84 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.009 1.324 . . . . 0.0 108.793 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -92.17 123.03 35.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.58 130.15 21.36 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t 51.85 37.04 19.63 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.766 0.826 . . . . 0.0 111.201 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.0 t70 64.25 12.79 7.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.774 1.23 . . . . 0.0 113.249 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -109.82 147.35 33.46 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.52 1.128 . . . . 0.0 107.995 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.53 112.74 24.7 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.983 1.313 . . . . 0.0 107.609 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.49 162.5 17.49 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.282 1.033 . . . . 0.0 108.324 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -112.56 128.22 56.3 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.26 134.95 54.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -112.21 107.86 16.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mp -97.6 151.6 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.6 m -128.98 152.71 48.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 169.384 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -117.35 125.48 51.09 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -87.97 125.36 34.48 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -66.98 -45.59 77.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.818 0.847 . . . . 0.0 110.625 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.78 -43.55 88.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.098 0.559 . . . . 0.0 110.416 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.0 m -69.42 -37.28 77.37 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 60.52 49.43 6.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.457 1.503 . . . . 0.0 108.777 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.87 154.79 26.03 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.94 168.48 9.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.609 0.764 . . . . 0.0 111.928 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -163.72 139.46 6.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.772 1.229 . . . . 0.0 110.869 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 34.7 tp -63.16 122.76 16.92 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.929 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 tp -83.27 -57.45 3.26 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.12 152.25 37.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.29 0.636 . . . . 0.0 109.472 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -117.05 134.85 54.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 168.281 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -134.67 149.36 50.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 130.7 -166.52 22.47 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.35 -0.695 . . . . 0.0 112.061 171.431 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.57 151.69 78.14 Favored 'Cis proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.752 -0.937 . . . . 0.0 110.045 -1.939 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.46 130.12 18.89 Favored Pre-proline 0 N--CA 1.462 0.144 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.16 153.31 75.02 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.271 1.314 . . . . 0.0 109.302 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.35 153.67 76.24 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.071 1.847 . . . . 0.0 109.659 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 0 C--O 1.252 1.197 0 C-N-CA 122.707 2.271 . . . . 0.0 110.807 177.35 . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.328 0 N-CA-C 112.135 -0.386 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 48.4 48.06 19.48 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.921 1.288 . . . . 0.0 112.402 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -141.66 135.52 30.0 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 172.039 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -157.12 158.83 37.09 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 5' ' ' ILE . 3.5 mp -88.82 139.12 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.95 161.1 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 123.811 0.845 . . . . 0.0 110.517 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.01 135.63 41.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.667 0.787 . . . . 0.0 110.357 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.59 124.87 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 167.49 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.05 -167.5 30.6 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -56.76 -44.02 49.12 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.933 2.422 . . . . 0.0 111.602 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -53.94 -52.76 59.59 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.167 0.984 . . . . 0.0 111.043 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -45.37 93.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.19 0.996 . . . . 0.0 109.767 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -60.42 -41.33 93.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.306 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -56.7 -49.86 73.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.012 0.824 . . . . 0.0 110.42 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 15' ' ' LEU . 12.9 mt -57.48 -45.55 84.74 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.805 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.11 -46.55 62.01 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -60.0 -51.77 68.23 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -51.85 -47.16 64.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.054 0.541 . . . . 0.0 111.06 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.03 -50.16 74.38 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.317 0.58 . . . . 0.0 110.326 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.7 -40.75 90.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.098 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.49 -46.87 85.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.219 0.608 . . . . 0.0 110.058 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.91 -54.02 51.32 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.264 1.026 . . . . 0.0 109.041 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -57.29 -48.0 80.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.637 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -57.6 -45.12 85.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.35 1.06 . . . . 0.0 110.094 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.76 -41.37 86.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.569 0.348 . . . . 0.0 110.37 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.3 mt -72.24 -45.38 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.89 15.56 48.53 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.976 1.274 . . . . 0.0 112.838 174.251 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -53.79 -42.94 68.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.351 1.076 . . . . 0.0 111.963 -175.631 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.77 33.0 4.46 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.955 0.902 . . . . 0.0 109.707 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.44 -142.07 47.58 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -106.47 120.09 41.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.517 1.127 . . . . 0.0 109.213 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mt -106.73 168.78 8.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.364 1.065 . . . . 0.0 108.546 170.23 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.2 m -120.67 103.83 9.43 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -46.23 130.09 10.34 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.713 0.233 . . . . 0.0 110.989 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -106.49 -66.87 0.97 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -167.4 -169.39 1.22 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.293 0.637 . . . . 0.0 109.996 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.51 146.4 34.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 125.594 1.557 . . . . 0.0 106.809 174.716 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.55 166.57 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.358 0.599 . . . . 0.0 110.631 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.33 158.58 81.46 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 125.48 1.512 . . . . 0.0 111.94 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -67.63 148.33 80.79 Favored 'Cis proline' 0 N--CA 1.456 -0.688 0 CA-C-N 118.861 0.629 . . . . 0.0 111.168 -8.54 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 71.6 m -131.41 94.32 3.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.86 128.55 55.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.721 0.808 . . . . 0.0 109.809 -168.287 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -104.85 140.8 37.59 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.642 1.177 . . . . 0.0 109.186 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -133.83 152.02 51.73 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.453 1.101 . . . . 0.0 108.969 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 m -82.86 136.93 34.46 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.505 1.122 . . . . 0.0 109.844 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.16 131.87 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.262 1.425 . . . . 0.0 108.771 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -166.16 176.5 7.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.33 0.652 . . . . 0.0 109.857 -167.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -134.57 162.96 30.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -50.97 -58.77 5.19 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.016 1.327 . . . . 0.0 110.692 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 59.7 -176.07 0.1 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.016 0.927 . . . . 0.0 109.924 -174.034 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.88 -39.47 56.18 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.338 -0.851 . . . . 0.0 112.04 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -140.02 -55.43 0.54 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.274 1.03 . . . . 0.0 110.203 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -172.48 148.48 2.02 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -165.77 96.0 0.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.301 1.44 . . . . 0.0 107.174 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.5 110.18 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.066 0.546 . . . . 0.0 110.193 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -81.56 -33.43 31.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.049 0.54 . . . . 0.0 110.792 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.23 -161.74 24.05 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.201 -1.0 . . . . 0.0 112.116 -170.823 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -147.68 159.6 43.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -121.87 149.19 43.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.978 1.311 . . . . 0.0 108.459 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -132.61 107.76 8.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -97.27 118.18 33.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -146.37 158.71 43.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.808 0.443 . . . . 0.0 111.133 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.99 112.55 24.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.524 0.73 . . . . 0.0 109.579 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -99.88 133.0 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 109.617 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.08 122.36 35.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.441 1.496 . . . . 0.0 107.521 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.6 127.15 28.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.812 0.845 . . . . 0.0 109.395 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t 70.74 -64.17 0.38 Allowed 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 129.593 3.157 . . . . 0.0 108.432 -169.264 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 179.72 11.09 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.518 3.127 . . . . 0.0 111.207 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -119.55 149.29 42.17 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.923 1.289 . . . . 0.0 107.832 -174.555 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 tp -106.79 120.98 43.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.45 0.7 . . . . 0.0 109.759 -169.817 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.4 137.93 54.7 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.738 1.215 . . . . 0.0 108.364 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -94.69 115.82 28.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.25 135.5 54.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.188 0.995 . . . . 0.0 109.559 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.58 103.67 14.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.531 1.132 . . . . 0.0 108.208 169.893 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.455 HG21 HD22 ' A' ' 15' ' ' LEU . 10.9 mm -91.26 161.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.86 1.664 . . . . 0.0 106.9 176.298 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.6 p -145.6 167.57 22.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.65 0.659 . . . . 0.0 111.438 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -136.52 131.24 33.65 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.553 1.941 . . . . 0.0 108.277 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -98.37 107.86 20.42 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 169.47 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -53.03 -37.48 61.58 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 124.439 1.096 . . . . 0.0 111.194 -173.478 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -43.07 -40.55 3.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.414 1.886 . . . . 0.0 112.464 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 m -121.54 0.52 9.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.798 0.439 . . . . 0.0 110.99 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 52.77 28.78 6.71 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.686 0.795 . . . . 0.0 109.126 -165.711 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.99 128.13 9.3 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -168.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -105.88 170.04 8.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.567 0.699 . . . . 0.0 112.36 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -177.58 161.57 1.71 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.044 1.737 . . . . 0.0 112.35 -166.648 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.1 tp -89.84 138.18 31.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.3 1.44 . . . . 0.0 108.88 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.9 mt -104.47 -58.24 1.91 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.628 0.649 . . . . 0.0 110.245 169.447 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -136.2 150.56 49.06 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -143.77 106.33 4.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -115.39 147.84 40.05 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.68 -167.5 27.09 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.504 -0.609 . . . . 0.0 111.925 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.4 143.27 62.56 Favored 'Cis proline' 0 N--CA 1.455 -0.739 0 C-N-CA 124.373 -1.095 . . . . 0.0 110.002 -2.573 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.72 120.17 8.53 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -70.04 157.33 60.18 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.898 1.732 . . . . 0.0 108.583 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.21 150.72 76.99 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.936 1.757 . . . . 0.0 109.78 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo . . . . . 0 C--O 1.25 1.109 0 C-N-CA 122.59 2.193 . . . . 0.0 110.76 178.052 . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.236 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -62.25 141.58 58.16 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -133.45 141.89 48.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -163.09 155.45 18.44 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mp -99.2 139.38 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.3 pt -103.02 154.23 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 123.842 0.857 . . . . 0.0 109.66 171.932 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.46 134.21 42.33 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.8 pt -62.27 141.36 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 165.543 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.66 -169.35 34.5 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -168.584 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.41 -48.77 17.48 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.427 2.751 . . . . 0.0 112.769 -169.816 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.37 -55.0 24.54 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.124 0.964 . . . . 0.0 111.066 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -67.37 -44.27 79.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.215 1.006 . . . . 0.0 110.018 -172.567 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -56.4 -49.25 75.04 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 118.93 -0.557 . . . . 0.0 109.882 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -56.31 -46.47 79.82 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.624 0.647 . . . . 0.0 110.928 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 mt -55.95 -51.87 66.13 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 117.894 0.315 . . . . 0.0 110.515 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.58 -45.07 90.63 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -59.81 -52.12 66.82 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -49.94 -48.48 51.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.731 1.212 . . . . 0.0 110.201 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.58 72.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.49 -39.95 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.776 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.94 -48.75 80.38 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.378 0.671 . . . . 0.0 109.938 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.74 -52.82 63.88 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.077 0.951 . . . . 0.0 109.152 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -54.08 -46.65 72.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.485 1.114 . . . . 0.0 110.315 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -69.65 -42.02 74.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.554 1.542 . . . . 0.0 110.518 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.55 -47.77 84.24 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.321 0.648 . . . . 0.0 109.718 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.32 -41.74 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.8 18.43 51.27 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.633 1.111 . . . . 0.0 112.26 173.713 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -55.6 -40.81 72.54 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.974 0.887 . . . . 0.0 111.091 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -111.75 33.29 4.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.208 1.003 . . . . 0.0 109.976 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.03 -140.09 45.23 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.91 108.3 19.89 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.538 0.735 . . . . 0.0 109.65 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.8 mt -93.85 141.66 28.26 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 167.402 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 m -100.74 95.34 6.59 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.227 1.011 . . . . 0.0 108.346 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -51.21 133.82 27.99 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.179 0.592 . . . . 0.0 111.448 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -100.27 -67.41 0.85 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -169.57 -159.5 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.444 1.098 . . . . 0.0 108.533 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.12 141.68 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.15 174.7 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.023 0.529 . . . . 0.0 110.884 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -63.49 153.57 82.36 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.095 1.358 . . . . 0.0 112.889 -170.844 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.11 159.14 97.18 Favored 'Cis proline' 0 N--CA 1.449 -1.094 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 -7.573 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -133.91 87.24 2.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.49 140.15 48.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.896 0.878 . . . . 0.0 109.421 -167.592 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -122.12 162.13 21.84 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.197 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -138.45 147.52 43.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.852 1.661 . . . . 0.0 108.488 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -83.6 130.49 34.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.226 1.01 . . . . 0.0 110.089 172.305 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.44 120.87 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.665 1.186 . . . . 0.0 108.856 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -144.84 162.23 37.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.394 -0.816 . . . . 0.0 111.272 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -98.39 -166.63 1.39 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -158.69 -51.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.485 0.714 . . . . 0.0 111.763 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.66 105.2 0.14 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.826 0.85 . . . . 0.0 110.501 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.76 78.67 0.56 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.1 t80 74.16 84.46 0.11 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.36 1.464 . . . . 0.0 110.254 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.2 ppt_? -58.23 135.39 57.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.288 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -158.83 151.43 21.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt -71.71 124.23 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 -20.68 12.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 123.496 0.497 . . . . 0.0 111.069 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.94 -168.59 32.04 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.817 0.735 . . . . 0.0 112.59 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -142.9 157.8 44.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -130.72 145.26 51.9 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.973 1.309 . . . . 0.0 108.353 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -136.86 119.38 15.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.4 1.48 . . . . 0.0 107.878 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -107.86 126.1 52.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.866 1.267 . . . . 0.0 108.291 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pp -145.99 147.96 32.23 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.421 0.288 . . . . 0.0 110.269 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.2 99.48 11.97 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -83.17 134.07 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -102.22 122.78 44.85 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.39 136.04 25.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.77 37.66 24.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.457 1.103 . . . . 0.0 110.89 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 t70 56.63 28.84 14.66 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.987 1.315 . . . . 0.0 112.335 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -130.2 149.17 52.02 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.75 1.22 . . . . 0.0 108.218 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.7 tp -101.9 127.0 48.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.789 0.836 . . . . 0.0 109.637 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.24 136.9 50.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.861 1.264 . . . . 0.0 108.765 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -83.81 115.15 22.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.47 135.24 40.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -116.02 115.11 25.55 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.81 151.44 14.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.41 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.8 t -133.07 156.08 48.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.59 0.632 . . . . 0.0 109.574 169.281 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.05 131.34 52.18 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.322 1.849 . . . . 0.0 106.867 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -97.6 115.7 28.39 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -50.94 -48.33 60.85 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.647 1.579 . . . . 0.0 111.813 -168.946 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.26 -30.41 71.28 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.703 0.801 . . . . 0.0 110.972 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.4 m -84.13 -33.59 24.25 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 49.36 44.33 23.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.5 1.12 . . . . 0.0 109.759 -167.562 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.11 150.8 22.66 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.1 mtt85 -111.39 169.31 8.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.395 0.617 . . . . 0.0 112.271 -170.847 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.07 145.82 23.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.189 174.44 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.4 tp -71.83 138.05 48.01 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.755 0.822 . . . . 0.0 108.904 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.63 -57.05 2.4 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.934 0.894 . . . . 0.0 108.75 168.637 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.39 160.1 43.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.835 0.35 . . . . 0.0 110.959 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -136.25 92.24 2.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.63 1.972 . . . . 0.0 106.494 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.88 145.56 25.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.51 -167.88 24.35 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -71.12 157.74 95.51 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 118.644 1.222 . . . . 0.0 110.588 0.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 m -132.23 140.34 37.72 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.345 0.658 . . . . 0.0 109.595 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.05 122.74 4.87 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.577 2.185 . . . . 0.0 108.787 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.26 154.52 56.53 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.48 1.453 . . . . 0.0 109.618 174.096 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.25 1.123 0 C-N-CA 122.546 2.164 . . . . 0.0 110.688 175.805 . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.294 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.19 115.19 21.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.555 1.542 . . . . 0.0 108.884 -171.786 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -73.64 99.29 3.05 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -115.31 139.01 50.35 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.642 0.777 . . . . 0.0 109.677 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.557 HD12 ' H ' ' A' ' 5' ' ' ILE . 3.4 mp -79.27 143.57 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.9 pt -120.91 158.49 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.718 0.807 . . . . 0.0 110.373 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.16 140.78 58.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.919 0.888 . . . . 0.0 109.856 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -92.7 121.45 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.426 1.09 . . . . 0.0 108.425 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.48 -169.54 33.71 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -51.16 -45.97 33.77 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.723 2.948 . . . . 0.0 112.75 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -49.22 -55.28 13.06 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.114 0.959 . . . . 0.0 111.043 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -41.3 90.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.663 1.185 . . . . 0.0 110.591 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -56.67 -44.71 81.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.979 0.912 . . . . 0.0 109.55 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -51.8 -52.76 46.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.889 0.768 . . . . 0.0 110.75 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.47 -46.19 89.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 110.537 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.97 -42.2 86.23 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -64.7 -50.13 68.16 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -50.91 -46.15 60.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.12 0.968 . . . . 0.0 110.996 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 75' ' ' ILE . . . -58.06 -53.05 62.68 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.793 0.806 . . . . 0.0 110.398 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.9 t -63.78 -36.57 77.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.678 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.02 -47.16 84.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.201 1.0 . . . . 0.0 110.091 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.97 -50.87 67.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.69 -41.71 95.67 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 121.635 -0.665 . . . . 0.0 111.383 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -56.42 -42.85 78.7 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.235 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.34 -39.97 96.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.312 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.7 mm -62.54 -46.27 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.16 0.891 . . . . 0.0 109.376 174.095 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.13 3.91 85.65 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.137 1.351 . . . . 0.0 112.78 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -29.12 70.04 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.071 1.436 . . . . 0.0 113.061 -171.676 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -110.44 27.03 10.04 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.584 0.753 . . . . 0.0 110.024 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.27 -164.07 52.44 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -95.34 107.45 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.199 1.0 . . . . 0.0 108.547 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.9 140.23 35.48 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.145 0.429 . . . . 0.0 110.776 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.6 m -85.48 103.78 14.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -49.03 128.86 16.87 Favored 'General case' 0 N--CA 1.457 -0.079 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -102.82 -64.51 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -167.8 170.64 10.63 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.341 1.056 . . . . 0.0 109.998 172.954 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.5 p -98.48 149.5 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.318 1.047 . . . . 0.0 108.745 169.352 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -138.8 170.8 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 123.374 0.67 . . . . 0.0 110.258 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -61.84 152.46 76.18 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.967 0.907 . . . . 0.0 110.421 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.35 152.31 97.49 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 CA-C-N 119.184 0.744 . . . . 0.0 110.453 -4.791 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 46.9 t -143.72 101.65 3.79 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 ttp -128.47 136.19 50.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.877 0.871 . . . . 0.0 110.271 -166.019 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -119.84 157.3 28.96 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.195 0.998 . . . . 0.0 110.846 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -146.69 146.28 30.3 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.375 1.07 . . . . 0.0 109.635 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -76.06 132.52 40.15 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.98 0.912 . . . . 0.0 109.955 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.48 116.54 51.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.281 1.433 . . . . 0.0 108.476 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -148.91 174.07 12.64 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.668 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -131.56 154.57 48.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -89.38 -64.84 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.348 1.859 . . . . 0.0 107.556 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -7.42 84.57 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 129.6 3.16 . . . . 0.0 113.598 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.29 -75.81 0.42 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 -171.972 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -156.67 -66.18 0.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.247 1.419 . . . . 0.0 108.279 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -170.79 145.99 2.52 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.205 1.402 . . . . 0.0 107.794 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -162.36 114.34 1.65 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.495 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 87.6 mt -71.28 123.08 24.69 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -101.53 -34.83 9.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.33 -161.85 24.98 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -139.93 158.83 43.45 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -123.9 147.25 47.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.137 1.375 . . . . 0.0 108.363 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -135.67 111.23 9.22 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.195 1.398 . . . . 0.0 107.641 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.27 112.55 25.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.596 1.558 . . . . 0.0 107.83 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -139.81 146.42 39.4 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.689 0.796 . . . . 0.0 111.267 -171.016 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -99.44 115.97 30.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.064 0.945 . . . . 0.0 109.62 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 p -113.53 129.17 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.193 1.397 . . . . 0.0 110.866 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.33 118.55 26.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.749 1.22 . . . . 0.0 107.997 173.111 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.76 128.99 43.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 t 52.25 41.17 30.22 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.683 0.793 . . . . 0.0 111.401 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t0 51.54 32.83 9.47 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.067 1.347 . . . . 0.0 112.938 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -125.34 131.22 53.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 169.753 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.4 tp -89.3 128.79 35.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -125.34 152.37 44.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.001 1.321 . . . . 0.0 108.294 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -92.49 129.44 38.43 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 132.54 56.65 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.563 1.145 . . . . 0.0 108.506 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -112.01 107.47 16.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 19' ' ' ALA . 13.1 mm -100.45 153.91 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 125.976 1.71 . . . . 0.0 107.961 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 t -132.34 159.96 37.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.167 0.508 . . . . 0.0 109.928 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -130.16 122.08 27.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.9 1.68 . . . . 0.0 106.483 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -83.89 119.06 24.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.403 1.081 . . . . 0.0 108.096 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -58.26 -58.3 9.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.643 0.777 . . . . 0.0 111.476 -170.643 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -68.94 -43.47 75.0 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.859 0.361 . . . . 0.0 110.039 -171.346 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.38 -30.29 70.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.565 0.746 . . . . 0.0 110.895 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 54.6 47.88 21.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.496 1.119 . . . . 0.0 110.069 -168.777 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -126.77 139.63 11.4 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -92.14 172.72 8.24 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.547 0.739 . . . . 0.0 110.689 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -174.94 143.18 0.7 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.853 2.061 . . . . 0.0 110.743 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.29 124.51 28.46 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 166.679 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.6 -59.92 2.36 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 169.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -142.75 150.42 40.04 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.178 0.591 . . . . 0.0 109.573 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -132.13 122.32 25.17 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -132.69 146.4 51.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -173.922 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 141.74 -165.23 26.55 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 123.578 0.609 . . . . 0.0 111.606 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.35 147.68 67.9 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 CA-C-N 118.045 0.923 . . . . 0.0 111.307 2.597 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.53 136.0 15.24 Favored Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 124.853 1.261 . . . . 0.0 108.05 177.465 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -70.35 164.26 35.76 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.046 1.831 . . . . 0.0 109.511 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -69.08 153.44 72.06 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.839 1.693 . . . . 0.0 109.244 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.536 2.157 . . . . 0.0 110.734 177.197 . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.115 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 179.9 71.96 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.412 1.885 . . . . 0.0 107.454 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -69.53 121.23 16.63 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.49 152.86 37.61 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.368 0.531 . . . . 0.0 109.658 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 mt -77.44 138.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 125.094 1.357 . . . . 0.0 107.58 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 pt -103.2 155.98 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 123.273 0.629 . . . . 0.0 110.422 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.75 131.38 45.08 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.7 pt -73.32 154.35 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 164.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.9 -175.68 29.77 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -166.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -58.95 -45.22 29.68 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.681 2.921 . . . . 0.0 112.667 -171.182 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -54.29 -53.12 58.07 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 122.144 0.973 . . . . 0.0 110.943 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 m -68.31 -39.28 82.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.219 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -52.98 -56.61 14.78 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.063 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -46.71 -50.32 18.12 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.337 0.971 . . . . 0.0 110.805 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.01 -50.43 72.08 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.915 -0.491 . . . . 0.0 111.567 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.34 -25.11 62.23 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 121.661 -0.649 . . . . 0.0 112.851 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -80.59 -54.85 5.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -45.03 -45.52 10.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.757 1.623 . . . . 0.0 110.47 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.56 -53.84 51.4 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.93 0.395 . . . . 0.0 110.738 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.31 -38.97 82.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.243 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.68 -48.96 79.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.472 0.709 . . . . 0.0 109.693 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.07 -50.05 74.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.18 0.992 . . . . 0.0 108.967 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -56.29 -49.66 73.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -59.86 -41.42 91.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.285 1.434 . . . . 0.0 110.069 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -61.47 -37.72 84.63 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 119.637 -0.221 . . . . 0.0 110.676 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.73 -47.33 80.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.42 19.0 61.14 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.624 1.583 . . . . 0.0 111.719 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -56.74 -41.63 77.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.964 0.882 . . . . 0.0 110.808 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -110.82 35.21 3.59 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.951 0.901 . . . . 0.0 110.179 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.85 -154.59 43.13 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.432 0.539 . . . . 0.0 112.051 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.4 ptt85 -93.44 84.91 4.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.084 1.354 . . . . 0.0 109.834 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.11 144.04 38.77 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.932 -0.48 . . . . 0.0 110.169 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 m -100.69 96.98 7.69 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -45.9 125.57 6.38 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.879 0.471 . . . . 0.0 110.473 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.27 -64.96 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.97 169.84 3.33 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 125.005 1.322 . . . . 0.0 108.418 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 p -110.78 141.09 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 124.74 1.216 . . . . 0.0 109.297 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.79 178.72 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 123.587 0.554 . . . . 0.0 110.411 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -60.7 154.99 54.04 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.162 0.985 . . . . 0.0 111.663 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.92 155.61 93.6 Favored 'Cis proline' 0 N--CA 1.458 -0.569 0 CA-C-N 119.414 0.827 . . . . 0.0 110.717 -9.616 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 17.1 p -161.29 79.0 0.59 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -166.218 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -99.16 160.46 14.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.37 1.068 . . . . 0.0 110.936 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -140.78 149.4 42.03 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.055 1.342 . . . . 0.0 108.608 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -147.61 143.58 27.82 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.84 0.856 . . . . 0.0 110.693 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -59.76 141.39 55.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.533 1.533 . . . . 0.0 111.969 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.07 124.76 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.645 1.578 . . . . 0.0 109.23 173.428 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -101.83 165.73 11.04 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.79 1.636 . . . . 0.0 108.784 176.139 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -100.71 -146.42 0.35 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -164.28 -43.78 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 124.686 1.194 . . . . 0.0 110.473 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -73.29 62.68 0.7 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.762 0.825 . . . . 0.0 111.296 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.51 -165.33 37.83 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 106.695 -2.562 . . . . 0.0 106.695 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -75.61 168.94 19.07 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 168.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -56.52 113.21 1.51 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -144.35 147.54 33.58 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.31 1.444 . . . . 0.0 108.458 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.1 mt -74.85 127.02 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -89.91 -37.6 14.29 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.13 -157.36 17.97 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.01 151.86 39.24 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -104.89 144.85 31.21 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.834 1.654 . . . . 0.0 107.309 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.07 139.12 51.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -141.05 99.9 3.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -170.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -122.06 138.6 54.38 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.574 1.149 . . . . 0.0 111.328 -164.037 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -87.34 102.27 14.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.728 0.775 . . . . 0.0 109.013 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.77 131.08 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.401 1.48 . . . . 0.0 109.378 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -98.65 124.25 43.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.227 1.411 . . . . 0.0 108.181 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.03 134.98 21.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.077 0.951 . . . . 0.0 108.897 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 t 52.46 32.62 11.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.173 0.989 . . . . 0.0 111.211 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.7 23.22 12.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.046 1.338 . . . . 0.0 113.45 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -116.75 143.66 45.39 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.434 1.494 . . . . 0.0 107.743 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.8 tp -103.5 129.15 50.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.493 0.717 . . . . 0.0 109.882 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -134.61 148.08 50.34 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 125.206 1.403 . . . . 0.0 109.902 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -94.15 110.59 22.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.711 1.204 . . . . 0.0 108.695 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.35 121.82 42.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.855 1.262 . . . . 0.0 107.903 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -108.63 121.62 45.4 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.86 153.58 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 126.448 1.899 . . . . 0.0 107.607 -175.142 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.1 p -123.77 146.28 48.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 126.64 51.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 168.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -96.86 119.37 35.21 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -63.92 -28.86 70.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.142 0.577 . . . . 0.0 111.047 -174.245 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -63.56 -18.14 63.56 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.5 0.72 . . . . 0.0 112.656 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -143.75 8.57 1.51 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.307 -0.871 . . . . 0.0 111.721 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 44.8 ttt85 50.98 40.41 25.26 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.407 0.683 . . . . 0.0 110.156 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -110.21 137.85 14.52 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -109.79 164.02 12.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 117.503 0.652 . . . . 0.0 111.276 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -157.34 148.7 21.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.551 1.141 . . . . 0.0 110.963 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.19 135.04 39.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.718 1.207 . . . . 0.0 109.264 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.61 -67.11 0.8 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.542 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.31 160.27 43.84 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.255 1.022 . . . . 0.0 109.22 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -126.08 83.83 2.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.688 1.995 . . . . 0.0 106.657 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.6 145.69 26.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.87 -165.04 27.75 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.081 172.93 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.96 148.57 72.76 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 CA-C-N 117.966 0.883 . . . . 0.0 111.318 2.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.02 127.97 18.42 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 125.012 1.325 . . . . 0.0 108.145 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.9 163.3 37.33 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.408 2.072 . . . . 0.0 109.786 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -69.66 154.38 68.22 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.965 1.777 . . . . 0.0 109.35 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.458 2.106 . . . . 0.0 110.812 176.651 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.336 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -145.69 163.09 35.98 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.871 1.668 . . . . 0.0 106.645 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 3' ' ' TRP . . . . . 0.401 ' CE3' ' HB2' ' A' ' 44' ' ' LYS . 7.3 m95 48.59 68.85 0.63 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.475 0.71 . . . . 0.0 111.277 -173.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -122.81 154.99 37.49 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.568 0.747 . . . . 0.0 109.133 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.6 mm -78.04 140.69 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -106.14 154.3 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.257 0.623 . . . . 0.0 109.961 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -73.89 124.46 26.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.5 pt -65.53 122.24 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 123.056 0.542 . . . . 0.0 109.626 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.82 -167.16 21.86 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -175.648 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -56.13 -41.64 74.66 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.239 2.626 . . . . 0.0 111.464 -175.832 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -51.81 -50.01 61.66 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.889 0.875 . . . . 0.0 110.729 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.23 -49.51 71.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.948 0.899 . . . . 0.0 110.62 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -51.97 -53.26 43.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -54.91 -47.83 73.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.999 0.92 . . . . 0.0 111.423 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 mt -59.97 -48.27 82.38 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.979 0.354 . . . . 0.0 110.93 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.11 -48.61 85.27 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -54.9 -49.43 71.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.104 1.361 . . . . 0.0 110.25 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -55.87 -48.21 75.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.106 1.362 . . . . 0.0 110.52 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -49.55 74.86 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.34 -42.63 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.406 0.682 . . . . 0.0 110.783 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.25 -51.58 68.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.961 0.904 . . . . 0.0 109.664 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -58.22 -46.79 85.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.693 1.197 . . . . 0.0 109.746 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -56.16 -56.94 14.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -56.97 -38.72 73.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.578 1.151 . . . . 0.0 110.955 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -56.77 -39.21 73.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.853 0.461 . . . . 0.0 110.608 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.6 mt -83.1 -47.6 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.081 0.552 . . . . 0.0 110.235 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.25 10.83 58.02 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.556 1.55 . . . . 0.0 113.921 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -54.73 -42.64 71.8 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.035 1.417 . . . . 0.0 112.053 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -107.12 37.83 2.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.696 0.798 . . . . 0.0 110.076 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.11 -138.42 47.82 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -115.24 93.39 4.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.134 1.373 . . . . 0.0 108.837 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.3 mt -79.0 142.16 36.84 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.164 0.585 . . . . 0.0 109.575 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 t -103.84 106.92 17.58 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -59.04 133.73 56.36 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.458 0.703 . . . . 0.0 109.916 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -100.48 -64.69 1.02 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 168.661 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -167.61 179.03 5.06 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.356 1.062 . . . . 0.0 108.915 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.06 134.21 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -176.488 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 38' ' ' ILE . . . . . 0.492 HD11 ' CZ ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -146.41 167.2 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 122.741 0.416 . . . . 0.0 110.335 -173.842 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -53.71 150.97 12.17 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.482 1.113 . . . . 0.0 111.831 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.38 142.76 72.72 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 CA-C-N 119.018 0.685 . . . . 0.0 110.701 -1.495 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.6 m -133.68 101.73 5.22 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 33.2 ttm -118.37 138.82 52.16 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.242 0.617 . . . . 0.0 110.491 -169.204 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -121.48 144.57 48.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.956 1.302 . . . . 0.0 110.132 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' HB2' ' CE3' ' A' ' 3' ' ' TRP . 13.3 tmtt? -146.38 149.8 34.46 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.456 0.702 . . . . 0.0 110.885 171.916 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -80.63 137.62 36.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.414 1.485 . . . . 0.0 111.365 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.53 120.74 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.79 1.236 . . . . 0.0 108.303 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -146.94 165.27 30.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.865 0.866 . . . . 0.0 109.275 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -98.44 -151.04 0.37 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -169.1 -52.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.32 1.048 . . . . 0.0 109.245 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -53.85 144.29 18.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.652 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.89 -81.28 1.16 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -150.36 150.82 31.93 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.594 1.157 . . . . 0.0 108.984 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.88 126.64 29.14 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.686 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -164.38 140.13 6.01 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.649 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -74.63 133.37 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 123.779 0.831 . . . . 0.0 108.853 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -119.59 -22.29 7.0 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 123.547 0.529 . . . . 0.0 111.166 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.95 -168.01 31.24 Favored Glycine 0 N--CA 1.448 -0.543 0 O-C-N 121.432 -0.792 . . . . 0.0 111.445 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -148.82 163.69 36.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.328 1.451 . . . . 0.0 107.693 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.84 148.83 52.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.688 1.195 . . . . 0.0 108.97 169.026 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -134.32 115.66 14.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -107.68 129.74 54.99 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.201 0.91 . . . . 0.0 109.263 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 pp -149.27 152.3 35.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.568 0.699 . . . . 0.0 111.568 -172.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 63' ' ' TYR . . . . . 0.612 ' CZ ' HD22 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -89.02 111.34 22.03 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.537 1.535 . . . . 0.0 107.036 177.479 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.1 t -93.35 124.23 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 169.296 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.29 116.55 23.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 169.66 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 132.51 36.95 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.8 t 53.8 34.72 19.8 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.968 0.907 . . . . 0.0 111.708 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 t0 46.94 42.85 12.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.098 1.359 . . . . 0.0 111.064 -169.434 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -137.96 155.15 49.18 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.255 1.422 . . . . 0.0 107.953 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LEU . . . . . 0.612 HD22 ' CZ ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -81.74 118.11 22.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -173.898 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -130.07 112.63 13.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.451 1.1 . . . . 0.0 108.69 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -97.13 131.12 44.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.3 142.73 50.16 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.202 0.91 . . . . 0.0 110.204 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.9 120.68 42.25 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.226 1.01 . . . . 0.0 108.363 168.727 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.74 140.08 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.9 p -111.38 147.65 34.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.581 1.152 . . . . 0.0 108.108 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -126.78 134.35 50.61 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.907 1.683 . . . . 0.0 107.798 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -107.31 114.49 28.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.519 1.128 . . . . 0.0 108.846 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.28 -27.9 67.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.728 1.211 . . . . 0.0 111.365 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -58.04 -23.22 53.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.88 0.872 . . . . 0.0 112.407 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -141.14 6.07 1.93 Allowed 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.468 -0.77 . . . . 0.0 111.328 174.001 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 49.94 40.55 21.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.826 0.851 . . . . 0.0 110.028 -171.294 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.69 140.74 15.35 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 107.699 -2.161 . . . . 0.0 107.699 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -116.85 164.99 13.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.986 0.893 . . . . 0.0 110.787 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -161.2 150.69 16.79 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.842 0.857 . . . . 0.0 110.326 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.57 110.98 0.98 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.346 1.059 . . . . 0.0 108.677 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.7 tp -71.89 -48.26 46.96 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -162.56 155.57 19.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -119.32 141.5 48.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.85 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.4 131.7 40.31 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.93 -176.17 27.84 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.86 162.03 85.26 Favored 'Cis proline' 0 N--CA 1.455 -0.761 0 CA-C-N 118.223 1.012 . . . . 0.0 110.508 -3.516 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.09 162.79 47.94 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 171.171 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.27 158.95 37.08 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.0 1.8 . . . . 0.0 109.323 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.52 152.02 75.16 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.093 1.862 . . . . 0.0 109.335 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--O 1.252 1.21 0 C-N-CA 122.689 2.26 . . . . 0.0 110.5 178.493 . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -169.84 179.69 3.58 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.579 1.551 . . . . 0.0 107.246 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -56.55 109.84 0.68 Allowed 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.472 0.483 . . . . 0.0 109.971 170.643 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -153.76 158.26 40.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.88 138.48 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.11 157.35 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.1 0.96 . . . . 0.0 110.475 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.52 125.39 29.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.503 0.721 . . . . 0.0 109.387 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 pt -65.13 136.32 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 165.851 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.11 -175.07 41.04 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -169.841 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.37 -46.78 31.35 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.745 2.963 . . . . 0.0 113.195 -170.354 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -52.13 -55.01 23.61 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.918 1.342 . . . . 0.0 110.871 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.9 m -66.73 -42.42 86.32 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.28 1.032 . . . . 0.0 110.198 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -57.03 -48.66 77.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.405 0.682 . . . . 0.0 110.078 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -54.02 -47.62 71.34 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 123.131 0.572 . . . . 0.0 110.839 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.06 -41.05 95.5 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.208 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.28 -51.63 40.95 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -51.3 -55.27 19.19 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.353 1.061 . . . . 0.0 110.185 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -51.26 -47.6 62.4 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.826 0.851 . . . . 0.0 110.447 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.35 -50.84 68.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.9 -40.87 90.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.39 -48.31 82.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.465 0.706 . . . . 0.0 110.076 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -63.09 -49.23 75.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.086 0.955 . . . . 0.0 109.698 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -54.74 -46.64 74.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -63.46 -44.94 93.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.635 1.574 . . . . 0.0 110.12 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -56.03 -46.0 78.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.55 0.74 . . . . 0.0 110.022 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -68.9 -47.56 75.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.98 14.9 55.65 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.219 1.39 . . . . 0.0 113.211 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -50.87 -44.46 59.65 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.621 1.21 . . . . 0.0 111.44 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -113.34 38.07 2.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.881 0.873 . . . . 0.0 109.984 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.4 -141.23 47.5 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -111.83 114.93 28.19 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.776 1.231 . . . . 0.0 109.344 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.3 152.25 21.76 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.351 0.66 . . . . 0.0 111.005 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.4 m -92.87 100.1 12.63 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.442 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -49.53 130.61 20.54 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -101.53 -63.63 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -171.58 -166.67 0.46 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.007 0.923 . . . . 0.0 109.122 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.53 144.81 35.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.11 165.34 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.544 0.611 . . . . 0.0 110.417 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -63.96 151.18 90.18 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.078 0.951 . . . . 0.0 111.4 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.1 151.47 96.82 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 119.268 0.774 . . . . 0.0 111.572 0.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.4 m -139.89 94.81 2.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.4 mtt -108.33 157.81 18.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.998 0.919 . . . . 0.0 110.673 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -131.96 154.44 49.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.031 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -130.04 151.9 50.08 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.148 2.179 . . . . 0.0 107.815 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.2 m -98.74 133.64 42.78 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.039 0.936 . . . . 0.0 109.319 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.58 128.19 62.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 125.006 1.323 . . . . 0.0 110.501 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -146.7 175.7 10.41 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.553 1.541 . . . . 0.0 107.607 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 76.94 145.96 0.09 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 127.657 2.383 . . . . 0.0 111.925 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -169.72 -67.1 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.529 1.532 . . . . 0.0 109.521 170.349 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -80.44 173.54 12.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.93 -43.22 61.13 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -76.64 72.68 3.31 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 172.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -42.34 127.43 3.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.282 1.833 . . . . 0.0 109.668 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -149.42 150.79 32.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.863 0.865 . . . . 0.0 110.686 -173.35 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.16 136.73 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 124.233 1.013 . . . . 0.0 109.821 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -127.94 -34.71 2.12 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.207 0.603 . . . . 0.0 112.09 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.91 -164.43 28.99 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.02 -1.086 . . . . 0.0 111.862 -170.522 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -145.02 160.71 40.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.613 1.165 . . . . 0.0 108.027 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -126.41 144.1 50.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.532 1.533 . . . . 0.0 107.579 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -129.95 124.15 32.38 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -113.33 117.75 32.68 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.782 1.633 . . . . 0.0 106.723 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 pp -152.18 153.99 34.93 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.272 0.487 . . . . 0.0 111.535 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -96.1 104.58 16.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.232 1.013 . . . . 0.0 109.348 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.39 130.72 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.374 1.869 . . . . 0.0 108.571 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.57 120.12 39.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.809 1.244 . . . . 0.0 107.674 173.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.7 131.12 20.99 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.275 1.03 . . . . 0.0 108.81 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.43 39.22 29.62 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.18 0.992 . . . . 0.0 110.974 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.9 t0 45.95 37.5 3.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.081 1.352 . . . . 0.0 113.005 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -125.72 139.01 53.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 168.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.4 tp -98.54 126.9 44.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -124.89 140.4 52.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.679 1.592 . . . . 0.0 107.965 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -88.8 123.59 33.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.27 146.82 44.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.662 0.785 . . . . 0.0 109.158 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.58 124.5 43.64 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 mm -112.34 150.17 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 127.006 2.123 . . . . 0.0 107.05 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -120.86 148.91 43.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.599 1.16 . . . . 0.0 108.403 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -122.24 127.25 49.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.393 1.877 . . . . 0.0 106.63 169.207 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -102.78 119.22 38.45 Favored 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.379 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -66.45 -23.07 66.22 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.659 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -63.85 -55.56 21.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.103 0.865 . . . . 0.0 110.495 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.4 p -79.84 -26.84 40.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 68.31 13.96 9.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.053 1.341 . . . . 0.0 109.023 -164.044 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.02 155.09 34.43 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -115.51 171.92 7.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.948 0.499 . . . . 0.0 110.626 176.415 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.26 157.53 30.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.698 174.642 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 tp -78.5 119.2 21.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.1 tp -82.67 -59.78 2.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -144.84 154.35 42.57 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.065 0.946 . . . . 0.0 109.563 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -144.73 102.33 3.78 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.926 1.69 . . . . 0.0 106.838 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -117.11 142.27 47.21 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -172.291 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.74 -165.96 27.92 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.614 -0.548 . . . . 0.0 112.158 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.58 148.03 73.85 Favored 'Cis proline' 0 N--CA 1.458 -0.588 0 CA-C-N 118.006 0.903 . . . . 0.0 111.237 2.137 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.02 130.94 14.23 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 124.776 1.23 . . . . 0.0 108.243 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.56 161.51 43.89 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.1 1.866 . . . . 0.0 109.942 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -69.76 157.89 58.82 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.247 1.964 . . . . 0.0 109.303 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 C--O 1.251 1.173 0 C-N-CA 122.454 2.103 . . . . 0.0 110.763 176.115 . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.076 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.51 171.81 10.69 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.741 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -55.43 103.7 0.1 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.485 0.714 . . . . 0.0 110.373 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -142.9 154.09 43.76 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.803 0.841 . . . . 0.0 109.09 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.53 139.99 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.043 1.337 . . . . 0.0 108.662 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.5 pt -104.25 156.74 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.481 1.113 . . . . 0.0 109.865 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.51 118.13 18.86 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.4 pt -55.56 133.47 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 166.192 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.4 -169.32 42.44 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -172.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -52.17 -44.08 48.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.628 2.885 . . . . 0.0 112.676 -172.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -53.15 -57.13 11.52 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.554 0.692 . . . . 0.0 111.463 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.97 -45.07 94.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.507 0.723 . . . . 0.0 109.974 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -55.85 -48.83 74.83 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.492 0.717 . . . . 0.0 109.22 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -55.08 -51.81 65.2 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.322 0.649 . . . . 0.0 110.608 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 15' ' ' LEU . 19.6 mt -59.23 -45.23 91.69 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.675 -0.64 . . . . 0.0 111.642 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.98 -39.93 92.58 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -64.74 -52.33 57.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -50.98 -45.29 60.93 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.582 1.153 . . . . 0.0 110.849 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.1 70.67 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.0 -41.68 93.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.019 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.0 -48.81 77.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.236 0.614 . . . . 0.0 109.458 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.24 -52.77 63.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.575 1.15 . . . . 0.0 109.36 175.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -57.71 -45.01 86.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 122.997 0.519 . . . . 0.0 110.365 -174.919 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -67.57 -43.77 79.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.786 1.634 . . . . 0.0 110.633 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.35 -44.48 96.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.9 0.48 . . . . 0.0 110.048 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.2 -43.67 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.47 12.94 57.82 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.444 1.021 . . . . 0.0 112.741 173.412 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -47.99 -46.08 32.34 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.246 1.023 . . . . 0.0 111.868 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -111.16 24.02 13.39 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.524 1.13 . . . . 0.0 110.798 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.33 -158.44 26.75 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -81.11 89.86 6.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.4 0.68 . . . . 0.0 110.796 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.6 140.52 48.09 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 169.465 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.5 m -95.56 93.84 7.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -48.67 129.37 16.5 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.689 0.222 . . . . 0.0 110.71 177.165 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -102.82 -62.05 1.32 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -174.16 -161.36 0.12 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.057 1.343 . . . . 0.0 108.741 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.37 145.19 34.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.43 162.7 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 118.353 0.524 . . . . 0.0 110.388 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 151.32 67.38 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.77 1.228 . . . . 0.0 111.22 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.8 130.99 21.9 Favored 'Cis proline' 0 C--N 1.348 0.545 0 CA-C-N 120.035 1.048 . . . . 0.0 112.353 4.765 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 96.3 m -125.39 99.93 6.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 96.5 mtp -115.28 160.05 20.26 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.689 0.796 . . . . 0.0 110.902 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -133.94 158.48 43.37 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 167.617 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -150.58 173.16 14.43 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.9 m -98.27 135.18 40.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.531 1.132 . . . . 0.0 112.041 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.19 136.71 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.286 1.834 . . . . 0.0 108.705 171.156 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -161.91 174.86 12.52 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -170.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.38 172.59 15.17 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 172.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -78.54 -28.26 46.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.582 2.353 . . . . 0.0 111.758 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -15.64 89.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.178 2.591 . . . . 0.0 114.133 -174.644 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.22 -62.44 3.0 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -142.68 158.46 43.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.001 1.32 . . . . 0.0 107.781 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -54.87 129.42 37.33 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 119.416 -0.326 . . . . 0.0 110.153 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -154.11 134.84 13.65 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.073 0.397 . . . . 0.0 110.81 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.51 127.99 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.998 1.319 . . . . 0.0 109.625 171.766 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -108.56 -22.37 12.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.749 0.82 . . . . 0.0 110.539 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.54 -162.39 28.55 Favored Glycine 0 C--N 1.336 0.566 0 O-C-N 121.408 -0.807 . . . . 0.0 111.479 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -142.59 155.14 44.94 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.118 1.367 . . . . 0.0 107.679 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -108.59 150.16 27.88 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.835 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -129.2 120.95 26.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -104.05 128.51 51.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 pp -151.88 153.02 33.34 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.814 0.734 . . . . 0.0 111.519 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -96.73 99.81 11.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.264 1.026 . . . . 0.0 108.7 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.77 135.46 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.9 113.09 26.43 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.462 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.01 132.48 23.55 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 123.568 0.747 . . . . 0.0 109.31 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 m 51.08 36.3 15.1 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.759 1.223 . . . . 0.0 111.185 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 56.12 30.87 17.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.272 1.029 . . . . 0.0 112.726 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.5 150.32 42.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 168.737 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mp -92.59 128.53 38.48 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.939 1.296 . . . . 0.0 108.452 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -127.05 132.04 50.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.27 1.028 . . . . 0.0 108.283 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 112.31 21.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.41 139.55 42.98 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -114.15 123.6 50.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.501 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mm -112.46 149.88 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.501 1.92 . . . . 0.0 105.907 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.9 t -117.7 150.37 39.18 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.94 113.47 15.24 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 127.363 2.265 . . . . 0.0 105.585 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -82.28 118.76 23.37 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -58.28 -52.3 66.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.302 1.441 . . . . 0.0 111.502 -171.218 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.17 -45.02 71.03 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 m -72.19 -29.78 64.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.45 0.3 . . . . 0.0 110.591 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 55.35 49.01 17.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.405 1.082 . . . . 0.0 109.53 -168.469 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -133.58 140.61 11.95 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.78 172.8 6.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.583 0.753 . . . . 0.0 111.187 -174.215 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -167.63 142.51 3.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.226 1.011 . . . . 0.0 111.056 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.63 121.84 17.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.7 tp -84.6 -45.43 12.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -162.49 143.93 10.42 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.069 0.547 . . . . 0.0 110.24 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -125.82 111.9 15.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.838 1.655 . . . . 0.0 107.197 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 30.3 m120 -116.9 151.23 37.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.0 -170.79 22.72 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.622 1.106 . . . . 0.0 110.491 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.39 152.13 88.13 Favored 'Cis proline' 0 N--CA 1.455 -0.762 0 CA-C-N 118.324 1.062 . . . . 0.0 110.702 1.826 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.48 143.69 39.46 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.878 0.871 . . . . 0.0 108.851 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.24 158.24 37.38 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.302 2.002 . . . . 0.0 109.299 173.119 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -70.75 154.26 63.9 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.918 1.745 . . . . 0.0 108.927 169.347 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.25 1.104 0 C-N-CA 122.323 2.015 . . . . 0.0 110.639 175.671 . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.173 0 N-CA-C 111.677 -0.569 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.32 87.35 2.69 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.411 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.4 m95 29.73 73.03 0.05 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.506 1.922 . . . . 0.0 113.578 -174.614 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -122.41 148.86 44.58 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.109 0.563 . . . . 0.0 109.597 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.46 138.46 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.9 pt -106.35 155.41 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.014 0.926 . . . . 0.0 110.18 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.56 140.78 58.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.32 120.61 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.01 -167.43 33.59 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -174.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -52.99 -43.78 54.17 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.515 2.81 . . . . 0.0 113.326 -172.527 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -51.12 -55.99 14.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.481 1.134 . . . . 0.0 111.159 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.33 -42.87 96.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.757 1.223 . . . . 0.0 109.797 -175.761 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -56.69 -48.22 78.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.888 0.875 . . . . 0.0 109.408 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -56.57 -49.24 75.46 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.03 0.532 . . . . 0.0 110.921 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.08 -45.9 82.96 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 117.846 0.293 . . . . 0.0 110.997 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.69 -53.84 40.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -52.66 -48.45 66.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.398 1.079 . . . . 0.0 110.86 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -56.4 -49.1 75.46 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.709 0.804 . . . . 0.0 110.713 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.59 78.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 110.258 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.93 -47.64 85.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.374 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.1 -48.55 81.14 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.727 1.211 . . . . 0.0 110.06 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -65.14 -43.61 91.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.659 0.783 . . . . 0.0 109.902 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -58.99 -48.66 80.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.419 171.33 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -54.52 -39.9 68.06 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.399 1.08 . . . . 0.0 110.276 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -49.43 -37.79 26.95 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.0 0.92 . . . . 0.0 111.141 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.14 -47.43 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.228 1.011 . . . . 0.0 109.355 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.0 28.35 23.57 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.32 0.962 . . . . 0.0 111.19 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -55.99 -38.26 70.2 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.502 0.651 . . . . 0.0 111.39 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -117.59 42.76 2.53 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.838 0.828 . . . . 0.0 109.825 170.852 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.72 -148.1 39.28 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -102.6 115.18 30.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.809 0.844 . . . . 0.0 109.623 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 mp -110.62 137.0 48.86 Favored 'General case' 0 N--CA 1.458 -0.046 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.2 m -86.07 131.47 34.26 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -60.04 135.51 57.73 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -105.76 -64.01 1.19 Allowed 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -165.41 161.32 18.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.19 0.596 . . . . 0.0 109.637 -173.474 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.93 144.41 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 125.429 1.491 . . . . 0.0 107.594 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.16 159.99 9.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 123.011 0.524 . . . . 0.0 110.187 -176.26 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -61.39 152.89 71.61 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.831 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.43 153.79 98.71 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 CA-C-N 119.294 0.783 . . . . 0.0 111.08 -4.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.9 m -141.13 100.6 3.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.3 mtt -113.24 155.0 25.85 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.28 1.032 . . . . 0.0 110.704 -174.709 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -138.38 154.7 48.92 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 167.998 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -150.15 160.05 43.96 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.396 1.079 . . . . 0.0 110.981 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.9 m -84.06 139.55 32.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.741 1.216 . . . . 0.0 112.851 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.07 137.05 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.756 1.622 . . . . 0.0 109.712 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -169.54 174.48 5.87 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.23 0.612 . . . . 0.0 111.737 -167.246 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -110.59 -159.38 0.68 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.96 1.304 . . . . 0.0 110.564 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -164.06 -46.94 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.625 1.57 . . . . 0.0 109.812 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.47 72.83 0.22 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.031 1.332 . . . . 0.0 111.84 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.57 -82.57 0.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 107.604 -2.199 . . . . 0.0 107.604 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -141.07 140.37 34.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -64.82 100.61 0.41 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -138.81 125.38 20.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.489 1.115 . . . . 0.0 108.581 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.84 132.67 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 170.276 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -112.69 -27.51 8.15 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.352 0.661 . . . . 0.0 111.458 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.11 -160.48 24.57 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.08 163.57 33.17 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.795 1.238 . . . . 0.0 108.356 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.57 145.76 48.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.492 1.517 . . . . 0.0 107.972 168.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -121.3 140.37 52.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -136.78 114.2 10.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.66 163.17 39.18 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.289 0.236 . . . . 0.0 110.711 -169.378 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -103.16 139.21 38.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 123.728 0.811 . . . . 0.0 110.345 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.48 137.4 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.421 1.488 . . . . 0.0 108.037 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.38 124.17 38.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 168.325 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.45 121.08 23.95 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.476 1.11 . . . . 0.0 109.554 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t 71.87 -63.31 0.43 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 129.318 3.047 . . . . 0.0 108.588 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -173.22 10.8 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.965 2.906 . . . . 0.0 111.064 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -113.77 130.75 56.4 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 119.432 1.014 . . . . 0.0 108.828 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 tt -87.96 123.49 32.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.775 1.23 . . . . 0.0 108.116 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -133.3 159.23 40.85 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.81 0.844 . . . . 0.0 110.035 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -91.35 136.59 33.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.692 0.797 . . . . 0.0 108.957 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.57 135.26 53.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.94 130.5 56.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 169.785 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.81 136.73 58.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 125.513 1.525 . . . . 0.0 106.89 -173.558 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.3 p -103.4 151.32 22.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.437 0.695 . . . . 0.0 109.295 171.676 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -126.62 119.6 27.45 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 126.802 2.041 . . . . 0.0 106.857 173.861 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.45 118.82 30.89 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -60.57 -46.47 90.1 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.081 0.953 . . . . 0.0 111.446 -171.916 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -63.74 -49.5 72.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.902 0.481 . . . . 0.0 111.542 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.8 m -71.27 -30.25 66.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.8 ttm-85 58.04 41.9 23.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.538 1.135 . . . . 0.0 109.056 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -131.23 150.76 19.5 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -120.35 167.72 12.03 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.539 0.735 . . . . 0.0 109.705 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.09 147.68 19.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 169.999 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.0 tp -57.33 109.9 0.76 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.295 1.438 . . . . 0.0 108.147 170.96 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.92 -54.53 8.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.188 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.78 156.78 42.42 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.598 0.759 . . . . 0.0 109.541 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -120.98 127.36 51.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 168.737 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -137.19 155.43 49.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.91 -159.57 21.5 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -169.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -66.09 159.62 76.66 Favored 'Cis proline' 0 N--CA 1.457 -0.674 0 CA-C-N 119.099 1.45 . . . . 0.0 112.07 2.99 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.13 136.99 23.67 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.4 157.55 41.03 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.998 1.798 . . . . 0.0 109.646 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -67.92 154.14 73.6 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.827 1.685 . . . . 0.0 109.229 169.36 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--O 1.251 1.173 0 C-N-CA 122.493 2.129 . . . . 0.0 110.839 177.822 . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.295 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -163.28 157.35 20.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 m95 37.37 56.64 1.37 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.103 1.361 . . . . 0.0 111.748 -169.369 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.72 143.22 33.08 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.455 -178.307 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mp -78.26 140.26 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 pt -113.82 156.24 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.072 0.949 . . . . 0.0 109.673 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.3 167.44 18.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.807 0.813 . . . . 0.0 109.773 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pp -100.44 164.21 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 164.89 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.46 -174.12 23.54 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -169.109 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.05 -43.19 50.34 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.847 3.031 . . . . 0.0 112.382 -173.097 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -51.22 -58.11 7.02 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.019 0.914 . . . . 0.0 110.871 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.14 -41.18 86.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.665 -171.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -53.71 -53.79 47.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.643 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -51.68 -50.31 60.68 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.771 0.714 . . . . 0.0 110.712 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.22 -49.92 74.48 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.032 -0.418 . . . . 0.0 110.877 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.0 -34.23 71.7 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 122.142 -0.349 . . . . 0.0 112.257 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -73.06 -48.18 38.28 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -51.58 -47.19 63.6 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.279 1.031 . . . . 0.0 110.554 169.569 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.97 -53.33 59.3 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.093 0.473 . . . . 0.0 110.052 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.36 -40.08 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.771 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.72 -48.11 83.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.436 -0.79 . . . . 0.0 109.666 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -58.81 -50.27 74.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.282 1.033 . . . . 0.0 109.516 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -53.78 -44.94 70.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.278 0.631 . . . . 0.0 110.778 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -69.98 -39.69 75.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.554 1.542 . . . . 0.0 110.589 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -58.33 -46.03 86.99 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.86 -43.77 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.41 24.59 33.3 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.243 1.401 . . . . 0.0 110.282 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -57.85 -35.33 70.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.519 0.728 . . . . 0.0 111.47 -169.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -129.27 45.43 2.8 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.013 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.17 -140.11 46.44 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 86.33 2.97 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.066 1.346 . . . . 0.0 109.219 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.94 138.1 37.02 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.494 -0.754 . . . . 0.0 110.124 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 m -96.61 95.55 8.04 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -45.67 131.45 8.96 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 123.245 0.618 . . . . 0.0 110.234 173.113 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -102.0 -66.12 0.94 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -173.36 154.16 2.57 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.93 0.892 . . . . 0.0 110.546 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.79 144.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 168.439 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.97 156.92 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.815 0.846 . . . . 0.0 110.144 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.9 ptt85 -63.42 153.01 83.96 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.708 1.203 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.11 154.72 98.36 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 CA-C-N 119.443 0.837 . . . . 0.0 111.268 -5.335 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 89.9 m -137.66 131.04 30.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 mtp -135.82 158.08 45.26 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.44 0.696 . . . . 0.0 110.965 -169.965 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -145.07 154.58 42.64 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.251 0.621 . . . . 0.0 111.059 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -144.47 142.09 30.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.054 0.942 . . . . 0.0 111.381 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -73.95 123.36 24.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.753 2.421 . . . . 0.0 111.395 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.61 100.91 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 122.387 1.089 . . . . 0.0 108.17 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -81.09 166.48 20.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.517 1.127 . . . . 0.0 110.348 174.339 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -148.04 162.23 39.78 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 166.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -58.12 -52.99 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.794 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 45.86 -151.36 0.07 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.957 1.703 . . . . 0.0 112.366 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.15 64.34 3.75 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 169.306 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.4 t80 73.01 163.24 0.27 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.165 1.786 . . . . 0.0 110.43 -167.532 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -33.2 112.29 0.12 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.107 1.763 . . . . 0.0 112.338 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -142.92 145.63 33.23 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.935 0.494 . . . . 0.0 109.742 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.9 mt -80.64 101.95 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 172.432 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -19.44 33.85 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.612 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.71 -167.1 30.61 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.464 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -142.29 164.63 29.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.313 1.445 . . . . 0.0 108.157 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -122.49 146.22 47.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 106.725 171.025 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -127.42 138.85 53.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 176.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -136.86 117.64 14.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 pp -150.87 146.27 26.22 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 118.438 0.563 . . . . 0.0 111.573 -169.15 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -89.98 130.62 36.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.022 0.929 . . . . 0.0 109.446 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.08 135.06 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 124.336 1.054 . . . . 0.0 110.424 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -89.22 128.81 35.85 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.592 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 125.49 25.56 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 t 52.34 40.0 28.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.961 0.905 . . . . 0.0 111.105 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.1 t70 57.54 23.0 8.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.012 1.325 . . . . 0.0 113.359 -176.873 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.78 132.08 54.5 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 169.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -91.2 124.52 35.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.818 0.847 . . . . 0.0 108.725 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.05 159.29 37.98 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.176 1.39 . . . . 0.0 109.215 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -101.08 123.11 44.74 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 167.623 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.83 133.85 41.78 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -122.77 124.8 44.17 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.359 1.063 . . . . 0.0 108.37 172.121 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.46 155.02 41.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 126.557 1.943 . . . . 0.0 106.684 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.9 m -127.79 164.94 21.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.424 0.556 . . . . 0.0 109.813 168.645 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.97 133.37 44.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.431 1.892 . . . . 0.0 107.595 175.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -105.21 109.11 20.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.256 1.422 . . . . 0.0 107.911 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -56.89 -31.95 65.39 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.394 1.477 . . . . 0.0 111.092 -173.327 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -48.86 -26.91 2.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.416 1.486 . . . . 0.0 112.928 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.1 m -144.22 17.54 1.72 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.64 0.654 . . . . 0.0 111.151 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 49.07 30.86 3.08 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.896 0.878 . . . . 0.0 110.442 -169.841 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.36 125.8 8.17 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -168.554 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -98.03 167.14 11.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.855 0.836 . . . . 0.0 112.433 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -164.53 128.22 2.5 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.035 -170.877 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.28 121.97 16.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.5 mp -84.33 -50.58 7.7 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 170.096 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -161.88 161.42 28.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.724 0.297 . . . . 0.0 110.649 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -127.79 82.34 2.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -83.33 137.85 33.79 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.18 -166.61 25.69 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -68.68 154.32 90.16 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 118.175 0.988 . . . . 0.0 110.726 1.643 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.6 149.21 49.75 Favored Pre-proline 0 C--O 1.227 -0.108 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.1 155.88 52.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.505 1.47 . . . . 0.0 109.076 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.03 145.29 73.17 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.632 1.555 . . . . 0.0 108.782 169.56 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.25 1.11 0 C-N-CA 122.465 2.11 . . . . 0.0 110.763 179.101 . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.216 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.79 70.08 1.87 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.97 0.508 . . . . 0.0 111.621 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -163.88 82.87 0.44 Allowed 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 125.225 1.41 . . . . 0.0 107.783 168.358 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -147.13 156.71 43.22 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 5' ' ' ILE . 3.4 mp -76.08 131.34 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.1 153.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.54 0.736 . . . . 0.0 109.626 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.49 122.65 19.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.5 pt -64.44 146.34 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.222 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.2 -177.59 32.33 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -166.936 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.95 -47.27 27.53 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.041 3.161 . . . . 0.0 113.352 -169.089 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -54.22 -54.19 43.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 122.217 1.008 . . . . 0.0 111.101 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.3 m -65.92 -41.48 91.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.438 0.695 . . . . 0.0 110.239 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -54.15 -54.69 36.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.45 169.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -50.02 -49.39 50.97 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.898 0.772 . . . . 0.0 111.004 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.79 -49.42 76.4 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.074 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.78 -27.93 62.39 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.945 -0.472 . . . . 0.0 112.762 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -79.7 -52.82 7.47 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -46.26 -45.15 17.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.386 1.475 . . . . 0.0 110.802 172.165 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.46 -55.64 26.91 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.517 0.675 . . . . 0.0 110.523 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.32 -39.93 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.754 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.58 -48.9 78.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.615 0.766 . . . . 0.0 109.701 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -59.94 -49.55 77.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.216 1.007 . . . . 0.0 109.24 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -54.93 -47.0 75.01 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.96 0.504 . . . . 0.0 110.732 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -65.78 -40.53 92.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.315 1.446 . . . . 0.0 110.298 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -58.07 -45.16 87.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.4 mt -69.1 -42.72 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.29 37.75 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.276 1.417 . . . . 0.0 112.167 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.69 -39.45 80.75 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.978 0.889 . . . . 0.0 111.581 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -110.84 34.83 3.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.108 0.963 . . . . 0.0 109.794 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.08 -130.42 44.63 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -119.92 84.73 2.26 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.923 1.289 . . . . 0.0 109.305 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.01 139.82 40.19 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.95 -0.469 . . . . 0.0 109.946 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.4 m -97.39 94.57 7.13 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -48.33 135.31 13.86 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 122.756 0.422 . . . . 0.0 110.204 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.86 -62.47 1.47 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.089 0.956 . . . . 0.0 109.097 176.668 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.15 178.3 4.46 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.551 1.14 . . . . 0.0 108.959 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.48 142.88 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.838 1.255 . . . . 0.0 109.348 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.6 171.56 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.873 0.869 . . . . 0.0 109.37 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 151.4 94.1 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.532 -175.225 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.33 160.97 85.88 Favored 'Cis proline' 0 C--N 1.348 0.519 0 CA-C-N 120.098 1.071 . . . . 0.0 111.649 0.049 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.9 p -177.0 77.52 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 -163.935 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.5 ttt -122.01 134.25 54.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.42 1.088 . . . . 0.0 109.225 -165.596 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -103.47 138.44 40.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 117.991 -1.004 . . . . 0.0 111.027 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -134.62 145.59 48.77 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.944 0.793 . . . . 0.0 111.471 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.6 m -74.46 139.02 43.62 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.884 0.473 . . . . 0.0 109.925 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.62 126.06 71.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.905 1.282 . . . . 0.0 109.257 175.296 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -139.65 150.72 45.27 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.009 0.924 . . . . 0.0 109.946 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -176.51 173.24 2.07 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.996 1.718 . . . . 0.0 107.23 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -150.05 -65.23 0.21 Allowed 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 125.048 1.339 . . . . 0.0 108.663 169.336 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -175.07 77.21 0.03 OUTLIER 'General case' 0 C--O 1.247 0.966 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.38 -60.58 2.36 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -165.434 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -57.57 165.5 1.58 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.331 1.452 . . . . 0.0 110.843 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.2 ptt-85 -109.31 160.48 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.45 1.9 . . . . 0.0 110.609 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.47 139.19 0.56 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.16 2.184 . . . . 0.0 105.898 167.555 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.28 125.48 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 119.427 1.012 . . . . 0.0 109.158 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -122.44 -34.19 3.31 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.235 0.614 . . . . 0.0 111.482 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -172.35 -160.1 20.21 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.507 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -135.67 163.9 29.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.675 1.19 . . . . 0.0 108.244 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -124.59 143.54 50.64 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.664 1.585 . . . . 0.0 108.043 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -124.13 111.91 16.47 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -106.62 110.72 22.99 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.87 141.72 34.6 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.028 0.831 . . . . 0.0 112.46 -172.432 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -87.91 101.99 14.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.896 0.879 . . . . 0.0 109.464 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.83 125.68 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.509 1.524 . . . . 0.0 109.301 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.8 117.79 24.89 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.889 1.276 . . . . 0.0 107.988 169.982 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.2 127.98 36.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.581 1.152 . . . . 0.0 108.17 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 t 51.27 39.4 23.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.104 0.962 . . . . 0.0 111.322 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.0 t0 55.26 22.79 5.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.087 1.355 . . . . 0.0 113.707 -176.242 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -111.76 135.87 51.79 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.4 tp -100.11 126.39 46.34 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -131.63 142.8 49.95 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.604 1.162 . . . . 0.0 109.674 -176.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -82.69 106.9 14.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.13 0.972 . . . . 0.0 108.707 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.43 124.64 34.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -110.62 108.9 18.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.27 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.0 mp -104.64 152.72 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.5 t -125.48 152.61 44.72 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.796 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.57 131.81 54.33 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.718 1.607 . . . . 0.0 107.779 173.538 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.04 124.03 35.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.768 0.827 . . . . 0.0 109.519 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -66.92 -29.41 69.28 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.197 -0.939 . . . . 0.0 111.979 -172.861 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -58.41 8.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.45 0.7 . . . . 0.0 111.329 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.24 -14.72 22.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.324 0.65 . . . . 0.0 110.827 -173.567 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.3 mtm-85 54.53 41.75 31.76 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.462 1.105 . . . . 0.0 110.737 -174.26 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.91 158.2 14.56 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 173.774 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.12 165.92 12.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.673 0.736 . . . . 0.0 111.548 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -157.92 148.74 20.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.875 1.27 . . . . 0.0 110.985 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 tp -69.57 127.4 32.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.936 0.894 . . . . 0.0 109.091 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.4 -51.43 6.22 Favored 'General case' 0 C--O 1.228 -0.039 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 167.288 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.3 167.55 25.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 117.909 0.322 . . . . 0.0 111.502 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -133.59 86.06 2.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.678 1.591 . . . . 0.0 107.264 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.7 146.65 25.59 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.25 -164.77 28.66 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.052 -0.86 . . . . 0.0 111.101 174.873 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.09 146.85 64.48 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 CA-C-N 118.155 0.978 . . . . 0.0 110.744 -0.572 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.5 126.46 17.17 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 124.91 1.284 . . . . 0.0 108.168 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.66 162.6 40.83 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.426 2.084 . . . . 0.0 108.936 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.55 119.0 6.01 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.634 1.556 . . . . 0.0 108.575 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--O 1.251 1.138 0 C-N-CA 121.969 1.78 . . . . 0.0 110.874 -176.587 . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.274 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.88 139.34 33.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 87.08 115.52 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 129.443 3.097 . . . . 0.0 108.384 167.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.99 158.78 28.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.761 0.71 . . . . 0.0 110.694 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.6 mm -64.93 148.34 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.906 1.282 . . . . 0.0 108.801 171.435 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 pt -114.08 152.06 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.145 1.378 . . . . 0.0 108.852 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -82.12 125.62 31.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 pt -60.19 132.79 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 166.871 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.61 -176.22 44.2 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -52.1 -49.04 18.68 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.71 2.94 . . . . 0.0 113.237 -169.773 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -54.31 -56.06 22.21 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.153 0.978 . . . . 0.0 110.849 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -64.94 -39.27 93.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.383 1.073 . . . . 0.0 110.497 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -59.28 -46.73 87.74 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.437 0.695 . . . . 0.0 109.813 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -57.0 -46.7 82.11 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 118.592 0.633 . . . . 0.0 110.633 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.27 -46.07 83.45 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.209 -0.307 . . . . 0.0 110.64 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.49 -51.84 53.89 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.596 -0.601 . . . . 0.0 111.596 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -57.4 -48.02 80.19 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.539 1.535 . . . . 0.0 109.063 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -55.21 -47.44 75.28 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.705 1.202 . . . . 0.0 110.702 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.19 -53.4 57.64 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.672 0.749 . . . . 0.0 110.274 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.55 -39.81 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.125 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.62 -48.86 75.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.817 1.247 . . . . 0.0 109.494 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -55.99 -51.73 66.72 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.105 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.71 -46.08 88.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.111 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -59.26 -45.63 90.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.182 0.993 . . . . 0.0 109.495 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.35 -45.29 95.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.446 0.698 . . . . 0.0 110.351 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.5 mt -70.39 -43.27 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.78 14.18 55.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.726 1.155 . . . . 0.0 112.863 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -50.32 -44.43 54.21 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.232 1.016 . . . . 0.0 111.995 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.09 34.79 4.25 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.75 0.786 . . . . 0.0 110.099 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.93 -143.43 48.64 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 -100.19 124.23 45.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.292 1.037 . . . . 0.0 108.961 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.53 134.9 50.76 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.111 0.964 . . . . 0.0 110.289 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.0 m -95.59 99.02 10.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.032 1.333 . . . . 0.0 108.994 -174.901 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -45.41 122.83 3.73 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 122.892 0.477 . . . . 0.0 110.712 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.15 -61.0 1.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.309 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -169.52 -165.63 0.53 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.19 149.85 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 126.342 1.857 . . . . 0.0 107.327 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -142.55 160.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -66.72 154.42 91.67 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.515 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.65 141.85 72.59 Favored 'Cis proline' 0 N--CA 1.455 -0.76 0 CA-C-N 118.89 0.639 . . . . 0.0 111.322 0.176 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -132.91 108.87 9.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.4 ttt -133.57 143.46 48.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 119.148 0.885 . . . . 0.0 109.529 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -119.48 144.44 46.99 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.057 0.39 . . . . 0.0 111.95 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -121.37 149.53 42.83 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.2 m -80.77 137.97 36.27 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.62 132.02 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.205 1.402 . . . . 0.0 108.211 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -168.2 176.78 5.8 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.448 -0.782 . . . . 0.0 110.217 -167.58 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -159.53 170.92 20.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -79.08 -59.3 2.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.152 0.981 . . . . 0.0 109.384 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 45.72 55.51 6.75 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.594 1.158 . . . . 0.0 109.796 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.96 -71.33 1.42 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -115.47 103.18 10.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.205 1.002 . . . . 0.0 110.414 -174.668 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -28.72 126.24 0.1 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.283 2.233 . . . . 0.0 114.238 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.95 134.63 15.48 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.4 mm -64.5 127.14 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -100.44 -25.16 14.3 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.227 0.467 . . . . 0.0 111.431 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.73 -164.49 32.17 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 118.649 0.659 . . . . 0.0 111.461 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -144.22 164.77 29.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.038 1.335 . . . . 0.0 107.561 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -127.4 145.19 50.9 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.063 0.945 . . . . 0.0 108.816 167.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.2 119.12 32.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -114.84 105.36 12.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.12 143.41 47.95 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.819 0.848 . . . . 0.0 111.191 -168.974 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -87.71 110.12 20.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.1 p -95.24 139.43 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.502 1.121 . . . . 0.0 108.824 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -108.38 120.81 43.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.94 132.88 22.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m 46.81 45.08 14.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.117 0.967 . . . . 0.0 111.309 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t70 63.57 10.89 5.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.105 1.362 . . . . 0.0 113.656 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -110.52 140.22 45.02 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.227 1.411 . . . . 0.0 107.94 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.1 tp -98.69 120.47 39.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.135 0.974 . . . . 0.0 109.018 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -123.18 154.28 38.92 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.961 1.304 . . . . 0.0 108.638 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -96.45 128.79 43.71 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.647 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.11 126.92 55.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.809 1.244 . . . . 0.0 107.903 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -112.64 100.92 9.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.7 mm -96.21 147.34 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.727 1.611 . . . . 0.0 107.51 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -121.44 148.43 44.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 170.244 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.9 120.83 34.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 127.714 2.406 . . . . 0.0 106.194 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -97.27 115.72 28.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -63.48 -45.9 88.64 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.9 1.68 . . . . 0.0 110.701 -169.861 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -64.68 -50.21 67.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.83 0.452 . . . . 0.0 110.082 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 m -62.9 -35.18 79.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.063 0.945 . . . . 0.0 110.15 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 55.31 48.07 20.02 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.782 2.033 . . . . 0.0 110.141 -168.702 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.02 155.13 22.58 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -115.61 170.23 8.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.447 0.699 . . . . 0.0 111.124 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -165.29 149.08 8.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.544 1.138 . . . . 0.0 111.183 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.73 117.2 6.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 168.567 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.2 tp -85.0 -54.72 4.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -142.79 155.33 44.8 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -133.05 134.2 44.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 167.43 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -141.68 155.42 45.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -174.748 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.28 -164.99 16.08 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.11 154.68 91.6 Favored 'Cis proline' 0 N--CA 1.455 -0.739 0 CA-C-N 118.249 1.025 . . . . 0.0 110.275 1.318 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.61 133.47 16.84 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.69 154.18 54.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.696 1.597 . . . . 0.0 109.355 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.81 155.21 69.41 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.097 1.865 . . . . 0.0 109.374 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo . . . . . 0 C--O 1.25 1.087 0 C-N-CA 122.566 2.177 . . . . 0.0 110.736 176.901 . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.117 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -138.29 90.49 2.47 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.155 0.982 . . . . 0.0 109.153 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -159.32 110.7 2.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.94 1.696 . . . . 0.0 107.034 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -164.37 166.67 20.5 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.25 141.69 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.833 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.74 157.95 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 123.837 0.855 . . . . 0.0 109.902 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.99 148.56 48.73 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.385 0.674 . . . . 0.0 109.709 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.11 137.63 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 167.061 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.31 -171.24 44.33 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -170.18 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.03 -42.72 64.54 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.635 2.89 . . . . 0.0 113.006 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -58.25 -52.88 63.74 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.087 0.946 . . . . 0.0 111.053 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 -41.38 87.87 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.74 0.816 . . . . 0.0 109.63 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -57.38 -50.77 71.92 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.577 0.751 . . . . 0.0 109.875 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -48.96 -54.9 13.59 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.262 1.025 . . . . 0.0 109.828 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 mt -55.37 -44.34 75.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.517 0.144 . . . . 0.0 111.157 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.27 -53.63 44.21 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.283 0.468 . . . . 0.0 112.31 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -55.88 -47.84 76.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.457 1.103 . . . . 0.0 109.286 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -56.85 -48.32 78.37 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.604 0.762 . . . . 0.0 110.412 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.13 -51.19 70.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.99 -37.74 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.66 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.73 -49.7 75.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.238 1.015 . . . . 0.0 109.843 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.3 -49.52 77.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.471 0.708 . . . . 0.0 109.328 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -53.38 -50.32 65.37 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -57.65 -48.32 79.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.301 1.04 . . . . 0.0 109.945 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.95 -38.95 87.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.528 0.331 . . . . 0.0 110.632 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.7 mt -73.87 -52.83 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.07 13.18 46.91 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.46 1.505 . . . . 0.0 113.701 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -53.05 -43.68 66.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.594 1.197 . . . . 0.0 112.041 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -108.24 36.42 2.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.598 0.759 . . . . 0.0 110.005 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.97 -149.63 50.59 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -111.16 76.99 1.01 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.557 1.143 . . . . 0.0 108.802 -169.317 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.7 139.51 45.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.776 0.43 . . . . 0.0 111.448 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m -93.42 104.3 16.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -48.98 133.53 18.02 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -106.79 -65.39 1.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.57 0.748 . . . . 0.0 109.058 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -167.11 164.43 15.77 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.689 1.196 . . . . 0.0 109.017 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.43 141.42 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.354 1.062 . . . . 0.0 108.958 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -141.24 168.49 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.369 0.668 . . . . 0.0 110.67 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.59 154.66 79.11 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.11 0.964 . . . . 0.0 110.864 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.03 137.67 50.79 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 CA-C-N 119.539 0.871 . . . . 0.0 111.746 -3.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 68.9 m -126.77 121.18 31.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.2 ttm -138.77 138.71 37.86 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.199 0.6 . . . . 0.0 109.75 -167.577 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -121.29 142.95 49.46 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.999 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -132.14 141.55 49.17 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.927 0.891 . . . . 0.0 110.153 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.4 m -76.23 141.21 41.81 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.362 0.265 . . . . 0.0 110.989 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -110.56 123.72 66.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 125.772 1.629 . . . . 0.0 109.19 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -103.82 168.03 9.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.305 1.442 . . . . 0.0 110.693 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -123.19 155.86 36.26 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.147 1.379 . . . . 0.0 108.233 168.027 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -113.44 -36.6 4.91 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 128.949 2.9 . . . . 0.0 109.094 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -68.55 77.29 0.28 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.082 0.953 . . . . 0.0 110.58 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.67 -69.07 0.18 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -167.03 -59.14 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.684 1.193 . . . . 0.0 108.597 173.551 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -179.82 121.61 0.07 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.782 2.033 . . . . 0.0 105.594 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -163.97 161.53 22.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.203 0.91 . . . . 0.0 110.079 171.506 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.56 131.27 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -99.43 -34.62 10.2 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.354 0.661 . . . . 0.0 109.936 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.6 -157.64 19.61 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -172.452 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -142.96 160.0 41.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -123.14 150.28 43.47 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.354 1.461 . . . . 0.0 109.05 170.739 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -133.81 123.59 25.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -122.21 127.9 50.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.77 158.08 38.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.94 0.4 . . . . 0.0 110.839 -174.415 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -96.63 112.74 24.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.998 0.919 . . . . 0.0 109.355 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 p -103.28 132.45 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 124.091 0.956 . . . . 0.0 109.543 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.72 119.95 28.56 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.655 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.84 127.6 36.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 t 53.06 39.81 30.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.58 0.752 . . . . 0.0 111.001 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.8 t0 53.45 28.1 7.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.064 1.345 . . . . 0.0 113.245 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -118.61 134.88 54.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.2 tp -89.73 128.37 36.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -129.32 139.87 51.6 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.992 1.317 . . . . 0.0 109.711 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -88.19 108.2 19.16 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.868 1.267 . . . . 0.0 108.566 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.57 134.6 48.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -123.63 125.24 44.47 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.517 1.527 . . . . 0.0 107.608 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.09 146.74 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 126.004 1.721 . . . . 0.0 108.132 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.5 161.16 15.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.912 0.885 . . . . 0.0 108.744 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.66 119.33 11.1 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -97.32 122.06 39.92 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.729 1.212 . . . . 0.0 109.837 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -58.04 -39.38 78.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.27 0.628 . . . . 0.0 112.423 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -56.48 -51.62 67.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.153 0.581 . . . . 0.0 111.039 -171.187 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.6 p -107.31 4.81 26.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.547 1.139 . . . . 0.0 111.555 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.9 ptt85 46.78 40.72 9.28 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.809 1.244 . . . . 0.0 110.185 -168.618 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.88 125.31 8.36 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.6 -167.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -78.66 175.07 10.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.617 1.167 . . . . 0.0 109.952 171.555 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.67 118.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.994 2.117 . . . . 0.0 113.512 -167.891 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.1 tp -65.82 132.1 47.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.89 -62.58 1.46 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 167.751 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -145.65 151.95 38.87 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.322 0.649 . . . . 0.0 109.699 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -135.46 115.12 12.8 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 176.345 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.39 143.12 51.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.662 0.785 . . . . 0.0 108.893 -167.809 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.0 -157.69 25.49 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.79 156.75 82.75 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 CA-C-N 118.757 1.279 . . . . 0.0 110.123 -1.973 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 m -120.46 135.98 24.94 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.16 152.85 31.47 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.034 1.823 . . . . 0.0 108.772 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.51 151.08 64.55 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.824 1.682 . . . . 0.0 109.171 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.479 2.119 . . . . 0.0 110.674 176.398 . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.356 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.01 59.38 1.74 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 172.519 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER 61.35 96.91 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.351 1.46 . . . . 0.0 110.737 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -149.38 154.92 39.66 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.377 -0.827 . . . . 0.0 110.367 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.0 mt -72.65 132.57 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 pt -99.14 153.79 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.299 0.64 . . . . 0.0 110.7 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.92 124.45 20.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.754 0.821 . . . . 0.0 108.791 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.29 122.12 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.653 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.79 -160.47 26.98 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.44 -46.24 25.6 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.865 2.377 . . . . 0.0 112.974 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -53.07 -54.72 31.3 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.31 1.052 . . . . 0.0 111.076 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -47.46 83.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.963 1.305 . . . . 0.0 109.416 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -53.74 -49.24 68.59 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.636 0.774 . . . . 0.0 110.025 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -55.94 -49.2 74.16 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.315 0.646 . . . . 0.0 110.859 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.27 -44.41 95.36 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.779 -0.576 . . . . 0.0 111.218 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.73 -47.53 87.98 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -52.84 -54.02 40.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.929 1.292 . . . . 0.0 109.793 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -55.95 -46.22 78.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.472 1.109 . . . . 0.0 110.623 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.02 -51.69 68.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.924 0.392 . . . . 0.0 110.467 177.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.91 -39.41 85.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.57 -50.86 70.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.976 0.91 . . . . 0.0 109.479 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -56.15 -51.04 69.42 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.13 0.972 . . . . 0.0 109.286 176.907 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -57.04 -51.24 70.05 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -55.32 -44.22 75.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.759 1.224 . . . . 0.0 109.999 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -58.07 -42.63 85.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.894 0.478 . . . . 0.0 110.414 -177.18 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.1 mt -73.41 -46.69 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.42 18.83 43.93 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.386 1.47 . . . . 0.0 112.716 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -54.42 -43.09 71.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.378 1.089 . . . . 0.0 111.256 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -107.74 30.69 6.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.938 0.895 . . . . 0.0 110.473 176.076 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.57 -152.15 52.49 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -100.01 118.24 35.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.118 0.967 . . . . 0.0 109.227 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.28 -171.89 1.93 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.721 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.0 m -141.36 125.4 17.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -55.03 132.6 47.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -107.66 -65.31 1.12 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -175.78 4.05 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.363 0.665 . . . . 0.0 110.842 173.107 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 t -120.72 141.19 42.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.43 168.25 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.477 0.581 . . . . 0.0 110.254 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 147.91 71.11 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.682 0.793 . . . . 0.0 111.658 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.31 153.31 91.93 Favored 'Cis proline' 0 N--CA 1.455 -0.787 0 CA-C-N 119.085 0.709 . . . . 0.0 111.058 -1.317 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.8 m -142.4 87.69 2.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.8 ttt -112.43 123.5 50.43 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.149 0.58 . . . . 0.0 110.938 -167.606 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -100.23 136.37 40.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.09 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -122.85 153.91 38.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.227 1.811 . . . . 0.0 109.379 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.1 m -89.65 138.99 30.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.417 1.087 . . . . 0.0 110.124 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.64 122.71 62.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.944 1.297 . . . . 0.0 109.31 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -140.16 161.44 37.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.848 0.859 . . . . 0.0 111.227 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -106.19 162.24 13.82 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.675 1.59 . . . . 0.0 106.799 169.885 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -55.68 -69.57 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.326 1.45 . . . . 0.0 111.761 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 57.15 -171.19 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.972 0.509 . . . . 0.0 109.758 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.27 9.28 20.89 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 120.86 -1.15 . . . . 0.0 113.454 174.002 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -163.69 -72.44 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.985 1.392 . . . . 0.0 108.126 174.343 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -163.0 138.74 6.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.703 2.001 . . . . 0.0 106.334 171.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -114.33 95.37 5.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.061 1.744 . . . . 0.0 106.839 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.5 mt -64.47 115.08 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -91.17 -33.03 15.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.54 -148.93 9.01 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -169.232 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -147.54 169.06 20.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.376 1.07 . . . . 0.0 109.531 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -136.89 155.22 50.05 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.126 0.97 . . . . 0.0 110.203 167.381 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -133.42 118.07 17.98 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -175.395 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.59 107.95 16.86 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -150.34 152.63 34.71 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -169.286 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -99.3 116.74 32.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.272 1.029 . . . . 0.0 110.552 -173.561 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.48 127.8 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 126.06 1.744 . . . . 0.0 109.123 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -84.66 114.97 22.4 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 170.278 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.42 121.81 40.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.9 1.28 . . . . 0.0 109.016 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 t 71.15 -67.93 0.24 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 128.969 2.907 . . . . 0.0 107.058 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -178.13 26.6 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.295 2.638 . . . . 0.0 110.047 170.72 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -111.71 135.75 51.89 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.4 tp -86.9 124.44 33.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -120.5 145.19 47.52 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -86.28 131.11 34.3 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.27 138.95 53.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -118.45 121.84 41.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 171.643 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.9 mm -120.84 150.44 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.487 1.915 . . . . 0.0 106.255 -173.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t -124.48 158.16 33.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.153 0.888 . . . . 0.0 109.612 168.045 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.77 133.55 46.09 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 170.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -103.15 118.98 38.0 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 124.155 0.909 . . . . 0.0 108.818 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -64.7 -24.02 67.44 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.965 0.906 . . . . 0.0 112.304 -171.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -56.97 -40.92 77.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.586 0.63 . . . . 0.0 111.018 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.0 m -103.87 -16.88 15.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.576 0.751 . . . . 0.0 110.652 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 55.2 36.25 26.61 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.944 1.298 . . . . 0.0 109.646 -167.313 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.53 137.99 14.59 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.54 164.69 13.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.296 0.638 . . . . 0.0 111.852 -176.089 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.77 140.09 16.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.004 1.321 . . . . 0.0 110.56 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.3 125.07 22.64 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 170.03 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.54 -56.76 3.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.878 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -148.12 157.78 43.7 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.926 1.29 . . . . 0.0 109.292 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -138.07 125.15 21.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -137.65 149.49 46.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.77 -166.25 24.62 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.45 146.11 64.08 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 CA-C-N 118.23 1.015 . . . . 0.0 110.954 2.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.31 130.64 11.7 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 124.396 1.078 . . . . 0.0 108.585 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.68 161.91 43.74 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.867 1.711 . . . . 0.0 108.799 173.356 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.75 147.27 68.91 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.553 1.502 . . . . 0.0 108.969 172.451 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 122.403 2.069 . . . . 0.0 110.797 178.131 . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.272 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -75.61 66.56 1.98 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.169 0.987 . . . . 0.0 111.83 -172.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -59.68 123.82 18.15 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 169.359 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -169.02 163.5 11.3 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.6 mm -76.1 135.22 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.44 163.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 123.92 0.888 . . . . 0.0 109.759 174.126 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.01 154.85 40.33 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.788 0.804 . . . . 0.0 110.446 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -94.41 138.24 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 167.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.58 -170.53 43.66 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -55.91 -45.5 38.25 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.298 2.666 . . . . 0.0 111.907 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -53.59 -52.33 60.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.043 0.925 . . . . 0.0 110.732 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -42.67 91.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.794 0.838 . . . . 0.0 110.083 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -54.1 -51.98 62.46 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.478 -0.773 . . . . 0.0 109.752 172.686 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -50.48 -50.96 51.18 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.915 0.779 . . . . 0.0 110.865 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.3 mt -58.42 -49.09 78.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.96 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.91 -37.01 75.92 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 122.108 -0.37 . . . . 0.0 112.238 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -73.96 -45.37 50.64 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.24 -48.32 65.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.03 0.932 . . . . 0.0 110.876 169.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.26 -53.44 58.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.574 0.702 . . . . 0.0 110.369 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.0 t -61.42 -38.47 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.632 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.55 -48.63 76.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.924 0.89 . . . . 0.0 109.974 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.77 -49.82 72.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.996 0.918 . . . . 0.0 108.727 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.22 -44.29 95.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.376 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -62.42 -44.7 95.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.228 1.011 . . . . 0.0 109.795 175.232 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -58.62 -47.81 83.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.486 0.714 . . . . 0.0 109.892 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.01 -39.53 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.58 22.83 61.39 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.73 1.157 . . . . 0.0 110.474 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -60.79 -33.64 73.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 117.651 0.726 . . . . 0.0 111.312 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -116.01 32.03 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.446 1.098 . . . . 0.0 109.591 174.427 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.7 -151.96 46.2 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -87.56 135.0 33.53 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.136 0.575 . . . . 0.0 109.636 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.6 mt -127.99 133.42 49.17 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.132 0.973 . . . . 0.0 109.319 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.2 m -99.68 97.6 8.54 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.523 1.129 . . . . 0.0 108.321 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -50.21 132.94 24.06 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 123.466 0.706 . . . . 0.0 111.074 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -98.94 -65.11 0.98 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 168.701 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -172.26 167.63 5.79 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 123.451 0.7 . . . . 0.0 110.11 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.24 142.48 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 124.432 1.093 . . . . 0.0 109.09 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.98 177.0 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.281 0.632 . . . . 0.0 110.251 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -63.13 153.26 81.96 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.654 0.782 . . . . 0.0 112.716 -172.374 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -83.12 169.63 57.53 Favored 'Cis proline' 0 N--CA 1.45 -1.047 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 -7.895 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.9 t -132.97 97.8 4.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 168.179 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 126.78 33.61 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.47 1.508 . . . . 0.0 107.765 -174.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -114.01 113.77 25.24 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 118.093 -0.956 . . . . 0.0 108.652 168.539 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -114.37 141.47 47.59 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.606 1.162 . . . . 0.0 111.158 173.864 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.5 142.25 46.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.778 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.69 120.18 62.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.392 1.091 . . . . 0.0 109.251 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -151.59 178.04 9.73 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -87.99 -128.12 0.06 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -159.68 -41.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.708 0.686 . . . . 0.0 112.254 168.801 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -23.57 97.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.755 2.422 . . . . 0.0 113.884 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.41 43.21 84.97 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.355 0.502 . . . . 0.0 113.221 175.87 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.8 t80 73.04 60.18 0.1 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.663 1.585 . . . . 0.0 109.904 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -59.9 149.55 31.3 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.582 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.31 148.12 52.32 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.138 0.975 . . . . 0.0 110.063 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.41 128.73 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.16 -35.38 14.58 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.31 -152.25 9.21 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -148.42 159.72 43.75 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.584 1.554 . . . . 0.0 107.818 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -126.93 142.74 51.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.147 1.779 . . . . 0.0 108.358 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -126.9 105.63 8.76 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -106.16 117.77 34.88 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -175.384 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 pp -149.64 146.44 27.29 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.897 0.771 . . . . 0.0 111.974 -166.818 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -88.51 112.69 23.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 p -106.39 138.6 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.101 0.961 . . . . 0.0 109.523 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -103.54 123.12 46.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.133 1.773 . . . . 0.0 106.966 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.45 132.09 25.57 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t 46.77 41.48 10.4 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.447 1.099 . . . . 0.0 111.331 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.4 t70 62.45 19.47 11.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.11 1.364 . . . . 0.0 113.343 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -113.94 135.15 54.31 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.809 1.243 . . . . 0.0 107.873 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.51 126.81 37.76 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.4 143.39 50.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.934 1.294 . . . . 0.0 108.748 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -85.32 110.48 19.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.55 126.69 38.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -108.0 111.23 23.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.973 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -100.59 150.74 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.9 p -127.62 154.27 45.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.47 0.708 . . . . 0.0 109.198 176.83 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -123.33 135.97 54.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.92 120.98 40.95 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.161 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -67.31 -33.49 75.39 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.7 -0.625 . . . . 0.0 110.703 -172.947 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.062 0.945 . . . . 0.0 111.209 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -90.61 -22.95 20.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.084 0.554 . . . . 0.0 110.243 175.783 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 65.17 33.73 9.13 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.782 1.233 . . . . 0.0 110.233 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.18 155.74 15.95 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.3 mtt85 -115.13 163.74 15.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 117.446 0.623 . . . . 0.0 111.285 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 152.39 16.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.275 1.43 . . . . 0.0 111.331 177.528 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 tp -69.63 127.56 33.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.634 1.174 . . . . 0.0 109.845 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.69 -54.78 5.33 Favored 'General case' 0 C--N 1.337 0.041 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -170.44 169.05 7.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 111.197 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -131.87 88.44 2.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.288 1.835 . . . . 0.0 108.166 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.65 145.7 27.86 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.65 -159.85 24.63 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -65.42 157.05 77.35 Favored 'Cis proline' 0 N--CA 1.458 -0.559 0 CA-C-N 118.808 1.304 . . . . 0.0 110.071 -1.993 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.97 148.72 68.5 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.459 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.74 162.95 36.72 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.361 2.041 . . . . 0.0 108.722 168.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.4 153.96 75.29 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.689 1.593 . . . . 0.0 109.181 169.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.529 2.153 . . . . 0.0 110.851 177.205 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 . . . . . 0 N--CA 1.464 0.256 0 N-CA-C 109.536 -0.542 . . . . 0.0 109.536 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.4 mm -84.28 143.32 12.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 pt -104.99 154.84 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.637 0.775 . . . . 0.0 110.825 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.48 118.58 12.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.849 0.86 . . . . 0.0 109.388 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.45 129.13 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 172.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.01 -167.15 39.53 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -50.97 -41.73 55.1 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.711 2.941 . . . . 0.0 112.857 -174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -53.85 -60.75 2.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.648 0.779 . . . . 0.0 111.64 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -63.09 -43.55 98.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.617 -0.677 . . . . 0.0 110.082 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -51.03 -53.46 33.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -53.13 -49.71 65.99 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.451 0.7 . . . . 0.0 111.34 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 mt -63.98 -45.08 90.63 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.644 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.63 -43.47 96.19 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -57.23 -53.4 58.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.034 0.934 . . . . 0.0 108.872 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -53.6 -45.04 69.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.881 1.272 . . . . 0.0 110.829 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.87 -51.88 67.33 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.908 0.385 . . . . 0.0 110.585 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.12 -39.48 84.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.468 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.01 -47.58 84.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.955 0.902 . . . . 0.0 110.195 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -58.71 -53.98 52.23 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.048 0.939 . . . . 0.0 109.095 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -54.08 -48.18 70.92 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.987 0.515 . . . . 0.0 110.116 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -60.95 -44.24 97.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.343 1.457 . . . . 0.0 110.246 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.82 -42.02 96.89 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.678 0.391 . . . . 0.0 110.108 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.3 -43.51 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.58 17.78 59.65 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.983 1.278 . . . . 0.0 111.749 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -57.93 -38.45 75.96 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.7 0.75 . . . . 0.0 111.329 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -118.81 41.72 2.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.812 1.245 . . . . 0.0 109.421 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.51 -141.9 48.03 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -118.51 106.12 12.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.611 1.165 . . . . 0.0 109.2 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.49 151.92 18.88 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.177 0.444 . . . . 0.0 110.854 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.2 m -93.27 96.13 9.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -45.27 130.85 8.14 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 122.465 0.306 . . . . 0.0 110.474 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -105.82 -66.23 1.01 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.928 0.891 . . . . 0.0 109.141 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -165.56 -175.01 3.34 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -124.62 143.02 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.45 167.05 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.097 0.559 . . . . 0.0 110.057 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.04 152.12 72.31 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 122.875 0.47 . . . . 0.0 112.088 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.33 152.01 97.69 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 CA-C-N 119.074 0.705 . . . . 0.0 111.064 -3.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.8 m -138.85 81.07 1.82 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.5 ttm -105.77 138.53 41.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.047 0.539 . . . . 0.0 110.684 -167.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -122.29 144.84 48.75 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.76 1.624 . . . . 0.0 109.69 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -141.11 141.75 34.18 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.061 0.944 . . . . 0.0 109.7 169.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.5 t -63.86 142.39 58.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.625 0.37 . . . . 0.0 110.311 168.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.05 126.11 72.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.005 1.322 . . . . 0.0 110.27 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 . . . . . 0 N--CA 1.452 -0.356 0 C-N-CA 124.931 1.292 . . . . 0.0 110.08 177.418 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.3 mt . . . . . 0 CA--C 1.532 0.261 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -117.92 -33.72 4.39 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.502 0.592 . . . . 0.0 111.655 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.93 -154.02 11.09 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.206 -170.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.67 161.24 39.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.087 1.355 . . . . 0.0 108.185 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -125.0 151.1 45.98 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.482 1.113 . . . . 0.0 109.28 169.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -134.76 118.32 16.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.616 1.566 . . . . 0.0 107.58 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.58 111.65 24.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.775 1.23 . . . . 0.0 107.842 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 pp -138.52 154.29 48.77 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 122.791 0.437 . . . . 0.0 111.516 -172.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -103.07 104.55 14.73 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.214 1.006 . . . . 0.0 109.312 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.55 133.56 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.558 1.543 . . . . 0.0 110.102 -175.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.78 123.28 41.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.433 1.493 . . . . 0.0 108.476 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.51 130.63 26.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.4 m 50.45 40.28 22.74 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.419 1.088 . . . . 0.0 111.584 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t0 50.11 32.66 6.1 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.884 1.274 . . . . 0.0 112.972 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -119.07 129.79 55.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.3 tp -94.66 125.65 39.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -124.62 149.5 47.02 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 125.313 1.445 . . . . 0.0 108.17 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -92.15 123.64 35.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.65 133.08 54.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -107.4 122.01 45.75 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mm -113.27 146.19 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.098 1.759 . . . . 0.0 106.82 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 154.47 25.5 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -130.95 115.47 16.56 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.643 1.977 . . . . 0.0 106.669 169.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.93 124.42 33.12 Favored 'General case' 0 CA--C 1.526 0.03 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -58.34 -49.26 77.82 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.659 0.784 . . . . 0.0 111.063 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -68.89 -51.73 37.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.535 0.734 . . . . 0.0 110.777 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -62.86 -34.0 76.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 64.04 34.69 11.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.202 1.401 . . . . 0.0 109.933 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.33 143.71 14.68 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.11 165.31 12.89 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 122.795 0.438 . . . . 0.0 110.654 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.13 152.87 19.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.176 0.59 . . . . 0.0 111.299 170.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -71.67 118.64 14.76 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 mt -75.57 -50.87 14.29 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 167.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -156.73 160.67 39.52 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.897 0.317 . . . . 0.0 111.145 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -135.75 101.22 4.69 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.142 1.777 . . . . 0.0 107.074 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -105.8 152.29 23.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.928 0.891 . . . . 0.0 109.086 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 134.59 -168.03 23.69 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo . . . . . 0 N--CA 1.457 -0.673 0 CA-C-N 118.24 1.02 . . . . 0.0 111.167 2.966 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 . . . . . 0 C--O 1.233 0.189 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.42 HD12 ' H ' ' A' ' 5' ' ' ILE . 4.7 mp -78.72 138.57 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 pt -106.46 154.32 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.322 1.049 . . . . 0.0 109.833 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.66 145.41 55.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.207 0.603 . . . . 0.0 109.814 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.2 pt -83.3 122.43 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.14 -165.23 31.6 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.41 -41.77 72.79 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.942 2.428 . . . . 0.0 112.282 -172.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -58.87 -49.29 78.31 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.809 0.814 . . . . 0.0 110.91 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -47.54 82.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.859 1.264 . . . . 0.0 109.688 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -54.52 -49.28 70.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.107 0.563 . . . . 0.0 110.054 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -55.92 -48.58 75.44 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.715 0.806 . . . . 0.0 110.499 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -56.15 -46.54 79.21 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.992 -0.442 . . . . 0.0 110.949 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.76 -56.32 25.77 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -51.71 -50.45 60.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.668 1.587 . . . . 0.0 109.822 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -55.08 -50.34 69.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.884 1.273 . . . . 0.0 110.75 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.29 -50.37 71.61 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.85 -39.83 86.84 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.478 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.93 -49.78 73.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.28 1.032 . . . . 0.0 109.544 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.43 -53.84 52.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.033 0.933 . . . . 0.0 108.897 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.4 -41.05 84.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.474 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -70.46 -39.46 74.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.459 1.503 . . . . 0.0 110.136 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -60.52 -45.99 91.81 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.279 0.632 . . . . 0.0 109.363 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.66 -40.47 89.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 171.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.05 19.88 58.47 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.44 1.495 . . . . 0.0 110.896 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -61.49 -35.7 78.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.858 0.829 . . . . 0.0 111.152 -170.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -118.87 39.97 3.39 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.804 0.842 . . . . 0.0 109.337 171.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.51 -141.29 44.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -101.92 93.72 5.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.58 1.152 . . . . 0.0 109.629 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.2 mt -80.72 139.99 35.81 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.197 0.453 . . . . 0.0 110.02 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.2 m -94.0 90.13 6.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.508 1.123 . . . . 0.0 108.49 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -51.42 132.7 29.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 122.188 -0.32 . . . . 0.0 111.458 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -104.07 -66.09 0.98 Allowed 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 123.544 0.738 . . . . 0.0 109.193 169.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -164.93 -168.59 1.48 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.151 0.58 . . . . 0.0 109.593 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.9 145.45 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.7 pt -133.62 173.42 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.351 0.66 . . . . 0.0 110.22 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 152.6 82.47 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 123.893 0.877 . . . . 0.0 110.795 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.07 151.83 96.34 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 N-CA-C 110.452 -0.634 . . . . 0.0 110.452 -5.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.4 m -138.9 90.36 2.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.1 ttt -111.31 138.43 47.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.406 0.682 . . . . 0.0 110.57 -169.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -116.23 149.78 38.59 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.642 1.177 . . . . 0.0 108.492 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.5 tmtp? -149.49 151.29 33.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.599 0.76 . . . . 0.0 111.205 166.964 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 m -85.43 127.94 34.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.243 1.817 . . . . 0.0 111.586 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -99.44 136.29 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.486 1.515 . . . . 0.0 109.369 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 . . . . . 0 CA--C 1.529 0.148 0 C-N-CA 126.061 1.744 . . . . 0.0 109.985 -179.408 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.8 mt . . . . . 0 CA--C 1.53 0.186 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -115.61 -31.85 5.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.677 1.191 . . . . 0.0 110.592 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.01 -158.91 20.79 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -144.73 158.65 43.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.83 1.252 . . . . 0.0 108.217 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -114.19 153.54 29.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.211 1.404 . . . . 0.0 108.631 168.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -136.42 117.21 14.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -110.47 113.88 26.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 pp -146.2 146.03 30.66 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.153 0.433 . . . . 0.0 111.726 -170.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -89.18 99.74 12.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.516 0.726 . . . . 0.0 109.242 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.7 t -81.65 132.4 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.941 1.696 . . . . 0.0 109.013 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.34 114.63 29.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.489 1.516 . . . . 0.0 107.617 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.06 130.95 26.05 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.103 0.961 . . . . 0.0 108.676 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.0 t 50.67 39.23 21.17 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.461 1.104 . . . . 0.0 111.861 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.3 t0 53.25 33.93 16.55 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.316 1.046 . . . . 0.0 112.523 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -122.68 138.63 54.55 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 168.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.0 tp -105.32 127.08 52.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -132.76 143.93 49.92 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 125.137 1.375 . . . . 0.0 108.636 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -82.35 116.16 21.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.6 132.76 43.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -110.47 125.28 53.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.98 152.91 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 125.372 1.469 . . . . 0.0 107.28 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.7 m -119.08 149.83 41.02 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.15 0.98 . . . . 0.0 109.151 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.04 122.4 37.16 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 168.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.46 120.63 38.19 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.02 -53.0 62.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.203 1.001 . . . . 0.0 110.767 -170.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -58.62 -48.02 82.38 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.124 0.569 . . . . 0.0 110.111 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 m -71.92 -20.24 61.8 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.629 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 43.14 45.59 4.77 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 125.969 1.707 . . . . 0.0 111.091 -171.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -140.8 155.33 24.84 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.8 mtt85 -114.95 171.28 7.75 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.306 0.642 . . . . 0.0 110.841 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -155.35 146.95 23.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.298 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.4 tp -71.58 119.09 15.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.83 -50.91 18.17 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -168.95 156.83 7.62 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -171.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -133.53 89.11 2.55 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.641 1.576 . . . . 0.0 107.476 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -98.4 138.27 35.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -170.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.43 -167.07 32.4 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.254 -0.748 . . . . 0.0 111.473 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo . . . . . 0 N--CA 1.457 -0.637 0 CA-C-N 118.05 0.925 . . . . 0.0 111.113 2.123 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 . . . . . 0 N--CA 1.456 -0.161 0 N-CA-C 108.868 -0.789 . . . . 0.0 108.868 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.6 144.19 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.6 pt -119.5 164.81 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.745 0.702 . . . . 0.0 110.377 169.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.61 141.85 51.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 110.461 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -88.54 120.52 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.2 -165.37 25.49 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -54.98 -44.56 48.51 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.196 2.597 . . . . 0.0 112.516 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -48.96 -58.44 4.87 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.232 1.015 . . . . 0.0 110.913 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -43.52 92.48 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.31 1.044 . . . . 0.0 109.808 -172.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -56.5 -49.84 73.55 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.354 1.062 . . . . 0.0 109.801 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -53.92 -52.18 61.4 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.395 0.543 . . . . 0.0 110.44 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -59.98 -44.58 94.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.729 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.33 -44.49 93.43 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -64.29 -50.53 67.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -50.46 -47.57 56.85 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.508 1.123 . . . . 0.0 110.914 173.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -52.83 63.78 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 110.152 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.5 -39.08 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.464 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.0 -49.65 75.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.349 0.66 . . . . 0.0 110.162 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -57.12 -50.26 73.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.84 0.856 . . . . 0.0 109.022 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -55.24 -51.23 67.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.45 0.7 . . . . 0.0 109.472 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -60.49 -40.36 91.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.536 1.135 . . . . 0.0 110.591 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -59.52 -42.65 92.71 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.6 mt -67.45 -44.22 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.91 22.74 57.23 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.041 1.305 . . . . 0.0 111.295 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.8 -38.87 86.83 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.79 0.795 . . . . 0.0 110.715 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -108.35 34.76 3.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.73 1.212 . . . . 0.0 109.978 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.52 -141.04 44.79 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -100.17 91.83 4.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.398 1.079 . . . . 0.0 109.783 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.28 173.21 10.51 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 168.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 m -138.25 102.49 4.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -51.94 134.26 31.79 Favored 'General case' 0 CA--C 1.524 -0.046 0 C-N-CA 122.838 0.455 . . . . 0.0 110.377 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -103.2 -63.18 1.2 Allowed 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -173.43 174.58 3.24 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.141 1.376 . . . . 0.0 108.711 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.66 150.12 14.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 124.489 1.116 . . . . 0.0 108.779 173.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.9 pt -138.26 168.37 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.067 0.547 . . . . 0.0 110.439 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . 0.426 ' CD ' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -62.17 154.43 70.21 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 170.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.28 150.15 95.23 Favored 'Cis proline' 0 N--CA 1.458 -0.581 0 CA-C-N 119.193 0.748 . . . . 0.0 111.012 -3.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.1 t -140.87 102.2 4.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -121.33 141.56 50.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.708 1.203 . . . . 0.0 109.682 -166.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -126.56 158.77 35.34 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.792 0.837 . . . . 0.0 111.269 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -147.35 152.74 38.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.31 1.444 . . . . 0.0 108.334 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.3 m -85.04 137.69 32.9 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.709 0.803 . . . . 0.0 109.954 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.88 129.72 64.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.942 1.297 . . . . 0.0 110.196 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 . . . . . 0 N--CA 1.448 -0.528 0 C-N-CA 125.697 1.599 . . . . 0.0 108.863 -177.049 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.9 mt . . . . . 0 CA--C 1.529 0.159 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -109.18 -25.8 10.44 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.992 0.36 . . . . 0.0 110.825 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.16 -163.51 28.84 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.638 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -142.45 156.16 45.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -120.83 142.4 49.66 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.006 1.322 . . . . 0.0 107.45 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -131.02 108.35 9.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.385 1.874 . . . . 0.0 106.745 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -105.08 123.11 47.25 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.116 1.767 . . . . 0.0 108.747 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.71 164.84 36.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -104.69 113.69 27.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.165 0.986 . . . . 0.0 110.898 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.44 130.1 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.558 1.543 . . . . 0.0 108.223 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -92.77 120.44 33.15 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.28 131.95 24.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.398 1.079 . . . . 0.0 108.119 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 t 49.76 45.45 24.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.219 1.008 . . . . 0.0 110.129 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 p30 53.34 17.76 1.14 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.361 1.864 . . . . 0.0 115.459 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -116.29 151.7 35.31 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.36 127.24 42.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -127.8 136.68 51.8 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.347 1.459 . . . . 0.0 108.444 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -85.3 137.37 33.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.03 139.53 53.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -115.83 114.99 25.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 168.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.88 145.0 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 m -119.38 144.25 47.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -113.04 129.43 56.5 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.8 2.04 . . . . 0.0 107.014 170.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -92.49 125.56 37.18 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -58.54 -43.55 89.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.373 1.069 . . . . 0.0 111.372 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -70.66 -48.65 53.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.1 m -67.74 -31.48 71.42 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.364 0.266 . . . . 0.0 111.263 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 55.41 41.01 31.44 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.235 1.014 . . . . 0.0 109.602 -169.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.1 155.62 25.62 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 -114.95 171.46 7.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.407 0.683 . . . . 0.0 112.28 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -162.56 148.7 12.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.107 1.763 . . . . 0.0 110.594 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.5 tp -68.1 134.87 51.28 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.7 tp -106.33 -64.54 1.16 Allowed 'General case' 0 C--N 1.338 0.076 0 C-N-CA 123.238 0.615 . . . . 0.0 109.779 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.14 146.47 45.94 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -136.71 130.94 32.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -145.03 155.21 43.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 126.89 -164.59 20.41 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo . . . . . 0 N--CA 1.454 -0.81 0 CA-C-N 118.797 1.299 . . . . 0.0 109.91 -6.755 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.226 -0.156 0 N-CA-C 109.562 -0.532 . . . . 0.0 109.562 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.418 HD12 ' H ' ' A' ' 5' ' ' ILE . 3.3 mp -86.73 139.37 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.5 pt -101.04 151.35 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.403 0.681 . . . . 0.0 110.221 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -71.96 128.22 35.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.75 132.39 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 168.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.85 -172.34 44.58 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -53.65 -44.87 45.35 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.701 2.934 . . . . 0.0 112.677 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -50.16 -57.35 7.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.269 1.033 . . . . 0.0 110.853 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.02 -41.11 95.58 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.533 1.133 . . . . 0.0 109.81 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -58.12 -45.98 86.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.085 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -58.11 -46.8 84.94 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.6 0.637 . . . . 0.0 110.748 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.7 mt -58.22 -41.89 85.09 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.942 -0.474 . . . . 0.0 111.17 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.31 -58.31 15.23 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -44.12 -52.57 7.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.888 0.875 . . . . 0.0 111.616 172.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -55.59 -49.71 72.03 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.047 0.939 . . . . 0.0 110.808 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.92 69.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.73 -40.49 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.423 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.62 -50.29 71.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.09 0.956 . . . . 0.0 110.225 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -61.66 -47.49 85.13 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.138 0.975 . . . . 0.0 109.318 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -56.98 -49.8 74.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.497 0.319 . . . . 0.0 110.24 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -56.88 -43.42 81.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.464 1.106 . . . . 0.0 110.143 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -59.7 -39.92 86.17 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.2 mt -67.71 -45.53 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.48 18.03 57.65 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.174 1.369 . . . . 0.0 111.584 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -57.95 -39.88 79.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.702 0.751 . . . . 0.0 111.251 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.24 41.48 2.12 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.172 0.989 . . . . 0.0 109.62 172.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.17 -142.11 45.64 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -122.76 93.35 3.94 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.955 0.902 . . . . 0.0 109.079 -170.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp -85.53 -169.96 2.89 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.773 0.797 . . . . 0.0 109.392 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.9 m -145.23 124.74 13.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 172.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.57 140.07 42.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.626 0.371 . . . . 0.0 111.164 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -111.4 -64.29 1.3 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.648 0.779 . . . . 0.0 109.504 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.37 -179.92 4.16 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.097 0.959 . . . . 0.0 109.595 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.84 143.32 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.6 165.44 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.809 0.444 . . . . 0.0 110.236 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 158.53 79.54 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.113 0.965 . . . . 0.0 111.697 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.21 152.84 91.31 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 CA-C-N 119.468 0.846 . . . . 0.0 111.756 -9.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 76.4 m -138.79 100.25 4.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.8 ttt -118.27 142.44 47.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.321 0.648 . . . . 0.0 111.432 -167.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -120.97 143.12 49.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.409 2.284 . . . . 0.0 109.067 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -144.92 147.94 33.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.726 1.61 . . . . 0.0 110.123 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.49 134.66 35.56 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.778 1.631 . . . . 0.0 110.508 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -112.79 127.5 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.73 1.212 . . . . 0.0 110.816 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 . . . . . 0 CA--C 1.528 0.132 0 C-N-CA 125.197 1.399 . . . . 0.0 111.759 -176.942 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.3 mt . . . . . 0 N--CA 1.454 -0.227 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -96.13 -27.91 14.83 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.59 -158.89 21.6 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -145.9 159.48 43.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.007 1.323 . . . . 0.0 107.699 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -124.57 135.58 53.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 125.599 1.559 . . . . 0.0 108.773 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.97 106.33 9.55 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.866 1.666 . . . . 0.0 107.519 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -94.53 124.11 38.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.303 1.041 . . . . 0.0 108.716 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.0 153.33 39.92 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.282 0.492 . . . . 0.0 111.023 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -95.28 105.04 16.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 123.983 0.913 . . . . 0.0 109.542 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.81 124.99 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.357 1.063 . . . . 0.0 109.729 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -79.8 117.21 20.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.28 122.86 40.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.032 1.333 . . . . 0.0 108.418 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t 72.37 -60.85 0.52 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 130.041 3.336 . . . . 0.0 108.327 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -177.1 0.23 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.757 2.823 . . . . 0.0 111.798 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -111.31 144.16 40.95 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.31 122.64 34.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.568 0.747 . . . . 0.0 109.147 -173.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -118.43 141.74 48.25 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 124.301 1.041 . . . . 0.0 109.179 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -86.53 104.24 15.8 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.778 1.231 . . . . 0.0 107.707 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.41 127.07 49.59 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -103.3 106.75 17.34 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.54 122.63 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.0 m -96.18 156.65 16.25 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 170.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -128.72 123.47 33.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.869 1.268 . . . . 0.0 107.796 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -96.08 113.02 24.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.513 1.125 . . . . 0.0 107.984 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -60.7 -27.17 67.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.172 0.589 . . . . 0.0 111.167 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -58.89 -24.66 62.55 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.607 0.763 . . . . 0.0 112.411 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.2 m -144.95 16.29 1.57 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.62 -0.675 . . . . 0.0 111.415 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 52.4 38.9 26.42 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.368 1.067 . . . . 0.0 111.021 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.58 138.31 14.88 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -102.75 167.64 9.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.724 0.762 . . . . 0.0 112.477 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.77 130.83 1.05 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.282 -168.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.5 tp -71.12 116.27 11.22 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.5 -56.74 3.01 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 123.352 0.661 . . . . 0.0 110.258 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -127.5 141.76 51.57 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -138.0 91.08 2.54 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -107.33 160.75 15.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -173.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.18 -163.97 12.13 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo . . . . . 0 N--CA 1.454 -0.817 0 CA-C-N 118.807 1.303 . . . . 0.0 110.479 3.138 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 N--CA 1.462 0.151 0 CA-C-O 120.312 0.101 . . . . 0.0 110.733 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mt -76.55 139.87 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.8 pt -110.06 156.78 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 123.178 0.591 . . . . 0.0 110.074 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.51 131.35 48.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.916 0.887 . . . . 0.0 109.777 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.29 120.99 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.15 -165.88 29.13 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -172.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -54.12 -45.65 39.41 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.806 3.004 . . . . 0.0 112.649 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -47.24 -56.84 5.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.654 1.181 . . . . 0.0 110.909 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -39.94 82.46 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.153 1.381 . . . . 0.0 110.005 -174.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -50.76 -53.21 33.61 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.779 1.631 . . . . 0.0 109.956 170.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -54.61 -48.86 71.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.666 0.387 . . . . 0.0 111.092 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.8 mt -63.87 -41.49 97.74 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.406 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.17 -51.24 55.4 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -54.13 -59.36 4.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.768 0.827 . . . . 0.0 110.708 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -49.84 -44.28 49.36 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.265 0.626 . . . . 0.0 111.624 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.36 70.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.896 0.379 . . . . 0.0 110.229 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.41 -43.4 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.145 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.18 -46.08 89.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.881 0.872 . . . . 0.0 109.971 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -63.98 -49.72 71.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.076 0.95 . . . . 0.0 109.376 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -57.44 -43.44 83.88 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.751 -0.593 . . . . 0.0 110.954 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -63.85 -39.51 94.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.871 1.268 . . . . 0.0 110.684 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -61.48 -43.77 98.27 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.395 0.678 . . . . 0.0 109.239 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.61 -40.17 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.1 20.62 58.84 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.336 1.446 . . . . 0.0 110.167 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.79 -35.95 75.7 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 117.404 0.602 . . . . 0.0 111.105 -168.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.46 33.87 5.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.084 0.953 . . . . 0.0 109.815 175.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.25 -145.37 49.57 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -171.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -106.46 88.5 2.79 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.525 1.13 . . . . 0.0 108.975 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -70.13 153.86 42.63 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.3 m -109.07 102.26 11.26 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -52.29 144.72 12.26 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.655 0.382 . . . . 0.0 110.446 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -120.84 -66.19 1.08 Allowed 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.901 0.48 . . . . 0.0 110.205 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 166.82 27.14 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 117.812 0.278 . . . . 0.0 110.452 175.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -91.62 150.23 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.194 0.998 . . . . 0.0 108.591 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -144.55 174.96 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.832 0.853 . . . . 0.0 109.195 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.49 154.79 85.77 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.632 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.02 157.32 97.28 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 119.67 0.918 . . . . 0.0 111.246 -4.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.3 t -153.98 93.88 1.69 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.716 0.806 . . . . 0.0 109.395 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -102.92 154.76 18.89 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.467 1.507 . . . . 0.0 110.546 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -133.79 143.49 48.43 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.42 1.488 . . . . 0.0 109.271 170.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.1 tmtp? -147.1 144.98 29.44 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.608 0.763 . . . . 0.0 111.598 169.09 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -65.34 139.04 58.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.862 1.265 . . . . 0.0 111.684 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.81 127.21 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.193 1.397 . . . . 0.0 108.443 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.7 p90 . . . . . 0 N--CA 1.455 -0.2 0 O-C-N 121.505 -0.747 . . . . 0.0 110.878 -163.813 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.8 mt . . . . . 0 CA--C 1.529 0.156 0 N-CA-C 109.276 -0.639 . . . . 0.0 109.276 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -117.3 -21.14 8.87 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.153 0.581 . . . . 0.0 111.663 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.79 -167.71 33.82 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -130.03 164.9 23.31 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.17 144.79 50.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.64 1.576 . . . . 0.0 107.193 168.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -130.52 133.9 46.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -130.62 112.57 13.26 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -148.64 160.08 43.48 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.205 0.457 . . . . 0.0 112.203 -166.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.28 140.31 37.57 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 123.643 0.777 . . . . 0.0 110.528 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.17 133.09 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.819 1.647 . . . . 0.0 109.147 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.75 119.2 25.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.15 130.69 37.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t 51.27 41.41 27.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.461 1.105 . . . . 0.0 111.526 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 t0 49.3 35.74 8.24 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.87 1.668 . . . . 0.0 112.499 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -127.97 142.03 51.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 tp -87.37 117.0 25.85 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -113.96 155.12 26.41 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.735 0.814 . . . . 0.0 108.862 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -108.88 138.47 45.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.461 1.104 . . . . 0.0 108.223 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.04 137.81 46.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.977 0.911 . . . . 0.0 109.343 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -114.04 116.78 29.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 mm -109.26 155.11 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 126.373 1.869 . . . . 0.0 106.406 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.84 164.57 22.78 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 118.516 0.598 . . . . 0.0 109.517 167.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.65 138.89 52.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.152 2.181 . . . . 0.0 106.557 170.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.04 114.59 28.62 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.209 1.403 . . . . 0.0 107.298 174.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -56.44 -36.29 68.84 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.194 0.998 . . . . 0.0 111.452 -171.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -53.58 -23.6 11.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.62 1.568 . . . . 0.0 113.339 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -143.14 15.35 1.88 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.643 -0.661 . . . . 0.0 110.844 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 48.28 32.47 3.17 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.626 0.77 . . . . 0.0 111.023 -170.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.63 129.66 9.99 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -171.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -100.19 166.64 10.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.699 0.75 . . . . 0.0 112.694 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.35 140.09 4.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.405 -169.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.03 121.73 14.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 168.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mt -85.56 -60.2 2.09 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -145.03 154.96 43.07 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.329 0.652 . . . . 0.0 109.25 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -131.32 150.47 52.14 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -156.01 163.91 39.12 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.63 0.772 . . . . 0.0 109.288 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.93 -162.91 12.27 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo . . . . . 0 N--CA 1.453 -0.89 0 CA-C-N 118.75 1.275 . . . . 0.0 110.027 -2.801 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 . . . . . 0 N--CA 1.453 -0.318 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.3 mm -81.87 138.15 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.5 pt -101.4 155.66 4.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.178 0.591 . . . . 0.0 110.553 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.06 148.82 50.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.79 132.34 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 C-N-CA 125.017 1.327 . . . . 0.0 108.224 169.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.89 -168.97 39.6 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 108.269 -1.933 . . . . 0.0 108.269 -174.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.5 -43.29 59.56 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.446 2.764 . . . . 0.0 112.153 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -51.88 -57.42 9.42 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 122.004 0.907 . . . . 0.0 111.286 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -45.49 89.76 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.269 1.028 . . . . 0.0 109.964 -173.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -49.99 -58.31 5.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 118.36 -0.829 . . . . 0.0 108.923 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -49.34 -46.18 46.54 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.73 0.812 . . . . 0.0 111.013 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.32 -51.64 65.19 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.605 -0.684 . . . . 0.0 111.751 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.23 83.32 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 122.396 0.998 . . . . 0.0 112.414 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.73 -57.93 6.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.473 1.909 . . . . 0.0 106.808 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -47.45 -44.85 25.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.852 1.661 . . . . 0.0 110.417 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.54 -54.14 49.3 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.909 0.385 . . . . 0.0 110.495 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.75 -38.54 76.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 122.817 0.447 . . . . 0.0 111.31 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.86 -46.82 83.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.029 0.931 . . . . 0.0 109.99 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -60.89 -47.32 86.95 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.801 0.84 . . . . 0.0 108.977 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -55.99 -50.81 69.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.017 0.527 . . . . 0.0 109.67 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -57.94 -42.68 85.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.796 1.638 . . . . 0.0 110.209 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.5 -45.95 87.7 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.098 0.559 . . . . 0.0 110.19 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.6 mt -64.68 -42.96 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.53 18.55 65.96 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.988 1.28 . . . . 0.0 111.018 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -55.23 -41.61 72.32 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 117.762 0.781 . . . . 0.0 111.0 -173.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.54 25.95 11.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.397 1.079 . . . . 0.0 110.44 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.06 -152.91 46.11 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -117.25 120.68 38.99 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.953 1.301 . . . . 0.0 108.148 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.87 156.95 30.87 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.446 0.698 . . . . 0.0 111.805 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 m -97.56 95.89 7.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -45.3 132.14 7.75 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -101.02 -68.5 0.81 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -168.61 165.11 12.33 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -171.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -102.58 141.59 18.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 124.67 1.188 . . . . 0.0 108.109 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.54 172.3 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.488 0.715 . . . . 0.0 110.012 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.73 154.99 83.88 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.722 0.809 . . . . 0.0 111.405 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.56 158.23 98.66 Favored 'Cis proline' 0 N--CA 1.455 -0.755 0 N-CA-C 110.373 -0.664 . . . . 0.0 110.373 -4.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 77.0 m -141.79 91.31 2.35 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.26 127.84 53.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.306 1.042 . . . . 0.0 110.28 -168.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -102.68 145.31 29.87 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.705 0.802 . . . . 0.0 110.018 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -148.34 141.74 25.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.184 0.594 . . . . 0.0 110.237 166.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.5 m -58.49 134.61 56.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.577 0.751 . . . . 0.0 110.453 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 tp -115.61 127.68 73.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.632 1.173 . . . . 0.0 108.614 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.1 p90 . . . . . 0 N--CA 1.447 -0.596 0 C-N-CA 123.3 0.64 . . . . 0.0 110.115 -169.74 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.1 mt . . . . . 0 N--CA 1.455 -0.21 0 N-CA-C 109.092 -0.707 . . . . 0.0 109.092 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.16 -39.62 14.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.58 -152.11 9.78 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -172.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.16 152.95 42.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.966 1.306 . . . . 0.0 107.662 174.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.9 155.98 21.01 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.763 1.225 . . . . 0.0 108.875 170.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -138.27 102.72 4.73 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.511 1.924 . . . . 0.0 106.239 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 126.62 38.56 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 pp -152.24 153.55 33.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.308 0.503 . . . . 0.0 112.078 -172.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -85.88 118.19 25.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.51 125.84 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.009 1.324 . . . . 0.0 108.793 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -92.17 123.03 35.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.58 130.15 21.36 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t 51.85 37.04 19.63 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.766 0.826 . . . . 0.0 111.201 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.0 t70 64.25 12.79 7.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.774 1.23 . . . . 0.0 113.249 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -109.82 147.35 33.46 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.52 1.128 . . . . 0.0 107.995 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.53 112.74 24.7 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.983 1.313 . . . . 0.0 107.609 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.49 162.5 17.49 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.282 1.033 . . . . 0.0 108.324 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -112.56 128.22 56.3 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.26 134.95 54.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -112.21 107.86 16.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mp -97.6 151.6 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.6 m -128.98 152.71 48.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 169.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -117.35 125.48 51.09 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -87.97 125.36 34.48 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -66.98 -45.59 77.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.818 0.847 . . . . 0.0 110.625 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.78 -43.55 88.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.098 0.559 . . . . 0.0 110.416 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.0 m -69.42 -37.28 77.37 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 60.52 49.43 6.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.457 1.503 . . . . 0.0 108.777 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.87 154.79 26.03 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.94 168.48 9.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.609 0.764 . . . . 0.0 111.928 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -163.72 139.46 6.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.772 1.229 . . . . 0.0 110.869 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 34.7 tp -63.16 122.76 16.92 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 tp -83.27 -57.45 3.26 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.12 152.25 37.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.29 0.636 . . . . 0.0 109.472 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -117.05 134.85 54.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 168.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -134.67 149.36 50.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 130.7 -166.52 22.47 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.35 -0.695 . . . . 0.0 112.061 171.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 0 N--CA 1.456 -0.73 0 C-N-CA 124.752 -0.937 . . . . 0.0 110.045 -1.939 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 . . . . . 0 N--CA 1.457 -0.091 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 5' ' ' ILE . 3.5 mp -88.82 139.12 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.95 161.1 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 123.811 0.845 . . . . 0.0 110.517 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.01 135.63 41.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.667 0.787 . . . . 0.0 110.357 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.59 124.87 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 167.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.05 -167.5 30.6 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -56.76 -44.02 49.12 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.933 2.422 . . . . 0.0 111.602 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -53.94 -52.76 59.59 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.167 0.984 . . . . 0.0 111.043 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -45.37 93.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.19 0.996 . . . . 0.0 109.767 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -60.42 -41.33 93.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.306 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -56.7 -49.86 73.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.012 0.824 . . . . 0.0 110.42 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 15' ' ' LEU . 12.9 mt -57.48 -45.55 84.74 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.805 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.11 -46.55 62.01 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -60.0 -51.77 68.23 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -51.85 -47.16 64.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.054 0.541 . . . . 0.0 111.06 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.03 -50.16 74.38 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.317 0.58 . . . . 0.0 110.326 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.7 -40.75 90.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.098 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.49 -46.87 85.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.219 0.608 . . . . 0.0 110.058 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.91 -54.02 51.32 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.264 1.026 . . . . 0.0 109.041 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -57.29 -48.0 80.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.637 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -57.6 -45.12 85.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.35 1.06 . . . . 0.0 110.094 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.76 -41.37 86.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.569 0.348 . . . . 0.0 110.37 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.3 mt -72.24 -45.38 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.89 15.56 48.53 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.976 1.274 . . . . 0.0 112.838 174.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -53.79 -42.94 68.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.351 1.076 . . . . 0.0 111.963 -175.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.77 33.0 4.46 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.955 0.902 . . . . 0.0 109.707 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.44 -142.07 47.58 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -106.47 120.09 41.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.517 1.127 . . . . 0.0 109.213 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mt -106.73 168.78 8.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.364 1.065 . . . . 0.0 108.546 170.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.2 m -120.67 103.83 9.43 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -46.23 130.09 10.34 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.713 0.233 . . . . 0.0 110.989 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -106.49 -66.87 0.97 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -167.4 -169.39 1.22 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.293 0.637 . . . . 0.0 109.996 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.51 146.4 34.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 125.594 1.557 . . . . 0.0 106.809 174.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.55 166.57 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.358 0.599 . . . . 0.0 110.631 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.33 158.58 81.46 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 125.48 1.512 . . . . 0.0 111.94 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -67.63 148.33 80.79 Favored 'Cis proline' 0 N--CA 1.456 -0.688 0 CA-C-N 118.861 0.629 . . . . 0.0 111.168 -8.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 71.6 m -131.41 94.32 3.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.86 128.55 55.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.721 0.808 . . . . 0.0 109.809 -168.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -104.85 140.8 37.59 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.642 1.177 . . . . 0.0 109.186 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -133.83 152.02 51.73 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.453 1.101 . . . . 0.0 108.969 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 m -82.86 136.93 34.46 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.505 1.122 . . . . 0.0 109.844 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.16 131.87 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.262 1.425 . . . . 0.0 108.771 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.4 p90 . . . . . 0 N--CA 1.448 -0.554 0 C-N-CA 123.33 0.652 . . . . 0.0 109.857 -167.932 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.1 mt . . . . . 0 CA--C 1.533 0.289 0 N-CA-C 110.193 -0.299 . . . . 0.0 110.193 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -81.56 -33.43 31.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.049 0.54 . . . . 0.0 110.792 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.23 -161.74 24.05 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.201 -1.0 . . . . 0.0 112.116 -170.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -147.68 159.6 43.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -121.87 149.19 43.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.978 1.311 . . . . 0.0 108.459 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -132.61 107.76 8.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -97.27 118.18 33.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -146.37 158.71 43.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.808 0.443 . . . . 0.0 111.133 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.99 112.55 24.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.524 0.73 . . . . 0.0 109.579 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -99.88 133.0 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 109.617 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.08 122.36 35.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.441 1.496 . . . . 0.0 107.521 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.6 127.15 28.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.812 0.845 . . . . 0.0 109.395 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t 70.74 -64.17 0.38 Allowed 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 129.593 3.157 . . . . 0.0 108.432 -169.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 179.72 11.09 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.518 3.127 . . . . 0.0 111.207 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -119.55 149.29 42.17 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.923 1.289 . . . . 0.0 107.832 -174.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 tp -106.79 120.98 43.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.45 0.7 . . . . 0.0 109.759 -169.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.4 137.93 54.7 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.738 1.215 . . . . 0.0 108.364 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -94.69 115.82 28.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.25 135.5 54.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.188 0.995 . . . . 0.0 109.559 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.58 103.67 14.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.531 1.132 . . . . 0.0 108.208 169.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.455 HG21 HD22 ' A' ' 15' ' ' LEU . 10.9 mm -91.26 161.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.86 1.664 . . . . 0.0 106.9 176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.6 p -145.6 167.57 22.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.65 0.659 . . . . 0.0 111.438 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -136.52 131.24 33.65 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.553 1.941 . . . . 0.0 108.277 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -98.37 107.86 20.42 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 169.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -53.03 -37.48 61.58 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 124.439 1.096 . . . . 0.0 111.194 -173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -43.07 -40.55 3.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.414 1.886 . . . . 0.0 112.464 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 m -121.54 0.52 9.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.798 0.439 . . . . 0.0 110.99 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 52.77 28.78 6.71 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.686 0.795 . . . . 0.0 109.126 -165.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.99 128.13 9.3 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -168.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -105.88 170.04 8.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.567 0.699 . . . . 0.0 112.36 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -177.58 161.57 1.71 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.044 1.737 . . . . 0.0 112.35 -166.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.1 tp -89.84 138.18 31.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.3 1.44 . . . . 0.0 108.88 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.9 mt -104.47 -58.24 1.91 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.628 0.649 . . . . 0.0 110.245 169.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -136.2 150.56 49.06 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -143.77 106.33 4.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -115.39 147.84 40.05 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.68 -167.5 27.09 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.504 -0.609 . . . . 0.0 111.925 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 N--CA 1.455 -0.739 0 C-N-CA 124.373 -1.095 . . . . 0.0 110.002 -2.573 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 . . . . . 0 N--CA 1.436 -1.159 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mp -99.2 139.38 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.3 pt -103.02 154.23 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 123.842 0.857 . . . . 0.0 109.66 171.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.46 134.21 42.33 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.8 pt -62.27 141.36 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 165.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.66 -169.35 34.5 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -168.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.41 -48.77 17.48 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.427 2.751 . . . . 0.0 112.769 -169.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.37 -55.0 24.54 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.124 0.964 . . . . 0.0 111.066 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -67.37 -44.27 79.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.215 1.006 . . . . 0.0 110.018 -172.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -56.4 -49.25 75.04 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 118.93 -0.557 . . . . 0.0 109.882 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -56.31 -46.47 79.82 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.624 0.647 . . . . 0.0 110.928 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 mt -55.95 -51.87 66.13 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 117.894 0.315 . . . . 0.0 110.515 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.58 -45.07 90.63 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -59.81 -52.12 66.82 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -49.94 -48.48 51.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.731 1.212 . . . . 0.0 110.201 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.58 72.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.49 -39.95 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.776 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.94 -48.75 80.38 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.378 0.671 . . . . 0.0 109.938 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.74 -52.82 63.88 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.077 0.951 . . . . 0.0 109.152 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -54.08 -46.65 72.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.485 1.114 . . . . 0.0 110.315 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -69.65 -42.02 74.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.554 1.542 . . . . 0.0 110.518 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.55 -47.77 84.24 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.321 0.648 . . . . 0.0 109.718 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.32 -41.74 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.8 18.43 51.27 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.633 1.111 . . . . 0.0 112.26 173.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -55.6 -40.81 72.54 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.974 0.887 . . . . 0.0 111.091 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -111.75 33.29 4.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.208 1.003 . . . . 0.0 109.976 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.03 -140.09 45.23 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.91 108.3 19.89 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.538 0.735 . . . . 0.0 109.65 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.8 mt -93.85 141.66 28.26 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 167.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 m -100.74 95.34 6.59 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.227 1.011 . . . . 0.0 108.346 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -51.21 133.82 27.99 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.179 0.592 . . . . 0.0 111.448 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -100.27 -67.41 0.85 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -169.57 -159.5 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.444 1.098 . . . . 0.0 108.533 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.12 141.68 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.15 174.7 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.023 0.529 . . . . 0.0 110.884 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -63.49 153.57 82.36 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.095 1.358 . . . . 0.0 112.889 -170.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.11 159.14 97.18 Favored 'Cis proline' 0 N--CA 1.449 -1.094 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 -7.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -133.91 87.24 2.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.49 140.15 48.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.896 0.878 . . . . 0.0 109.421 -167.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -122.12 162.13 21.84 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.197 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -138.45 147.52 43.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.852 1.661 . . . . 0.0 108.488 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -83.6 130.49 34.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.226 1.01 . . . . 0.0 110.089 172.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.44 120.87 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.665 1.186 . . . . 0.0 108.856 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 p90 . . . . . 0 N--CA 1.455 -0.214 0 O-C-N 121.394 -0.816 . . . . 0.0 111.272 -173.78 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt . . . . . 0 N--CA 1.455 -0.199 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 -20.68 12.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 123.496 0.497 . . . . 0.0 111.069 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.94 -168.59 32.04 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.817 0.735 . . . . 0.0 112.59 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -142.9 157.8 44.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -130.72 145.26 51.9 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.973 1.309 . . . . 0.0 108.353 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -136.86 119.38 15.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.4 1.48 . . . . 0.0 107.878 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -107.86 126.1 52.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.866 1.267 . . . . 0.0 108.291 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pp -145.99 147.96 32.23 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.421 0.288 . . . . 0.0 110.269 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.2 99.48 11.97 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -83.17 134.07 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -102.22 122.78 44.85 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.39 136.04 25.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.77 37.66 24.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.457 1.103 . . . . 0.0 110.89 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 t70 56.63 28.84 14.66 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.987 1.315 . . . . 0.0 112.335 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -130.2 149.17 52.02 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.75 1.22 . . . . 0.0 108.218 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.7 tp -101.9 127.0 48.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.789 0.836 . . . . 0.0 109.637 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.24 136.9 50.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.861 1.264 . . . . 0.0 108.765 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -83.81 115.15 22.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.47 135.24 40.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -116.02 115.11 25.55 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.81 151.44 14.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.41 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.8 t -133.07 156.08 48.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.59 0.632 . . . . 0.0 109.574 169.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.05 131.34 52.18 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.322 1.849 . . . . 0.0 106.867 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -97.6 115.7 28.39 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -50.94 -48.33 60.85 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.647 1.579 . . . . 0.0 111.813 -168.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.26 -30.41 71.28 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.703 0.801 . . . . 0.0 110.972 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.4 m -84.13 -33.59 24.25 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 49.36 44.33 23.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.5 1.12 . . . . 0.0 109.759 -167.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.11 150.8 22.66 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.1 mtt85 -111.39 169.31 8.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.395 0.617 . . . . 0.0 112.271 -170.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.07 145.82 23.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.189 174.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.4 tp -71.83 138.05 48.01 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.755 0.822 . . . . 0.0 108.904 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.63 -57.05 2.4 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.934 0.894 . . . . 0.0 108.75 168.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.39 160.1 43.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.835 0.35 . . . . 0.0 110.959 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -136.25 92.24 2.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.63 1.972 . . . . 0.0 106.494 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.88 145.56 25.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.51 -167.88 24.35 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo . . . . . 0 N--CA 1.456 -0.701 0 CA-C-N 118.644 1.222 . . . . 0.0 110.588 0.096 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 . . . . . 0 N--CA 1.455 -0.198 0 N-CA-C 109.677 -0.49 . . . . 0.0 109.677 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.557 HD12 ' H ' ' A' ' 5' ' ' ILE . 3.4 mp -79.27 143.57 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.9 pt -120.91 158.49 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.718 0.807 . . . . 0.0 110.373 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.16 140.78 58.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.919 0.888 . . . . 0.0 109.856 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -92.7 121.45 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.426 1.09 . . . . 0.0 108.425 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.48 -169.54 33.71 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -51.16 -45.97 33.77 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.723 2.948 . . . . 0.0 112.75 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -49.22 -55.28 13.06 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.114 0.959 . . . . 0.0 111.043 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -41.3 90.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.663 1.185 . . . . 0.0 110.591 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -56.67 -44.71 81.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.979 0.912 . . . . 0.0 109.55 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -51.8 -52.76 46.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.889 0.768 . . . . 0.0 110.75 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.47 -46.19 89.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 110.537 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.97 -42.2 86.23 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -64.7 -50.13 68.16 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -50.91 -46.15 60.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.12 0.968 . . . . 0.0 110.996 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 75' ' ' ILE . . . -58.06 -53.05 62.68 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.793 0.806 . . . . 0.0 110.398 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.9 t -63.78 -36.57 77.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.678 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.02 -47.16 84.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.201 1.0 . . . . 0.0 110.091 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.97 -50.87 67.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.69 -41.71 95.67 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 121.635 -0.665 . . . . 0.0 111.383 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -56.42 -42.85 78.7 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.34 -39.97 96.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.312 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.7 mm -62.54 -46.27 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.16 0.891 . . . . 0.0 109.376 174.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.13 3.91 85.65 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.137 1.351 . . . . 0.0 112.78 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -29.12 70.04 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.071 1.436 . . . . 0.0 113.061 -171.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -110.44 27.03 10.04 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.584 0.753 . . . . 0.0 110.024 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.27 -164.07 52.44 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -95.34 107.45 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.199 1.0 . . . . 0.0 108.547 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.9 140.23 35.48 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.145 0.429 . . . . 0.0 110.776 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.6 m -85.48 103.78 14.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -49.03 128.86 16.87 Favored 'General case' 0 N--CA 1.457 -0.079 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -102.82 -64.51 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -167.8 170.64 10.63 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.341 1.056 . . . . 0.0 109.998 172.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.5 p -98.48 149.5 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.318 1.047 . . . . 0.0 108.745 169.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -138.8 170.8 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 123.374 0.67 . . . . 0.0 110.258 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -61.84 152.46 76.18 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.967 0.907 . . . . 0.0 110.421 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.35 152.31 97.49 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 CA-C-N 119.184 0.744 . . . . 0.0 110.453 -4.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 46.9 t -143.72 101.65 3.79 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 ttp -128.47 136.19 50.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.877 0.871 . . . . 0.0 110.271 -166.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -119.84 157.3 28.96 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.195 0.998 . . . . 0.0 110.846 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -146.69 146.28 30.3 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.375 1.07 . . . . 0.0 109.635 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -76.06 132.52 40.15 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.98 0.912 . . . . 0.0 109.955 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.48 116.54 51.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.281 1.433 . . . . 0.0 108.476 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.7 p90 . . . . . 0 N--CA 1.448 -0.543 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.668 -174.766 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 87.6 mt . . . . . 0 N--CA 1.457 -0.107 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -101.53 -34.83 9.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.33 -161.85 24.98 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -139.93 158.83 43.45 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -123.9 147.25 47.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.137 1.375 . . . . 0.0 108.363 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -135.67 111.23 9.22 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.195 1.398 . . . . 0.0 107.641 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.27 112.55 25.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.596 1.558 . . . . 0.0 107.83 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -139.81 146.42 39.4 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.689 0.796 . . . . 0.0 111.267 -171.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -99.44 115.97 30.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.064 0.945 . . . . 0.0 109.62 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 p -113.53 129.17 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.193 1.397 . . . . 0.0 110.866 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.33 118.55 26.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.749 1.22 . . . . 0.0 107.997 173.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.76 128.99 43.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 t 52.25 41.17 30.22 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.683 0.793 . . . . 0.0 111.401 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t0 51.54 32.83 9.47 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.067 1.347 . . . . 0.0 112.938 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -125.34 131.22 53.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 169.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.4 tp -89.3 128.79 35.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -125.34 152.37 44.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.001 1.321 . . . . 0.0 108.294 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -92.49 129.44 38.43 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 132.54 56.65 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.563 1.145 . . . . 0.0 108.506 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -112.01 107.47 16.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 19' ' ' ALA . 13.1 mm -100.45 153.91 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 125.976 1.71 . . . . 0.0 107.961 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 t -132.34 159.96 37.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.167 0.508 . . . . 0.0 109.928 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -130.16 122.08 27.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.9 1.68 . . . . 0.0 106.483 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -83.89 119.06 24.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.403 1.081 . . . . 0.0 108.096 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -58.26 -58.3 9.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.643 0.777 . . . . 0.0 111.476 -170.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -68.94 -43.47 75.0 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.859 0.361 . . . . 0.0 110.039 -171.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.38 -30.29 70.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.565 0.746 . . . . 0.0 110.895 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 54.6 47.88 21.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.496 1.119 . . . . 0.0 110.069 -168.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -126.77 139.63 11.4 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -92.14 172.72 8.24 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.547 0.739 . . . . 0.0 110.689 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -174.94 143.18 0.7 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.853 2.061 . . . . 0.0 110.743 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.29 124.51 28.46 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 166.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.6 -59.92 2.36 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 169.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -142.75 150.42 40.04 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.178 0.591 . . . . 0.0 109.573 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -132.13 122.32 25.17 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -132.69 146.4 51.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -173.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 141.74 -165.23 26.55 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 123.578 0.609 . . . . 0.0 111.606 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo . . . . . 0 N--CA 1.458 -0.609 0 CA-C-N 118.045 0.923 . . . . 0.0 111.307 2.597 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 . . . . . 0 C--O 1.231 0.083 0 N-CA-C 109.658 -0.497 . . . . 0.0 109.658 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 mt -77.44 138.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 125.094 1.357 . . . . 0.0 107.58 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 pt -103.2 155.98 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 123.273 0.629 . . . . 0.0 110.422 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.75 131.38 45.08 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.7 pt -73.32 154.35 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 164.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.9 -175.68 29.77 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -166.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -58.95 -45.22 29.68 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.681 2.921 . . . . 0.0 112.667 -171.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -54.29 -53.12 58.07 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 122.144 0.973 . . . . 0.0 110.943 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 m -68.31 -39.28 82.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.219 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -52.98 -56.61 14.78 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.063 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -46.71 -50.32 18.12 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.337 0.971 . . . . 0.0 110.805 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.01 -50.43 72.08 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.915 -0.491 . . . . 0.0 111.567 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.34 -25.11 62.23 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 121.661 -0.649 . . . . 0.0 112.851 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -80.59 -54.85 5.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -45.03 -45.52 10.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.757 1.623 . . . . 0.0 110.47 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.56 -53.84 51.4 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.93 0.395 . . . . 0.0 110.738 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.31 -38.97 82.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.243 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.68 -48.96 79.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.472 0.709 . . . . 0.0 109.693 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.07 -50.05 74.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.18 0.992 . . . . 0.0 108.967 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -56.29 -49.66 73.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -59.86 -41.42 91.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.285 1.434 . . . . 0.0 110.069 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -61.47 -37.72 84.63 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 119.637 -0.221 . . . . 0.0 110.676 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.73 -47.33 80.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.42 19.0 61.14 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.624 1.583 . . . . 0.0 111.719 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -56.74 -41.63 77.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.964 0.882 . . . . 0.0 110.808 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -110.82 35.21 3.59 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.951 0.901 . . . . 0.0 110.179 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.85 -154.59 43.13 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.432 0.539 . . . . 0.0 112.051 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.4 ptt85 -93.44 84.91 4.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.084 1.354 . . . . 0.0 109.834 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.11 144.04 38.77 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.932 -0.48 . . . . 0.0 110.169 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 m -100.69 96.98 7.69 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -45.9 125.57 6.38 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.879 0.471 . . . . 0.0 110.473 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.27 -64.96 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.97 169.84 3.33 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 125.005 1.322 . . . . 0.0 108.418 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 p -110.78 141.09 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 124.74 1.216 . . . . 0.0 109.297 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.79 178.72 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 123.587 0.554 . . . . 0.0 110.411 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -60.7 154.99 54.04 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.162 0.985 . . . . 0.0 111.663 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.92 155.61 93.6 Favored 'Cis proline' 0 N--CA 1.458 -0.569 0 CA-C-N 119.414 0.827 . . . . 0.0 110.717 -9.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 17.1 p -161.29 79.0 0.59 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -166.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -99.16 160.46 14.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.37 1.068 . . . . 0.0 110.936 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -140.78 149.4 42.03 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.055 1.342 . . . . 0.0 108.608 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -147.61 143.58 27.82 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.84 0.856 . . . . 0.0 110.693 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -59.76 141.39 55.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.533 1.533 . . . . 0.0 111.969 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.07 124.76 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.645 1.578 . . . . 0.0 109.23 173.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 . . . . . 0 CA--C 1.529 0.138 0 C-N-CA 125.79 1.636 . . . . 0.0 108.784 176.139 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.1 mt . . . . . 0 N--CA 1.452 -0.353 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -89.91 -37.6 14.29 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.13 -157.36 17.97 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.01 151.86 39.24 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -104.89 144.85 31.21 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.834 1.654 . . . . 0.0 107.309 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.07 139.12 51.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -141.05 99.9 3.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -170.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -122.06 138.6 54.38 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.574 1.149 . . . . 0.0 111.328 -164.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -87.34 102.27 14.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.728 0.775 . . . . 0.0 109.013 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.77 131.08 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.401 1.48 . . . . 0.0 109.378 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -98.65 124.25 43.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.227 1.411 . . . . 0.0 108.181 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.03 134.98 21.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.077 0.951 . . . . 0.0 108.897 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 t 52.46 32.62 11.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.173 0.989 . . . . 0.0 111.211 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.7 23.22 12.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.046 1.338 . . . . 0.0 113.45 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -116.75 143.66 45.39 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.434 1.494 . . . . 0.0 107.743 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.8 tp -103.5 129.15 50.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.493 0.717 . . . . 0.0 109.882 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -134.61 148.08 50.34 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 125.206 1.403 . . . . 0.0 109.902 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -94.15 110.59 22.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.711 1.204 . . . . 0.0 108.695 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.35 121.82 42.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.855 1.262 . . . . 0.0 107.903 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -108.63 121.62 45.4 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.86 153.58 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 126.448 1.899 . . . . 0.0 107.607 -175.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.1 p -123.77 146.28 48.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 126.64 51.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 168.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -96.86 119.37 35.21 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -63.92 -28.86 70.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.142 0.577 . . . . 0.0 111.047 -174.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -63.56 -18.14 63.56 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.5 0.72 . . . . 0.0 112.656 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -143.75 8.57 1.51 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.307 -0.871 . . . . 0.0 111.721 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 44.8 ttt85 50.98 40.41 25.26 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.407 0.683 . . . . 0.0 110.156 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -110.21 137.85 14.52 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -109.79 164.02 12.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 117.503 0.652 . . . . 0.0 111.276 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -157.34 148.7 21.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.551 1.141 . . . . 0.0 110.963 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.19 135.04 39.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.718 1.207 . . . . 0.0 109.264 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.61 -67.11 0.8 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.31 160.27 43.84 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.255 1.022 . . . . 0.0 109.22 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -126.08 83.83 2.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.688 1.995 . . . . 0.0 106.657 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.6 145.69 26.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.87 -165.04 27.75 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.081 172.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo . . . . . 0 N--CA 1.458 -0.586 0 CA-C-N 117.966 0.883 . . . . 0.0 111.318 2.976 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 . . . . . 0 C--O 1.234 0.266 0 N-CA-C 109.133 -0.691 . . . . 0.0 109.133 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.6 mm -78.04 140.69 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -106.14 154.3 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.257 0.623 . . . . 0.0 109.961 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -73.89 124.46 26.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.5 pt -65.53 122.24 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 123.056 0.542 . . . . 0.0 109.626 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.82 -167.16 21.86 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -175.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -56.13 -41.64 74.66 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.239 2.626 . . . . 0.0 111.464 -175.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -51.81 -50.01 61.66 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.889 0.875 . . . . 0.0 110.729 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.23 -49.51 71.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.948 0.899 . . . . 0.0 110.62 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -51.97 -53.26 43.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -54.91 -47.83 73.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.999 0.92 . . . . 0.0 111.423 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 mt -59.97 -48.27 82.38 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.979 0.354 . . . . 0.0 110.93 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.11 -48.61 85.27 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -54.9 -49.43 71.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.104 1.361 . . . . 0.0 110.25 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -55.87 -48.21 75.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.106 1.362 . . . . 0.0 110.52 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -49.55 74.86 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.34 -42.63 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.406 0.682 . . . . 0.0 110.783 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.25 -51.58 68.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.961 0.904 . . . . 0.0 109.664 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -58.22 -46.79 85.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.693 1.197 . . . . 0.0 109.746 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -56.16 -56.94 14.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -56.97 -38.72 73.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.578 1.151 . . . . 0.0 110.955 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -56.77 -39.21 73.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.853 0.461 . . . . 0.0 110.608 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.6 mt -83.1 -47.6 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.081 0.552 . . . . 0.0 110.235 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.25 10.83 58.02 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.556 1.55 . . . . 0.0 113.921 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -54.73 -42.64 71.8 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.035 1.417 . . . . 0.0 112.053 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -107.12 37.83 2.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.696 0.798 . . . . 0.0 110.076 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.11 -138.42 47.82 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -115.24 93.39 4.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.134 1.373 . . . . 0.0 108.837 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.3 mt -79.0 142.16 36.84 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.164 0.585 . . . . 0.0 109.575 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 t -103.84 106.92 17.58 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -59.04 133.73 56.36 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.458 0.703 . . . . 0.0 109.916 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -100.48 -64.69 1.02 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 168.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -167.61 179.03 5.06 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.356 1.062 . . . . 0.0 108.915 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.06 134.21 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -176.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . 0.492 HD11 ' CZ ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -146.41 167.2 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 122.741 0.416 . . . . 0.0 110.335 -173.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -53.71 150.97 12.17 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.482 1.113 . . . . 0.0 111.831 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.38 142.76 72.72 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 CA-C-N 119.018 0.685 . . . . 0.0 110.701 -1.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.6 m -133.68 101.73 5.22 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 33.2 ttm -118.37 138.82 52.16 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.242 0.617 . . . . 0.0 110.491 -169.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -121.48 144.57 48.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.956 1.302 . . . . 0.0 110.132 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -146.38 149.8 34.46 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.456 0.702 . . . . 0.0 110.885 171.916 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -80.63 137.62 36.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.414 1.485 . . . . 0.0 111.365 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.53 120.74 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.79 1.236 . . . . 0.0 108.303 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.0 p90 . . . . . 0 N--CA 1.449 -0.519 0 C-N-CA 123.865 0.866 . . . . 0.0 109.275 179.291 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 N--CA 1.456 -0.162 0 N-CA-C 108.853 -0.795 . . . . 0.0 108.853 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -119.59 -22.29 7.0 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 123.547 0.529 . . . . 0.0 111.166 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.95 -168.01 31.24 Favored Glycine 0 N--CA 1.448 -0.543 0 O-C-N 121.432 -0.792 . . . . 0.0 111.445 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -148.82 163.69 36.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.328 1.451 . . . . 0.0 107.693 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.84 148.83 52.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.688 1.195 . . . . 0.0 108.97 169.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -134.32 115.66 14.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -107.68 129.74 54.99 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.201 0.91 . . . . 0.0 109.263 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 pp -149.27 152.3 35.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.568 0.699 . . . . 0.0 111.568 -172.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . 0.612 ' CZ ' HD22 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -89.02 111.34 22.03 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.537 1.535 . . . . 0.0 107.036 177.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.1 t -93.35 124.23 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 169.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.29 116.55 23.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 169.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 132.51 36.95 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.8 t 53.8 34.72 19.8 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.968 0.907 . . . . 0.0 111.708 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 t0 46.94 42.85 12.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.098 1.359 . . . . 0.0 111.064 -169.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -137.96 155.15 49.18 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.255 1.422 . . . . 0.0 107.953 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . 0.612 HD22 ' CZ ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -81.74 118.11 22.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -173.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -130.07 112.63 13.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.451 1.1 . . . . 0.0 108.69 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -97.13 131.12 44.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.3 142.73 50.16 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.202 0.91 . . . . 0.0 110.204 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.9 120.68 42.25 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.226 1.01 . . . . 0.0 108.363 168.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.74 140.08 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.9 p -111.38 147.65 34.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.581 1.152 . . . . 0.0 108.108 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -126.78 134.35 50.61 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.907 1.683 . . . . 0.0 107.798 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -107.31 114.49 28.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.519 1.128 . . . . 0.0 108.846 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.28 -27.9 67.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.728 1.211 . . . . 0.0 111.365 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -58.04 -23.22 53.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.88 0.872 . . . . 0.0 112.407 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -141.14 6.07 1.93 Allowed 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.468 -0.77 . . . . 0.0 111.328 174.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 49.94 40.55 21.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.826 0.851 . . . . 0.0 110.028 -171.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.69 140.74 15.35 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 107.699 -2.161 . . . . 0.0 107.699 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -116.85 164.99 13.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.986 0.893 . . . . 0.0 110.787 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -161.2 150.69 16.79 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.842 0.857 . . . . 0.0 110.326 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.57 110.98 0.98 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.346 1.059 . . . . 0.0 108.677 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.7 tp -71.89 -48.26 46.96 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -162.56 155.57 19.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -119.32 141.5 48.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.4 131.7 40.31 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.93 -176.17 27.84 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo . . . . . 0 N--CA 1.455 -0.761 0 CA-C-N 118.223 1.012 . . . . 0.0 110.508 -3.516 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 . . . . . 0 C--O 1.233 0.209 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.88 138.48 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.11 157.35 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.1 0.96 . . . . 0.0 110.475 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.52 125.39 29.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.503 0.721 . . . . 0.0 109.387 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 pt -65.13 136.32 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 165.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.11 -175.07 41.04 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -169.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.37 -46.78 31.35 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.745 2.963 . . . . 0.0 113.195 -170.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -52.13 -55.01 23.61 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.918 1.342 . . . . 0.0 110.871 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.9 m -66.73 -42.42 86.32 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.28 1.032 . . . . 0.0 110.198 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -57.03 -48.66 77.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.405 0.682 . . . . 0.0 110.078 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -54.02 -47.62 71.34 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 123.131 0.572 . . . . 0.0 110.839 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.06 -41.05 95.5 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.208 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.28 -51.63 40.95 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -51.3 -55.27 19.19 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.353 1.061 . . . . 0.0 110.185 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -51.26 -47.6 62.4 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.826 0.851 . . . . 0.0 110.447 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.35 -50.84 68.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.9 -40.87 90.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.39 -48.31 82.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.465 0.706 . . . . 0.0 110.076 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -63.09 -49.23 75.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.086 0.955 . . . . 0.0 109.698 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -54.74 -46.64 74.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -63.46 -44.94 93.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.635 1.574 . . . . 0.0 110.12 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -56.03 -46.0 78.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.55 0.74 . . . . 0.0 110.022 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -68.9 -47.56 75.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.98 14.9 55.65 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.219 1.39 . . . . 0.0 113.211 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -50.87 -44.46 59.65 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.621 1.21 . . . . 0.0 111.44 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -113.34 38.07 2.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.881 0.873 . . . . 0.0 109.984 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.4 -141.23 47.5 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -111.83 114.93 28.19 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.776 1.231 . . . . 0.0 109.344 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.3 152.25 21.76 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.351 0.66 . . . . 0.0 111.005 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.4 m -92.87 100.1 12.63 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -49.53 130.61 20.54 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -101.53 -63.63 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -171.58 -166.67 0.46 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.007 0.923 . . . . 0.0 109.122 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.53 144.81 35.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.11 165.34 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.544 0.611 . . . . 0.0 110.417 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -63.96 151.18 90.18 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.078 0.951 . . . . 0.0 111.4 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.1 151.47 96.82 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 119.268 0.774 . . . . 0.0 111.572 0.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.4 m -139.89 94.81 2.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.4 mtt -108.33 157.81 18.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.998 0.919 . . . . 0.0 110.673 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -131.96 154.44 49.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.031 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -130.04 151.9 50.08 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.148 2.179 . . . . 0.0 107.815 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.2 m -98.74 133.64 42.78 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.039 0.936 . . . . 0.0 109.319 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.58 128.19 62.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 125.006 1.323 . . . . 0.0 110.501 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.8 p90 . . . . . 0 N--CA 1.443 -0.783 0 C-N-CA 125.553 1.541 . . . . 0.0 107.607 -179.987 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.4 mt . . . . . 0 N--CA 1.463 0.192 0 N-CA-C 109.821 -0.437 . . . . 0.0 109.821 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -127.94 -34.71 2.12 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.207 0.603 . . . . 0.0 112.09 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.91 -164.43 28.99 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.02 -1.086 . . . . 0.0 111.862 -170.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -145.02 160.71 40.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.613 1.165 . . . . 0.0 108.027 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -126.41 144.1 50.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.532 1.533 . . . . 0.0 107.579 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -129.95 124.15 32.38 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -113.33 117.75 32.68 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.782 1.633 . . . . 0.0 106.723 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 pp -152.18 153.99 34.93 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.272 0.487 . . . . 0.0 111.535 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -96.1 104.58 16.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.232 1.013 . . . . 0.0 109.348 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.39 130.72 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.374 1.869 . . . . 0.0 108.571 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.57 120.12 39.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.809 1.244 . . . . 0.0 107.674 173.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.7 131.12 20.99 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.275 1.03 . . . . 0.0 108.81 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.43 39.22 29.62 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.18 0.992 . . . . 0.0 110.974 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.9 t0 45.95 37.5 3.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.081 1.352 . . . . 0.0 113.005 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -125.72 139.01 53.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 168.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.4 tp -98.54 126.9 44.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -124.89 140.4 52.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.679 1.592 . . . . 0.0 107.965 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -88.8 123.59 33.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.27 146.82 44.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.662 0.785 . . . . 0.0 109.158 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.58 124.5 43.64 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 mm -112.34 150.17 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 127.006 2.123 . . . . 0.0 107.05 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -120.86 148.91 43.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.599 1.16 . . . . 0.0 108.403 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -122.24 127.25 49.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.393 1.877 . . . . 0.0 106.63 169.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -102.78 119.22 38.45 Favored 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -66.45 -23.07 66.22 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -63.85 -55.56 21.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.103 0.865 . . . . 0.0 110.495 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.4 p -79.84 -26.84 40.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 68.31 13.96 9.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.053 1.341 . . . . 0.0 109.023 -164.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.02 155.09 34.43 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -115.51 171.92 7.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.948 0.499 . . . . 0.0 110.626 176.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.26 157.53 30.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.698 174.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 tp -78.5 119.2 21.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.1 tp -82.67 -59.78 2.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -144.84 154.35 42.57 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.065 0.946 . . . . 0.0 109.563 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -144.73 102.33 3.78 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.926 1.69 . . . . 0.0 106.838 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -117.11 142.27 47.21 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -172.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.74 -165.96 27.92 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.614 -0.548 . . . . 0.0 112.158 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo . . . . . 0 N--CA 1.458 -0.588 0 CA-C-N 118.006 0.903 . . . . 0.0 111.237 2.137 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 . . . . . 0 C--O 1.232 0.167 0 N-CA-C 109.09 -0.707 . . . . 0.0 109.09 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.53 139.99 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.043 1.337 . . . . 0.0 108.662 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.5 pt -104.25 156.74 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.481 1.113 . . . . 0.0 109.865 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.51 118.13 18.86 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.4 pt -55.56 133.47 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 166.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.4 -169.32 42.44 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -172.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -52.17 -44.08 48.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.628 2.885 . . . . 0.0 112.676 -172.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -53.15 -57.13 11.52 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.554 0.692 . . . . 0.0 111.463 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.97 -45.07 94.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.507 0.723 . . . . 0.0 109.974 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -55.85 -48.83 74.83 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.492 0.717 . . . . 0.0 109.22 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -55.08 -51.81 65.2 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.322 0.649 . . . . 0.0 110.608 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 15' ' ' LEU . 19.6 mt -59.23 -45.23 91.69 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.675 -0.64 . . . . 0.0 111.642 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.98 -39.93 92.58 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -64.74 -52.33 57.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -50.98 -45.29 60.93 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.582 1.153 . . . . 0.0 110.849 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.1 70.67 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.0 -41.68 93.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.019 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.0 -48.81 77.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.236 0.614 . . . . 0.0 109.458 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.24 -52.77 63.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.575 1.15 . . . . 0.0 109.36 175.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -57.71 -45.01 86.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 122.997 0.519 . . . . 0.0 110.365 -174.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -67.57 -43.77 79.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.786 1.634 . . . . 0.0 110.633 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.35 -44.48 96.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.9 0.48 . . . . 0.0 110.048 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.2 -43.67 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.47 12.94 57.82 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.444 1.021 . . . . 0.0 112.741 173.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -47.99 -46.08 32.34 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.246 1.023 . . . . 0.0 111.868 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -111.16 24.02 13.39 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.524 1.13 . . . . 0.0 110.798 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.33 -158.44 26.75 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -81.11 89.86 6.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.4 0.68 . . . . 0.0 110.796 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.6 140.52 48.09 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 169.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.5 m -95.56 93.84 7.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -48.67 129.37 16.5 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.689 0.222 . . . . 0.0 110.71 177.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -102.82 -62.05 1.32 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -174.16 -161.36 0.12 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.057 1.343 . . . . 0.0 108.741 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.37 145.19 34.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.43 162.7 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 118.353 0.524 . . . . 0.0 110.388 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 151.32 67.38 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.77 1.228 . . . . 0.0 111.22 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.8 130.99 21.9 Favored 'Cis proline' 0 C--N 1.348 0.545 0 CA-C-N 120.035 1.048 . . . . 0.0 112.353 4.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 96.3 m -125.39 99.93 6.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 96.5 mtp -115.28 160.05 20.26 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.689 0.796 . . . . 0.0 110.902 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -133.94 158.48 43.37 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 167.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -150.58 173.16 14.43 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.9 m -98.27 135.18 40.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.531 1.132 . . . . 0.0 112.041 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.19 136.71 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.286 1.834 . . . . 0.0 108.705 171.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.5 p90 . . . . . 0 N--CA 1.436 -1.14 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -170.825 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 N--CA 1.449 -0.494 0 N-CA-C 109.625 -0.509 . . . . 0.0 109.625 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -108.56 -22.37 12.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.749 0.82 . . . . 0.0 110.539 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.54 -162.39 28.55 Favored Glycine 0 C--N 1.336 0.566 0 O-C-N 121.408 -0.807 . . . . 0.0 111.479 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -142.59 155.14 44.94 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.118 1.367 . . . . 0.0 107.679 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -108.59 150.16 27.88 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -129.2 120.95 26.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -104.05 128.51 51.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 pp -151.88 153.02 33.34 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.814 0.734 . . . . 0.0 111.519 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -96.73 99.81 11.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.264 1.026 . . . . 0.0 108.7 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.77 135.46 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.9 113.09 26.43 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.01 132.48 23.55 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 123.568 0.747 . . . . 0.0 109.31 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 m 51.08 36.3 15.1 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.759 1.223 . . . . 0.0 111.185 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 56.12 30.87 17.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.272 1.029 . . . . 0.0 112.726 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.5 150.32 42.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 168.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mp -92.59 128.53 38.48 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.939 1.296 . . . . 0.0 108.452 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -127.05 132.04 50.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.27 1.028 . . . . 0.0 108.283 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 112.31 21.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.41 139.55 42.98 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -114.15 123.6 50.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mm -112.46 149.88 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.501 1.92 . . . . 0.0 105.907 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.9 t -117.7 150.37 39.18 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.94 113.47 15.24 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 127.363 2.265 . . . . 0.0 105.585 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -82.28 118.76 23.37 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -58.28 -52.3 66.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.302 1.441 . . . . 0.0 111.502 -171.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.17 -45.02 71.03 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 m -72.19 -29.78 64.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.45 0.3 . . . . 0.0 110.591 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 55.35 49.01 17.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.405 1.082 . . . . 0.0 109.53 -168.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -133.58 140.61 11.95 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.78 172.8 6.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.583 0.753 . . . . 0.0 111.187 -174.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -167.63 142.51 3.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.226 1.011 . . . . 0.0 111.056 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.63 121.84 17.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.7 tp -84.6 -45.43 12.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -162.49 143.93 10.42 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.069 0.547 . . . . 0.0 110.24 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -125.82 111.9 15.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.838 1.655 . . . . 0.0 107.197 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -116.9 151.23 37.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.0 -170.79 22.72 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.622 1.106 . . . . 0.0 110.491 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo . . . . . 0 N--CA 1.455 -0.762 0 CA-C-N 118.324 1.062 . . . . 0.0 110.702 1.826 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 . . . . . 0 C--O 1.233 0.215 0 N-CA-C 109.597 -0.519 . . . . 0.0 109.597 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.46 138.46 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.9 pt -106.35 155.41 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.014 0.926 . . . . 0.0 110.18 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.56 140.78 58.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.32 120.61 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.01 -167.43 33.59 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -174.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -52.99 -43.78 54.17 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.515 2.81 . . . . 0.0 113.326 -172.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -51.12 -55.99 14.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.481 1.134 . . . . 0.0 111.159 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.33 -42.87 96.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.757 1.223 . . . . 0.0 109.797 -175.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -56.69 -48.22 78.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.888 0.875 . . . . 0.0 109.408 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -56.57 -49.24 75.46 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.03 0.532 . . . . 0.0 110.921 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.08 -45.9 82.96 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 117.846 0.293 . . . . 0.0 110.997 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.69 -53.84 40.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -52.66 -48.45 66.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.398 1.079 . . . . 0.0 110.86 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -56.4 -49.1 75.46 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.709 0.804 . . . . 0.0 110.713 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.59 78.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 110.258 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.93 -47.64 85.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.374 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.1 -48.55 81.14 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.727 1.211 . . . . 0.0 110.06 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -65.14 -43.61 91.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.659 0.783 . . . . 0.0 109.902 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -58.99 -48.66 80.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.419 171.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -54.52 -39.9 68.06 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.399 1.08 . . . . 0.0 110.276 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -49.43 -37.79 26.95 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.0 0.92 . . . . 0.0 111.141 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.14 -47.43 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.228 1.011 . . . . 0.0 109.355 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.0 28.35 23.57 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.32 0.962 . . . . 0.0 111.19 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -55.99 -38.26 70.2 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.502 0.651 . . . . 0.0 111.39 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -117.59 42.76 2.53 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.838 0.828 . . . . 0.0 109.825 170.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.72 -148.1 39.28 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -102.6 115.18 30.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.809 0.844 . . . . 0.0 109.623 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 mp -110.62 137.0 48.86 Favored 'General case' 0 N--CA 1.458 -0.046 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.2 m -86.07 131.47 34.26 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -60.04 135.51 57.73 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -105.76 -64.01 1.19 Allowed 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -165.41 161.32 18.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.19 0.596 . . . . 0.0 109.637 -173.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.93 144.41 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 125.429 1.491 . . . . 0.0 107.594 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.16 159.99 9.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 123.011 0.524 . . . . 0.0 110.187 -176.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -61.39 152.89 71.61 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.831 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.43 153.79 98.71 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 CA-C-N 119.294 0.783 . . . . 0.0 111.08 -4.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.9 m -141.13 100.6 3.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.3 mtt -113.24 155.0 25.85 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.28 1.032 . . . . 0.0 110.704 -174.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -138.38 154.7 48.92 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 167.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -150.15 160.05 43.96 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.396 1.079 . . . . 0.0 110.981 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.9 m -84.06 139.55 32.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.741 1.216 . . . . 0.0 112.851 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.07 137.05 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.756 1.622 . . . . 0.0 109.712 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.1 p90 . . . . . 0 CA--C 1.531 0.25 0 C-N-CA 123.23 0.612 . . . . 0.0 111.737 -167.246 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt . . . . . 0 CA--C 1.533 0.3 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -112.69 -27.51 8.15 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.352 0.661 . . . . 0.0 111.458 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.11 -160.48 24.57 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.08 163.57 33.17 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.795 1.238 . . . . 0.0 108.356 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.57 145.76 48.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.492 1.517 . . . . 0.0 107.972 168.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -121.3 140.37 52.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -136.78 114.2 10.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.66 163.17 39.18 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.289 0.236 . . . . 0.0 110.711 -169.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -103.16 139.21 38.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 123.728 0.811 . . . . 0.0 110.345 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.48 137.4 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.421 1.488 . . . . 0.0 108.037 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.38 124.17 38.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 168.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.45 121.08 23.95 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.476 1.11 . . . . 0.0 109.554 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t 71.87 -63.31 0.43 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 129.318 3.047 . . . . 0.0 108.588 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -173.22 10.8 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.965 2.906 . . . . 0.0 111.064 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -113.77 130.75 56.4 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 119.432 1.014 . . . . 0.0 108.828 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 tt -87.96 123.49 32.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.775 1.23 . . . . 0.0 108.116 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -133.3 159.23 40.85 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.81 0.844 . . . . 0.0 110.035 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -91.35 136.59 33.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.692 0.797 . . . . 0.0 108.957 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.57 135.26 53.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.94 130.5 56.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 169.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.81 136.73 58.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 125.513 1.525 . . . . 0.0 106.89 -173.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.3 p -103.4 151.32 22.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.437 0.695 . . . . 0.0 109.295 171.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -126.62 119.6 27.45 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 126.802 2.041 . . . . 0.0 106.857 173.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.45 118.82 30.89 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -60.57 -46.47 90.1 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.081 0.953 . . . . 0.0 111.446 -171.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -63.74 -49.5 72.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.902 0.481 . . . . 0.0 111.542 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.8 m -71.27 -30.25 66.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.8 ttm-85 58.04 41.9 23.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.538 1.135 . . . . 0.0 109.056 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -131.23 150.76 19.5 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -120.35 167.72 12.03 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.539 0.735 . . . . 0.0 109.705 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.09 147.68 19.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 169.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.0 tp -57.33 109.9 0.76 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.295 1.438 . . . . 0.0 108.147 170.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.92 -54.53 8.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.78 156.78 42.42 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.598 0.759 . . . . 0.0 109.541 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -120.98 127.36 51.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 168.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -137.19 155.43 49.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.91 -159.57 21.5 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -169.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo . . . . . 0 N--CA 1.457 -0.674 0 CA-C-N 119.099 1.45 . . . . 0.0 112.07 2.99 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 . . . . . 0 N--CA 1.447 -0.592 0 N-CA-C 108.455 -0.943 . . . . 0.0 108.455 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mp -78.26 140.26 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 pt -113.82 156.24 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.072 0.949 . . . . 0.0 109.673 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.3 167.44 18.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.807 0.813 . . . . 0.0 109.773 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pp -100.44 164.21 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 164.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.46 -174.12 23.54 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -169.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.05 -43.19 50.34 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.847 3.031 . . . . 0.0 112.382 -173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -51.22 -58.11 7.02 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.019 0.914 . . . . 0.0 110.871 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.14 -41.18 86.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.665 -171.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -53.71 -53.79 47.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.643 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -51.68 -50.31 60.68 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.771 0.714 . . . . 0.0 110.712 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.22 -49.92 74.48 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.032 -0.418 . . . . 0.0 110.877 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.0 -34.23 71.7 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 122.142 -0.349 . . . . 0.0 112.257 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -73.06 -48.18 38.28 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -51.58 -47.19 63.6 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.279 1.031 . . . . 0.0 110.554 169.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.97 -53.33 59.3 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.093 0.473 . . . . 0.0 110.052 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.36 -40.08 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.771 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.72 -48.11 83.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.436 -0.79 . . . . 0.0 109.666 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -58.81 -50.27 74.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.282 1.033 . . . . 0.0 109.516 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -53.78 -44.94 70.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.278 0.631 . . . . 0.0 110.778 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -69.98 -39.69 75.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.554 1.542 . . . . 0.0 110.589 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -58.33 -46.03 86.99 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.86 -43.77 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.41 24.59 33.3 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.243 1.401 . . . . 0.0 110.282 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -57.85 -35.33 70.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.519 0.728 . . . . 0.0 111.47 -169.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -129.27 45.43 2.8 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.17 -140.11 46.44 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 86.33 2.97 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.066 1.346 . . . . 0.0 109.219 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.94 138.1 37.02 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.494 -0.754 . . . . 0.0 110.124 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 m -96.61 95.55 8.04 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -45.67 131.45 8.96 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 123.245 0.618 . . . . 0.0 110.234 173.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -102.0 -66.12 0.94 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -173.36 154.16 2.57 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.93 0.892 . . . . 0.0 110.546 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.79 144.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 168.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.97 156.92 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.815 0.846 . . . . 0.0 110.144 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.9 ptt85 -63.42 153.01 83.96 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.708 1.203 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.11 154.72 98.36 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 CA-C-N 119.443 0.837 . . . . 0.0 111.268 -5.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 89.9 m -137.66 131.04 30.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 mtp -135.82 158.08 45.26 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.44 0.696 . . . . 0.0 110.965 -169.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -145.07 154.58 42.64 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.251 0.621 . . . . 0.0 111.059 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -144.47 142.09 30.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.054 0.942 . . . . 0.0 111.381 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -73.95 123.36 24.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.753 2.421 . . . . 0.0 111.395 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.61 100.91 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 122.387 1.089 . . . . 0.0 108.17 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 . . . . . 0 N--CA 1.453 -0.31 0 C-N-CA 124.517 1.127 . . . . 0.0 110.348 174.339 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.9 mt . . . . . 0 N--CA 1.453 -0.298 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -19.44 33.85 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.612 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.71 -167.1 30.61 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.464 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -142.29 164.63 29.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.313 1.445 . . . . 0.0 108.157 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -122.49 146.22 47.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 106.725 171.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -127.42 138.85 53.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 176.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -136.86 117.64 14.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 pp -150.87 146.27 26.22 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 118.438 0.563 . . . . 0.0 111.573 -169.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -89.98 130.62 36.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.022 0.929 . . . . 0.0 109.446 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.08 135.06 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 124.336 1.054 . . . . 0.0 110.424 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -89.22 128.81 35.85 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 125.49 25.56 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 t 52.34 40.0 28.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.961 0.905 . . . . 0.0 111.105 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.1 t70 57.54 23.0 8.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.012 1.325 . . . . 0.0 113.359 -176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.78 132.08 54.5 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 169.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -91.2 124.52 35.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.818 0.847 . . . . 0.0 108.725 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.05 159.29 37.98 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.176 1.39 . . . . 0.0 109.215 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -101.08 123.11 44.74 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 167.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.83 133.85 41.78 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -122.77 124.8 44.17 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.359 1.063 . . . . 0.0 108.37 172.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.46 155.02 41.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 126.557 1.943 . . . . 0.0 106.684 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.9 m -127.79 164.94 21.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.424 0.556 . . . . 0.0 109.813 168.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.97 133.37 44.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.431 1.892 . . . . 0.0 107.595 175.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -105.21 109.11 20.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.256 1.422 . . . . 0.0 107.911 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -56.89 -31.95 65.39 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.394 1.477 . . . . 0.0 111.092 -173.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -48.86 -26.91 2.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.416 1.486 . . . . 0.0 112.928 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.1 m -144.22 17.54 1.72 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.64 0.654 . . . . 0.0 111.151 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 49.07 30.86 3.08 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.896 0.878 . . . . 0.0 110.442 -169.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.36 125.8 8.17 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -168.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -98.03 167.14 11.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.855 0.836 . . . . 0.0 112.433 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -164.53 128.22 2.5 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.035 -170.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.28 121.97 16.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.5 mp -84.33 -50.58 7.7 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 170.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -161.88 161.42 28.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.724 0.297 . . . . 0.0 110.649 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -127.79 82.34 2.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -83.33 137.85 33.79 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.18 -166.61 25.69 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo . . . . . 0 N--CA 1.457 -0.649 0 CA-C-N 118.175 0.988 . . . . 0.0 110.726 1.643 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 . . . . . 0 N--CA 1.451 -0.412 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 5' ' ' ILE . 3.4 mp -76.08 131.34 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.1 153.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.54 0.736 . . . . 0.0 109.626 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.49 122.65 19.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.5 pt -64.44 146.34 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.2 -177.59 32.33 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -166.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.95 -47.27 27.53 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.041 3.161 . . . . 0.0 113.352 -169.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -54.22 -54.19 43.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 122.217 1.008 . . . . 0.0 111.101 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.3 m -65.92 -41.48 91.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.438 0.695 . . . . 0.0 110.239 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -54.15 -54.69 36.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.45 169.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -50.02 -49.39 50.97 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.898 0.772 . . . . 0.0 111.004 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.79 -49.42 76.4 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.074 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.78 -27.93 62.39 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.945 -0.472 . . . . 0.0 112.762 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -79.7 -52.82 7.47 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -46.26 -45.15 17.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.386 1.475 . . . . 0.0 110.802 172.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.46 -55.64 26.91 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.517 0.675 . . . . 0.0 110.523 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.32 -39.93 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.754 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.58 -48.9 78.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.615 0.766 . . . . 0.0 109.701 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -59.94 -49.55 77.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.216 1.007 . . . . 0.0 109.24 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -54.93 -47.0 75.01 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.96 0.504 . . . . 0.0 110.732 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -65.78 -40.53 92.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.315 1.446 . . . . 0.0 110.298 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -58.07 -45.16 87.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.4 mt -69.1 -42.72 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.29 37.75 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.276 1.417 . . . . 0.0 112.167 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.69 -39.45 80.75 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.978 0.889 . . . . 0.0 111.581 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -110.84 34.83 3.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.108 0.963 . . . . 0.0 109.794 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.08 -130.42 44.63 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -119.92 84.73 2.26 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.923 1.289 . . . . 0.0 109.305 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.01 139.82 40.19 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.95 -0.469 . . . . 0.0 109.946 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.4 m -97.39 94.57 7.13 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -48.33 135.31 13.86 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 122.756 0.422 . . . . 0.0 110.204 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.86 -62.47 1.47 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.089 0.956 . . . . 0.0 109.097 176.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.15 178.3 4.46 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.551 1.14 . . . . 0.0 108.959 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.48 142.88 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.838 1.255 . . . . 0.0 109.348 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.6 171.56 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.873 0.869 . . . . 0.0 109.37 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 151.4 94.1 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.532 -175.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.33 160.97 85.88 Favored 'Cis proline' 0 C--N 1.348 0.519 0 CA-C-N 120.098 1.071 . . . . 0.0 111.649 0.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.9 p -177.0 77.52 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 -163.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.5 ttt -122.01 134.25 54.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.42 1.088 . . . . 0.0 109.225 -165.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -103.47 138.44 40.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 117.991 -1.004 . . . . 0.0 111.027 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -134.62 145.59 48.77 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.944 0.793 . . . . 0.0 111.471 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.6 m -74.46 139.02 43.62 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.884 0.473 . . . . 0.0 109.925 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.62 126.06 71.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.905 1.282 . . . . 0.0 109.257 175.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.7 p90 . . . . . 0 N--CA 1.448 -0.573 0 C-N-CA 124.009 0.924 . . . . 0.0 109.946 -178.356 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.4 mt . . . . . 0 CA--C 1.531 0.243 0 N-CA-C 109.158 -0.682 . . . . 0.0 109.158 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -122.44 -34.19 3.31 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.235 0.614 . . . . 0.0 111.482 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -172.35 -160.1 20.21 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.507 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -135.67 163.9 29.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.675 1.19 . . . . 0.0 108.244 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -124.59 143.54 50.64 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.664 1.585 . . . . 0.0 108.043 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -124.13 111.91 16.47 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -106.62 110.72 22.99 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.87 141.72 34.6 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.028 0.831 . . . . 0.0 112.46 -172.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -87.91 101.99 14.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.896 0.879 . . . . 0.0 109.464 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.83 125.68 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.509 1.524 . . . . 0.0 109.301 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.8 117.79 24.89 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.889 1.276 . . . . 0.0 107.988 169.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.2 127.98 36.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.581 1.152 . . . . 0.0 108.17 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 t 51.27 39.4 23.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.104 0.962 . . . . 0.0 111.322 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.0 t0 55.26 22.79 5.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.087 1.355 . . . . 0.0 113.707 -176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -111.76 135.87 51.79 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.4 tp -100.11 126.39 46.34 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -131.63 142.8 49.95 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.604 1.162 . . . . 0.0 109.674 -176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -82.69 106.9 14.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.13 0.972 . . . . 0.0 108.707 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.43 124.64 34.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -110.62 108.9 18.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.0 mp -104.64 152.72 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.5 t -125.48 152.61 44.72 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.57 131.81 54.33 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.718 1.607 . . . . 0.0 107.779 173.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.04 124.03 35.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.768 0.827 . . . . 0.0 109.519 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -66.92 -29.41 69.28 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.197 -0.939 . . . . 0.0 111.979 -172.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -58.41 8.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.45 0.7 . . . . 0.0 111.329 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.24 -14.72 22.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.324 0.65 . . . . 0.0 110.827 -173.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.3 mtm-85 54.53 41.75 31.76 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.462 1.105 . . . . 0.0 110.737 -174.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.91 158.2 14.56 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 173.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.12 165.92 12.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.673 0.736 . . . . 0.0 111.548 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -157.92 148.74 20.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.875 1.27 . . . . 0.0 110.985 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 tp -69.57 127.4 32.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.936 0.894 . . . . 0.0 109.091 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.4 -51.43 6.22 Favored 'General case' 0 C--O 1.228 -0.039 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 167.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.3 167.55 25.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 117.909 0.322 . . . . 0.0 111.502 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -133.59 86.06 2.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.678 1.591 . . . . 0.0 107.264 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.7 146.65 25.59 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.25 -164.77 28.66 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.052 -0.86 . . . . 0.0 111.101 174.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo . . . . . 0 N--CA 1.458 -0.599 0 CA-C-N 118.155 0.978 . . . . 0.0 110.744 -0.572 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 . . . . . 0 C--O 1.235 0.302 0 N-CA-C 110.694 -0.113 . . . . 0.0 110.694 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.6 mm -64.93 148.34 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.906 1.282 . . . . 0.0 108.801 171.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 pt -114.08 152.06 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.145 1.378 . . . . 0.0 108.852 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -82.12 125.62 31.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 pt -60.19 132.79 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 166.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.61 -176.22 44.2 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -52.1 -49.04 18.68 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.71 2.94 . . . . 0.0 113.237 -169.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -54.31 -56.06 22.21 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.153 0.978 . . . . 0.0 110.849 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -64.94 -39.27 93.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.383 1.073 . . . . 0.0 110.497 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -59.28 -46.73 87.74 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.437 0.695 . . . . 0.0 109.813 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -57.0 -46.7 82.11 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 118.592 0.633 . . . . 0.0 110.633 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.27 -46.07 83.45 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.209 -0.307 . . . . 0.0 110.64 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.49 -51.84 53.89 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.596 -0.601 . . . . 0.0 111.596 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -57.4 -48.02 80.19 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.539 1.535 . . . . 0.0 109.063 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -55.21 -47.44 75.28 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.705 1.202 . . . . 0.0 110.702 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.19 -53.4 57.64 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.672 0.749 . . . . 0.0 110.274 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.55 -39.81 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.125 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.62 -48.86 75.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.817 1.247 . . . . 0.0 109.494 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -55.99 -51.73 66.72 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.71 -46.08 88.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.111 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -59.26 -45.63 90.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.182 0.993 . . . . 0.0 109.495 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.35 -45.29 95.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.446 0.698 . . . . 0.0 110.351 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.5 mt -70.39 -43.27 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.78 14.18 55.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.726 1.155 . . . . 0.0 112.863 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -50.32 -44.43 54.21 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.232 1.016 . . . . 0.0 111.995 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.09 34.79 4.25 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.75 0.786 . . . . 0.0 110.099 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.93 -143.43 48.64 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 -100.19 124.23 45.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.292 1.037 . . . . 0.0 108.961 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.53 134.9 50.76 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.111 0.964 . . . . 0.0 110.289 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.0 m -95.59 99.02 10.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.032 1.333 . . . . 0.0 108.994 -174.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -45.41 122.83 3.73 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 122.892 0.477 . . . . 0.0 110.712 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.15 -61.0 1.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -169.52 -165.63 0.53 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.19 149.85 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 126.342 1.857 . . . . 0.0 107.327 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -142.55 160.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -66.72 154.42 91.67 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.515 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.65 141.85 72.59 Favored 'Cis proline' 0 N--CA 1.455 -0.76 0 CA-C-N 118.89 0.639 . . . . 0.0 111.322 0.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -132.91 108.87 9.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.4 ttt -133.57 143.46 48.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 119.148 0.885 . . . . 0.0 109.529 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -119.48 144.44 46.99 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.057 0.39 . . . . 0.0 111.95 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -121.37 149.53 42.83 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.2 m -80.77 137.97 36.27 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.62 132.02 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.205 1.402 . . . . 0.0 108.211 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.0 p90 . . . . . 0 N--CA 1.45 -0.445 0 O-C-N 121.448 -0.782 . . . . 0.0 110.217 -167.58 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.4 mm . . . . . 0 CA--C 1.53 0.201 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -100.44 -25.16 14.3 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.227 0.467 . . . . 0.0 111.431 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.73 -164.49 32.17 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 118.649 0.659 . . . . 0.0 111.461 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -144.22 164.77 29.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.038 1.335 . . . . 0.0 107.561 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -127.4 145.19 50.9 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.063 0.945 . . . . 0.0 108.816 167.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.2 119.12 32.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -114.84 105.36 12.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.12 143.41 47.95 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.819 0.848 . . . . 0.0 111.191 -168.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -87.71 110.12 20.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.1 p -95.24 139.43 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.502 1.121 . . . . 0.0 108.824 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -108.38 120.81 43.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.94 132.88 22.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m 46.81 45.08 14.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.117 0.967 . . . . 0.0 111.309 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t70 63.57 10.89 5.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.105 1.362 . . . . 0.0 113.656 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -110.52 140.22 45.02 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.227 1.411 . . . . 0.0 107.94 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.1 tp -98.69 120.47 39.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.135 0.974 . . . . 0.0 109.018 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -123.18 154.28 38.92 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.961 1.304 . . . . 0.0 108.638 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -96.45 128.79 43.71 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.11 126.92 55.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.809 1.244 . . . . 0.0 107.903 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -112.64 100.92 9.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.7 mm -96.21 147.34 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.727 1.611 . . . . 0.0 107.51 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -121.44 148.43 44.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 170.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.9 120.83 34.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 127.714 2.406 . . . . 0.0 106.194 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -97.27 115.72 28.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -63.48 -45.9 88.64 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.9 1.68 . . . . 0.0 110.701 -169.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -64.68 -50.21 67.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.83 0.452 . . . . 0.0 110.082 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 m -62.9 -35.18 79.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.063 0.945 . . . . 0.0 110.15 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 55.31 48.07 20.02 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.782 2.033 . . . . 0.0 110.141 -168.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.02 155.13 22.58 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -115.61 170.23 8.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.447 0.699 . . . . 0.0 111.124 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -165.29 149.08 8.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.544 1.138 . . . . 0.0 111.183 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.73 117.2 6.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 168.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.2 tp -85.0 -54.72 4.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -142.79 155.33 44.8 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -133.05 134.2 44.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 167.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -141.68 155.42 45.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -174.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.28 -164.99 16.08 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo . . . . . 0 N--CA 1.455 -0.739 0 CA-C-N 118.249 1.025 . . . . 0.0 110.275 1.318 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 . . . . . 0 N--CA 1.452 -0.34 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.25 141.69 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.74 157.95 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 123.837 0.855 . . . . 0.0 109.902 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.99 148.56 48.73 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.385 0.674 . . . . 0.0 109.709 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.11 137.63 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 167.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.31 -171.24 44.33 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -170.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.03 -42.72 64.54 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.635 2.89 . . . . 0.0 113.006 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -58.25 -52.88 63.74 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.087 0.946 . . . . 0.0 111.053 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 -41.38 87.87 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.74 0.816 . . . . 0.0 109.63 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -57.38 -50.77 71.92 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.577 0.751 . . . . 0.0 109.875 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -48.96 -54.9 13.59 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.262 1.025 . . . . 0.0 109.828 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 mt -55.37 -44.34 75.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.517 0.144 . . . . 0.0 111.157 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.27 -53.63 44.21 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.283 0.468 . . . . 0.0 112.31 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -55.88 -47.84 76.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.457 1.103 . . . . 0.0 109.286 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -56.85 -48.32 78.37 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.604 0.762 . . . . 0.0 110.412 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.13 -51.19 70.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.99 -37.74 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.66 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.73 -49.7 75.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.238 1.015 . . . . 0.0 109.843 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.3 -49.52 77.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.471 0.708 . . . . 0.0 109.328 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -53.38 -50.32 65.37 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -57.65 -48.32 79.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.301 1.04 . . . . 0.0 109.945 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.95 -38.95 87.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.528 0.331 . . . . 0.0 110.632 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.7 mt -73.87 -52.83 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.07 13.18 46.91 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.46 1.505 . . . . 0.0 113.701 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -53.05 -43.68 66.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.594 1.197 . . . . 0.0 112.041 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -108.24 36.42 2.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.598 0.759 . . . . 0.0 110.005 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.97 -149.63 50.59 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -111.16 76.99 1.01 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.557 1.143 . . . . 0.0 108.802 -169.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.7 139.51 45.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.776 0.43 . . . . 0.0 111.448 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m -93.42 104.3 16.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -48.98 133.53 18.02 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -106.79 -65.39 1.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.57 0.748 . . . . 0.0 109.058 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -167.11 164.43 15.77 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.689 1.196 . . . . 0.0 109.017 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.43 141.42 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.354 1.062 . . . . 0.0 108.958 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -141.24 168.49 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.369 0.668 . . . . 0.0 110.67 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.59 154.66 79.11 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.11 0.964 . . . . 0.0 110.864 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.03 137.67 50.79 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 CA-C-N 119.539 0.871 . . . . 0.0 111.746 -3.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 68.9 m -126.77 121.18 31.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.2 ttm -138.77 138.71 37.86 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.199 0.6 . . . . 0.0 109.75 -167.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -121.29 142.95 49.46 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.999 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -132.14 141.55 49.17 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.927 0.891 . . . . 0.0 110.153 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.4 m -76.23 141.21 41.81 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.362 0.265 . . . . 0.0 110.989 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -110.56 123.72 66.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 125.772 1.629 . . . . 0.0 109.19 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 . . . . . 0 N--CA 1.455 -0.2 0 C-N-CA 125.305 1.442 . . . . 0.0 110.693 -176.393 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt . . . . . 0 CA--C 1.531 0.224 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -99.43 -34.62 10.2 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.354 0.661 . . . . 0.0 109.936 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.6 -157.64 19.61 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -172.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -142.96 160.0 41.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -123.14 150.28 43.47 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.354 1.461 . . . . 0.0 109.05 170.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -133.81 123.59 25.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -122.21 127.9 50.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.77 158.08 38.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.94 0.4 . . . . 0.0 110.839 -174.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -96.63 112.74 24.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.998 0.919 . . . . 0.0 109.355 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 p -103.28 132.45 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 124.091 0.956 . . . . 0.0 109.543 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.72 119.95 28.56 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.84 127.6 36.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 t 53.06 39.81 30.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.58 0.752 . . . . 0.0 111.001 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.8 t0 53.45 28.1 7.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.064 1.345 . . . . 0.0 113.245 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -118.61 134.88 54.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.2 tp -89.73 128.37 36.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -129.32 139.87 51.6 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.992 1.317 . . . . 0.0 109.711 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -88.19 108.2 19.16 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.868 1.267 . . . . 0.0 108.566 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.57 134.6 48.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -123.63 125.24 44.47 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.517 1.527 . . . . 0.0 107.608 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.09 146.74 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 126.004 1.721 . . . . 0.0 108.132 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.5 161.16 15.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.912 0.885 . . . . 0.0 108.744 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.66 119.33 11.1 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -97.32 122.06 39.92 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.729 1.212 . . . . 0.0 109.837 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -58.04 -39.38 78.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.27 0.628 . . . . 0.0 112.423 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -56.48 -51.62 67.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.153 0.581 . . . . 0.0 111.039 -171.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.6 p -107.31 4.81 26.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.547 1.139 . . . . 0.0 111.555 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.9 ptt85 46.78 40.72 9.28 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.809 1.244 . . . . 0.0 110.185 -168.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.88 125.31 8.36 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.6 -167.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -78.66 175.07 10.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.617 1.167 . . . . 0.0 109.952 171.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.67 118.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.994 2.117 . . . . 0.0 113.512 -167.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.1 tp -65.82 132.1 47.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.89 -62.58 1.46 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 167.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -145.65 151.95 38.87 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.322 0.649 . . . . 0.0 109.699 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -135.46 115.12 12.8 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.39 143.12 51.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.662 0.785 . . . . 0.0 108.893 -167.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.0 -157.69 25.49 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 N--CA 1.457 -0.624 0 CA-C-N 118.757 1.279 . . . . 0.0 110.123 -1.973 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 . . . . . 0 C--O 1.232 0.183 0 N-CA-C 110.367 -0.235 . . . . 0.0 110.367 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.0 mt -72.65 132.57 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 pt -99.14 153.79 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.299 0.64 . . . . 0.0 110.7 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.92 124.45 20.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.754 0.821 . . . . 0.0 108.791 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.29 122.12 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.79 -160.47 26.98 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.44 -46.24 25.6 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.865 2.377 . . . . 0.0 112.974 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -53.07 -54.72 31.3 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.31 1.052 . . . . 0.0 111.076 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -47.46 83.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.963 1.305 . . . . 0.0 109.416 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -53.74 -49.24 68.59 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.636 0.774 . . . . 0.0 110.025 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -55.94 -49.2 74.16 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.315 0.646 . . . . 0.0 110.859 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.27 -44.41 95.36 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.779 -0.576 . . . . 0.0 111.218 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.73 -47.53 87.98 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -52.84 -54.02 40.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.929 1.292 . . . . 0.0 109.793 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -55.95 -46.22 78.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.472 1.109 . . . . 0.0 110.623 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.02 -51.69 68.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.924 0.392 . . . . 0.0 110.467 177.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.91 -39.41 85.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.57 -50.86 70.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.976 0.91 . . . . 0.0 109.479 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -56.15 -51.04 69.42 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.13 0.972 . . . . 0.0 109.286 176.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -57.04 -51.24 70.05 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -55.32 -44.22 75.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.759 1.224 . . . . 0.0 109.999 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -58.07 -42.63 85.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.894 0.478 . . . . 0.0 110.414 -177.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.1 mt -73.41 -46.69 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.42 18.83 43.93 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.386 1.47 . . . . 0.0 112.716 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -54.42 -43.09 71.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.378 1.089 . . . . 0.0 111.256 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -107.74 30.69 6.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.938 0.895 . . . . 0.0 110.473 176.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.57 -152.15 52.49 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -100.01 118.24 35.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.118 0.967 . . . . 0.0 109.227 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.28 -171.89 1.93 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.0 m -141.36 125.4 17.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -55.03 132.6 47.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -107.66 -65.31 1.12 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -175.78 4.05 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.363 0.665 . . . . 0.0 110.842 173.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 t -120.72 141.19 42.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.43 168.25 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.477 0.581 . . . . 0.0 110.254 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 147.91 71.11 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.682 0.793 . . . . 0.0 111.658 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.31 153.31 91.93 Favored 'Cis proline' 0 N--CA 1.455 -0.787 0 CA-C-N 119.085 0.709 . . . . 0.0 111.058 -1.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.8 m -142.4 87.69 2.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.8 ttt -112.43 123.5 50.43 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.149 0.58 . . . . 0.0 110.938 -167.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -100.23 136.37 40.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.09 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -122.85 153.91 38.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.227 1.811 . . . . 0.0 109.379 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.1 m -89.65 138.99 30.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.417 1.087 . . . . 0.0 110.124 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.64 122.71 62.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.944 1.297 . . . . 0.0 109.31 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.2 p90 . . . . . 0 N--CA 1.449 -0.511 0 C-N-CA 123.848 0.859 . . . . 0.0 111.227 -177.764 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.5 mt . . . . . 0 N--CA 1.456 -0.142 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -91.17 -33.03 15.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.54 -148.93 9.01 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -169.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -147.54 169.06 20.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.376 1.07 . . . . 0.0 109.531 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -136.89 155.22 50.05 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.126 0.97 . . . . 0.0 110.203 167.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -133.42 118.07 17.98 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -175.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.59 107.95 16.86 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -150.34 152.63 34.71 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -169.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -99.3 116.74 32.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.272 1.029 . . . . 0.0 110.552 -173.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.48 127.8 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 126.06 1.744 . . . . 0.0 109.123 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -84.66 114.97 22.4 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 170.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.42 121.81 40.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.9 1.28 . . . . 0.0 109.016 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 t 71.15 -67.93 0.24 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 128.969 2.907 . . . . 0.0 107.058 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -178.13 26.6 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.295 2.638 . . . . 0.0 110.047 170.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -111.71 135.75 51.89 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.4 tp -86.9 124.44 33.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -120.5 145.19 47.52 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -86.28 131.11 34.3 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.27 138.95 53.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -118.45 121.84 41.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 171.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.9 mm -120.84 150.44 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.487 1.915 . . . . 0.0 106.255 -173.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t -124.48 158.16 33.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.153 0.888 . . . . 0.0 109.612 168.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.77 133.55 46.09 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 170.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -103.15 118.98 38.0 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 124.155 0.909 . . . . 0.0 108.818 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -64.7 -24.02 67.44 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.965 0.906 . . . . 0.0 112.304 -171.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -56.97 -40.92 77.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.586 0.63 . . . . 0.0 111.018 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.0 m -103.87 -16.88 15.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.576 0.751 . . . . 0.0 110.652 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 55.2 36.25 26.61 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.944 1.298 . . . . 0.0 109.646 -167.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.53 137.99 14.59 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.54 164.69 13.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.296 0.638 . . . . 0.0 111.852 -176.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.77 140.09 16.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.004 1.321 . . . . 0.0 110.56 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.3 125.07 22.64 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 170.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.54 -56.76 3.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -148.12 157.78 43.7 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.926 1.29 . . . . 0.0 109.292 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -138.07 125.15 21.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -137.65 149.49 46.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.77 -166.25 24.62 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo . . . . . 0 N--CA 1.456 -0.685 0 CA-C-N 118.23 1.015 . . . . 0.0 110.954 2.493 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 . . . . . 0 N--CA 1.457 -0.092 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.6 mm -76.1 135.22 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.44 163.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 123.92 0.888 . . . . 0.0 109.759 174.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.01 154.85 40.33 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.788 0.804 . . . . 0.0 110.446 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -94.41 138.24 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 167.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.58 -170.53 43.66 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -55.91 -45.5 38.25 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.298 2.666 . . . . 0.0 111.907 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -53.59 -52.33 60.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.043 0.925 . . . . 0.0 110.732 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -42.67 91.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.794 0.838 . . . . 0.0 110.083 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -54.1 -51.98 62.46 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.478 -0.773 . . . . 0.0 109.752 172.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -50.48 -50.96 51.18 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.915 0.779 . . . . 0.0 110.865 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.3 mt -58.42 -49.09 78.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.96 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.91 -37.01 75.92 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 122.108 -0.37 . . . . 0.0 112.238 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -73.96 -45.37 50.64 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.24 -48.32 65.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.03 0.932 . . . . 0.0 110.876 169.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.26 -53.44 58.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.574 0.702 . . . . 0.0 110.369 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.0 t -61.42 -38.47 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.632 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.55 -48.63 76.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.924 0.89 . . . . 0.0 109.974 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.77 -49.82 72.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.996 0.918 . . . . 0.0 108.727 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.22 -44.29 95.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.376 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -62.42 -44.7 95.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.228 1.011 . . . . 0.0 109.795 175.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -58.62 -47.81 83.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.486 0.714 . . . . 0.0 109.892 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.01 -39.53 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.58 22.83 61.39 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.73 1.157 . . . . 0.0 110.474 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -60.79 -33.64 73.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 117.651 0.726 . . . . 0.0 111.312 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -116.01 32.03 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.446 1.098 . . . . 0.0 109.591 174.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.7 -151.96 46.2 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -87.56 135.0 33.53 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.136 0.575 . . . . 0.0 109.636 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.6 mt -127.99 133.42 49.17 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.132 0.973 . . . . 0.0 109.319 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.2 m -99.68 97.6 8.54 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.523 1.129 . . . . 0.0 108.321 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -50.21 132.94 24.06 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 123.466 0.706 . . . . 0.0 111.074 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -98.94 -65.11 0.98 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 168.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -172.26 167.63 5.79 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 123.451 0.7 . . . . 0.0 110.11 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.24 142.48 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 124.432 1.093 . . . . 0.0 109.09 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.98 177.0 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.281 0.632 . . . . 0.0 110.251 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -63.13 153.26 81.96 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.654 0.782 . . . . 0.0 112.716 -172.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -83.12 169.63 57.53 Favored 'Cis proline' 0 N--CA 1.45 -1.047 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 -7.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.9 t -132.97 97.8 4.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 168.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 126.78 33.61 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.47 1.508 . . . . 0.0 107.765 -174.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -114.01 113.77 25.24 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 118.093 -0.956 . . . . 0.0 108.652 168.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -114.37 141.47 47.59 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.606 1.162 . . . . 0.0 111.158 173.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.5 142.25 46.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.69 120.18 62.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.392 1.091 . . . . 0.0 109.251 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 p90 . . . . . 0 N--CA 1.444 -0.764 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -176.362 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.6 mt . . . . . 0 N--CA 1.453 -0.299 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.16 -35.38 14.58 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.31 -152.25 9.21 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -148.42 159.72 43.75 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.584 1.554 . . . . 0.0 107.818 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -126.93 142.74 51.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.147 1.779 . . . . 0.0 108.358 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -126.9 105.63 8.76 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -106.16 117.77 34.88 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 pp -149.64 146.44 27.29 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.897 0.771 . . . . 0.0 111.974 -166.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -88.51 112.69 23.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 p -106.39 138.6 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.101 0.961 . . . . 0.0 109.523 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -103.54 123.12 46.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.133 1.773 . . . . 0.0 106.966 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.45 132.09 25.57 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t 46.77 41.48 10.4 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.447 1.099 . . . . 0.0 111.331 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.4 t70 62.45 19.47 11.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.11 1.364 . . . . 0.0 113.343 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -113.94 135.15 54.31 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.809 1.243 . . . . 0.0 107.873 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.51 126.81 37.76 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.4 143.39 50.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.934 1.294 . . . . 0.0 108.748 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -85.32 110.48 19.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.55 126.69 38.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -108.0 111.23 23.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -100.59 150.74 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.9 p -127.62 154.27 45.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.47 0.708 . . . . 0.0 109.198 176.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -123.33 135.97 54.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.92 120.98 40.95 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -67.31 -33.49 75.39 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.7 -0.625 . . . . 0.0 110.703 -172.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.062 0.945 . . . . 0.0 111.209 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -90.61 -22.95 20.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.084 0.554 . . . . 0.0 110.243 175.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 65.17 33.73 9.13 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.782 1.233 . . . . 0.0 110.233 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.18 155.74 15.95 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.3 mtt85 -115.13 163.74 15.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 117.446 0.623 . . . . 0.0 111.285 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 152.39 16.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.275 1.43 . . . . 0.0 111.331 177.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 tp -69.63 127.56 33.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.634 1.174 . . . . 0.0 109.845 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.69 -54.78 5.33 Favored 'General case' 0 C--N 1.337 0.041 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -170.44 169.05 7.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 111.197 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -131.87 88.44 2.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.288 1.835 . . . . 0.0 108.166 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.65 145.7 27.86 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.65 -159.85 24.63 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo . . . . . 0 N--CA 1.458 -0.559 0 CA-C-N 118.808 1.304 . . . . 0.0 110.071 -1.993 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 1.495 0 N-CA-C 112.072 -0.411 . . . . 0.0 112.072 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.9 mt-10 -103.44 103.0 12.94 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 106.896 -1.52 . . . . 0.0 106.896 172.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 22.2 m95 32.34 72.8 0.07 Allowed 'General case' 0 CA--C 1.537 0.48 0 C-N-CA 126.007 1.723 . . . . 0.0 113.751 -176.27 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -125.38 155.86 39.67 Favored 'General case' 0 N--CA 1.464 0.256 0 C-N-CA 123.58 0.752 . . . . 0.0 109.536 -178.027 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 22.4 mm -84.28 143.32 12.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.105 0 N-CA-C 108.058 -1.09 . . . . 0.0 108.058 179.607 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 17.7 pt -104.99 154.84 6.37 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.242 0 C-N-CA 123.637 0.775 . . . . 0.0 110.825 177.043 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -69.48 118.58 12.54 Favored 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 123.849 0.86 . . . . 0.0 109.388 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.7 OUTLIER -69.45 129.13 33.77 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.673 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 172.41 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.01 -167.15 39.53 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 107.317 -2.313 . . . . 0.0 107.317 -172.327 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -50.97 -41.73 55.1 Favored 'Trans proline' 0 N--CA 1.457 -0.635 0 C-N-CA 123.711 2.941 . . . . 0.0 112.857 -174.044 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 76.6 t80 -53.85 -60.75 2.91 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.648 0.779 . . . . 0.0 111.64 175.361 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 1.9 m -63.09 -43.55 98.21 Favored 'General case' 0 N--CA 1.453 -0.319 0 O-C-N 121.617 -0.677 . . . . 0.0 110.082 -176.584 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 37.4 mt-30 -51.03 -53.46 33.37 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 108.953 -0.758 . . . . 0.0 108.953 174.915 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 26.4 t-20 -53.13 -49.71 65.99 Favored 'General case' 0 CA--C 1.528 0.103 0 C-N-CA 123.451 0.7 . . . . 0.0 111.34 179.691 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 57.0 mt -63.98 -45.08 90.63 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 120.592 -0.443 . . . . 0.0 111.644 -179.12 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.63 -43.47 96.19 Favored Glycine 0 CA--C 1.53 0.978 0 N-CA-C 110.708 -0.957 . . . . 0.0 110.708 175.723 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.1 tmtt? -57.23 -53.4 58.55 Favored 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 124.034 0.934 . . . . 0.0 108.872 178.184 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 20.2 t80 -53.6 -45.04 69.9 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 124.881 1.272 . . . . 0.0 110.829 176.732 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.87 -51.88 67.33 Favored 'General case' 0 N--CA 1.456 -0.151 0 CA-C-O 120.908 0.385 . . . . 0.0 110.585 176.626 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.1 t -62.12 -39.48 84.04 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.326 0 CA-C-N 116.4 -0.364 . . . . 0.0 110.468 178.295 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.9 t70 -62.01 -47.58 84.13 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 123.955 0.902 . . . . 0.0 110.195 -179.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.5 tp10 -58.71 -53.98 52.23 Favored 'General case' 0 N--CA 1.454 -0.241 0 C-N-CA 124.048 0.939 . . . . 0.0 109.095 175.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.5 tm-20 -54.08 -48.18 70.92 Favored 'General case' 0 N--CA 1.451 -0.393 0 C-N-CA 122.987 0.515 . . . . 0.0 110.116 -179.76 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 39.8 m-20 -60.95 -44.24 97.57 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 125.343 1.457 . . . . 0.0 110.246 178.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.8 tttp -60.82 -42.02 96.89 Favored 'General case' 0 CA--C 1.53 0.198 0 C-N-CA 122.678 0.391 . . . . 0.0 110.108 -179.983 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 90.4 mt -65.3 -43.51 95.05 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.423 0 N-CA-C 109.57 -0.53 . . . . 0.0 109.57 172.381 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 86.58 17.78 59.65 Favored Glycine 0 CA--C 1.527 0.805 0 C-N-CA 124.983 1.278 . . . . 0.0 111.749 179.322 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 59.9 tt0 -57.93 -38.45 75.96 Favored 'General case' 0 CA--C 1.534 0.334 0 CA-C-N 117.7 0.75 . . . . 0.0 111.329 -172.232 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 21.8 m-85 -118.81 41.72 2.96 Favored 'General case' 0 CA--C 1.532 0.27 0 C-N-CA 124.812 1.245 . . . . 0.0 109.421 170.868 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.51 -141.9 48.03 Favored Glycine 0 CA--C 1.529 0.939 0 N-CA-C 110.428 -1.069 . . . . 0.0 110.428 -177.054 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 49.5 ttp180 -118.51 106.12 12.35 Favored 'General case' 0 CA--C 1.531 0.218 0 C-N-CA 124.611 1.165 . . . . 0.0 109.2 -175.787 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.6 mp -95.49 151.92 18.88 Favored 'General case' 0 CA--C 1.529 0.139 0 CA-C-N 118.177 0.444 . . . . 0.0 110.854 177.906 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.2 m -93.27 96.13 9.79 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.026 -1.102 . . . . 0.0 108.026 178.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 29.6 t80 -45.27 130.85 8.14 Favored 'General case' 0 N--CA 1.462 0.136 0 C-N-CA 122.465 0.306 . . . . 0.0 110.474 173.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.8 m-80 -105.82 -66.23 1.01 Allowed 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.928 0.891 . . . . 0.0 109.141 176.573 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 26.2 tttt -165.56 -175.01 3.34 Favored 'General case' 0 CA--C 1.533 0.324 0 N-CA-C 108.274 -1.01 . . . . 0.0 108.274 -174.986 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 20.6 t -124.62 143.02 39.55 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.188 0 N-CA-C 106.576 -1.639 . . . . 0.0 106.576 171.05 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.45 167.05 26.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.191 0 C-N-CA 123.097 0.559 . . . . 0.0 110.057 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -61.04 152.12 72.31 Favored Pre-proline 0 CA--C 1.541 0.596 0 C-N-CA 122.875 0.47 . . . . 0.0 112.088 -175.904 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 74.1 Cg_endo -74.33 152.01 97.69 Favored 'Cis proline' 0 N--CA 1.453 -0.884 0 CA-C-N 119.074 0.705 . . . . 0.0 111.064 -3.13 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 83.8 m -138.85 81.07 1.82 Allowed 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 178.124 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 34.5 ttm -105.77 138.53 41.82 Favored 'General case' 0 N--CA 1.455 -0.22 0 C-N-CA 123.047 0.539 . . . . 0.0 110.684 -167.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.8 ttpt -122.29 144.84 48.75 Favored 'General case' 0 C--O 1.235 0.32 0 C-N-CA 125.76 1.624 . . . . 0.0 109.69 -178.274 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -141.11 141.75 34.18 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 124.061 0.944 . . . . 0.0 109.7 169.919 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 14.5 t -63.86 142.39 58.42 Favored 'General case' 0 CA--C 1.536 0.409 0 C-N-CA 122.625 0.37 . . . . 0.0 110.311 168.323 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.05 126.11 72.54 Favored 'Isoleucine or valine' 0 C--O 1.239 0.535 0 C-N-CA 125.005 1.322 . . . . 0.0 110.27 178.093 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 91.7 m-85 -96.58 171.17 8.71 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 124.931 1.292 . . . . 0.0 110.08 177.418 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -153.9 -149.03 0.27 Allowed 'General case' 0 N--CA 1.449 -0.516 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 169.04 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER 70.44 -46.25 0.61 Allowed 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 127.969 2.508 . . . . 0.0 112.484 -176.752 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 67.14 165.83 0.22 Allowed 'General case' 0 CA--C 1.537 0.477 0 C-N-CA 125.898 1.679 . . . . 0.0 110.142 -175.568 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 62.43 -83.05 0.03 OUTLIER Glycine 0 CA--C 1.525 0.7 0 C-N-CA 125.077 1.322 . . . . 0.0 111.53 178.806 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 87.2 m-85 -67.42 -36.29 80.95 Favored 'General case' 0 C--N 1.33 -0.255 0 C-N-CA 124.393 1.077 . . . . 0.0 110.241 172.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 76.9 mtt180 73.25 154.08 0.14 Allowed 'General case' 0 CA--C 1.537 0.465 0 C-N-CA 125.947 1.699 . . . . 0.0 110.74 -175.453 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 34.3 tt0 -159.6 149.65 18.73 Favored 'General case' 0 N--CA 1.454 -0.226 0 N-CA-C 107.684 -1.228 . . . . 0.0 107.684 169.662 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 69.3 mt -69.49 134.83 29.49 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 N-CA-C 107.826 -1.175 . . . . 0.0 107.826 173.894 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 4.5 ttpm? -117.92 -33.72 4.39 Favored 'General case' 0 CA--C 1.53 0.197 0 CA-C-N 118.502 0.592 . . . . 0.0 111.655 175.494 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.93 -154.02 11.09 Favored Glycine 0 C--N 1.333 0.403 0 C-N-CA 120.603 -0.808 . . . . 0.0 111.206 -170.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.67 161.24 39.68 Favored 'General case' 0 N--CA 1.45 -0.431 0 C-N-CA 125.087 1.355 . . . . 0.0 108.185 175.59 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 77.8 mt-10 -125.0 151.1 45.98 Favored 'General case' 0 C--O 1.235 0.295 0 C-N-CA 124.482 1.113 . . . . 0.0 109.28 169.07 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 64.3 m-85 -134.76 118.32 16.94 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 125.616 1.566 . . . . 0.0 107.58 -179.038 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -107.58 111.65 24.0 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.775 1.23 . . . . 0.0 107.842 176.151 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.4 pp -138.52 154.29 48.77 Favored 'General case' 0 CA--C 1.527 0.088 0 C-N-CA 122.791 0.437 . . . . 0.0 111.516 -172.68 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -103.07 104.55 14.73 Favored 'General case' 0 N--CA 1.452 -0.373 0 C-N-CA 124.214 1.006 . . . . 0.0 109.312 -178.059 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -96.55 133.56 37.45 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 C-N-CA 125.558 1.543 . . . . 0.0 110.102 -175.885 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -97.78 123.28 41.67 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.433 1.493 . . . . 0.0 108.476 176.467 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -139.51 130.63 26.52 Favored 'General case' 0 N--CA 1.454 -0.237 0 N-CA-C 108.611 -0.885 . . . . 0.0 108.611 175.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 20.4 m 50.45 40.28 22.74 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.419 1.088 . . . . 0.0 111.584 -174.959 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.8 t0 50.11 32.66 6.1 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 124.884 1.274 . . . . 0.0 112.972 -174.192 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 34.4 mmtm -119.07 129.79 55.27 Favored 'General case' 0 N--CA 1.452 -0.342 0 N-CA-C 106.173 -1.788 . . . . 0.0 106.173 169.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.3 tp -94.66 125.65 39.45 Favored 'General case' 0 N--CA 1.451 -0.404 0 N-CA-C 108.456 -0.942 . . . . 0.0 108.456 -176.854 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.7 m-85 -124.62 149.5 47.02 Favored 'General case' 0 N--CA 1.457 -0.088 0 C-N-CA 125.313 1.445 . . . . 0.0 108.17 178.415 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 11.0 ttp180 -92.15 123.64 35.64 Favored 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 172.098 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -111.65 133.08 54.14 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 173.119 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.2 t0 -107.4 122.01 45.75 Favored 'General case' 0 CA--C 1.519 -0.214 0 N-CA-C 106.661 -1.607 . . . . 0.0 106.661 169.718 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mm -113.27 146.19 18.22 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.3 0 C-N-CA 126.098 1.759 . . . . 0.0 106.82 -178.033 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.4 t -112.2 154.47 25.5 Favored 'General case' 0 C--O 1.231 0.117 0 N-CA-C 107.784 -1.191 . . . . 0.0 107.784 169.563 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 53.7 tt0 -130.95 115.47 16.56 Favored 'General case' 0 N--CA 1.455 -0.223 0 C-N-CA 126.643 1.977 . . . . 0.0 106.669 169.221 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 10.9 t70 -86.93 124.42 33.12 Favored 'General case' 0 CA--C 1.526 0.03 0 N-CA-C 108.096 -1.076 . . . . 0.0 108.096 175.049 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.0 t80 -58.34 -49.26 77.82 Favored 'General case' 0 CA--C 1.53 0.195 0 C-N-CA 123.659 0.784 . . . . 0.0 111.063 -175.307 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.2 ttmt -68.89 -51.73 37.01 Favored 'General case' 0 N--CA 1.454 -0.243 0 C-N-CA 123.535 0.734 . . . . 0.0 110.777 -169.742 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 6.8 m -62.86 -34.0 76.45 Favored 'General case' 0 N--CA 1.455 -0.189 0 N-CA-C 109.575 -0.528 . . . . 0.0 109.575 172.756 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 12.8 ttt180 64.04 34.69 11.13 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 125.202 1.401 . . . . 0.0 109.933 -176.679 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -125.33 143.71 14.68 Favored Glycine 0 C--N 1.332 0.335 0 N-CA-C 108.368 -1.893 . . . . 0.0 108.368 -177.014 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -93.11 165.31 12.89 Favored 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 122.795 0.438 . . . . 0.0 110.654 174.433 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -161.13 152.87 19.45 Favored 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 123.176 0.59 . . . . 0.0 111.299 170.528 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.4 tp -71.67 118.64 14.76 Favored 'General case' 0 CA--C 1.533 0.312 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 175.525 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 24.3 mt -75.57 -50.87 14.29 Favored 'General case' 0 CA--C 1.527 0.08 0 N-CA-C 108.904 -0.776 . . . . 0.0 108.904 167.869 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 6.8 ptp180 -156.73 160.67 39.52 Favored 'General case' 0 C--O 1.232 0.149 0 CA-C-N 117.897 0.317 . . . . 0.0 111.145 179.945 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 54.1 t80 -135.75 101.22 4.69 Favored 'General case' 0 CA--C 1.529 0.162 0 C-N-CA 126.142 1.777 . . . . 0.0 107.074 177.786 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -105.8 152.29 23.41 Favored 'General case' 0 N--CA 1.452 -0.363 0 C-N-CA 123.928 0.891 . . . . 0.0 109.086 -179.529 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 134.59 -168.03 23.69 Favored Glycine 0 CA--C 1.528 0.865 0 N-CA-C 110.514 -1.034 . . . . 0.0 110.514 174.202 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 59.6 Cg_endo -66.6 149.34 79.42 Favored 'Cis proline' 0 N--CA 1.457 -0.673 0 CA-C-N 118.24 1.02 . . . . 0.0 111.167 2.966 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.99 131.92 15.78 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 124.738 1.215 . . . . 0.0 108.132 178.175 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.0 Cg_endo -73.03 159.47 47.75 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.061 1.841 . . . . 0.0 109.99 179.187 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.5 Cg_endo -68.01 157.14 63.09 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.156 1.904 . . . . 0.0 109.454 169.826 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 69.0 Cg_endo . . . . . 0 C--O 1.25 1.09 0 C-N-CA 122.534 2.156 . . . . 0.0 110.872 177.001 . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.299 0 N-CA-C 111.471 -0.652 . . . . 0.0 111.471 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 4.0 tt0 62.43 -172.39 0.16 Allowed 'General case' 0 CA--C 1.535 0.382 0 N-CA-C 109.558 -0.534 . . . . 0.0 109.558 -171.588 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.463 ' CE3' ' HB2' ' A' ' 44' ' ' LYS . 5.0 m95 -61.41 104.48 0.41 Allowed 'General case' 0 CA--C 1.53 0.181 0 N-CA-C 108.861 -0.792 . . . . 0.0 108.861 170.39 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -153.07 155.12 36.24 Favored 'General case' 0 C--O 1.233 0.189 0 N-CA-C 109.524 -0.547 . . . . 0.0 109.524 -179.799 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.42 HD12 ' H ' ' A' ' 5' ' ' ILE . 4.7 mp -78.72 138.57 19.89 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.262 0 N-CA-C 108.01 -1.107 . . . . 0.0 108.01 175.057 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 35.6 pt -106.46 154.32 7.54 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 124.322 1.049 . . . . 0.0 109.833 175.535 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.3 m-20 -66.66 145.41 55.59 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 123.207 0.603 . . . . 0.0 109.814 -179.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 7.2 pt -83.3 122.43 37.52 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.807 0 N-CA-C 107.568 -1.271 . . . . 0.0 107.568 167.955 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -176.14 -165.23 31.6 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 108.772 -1.731 . . . . 0.0 108.772 -174.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -56.41 -41.77 72.79 Favored 'Trans proline' 0 N--CA 1.456 -0.731 0 C-N-CA 122.942 2.428 . . . . 0.0 112.282 -172.429 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 30.0 t80 -58.87 -49.29 78.31 Favored 'General case' 0 CA--C 1.534 0.36 0 CA-C-O 121.809 0.814 . . . . 0.0 110.91 177.768 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.13 -47.54 82.31 Favored 'General case' 0 N--CA 1.45 -0.445 0 C-N-CA 124.859 1.264 . . . . 0.0 109.688 -179.296 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.6 mt-30 -54.52 -49.28 70.61 Favored 'General case' 0 N--CA 1.447 -0.618 0 C-N-CA 123.107 0.563 . . . . 0.0 110.054 174.915 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -55.92 -48.58 75.44 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 123.715 0.806 . . . . 0.0 110.499 177.838 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 31.5 mt -56.15 -46.54 79.21 Favored 'General case' 0 CA--C 1.529 0.146 0 O-C-N 121.992 -0.442 . . . . 0.0 110.949 175.48 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.76 -56.32 25.77 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 111.472 -0.651 . . . . 0.0 111.472 178.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.0 tmtt? -51.71 -50.45 60.48 Favored 'General case' 0 N--CA 1.444 -0.741 0 C-N-CA 125.668 1.587 . . . . 0.0 109.822 177.472 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 32.9 t80 -55.08 -50.34 69.41 Favored 'General case' 0 C--N 1.329 -0.323 0 C-N-CA 124.884 1.273 . . . . 0.0 110.75 177.069 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.29 -50.37 71.61 Favored 'General case' 0 N--CA 1.455 -0.216 0 N-CA-C 109.88 -0.415 . . . . 0.0 109.88 179.099 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.4 t -63.85 -39.83 86.84 Favored 'Isoleucine or valine' 0 C--O 1.222 -0.353 0 CA-C-N 116.286 -0.416 . . . . 0.0 110.478 179.259 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.3 t70 -62.93 -49.78 73.44 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.28 1.032 . . . . 0.0 109.544 -177.654 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -56.43 -53.84 52.68 Favored 'General case' 0 N--CA 1.454 -0.245 0 C-N-CA 124.033 0.933 . . . . 0.0 108.897 174.778 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 28.1 tt0 -58.4 -41.05 84.03 Favored 'General case' 0 N--CA 1.45 -0.441 0 CA-C-N 116.325 -0.398 . . . . 0.0 111.474 -176.384 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 45.8 m-20 -70.46 -39.46 74.28 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 125.459 1.503 . . . . 0.0 110.136 179.247 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 64.5 tttm -60.52 -45.99 91.81 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 123.279 0.632 . . . . 0.0 109.363 177.186 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.4 mt -64.66 -40.47 89.17 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.447 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 171.683 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 85.05 19.88 58.47 Favored Glycine 0 CA--C 1.527 0.812 0 C-N-CA 125.44 1.495 . . . . 0.0 110.896 -176.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.8 tt0 -61.49 -35.7 78.41 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.858 0.829 . . . . 0.0 111.152 -170.225 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.9 m-85 -118.87 39.97 3.39 Favored 'General case' 0 CA--C 1.534 0.345 0 C-N-CA 123.804 0.842 . . . . 0.0 109.337 171.134 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.51 -141.29 44.47 Favored Glycine 0 CA--C 1.53 1.008 0 N-CA-C 110.619 -0.993 . . . . 0.0 110.619 -176.261 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 97.0 mtt180 -101.92 93.72 5.43 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.58 1.152 . . . . 0.0 109.629 178.444 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 82.2 mt -80.72 139.99 35.81 Favored 'General case' 0 CA--C 1.529 0.169 0 CA-C-N 118.197 0.453 . . . . 0.0 110.02 173.706 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.2 m -94.0 90.13 6.32 Favored 'General case' 0 N--CA 1.454 -0.266 0 C-N-CA 124.508 1.123 . . . . 0.0 108.49 -179.151 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 73.7 t80 -51.42 132.7 29.74 Favored 'General case' 0 N--CA 1.457 -0.119 0 O-C-N 122.188 -0.32 . . . . 0.0 111.458 177.815 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 17.9 m-80 -104.07 -66.09 0.98 Allowed 'General case' 0 C--N 1.334 -0.093 0 C-N-CA 123.544 0.738 . . . . 0.0 109.193 169.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 25.6 pttm -164.93 -168.59 1.48 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 123.151 0.58 . . . . 0.0 109.593 -172.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 40.2 t -128.9 145.45 35.72 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.262 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 173.351 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 21.7 pt -133.62 173.42 14.75 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.164 0 C-N-CA 123.351 0.66 . . . . 0.0 110.22 175.14 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -62.87 152.6 82.47 Favored Pre-proline 0 CA--C 1.539 0.531 0 C-N-CA 123.893 0.877 . . . . 0.0 110.795 178.856 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 76.9 Cg_endo -72.07 151.83 96.34 Favored 'Cis proline' 0 N--CA 1.455 -0.767 0 N-CA-C 110.452 -0.634 . . . . 0.0 110.452 -5.788 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 60.4 m -138.9 90.36 2.43 Favored 'General case' 0 N--CA 1.453 -0.31 0 N-CA-C 105.622 -1.992 . . . . 0.0 105.622 177.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.1 ttt -111.31 138.43 47.79 Favored 'General case' 0 N--CA 1.456 -0.155 0 C-N-CA 123.406 0.682 . . . . 0.0 110.57 -169.59 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.4 ttmt -116.23 149.78 38.59 Favored 'General case' 0 N--CA 1.457 -0.093 0 C-N-CA 124.642 1.177 . . . . 0.0 108.492 -179.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.463 ' HB2' ' CE3' ' A' ' 3' ' ' TRP . 1.5 tmtp? -149.49 151.29 33.7 Favored 'General case' 0 CA--C 1.533 0.304 0 C-N-CA 123.599 0.76 . . . . 0.0 111.205 166.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.6 m -85.43 127.94 34.56 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 126.243 1.817 . . . . 0.0 111.586 -176.395 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.3 mp -99.44 136.29 31.2 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.377 0 C-N-CA 125.486 1.515 . . . . 0.0 109.369 177.387 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 41.8 m-85 -117.66 164.32 15.14 Favored 'General case' 0 CA--C 1.529 0.148 0 C-N-CA 126.061 1.744 . . . . 0.0 109.985 -179.408 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 6.9 tt0 -102.51 -153.73 0.47 Allowed 'General case' 0 CA--C 1.536 0.429 0 C-N-CA 123.963 0.905 . . . . 0.0 109.302 168.185 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 33.0 t30 -178.43 -38.06 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 126.154 1.782 . . . . 0.0 110.395 -169.602 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 48.8 tt0 -60.87 82.06 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.348 0 C-N-CA 125.383 1.473 . . . . 0.0 110.947 -178.695 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 92.35 63.15 1.13 Allowed Glycine 0 CA--C 1.522 0.52 0 N-CA-C 109.274 -1.53 . . . . 0.0 109.274 -177.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.0 t80 81.82 159.26 0.14 Allowed 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 126.478 1.911 . . . . 0.0 110.886 -179.092 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 74.0 ttt180 -99.01 129.67 45.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 124.079 0.952 . . . . 0.0 108.444 -177.498 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -157.47 156.82 32.76 Favored 'General case' 0 N--CA 1.451 -0.411 0 N-CA-C 107.302 -1.37 . . . . 0.0 107.302 178.466 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.8 mt -58.3 133.64 23.25 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.186 0 N-CA-C 108.115 -1.068 . . . . 0.0 108.115 172.63 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 80.4 tttt -115.61 -31.85 5.72 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 124.677 1.191 . . . . 0.0 110.592 177.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.01 -158.91 20.79 Favored Glycine 0 C--N 1.335 0.488 0 N-CA-C 110.916 -0.874 . . . . 0.0 110.916 -174.57 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -144.73 158.65 43.7 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 124.83 1.252 . . . . 0.0 108.217 176.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 16.3 pt-20 -114.19 153.54 29.42 Favored 'General case' 0 C--O 1.235 0.308 0 C-N-CA 125.211 1.404 . . . . 0.0 108.631 168.856 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.2 m-85 -136.42 117.21 14.07 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 179.949 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 72.7 mt-30 -110.47 113.88 26.86 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 107.649 -1.241 . . . . 0.0 107.649 175.345 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.6 pp -146.2 146.03 30.66 Favored 'General case' 0 N--CA 1.456 -0.155 0 CA-C-N 118.153 0.433 . . . . 0.0 111.726 -170.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -89.18 99.74 12.67 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 123.516 0.726 . . . . 0.0 109.242 -176.093 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 63.7 t -81.65 132.4 31.59 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 125.941 1.696 . . . . 0.0 109.013 -179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -103.34 114.63 29.07 Favored 'General case' 0 N--CA 1.453 -0.306 0 C-N-CA 125.489 1.516 . . . . 0.0 107.617 176.153 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -140.06 130.95 26.05 Favored 'General case' 0 C--O 1.225 -0.185 0 C-N-CA 124.103 0.961 . . . . 0.0 108.676 -177.953 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 25.0 t 50.67 39.23 21.17 Favored 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 124.461 1.104 . . . . 0.0 111.861 -178.758 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.3 t0 53.25 33.93 16.55 Favored 'General case' 0 CA--C 1.539 0.522 0 C-N-CA 124.316 1.046 . . . . 0.0 112.523 -175.478 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 72.6 mmtt -122.68 138.63 54.55 Favored 'General case' 0 N--CA 1.453 -0.324 0 N-CA-C 105.781 -1.933 . . . . 0.0 105.781 168.726 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 15.0 tp -105.32 127.08 52.78 Favored 'General case' 0 N--CA 1.45 -0.438 0 N-CA-C 108.516 -0.92 . . . . 0.0 108.516 179.641 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 -132.76 143.93 49.92 Favored 'General case' 0 C--O 1.227 -0.102 0 C-N-CA 125.137 1.375 . . . . 0.0 108.636 -177.878 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 10.1 ttm180 -82.35 116.16 21.72 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 107.986 -1.116 . . . . 0.0 107.986 170.811 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.6 132.76 43.75 Favored 'General case' 0 N--CA 1.451 -0.414 0 N-CA-C 107.534 -1.284 . . . . 0.0 107.534 168.813 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 48.5 t0 -110.47 125.28 53.12 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 106.486 -1.672 . . . . 0.0 106.486 169.809 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -123.98 152.91 29.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 C-N-CA 125.372 1.469 . . . . 0.0 107.28 -176.294 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 6.7 m -119.08 149.83 41.02 Favored 'General case' 0 N--CA 1.455 -0.19 0 C-N-CA 124.15 0.98 . . . . 0.0 109.151 169.323 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -125.04 122.4 37.16 Favored 'General case' 0 N--CA 1.463 0.18 0 N-CA-C 105.921 -1.881 . . . . 0.0 105.921 168.126 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -97.46 120.63 38.19 Favored 'General case' 0 C--O 1.231 0.09 0 N-CA-C 108.195 -1.039 . . . . 0.0 108.195 177.422 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 70.5 t80 -61.02 -53.0 62.54 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.203 1.001 . . . . 0.0 110.767 -170.079 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 87.3 tttt -58.62 -48.02 82.38 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.124 0.569 . . . . 0.0 110.111 -178.153 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 9.9 m -71.92 -20.24 61.8 Favored 'General case' 0 N--CA 1.452 -0.344 0 CA-C-O 119.054 -0.498 . . . . 0.0 110.629 -178.306 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 43.14 45.59 4.77 Favored 'General case' 0 C--N 1.343 0.305 0 C-N-CA 125.969 1.707 . . . . 0.0 111.091 -171.546 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -140.8 155.33 24.84 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 107.447 -2.261 . . . . 0.0 107.447 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.8 mtt85 -114.95 171.28 7.75 Favored 'General case' 0 N--CA 1.447 -0.595 0 C-N-CA 123.306 0.642 . . . . 0.0 110.841 -178.846 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.3 pptp? -155.35 146.95 23.08 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-N 115.587 -0.733 . . . . 0.0 111.298 170.617 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.4 tp -71.58 119.09 15.24 Favored 'General case' 0 N--CA 1.453 -0.28 0 N-CA-C 107.971 -1.122 . . . . 0.0 107.971 171.005 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.0 mt -73.83 -50.91 18.17 Favored 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 108.66 -0.867 . . . . 0.0 108.66 170.632 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 16.0 ptt180 -168.95 156.83 7.62 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 109.239 -0.652 . . . . 0.0 109.239 -171.346 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 49.1 t80 -133.53 89.11 2.55 Favored 'General case' 0 N--CA 1.455 -0.212 0 C-N-CA 125.641 1.576 . . . . 0.0 107.476 -177.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.3 m-20 -98.4 138.27 35.88 Favored 'General case' 0 N--CA 1.453 -0.323 0 N-CA-C 108.617 -0.883 . . . . 0.0 108.617 -170.057 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 154.43 -167.07 32.4 Favored Glycine 0 CA--C 1.527 0.834 0 CA-C-O 119.254 -0.748 . . . . 0.0 111.473 176.669 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.5 Cg_endo -64.55 145.9 63.92 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 CA-C-N 118.05 0.925 . . . . 0.0 111.113 2.123 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.08 127.77 15.0 Favored Pre-proline 0 CA--C 1.532 0.284 0 N-CA-C 107.919 -1.141 . . . . 0.0 107.919 176.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.2 Cg_endo -73.04 164.01 36.71 Favored 'Trans proline' 0 N--CA 1.454 -0.807 0 C-N-CA 122.471 2.114 . . . . 0.0 109.549 -179.606 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -72.62 153.14 54.41 Favored 'Trans proline' 0 N--CA 1.452 -0.92 0 C-N-CA 121.809 1.673 . . . . 0.0 109.231 176.497 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo . . . . . 0 C--O 1.25 1.097 0 C-N-CA 122.338 2.025 . . . . 0.0 110.766 176.445 . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.181 0 N-CA-C 111.414 -0.674 . . . . 0.0 111.414 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.1 tp10 54.27 49.33 18.8 Favored 'General case' 0 CA--C 1.536 0.442 0 C-N-CA 124.412 1.085 . . . . 0.0 110.901 -179.086 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 59.7 m95 -112.6 129.44 56.37 Favored 'General case' 0 N--CA 1.453 -0.312 0 N-CA-C 107.379 -1.341 . . . . 0.0 107.379 170.378 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 12.4 mp0 -120.54 144.4 48.08 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 123.948 0.899 . . . . 0.0 108.868 -179.199 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.5 mp -83.6 144.19 10.46 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.284 0 N-CA-C 107.855 -1.165 . . . . 0.0 107.855 177.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 13.6 pt -119.5 164.81 15.47 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.176 0 CA-C-N 118.745 0.702 . . . . 0.0 110.377 169.811 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.8 m-20 -70.61 141.85 51.72 Favored 'General case' 0 N--CA 1.448 -0.539 0 C-N-CA 123.761 0.825 . . . . 0.0 110.461 179.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -88.54 120.52 37.5 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.061 0 N-CA-C 107.744 -1.206 . . . . 0.0 107.744 167.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -168.2 -165.37 25.49 Favored Glycine 0 CA--C 1.528 0.904 0 N-CA-C 108.972 -1.651 . . . . 0.0 108.972 -173.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -54.98 -44.56 48.51 Favored 'Trans proline' 0 N--CA 1.458 -0.565 0 C-N-CA 123.196 2.597 . . . . 0.0 112.516 -172.856 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 60.6 t80 -48.96 -58.44 4.87 Favored 'General case' 0 CA--C 1.535 0.383 0 CA-C-O 122.232 1.015 . . . . 0.0 110.913 171.896 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.93 -43.52 92.48 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.31 1.044 . . . . 0.0 109.808 -172.621 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.6 mt-30 -56.5 -49.84 73.55 Favored 'General case' 0 N--CA 1.446 -0.66 0 C-N-CA 124.354 1.062 . . . . 0.0 109.801 173.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 23.8 t-20 -53.92 -52.18 61.4 Favored 'General case' 0 N--CA 1.457 -0.1 0 CA-C-N 118.395 0.543 . . . . 0.0 110.44 178.082 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.0 mt -59.98 -44.58 94.39 Favored 'General case' 0 CA--C 1.53 0.205 0 C-N-CA 120.945 -0.302 . . . . 0.0 110.729 179.476 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.33 -44.49 93.43 Favored Glycine 0 CA--C 1.533 1.169 0 N-CA-C 111.607 -0.597 . . . . 0.0 111.607 176.124 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -64.29 -50.53 67.49 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -177.62 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -50.46 -47.57 56.85 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.508 1.123 . . . . 0.0 110.914 173.974 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.48 -52.83 63.78 Favored 'General case' 0 N--CA 1.454 -0.252 0 CA-C-O 121.047 0.451 . . . . 0.0 110.152 179.54 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 70.2 t -60.5 -39.08 80.12 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.22 0 CA-C-N 115.994 -0.548 . . . . 0.0 110.464 178.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.6 t70 -62.0 -49.65 75.22 Favored 'General case' 0 N--CA 1.45 -0.436 0 C-N-CA 123.349 0.66 . . . . 0.0 110.162 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 50.2 tt0 -57.12 -50.26 73.34 Favored 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 123.84 0.856 . . . . 0.0 109.022 176.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -55.24 -51.23 67.27 Favored 'General case' 0 N--CA 1.45 -0.446 0 C-N-CA 123.45 0.7 . . . . 0.0 109.472 -178.917 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.2 m-20 -60.49 -40.36 91.05 Favored 'General case' 0 N--CA 1.449 -0.485 0 C-N-CA 124.536 1.135 . . . . 0.0 110.591 178.015 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 17.4 tptm -59.52 -42.65 92.71 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 110.038 -0.356 . . . . 0.0 110.038 -179.931 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 91.6 mt -67.45 -44.22 86.96 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.409 0 N-CA-C 109.539 -0.541 . . . . 0.0 109.539 172.57 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.91 22.74 57.23 Favored Glycine 0 CA--C 1.526 0.771 0 C-N-CA 125.041 1.305 . . . . 0.0 111.295 -179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 52.9 tt0 -60.8 -38.87 86.83 Favored 'General case' 0 CA--C 1.533 0.313 0 CA-C-N 117.79 0.795 . . . . 0.0 110.715 -175.132 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -108.35 34.76 3.46 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 124.73 1.212 . . . . 0.0 109.978 171.159 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.52 -141.04 44.79 Favored Glycine 0 CA--C 1.53 1.011 0 N-CA-C 110.809 -0.916 . . . . 0.0 110.809 -175.863 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 85.6 mtt-85 -100.17 91.83 4.94 Favored 'General case' 0 N--CA 1.452 -0.33 0 C-N-CA 124.398 1.079 . . . . 0.0 109.783 -177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 74.3 mt -74.28 173.21 10.51 Favored 'General case' 0 CA--C 1.532 0.282 0 N-CA-C 109.068 -0.715 . . . . 0.0 109.068 168.957 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 82.4 m -138.25 102.49 4.67 Favored 'General case' 0 N--CA 1.455 -0.222 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.423 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -51.94 134.26 31.79 Favored 'General case' 0 CA--C 1.524 -0.046 0 C-N-CA 122.838 0.455 . . . . 0.0 110.377 177.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -103.2 -63.18 1.2 Allowed 'General case' 0 CA--C 1.522 -0.132 0 N-CA-C 108.636 -0.876 . . . . 0.0 108.636 173.655 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.8 pttt -173.43 174.58 3.24 Favored 'General case' 0 C--O 1.226 -0.161 0 C-N-CA 125.141 1.376 . . . . 0.0 108.711 -178.643 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.3 p -112.66 150.12 14.95 Favored 'Isoleucine or valine' 0 C--O 1.231 0.122 0 C-N-CA 124.489 1.116 . . . . 0.0 108.779 173.849 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 24.9 pt -138.26 168.37 20.12 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.124 0 C-N-CA 123.067 0.547 . . . . 0.0 110.439 -179.749 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . 0.426 ' CD ' ' H ' ' A' ' 39' ' ' ARG . 0.0 OUTLIER -62.17 154.43 70.21 Favored Pre-proline 0 CA--C 1.538 0.481 0 N-CA-C 109.756 -0.461 . . . . 0.0 109.756 170.626 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.0 Cg_endo -73.28 150.15 95.23 Favored 'Cis proline' 0 N--CA 1.458 -0.581 0 CA-C-N 119.193 0.748 . . . . 0.0 111.012 -3.36 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 42.1 t -140.87 102.2 4.23 Favored 'General case' 0 N--CA 1.455 -0.212 0 N-CA-C 107.499 -1.296 . . . . 0.0 107.499 175.313 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.8 OUTLIER -121.33 141.56 50.81 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.708 1.203 . . . . 0.0 109.682 -166.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 19.6 pttp -126.56 158.77 35.34 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 123.792 0.837 . . . . 0.0 111.269 177.44 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.0 tttt -147.35 152.74 38.7 Favored 'General case' 0 CA--C 1.536 0.432 0 C-N-CA 125.31 1.444 . . . . 0.0 108.334 176.483 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 82.3 m -85.04 137.69 32.9 Favored 'General case' 0 CA--C 1.531 0.231 0 C-N-CA 123.709 0.803 . . . . 0.0 109.954 176.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -109.88 129.72 64.31 Favored 'Isoleucine or valine' 0 C--O 1.235 0.302 0 C-N-CA 124.942 1.297 . . . . 0.0 110.196 179.257 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 63.0 m-85 -115.23 168.44 9.95 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 125.697 1.599 . . . . 0.0 108.863 -177.049 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.4 mm-40 -118.55 154.25 32.89 Favored 'General case' 0 N--CA 1.44 -0.947 0 CA-C-O 122.397 1.094 . . . . 0.0 108.301 166.486 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.5 t30 -89.06 -45.19 9.81 Favored 'General case' 0 C--N 1.325 -0.48 0 CA-C-N 112.05 -2.341 . . . . 0.0 109.064 178.055 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 12.0 pt-20 -55.5 147.77 17.02 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-O 121.171 0.51 . . . . 0.0 110.545 176.578 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 85.56 -106.69 3.04 Favored Glycine 0 N--CA 1.445 -0.734 0 N-CA-C 106.094 -2.803 . . . . 0.0 106.094 -168.744 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.3 t80 -170.61 73.24 0.06 Allowed 'General case' 0 CA--C 1.533 0.298 0 C-N-CA 124.256 1.022 . . . . 0.0 110.144 -179.848 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 12.3 ttm180 62.39 89.91 0.08 Allowed 'General case' 0 CA--C 1.536 0.434 0 C-N-CA 124.447 1.099 . . . . 0.0 111.69 174.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 35.4 tt0 -141.89 143.7 33.44 Favored 'General case' 0 N--CA 1.454 -0.258 0 O-C-N 121.423 -0.798 . . . . 0.0 110.755 179.488 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.9 mt -67.13 129.8 31.98 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 N-CA-C 107.926 -1.139 . . . . 0.0 107.926 172.21 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 ttpp -109.18 -25.8 10.44 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-N 117.992 0.36 . . . . 0.0 110.825 172.805 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -176.16 -163.51 28.84 Favored Glycine 0 N--CA 1.449 -0.482 0 C-N-CA 120.468 -0.873 . . . . 0.0 111.638 -175.165 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.8 m-85 -142.45 156.16 45.15 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.446 -1.316 . . . . 0.0 107.446 174.542 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 2.1 mp0 -120.83 142.4 49.66 Favored 'General case' 0 C--N 1.331 -0.238 0 C-N-CA 125.006 1.322 . . . . 0.0 107.45 177.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 49.4 m-85 -131.02 108.35 9.73 Favored 'General case' 0 N--CA 1.452 -0.329 0 C-N-CA 126.385 1.874 . . . . 0.0 106.745 -179.562 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 55.8 tt0 -105.08 123.11 47.25 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 126.116 1.767 . . . . 0.0 108.747 -177.477 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -152.71 164.84 36.99 Favored 'General case' 0 N--CA 1.456 -0.162 0 N-CA-C 112.186 0.439 . . . . 0.0 112.186 -174.606 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -104.69 113.69 27.44 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 124.165 0.986 . . . . 0.0 110.898 -178.428 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 44.3 t -94.44 130.1 43.77 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.462 0 C-N-CA 125.558 1.543 . . . . 0.0 108.223 175.582 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.7 t80 -92.77 120.44 33.15 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 107.135 -1.432 . . . . 0.0 107.135 169.645 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.28 131.95 24.04 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 124.398 1.079 . . . . 0.0 108.119 -176.02 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 3.3 t 49.76 45.45 24.67 Favored 'General case' 0 CA--C 1.535 0.393 0 C-N-CA 124.219 1.008 . . . . 0.0 110.129 -177.625 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 2.6 p30 53.34 17.76 1.14 Allowed 'General case' 0 CA--C 1.54 0.591 0 C-N-CA 126.361 1.864 . . . . 0.0 115.459 -176.298 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -116.29 151.7 35.31 Favored 'General case' 0 C--N 1.34 0.161 0 N-CA-C 107.543 -1.28 . . . . 0.0 107.543 175.451 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.2 tp -96.36 127.24 42.17 Favored 'General case' 0 N--CA 1.451 -0.39 0 N-CA-C 108.427 -0.953 . . . . 0.0 108.427 -178.934 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 89.5 m-85 -127.8 136.68 51.8 Favored 'General case' 0 N--CA 1.456 -0.138 0 C-N-CA 125.347 1.459 . . . . 0.0 108.444 178.851 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 4.0 tmm_? -85.3 137.37 33.01 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 172.217 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -126.03 139.53 53.34 Favored 'General case' 0 N--CA 1.452 -0.327 0 N-CA-C 108.143 -1.058 . . . . 0.0 108.143 169.537 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -115.83 114.99 25.49 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 107.691 -1.226 . . . . 0.0 107.691 168.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 10.6 mm -98.88 145.0 10.93 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.534 -1.654 . . . . 0.0 106.534 179.064 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 32.6 m -119.38 144.25 47.0 Favored 'General case' 0 CA--C 1.519 -0.231 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 176.007 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 77.8 tt0 -113.04 129.43 56.5 Favored 'General case' 0 CA--C 1.519 -0.214 0 C-N-CA 126.8 2.04 . . . . 0.0 107.014 170.235 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.7 t70 -92.49 125.56 37.18 Favored 'General case' 0 CA--C 1.528 0.13 0 N-CA-C 108.474 -0.936 . . . . 0.0 108.474 172.889 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 89.3 t80 -58.54 -43.55 89.32 Favored 'General case' 0 N--CA 1.455 -0.195 0 C-N-CA 124.373 1.069 . . . . 0.0 111.372 -176.087 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 40.2 ttmt -70.66 -48.65 53.81 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 109.529 -0.545 . . . . 0.0 109.529 -177.109 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.1 m -67.74 -31.48 71.42 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 122.364 0.266 . . . . 0.0 111.263 -177.37 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 36.3 mmt180 55.41 41.01 31.44 Favored 'General case' 0 CA--C 1.531 0.223 0 C-N-CA 124.235 1.014 . . . . 0.0 109.602 -169.409 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -142.1 155.62 25.62 Favored Glycine 0 N--CA 1.449 -0.478 0 N-CA-C 107.58 -2.208 . . . . 0.0 107.58 -179.147 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 46.7 mtt85 -114.95 171.46 7.64 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.407 0.683 . . . . 0.0 112.28 -176.151 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.9 ptmt -162.56 148.7 12.75 Favored 'General case' 0 N--CA 1.451 -0.416 0 C-N-CA 126.107 1.763 . . . . 0.0 110.594 -175.602 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 55.5 tp -68.1 134.87 51.28 Favored 'General case' 0 CA--C 1.532 0.269 0 N-CA-C 108.764 -0.828 . . . . 0.0 108.764 170.462 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.7 tp -106.33 -64.54 1.16 Allowed 'General case' 0 C--N 1.338 0.076 0 C-N-CA 123.238 0.615 . . . . 0.0 109.779 176.234 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -120.14 146.47 45.94 Favored 'General case' 0 N--CA 1.462 0.167 0 N-CA-C 107.673 -1.232 . . . . 0.0 107.673 177.893 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 82.8 t80 -136.71 130.94 32.83 Favored 'General case' 0 N--CA 1.451 -0.395 0 N-CA-C 106.008 -1.849 . . . . 0.0 106.008 169.983 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 20.3 m120 -145.03 155.21 43.23 Favored 'General case' 0 N--CA 1.449 -0.496 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -172.783 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 126.89 -164.59 20.41 Favored Glycine 0 CA--C 1.53 0.989 0 N-CA-C 109.185 -1.566 . . . . 0.0 109.185 -175.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.3 Cg_endo -67.11 155.38 84.73 Favored 'Cis proline' 0 N--CA 1.454 -0.81 0 CA-C-N 118.797 1.299 . . . . 0.0 109.91 -6.755 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 3.0 m -136.92 154.28 76.06 Favored Pre-proline 0 CA--C 1.532 0.256 0 C-N-CA 124.084 0.954 . . . . 0.0 108.752 172.284 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.1 Cg_endo -74.21 158.36 45.23 Favored 'Trans proline' 0 N--CA 1.452 -0.921 0 C-N-CA 122.312 2.008 . . . . 0.0 108.969 169.352 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 96.9 Cg_endo -69.7 156.29 63.89 Favored 'Trans proline' 0 N--CA 1.452 -0.961 0 C-N-CA 121.937 1.758 . . . . 0.0 109.202 169.493 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.2 Cg_endo . . . . . 0 C--O 1.251 1.127 0 C-N-CA 122.529 2.153 . . . . 0.0 110.775 175.817 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.274 0 N-CA-C 111.528 -0.629 . . . . 0.0 111.528 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.9 mt-10 -90.12 89.35 7.63 Favored 'General case' 0 N--CA 1.455 -0.216 0 CA-C-N 117.244 0.522 . . . . 0.0 111.166 -169.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 5.2 m95 -60.76 114.09 2.84 Favored 'General case' 0 CA--C 1.532 0.268 0 N-CA-C 108.924 -0.769 . . . . 0.0 108.924 167.619 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -148.76 154.89 40.21 Favored 'General case' 0 C--O 1.226 -0.156 0 CA-C-N 118.383 0.538 . . . . 0.0 109.562 178.684 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.418 HD12 ' H ' ' A' ' 5' ' ' ILE . 3.3 mp -86.73 139.37 17.44 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.199 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 176.525 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 42.5 pt -101.04 151.35 5.4 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.154 0 C-N-CA 123.403 0.681 . . . . 0.0 110.221 173.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -71.96 128.22 35.03 Favored 'General case' 0 N--CA 1.451 -0.417 0 N-CA-C 108.479 -0.934 . . . . 0.0 108.479 179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -71.75 132.39 33.41 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.626 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 168.15 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 178.85 -172.34 44.58 Favored Glycine 0 CA--C 1.528 0.895 0 N-CA-C 107.825 -2.11 . . . . 0.0 107.825 -174.183 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -53.65 -44.87 45.35 Favored 'Trans proline' 0 N--CA 1.458 -0.617 0 C-N-CA 123.701 2.934 . . . . 0.0 112.677 -173.636 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 81.8 t80 -50.16 -57.35 7.93 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.269 1.033 . . . . 0.0 110.853 174.091 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -65.02 -41.11 95.58 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.533 1.133 . . . . 0.0 109.81 -174.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 71.9 mt-30 -58.12 -45.98 86.38 Favored 'General case' 0 N--CA 1.444 -0.758 0 CA-C-O 119.041 -0.504 . . . . 0.0 110.085 173.878 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 50.1 t30 -58.11 -46.8 84.94 Favored 'General case' 0 CA--C 1.528 0.134 0 CA-C-N 118.6 0.637 . . . . 0.0 110.748 176.199 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 35.7 mt -58.22 -41.89 85.09 Favored 'General case' 0 CA--C 1.532 0.282 0 O-C-N 121.942 -0.474 . . . . 0.0 111.17 174.731 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.31 -58.31 15.23 Favored Glycine 0 CA--C 1.525 0.698 0 N-CA-C 110.349 -1.101 . . . . 0.0 110.349 176.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.3 tmtt? -44.12 -52.57 7.14 Favored 'General case' 0 N--CA 1.448 -0.552 0 C-N-CA 123.888 0.875 . . . . 0.0 111.616 172.446 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 31.2 t80 -55.59 -49.71 72.03 Favored 'General case' 0 C--N 1.332 -0.182 0 C-N-CA 124.047 0.939 . . . . 0.0 110.808 179.223 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.7 -50.92 69.01 Favored 'General case' 0 N--CA 1.453 -0.286 0 N-CA-C 109.952 -0.388 . . . . 0.0 109.952 178.586 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 93.2 t -62.73 -40.49 88.78 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.179 0 CA-C-N 116.569 -0.287 . . . . 0.0 110.423 -179.645 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 18.5 t70 -62.62 -50.29 71.84 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.09 0.956 . . . . 0.0 110.225 -178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 21.6 tt0 -61.66 -47.49 85.13 Favored 'General case' 0 N--CA 1.453 -0.315 0 C-N-CA 124.138 0.975 . . . . 0.0 109.318 179.376 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -56.98 -49.8 74.63 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 122.497 0.319 . . . . 0.0 110.24 177.215 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.8 m-20 -56.88 -43.42 81.25 Favored 'General case' 0 N--CA 1.454 -0.273 0 C-N-CA 124.464 1.106 . . . . 0.0 110.143 176.867 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 82.7 tttt -59.7 -39.92 86.17 Favored 'General case' 0 CA--C 1.532 0.274 0 N-CA-C 110.411 -0.218 . . . . 0.0 110.411 -179.085 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 94.2 mt -67.71 -45.53 84.45 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.496 0 N-CA-C 109.74 -0.467 . . . . 0.0 109.74 171.291 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 87.48 18.03 57.65 Favored Glycine 0 CA--C 1.526 0.745 0 C-N-CA 125.174 1.369 . . . . 0.0 111.584 -179.65 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.4 tt0 -57.95 -39.88 79.16 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-N 117.702 0.751 . . . . 0.0 111.251 -172.147 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.24 41.48 2.12 Favored 'General case' 0 CA--C 1.533 0.292 0 C-N-CA 124.172 0.989 . . . . 0.0 109.62 172.656 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.17 -142.11 45.64 Favored Glycine 0 CA--C 1.528 0.847 0 N-CA-C 110.323 -1.111 . . . . 0.0 110.323 -179.336 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 36.1 ttt180 -122.76 93.35 3.94 Favored 'General case' 0 CA--C 1.531 0.242 0 C-N-CA 123.955 0.902 . . . . 0.0 109.079 -170.139 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.7 mp -85.53 -169.96 2.89 Favored 'General case' 0 CA--C 1.528 0.12 0 CA-C-O 121.773 0.797 . . . . 0.0 109.392 175.933 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 97.9 m -145.23 124.74 13.15 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.019 -1.475 . . . . 0.0 107.019 172.161 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 60.9 t80 -55.57 140.07 42.05 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 122.626 0.371 . . . . 0.0 111.164 -178.236 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 t-20 -111.4 -64.29 1.3 Allowed 'General case' 0 CA--C 1.528 0.115 0 C-N-CA 123.648 0.779 . . . . 0.0 109.504 176.194 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -168.37 -179.92 4.16 Favored 'General case' 0 N--CA 1.466 0.342 0 C-N-CA 124.097 0.959 . . . . 0.0 109.595 177.749 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 57.8 t -115.84 143.32 26.06 Favored 'Isoleucine or valine' 0 CA--C 1.523 -0.086 0 N-CA-C 106.915 -1.513 . . . . 0.0 106.915 169.321 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -135.6 165.44 30.15 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.176 0 C-N-CA 122.809 0.444 . . . . 0.0 110.236 173.6 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -66.76 158.53 79.54 Favored Pre-proline 0 CA--C 1.54 0.591 0 C-N-CA 124.113 0.965 . . . . 0.0 111.697 -174.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo -69.21 152.84 91.31 Favored 'Cis proline' 0 N--CA 1.457 -0.625 0 CA-C-N 119.468 0.846 . . . . 0.0 111.756 -9.197 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 76.4 m -138.79 100.25 4.01 Favored 'General case' 0 N--CA 1.45 -0.451 0 N-CA-C 105.009 -2.219 . . . . 0.0 105.009 175.768 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.8 ttt -118.27 142.44 47.48 Favored 'General case' 0 N--CA 1.455 -0.21 0 C-N-CA 123.321 0.648 . . . . 0.0 111.432 -167.981 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 14.4 tttm -120.97 143.12 49.18 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 127.409 2.284 . . . . 0.0 109.067 -170.115 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 51.3 tptt -144.92 147.94 33.31 Favored 'General case' 0 CA--C 1.533 0.319 0 C-N-CA 125.726 1.61 . . . . 0.0 110.123 178.733 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -81.49 134.66 35.56 Favored 'General case' 0 CA--C 1.537 0.467 0 C-N-CA 125.778 1.631 . . . . 0.0 110.508 175.849 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -112.79 127.5 70.0 Favored 'Isoleucine or valine' 0 CA--C 1.54 0.565 0 C-N-CA 124.73 1.212 . . . . 0.0 110.816 177.066 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 21.6 m-85 -106.58 163.65 12.71 Favored 'General case' 0 CA--C 1.528 0.132 0 C-N-CA 125.197 1.399 . . . . 0.0 111.759 -176.942 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -91.81 -168.96 2.14 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 126.47 1.908 . . . . 0.0 108.717 169.236 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -168.13 -36.54 0.02 OUTLIER 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 126.847 2.059 . . . . 0.0 110.469 -174.673 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.7 tt0 -70.88 75.17 0.63 Allowed 'General case' 0 CA--C 1.533 0.308 0 C-N-CA 124.515 1.126 . . . . 0.0 110.087 -177.195 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 97.3 89.07 1.87 Allowed Glycine 0 CA--C 1.522 0.472 0 N-CA-C 108.158 -1.977 . . . . 0.0 108.158 -175.664 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 13.7 m-85 61.43 167.98 0.1 Allowed 'General case' 0 CA--C 1.536 0.425 0 C-N-CA 126.322 1.849 . . . . 0.0 112.075 -173.583 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 66.5 mtm180 -100.34 134.88 42.63 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 106.742 -1.577 . . . . 0.0 106.742 167.643 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -157.79 156.41 31.49 Favored 'General case' 0 N--CA 1.446 -0.628 0 N-CA-C 105.577 -2.008 . . . . 0.0 105.577 173.02 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.3 mt -62.95 119.05 5.95 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.227 0 N-CA-C 107.832 -1.173 . . . . 0.0 107.832 175.524 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 11.1 ttpt -96.13 -27.91 14.83 Favored 'General case' 0 CA--C 1.529 0.153 0 N-CA-C 109.919 -0.401 . . . . 0.0 109.919 174.096 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.59 -158.89 21.6 Favored Glycine 0 N--CA 1.446 -0.67 0 N-CA-C 110.657 -0.977 . . . . 0.0 110.657 -173.885 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -145.9 159.48 43.17 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 125.007 1.323 . . . . 0.0 107.699 -177.108 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 68.6 mt-10 -124.57 135.58 53.25 Favored 'General case' 0 C--N 1.333 -0.13 0 C-N-CA 125.599 1.559 . . . . 0.0 108.773 172.289 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 7.1 m-85 -125.97 106.33 9.55 Favored 'General case' 0 N--CA 1.452 -0.344 0 C-N-CA 125.866 1.666 . . . . 0.0 107.519 178.123 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 12.3 pt20 -94.53 124.11 38.36 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 124.303 1.041 . . . . 0.0 108.716 175.881 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -147.0 153.33 39.92 Favored 'General case' 0 N--CA 1.455 -0.21 0 CA-C-N 118.282 0.492 . . . . 0.0 111.023 -177.367 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.3 m-85 -95.28 105.04 16.95 Favored 'General case' 0 N--CA 1.444 -0.726 0 C-N-CA 123.983 0.913 . . . . 0.0 109.542 179.774 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 7.4 p -97.81 124.99 51.11 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.395 0 C-N-CA 124.357 1.063 . . . . 0.0 109.729 179.701 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.6 m-85 -79.8 117.21 20.48 Favored 'General case' 0 N--CA 1.444 -0.735 0 N-CA-C 107.655 -1.239 . . . . 0.0 107.655 169.484 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -122.28 122.86 40.08 Favored 'General case' 0 N--CA 1.45 -0.462 0 C-N-CA 125.032 1.333 . . . . 0.0 108.418 177.518 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.4 t 72.37 -60.85 0.52 Allowed 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 130.041 3.336 . . . . 0.0 108.327 -171.982 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.1 p-10 -177.1 0.23 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.526 0 C-N-CA 128.757 2.823 . . . . 0.0 111.798 -177.574 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 1.7 mptm? -111.31 144.16 40.95 Favored 'General case' 0 C--N 1.341 0.239 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 -176.06 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.0 tp -92.31 122.64 34.96 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.568 0.747 . . . . 0.0 109.147 -173.53 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 82.3 m-85 -118.43 141.74 48.25 Favored 'General case' 0 C--O 1.23 0.058 0 C-N-CA 124.301 1.041 . . . . 0.0 109.179 177.88 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.6 tpt180 -86.53 104.24 15.8 Favored 'General case' 0 N--CA 1.452 -0.365 0 C-N-CA 124.778 1.231 . . . . 0.0 107.707 175.694 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -102.41 127.07 49.59 Favored 'General case' 0 N--CA 1.454 -0.262 0 N-CA-C 108.65 -0.871 . . . . 0.0 108.65 178.396 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.0 t70 -103.3 106.75 17.34 Favored 'General case' 0 N--CA 1.455 -0.19 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 168.912 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -94.54 122.63 46.16 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.506 0 N-CA-C 105.533 -2.025 . . . . 0.0 105.533 174.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 17.0 m -96.18 156.65 16.25 Favored 'General case' 0 N--CA 1.453 -0.283 0 N-CA-C 108.382 -0.97 . . . . 0.0 108.382 170.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 50.8 tt0 -128.72 123.47 33.13 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 124.869 1.268 . . . . 0.0 107.796 172.496 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -96.08 113.02 24.59 Favored 'General case' 0 N--CA 1.453 -0.323 0 C-N-CA 124.513 1.125 . . . . 0.0 107.984 -176.276 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.1 t80 -60.7 -27.17 67.68 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.172 0.589 . . . . 0.0 111.167 -177.893 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 18.6 tptm -58.89 -24.66 62.55 Favored 'General case' 0 CA--C 1.532 0.28 0 C-N-CA 123.607 0.763 . . . . 0.0 112.411 -175.916 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.2 m -144.95 16.29 1.57 Allowed 'General case' 0 CA--C 1.535 0.39 0 O-C-N 121.62 -0.675 . . . . 0.0 111.415 170.374 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.9 ttm180 52.4 38.9 26.42 Favored 'General case' 0 CA--C 1.539 0.524 0 C-N-CA 124.368 1.067 . . . . 0.0 111.021 -179.111 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.58 138.31 14.88 Favored Glycine 0 C--N 1.337 0.629 0 N-CA-C 109.646 -1.381 . . . . 0.0 109.646 -173.475 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 56.3 mtt85 -102.75 167.64 9.75 Favored 'General case' 0 N--CA 1.455 -0.178 0 CA-C-N 117.724 0.762 . . . . 0.0 112.477 -176.429 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -169.77 130.83 1.05 Allowed 'General case' 0 N--CA 1.456 -0.167 0 CA-C-N 115.319 -0.855 . . . . 0.0 112.282 -168.899 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 57.5 tp -71.12 116.27 11.22 Favored 'General case' 0 CA--C 1.532 0.287 0 N-CA-C 108.938 -0.764 . . . . 0.0 108.938 171.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 2.0 mm? -91.5 -56.74 3.01 Favored 'General case' 0 N--CA 1.46 0.042 0 C-N-CA 123.352 0.661 . . . . 0.0 110.258 178.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 65.4 mtm180 -127.5 141.76 51.57 Favored 'General case' 0 C--N 1.334 -0.089 0 N-CA-C 107.944 -1.132 . . . . 0.0 107.944 -176.375 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 74.6 t80 -138.0 91.08 2.54 Favored 'General case' 0 N--CA 1.452 -0.348 0 N-CA-C 106.665 -1.606 . . . . 0.0 106.665 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 3.4 m-20 -107.33 160.75 15.38 Favored 'General case' 0 N--CA 1.451 -0.381 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 -173.208 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 112.18 -163.97 12.13 Favored Glycine 0 CA--C 1.531 1.063 0 N-CA-C 109.587 -1.405 . . . . 0.0 109.587 -174.41 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 61.3 Cg_endo -66.63 145.69 72.03 Favored 'Cis proline' 0 N--CA 1.454 -0.817 0 CA-C-N 118.807 1.303 . . . . 0.0 110.479 3.138 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.1 m -103.26 130.19 24.08 Favored Pre-proline 0 CA--C 1.535 0.394 0 N-CA-C 108.275 -1.009 . . . . 0.0 108.275 174.11 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.1 Cg_endo -77.78 162.25 29.87 Favored 'Trans proline' 0 N--CA 1.453 -0.865 0 C-N-CA 121.993 1.796 . . . . 0.0 108.673 169.882 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo -66.82 150.47 83.26 Favored 'Trans proline' 0 N--CA 1.453 -0.883 0 C-N-CA 121.596 1.53 . . . . 0.0 109.16 169.741 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 C--O 1.251 1.144 0 C-N-CA 122.461 2.107 . . . . 0.0 110.828 178.142 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.329 0 N-CA-C 111.082 -0.807 . . . . 0.0 111.082 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 28.7 mp0 -80.91 61.8 4.66 Favored 'General case' 0 CA--C 1.534 0.358 0 N-CA-C 108.391 -0.966 . . . . 0.0 108.391 174.309 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.414 ' CE3' ' HB2' ' A' ' 44' ' ' LYS . 14.8 m95 53.27 98.42 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 126.858 2.063 . . . . 0.0 111.995 -169.664 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -143.25 154.42 43.8 Favored 'General case' 0 N--CA 1.462 0.151 0 O-C-N 121.61 -0.681 . . . . 0.0 110.733 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mt -76.55 139.87 18.13 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.127 0 N-CA-C 107.666 -1.235 . . . . 0.0 107.666 174.303 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 18.8 pt -110.06 156.78 10.88 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.284 0 C-N-CA 123.178 0.591 . . . . 0.0 110.074 176.72 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -62.51 131.35 48.84 Favored 'General case' 0 N--CA 1.45 -0.448 0 C-N-CA 123.916 0.887 . . . . 0.0 109.777 179.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -82.29 120.99 34.81 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.905 0 N-CA-C 108.285 -1.006 . . . . 0.0 108.285 167.929 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -171.15 -165.88 29.13 Favored Glycine 0 CA--C 1.531 1.062 0 N-CA-C 109.538 -1.425 . . . . 0.0 109.538 -172.623 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 16.1 Cg_endo -54.12 -45.65 39.41 Favored 'Trans proline' 0 CA--C 1.536 0.6 0 C-N-CA 123.806 3.004 . . . . 0.0 112.649 -175.653 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.9 t80 -47.24 -56.84 5.98 Favored 'General case' 0 CA--C 1.535 0.386 0 C-N-CA 124.654 1.181 . . . . 0.0 110.909 172.387 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -68.16 -39.94 82.46 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 125.153 1.381 . . . . 0.0 110.005 -174.267 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 4.4 mm-40 -50.76 -53.21 33.61 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 125.779 1.631 . . . . 0.0 109.956 170.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -54.61 -48.86 71.68 Favored 'General case' 0 CA--C 1.531 0.227 0 C-N-CA 122.666 0.387 . . . . 0.0 111.092 -179.774 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 41.8 mt -63.87 -41.49 97.74 Favored 'General case' 0 CA--C 1.527 0.083 0 C-N-CA 120.445 -0.502 . . . . 0.0 111.406 177.544 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.17 -51.24 55.4 Favored Glycine 0 CA--C 1.531 1.08 0 N-CA-C 110.918 -0.873 . . . . 0.0 110.918 176.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 49.3 mttm -54.13 -59.36 4.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 C-N-CA 123.768 0.827 . . . . 0.0 110.708 175.156 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 30.9 t80 -49.84 -44.28 49.36 Favored 'General case' 0 C--N 1.332 -0.175 0 C-N-CA 123.265 0.626 . . . . 0.0 111.624 178.287 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.88 -51.36 70.35 Favored 'General case' 0 C--O 1.234 0.255 0 CA-C-O 120.896 0.379 . . . . 0.0 110.229 179.873 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.3 t -62.41 -43.4 98.18 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.289 -0.414 . . . . 0.0 110.145 178.157 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 25.3 t70 -59.18 -46.08 89.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.881 0.872 . . . . 0.0 109.971 -178.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -63.98 -49.72 71.4 Favored 'General case' 0 N--CA 1.449 -0.497 0 C-N-CA 124.076 0.95 . . . . 0.0 109.376 -179.684 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 29.0 tt0 -57.44 -43.44 83.88 Favored 'General case' 0 CA--C 1.536 0.432 0 O-C-N 121.751 -0.593 . . . . 0.0 110.954 176.779 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 26.9 m-20 -63.85 -39.51 94.37 Favored 'General case' 0 N--CA 1.453 -0.321 0 C-N-CA 124.871 1.268 . . . . 0.0 110.684 178.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 51.4 tttp -61.48 -43.77 98.27 Favored 'General case' 0 N--CA 1.454 -0.242 0 C-N-CA 123.395 0.678 . . . . 0.0 109.239 179.464 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -64.61 -40.17 88.14 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.458 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 170.188 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.1 20.62 58.84 Favored Glycine 0 CA--C 1.525 0.697 0 C-N-CA 125.336 1.446 . . . . 0.0 110.167 -174.487 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 7.7 tp-100 -59.79 -35.95 75.7 Favored 'General case' 0 CA--C 1.53 0.194 0 CA-C-N 117.404 0.602 . . . . 0.0 111.105 -168.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -117.46 33.87 5.41 Favored 'General case' 0 CA--C 1.532 0.267 0 C-N-CA 124.084 0.953 . . . . 0.0 109.815 175.677 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 64.25 -145.37 49.57 Favored Glycine 0 CA--C 1.53 0.971 0 N-CA-C 109.635 -1.386 . . . . 0.0 109.635 -171.217 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 38.1 ttm180 -106.46 88.5 2.79 Favored 'General case' 0 N--CA 1.455 -0.209 0 C-N-CA 124.525 1.13 . . . . 0.0 108.975 -177.316 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.3 mt -70.13 153.86 42.63 Favored 'General case' 0 CA--C 1.53 0.211 0 N-CA-C 109.572 -0.529 . . . . 0.0 109.572 174.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 91.3 m -109.07 102.26 11.26 Favored 'General case' 0 N--CA 1.456 -0.133 0 N-CA-C 107.465 -1.309 . . . . 0.0 107.465 173.556 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 52.4 t80 -52.29 144.72 12.26 Favored 'General case' 0 C--O 1.232 0.164 0 C-N-CA 122.655 0.382 . . . . 0.0 110.446 175.815 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 9.0 m120 -120.84 -66.19 1.08 Allowed 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 122.901 0.48 . . . . 0.0 110.205 173.52 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.23 166.82 27.14 Favored 'General case' 0 C--O 1.225 -0.185 0 CA-C-N 117.812 0.278 . . . . 0.0 110.452 175.304 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.5 p -91.62 150.23 3.86 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.25 0 C-N-CA 124.194 0.998 . . . . 0.0 108.591 171.409 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 1.6 pp -144.55 174.96 3.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.32 0 C-N-CA 123.832 0.853 . . . . 0.0 109.195 -179.473 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.49 154.79 85.77 Favored Pre-proline 0 CA--C 1.539 0.525 0 CA-C-O 118.894 -0.574 . . . . 0.0 109.632 175.821 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -77.02 157.32 97.28 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 119.67 0.918 . . . . 0.0 111.246 -4.532 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 48.3 t -153.98 93.88 1.69 Allowed 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.716 0.806 . . . . 0.0 109.395 -176.429 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.7 OUTLIER -102.92 154.76 18.89 Favored 'General case' 0 C--N 1.332 -0.157 0 C-N-CA 125.467 1.507 . . . . 0.0 110.546 -170.23 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.4 ttpt -133.79 143.49 48.43 Favored 'General case' 0 C--O 1.236 0.349 0 C-N-CA 125.42 1.488 . . . . 0.0 109.271 170.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.414 ' HB2' ' CE3' ' A' ' 3' ' ' TRP . 1.1 tmtp? -147.1 144.98 29.44 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 123.608 0.763 . . . . 0.0 111.598 169.09 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 5.0 m -65.34 139.04 58.54 Favored 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 124.862 1.265 . . . . 0.0 111.684 177.564 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.81 127.21 71.29 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.479 0 C-N-CA 125.193 1.397 . . . . 0.0 108.443 176.882 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 43.7 p90 -162.73 177.8 9.03 Favored 'General case' 0 N--CA 1.455 -0.2 0 O-C-N 121.505 -0.747 . . . . 0.0 110.878 -163.813 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 15.3 mt-10 -138.22 162.87 33.18 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.452 1.101 . . . . 0.0 108.784 169.248 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.4 t30 -114.91 -41.28 3.38 Favored 'General case' 0 C--N 1.331 -0.236 0 C-N-CA 127.165 2.186 . . . . 0.0 110.794 -177.985 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.7 mt-10 -58.37 149.55 24.46 Favored 'General case' 0 CA--C 1.53 0.203 0 C-N-CA 122.86 0.464 . . . . 0.0 110.073 176.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 75.2 -69.23 1.96 Allowed Glycine 0 CA--C 1.522 0.508 0 N-CA-C 109.056 -1.618 . . . . 0.0 109.056 -170.107 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 15.2 t80 -160.51 162.77 33.12 Favored 'General case' 0 N--CA 1.449 -0.493 0 C-N-CA 124.322 1.049 . . . . 0.0 109.598 170.706 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 35.7 ptt85 -63.55 110.49 2.0 Allowed 'General case' 0 CA--C 1.532 0.275 0 N-CA-C 108.939 -0.763 . . . . 0.0 108.939 171.111 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.6 tp10 -153.33 125.55 8.01 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-N 118.649 0.659 . . . . 0.0 112.394 -179.038 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 83.8 mt -68.25 135.06 29.2 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.156 0 C-N-CA 125.359 1.464 . . . . 0.0 109.276 169.155 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.6 pttm -117.3 -21.14 8.87 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.153 0.581 . . . . 0.0 111.663 175.196 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.79 -167.71 33.82 Favored Glycine 0 C--N 1.336 0.561 0 N-CA-C 111.326 -0.71 . . . . 0.0 111.326 -176.362 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 6.2 m-85 -130.03 164.9 23.31 Favored 'General case' 0 C--O 1.233 0.216 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 169.114 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 42.9 tt0 -126.17 144.79 50.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 125.64 1.576 . . . . 0.0 107.193 168.914 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 62.2 m-85 -130.52 133.9 46.62 Favored 'General case' 0 N--CA 1.448 -0.552 0 N-CA-C 105.416 -2.068 . . . . 0.0 105.416 176.329 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 17.6 tt0 -130.62 112.57 13.26 Favored 'General case' 0 C--N 1.332 -0.177 0 N-CA-C 106.971 -1.492 . . . . 0.0 106.971 -177.496 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -148.64 160.08 43.48 Favored 'General case' 0 CA--C 1.52 -0.193 0 CA-C-N 118.205 0.457 . . . . 0.0 112.203 -166.634 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 22.9 m-85 -103.28 140.31 37.57 Favored 'General case' 0 N--CA 1.445 -0.713 0 C-N-CA 123.643 0.777 . . . . 0.0 110.528 173.463 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.5 p -126.17 133.09 69.67 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.551 0 C-N-CA 125.819 1.647 . . . . 0.0 109.147 178.837 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.75 119.2 25.01 Favored 'General case' 0 N--CA 1.45 -0.449 0 N-CA-C 107.752 -1.203 . . . . 0.0 107.752 170.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -134.15 130.69 37.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 N-CA-C 107.634 -1.247 . . . . 0.0 107.634 175.035 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 27.1 t 51.27 41.41 27.91 Favored 'General case' 0 CA--C 1.536 0.421 0 C-N-CA 124.461 1.105 . . . . 0.0 111.526 -178.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.9 t0 49.3 35.74 8.24 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 125.87 1.668 . . . . 0.0 112.499 -174.528 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 97.8 mttt -127.97 142.03 51.36 Favored 'General case' 0 N--CA 1.451 -0.399 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 169.844 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 2.1 tp -87.37 117.0 25.85 Favored 'General case' 0 N--CA 1.45 -0.471 0 N-CA-C 107.697 -1.223 . . . . 0.0 107.697 -176.785 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 76.0 m-85 -113.96 155.12 26.41 Favored 'General case' 0 C--N 1.334 -0.101 0 C-N-CA 123.735 0.814 . . . . 0.0 108.862 173.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 tmm_? -108.88 138.47 45.16 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 124.461 1.104 . . . . 0.0 108.223 177.465 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -133.04 137.81 46.56 Favored 'General case' 0 N--CA 1.452 -0.356 0 C-N-CA 123.977 0.911 . . . . 0.0 109.343 176.49 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 18.9 t70 -114.04 116.78 29.71 Favored 'General case' 0 N--CA 1.45 -0.463 0 N-CA-C 107.041 -1.466 . . . . 0.0 107.041 169.395 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.8 mm -109.26 155.11 10.46 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.33 0 C-N-CA 126.373 1.869 . . . . 0.0 106.406 -178.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -128.84 164.57 22.78 Favored 'General case' 0 CA--C 1.516 -0.344 0 CA-C-N 118.516 0.598 . . . . 0.0 109.517 167.902 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -119.65 138.89 52.97 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 127.152 2.181 . . . . 0.0 106.557 170.446 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -108.04 114.59 28.62 Favored 'General case' 0 C--O 1.236 0.35 0 C-N-CA 125.209 1.403 . . . . 0.0 107.298 174.289 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 75.2 t80 -56.44 -36.29 68.84 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.194 0.998 . . . . 0.0 111.452 -171.356 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 92.1 mttt -53.58 -23.6 11.3 Favored 'General case' 0 N--CA 1.453 -0.288 0 C-N-CA 125.62 1.568 . . . . 0.0 113.339 -175.394 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -143.14 15.35 1.88 Allowed 'General case' 0 CA--C 1.533 0.305 0 O-C-N 121.643 -0.661 . . . . 0.0 110.844 171.65 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.1 ttm180 48.28 32.47 3.17 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 123.626 0.77 . . . . 0.0 111.023 -170.63 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -94.63 129.66 9.99 Favored Glycine 0 C--N 1.334 0.472 0 N-CA-C 108.38 -1.888 . . . . 0.0 108.38 -171.257 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 22.8 mtt85 -100.19 166.64 10.9 Favored 'General case' 0 N--CA 1.452 -0.363 0 CA-C-N 117.699 0.75 . . . . 0.0 112.694 -178.98 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -165.35 140.09 4.97 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 114.758 -1.11 . . . . 0.0 111.405 -169.746 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.8 tp -64.03 121.73 14.85 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 108.245 -1.021 . . . . 0.0 108.245 168.58 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.7 mt -85.56 -60.2 2.09 Favored 'General case' 0 N--CA 1.457 -0.092 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 171.628 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -145.03 154.96 43.07 Favored 'General case' 0 CA--C 1.528 0.101 0 C-N-CA 123.329 0.652 . . . . 0.0 109.25 179.425 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 4.0 t80 -131.32 150.47 52.14 Favored 'General case' 0 C--O 1.232 0.137 0 N-CA-C 106.611 -1.625 . . . . 0.0 106.611 178.072 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 16.8 t-20 -156.01 163.91 39.12 Favored 'General case' 0 N--CA 1.456 -0.137 0 C-N-CA 123.63 0.772 . . . . 0.0 109.288 -173.963 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 111.93 -162.91 12.27 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 109.586 -1.406 . . . . 0.0 109.586 -177.795 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 85.7 Cg_endo -67.97 160.2 82.36 Favored 'Cis proline' 0 N--CA 1.453 -0.89 0 CA-C-N 118.75 1.275 . . . . 0.0 110.027 -2.801 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.2 m -126.11 149.41 66.53 Favored Pre-proline 0 C--O 1.235 0.29 0 N-CA-C 107.61 -1.255 . . . . 0.0 107.61 169.386 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 78.6 Cg_endo -69.84 156.44 63.12 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 121.86 1.706 . . . . 0.0 109.388 173.918 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 81.0 Cg_endo -67.51 154.46 73.6 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 122.034 1.823 . . . . 0.0 109.371 171.253 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.1 Cg_endo . . . . . 0 C--O 1.25 1.076 0 C-N-CA 122.585 2.19 . . . . 0.0 110.718 177.506 . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.201 0 N-CA-C 111.508 -0.637 . . . . 0.0 111.508 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 43.8 mt-10 -66.13 165.44 13.6 Favored 'General case' 0 CA--C 1.535 0.393 0 N-CA-C 109.009 -0.737 . . . . 0.0 109.009 169.229 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -53.47 114.33 1.47 Allowed 'General case' 0 CA--C 1.528 0.111 0 N-CA-C 110.41 -0.219 . . . . 0.0 110.41 176.737 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.4 tp10 -154.28 154.65 33.76 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.688 -0.856 . . . . 0.0 108.688 177.334 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 7.3 mm -81.87 138.15 19.99 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.44 0 N-CA-C 108.114 -1.069 . . . . 0.0 108.114 176.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.5 pt -101.4 155.66 4.6 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.179 0 C-N-CA 123.178 0.591 . . . . 0.0 110.553 174.064 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -65.06 148.82 50.97 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 109.099 -0.704 . . . . 0.0 109.099 173.774 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -95.79 132.34 40.22 Favored 'Isoleucine or valine' 0 N--CA 1.442 -0.846 0 C-N-CA 125.017 1.327 . . . . 0.0 108.224 169.347 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 179.89 -168.97 39.6 Favored Glycine 0 CA--C 1.528 0.858 0 N-CA-C 108.269 -1.933 . . . . 0.0 108.269 -174.911 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -55.5 -43.29 59.56 Favored 'Trans proline' 0 N--CA 1.456 -0.7 0 C-N-CA 123.446 2.764 . . . . 0.0 112.153 -174.677 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 75.0 t80 -51.88 -57.42 9.42 Favored 'General case' 0 CA--C 1.536 0.439 0 CA-C-O 122.004 0.907 . . . . 0.0 111.286 173.795 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -63.71 -45.49 89.76 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.269 1.028 . . . . 0.0 109.964 -173.92 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -49.99 -58.31 5.75 Favored 'General case' 0 N--CA 1.441 -0.92 0 CA-C-O 118.36 -0.829 . . . . 0.0 108.923 170.553 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 54.8 t-20 -49.34 -46.18 46.54 Favored 'General case' 0 C--O 1.226 -0.162 0 C-N-CA 123.73 0.812 . . . . 0.0 111.013 -177.519 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 80.0 mt -63.32 -51.64 65.19 Favored 'General case' 0 CA--C 1.535 0.387 0 O-C-N 121.605 -0.684 . . . . 0.0 111.751 177.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -61.09 -33.23 83.32 Favored Glycine 0 CA--C 1.537 1.424 0 CA-C-O 122.396 0.998 . . . . 0.0 112.414 178.251 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.2 tmtp? -66.73 -57.93 6.12 Favored 'General case' 0 N--CA 1.449 -0.513 0 C-N-CA 126.473 1.909 . . . . 0.0 106.808 -179.353 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 34.1 t80 -47.45 -44.85 25.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.852 1.661 . . . . 0.0 110.417 173.285 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.54 -54.14 49.3 Favored 'General case' 0 CA--C 1.53 0.19 0 CA-C-O 120.909 0.385 . . . . 0.0 110.495 175.879 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 65.0 t -59.75 -38.54 76.45 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.308 0 C-N-CA 122.817 0.447 . . . . 0.0 111.31 177.376 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.9 t70 -63.86 -46.82 83.26 Favored 'General case' 0 N--CA 1.453 -0.295 0 C-N-CA 124.029 0.931 . . . . 0.0 109.99 -179.828 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -60.89 -47.32 86.95 Favored 'General case' 0 CA--C 1.535 0.399 0 C-N-CA 123.801 0.84 . . . . 0.0 108.977 176.038 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 1.9 tm-20 -55.99 -50.81 69.82 Favored 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 123.017 0.527 . . . . 0.0 109.67 178.403 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 48.0 m-20 -57.94 -42.68 85.4 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 125.796 1.638 . . . . 0.0 110.209 177.12 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.4 tttt -58.5 -45.95 87.7 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.098 0.559 . . . . 0.0 110.19 178.905 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 83.6 mt -64.68 -42.96 96.5 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.376 0 N-CA-C 109.617 -0.512 . . . . 0.0 109.617 172.752 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 82.53 18.55 65.96 Favored Glycine 0 CA--C 1.525 0.7 0 C-N-CA 124.988 1.28 . . . . 0.0 111.018 -175.784 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.1 tt0 -55.23 -41.61 72.32 Favored 'General case' 0 C--N 1.341 0.202 0 CA-C-N 117.762 0.781 . . . . 0.0 111.0 -173.67 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -110.54 25.95 11.22 Favored 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.397 1.079 . . . . 0.0 110.44 177.578 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 74.06 -152.91 46.11 Favored Glycine 0 CA--C 1.53 0.99 0 N-CA-C 110.184 -1.167 . . . . 0.0 110.184 -170.419 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 28.3 ttm180 -117.25 120.68 38.99 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 124.953 1.301 . . . . 0.0 108.148 -176.518 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.1 mp -120.87 156.95 30.87 Favored 'General case' 0 C--O 1.231 0.128 0 C-N-CA 123.446 0.698 . . . . 0.0 111.805 -175.761 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 61.2 m -97.56 95.89 7.93 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 107.476 -1.305 . . . . 0.0 107.476 179.443 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -45.3 132.14 7.75 Favored 'General case' 0 CA--C 1.528 0.131 0 N-CA-C 109.711 -0.477 . . . . 0.0 109.711 169.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.1 m-80 -101.02 -68.5 0.81 Allowed 'General case' 0 C--N 1.331 -0.226 0 N-CA-C 108.443 -0.947 . . . . 0.0 108.443 174.165 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 30.7 ttmt -168.61 165.11 12.33 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 108.601 -0.889 . . . . 0.0 108.601 -171.953 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 86.2 t -102.58 141.59 18.36 Favored 'Isoleucine or valine' 0 C--O 1.232 0.132 0 C-N-CA 124.67 1.188 . . . . 0.0 108.109 173.069 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -137.54 172.3 14.79 Favored 'Isoleucine or valine' 0 CA--C 1.529 0.159 0 C-N-CA 123.488 0.715 . . . . 0.0 110.012 175.395 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -64.73 154.99 83.88 Favored Pre-proline 0 CA--C 1.539 0.533 0 C-N-CA 123.722 0.809 . . . . 0.0 111.405 -176.807 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -73.56 158.23 98.66 Favored 'Cis proline' 0 N--CA 1.455 -0.755 0 N-CA-C 110.373 -0.664 . . . . 0.0 110.373 -4.538 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 77.0 m -141.79 91.31 2.35 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.162 -1.792 . . . . 0.0 106.162 176.861 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.26 127.84 53.53 Favored 'General case' 0 CA--C 1.532 0.277 0 C-N-CA 124.306 1.042 . . . . 0.0 110.28 -168.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 29.3 ttmt -102.68 145.31 29.87 Favored 'General case' 0 CA--C 1.529 0.153 0 C-N-CA 123.705 0.802 . . . . 0.0 110.018 175.559 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 23.8 tptm -148.34 141.74 25.27 Favored 'General case' 0 CA--C 1.533 0.3 0 C-N-CA 123.184 0.594 . . . . 0.0 110.237 166.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 48.5 m -58.49 134.61 56.84 Favored 'General case' 0 CA--C 1.532 0.264 0 C-N-CA 123.577 0.751 . . . . 0.0 110.453 170.144 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 tp -115.61 127.68 73.1 Favored 'Isoleucine or valine' 0 C--O 1.235 0.306 0 C-N-CA 124.632 1.173 . . . . 0.0 108.614 -179.339 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 25.1 p90 -161.57 -179.92 7.69 Favored 'General case' 0 N--CA 1.447 -0.596 0 C-N-CA 123.3 0.64 . . . . 0.0 110.115 -169.74 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 11.7 tt0 -82.49 -143.97 0.06 Allowed 'General case' 0 CA--C 1.538 0.499 0 O-C-N 123.934 0.772 . . . . 0.0 109.474 179.054 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.7 t30 -166.26 -48.03 0.03 OUTLIER 'General case' 0 CA--C 1.528 0.102 0 C-N-CA 124.299 1.04 . . . . 0.0 109.299 -177.186 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.4 tt0 -53.94 157.14 2.57 Favored 'General case' 0 CA--C 1.535 0.401 0 C-N-CA 123.1 0.56 . . . . 0.0 109.939 170.539 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -46.43 -13.9 0.09 OUTLIER Glycine 0 CA--C 1.533 1.176 0 C-N-CA 127.524 2.488 . . . . 0.0 117.604 -169.935 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 9.5 t80 -54.51 -40.87 69.0 Favored 'General case' 0 CA--C 1.535 0.398 0 CA-C-N 119.124 1.462 . . . . 0.0 109.209 168.988 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 36.64 68.53 0.25 Allowed 'General case' 0 CA--C 1.533 0.312 0 C-N-CA 126.932 2.093 . . . . 0.0 112.943 166.679 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -143.11 147.15 34.52 Favored 'General case' 0 N--CA 1.449 -0.514 0 N-CA-C 106.981 -1.488 . . . . 0.0 106.981 -179.91 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.1 mt -79.97 125.11 38.78 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.21 0 C-N-CA 123.786 0.834 . . . . 0.0 109.092 -176.844 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -88.16 -39.62 14.37 Favored 'General case' 0 N--CA 1.456 -0.17 0 N-CA-C 109.875 -0.417 . . . . 0.0 109.875 179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.58 -152.11 9.78 Favored Glycine 0 N--CA 1.448 -0.539 0 N-CA-C 111.877 -0.489 . . . . 0.0 111.877 -172.374 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.6 OUTLIER -143.16 152.95 42.36 Favored 'General case' 0 N--CA 1.449 -0.476 0 C-N-CA 124.966 1.306 . . . . 0.0 107.662 174.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 11.6 pt-20 -109.9 155.98 21.01 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 124.763 1.225 . . . . 0.0 108.875 170.536 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -138.27 102.72 4.73 Favored 'General case' 0 N--CA 1.445 -0.711 0 C-N-CA 126.511 1.924 . . . . 0.0 106.239 178.133 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -93.33 126.62 38.56 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.698 -0.853 . . . . 0.0 108.698 175.261 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.0 pp -152.24 153.55 33.99 Favored 'General case' 0 N--CA 1.454 -0.241 0 CA-C-N 118.308 0.503 . . . . 0.0 112.078 -172.264 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 5.9 m-30 -85.88 118.19 25.21 Favored 'General case' 0 N--CA 1.45 -0.464 0 N-CA-C 108.032 -1.099 . . . . 0.0 108.032 174.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.0 p -107.51 125.84 63.83 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.466 0 C-N-CA 125.009 1.324 . . . . 0.0 108.793 176.089 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 3.7 t80 -92.17 123.03 35.21 Favored 'General case' 0 N--CA 1.448 -0.554 0 N-CA-C 106.856 -1.535 . . . . 0.0 106.856 176.041 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -142.58 130.15 21.36 Favored 'General case' 0 N--CA 1.454 -0.231 0 N-CA-C 107.892 -1.151 . . . . 0.0 107.892 -176.773 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.3 t 51.85 37.04 19.63 Favored 'General case' 0 CA--C 1.534 0.339 0 C-N-CA 123.766 0.826 . . . . 0.0 111.201 -174.637 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 9.0 t70 64.25 12.79 7.44 Favored 'General case' 0 CA--C 1.541 0.612 0 C-N-CA 124.774 1.23 . . . . 0.0 113.249 -178.199 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 2.3 mptm? -109.82 147.35 33.46 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 124.52 1.128 . . . . 0.0 107.995 177.523 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -93.53 112.74 24.7 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.983 1.313 . . . . 0.0 107.609 -176.205 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.7 m-85 -116.49 162.5 17.49 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 124.282 1.033 . . . . 0.0 108.324 171.406 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.3 ttt180 -112.56 128.22 56.3 Favored 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.195 -1.409 . . . . 0.0 107.195 174.516 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.26 134.95 54.34 Favored 'General case' 0 N--CA 1.452 -0.346 0 N-CA-C 107.807 -1.183 . . . . 0.0 107.807 174.477 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.5 t0 -112.21 107.86 16.89 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 107.367 -1.345 . . . . 0.0 107.367 168.502 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mp -97.6 151.6 4.27 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.256 0 N-CA-C 106.353 -1.721 . . . . 0.0 106.353 177.769 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 61.6 m -128.98 152.71 48.3 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 109.131 -0.692 . . . . 0.0 109.131 169.384 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -117.35 125.48 51.09 Favored 'General case' 0 CA--C 1.518 -0.275 0 N-CA-C 105.347 -2.094 . . . . 0.0 105.347 169.876 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 t70 -87.97 125.36 34.48 Favored 'General case' 0 N--CA 1.455 -0.225 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 171.126 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 38.2 t80 -66.98 -45.59 77.19 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 123.818 0.847 . . . . 0.0 110.625 -173.13 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.78 -43.55 88.47 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.098 0.559 . . . . 0.0 110.416 -177.268 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 4.0 m -69.42 -37.28 77.37 Favored 'General case' 0 N--CA 1.457 -0.08 0 N-CA-C 109.306 -0.628 . . . . 0.0 109.306 175.932 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER 60.52 49.43 6.66 Favored 'General case' 0 N--CA 1.447 -0.588 0 C-N-CA 125.457 1.503 . . . . 0.0 108.777 -173.234 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -148.87 154.79 26.03 Favored Glycine 0 CA--C 1.523 0.59 0 N-CA-C 108.63 -1.788 . . . . 0.0 108.63 -179.663 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -102.94 168.48 9.17 Favored 'General case' 0 N--CA 1.454 -0.27 0 C-N-CA 123.609 0.764 . . . . 0.0 111.928 -174.925 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 12.3 ptmt -163.72 139.46 6.49 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.772 1.229 . . . . 0.0 110.869 -178.448 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 34.7 tp -63.16 122.76 16.92 Favored 'General case' 0 CA--C 1.533 0.325 0 N-CA-C 107.78 -1.193 . . . . 0.0 107.78 167.929 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.0 tp -83.27 -57.45 3.26 Favored 'General case' 0 C--N 1.339 0.118 0 N-CA-C 108.324 -0.991 . . . . 0.0 108.324 169.751 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -148.12 152.25 37.0 Favored 'General case' 0 N--CA 1.455 -0.213 0 C-N-CA 123.29 0.636 . . . . 0.0 109.472 176.573 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 86.4 t80 -117.05 134.85 54.24 Favored 'General case' 0 N--CA 1.449 -0.508 0 N-CA-C 104.869 -2.271 . . . . 0.0 104.869 168.281 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 8.3 m120 -134.67 149.36 50.51 Favored 'General case' 0 N--CA 1.446 -0.642 0 N-CA-C 106.95 -1.5 . . . . 0.0 106.95 -179.259 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 130.7 -166.52 22.47 Favored Glycine 0 CA--C 1.529 0.909 0 CA-C-O 119.35 -0.695 . . . . 0.0 112.061 171.431 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo -65.57 151.69 78.14 Favored 'Cis proline' 0 N--CA 1.456 -0.73 0 C-N-CA 124.752 -0.937 . . . . 0.0 110.045 -1.939 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.3 m -135.46 130.12 18.89 Favored Pre-proline 0 N--CA 1.462 0.144 0 N-CA-C 107.567 -1.271 . . . . 0.0 107.567 175.179 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 73.3 Cg_endo -68.16 153.31 75.02 Favored 'Trans proline' 0 N--CA 1.453 -0.91 0 C-N-CA 121.271 1.314 . . . . 0.0 109.302 -179.983 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.35 153.67 76.24 Favored 'Trans proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.071 1.847 . . . . 0.0 109.659 175.623 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 67.7 Cg_endo . . . . . 0 C--O 1.252 1.197 0 C-N-CA 122.707 2.271 . . . . 0.0 110.807 177.35 . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.328 0 N-CA-C 112.135 -0.386 . . . . 0.0 112.135 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 45.1 mt-10 48.4 48.06 19.48 Favored 'General case' 0 CA--C 1.533 0.316 0 C-N-CA 124.921 1.288 . . . . 0.0 112.402 178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 34.8 m95 -141.66 135.52 30.0 Favored 'General case' 0 N--CA 1.452 -0.331 0 N-CA-C 107.145 -1.428 . . . . 0.0 107.145 172.039 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 31.2 tt0 -157.12 158.83 37.09 Favored 'General case' 0 N--CA 1.457 -0.091 0 N-CA-C 108.276 -1.009 . . . . 0.0 108.276 171.856 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.408 ' H ' HD12 ' A' ' 5' ' ' ILE . 3.5 mp -88.82 139.12 17.88 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.137 -1.431 . . . . 0.0 107.137 175.924 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.3 pp -109.95 161.1 8.57 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.245 0 C-N-CA 123.811 0.845 . . . . 0.0 110.517 177.913 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -75.01 135.63 41.29 Favored 'General case' 0 N--CA 1.45 -0.434 0 C-N-CA 123.667 0.787 . . . . 0.0 110.357 -174.399 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -82.59 124.87 39.76 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.767 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 167.49 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.05 -167.5 30.6 Favored Glycine 0 CA--C 1.53 1.026 0 N-CA-C 109.07 -1.612 . . . . 0.0 109.07 -174.849 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -56.76 -44.02 49.12 Favored 'Trans proline' 0 N--CA 1.458 -0.616 0 C-N-CA 122.933 2.422 . . . . 0.0 111.602 -176.451 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 48.7 t80 -53.94 -52.76 59.59 Favored 'General case' 0 CA--C 1.535 0.378 0 CA-C-O 122.167 0.984 . . . . 0.0 111.043 176.628 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -62.49 -45.37 93.34 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 124.19 0.996 . . . . 0.0 109.767 -178.392 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.3 mt-30 -60.42 -41.33 93.72 Favored 'General case' 0 N--CA 1.445 -0.7 0 CA-C-O 118.979 -0.534 . . . . 0.0 111.306 176.598 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.7 t-20 -56.7 -49.86 73.87 Favored 'General case' 0 C--O 1.233 0.218 0 CA-C-N 119.012 0.824 . . . . 0.0 110.42 174.78 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.471 HD23 ' HA ' ' A' ' 15' ' ' LEU . 12.9 mt -57.48 -45.55 84.74 Favored 'General case' 0 N--CA 1.46 0.069 0 C-N-CA 120.818 -0.353 . . . . 0.0 110.805 175.757 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -53.11 -46.55 62.01 Favored Glycine 0 CA--C 1.528 0.9 0 N-CA-C 111.403 -0.679 . . . . 0.0 111.403 174.494 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.7 tmtp? -60.0 -51.77 68.23 Favored 'General case' 0 N--CA 1.445 -0.722 0 N-CA-C 108.571 -0.9 . . . . 0.0 108.571 -178.791 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.6 t80 -51.85 -47.16 64.54 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.054 0.541 . . . . 0.0 111.06 175.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.03 -50.16 74.38 Favored 'General case' 0 C--O 1.233 0.217 0 CA-C-O 121.317 0.58 . . . . 0.0 110.326 -177.786 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 76.0 t -64.7 -40.75 90.15 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.125 0 CA-C-N 115.942 -0.572 . . . . 0.0 110.098 178.295 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.8 t70 -58.49 -46.87 85.8 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.219 0.608 . . . . 0.0 110.058 -179.909 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.8 tp10 -56.91 -54.02 51.32 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.264 1.026 . . . . 0.0 109.041 176.401 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 41.5 tt0 -57.29 -48.0 80.05 Favored 'General case' 0 N--CA 1.453 -0.316 0 C-N-CA 120.783 -0.367 . . . . 0.0 110.637 -178.182 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 4.5 m-20 -57.6 -45.12 85.7 Favored 'General case' 0 N--CA 1.451 -0.403 0 C-N-CA 124.35 1.06 . . . . 0.0 110.094 178.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 85.3 tttt -58.76 -41.37 86.42 Favored 'General case' 0 N--CA 1.455 -0.221 0 C-N-CA 122.569 0.348 . . . . 0.0 110.37 -177.82 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.3 mt -72.24 -45.38 61.73 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.517 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 175.326 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.89 15.56 48.53 Favored Glycine 0 CA--C 1.528 0.897 0 C-N-CA 124.976 1.274 . . . . 0.0 112.838 174.251 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -53.79 -42.94 68.86 Favored 'General case' 0 N--CA 1.464 0.232 0 CA-C-N 118.351 1.076 . . . . 0.0 111.963 -175.631 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -108.77 33.0 4.46 Favored 'General case' 0 CA--C 1.536 0.431 0 C-N-CA 123.955 0.902 . . . . 0.0 109.707 177.419 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.44 -142.07 47.58 Favored Glycine 0 CA--C 1.528 0.85 0 N-CA-C 109.98 -1.248 . . . . 0.0 109.98 -174.647 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 98.8 mtt180 -106.47 120.09 41.0 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.517 1.127 . . . . 0.0 109.213 179.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 7.6 mt -106.73 168.78 8.95 Favored 'General case' 0 CA--C 1.533 0.327 0 C-N-CA 124.364 1.065 . . . . 0.0 108.546 170.23 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 28.2 m -120.67 103.83 9.43 Favored 'General case' 0 C--O 1.231 0.106 0 N-CA-C 108.304 -0.998 . . . . 0.0 108.304 179.629 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 68.7 t80 -46.23 130.09 10.34 Favored 'General case' 0 C--N 1.338 0.079 0 CA-C-N 117.713 0.233 . . . . 0.0 110.989 179.505 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.7 m-80 -106.49 -66.87 0.97 Allowed 'General case' 0 N--CA 1.454 -0.261 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 178.018 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 63.2 pttt -167.4 -169.39 1.22 Allowed 'General case' 0 CA--C 1.533 0.299 0 C-N-CA 123.293 0.637 . . . . 0.0 109.996 -176.142 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 96.9 t -128.51 146.4 34.0 Favored 'Isoleucine or valine' 0 C--O 1.231 0.129 0 C-N-CA 125.594 1.557 . . . . 0.0 106.809 174.716 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 16.6 pt -138.55 166.57 22.75 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-O 121.358 0.599 . . . . 0.0 110.631 176.012 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -67.33 158.58 81.46 Favored Pre-proline 0 CA--C 1.54 0.571 0 C-N-CA 125.48 1.512 . . . . 0.0 111.94 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 64.9 Cg_endo -67.63 148.33 80.79 Favored 'Cis proline' 0 N--CA 1.456 -0.688 0 CA-C-N 118.861 0.629 . . . . 0.0 111.168 -8.54 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 71.6 m -131.41 94.32 3.52 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 104.926 -2.25 . . . . 0.0 104.926 174.061 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -108.86 128.55 55.0 Favored 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.721 0.808 . . . . 0.0 109.809 -168.287 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 40.1 ttpt -104.85 140.8 37.59 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 124.642 1.177 . . . . 0.0 109.186 -179.807 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 47.5 tttm -133.83 152.02 51.73 Favored 'General case' 0 CA--C 1.531 0.216 0 C-N-CA 124.453 1.101 . . . . 0.0 108.969 169.343 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.7 m -82.86 136.93 34.46 Favored 'General case' 0 CA--C 1.534 0.335 0 C-N-CA 124.505 1.122 . . . . 0.0 109.844 176.87 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -115.16 131.87 66.15 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.247 0 C-N-CA 125.262 1.425 . . . . 0.0 108.771 -179.831 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 51.4 p90 -166.16 176.5 7.59 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 123.33 0.652 . . . . 0.0 109.857 -167.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 79.3 mm-40 -134.57 162.96 30.81 Favored 'General case' 0 N--CA 1.444 -0.77 0 N-CA-C 106.441 -1.689 . . . . 0.0 106.441 177.508 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 68.3 m-80 -50.97 -58.77 5.19 Favored 'General case' 0 C--N 1.331 -0.219 0 C-N-CA 125.016 1.327 . . . . 0.0 110.692 -179.542 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 59.7 -176.07 0.1 Allowed 'General case' 0 CA--C 1.542 0.64 0 C-N-CA 124.016 0.927 . . . . 0.0 109.924 -174.034 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.88 -39.47 56.18 Favored Glycine 0 CA--C 1.53 0.994 0 O-C-N 121.338 -0.851 . . . . 0.0 112.04 175.673 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 85.6 m-85 -140.02 -55.43 0.54 Allowed 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.274 1.03 . . . . 0.0 110.203 175.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 4.8 ptm85 -172.48 148.48 2.02 Favored 'General case' 0 N--CA 1.455 -0.197 0 N-CA-C 107.679 -1.23 . . . . 0.0 107.679 -178.638 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 2.3 tm-20 -165.77 96.0 0.63 Allowed 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 125.301 1.44 . . . . 0.0 107.174 169.826 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 80.1 mt -63.5 110.18 0.81 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.289 0 C-N-CA 123.066 0.546 . . . . 0.0 110.193 178.734 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 37.0 ttpt -81.56 -33.43 31.67 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 123.049 0.54 . . . . 0.0 110.792 -175.021 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.23 -161.74 24.05 Favored Glycine 0 N--CA 1.447 -0.599 0 C-N-CA 120.201 -1.0 . . . . 0.0 112.116 -170.823 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 7.0 m-85 -147.68 159.6 43.61 Favored 'General case' 0 N--CA 1.448 -0.526 0 N-CA-C 107.951 -1.129 . . . . 0.0 107.951 -179.498 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.5 pt-20 -121.87 149.19 43.74 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 124.978 1.311 . . . . 0.0 108.459 170.081 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 29.2 m-85 -132.61 107.76 8.64 Favored 'General case' 0 N--CA 1.448 -0.539 0 N-CA-C 106.518 -1.66 . . . . 0.0 106.518 -179.342 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.2 tt0 -97.27 118.18 33.15 Favored 'General case' 0 N--CA 1.453 -0.276 0 N-CA-C 107.864 -1.162 . . . . 0.0 107.864 177.511 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.2 pp -146.37 158.71 43.92 Favored 'General case' 0 N--CA 1.455 -0.201 0 C-N-CA 122.808 0.443 . . . . 0.0 111.133 -170.841 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -96.99 112.55 24.26 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.524 0.73 . . . . 0.0 109.579 179.404 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 11.9 p -99.88 133.0 44.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.347 0 C-N-CA 123.626 0.77 . . . . 0.0 109.617 176.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -93.08 122.36 35.38 Favored 'General case' 0 N--CA 1.449 -0.503 0 C-N-CA 125.441 1.496 . . . . 0.0 107.521 174.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.6 127.15 28.8 Favored 'General case' 0 N--CA 1.453 -0.29 0 C-N-CA 123.812 0.845 . . . . 0.0 109.395 -178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 8.0 t 70.74 -64.17 0.38 Allowed 'General case' 0 N--CA 1.457 -0.11 0 C-N-CA 129.593 3.157 . . . . 0.0 108.432 -169.264 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 11.3 p-10 179.72 11.09 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.535 0 C-N-CA 129.518 3.127 . . . . 0.0 111.207 -175.561 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 91.4 mttt -119.55 149.29 42.17 Favored 'General case' 0 N--CA 1.454 -0.25 0 C-N-CA 124.923 1.289 . . . . 0.0 107.832 -174.555 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 10.9 tp -106.79 120.98 43.47 Favored 'General case' 0 N--CA 1.451 -0.418 0 C-N-CA 123.45 0.7 . . . . 0.0 109.759 -169.817 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 70.9 m-85 -122.4 137.93 54.7 Favored 'General case' 0 N--CA 1.455 -0.182 0 C-N-CA 124.738 1.215 . . . . 0.0 108.364 -177.031 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 52.9 ttt180 -94.69 115.82 28.0 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 107.96 -1.126 . . . . 0.0 107.96 -178.984 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -114.25 135.5 54.0 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 124.188 0.995 . . . . 0.0 109.559 -175.319 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 34.5 t70 -102.58 103.67 14.0 Favored 'General case' 0 N--CA 1.451 -0.41 0 C-N-CA 124.531 1.132 . . . . 0.0 108.208 169.893 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.455 HG21 HD22 ' A' ' 15' ' ' LEU . 10.9 mm -91.26 161.35 2.59 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 C-N-CA 125.86 1.664 . . . . 0.0 106.9 176.298 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.6 p -145.6 167.57 22.74 Favored 'General case' 0 N--CA 1.449 -0.523 0 CA-C-N 118.65 0.659 . . . . 0.0 111.438 177.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 61.2 tt0 -136.52 131.24 33.65 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 126.553 1.941 . . . . 0.0 108.277 179.233 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -98.37 107.86 20.42 Favored 'General case' 0 C--O 1.235 0.335 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 169.47 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.7 t80 -53.03 -37.48 61.58 Favored 'General case' 0 C--O 1.227 -0.079 0 C-N-CA 124.439 1.096 . . . . 0.0 111.194 -173.478 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 56.5 mttm -43.07 -40.55 3.18 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 126.414 1.886 . . . . 0.0 112.464 179.088 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 3.2 m -121.54 0.52 9.95 Favored 'General case' 0 CA--C 1.536 0.42 0 C-N-CA 122.798 0.439 . . . . 0.0 110.99 178.81 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 15.3 ttm180 52.77 28.78 6.71 Favored 'General case' 0 CA--C 1.539 0.556 0 C-N-CA 123.686 0.795 . . . . 0.0 109.126 -165.711 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -92.99 128.13 9.3 Favored Glycine 0 C--N 1.337 0.598 0 N-CA-C 108.311 -1.916 . . . . 0.0 108.311 -168.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 60.5 mtt85 -105.88 170.04 8.13 Favored 'General case' 0 N--CA 1.451 -0.381 0 CA-C-O 121.567 0.699 . . . . 0.0 112.36 -176.713 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 15.4 ptmt -177.58 161.57 1.71 Allowed 'General case' 0 CA--C 1.532 0.269 0 C-N-CA 126.044 1.737 . . . . 0.0 112.35 -166.648 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 67.1 tp -89.84 138.18 31.71 Favored 'General case' 0 CA--C 1.531 0.229 0 C-N-CA 125.3 1.44 . . . . 0.0 108.88 172.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 73.9 mt -104.47 -58.24 1.91 Allowed 'General case' 0 N--CA 1.464 0.254 0 CA-C-N 118.628 0.649 . . . . 0.0 110.245 169.447 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 62.3 mtm180 -136.2 150.56 49.06 Favored 'General case' 0 C--O 1.231 0.092 0 N-CA-C 109.328 -0.619 . . . . 0.0 109.328 -177.387 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.5 t80 -143.77 106.33 4.44 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 -175.969 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 64.0 m-20 -115.39 147.84 40.05 Favored 'General case' 0 N--CA 1.451 -0.403 0 N-CA-C 108.386 -0.968 . . . . 0.0 108.386 -176.202 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.68 -167.5 27.09 Favored Glycine 0 CA--C 1.529 0.942 0 CA-C-O 119.504 -0.609 . . . . 0.0 111.925 173.41 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -66.4 143.27 62.56 Favored 'Cis proline' 0 N--CA 1.455 -0.739 0 C-N-CA 124.373 -1.095 . . . . 0.0 110.002 -2.573 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.5 m -140.72 120.17 8.53 Favored Pre-proline 0 CA--C 1.531 0.216 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 174.492 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.5 Cg_endo -70.04 157.33 60.18 Favored 'Trans proline' 0 N--CA 1.452 -0.933 0 C-N-CA 121.898 1.732 . . . . 0.0 108.583 177.948 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -68.21 150.72 76.99 Favored 'Trans proline' 0 N--CA 1.452 -0.934 0 C-N-CA 121.936 1.757 . . . . 0.0 109.78 179.369 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 70.7 Cg_endo . . . . . 0 C--O 1.25 1.109 0 C-N-CA 122.59 2.193 . . . . 0.0 110.76 178.052 . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.236 0 N-CA-C 111.313 -0.715 . . . . 0.0 111.313 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 51.4 mp0 -62.25 141.58 58.16 Favored 'General case' 0 N--CA 1.452 -0.366 0 N-CA-C 109.656 -0.498 . . . . 0.0 109.656 179.315 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 65.8 m95 -133.45 141.89 48.04 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 105.882 -1.896 . . . . 0.0 105.882 167.86 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -163.09 155.45 18.44 Favored 'General case' 0 N--CA 1.436 -1.159 0 N-CA-C 107.33 -1.359 . . . . 0.0 107.33 -176.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.4 mp -99.2 139.38 21.07 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.478 0 N-CA-C 107.732 -1.21 . . . . 0.0 107.732 -174.822 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 45.3 pt -103.02 154.23 5.48 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 123.842 0.857 . . . . 0.0 109.66 171.932 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.0 m-20 -74.46 134.21 42.33 Favored 'General case' 0 N--CA 1.45 -0.448 0 N-CA-C 109.257 -0.646 . . . . 0.0 109.257 179.523 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 40.8 pt -62.27 141.36 17.94 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.971 0 N-CA-C 107.521 -1.288 . . . . 0.0 107.521 165.543 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 157.66 -169.35 34.5 Favored Glycine 0 CA--C 1.527 0.842 0 N-CA-C 108.316 -1.914 . . . . 0.0 108.316 -168.584 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -56.41 -48.77 17.48 Favored 'Trans proline' 0 N--CA 1.456 -0.693 0 C-N-CA 123.427 2.751 . . . . 0.0 112.769 -169.816 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 59.7 t80 -52.37 -55.0 24.54 Favored 'General case' 0 CA--C 1.535 0.386 0 CA-C-O 122.124 0.964 . . . . 0.0 111.066 177.224 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 11.7 m -67.37 -44.27 79.39 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 124.215 1.006 . . . . 0.0 110.018 -172.567 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 44.4 mt-30 -56.4 -49.25 75.04 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-O 118.93 -0.557 . . . . 0.0 109.882 172.262 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 47.8 t30 -56.31 -46.47 79.82 Favored 'General case' 0 C--O 1.227 -0.127 0 CA-C-N 118.624 0.647 . . . . 0.0 110.928 178.924 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 13.2 mt -55.95 -51.87 66.13 Favored 'General case' 0 N--CA 1.461 0.087 0 CA-C-N 117.894 0.315 . . . . 0.0 110.515 175.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.58 -45.07 90.63 Favored Glycine 0 CA--C 1.528 0.857 0 N-CA-C 111.365 -0.694 . . . . 0.0 111.365 178.74 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 1.6 tmtp? -59.81 -52.12 66.82 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 108.685 -0.857 . . . . 0.0 108.685 -178.878 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -49.94 -48.48 51.86 Favored 'General case' 0 N--CA 1.455 -0.222 0 C-N-CA 124.731 1.212 . . . . 0.0 110.201 174.025 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.84 -50.58 72.83 Favored 'General case' 0 N--CA 1.453 -0.288 0 N-CA-C 109.866 -0.42 . . . . 0.0 109.866 -178.866 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 74.0 t -61.49 -39.95 84.7 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.261 0 CA-C-N 116.56 -0.291 . . . . 0.0 110.776 177.243 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.5 t70 -60.94 -48.75 80.38 Favored 'General case' 0 N--CA 1.452 -0.374 0 C-N-CA 123.378 0.671 . . . . 0.0 109.938 -179.792 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -57.74 -52.82 63.88 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.077 0.951 . . . . 0.0 109.152 175.666 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 47.8 tp10 -54.08 -46.65 72.09 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 124.485 1.114 . . . . 0.0 110.315 -177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 40.7 m-20 -69.65 -42.02 74.79 Favored 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 125.554 1.542 . . . . 0.0 110.518 179.475 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 87.9 tttt -59.55 -47.77 84.24 Favored 'General case' 0 CA--C 1.529 0.151 0 C-N-CA 123.321 0.648 . . . . 0.0 109.718 -179.707 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 68.5 mt -68.32 -41.74 83.88 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.416 0 N-CA-C 108.825 -0.805 . . . . 0.0 108.825 174.316 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 89.8 18.43 51.27 Favored Glycine 0 CA--C 1.525 0.68 0 C-N-CA 124.633 1.111 . . . . 0.0 112.26 173.713 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 84.9 mt-30 -55.6 -40.81 72.54 Favored 'General case' 0 CA--C 1.531 0.224 0 CA-C-N 117.974 0.887 . . . . 0.0 111.091 -176.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 12.4 m-85 -111.75 33.29 4.85 Favored 'General case' 0 CA--C 1.536 0.433 0 C-N-CA 124.208 1.003 . . . . 0.0 109.976 175.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 57.03 -140.09 45.23 Favored Glycine 0 CA--C 1.53 1.005 0 N-CA-C 110.998 -0.841 . . . . 0.0 110.998 -178.506 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.2 mpt_? -92.91 108.3 19.89 Favored 'General case' 0 CA--C 1.528 0.116 0 C-N-CA 123.538 0.735 . . . . 0.0 109.65 173.808 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 71.8 mt -93.85 141.66 28.26 Favored 'General case' 0 C--O 1.232 0.174 0 N-CA-C 108.57 -0.9 . . . . 0.0 108.57 167.402 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 68.6 m -100.74 95.34 6.59 Favored 'General case' 0 N--CA 1.456 -0.133 0 C-N-CA 124.227 1.011 . . . . 0.0 108.346 -178.748 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 69.7 t80 -51.21 133.82 27.99 Favored 'General case' 0 CA--C 1.527 0.072 0 C-N-CA 123.179 0.592 . . . . 0.0 111.448 177.818 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.3 m120 -100.27 -67.41 0.85 Allowed 'General case' 0 C--N 1.332 -0.17 0 N-CA-C 108.613 -0.884 . . . . 0.0 108.613 169.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.6 ptpt -169.57 -159.5 0.22 Allowed 'General case' 0 CA--C 1.531 0.243 0 C-N-CA 124.444 1.098 . . . . 0.0 108.533 -177.132 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 39.1 t -134.12 141.68 43.13 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.182 0 N-CA-C 107.263 -1.384 . . . . 0.0 107.263 177.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.1 pp -137.15 174.7 11.29 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.314 0 C-N-CA 123.023 0.529 . . . . 0.0 110.884 177.176 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 35.9 ptt-85 -63.49 153.57 82.36 Favored Pre-proline 0 CA--C 1.542 0.64 0 C-N-CA 125.095 1.358 . . . . 0.0 112.889 -170.844 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 86.0 Cg_endo -76.11 159.14 97.18 Favored 'Cis proline' 0 N--CA 1.449 -1.094 0 N-CA-C 109.066 -1.167 . . . . 0.0 109.066 -7.573 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.1 m -133.91 87.24 2.35 Favored 'General case' 0 N--CA 1.446 -0.643 0 N-CA-C 103.911 -2.626 . . . . 0.0 103.911 175.296 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.2 OUTLIER -113.49 140.15 48.36 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 123.896 0.878 . . . . 0.0 109.421 -167.592 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 53.3 pttt -122.12 162.13 21.84 Favored 'General case' 0 N--CA 1.457 -0.082 0 CA-C-O 119.61 -0.233 . . . . 0.0 111.197 176.57 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 87.1 tttt -138.45 147.52 43.37 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 125.852 1.661 . . . . 0.0 108.488 175.383 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 17.8 m -83.6 130.49 34.99 Favored 'General case' 0 CA--C 1.533 0.325 0 C-N-CA 124.226 1.01 . . . . 0.0 110.089 172.305 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -108.44 120.87 60.59 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.502 0 C-N-CA 124.665 1.186 . . . . 0.0 108.856 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 26.9 p90 -144.84 162.23 37.32 Favored 'General case' 0 N--CA 1.455 -0.214 0 O-C-N 121.394 -0.816 . . . . 0.0 111.272 -173.78 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 -98.39 -166.63 1.39 Allowed 'General case' 0 N--CA 1.45 -0.431 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -177.581 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 25.5 t30 -158.69 -51.25 0.06 Allowed 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 123.485 0.714 . . . . 0.0 111.763 -179.313 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.7 tt0 -54.66 105.2 0.14 Allowed 'General case' 0 CA--C 1.534 0.336 0 C-N-CA 123.826 0.85 . . . . 0.0 110.501 -179.077 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.76 78.67 0.56 Allowed Glycine 0 CA--C 1.525 0.709 0 N-CA-C 111.432 -0.667 . . . . 0.0 111.432 175.018 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 28.1 t80 74.16 84.46 0.11 Allowed 'General case' 0 CA--C 1.531 0.22 0 C-N-CA 125.36 1.464 . . . . 0.0 110.254 175.782 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 1.2 ppt_? -58.23 135.39 57.09 Favored 'General case' 0 CA--C 1.531 0.213 0 CA-C-N 116.347 -0.388 . . . . 0.0 110.288 -179.647 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.0 tt0 -158.83 151.43 21.83 Favored 'General case' 0 N--CA 1.447 -0.584 0 N-CA-C 108.061 -1.089 . . . . 0.0 108.061 -179.27 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 92.3 mt -71.71 124.23 27.77 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.199 0 N-CA-C 107.837 -1.171 . . . . 0.0 107.837 177.417 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.14 -20.68 12.27 Favored 'General case' 0 N--CA 1.456 -0.164 0 O-C-N 123.496 0.497 . . . . 0.0 111.069 -179.178 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.94 -168.59 32.04 Favored Glycine 0 C--N 1.337 0.629 0 CA-C-N 118.817 0.735 . . . . 0.0 112.59 176.01 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 5.6 m-85 -142.9 157.8 44.24 Favored 'General case' 0 N--CA 1.449 -0.487 0 N-CA-C 106.76 -1.57 . . . . 0.0 106.76 175.992 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 32.2 tt0 -130.72 145.26 51.9 Favored 'General case' 0 C--N 1.33 -0.252 0 C-N-CA 124.973 1.309 . . . . 0.0 108.353 -179.255 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 88.5 m-85 -136.86 119.38 15.92 Favored 'General case' 0 N--CA 1.453 -0.276 0 C-N-CA 125.4 1.48 . . . . 0.0 107.878 -173.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 72.1 mt-30 -107.86 126.1 52.25 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 124.866 1.267 . . . . 0.0 108.291 171.954 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.5 pp -145.99 147.96 32.23 Favored 'General case' 0 N--CA 1.454 -0.272 0 C-N-CA 122.421 0.288 . . . . 0.0 110.269 -178.769 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 1.0 OUTLIER -87.2 99.48 11.97 Favored 'General case' 0 N--CA 1.448 -0.529 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 174.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 6.4 p -83.17 134.07 27.71 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.441 0 N-CA-C 108.442 -0.947 . . . . 0.0 108.442 173.198 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 14.0 t80 -102.22 122.78 44.85 Favored 'General case' 0 N--CA 1.45 -0.436 0 N-CA-C 107.172 -1.418 . . . . 0.0 107.172 -179.935 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -144.39 136.04 25.81 Favored 'General case' 0 N--CA 1.452 -0.368 0 N-CA-C 108.45 -0.945 . . . . 0.0 108.45 -177.248 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.8 OUTLIER 52.77 37.66 24.44 Favored 'General case' 0 CA--C 1.537 0.452 0 C-N-CA 124.457 1.103 . . . . 0.0 110.89 -177.083 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.5 t70 56.63 28.84 14.66 Favored 'General case' 0 CA--C 1.538 0.494 0 C-N-CA 124.987 1.315 . . . . 0.0 112.335 -176.795 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.5 mmtt -130.2 149.17 52.02 Favored 'General case' 0 N--CA 1.456 -0.153 0 C-N-CA 124.75 1.22 . . . . 0.0 108.218 176.309 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.7 tp -101.9 127.0 48.92 Favored 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 123.789 0.836 . . . . 0.0 109.637 -171.406 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 96.6 m-85 -129.24 136.9 50.7 Favored 'General case' 0 N--CA 1.457 -0.109 0 C-N-CA 124.861 1.264 . . . . 0.0 108.765 -179.73 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 31.0 ttm180 -83.81 115.15 22.1 Favored 'General case' 0 N--CA 1.455 -0.196 0 N-CA-C 107.811 -1.181 . . . . 0.0 107.811 172.485 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -98.47 135.24 40.32 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 107.651 -1.24 . . . . 0.0 107.651 169.363 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 65.4 t0 -116.02 115.11 25.55 Favored 'General case' 0 N--CA 1.454 -0.252 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 172.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.2 mp -112.81 151.44 14.73 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.229 0 C-N-CA 125.768 1.627 . . . . 0.0 107.41 -178.455 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 47.8 t -133.07 156.08 48.04 Favored 'General case' 0 CA--C 1.52 -0.194 0 CA-C-N 118.59 0.632 . . . . 0.0 109.574 169.281 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -126.05 131.34 52.18 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 126.322 1.849 . . . . 0.0 106.867 175.196 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.7 m-20 -97.6 115.7 28.39 Favored 'General case' 0 N--CA 1.456 -0.138 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 175.821 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 44.8 t80 -50.94 -48.33 60.85 Favored 'General case' 0 CA--C 1.529 0.165 0 C-N-CA 125.647 1.579 . . . . 0.0 111.813 -168.946 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 14.6 tmtt? -65.26 -30.41 71.28 Favored 'General case' 0 C--N 1.333 -0.151 0 C-N-CA 123.703 0.801 . . . . 0.0 110.972 -177.451 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 27.4 m -84.13 -33.59 24.25 Favored 'General case' 0 CA--C 1.529 0.171 0 N-CA-C 109.442 -0.577 . . . . 0.0 109.442 178.709 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 23.5 ttm-85 49.36 44.33 23.61 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 124.5 1.12 . . . . 0.0 109.759 -167.562 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -143.11 150.8 22.66 Favored Glycine 0 N--CA 1.449 -0.466 0 N-CA-C 106.412 -2.675 . . . . 0.0 106.412 178.733 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 44.1 mtt85 -111.39 169.31 8.89 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.395 0.617 . . . . 0.0 112.271 -170.847 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.07 145.82 23.38 Favored 'General case' 0 N--CA 1.448 -0.574 0 CA-C-N 114.388 -1.278 . . . . 0.0 111.189 174.44 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 25.4 tp -71.83 138.05 48.01 Favored 'General case' 0 CA--C 1.535 0.387 0 C-N-CA 123.755 0.822 . . . . 0.0 108.904 169.983 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 6.8 mp -96.63 -57.05 2.4 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 123.934 0.894 . . . . 0.0 108.75 168.637 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -148.39 160.1 43.35 Favored 'General case' 0 N--CA 1.454 -0.271 0 CA-C-O 120.835 0.35 . . . . 0.0 110.959 -179.718 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.6 t80 -136.25 92.24 2.76 Favored 'General case' 0 N--CA 1.449 -0.487 0 C-N-CA 126.63 1.972 . . . . 0.0 106.494 179.432 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 22.7 m120 -96.88 145.56 25.76 Favored 'General case' 0 N--CA 1.454 -0.228 0 N-CA-C 109.061 -0.718 . . . . 0.0 109.061 -175.367 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.51 -167.88 24.35 Favored Glycine 0 CA--C 1.529 0.934 0 N-CA-C 110.697 -0.961 . . . . 0.0 110.697 174.727 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 81.4 Cg_endo -71.12 157.74 95.51 Favored 'Cis proline' 0 N--CA 1.456 -0.701 0 CA-C-N 118.644 1.222 . . . . 0.0 110.588 0.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 11.2 m -132.23 140.34 37.72 Favored Pre-proline 0 CA--C 1.534 0.353 0 C-N-CA 123.345 0.658 . . . . 0.0 109.595 170.13 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.5 Cg_endo -80.05 122.74 4.87 Favored 'Trans proline' 0 N--CA 1.452 -0.923 0 C-N-CA 122.577 2.185 . . . . 0.0 108.787 171.985 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 86.2 Cg_endo -72.26 154.52 56.53 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 121.48 1.453 . . . . 0.0 109.618 174.096 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.25 1.123 0 C-N-CA 122.546 2.164 . . . . 0.0 110.688 175.805 . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.294 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -122.19 115.19 21.98 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 125.555 1.542 . . . . 0.0 108.884 -171.786 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 26.0 m95 -73.64 99.29 3.05 Favored 'General case' 0 CA--C 1.53 0.209 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 173.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 75.9 mm-40 -115.31 139.01 50.35 Favored 'General case' 0 N--CA 1.455 -0.198 0 C-N-CA 123.642 0.777 . . . . 0.0 109.677 -179.507 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.557 HD12 ' H ' ' A' ' 5' ' ' ILE . 3.4 mp -79.27 143.57 12.33 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.194 0 N-CA-C 107.323 -1.362 . . . . 0.0 107.323 177.427 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 37.9 pt -120.91 158.49 23.37 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.289 0 C-N-CA 123.718 0.807 . . . . 0.0 110.373 174.553 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -64.16 140.78 58.9 Favored 'General case' 0 N--CA 1.449 -0.489 0 C-N-CA 123.919 0.888 . . . . 0.0 109.856 178.665 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -92.7 121.45 43.36 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.03 0 C-N-CA 124.426 1.09 . . . . 0.0 108.425 168.488 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -170.48 -169.54 33.71 Favored Glycine 0 CA--C 1.528 0.877 0 N-CA-C 108.493 -1.843 . . . . 0.0 108.493 -176.265 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.4 Cg_endo -51.16 -45.97 33.77 Favored 'Trans proline' 0 CA--C 1.534 0.482 0 C-N-CA 123.723 2.948 . . . . 0.0 112.75 -173.949 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -49.22 -55.28 13.06 Favored 'General case' 0 CA--C 1.536 0.413 0 CA-C-O 122.114 0.959 . . . . 0.0 111.043 174.183 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.18 -41.3 90.45 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 124.663 1.185 . . . . 0.0 110.591 -178.124 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 40.5 mt-30 -56.67 -44.71 81.68 Favored 'General case' 0 N--CA 1.445 -0.678 0 C-N-CA 123.979 0.912 . . . . 0.0 109.55 176.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 20.9 t-20 -51.8 -52.76 46.71 Favored 'General case' 0 CA--C 1.534 0.329 0 CA-C-N 118.889 0.768 . . . . 0.0 110.75 175.748 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 96.6 mt -59.47 -46.19 89.5 Favored 'General case' 0 CA--C 1.532 0.269 0 CA-C-O 120.712 0.291 . . . . 0.0 110.537 178.788 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -55.97 -42.2 86.23 Favored Glycine 0 CA--C 1.533 1.217 0 N-CA-C 112.012 -0.435 . . . . 0.0 112.012 175.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.6 tmtp? -64.7 -50.13 68.16 Favored 'General case' 0 N--CA 1.443 -0.789 0 N-CA-C 107.593 -1.262 . . . . 0.0 107.593 -177.937 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 6.4 t80 -50.91 -46.15 60.59 Favored 'General case' 0 N--CA 1.455 -0.219 0 C-N-CA 124.12 0.968 . . . . 0.0 110.996 173.42 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 75' ' ' ILE . . . -58.06 -53.05 62.68 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-O 121.793 0.806 . . . . 0.0 110.398 179.473 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 68.9 t -63.78 -36.57 77.05 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 115.549 -0.751 . . . . 0.0 110.678 179.917 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 23.8 t70 -63.02 -47.16 84.23 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.201 1.0 . . . . 0.0 110.091 178.633 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.7 tp10 -54.97 -50.87 67.86 Favored 'General case' 0 N--CA 1.45 -0.454 0 N-CA-C 108.394 -0.965 . . . . 0.0 108.394 173.379 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.6 tm-20 -60.69 -41.71 95.67 Favored 'General case' 0 C--O 1.226 -0.176 0 O-C-N 121.635 -0.665 . . . . 0.0 111.383 -179.425 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.8 m-80 -56.42 -42.85 78.7 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 109.175 -0.676 . . . . 0.0 109.175 173.235 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 15.0 tmtt? -63.34 -39.97 96.02 Favored 'General case' 0 CA--C 1.537 0.469 0 CA-C-O 119.253 -0.403 . . . . 0.0 111.312 176.648 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 8.7 mm -62.54 -46.27 96.79 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.429 0 CA-C-N 119.16 0.891 . . . . 0.0 109.376 174.095 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 78.13 3.91 85.65 Favored Glycine 0 CA--C 1.529 0.927 0 C-N-CA 125.137 1.351 . . . . 0.0 112.78 -178.083 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -64.9 -29.12 70.04 Favored 'General case' 0 C--N 1.339 0.138 0 CA-C-N 119.071 1.436 . . . . 0.0 113.061 -171.676 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 60.1 m-85 -110.44 27.03 10.04 Favored 'General case' 0 CA--C 1.539 0.541 0 C-N-CA 123.584 0.753 . . . . 0.0 110.024 170.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 70.27 -164.07 52.44 Favored Glycine 0 CA--C 1.529 0.943 0 N-CA-C 110.963 -0.855 . . . . 0.0 110.963 -173.359 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.2 mtt180 -95.34 107.45 19.58 Favored 'General case' 0 N--CA 1.455 -0.207 0 C-N-CA 124.199 1.0 . . . . 0.0 108.547 177.186 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.6 mp -100.9 140.23 35.48 Favored 'General case' 0 N--CA 1.457 -0.092 0 CA-C-N 118.145 0.429 . . . . 0.0 110.776 -177.789 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 5.6 m -85.48 103.78 14.66 Favored 'General case' 0 N--CA 1.448 -0.528 0 N-CA-C 108.417 -0.957 . . . . 0.0 108.417 -178.395 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 31.9 t80 -49.03 128.86 16.87 Favored 'General case' 0 N--CA 1.457 -0.079 0 N-CA-C 109.452 -0.573 . . . . 0.0 109.452 170.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 2.7 t-20 -102.82 -64.51 1.07 Allowed 'General case' 0 C--N 1.33 -0.262 0 N-CA-C 108.256 -1.016 . . . . 0.0 108.256 178.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -167.8 170.64 10.63 Favored 'General case' 0 N--CA 1.462 0.141 0 C-N-CA 124.341 1.056 . . . . 0.0 109.998 172.954 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 14.5 p -98.48 149.5 5.31 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.178 0 C-N-CA 124.318 1.047 . . . . 0.0 108.745 169.352 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 19.6 pt -138.8 170.8 15.85 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.227 0 C-N-CA 123.374 0.67 . . . . 0.0 110.258 177.025 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 34.4 ptt180 -61.84 152.46 76.18 Favored Pre-proline 0 CA--C 1.54 0.589 0 C-N-CA 123.967 0.907 . . . . 0.0 110.421 171.744 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 87.1 Cg_endo -75.35 152.31 97.49 Favored 'Cis proline' 0 N--CA 1.455 -0.754 0 CA-C-N 119.184 0.744 . . . . 0.0 110.453 -4.791 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 46.9 t -143.72 101.65 3.79 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 107.158 -1.423 . . . . 0.0 107.158 177.806 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 14.4 ttp -128.47 136.19 50.48 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 123.877 0.871 . . . . 0.0 110.271 -166.019 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 23.9 pttm -119.84 157.3 28.96 Favored 'General case' 0 N--CA 1.455 -0.18 0 C-N-CA 124.195 0.998 . . . . 0.0 110.846 -178.157 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 60.4 tttm -146.69 146.28 30.3 Favored 'General case' 0 CA--C 1.532 0.266 0 C-N-CA 124.375 1.07 . . . . 0.0 109.635 174.116 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.6 m -76.06 132.52 40.15 Favored 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 123.98 0.912 . . . . 0.0 109.955 172.89 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -107.48 116.54 51.28 Favored 'Isoleucine or valine' 0 C--O 1.236 0.39 0 C-N-CA 125.281 1.433 . . . . 0.0 108.476 178.4 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 19.7 p90 -148.91 174.07 12.64 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.779 -0.646 . . . . 0.0 109.668 -174.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 69.5 mt-10 -131.56 154.57 48.69 Favored 'General case' 0 N--CA 1.444 -0.768 0 N-CA-C 107.244 -1.391 . . . . 0.0 107.244 174.484 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 30.9 t-20 -89.38 -64.84 1.08 Allowed 'General case' 0 C--N 1.328 -0.335 0 C-N-CA 126.348 1.859 . . . . 0.0 107.556 177.882 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 1.9 mp0 -7.42 84.57 0.0 OUTLIER 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 129.6 3.16 . . . . 0.0 113.598 -178.57 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 129.29 -75.81 0.42 Allowed Glycine 0 C--N 1.336 0.55 0 N-CA-C 107.958 -2.057 . . . . 0.0 107.958 -171.972 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 80.3 m-85 -156.67 -66.18 0.1 Allowed 'General case' 0 CA--C 1.531 0.221 0 C-N-CA 125.247 1.419 . . . . 0.0 108.279 178.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 6.5 ppt_? -170.79 145.99 2.52 Favored 'General case' 0 N--CA 1.453 -0.283 0 C-N-CA 125.205 1.402 . . . . 0.0 107.794 -178.886 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -162.36 114.34 1.65 Allowed 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 108.181 -1.044 . . . . 0.0 108.181 167.495 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 87.6 mt -71.28 123.08 24.69 Favored 'Isoleucine or valine' 0 C--N 1.338 0.108 0 N-CA-C 107.631 -1.248 . . . . 0.0 107.631 171.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 28.9 mtpp -101.53 -34.83 9.38 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 109.353 -0.61 . . . . 0.0 109.353 -176.809 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -174.33 -161.85 24.98 Favored Glycine 0 N--CA 1.446 -0.651 0 N-CA-C 110.608 -0.997 . . . . 0.0 110.608 178.715 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 8.7 m-85 -139.93 158.83 43.45 Favored 'General case' 0 N--CA 1.447 -0.599 0 N-CA-C 107.03 -1.47 . . . . 0.0 107.03 174.794 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 95.3 mt-10 -123.9 147.25 47.84 Favored 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 125.137 1.375 . . . . 0.0 108.363 174.934 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 59.6 m-85 -135.67 111.23 9.22 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 125.195 1.398 . . . . 0.0 107.641 -179.065 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -101.27 112.55 25.09 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 125.596 1.558 . . . . 0.0 107.83 178.957 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 3.7 pp -139.81 146.42 39.4 Favored 'General case' 0 C--N 1.334 -0.096 0 C-N-CA 123.689 0.796 . . . . 0.0 111.267 -171.016 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -99.44 115.97 30.5 Favored 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 124.064 0.945 . . . . 0.0 109.62 -175.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 13.1 p -113.53 129.17 69.81 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.206 0 C-N-CA 125.193 1.397 . . . . 0.0 110.866 -173.773 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.33 118.55 26.84 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.749 1.22 . . . . 0.0 107.997 173.111 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -129.76 128.99 43.53 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.486 -1.301 . . . . 0.0 107.486 174.43 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.2 t 52.25 41.17 30.22 Favored 'General case' 0 CA--C 1.54 0.563 0 C-N-CA 123.683 0.793 . . . . 0.0 111.401 -178.499 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.7 t0 51.54 32.83 9.47 Favored 'General case' 0 CA--C 1.539 0.538 0 C-N-CA 125.067 1.347 . . . . 0.0 112.938 -175.916 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 44.1 mmtm -125.34 131.22 53.04 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.718 -1.586 . . . . 0.0 106.718 169.753 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 18.4 tp -89.3 128.79 35.9 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 108.503 -0.925 . . . . 0.0 108.503 -177.581 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 84.4 m-85 -125.34 152.37 44.84 Favored 'General case' 0 N--CA 1.455 -0.206 0 C-N-CA 125.001 1.321 . . . . 0.0 108.294 177.234 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 16.3 ttp180 -92.49 129.44 38.43 Favored 'General case' 0 N--CA 1.452 -0.361 0 N-CA-C 107.734 -1.21 . . . . 0.0 107.734 170.475 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -116.47 132.54 56.65 Favored 'General case' 0 N--CA 1.451 -0.414 0 C-N-CA 124.563 1.145 . . . . 0.0 108.506 173.431 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -112.01 107.47 16.46 Favored 'General case' 0 N--CA 1.453 -0.291 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 173.864 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 19' ' ' ALA . 13.1 mm -100.45 153.91 4.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 C-N-CA 125.976 1.71 . . . . 0.0 107.961 -179.659 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 22.9 t -132.34 159.96 37.66 Favored 'General case' 0 N--CA 1.451 -0.41 0 CA-C-O 121.167 0.508 . . . . 0.0 109.928 170.954 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 7.5 tm-20 -130.16 122.08 27.49 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 125.9 1.68 . . . . 0.0 106.483 174.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 75.2 m-20 -83.89 119.06 24.42 Favored 'General case' 0 N--CA 1.453 -0.303 0 C-N-CA 124.403 1.081 . . . . 0.0 108.096 176.758 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 26.8 t80 -58.26 -58.3 9.1 Favored 'General case' 0 N--CA 1.457 -0.121 0 C-N-CA 123.643 0.777 . . . . 0.0 111.476 -170.643 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 61.0 tttm -68.94 -43.47 75.0 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-O 120.859 0.361 . . . . 0.0 110.039 -171.346 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -67.38 -30.29 70.03 Favored 'General case' 0 N--CA 1.45 -0.454 0 C-N-CA 123.565 0.746 . . . . 0.0 110.895 179.314 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 94.9 mtt180 54.6 47.88 21.64 Favored 'General case' 0 N--CA 1.449 -0.479 0 C-N-CA 124.496 1.119 . . . . 0.0 110.069 -168.777 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -126.77 139.63 11.4 Favored Glycine 0 CA--C 1.525 0.67 0 N-CA-C 109.95 -1.26 . . . . 0.0 109.95 -177.052 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 25.1 mmt180 -92.14 172.72 8.24 Favored 'General case' 0 C--O 1.232 0.168 0 C-N-CA 123.547 0.739 . . . . 0.0 110.689 176.33 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 9.9 ptmt -174.94 143.18 0.7 Allowed 'General case' 0 N--CA 1.454 -0.236 0 C-N-CA 126.853 2.061 . . . . 0.0 110.743 -177.27 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 60.3 tp -79.29 124.51 28.46 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.139 -1.43 . . . . 0.0 107.139 166.679 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 79.5 mt -82.6 -59.92 2.36 Favored 'General case' 0 N--CA 1.457 -0.107 0 N-CA-C 108.388 -0.968 . . . . 0.0 108.388 169.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 41.5 mtm180 -142.75 150.42 40.04 Favored 'General case' 0 N--CA 1.456 -0.163 0 C-N-CA 123.178 0.591 . . . . 0.0 109.573 -173.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 57.0 t80 -132.13 122.32 25.17 Favored 'General case' 0 N--CA 1.452 -0.352 0 N-CA-C 105.325 -2.102 . . . . 0.0 105.325 171.509 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 29.4 m120 -132.69 146.4 51.83 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 -173.922 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 141.74 -165.23 26.55 Favored Glycine 0 CA--C 1.529 0.917 0 C-N-CA 123.578 0.609 . . . . 0.0 111.606 173.918 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.1 Cg_endo -64.35 147.68 67.9 Favored 'Cis proline' 0 N--CA 1.458 -0.609 0 CA-C-N 118.045 0.923 . . . . 0.0 111.307 2.597 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -141.53 136.0 15.24 Favored Pre-proline 0 CA--C 1.531 0.22 0 C-N-CA 124.853 1.261 . . . . 0.0 108.05 177.465 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.2 Cg_endo -70.35 164.26 35.76 Favored 'Trans proline' 0 N--CA 1.453 -0.853 0 C-N-CA 122.046 1.831 . . . . 0.0 109.511 176.243 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.0 Cg_endo -69.08 153.44 72.06 Favored 'Trans proline' 0 N--CA 1.451 -0.979 0 C-N-CA 121.839 1.693 . . . . 0.0 109.244 173.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.8 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.536 2.157 . . . . 0.0 110.734 177.197 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.115 0 N-CA-C 111.051 -0.82 . . . . 0.0 111.051 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 3.1 mm-40 179.9 71.96 0.01 OUTLIER 'General case' 0 CA--C 1.534 0.34 0 C-N-CA 126.412 1.885 . . . . 0.0 107.454 178.865 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 9.8 m95 -69.53 121.23 16.63 Favored 'General case' 0 N--CA 1.458 -0.074 0 N-CA-C 107.915 -1.142 . . . . 0.0 107.915 169.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -148.49 152.86 37.61 Favored 'General case' 0 C--O 1.231 0.083 0 CA-C-N 118.368 0.531 . . . . 0.0 109.658 173.333 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 6.5 mt -77.44 138.04 21.2 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.195 0 C-N-CA 125.094 1.357 . . . . 0.0 107.58 176.095 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 15.4 pt -103.2 155.98 5.26 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.217 0 C-N-CA 123.273 0.629 . . . . 0.0 110.422 177.359 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.5 m-20 -68.75 131.38 45.08 Favored 'General case' 0 CA--C 1.516 -0.348 0 N-CA-C 109.34 -0.615 . . . . 0.0 109.34 177.707 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 18.7 pt -73.32 154.35 7.11 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.982 0 N-CA-C 107.526 -1.287 . . . . 0.0 107.526 164.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 150.9 -175.68 29.77 Favored Glycine 0 CA--C 1.533 1.208 0 N-CA-C 108.133 -1.987 . . . . 0.0 108.133 -166.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -58.95 -45.22 29.68 Favored 'Trans proline' 0 N--CA 1.459 -0.547 0 C-N-CA 123.681 2.921 . . . . 0.0 112.667 -171.182 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 89.1 t80 -54.29 -53.12 58.07 Favored 'General case' 0 CA--C 1.535 0.392 0 CA-C-O 122.144 0.973 . . . . 0.0 110.943 177.116 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 33.3 m -68.31 -39.28 82.08 Favored 'General case' 0 N--CA 1.449 -0.481 0 CA-C-N 115.966 -0.561 . . . . 0.0 110.219 -174.173 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -52.98 -56.61 14.78 Favored 'General case' 0 N--CA 1.446 -0.656 0 CA-C-O 117.98 -1.009 . . . . 0.0 109.063 168.611 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 37.4 t-20 -46.71 -50.32 18.12 Favored 'General case' 0 CA--C 1.532 0.283 0 CA-C-N 119.337 0.971 . . . . 0.0 110.805 -178.89 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 85.5 mt -62.01 -50.43 72.08 Favored 'General case' 0 CA--C 1.536 0.412 0 O-C-N 121.915 -0.491 . . . . 0.0 111.567 177.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.34 -25.11 62.23 Favored Glycine 0 CA--C 1.535 1.321 0 O-C-N 121.661 -0.649 . . . . 0.0 112.851 176.92 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 5.4 tmtt? -80.59 -54.85 5.29 Favored 'General case' 0 N--CA 1.447 -0.609 0 N-CA-C 105.895 -1.891 . . . . 0.0 105.895 -174.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 29.8 t80 -45.03 -45.52 10.81 Favored 'General case' 0 N--CA 1.45 -0.437 0 C-N-CA 125.757 1.623 . . . . 0.0 110.47 169.753 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.56 -53.84 51.4 Favored 'General case' 0 CA--C 1.53 0.195 0 CA-C-O 120.93 0.395 . . . . 0.0 110.738 176.35 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.7 t -62.31 -38.97 82.48 Favored 'Isoleucine or valine' 0 C--O 1.224 -0.283 0 CA-C-N 116.548 -0.296 . . . . 0.0 111.243 178.574 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.3 t70 -60.68 -48.96 79.44 Favored 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.472 0.709 . . . . 0.0 109.693 179.68 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 5.2 tm-20 -58.07 -50.05 74.81 Favored 'General case' 0 CA--C 1.534 0.357 0 C-N-CA 124.18 0.992 . . . . 0.0 108.967 175.617 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.1 tm-20 -56.29 -49.66 73.62 Favored 'General case' 0 N--CA 1.454 -0.259 0 N-CA-C 109.923 -0.399 . . . . 0.0 109.923 -178.74 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 38.1 m-20 -59.86 -41.42 91.41 Favored 'General case' 0 N--CA 1.448 -0.56 0 C-N-CA 125.285 1.434 . . . . 0.0 110.069 177.955 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 72.9 tttt -61.47 -37.72 84.63 Favored 'General case' 0 CA--C 1.533 0.325 0 CA-C-O 119.637 -0.221 . . . . 0.0 110.676 179.82 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 81.5 mt -67.73 -47.33 80.21 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.487 0 N-CA-C 109.364 -0.606 . . . . 0.0 109.364 168.742 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 84.42 19.0 61.14 Favored Glycine 0 CA--C 1.527 0.804 0 C-N-CA 125.624 1.583 . . . . 0.0 111.719 -179.298 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 23.3 tt0 -56.74 -41.63 77.86 Favored 'General case' 0 CA--C 1.531 0.243 0 CA-C-N 117.964 0.882 . . . . 0.0 110.808 -176.576 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 84.7 m-85 -110.82 35.21 3.59 Favored 'General case' 0 CA--C 1.533 0.302 0 C-N-CA 123.951 0.901 . . . . 0.0 110.179 173.243 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.85 -154.59 43.13 Favored Glycine 0 CA--C 1.531 1.086 0 C-N-CA 123.432 0.539 . . . . 0.0 112.051 179.506 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 20.4 ptt85 -93.44 84.91 4.8 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.084 1.354 . . . . 0.0 109.834 -178.187 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 89.7 mt -77.11 144.04 38.77 Favored 'General case' 0 CA--C 1.53 0.203 0 O-C-N 121.932 -0.48 . . . . 0.0 110.169 177.522 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.4 m -100.69 96.98 7.69 Favored 'General case' 0 CA--C 1.53 0.182 0 N-CA-C 108.643 -0.873 . . . . 0.0 108.643 177.858 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 47.8 t80 -45.9 125.57 6.38 Favored 'General case' 0 C--N 1.34 0.153 0 C-N-CA 122.879 0.471 . . . . 0.0 110.473 175.425 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -95.27 -64.96 1.01 Allowed 'General case' 0 C--N 1.33 -0.259 0 N-CA-C 107.191 -1.411 . . . . 0.0 107.191 175.093 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -174.97 169.84 3.33 Favored 'General case' 0 CA--C 1.527 0.09 0 C-N-CA 125.005 1.322 . . . . 0.0 108.418 -179.019 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 10.4 p -110.78 141.09 27.13 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.139 0 C-N-CA 124.74 1.216 . . . . 0.0 109.297 176.439 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.1 OUTLIER -138.79 178.72 3.73 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 O-C-N 123.587 0.554 . . . . 0.0 110.411 177.099 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 16.7 ptt180 -60.7 154.99 54.04 Favored Pre-proline 0 CA--C 1.542 0.637 0 C-N-CA 124.162 0.985 . . . . 0.0 111.663 178.251 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 60.3 Cg_endo -69.92 155.61 93.6 Favored 'Cis proline' 0 N--CA 1.458 -0.569 0 CA-C-N 119.414 0.827 . . . . 0.0 110.717 -9.616 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 17.1 p -161.29 79.0 0.59 Allowed 'General case' 0 N--CA 1.44 -0.968 0 N-CA-C 107.776 -1.194 . . . . 0.0 107.776 -166.218 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 1.3 mpt? -99.16 160.46 14.25 Favored 'General case' 0 N--CA 1.452 -0.354 0 C-N-CA 124.37 1.068 . . . . 0.0 110.936 -170.764 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 21.1 ttpt -140.78 149.4 42.03 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 125.055 1.342 . . . . 0.0 108.608 171.713 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 26.7 ttpp -147.61 143.58 27.82 Favored 'General case' 0 C--N 1.343 0.287 0 C-N-CA 123.84 0.856 . . . . 0.0 110.693 168.452 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 4.3 m -59.76 141.39 55.32 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 125.533 1.533 . . . . 0.0 111.969 171.202 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -118.07 124.76 73.56 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.519 0 C-N-CA 125.645 1.578 . . . . 0.0 109.23 173.428 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 70.2 m-85 -101.83 165.73 11.04 Favored 'General case' 0 CA--C 1.529 0.138 0 C-N-CA 125.79 1.636 . . . . 0.0 108.784 176.139 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 9.0 tt0 -100.71 -146.42 0.35 Allowed 'General case' 0 CA--C 1.536 0.433 0 N-CA-C 109.804 -0.443 . . . . 0.0 109.804 171.302 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 10.1 t30 -164.28 -43.78 0.03 OUTLIER 'General case' 0 C--O 1.227 -0.105 0 C-N-CA 124.686 1.194 . . . . 0.0 110.473 -173.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -73.29 62.68 0.7 Allowed 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.762 0.825 . . . . 0.0 111.296 -179.696 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 165.51 -165.33 37.83 Favored Glycine 0 N--CA 1.444 -0.805 0 N-CA-C 106.695 -2.562 . . . . 0.0 106.695 -178.864 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 59.4 t80 -75.61 168.94 19.07 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.681 -0.859 . . . . 0.0 108.681 168.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 37.1 ttm180 -56.52 113.21 1.51 Allowed 'General case' 0 CA--C 1.533 0.297 0 N-CA-C 109.816 -0.438 . . . . 0.0 109.816 174.776 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 39.6 mt-10 -144.35 147.54 33.58 Favored 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 125.31 1.444 . . . . 0.0 108.458 169.791 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 97.1 mt -74.85 127.02 36.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.353 0 N-CA-C 106.945 -1.502 . . . . 0.0 106.945 170.837 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 56.8 tttm -89.91 -37.6 14.29 Favored 'General case' 0 N--CA 1.454 -0.232 0 N-CA-C 109.339 -0.615 . . . . 0.0 109.339 176.672 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -177.13 -157.36 17.97 Favored Glycine 0 N--CA 1.446 -0.698 0 N-CA-C 110.38 -1.088 . . . . 0.0 110.38 -171.552 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 0.8 OUTLIER -145.01 151.86 39.24 Favored 'General case' 0 N--CA 1.446 -0.635 0 N-CA-C 107.346 -1.353 . . . . 0.0 107.346 176.741 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 33.5 tt0 -104.89 144.85 31.21 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 125.834 1.654 . . . . 0.0 107.309 171.544 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 65.1 m-85 -130.07 139.12 51.01 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 105.272 -2.121 . . . . 0.0 105.272 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 16.5 tt0 -141.05 99.9 3.7 Favored 'General case' 0 N--CA 1.451 -0.419 0 N-CA-C 107.062 -1.458 . . . . 0.0 107.062 -170.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 15.4 mt -122.06 138.6 54.38 Favored 'General case' 0 C--N 1.34 0.161 0 C-N-CA 124.574 1.149 . . . . 0.0 111.328 -164.037 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 6.5 m-85 -87.34 102.27 14.36 Favored 'General case' 0 N--CA 1.451 -0.417 0 CA-C-O 121.728 0.775 . . . . 0.0 109.013 170.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.8 t -96.77 131.08 44.42 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.277 0 C-N-CA 125.401 1.48 . . . . 0.0 109.378 -176.67 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.1 t80 -98.65 124.25 43.34 Favored 'General case' 0 N--CA 1.45 -0.45 0 C-N-CA 125.227 1.411 . . . . 0.0 108.181 175.759 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -147.03 134.98 21.39 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.077 0.951 . . . . 0.0 108.897 -178.078 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 23.1 t 52.46 32.62 11.67 Favored 'General case' 0 CA--C 1.534 0.344 0 C-N-CA 124.173 0.989 . . . . 0.0 111.211 -172.344 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 7.6 m-20 59.7 23.22 12.05 Favored 'General case' 0 CA--C 1.538 0.513 0 C-N-CA 125.046 1.338 . . . . 0.0 113.45 -174.854 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 47.7 mttm -116.75 143.66 45.39 Favored 'General case' 0 CA--C 1.527 0.096 0 C-N-CA 125.434 1.494 . . . . 0.0 107.743 174.232 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.8 tp -103.5 129.15 50.61 Favored 'General case' 0 N--CA 1.455 -0.181 0 C-N-CA 123.493 0.717 . . . . 0.0 109.882 -172.989 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 38.8 m-85 -134.61 148.08 50.34 Favored 'General case' 0 C--O 1.227 -0.129 0 C-N-CA 125.206 1.403 . . . . 0.0 109.902 -175.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 51.5 ttt180 -94.15 110.59 22.3 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 124.711 1.204 . . . . 0.0 108.695 176.107 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -101.35 121.82 42.6 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.855 1.262 . . . . 0.0 107.903 -179.705 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 27.4 t70 -108.63 121.62 45.4 Favored 'General case' 0 N--CA 1.457 -0.087 0 N-CA-C 108.016 -1.105 . . . . 0.0 108.016 174.055 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -121.86 153.58 26.02 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.283 0 C-N-CA 126.448 1.899 . . . . 0.0 107.607 -175.142 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 11.1 p -123.77 146.28 48.43 Favored 'General case' 0 N--CA 1.451 -0.382 0 N-CA-C 108.116 -1.068 . . . . 0.0 108.116 172.234 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -120.18 126.64 51.17 Favored 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 106.415 -1.698 . . . . 0.0 106.415 168.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.1 t70 -96.86 119.37 35.21 Favored 'General case' 0 C--O 1.234 0.266 0 N-CA-C 108.779 -0.823 . . . . 0.0 108.779 175.892 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 47.2 t80 -63.92 -28.86 70.12 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.142 0.577 . . . . 0.0 111.047 -174.245 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 34.6 ttmt -63.56 -18.14 63.56 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 123.5 0.72 . . . . 0.0 112.656 -173.843 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.9 m -143.75 8.57 1.51 Allowed 'General case' 0 CA--C 1.534 0.358 0 O-C-N 121.307 -0.871 . . . . 0.0 111.721 171.045 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 44.8 ttt85 50.98 40.41 25.26 Favored 'General case' 0 CA--C 1.537 0.455 0 C-N-CA 123.407 0.683 . . . . 0.0 110.156 -174.503 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -110.21 137.85 14.52 Favored Glycine 0 C--N 1.334 0.461 0 N-CA-C 107.712 -2.155 . . . . 0.0 107.712 -178.486 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 4.8 mpt_? -109.79 164.02 12.97 Favored 'General case' 0 N--CA 1.449 -0.493 0 CA-C-N 117.503 0.652 . . . . 0.0 111.276 -177.811 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.7 pptp? -157.34 148.7 21.9 Favored 'General case' 0 N--CA 1.45 -0.459 0 C-N-CA 124.551 1.141 . . . . 0.0 110.963 168.29 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -76.19 135.04 39.74 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.718 1.207 . . . . 0.0 109.264 176.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 3.4 mm? -80.61 -67.11 0.8 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 107.31 -1.367 . . . . 0.0 107.31 167.542 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.0 OUTLIER -150.31 160.27 43.84 Favored 'General case' 0 C--O 1.233 0.229 0 C-N-CA 124.255 1.022 . . . . 0.0 109.22 -177.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 59.5 t80 -126.08 83.83 2.21 Favored 'General case' 0 N--CA 1.454 -0.244 0 C-N-CA 126.688 1.995 . . . . 0.0 106.657 177.505 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 68.9 m-20 -86.6 145.69 26.64 Favored 'General case' 0 CA--C 1.52 -0.211 0 N-CA-C 108.959 -0.756 . . . . 0.0 108.959 -171.615 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 144.87 -165.04 27.75 Favored Glycine 0 CA--C 1.528 0.852 0 CA-C-O 119.567 -0.574 . . . . 0.0 112.081 172.93 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.7 Cg_endo -64.96 148.57 72.76 Favored 'Cis proline' 0 N--CA 1.458 -0.586 0 CA-C-N 117.966 0.883 . . . . 0.0 111.318 2.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.02 127.97 18.42 Favored Pre-proline 0 CA--C 1.533 0.304 0 C-N-CA 125.012 1.325 . . . . 0.0 108.145 176.43 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 85.4 Cg_endo -73.9 163.3 37.33 Favored 'Trans proline' 0 N--CA 1.454 -0.843 0 C-N-CA 122.408 2.072 . . . . 0.0 109.786 179.8 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -69.66 154.38 68.22 Favored 'Trans proline' 0 N--CA 1.452 -0.918 0 C-N-CA 121.965 1.777 . . . . 0.0 109.35 172.609 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.9 Cg_endo . . . . . 0 C--O 1.25 1.078 0 C-N-CA 122.458 2.106 . . . . 0.0 110.812 176.651 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.336 0 N-CA-C 111.697 -0.561 . . . . 0.0 111.697 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 36.8 mt-10 -145.69 163.09 35.98 Favored 'General case' 0 CA--C 1.53 0.201 0 C-N-CA 125.871 1.668 . . . . 0.0 106.645 177.599 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . 0.401 ' CE3' ' HB2' ' A' ' 44' ' ' LYS . 7.3 m95 48.59 68.85 0.63 Allowed 'General case' 0 CA--C 1.534 0.342 0 C-N-CA 123.475 0.71 . . . . 0.0 111.277 -173.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 10.0 tp10 -122.81 154.99 37.49 Favored 'General case' 0 C--O 1.234 0.266 0 C-N-CA 123.568 0.747 . . . . 0.0 109.133 179.839 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 18.6 mm -78.04 140.69 16.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.225 0 N-CA-C 107.335 -1.357 . . . . 0.0 107.335 178.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.4 pp -106.14 154.3 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 C-N-CA 123.257 0.623 . . . . 0.0 109.961 175.543 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.1 m-20 -73.89 124.46 26.2 Favored 'General case' 0 N--CA 1.451 -0.397 0 N-CA-C 108.164 -1.05 . . . . 0.0 108.164 179.274 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 26.5 pt -65.53 122.24 16.11 Favored 'Isoleucine or valine' 0 N--CA 1.438 -1.065 0 C-N-CA 123.056 0.542 . . . . 0.0 109.626 177.113 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -161.82 -167.16 21.86 Favored Glycine 0 CA--C 1.53 0.972 0 N-CA-C 110.475 -1.05 . . . . 0.0 110.475 -175.648 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 22.1 Cg_endo -56.13 -41.64 74.66 Favored 'Trans proline' 0 N--CA 1.455 -0.743 0 C-N-CA 123.239 2.626 . . . . 0.0 111.464 -175.832 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 52.2 t80 -51.81 -50.01 61.66 Favored 'General case' 0 CA--C 1.537 0.45 0 C-N-CA 123.889 0.875 . . . . 0.0 110.729 172.873 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -64.23 -49.51 71.66 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.948 0.899 . . . . 0.0 110.62 -177.82 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 52.2 mt-30 -51.97 -53.26 43.47 Favored 'General case' 0 N--CA 1.444 -0.772 0 N-CA-C 108.987 -0.745 . . . . 0.0 108.987 175.996 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -54.91 -47.83 73.84 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.999 0.92 . . . . 0.0 111.423 179.63 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 12.8 mt -59.97 -48.27 82.38 Favored 'General case' 0 N--CA 1.456 -0.168 0 CA-C-N 117.979 0.354 . . . . 0.0 110.93 179.104 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -60.11 -48.61 85.27 Favored Glycine 0 CA--C 1.528 0.89 0 N-CA-C 110.758 -0.937 . . . . 0.0 110.758 179.32 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 3.8 tmtt? -54.9 -49.43 71.25 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 125.104 1.361 . . . . 0.0 110.25 177.72 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 58.0 t80 -55.87 -48.21 75.97 Favored 'General case' 0 C--N 1.33 -0.272 0 C-N-CA 125.106 1.362 . . . . 0.0 110.52 175.575 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.72 -49.55 74.86 Favored 'General case' 0 N--CA 1.455 -0.179 0 N-CA-C 110.395 -0.224 . . . . 0.0 110.395 176.693 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 49.6 t -60.34 -42.63 91.47 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.336 0 C-N-CA 123.406 0.682 . . . . 0.0 110.783 177.852 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 17.5 t70 -61.25 -51.58 68.34 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.961 0.904 . . . . 0.0 109.664 -179.985 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -58.22 -46.79 85.26 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.693 1.197 . . . . 0.0 109.746 177.578 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 2.1 tm-20 -56.16 -56.94 14.81 Favored 'General case' 0 N--CA 1.451 -0.401 0 N-CA-C 108.283 -1.006 . . . . 0.0 108.283 178.844 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 14.5 m-20 -56.97 -38.72 73.38 Favored 'General case' 0 N--CA 1.449 -0.492 0 C-N-CA 124.578 1.151 . . . . 0.0 110.955 -179.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 52.4 tttp -56.77 -39.21 73.63 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 122.853 0.461 . . . . 0.0 110.608 177.519 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 70.6 mt -83.1 -47.6 18.21 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 C-N-CA 123.081 0.552 . . . . 0.0 110.235 -179.859 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 94.25 10.83 58.02 Favored Glycine 0 CA--C 1.53 0.994 0 C-N-CA 125.556 1.55 . . . . 0.0 113.921 175.414 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 25.6 mt-30 -54.73 -42.64 71.8 Favored 'General case' 0 CA--C 1.534 0.33 0 CA-C-N 119.035 1.417 . . . . 0.0 112.053 -178.644 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 83.3 m-85 -107.12 37.83 2.27 Favored 'General case' 0 CA--C 1.532 0.287 0 C-N-CA 123.696 0.798 . . . . 0.0 110.076 172.921 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.11 -138.42 47.82 Favored Glycine 0 CA--C 1.528 0.873 0 N-CA-C 111.238 -0.745 . . . . 0.0 111.238 179.089 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 97.5 mtt180 -115.24 93.39 4.27 Favored 'General case' 0 N--CA 1.452 -0.339 0 C-N-CA 125.134 1.373 . . . . 0.0 108.837 -175.394 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 55.3 mt -79.0 142.16 36.84 Favored 'General case' 0 N--CA 1.453 -0.308 0 C-N-CA 123.164 0.585 . . . . 0.0 109.575 -179.93 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 7.3 t -103.84 106.92 17.58 Favored 'General case' 0 CA--C 1.531 0.246 0 N-CA-C 108.267 -1.012 . . . . 0.0 108.267 174.377 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -59.04 133.73 56.36 Favored 'General case' 0 CA--C 1.522 -0.097 0 C-N-CA 123.458 0.703 . . . . 0.0 109.916 177.303 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 34.1 m120 -100.48 -64.69 1.02 Allowed 'General case' 0 C--N 1.333 -0.147 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 168.661 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 19.1 pttp -167.61 179.03 5.06 Favored 'General case' 0 CA--C 1.53 0.21 0 C-N-CA 124.356 1.062 . . . . 0.0 108.915 -178.421 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 5.2 t -127.06 134.21 66.6 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.163 0 N-CA-C 106.841 -1.54 . . . . 0.0 106.841 -176.488 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . 0.492 HD11 ' CZ ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -146.41 167.2 7.32 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.093 0 C-N-CA 122.741 0.416 . . . . 0.0 110.335 -173.842 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 6.0 ptm180 -53.71 150.97 12.17 Favored Pre-proline 0 CA--C 1.538 0.485 0 C-N-CA 124.482 1.113 . . . . 0.0 111.831 -178.825 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.9 Cg_endo -77.38 142.76 72.72 Favored 'Cis proline' 0 N--CA 1.457 -0.623 0 CA-C-N 119.018 0.685 . . . . 0.0 110.701 -1.495 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 90.6 m -133.68 101.73 5.22 Favored 'General case' 0 CA--C 1.519 -0.215 0 N-CA-C 106.19 -1.781 . . . . 0.0 106.19 179.837 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 33.2 ttm -118.37 138.82 52.16 Favored 'General case' 0 CA--C 1.53 0.176 0 C-N-CA 123.242 0.617 . . . . 0.0 110.491 -169.204 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 38.5 ttpt -121.48 144.57 48.63 Favored 'General case' 0 C--O 1.234 0.254 0 C-N-CA 124.956 1.302 . . . . 0.0 110.132 -177.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . 0.401 ' HB2' ' CE3' ' A' ' 3' ' ' TRP . 13.3 tmtt? -146.38 149.8 34.46 Favored 'General case' 0 CA--C 1.534 0.331 0 C-N-CA 123.456 0.702 . . . . 0.0 110.885 171.916 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 7.3 m -80.63 137.62 36.36 Favored 'General case' 0 CA--C 1.533 0.297 0 C-N-CA 125.414 1.485 . . . . 0.0 111.365 -179.508 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -102.53 120.74 52.72 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.362 0 C-N-CA 124.79 1.236 . . . . 0.0 108.303 170.425 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 30.0 p90 -146.94 165.27 30.31 Favored 'General case' 0 N--CA 1.449 -0.519 0 C-N-CA 123.865 0.866 . . . . 0.0 109.275 179.291 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.2 tp10 -98.44 -151.04 0.37 Allowed 'General case' 0 CA--C 1.535 0.391 0 N-CA-C 108.753 -0.832 . . . . 0.0 108.753 -178.652 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 39.0 t30 -169.1 -52.93 0.02 OUTLIER 'General case' 0 C--N 1.332 -0.189 0 C-N-CA 124.32 1.048 . . . . 0.0 109.245 -177.874 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 32.8 tt0 -53.85 144.29 18.94 Favored 'General case' 0 CA--C 1.534 0.357 0 CA-C-N 115.823 -0.626 . . . . 0.0 109.652 175.359 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.89 -81.28 1.16 Allowed Glycine 0 CA--C 1.525 0.664 0 N-CA-C 109.107 -1.597 . . . . 0.0 109.107 -171.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 25.4 m-85 -150.36 150.82 31.93 Favored 'General case' 0 C--N 1.332 -0.183 0 C-N-CA 124.594 1.157 . . . . 0.0 108.984 179.295 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -65.88 126.64 29.14 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 168.686 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 19.0 tt0 -164.38 140.13 6.01 Favored 'General case' 0 N--CA 1.452 -0.337 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 170.649 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -74.63 133.37 31.67 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.162 0 C-N-CA 123.779 0.831 . . . . 0.0 108.853 179.391 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 18.1 ttpp -119.59 -22.29 7.0 Favored 'General case' 0 CA--C 1.528 0.116 0 O-C-N 123.547 0.529 . . . . 0.0 111.166 -175.983 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -169.95 -168.01 31.24 Favored Glycine 0 N--CA 1.448 -0.543 0 O-C-N 121.432 -0.792 . . . . 0.0 111.445 -178.183 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.8 m-85 -148.82 163.69 36.66 Favored 'General case' 0 N--CA 1.449 -0.478 0 C-N-CA 125.328 1.451 . . . . 0.0 107.693 177.988 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 12.9 pt-20 -130.84 148.83 52.66 Favored 'General case' 0 N--CA 1.448 -0.527 0 C-N-CA 124.688 1.195 . . . . 0.0 108.97 169.026 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 36.5 m-85 -134.32 115.66 14.34 Favored 'General case' 0 N--CA 1.451 -0.422 0 N-CA-C 106.228 -1.767 . . . . 0.0 106.228 178.86 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 33.1 tt0 -107.68 129.74 54.99 Favored 'General case' 0 C--O 1.234 0.238 0 CA-C-N 119.201 0.91 . . . . 0.0 109.263 172.642 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 pp -149.27 152.3 35.68 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-O 121.568 0.699 . . . . 0.0 111.568 -172.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . 0.612 ' CZ ' HD22 ' A' ' 70' ' ' LEU . 0.1 OUTLIER -89.02 111.34 22.03 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 125.537 1.535 . . . . 0.0 107.036 177.479 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 24.1 t -93.35 124.23 45.72 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.589 0 N-CA-C 107.304 -1.369 . . . . 0.0 107.304 169.296 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -84.29 116.55 23.05 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 104.676 -2.342 . . . . 0.0 104.676 169.66 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 132.51 36.95 Favored 'General case' 0 C--O 1.226 -0.169 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 -176.065 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.8 t 53.8 34.72 19.8 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.968 0.907 . . . . 0.0 111.708 -174.203 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 31.7 t0 46.94 42.85 12.93 Favored 'General case' 0 CA--C 1.534 0.343 0 C-N-CA 125.098 1.359 . . . . 0.0 111.064 -169.434 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 7.9 tptm -137.96 155.15 49.18 Favored 'General case' 0 N--CA 1.447 -0.575 0 C-N-CA 125.255 1.422 . . . . 0.0 107.953 179.298 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . 0.612 HD22 ' CZ ' ' A' ' 63' ' ' TYR . 0.1 OUTLIER -81.74 118.11 22.59 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 108.422 -0.955 . . . . 0.0 108.422 -173.898 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 11.4 m-85 -130.07 112.63 13.62 Favored 'General case' 0 CA--C 1.538 0.488 0 C-N-CA 124.451 1.1 . . . . 0.0 108.69 177.569 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 24.1 tpt180 -97.13 131.12 44.21 Favored 'General case' 0 CA--C 1.532 0.255 0 N-CA-C 108.331 -0.989 . . . . 0.0 108.331 -175.34 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -131.3 142.73 50.16 Favored 'General case' 0 N--CA 1.463 0.192 0 CA-C-N 119.202 0.91 . . . . 0.0 110.204 -178.106 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -112.9 120.68 42.25 Favored 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.226 1.01 . . . . 0.0 108.363 168.727 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -103.74 140.08 22.9 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.514 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 173.998 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.9 p -111.38 147.65 34.72 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 124.581 1.152 . . . . 0.0 108.108 174.704 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 72.7 tt0 -126.78 134.35 50.61 Favored 'General case' 0 N--CA 1.455 -0.193 0 C-N-CA 125.907 1.683 . . . . 0.0 107.798 175.59 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 16.0 t0 -107.31 114.49 28.56 Favored 'General case' 0 C--O 1.235 0.291 0 C-N-CA 124.519 1.128 . . . . 0.0 108.846 174.19 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 39.0 t80 -60.28 -27.9 67.65 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.728 1.211 . . . . 0.0 111.365 -179.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 82.9 tttt -58.04 -23.22 53.48 Favored 'General case' 0 CA--C 1.531 0.23 0 C-N-CA 123.88 0.872 . . . . 0.0 112.407 -177.658 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 5.0 m -141.14 6.07 1.93 Allowed 'General case' 0 CA--C 1.536 0.423 0 O-C-N 121.468 -0.77 . . . . 0.0 111.328 174.001 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.4 ttm180 49.94 40.55 21.23 Favored 'General case' 0 CA--C 1.537 0.468 0 C-N-CA 123.826 0.851 . . . . 0.0 110.028 -171.294 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -106.69 140.74 15.35 Favored Glycine 0 C--N 1.336 0.531 0 N-CA-C 107.699 -2.161 . . . . 0.0 107.699 179.794 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 41.7 mtt180 -116.85 164.99 13.83 Favored 'General case' 0 N--CA 1.449 -0.513 0 CA-C-N 117.986 0.893 . . . . 0.0 110.787 -179.268 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.4 pptp? -161.2 150.69 16.79 Favored 'General case' 0 N--CA 1.446 -0.675 0 C-N-CA 123.842 0.857 . . . . 0.0 110.326 172.958 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 36.2 tp -57.57 110.98 0.98 Allowed 'General case' 0 CA--C 1.531 0.249 0 C-N-CA 124.346 1.059 . . . . 0.0 108.677 172.703 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 29.7 tp -71.89 -48.26 46.96 Favored 'General case' 0 CA--C 1.515 -0.379 0 N-CA-C 108.335 -0.987 . . . . 0.0 108.335 177.904 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 mtm180 -162.56 155.57 19.81 Favored 'General case' 0 N--CA 1.447 -0.602 0 N-CA-C 108.802 -0.814 . . . . 0.0 108.802 -178.13 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 0.6 OUTLIER -119.32 141.5 48.95 Favored 'General case' 0 N--CA 1.448 -0.54 0 N-CA-C 105.827 -1.916 . . . . 0.0 105.827 174.85 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -133.4 131.7 40.31 Favored 'General case' 0 N--CA 1.447 -0.619 0 N-CA-C 107.513 -1.291 . . . . 0.0 107.513 179.609 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 148.93 -176.17 27.84 Favored Glycine 0 CA--C 1.527 0.833 0 N-CA-C 110.536 -1.026 . . . . 0.0 110.536 179.335 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 94.0 Cg_endo -69.86 162.03 85.26 Favored 'Cis proline' 0 N--CA 1.455 -0.761 0 CA-C-N 118.223 1.012 . . . . 0.0 110.508 -3.516 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -128.09 162.79 47.94 Favored Pre-proline 0 CA--C 1.543 0.676 0 N-CA-C 106.615 -1.624 . . . . 0.0 106.615 171.171 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -76.27 158.95 37.08 Favored 'Trans proline' 0 N--CA 1.453 -0.861 0 C-N-CA 122.0 1.8 . . . . 0.0 109.323 179.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 84.3 Cg_endo -68.52 152.02 75.16 Favored 'Trans proline' 0 N--CA 1.452 -0.955 0 C-N-CA 122.093 1.862 . . . . 0.0 109.335 172.606 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 63.8 Cg_endo . . . . . 0 C--O 1.252 1.21 0 C-N-CA 122.689 2.26 . . . . 0.0 110.5 178.493 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.277 0 N-CA-C 111.66 -0.576 . . . . 0.0 111.66 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -169.84 179.69 3.58 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.579 1.551 . . . . 0.0 107.246 -173.566 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 6.9 m95 -56.55 109.84 0.68 Allowed 'General case' 0 CA--C 1.53 0.197 0 O-C-N 123.472 0.483 . . . . 0.0 109.971 170.643 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.1 tt0 -153.76 158.26 40.68 Favored 'General case' 0 C--O 1.233 0.209 0 N-CA-C 108.724 -0.843 . . . . 0.0 108.724 176.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 3.0 mp -86.88 138.48 18.97 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.203 0 N-CA-C 107.705 -1.22 . . . . 0.0 107.705 178.498 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 6.8 pt -101.11 157.35 4.25 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 C-N-CA 124.1 0.96 . . . . 0.0 110.475 178.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.1 m-20 -77.52 125.39 29.26 Favored 'General case' 0 N--CA 1.451 -0.401 0 C-N-CA 123.503 0.721 . . . . 0.0 109.387 178.246 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 12.8 pt -65.13 136.32 26.88 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 107.337 -1.356 . . . . 0.0 107.337 165.851 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 165.11 -175.07 41.04 Favored Glycine 0 CA--C 1.528 0.867 0 N-CA-C 107.65 -2.18 . . . . 0.0 107.65 -169.841 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.7 Cg_endo -53.37 -46.78 31.35 Favored 'Trans proline' 0 N--CA 1.458 -0.609 0 C-N-CA 123.745 2.963 . . . . 0.0 113.195 -170.354 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 46.1 t80 -52.13 -55.01 23.61 Favored 'General case' 0 CA--C 1.537 0.453 0 CA-C-O 122.918 1.342 . . . . 0.0 110.871 176.506 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 32.9 m -66.73 -42.42 86.32 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 124.28 1.032 . . . . 0.0 110.198 -174.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 43.6 mt-30 -57.03 -48.66 77.97 Favored 'General case' 0 N--CA 1.444 -0.728 0 C-N-CA 123.405 0.682 . . . . 0.0 110.078 173.081 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -54.02 -47.62 71.34 Favored 'General case' 0 N--CA 1.458 -0.059 0 C-N-CA 123.131 0.572 . . . . 0.0 110.839 177.611 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 32.7 mt -65.06 -41.05 95.5 Favored 'General case' 0 C--N 1.334 -0.083 0 C-N-CA 120.087 -0.645 . . . . 0.0 112.208 178.345 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -52.28 -51.63 40.95 Favored Glycine 0 CA--C 1.53 0.977 0 N-CA-C 110.573 -1.011 . . . . 0.0 110.573 171.534 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.1 tmtp? -51.3 -55.27 19.19 Favored 'General case' 0 N--CA 1.448 -0.543 0 C-N-CA 124.353 1.061 . . . . 0.0 110.185 175.996 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 23.1 t80 -51.26 -47.6 62.4 Favored 'General case' 0 C--N 1.333 -0.12 0 C-N-CA 123.826 0.851 . . . . 0.0 110.447 177.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -55.35 -50.84 68.62 Favored 'General case' 0 N--CA 1.453 -0.306 0 N-CA-C 109.576 -0.527 . . . . 0.0 109.576 -179.41 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.5 t -63.9 -40.87 90.61 Favored 'Isoleucine or valine' 0 C--O 1.223 -0.314 0 CA-C-N 116.474 -0.33 . . . . 0.0 110.964 178.067 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.7 t70 -59.39 -48.31 82.13 Favored 'General case' 0 N--CA 1.452 -0.328 0 C-N-CA 123.465 0.706 . . . . 0.0 110.076 -179.01 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -63.09 -49.23 75.28 Favored 'General case' 0 N--CA 1.452 -0.359 0 C-N-CA 124.086 0.955 . . . . 0.0 109.698 177.553 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 5.5 tm-20 -54.74 -46.64 74.3 Favored 'General case' 0 N--CA 1.453 -0.321 0 N-CA-C 109.637 -0.505 . . . . 0.0 109.637 179.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 47.3 m-20 -63.46 -44.94 93.0 Favored 'General case' 0 N--CA 1.446 -0.635 0 C-N-CA 125.635 1.574 . . . . 0.0 110.12 178.702 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 60.6 tttp -56.03 -46.0 78.98 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 123.55 0.74 . . . . 0.0 110.022 178.724 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 86.9 mt -68.9 -47.56 75.24 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.451 0 N-CA-C 109.628 -0.508 . . . . 0.0 109.628 176.869 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.98 14.9 55.65 Favored Glycine 0 CA--C 1.528 0.873 0 C-N-CA 125.219 1.39 . . . . 0.0 113.211 174.268 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 20.5 mm-40 -50.87 -44.46 59.65 Favored 'General case' 0 CA--C 1.533 0.292 0 CA-C-N 118.621 1.21 . . . . 0.0 111.44 -179.5 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 54.6 m-85 -113.34 38.07 2.99 Favored 'General case' 0 CA--C 1.534 0.362 0 C-N-CA 123.881 0.873 . . . . 0.0 109.984 174.691 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 59.4 -141.23 47.5 Favored Glycine 0 CA--C 1.529 0.95 0 N-CA-C 110.588 -1.005 . . . . 0.0 110.588 -177.198 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 82.8 mtp180 -111.83 114.93 28.19 Favored 'General case' 0 N--CA 1.455 -0.205 0 C-N-CA 124.776 1.231 . . . . 0.0 109.344 -178.976 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 3.3 mp -103.3 152.25 21.76 Favored 'General case' 0 C--O 1.231 0.13 0 C-N-CA 123.351 0.66 . . . . 0.0 111.005 174.328 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 88.4 m -92.87 100.1 12.63 Favored 'General case' 0 N--CA 1.452 -0.328 0 N-CA-C 107.559 -1.274 . . . . 0.0 107.559 176.442 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.5 t80 -49.53 130.61 20.54 Favored 'General case' 0 N--CA 1.457 -0.123 0 N-CA-C 110.226 -0.287 . . . . 0.0 110.226 174.156 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.4 m-80 -101.53 -63.63 1.13 Allowed 'General case' 0 C--N 1.33 -0.25 0 N-CA-C 108.075 -1.083 . . . . 0.0 108.075 176.465 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 53.1 pttt -171.58 -166.67 0.46 Allowed 'General case' 0 CA--C 1.533 0.289 0 C-N-CA 124.007 0.923 . . . . 0.0 109.122 -177.631 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 43.2 t -126.53 144.81 35.43 Favored 'Isoleucine or valine' 0 C--O 1.233 0.19 0 N-CA-C 105.81 -1.922 . . . . 0.0 105.81 172.54 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -134.11 165.34 31.97 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.12 0 CA-C-N 118.544 0.611 . . . . 0.0 110.417 174.55 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 23.3 ptt180 -63.96 151.18 90.18 Favored Pre-proline 0 CA--C 1.537 0.477 0 C-N-CA 124.078 0.951 . . . . 0.0 111.4 -175.832 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 88.2 Cg_endo -75.1 151.47 96.82 Favored 'Cis proline' 0 N--CA 1.457 -0.621 0 CA-C-N 119.268 0.774 . . . . 0.0 111.572 0.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 79.4 m -139.89 94.81 2.81 Favored 'General case' 0 N--CA 1.45 -0.457 0 N-CA-C 106.541 -1.651 . . . . 0.0 106.541 178.203 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 15.4 mtt -108.33 157.81 18.05 Favored 'General case' 0 N--CA 1.456 -0.172 0 C-N-CA 123.998 0.919 . . . . 0.0 110.673 -176.242 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 11.4 pttp -131.96 154.44 49.29 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 119.171 -0.442 . . . . 0.0 110.031 168.656 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 63.8 tttp -130.04 151.9 50.08 Favored 'General case' 0 CA--C 1.535 0.396 0 C-N-CA 127.148 2.179 . . . . 0.0 107.815 174.532 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 97.2 m -98.74 133.64 42.78 Favored 'General case' 0 CA--C 1.528 0.131 0 C-N-CA 124.039 0.936 . . . . 0.0 109.319 172.142 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.58 128.19 62.93 Favored 'Isoleucine or valine' 0 C--O 1.236 0.356 0 C-N-CA 125.006 1.323 . . . . 0.0 110.501 -179.316 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 39.8 p90 -146.7 175.7 10.41 Favored 'General case' 0 N--CA 1.443 -0.783 0 C-N-CA 125.553 1.541 . . . . 0.0 107.607 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 82.7 tt0 76.94 145.96 0.09 Allowed 'General case' 0 N--CA 1.453 -0.313 0 C-N-CA 127.657 2.383 . . . . 0.0 111.925 -178.173 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 3.6 t30 -169.72 -67.1 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.529 1.532 . . . . 0.0 109.521 170.349 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 5.9 pt-20 -80.44 173.54 12.49 Favored 'General case' 0 N--CA 1.449 -0.48 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 171.771 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -52.93 -43.22 61.13 Favored Glycine 0 CA--C 1.526 0.737 0 N-CA-C 111.565 -0.614 . . . . 0.0 111.565 176.666 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.5 t80 -76.64 72.68 3.31 Favored 'General case' 0 CA--C 1.534 0.338 0 N-CA-C 108.621 -0.881 . . . . 0.0 108.621 172.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 85.4 mtt180 -42.34 127.43 3.66 Favored 'General case' 0 CA--C 1.539 0.548 0 C-N-CA 126.282 1.833 . . . . 0.0 109.668 179.127 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 11.5 pt-20 -149.42 150.79 32.96 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 123.863 0.865 . . . . 0.0 110.686 -173.35 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 93.4 mt -62.16 136.73 25.11 Favored 'Isoleucine or valine' 0 N--CA 1.463 0.192 0 C-N-CA 124.233 1.013 . . . . 0.0 109.821 -179.68 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 26.5 mtpp -127.94 -34.71 2.12 Favored 'General case' 0 C--N 1.34 0.165 0 C-N-CA 123.207 0.603 . . . . 0.0 112.09 -178.881 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -173.91 -164.43 28.99 Favored Glycine 0 C--N 1.335 0.505 0 C-N-CA 120.02 -1.086 . . . . 0.0 111.862 -170.522 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 22.3 m-85 -145.02 160.71 40.94 Favored 'General case' 0 N--CA 1.449 -0.486 0 C-N-CA 124.613 1.165 . . . . 0.0 108.027 178.187 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -126.41 144.1 50.95 Favored 'General case' 0 C--N 1.33 -0.263 0 C-N-CA 125.532 1.533 . . . . 0.0 107.579 175.155 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 16.1 m-85 -129.95 124.15 32.38 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 106.734 -1.58 . . . . 0.0 106.734 177.355 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.4 tm0? -113.33 117.75 32.68 Favored 'General case' 0 C--N 1.329 -0.295 0 C-N-CA 125.782 1.633 . . . . 0.0 106.723 -179.37 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.9 pp -152.18 153.99 34.93 Favored 'General case' 0 C--O 1.231 0.121 0 CA-C-N 118.272 0.487 . . . . 0.0 111.535 -174.277 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.9 m-85 -96.1 104.58 16.53 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.232 1.013 . . . . 0.0 109.348 -177.555 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 57.9 t -86.39 130.72 36.19 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.366 0 C-N-CA 126.374 1.869 . . . . 0.0 108.571 -176.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.1 OUTLIER -99.57 120.12 39.15 Favored 'General case' 0 N--CA 1.45 -0.458 0 C-N-CA 124.809 1.244 . . . . 0.0 107.674 173.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.7 131.12 20.99 Favored 'General case' 0 N--CA 1.456 -0.166 0 C-N-CA 124.275 1.03 . . . . 0.0 108.81 -178.823 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER 53.43 39.22 29.62 Favored 'General case' 0 CA--C 1.538 0.517 0 C-N-CA 124.18 0.992 . . . . 0.0 110.974 -177.476 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 28.9 t0 45.95 37.5 3.73 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 125.081 1.352 . . . . 0.0 113.005 -171.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 69.2 mmtt -125.72 139.01 53.89 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 168.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 13.4 tp -98.54 126.9 44.27 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 108.595 -0.891 . . . . 0.0 108.595 -176.441 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 67.4 m-85 -124.89 140.4 52.96 Favored 'General case' 0 N--CA 1.456 -0.158 0 C-N-CA 125.679 1.592 . . . . 0.0 107.965 179.368 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 3.9 tmm_? -88.8 123.59 33.35 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 107.802 -1.185 . . . . 0.0 107.802 173.45 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -118.27 146.82 44.01 Favored 'General case' 0 C--O 1.236 0.356 0 C-N-CA 123.662 0.785 . . . . 0.0 109.158 -179.1 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -122.58 124.5 43.64 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 169.306 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 7.7 mm -112.34 150.17 14.66 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.206 0 C-N-CA 127.006 2.123 . . . . 0.0 107.05 -178.678 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 19.4 m -120.86 148.91 43.39 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.599 1.16 . . . . 0.0 108.403 177.436 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 65.3 tt0 -122.24 127.25 49.7 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 126.393 1.877 . . . . 0.0 106.63 169.207 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 9.4 t0 -102.78 119.22 38.45 Favored 'General case' 0 C--N 1.338 0.086 0 N-CA-C 108.005 -1.109 . . . . 0.0 108.005 172.379 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 42.2 t80 -66.45 -23.07 66.22 Favored 'General case' 0 CA--C 1.534 0.332 0 N-CA-C 112.916 0.71 . . . . 0.0 112.916 -171.659 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 25.8 mtpp -63.85 -55.56 21.91 Favored 'General case' 0 N--CA 1.451 -0.402 0 CA-C-N 119.103 0.865 . . . . 0.0 110.495 -177.079 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 26.4 p -79.84 -26.84 40.27 Favored 'General case' 0 N--CA 1.45 -0.444 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 173.977 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 25.1 ttt180 68.31 13.96 9.11 Favored 'General case' 0 N--CA 1.45 -0.452 0 C-N-CA 125.053 1.341 . . . . 0.0 109.023 -164.044 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -82.02 155.09 34.43 Favored Glycine 0 C--N 1.339 0.745 0 N-CA-C 108.748 -1.741 . . . . 0.0 108.748 177.208 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 14.8 mtt180 -115.51 171.92 7.42 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.948 0.499 . . . . 0.0 110.626 176.415 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -159.26 157.53 30.81 Favored 'General case' 0 N--CA 1.45 -0.432 0 CA-C-N 114.785 -1.098 . . . . 0.0 111.698 174.642 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 59.0 tp -78.5 119.2 21.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 107.671 -1.233 . . . . 0.0 107.671 175.179 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 18.1 tp -82.67 -59.78 2.4 Favored 'General case' 0 N--CA 1.454 -0.229 0 N-CA-C 108.689 -0.856 . . . . 0.0 108.689 178.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 74.4 mtm180 -144.84 154.35 42.57 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.065 0.946 . . . . 0.0 109.563 -177.211 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 69.3 t80 -144.73 102.33 3.78 Favored 'General case' 0 N--CA 1.456 -0.152 0 C-N-CA 125.926 1.69 . . . . 0.0 106.838 -179.007 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 45.5 m-20 -117.11 142.27 47.21 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 108.401 -0.963 . . . . 0.0 108.401 -172.291 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 145.74 -165.96 27.92 Favored Glycine 0 CA--C 1.529 0.916 0 CA-C-O 119.614 -0.548 . . . . 0.0 112.158 174.557 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 57.2 Cg_endo -65.58 148.03 73.85 Favored 'Cis proline' 0 N--CA 1.458 -0.588 0 CA-C-N 118.006 0.903 . . . . 0.0 111.237 2.137 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -140.02 130.94 14.23 Favored Pre-proline 0 CA--C 1.532 0.28 0 C-N-CA 124.776 1.23 . . . . 0.0 108.243 177.088 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 91.8 Cg_endo -72.56 161.51 43.89 Favored 'Trans proline' 0 N--CA 1.454 -0.821 0 C-N-CA 122.1 1.866 . . . . 0.0 109.942 178.743 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 90.7 Cg_endo -69.76 157.89 58.82 Favored 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.247 1.964 . . . . 0.0 109.303 169.89 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 68.6 Cg_endo . . . . . 0 C--O 1.251 1.173 0 C-N-CA 122.454 2.103 . . . . 0.0 110.763 176.115 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.531 1.076 0 N-CA-C 111.164 -0.774 . . . . 0.0 111.164 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 42.1 mt-10 -71.51 171.81 10.69 Favored 'General case' 0 CA--C 1.538 0.492 0 N-CA-C 108.89 -0.781 . . . . 0.0 108.89 169.741 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 29.0 m95 -55.43 103.7 0.1 Allowed 'General case' 0 N--CA 1.452 -0.368 0 C-N-CA 123.485 0.714 . . . . 0.0 110.373 174.464 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 37.7 tt0 -142.9 154.09 43.76 Favored 'General case' 0 C--O 1.232 0.167 0 C-N-CA 123.803 0.841 . . . . 0.0 109.09 -179.725 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.3 mp -80.53 139.99 17.33 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.26 0 C-N-CA 125.043 1.337 . . . . 0.0 108.662 -177.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 14.5 pt -104.25 156.74 5.66 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.265 0 C-N-CA 124.481 1.113 . . . . 0.0 109.865 173.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 7.7 m-20 -76.51 118.13 18.86 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 109.823 -0.436 . . . . 0.0 109.823 177.112 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 31.4 pt -55.56 133.47 19.35 Favored 'Isoleucine or valine' 0 N--CA 1.44 -0.952 0 N-CA-C 108.548 -0.908 . . . . 0.0 108.548 166.192 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 172.4 -169.32 42.44 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 107.994 -2.042 . . . . 0.0 107.994 -172.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -52.17 -44.08 48.57 Favored 'Trans proline' 0 N--CA 1.454 -0.809 0 C-N-CA 123.628 2.885 . . . . 0.0 112.676 -172.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 72.7 t80 -53.15 -57.13 11.52 Favored 'General case' 0 CA--C 1.537 0.451 0 CA-C-O 121.554 0.692 . . . . 0.0 111.463 174.419 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -62.97 -45.07 94.18 Favored 'General case' 0 N--CA 1.45 -0.44 0 C-N-CA 123.507 0.723 . . . . 0.0 109.974 -175.571 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 47.3 mt-30 -55.85 -48.83 74.83 Favored 'General case' 0 N--CA 1.441 -0.913 0 C-N-CA 123.492 0.717 . . . . 0.0 109.22 176.011 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.5 t-20 -55.08 -51.81 65.2 Favored 'General case' 0 CA--C 1.529 0.141 0 C-N-CA 123.322 0.649 . . . . 0.0 110.608 177.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . 0.423 HD23 ' HA ' ' A' ' 15' ' ' LEU . 19.6 mt -59.23 -45.23 91.69 Favored 'General case' 0 CA--C 1.529 0.17 0 O-C-N 121.675 -0.64 . . . . 0.0 111.642 178.279 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.98 -39.93 92.58 Favored Glycine 0 CA--C 1.527 0.81 0 N-CA-C 111.05 -0.82 . . . . 0.0 111.05 175.128 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -64.74 -52.33 57.61 Favored 'General case' 0 N--CA 1.448 -0.547 0 N-CA-C 107.378 -1.342 . . . . 0.0 107.378 -177.261 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 19.0 t80 -50.98 -45.29 60.93 Favored 'General case' 0 N--CA 1.452 -0.371 0 C-N-CA 124.582 1.153 . . . . 0.0 110.849 173.55 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.21 -51.1 70.67 Favored 'General case' 0 N--CA 1.455 -0.201 0 N-CA-C 110.043 -0.354 . . . . 0.0 110.043 179.408 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 95.7 t -64.0 -41.68 93.25 Favored 'Isoleucine or valine' 0 C--N 1.334 -0.094 0 C-N-CA 120.826 -0.35 . . . . 0.0 111.019 177.938 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 22.1 t70 -57.0 -48.81 77.56 Favored 'General case' 0 N--CA 1.452 -0.367 0 C-N-CA 123.236 0.614 . . . . 0.0 109.458 179.612 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -57.24 -52.77 63.98 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.575 1.15 . . . . 0.0 109.36 175.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 46.0 tp10 -57.71 -45.01 86.32 Favored 'General case' 0 N--CA 1.449 -0.495 0 C-N-CA 122.997 0.519 . . . . 0.0 110.365 -174.919 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 36.3 m-20 -67.57 -43.77 79.81 Favored 'General case' 0 N--CA 1.445 -0.699 0 C-N-CA 125.786 1.634 . . . . 0.0 110.633 178.22 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -62.35 -44.48 96.39 Favored 'General case' 0 N--CA 1.456 -0.135 0 C-N-CA 122.9 0.48 . . . . 0.0 110.048 -177.344 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 72.5 mt -68.2 -43.67 84.69 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.392 0 N-CA-C 108.871 -0.789 . . . . 0.0 108.871 172.301 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.47 12.94 57.82 Favored Glycine 0 CA--C 1.528 0.896 0 C-N-CA 124.444 1.021 . . . . 0.0 112.741 173.412 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 64.6 mm-40 -47.99 -46.08 32.34 Favored 'General case' 0 CA--C 1.531 0.215 0 CA-C-N 118.246 1.023 . . . . 0.0 111.868 -179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -111.16 24.02 13.39 Favored 'General case' 0 CA--C 1.535 0.383 0 C-N-CA 124.524 1.13 . . . . 0.0 110.798 179.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 60.33 -158.44 26.75 Favored Glycine 0 CA--C 1.531 1.045 0 N-CA-C 111.248 -0.741 . . . . 0.0 111.248 -174.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 91.8 mtt180 -81.11 89.86 6.0 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 123.4 0.68 . . . . 0.0 110.796 179.45 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 15.7 mt -72.6 140.52 48.09 Favored 'General case' 0 CA--C 1.534 0.362 0 N-CA-C 108.544 -0.909 . . . . 0.0 108.544 169.465 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 75.5 m -95.56 93.84 7.4 Favored 'General case' 0 N--CA 1.454 -0.267 0 N-CA-C 107.997 -1.112 . . . . 0.0 107.997 179.594 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 79.9 t80 -48.67 129.37 16.5 Favored 'General case' 0 C--N 1.34 0.18 0 CA-C-N 117.689 0.222 . . . . 0.0 110.71 177.165 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -102.82 -62.05 1.32 Allowed 'General case' 0 N--CA 1.452 -0.355 0 N-CA-C 107.984 -1.117 . . . . 0.0 107.984 178.098 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 46.5 pttt -174.16 -161.36 0.12 Allowed 'General case' 0 CA--C 1.535 0.37 0 C-N-CA 125.057 1.343 . . . . 0.0 108.741 -179.274 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 23.6 t -133.37 145.19 34.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.123 0 N-CA-C 105.89 -1.893 . . . . 0.0 105.89 174.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.7 pp -136.43 162.7 35.09 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.276 0 CA-C-N 118.353 0.524 . . . . 0.0 110.388 176.225 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -60.16 151.32 67.38 Favored Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 124.77 1.228 . . . . 0.0 111.22 -179.775 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 75.9 Cg_endo -78.8 130.99 21.9 Favored 'Cis proline' 0 C--N 1.348 0.545 0 CA-C-N 120.035 1.048 . . . . 0.0 112.353 4.765 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 96.3 m -125.39 99.93 6.27 Favored 'General case' 0 N--CA 1.454 -0.227 0 N-CA-C 107.005 -1.48 . . . . 0.0 107.005 179.291 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 96.5 mtp -115.28 160.05 20.26 Favored 'General case' 0 CA--C 1.518 -0.272 0 C-N-CA 123.689 0.796 . . . . 0.0 110.902 -175.6 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 54.9 pttt -133.94 158.48 43.37 Favored 'General case' 0 N--CA 1.441 -0.877 0 N-CA-C 108.937 -0.764 . . . . 0.0 108.937 167.617 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 13.3 tmtt? -150.58 173.16 14.43 Favored 'General case' 0 CA--C 1.532 0.263 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 172.186 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 28.9 m -98.27 135.18 40.27 Favored 'General case' 0 CA--C 1.539 0.529 0 C-N-CA 124.531 1.132 . . . . 0.0 112.041 -173.191 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -101.19 136.71 31.62 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 126.286 1.834 . . . . 0.0 108.705 171.156 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 44.5 p90 -161.91 174.86 12.52 Favored 'General case' 0 N--CA 1.436 -1.14 0 N-CA-C 107.238 -1.393 . . . . 0.0 107.238 -170.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.3 tt0 -150.38 172.59 15.17 Favored 'General case' 0 N--CA 1.435 -1.195 0 N-CA-C 108.514 -0.921 . . . . 0.0 108.514 172.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 18.9 p-10 -78.54 -28.26 46.03 Favored 'General case' 0 N--CA 1.449 -0.524 0 C-N-CA 127.582 2.353 . . . . 0.0 111.758 176.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 36.0 tt0 -15.64 89.72 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.549 0 C-N-CA 128.178 2.591 . . . . 0.0 114.133 -174.644 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 76.22 -62.44 3.0 Favored Glycine 0 CA--C 1.531 1.041 0 N-CA-C 111.274 -0.73 . . . . 0.0 111.274 -177.798 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 44.2 t80 -142.68 158.46 43.63 Favored 'General case' 0 N--CA 1.45 -0.425 0 C-N-CA 125.001 1.32 . . . . 0.0 107.781 172.761 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 95.3 mtt180 -54.87 129.42 37.33 Favored 'General case' 0 C--O 1.232 0.14 0 CA-C-O 119.416 -0.326 . . . . 0.0 110.153 178.206 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 8.4 tp10 -154.11 134.84 13.65 Favored 'General case' 0 N--CA 1.454 -0.253 0 CA-C-N 118.073 0.397 . . . . 0.0 110.81 169.609 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -65.51 127.99 27.55 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.494 0 C-N-CA 124.998 1.319 . . . . 0.0 109.625 171.766 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 82.2 tttt -108.56 -22.37 12.3 Favored 'General case' 0 N--CA 1.455 -0.203 0 C-N-CA 123.749 0.82 . . . . 0.0 110.539 179.222 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.54 -162.39 28.55 Favored Glycine 0 C--N 1.336 0.566 0 O-C-N 121.408 -0.807 . . . . 0.0 111.479 -175.15 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 11.2 m-85 -142.59 155.14 44.94 Favored 'General case' 0 N--CA 1.446 -0.629 0 C-N-CA 125.118 1.367 . . . . 0.0 107.679 176.001 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 5.4 pm0 -108.59 150.16 27.88 Favored 'General case' 0 N--CA 1.447 -0.585 0 N-CA-C 107.911 -1.144 . . . . 0.0 107.911 167.835 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 69.6 m-85 -129.2 120.95 26.67 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.714 -1.587 . . . . 0.0 106.714 175.462 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 2.2 tm0? -104.05 128.51 51.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 106.524 -1.658 . . . . 0.0 106.524 174.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.8 pp -151.88 153.02 33.34 Favored 'General case' 0 CA--C 1.533 0.305 0 CA-C-N 118.814 0.734 . . . . 0.0 111.519 179.398 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.1 m-85 -96.73 99.81 11.39 Favored 'General case' 0 N--CA 1.45 -0.468 0 C-N-CA 124.264 1.026 . . . . 0.0 108.7 177.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 58.0 t -72.77 135.46 27.68 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.422 0 N-CA-C 107.888 -1.153 . . . . 0.0 107.888 174.66 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -105.9 113.09 26.43 Favored 'General case' 0 N--CA 1.453 -0.319 0 N-CA-C 105.926 -1.879 . . . . 0.0 105.926 174.462 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.01 132.48 23.55 Favored 'General case' 0 C--O 1.22 -0.494 0 C-N-CA 123.568 0.747 . . . . 0.0 109.31 -175.512 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 45.1 m 51.08 36.3 15.1 Favored 'General case' 0 C--O 1.24 0.577 0 C-N-CA 124.759 1.223 . . . . 0.0 111.185 -175.232 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 44.7 m-20 56.12 30.87 17.18 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 124.272 1.029 . . . . 0.0 112.726 -175.971 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 4.3 mptp? -122.5 150.32 42.7 Favored 'General case' 0 CA--C 1.531 0.236 0 N-CA-C 107.387 -1.338 . . . . 0.0 107.387 168.737 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 1.1 mp -92.59 128.53 38.48 Favored 'General case' 0 N--CA 1.452 -0.362 0 C-N-CA 124.939 1.296 . . . . 0.0 108.452 176.153 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 78.0 m-85 -127.05 132.04 50.8 Favored 'General case' 0 N--CA 1.453 -0.278 0 C-N-CA 124.27 1.028 . . . . 0.0 108.283 172.754 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -87.2 112.31 21.86 Favored 'General case' 0 N--CA 1.451 -0.38 0 N-CA-C 107.192 -1.411 . . . . 0.0 107.192 177.714 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -108.41 139.55 42.98 Favored 'General case' 0 N--CA 1.455 -0.175 0 N-CA-C 109.289 -0.634 . . . . 0.0 109.289 176.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 13.8 t70 -114.15 123.6 50.0 Favored 'General case' 0 N--CA 1.45 -0.435 0 N-CA-C 107.292 -1.373 . . . . 0.0 107.292 168.501 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.4 mm -112.46 149.88 14.86 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.54 0 C-N-CA 126.501 1.92 . . . . 0.0 105.907 -179.008 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 46.9 t -117.7 150.37 39.18 Favored 'General case' 0 C--O 1.235 0.316 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.876 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -128.94 113.47 15.24 Favored 'General case' 0 CA--C 1.53 0.181 0 C-N-CA 127.363 2.265 . . . . 0.0 105.585 179.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.0 t70 -82.28 118.76 23.37 Favored 'General case' 0 CA--C 1.531 0.214 0 N-CA-C 109.665 -0.494 . . . . 0.0 109.665 176.715 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 23.8 t80 -58.28 -52.3 66.18 Favored 'General case' 0 N--CA 1.456 -0.165 0 C-N-CA 125.302 1.441 . . . . 0.0 111.502 -171.218 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 39.7 ttmt -69.17 -45.02 71.03 Favored 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 110.085 -0.339 . . . . 0.0 110.085 -172.73 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 10.9 m -72.19 -29.78 64.32 Favored 'General case' 0 CA--C 1.532 0.279 0 C-N-CA 122.45 0.3 . . . . 0.0 110.591 -179.019 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 72.3 mtm180 55.35 49.01 17.88 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.405 1.082 . . . . 0.0 109.53 -168.469 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -133.58 140.61 11.95 Favored Glycine 0 C--N 1.337 0.585 0 N-CA-C 108.522 -1.831 . . . . 0.0 108.522 -177.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.4 OUTLIER -108.78 172.8 6.63 Favored 'General case' 0 N--CA 1.452 -0.334 0 C-N-CA 123.583 0.753 . . . . 0.0 111.187 -174.215 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 4.6 ptmm? -167.63 142.51 3.78 Favored 'General case' 0 N--CA 1.454 -0.249 0 C-N-CA 124.226 1.011 . . . . 0.0 111.056 178.31 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 1.9 tt -68.63 121.84 17.28 Favored 'General case' 0 N--CA 1.452 -0.329 0 N-CA-C 107.823 -1.177 . . . . 0.0 107.823 169.788 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 9.7 tp -84.6 -45.43 12.54 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 109.425 -0.583 . . . . 0.0 109.425 178.521 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 3.2 mtm180 -162.49 143.93 10.42 Favored 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 123.069 0.547 . . . . 0.0 110.24 -177.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 72.3 t80 -125.82 111.9 15.39 Favored 'General case' 0 N--CA 1.456 -0.128 0 C-N-CA 125.838 1.655 . . . . 0.0 107.197 179.964 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 79.9 m-20 -116.9 151.23 37.06 Favored 'General case' 0 N--CA 1.453 -0.285 0 N-CA-C 109.014 -0.735 . . . . 0.0 109.014 179.69 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.0 -170.79 22.72 Favored Glycine 0 CA--C 1.529 0.911 0 C-N-CA 124.622 1.106 . . . . 0.0 110.491 177.467 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 67.4 Cg_endo -68.39 152.13 88.13 Favored 'Cis proline' 0 N--CA 1.455 -0.762 0 CA-C-N 118.324 1.062 . . . . 0.0 110.702 1.826 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -138.48 143.69 39.46 Favored Pre-proline 0 CA--C 1.532 0.255 0 C-N-CA 123.878 0.871 . . . . 0.0 108.851 178.506 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 97.3 Cg_endo -76.24 158.24 37.38 Favored 'Trans proline' 0 N--CA 1.453 -0.871 0 C-N-CA 122.302 2.002 . . . . 0.0 109.299 173.119 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 93.4 Cg_endo -70.75 154.26 63.9 Favored 'Trans proline' 0 N--CA 1.452 -0.939 0 C-N-CA 121.918 1.745 . . . . 0.0 108.927 169.347 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.5 Cg_endo . . . . . 0 C--O 1.25 1.104 0 C-N-CA 122.323 2.015 . . . . 0.0 110.639 175.671 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.173 0 N-CA-C 111.677 -0.569 . . . . 0.0 111.677 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -117.32 87.35 2.69 Favored 'General case' 0 CA--C 1.53 0.194 0 N-CA-C 106.302 -1.74 . . . . 0.0 106.302 174.411 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 23.4 m95 29.73 73.03 0.05 Allowed 'General case' 0 CA--C 1.531 0.215 0 C-N-CA 126.506 1.922 . . . . 0.0 113.578 -174.614 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 38.0 tt0 -122.41 148.86 44.58 Favored 'General case' 0 C--O 1.233 0.215 0 C-N-CA 123.109 0.563 . . . . 0.0 109.597 179.983 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 16.4 mt -75.46 138.46 20.85 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.297 0 N-CA-C 107.644 -1.243 . . . . 0.0 107.644 177.598 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.9 pt -106.35 155.41 7.21 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.368 0 C-N-CA 124.014 0.926 . . . . 0.0 110.18 177.523 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.7 m-20 -62.56 140.78 58.65 Favored 'General case' 0 N--CA 1.449 -0.507 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 175.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -90.32 120.61 39.45 Favored 'Isoleucine or valine' 0 N--CA 1.443 -0.816 0 N-CA-C 108.336 -0.987 . . . . 0.0 108.336 169.066 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . -174.01 -167.43 33.59 Favored Glycine 0 CA--C 1.529 0.963 0 N-CA-C 108.865 -1.694 . . . . 0.0 108.865 -174.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 11.8 Cg_endo -52.99 -43.78 54.17 Favored 'Trans proline' 0 N--CA 1.46 -0.474 0 C-N-CA 123.515 2.81 . . . . 0.0 113.326 -172.527 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -51.12 -55.99 14.94 Favored 'General case' 0 CA--C 1.536 0.428 0 CA-C-O 122.481 1.134 . . . . 0.0 111.159 173.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -64.33 -42.87 96.08 Favored 'General case' 0 N--CA 1.448 -0.54 0 C-N-CA 124.757 1.223 . . . . 0.0 109.797 -175.761 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.5 mt-30 -56.69 -48.22 78.15 Favored 'General case' 0 N--CA 1.446 -0.671 0 C-N-CA 123.888 0.875 . . . . 0.0 109.408 174.521 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -56.57 -49.24 75.46 Favored 'General case' 0 CA--C 1.527 0.073 0 C-N-CA 123.03 0.532 . . . . 0.0 110.921 177.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 7.5 mt -57.08 -45.9 82.96 Favored 'General case' 0 N--CA 1.462 0.126 0 CA-C-N 117.846 0.293 . . . . 0.0 110.997 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.69 -53.84 40.84 Favored Glycine 0 CA--C 1.529 0.949 0 N-CA-C 110.54 -1.024 . . . . 0.0 110.54 178.336 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.4 tmtp? -52.66 -48.45 66.47 Favored 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 124.398 1.079 . . . . 0.0 110.86 176.171 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 44.9 t80 -56.4 -49.1 75.46 Favored 'General case' 0 C--N 1.332 -0.186 0 C-N-CA 123.709 0.804 . . . . 0.0 110.713 177.152 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.01 -48.59 78.11 Favored 'General case' 0 C--O 1.232 0.163 0 CA-C-O 120.856 0.36 . . . . 0.0 110.258 178.651 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 53.3 t -57.93 -47.64 85.96 Favored 'Isoleucine or valine' 0 C--O 1.227 -0.109 0 CA-C-N 116.105 -0.498 . . . . 0.0 110.374 176.366 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.3 t70 -61.1 -48.55 81.14 Favored 'General case' 0 N--CA 1.45 -0.438 0 C-N-CA 124.727 1.211 . . . . 0.0 110.06 -176.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 13.9 tt0 -65.14 -43.61 91.34 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 123.659 0.783 . . . . 0.0 109.902 -179.18 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 9.8 tm-20 -58.99 -48.66 80.79 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 119.03 -1.068 . . . . 0.0 111.419 171.33 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -54.52 -39.9 68.06 Favored 'General case' 0 CA--C 1.527 0.092 0 C-N-CA 124.399 1.08 . . . . 0.0 110.276 179.497 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 16.0 tptm -49.43 -37.79 26.95 Favored 'General case' 0 CA--C 1.533 0.314 0 C-N-CA 124.0 0.92 . . . . 0.0 111.141 175.78 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 61.2 mt -90.14 -47.43 14.74 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.353 0 C-N-CA 124.228 1.011 . . . . 0.0 109.355 -178.557 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.0 28.35 23.57 Favored Glycine 0 CA--C 1.527 0.82 0 C-N-CA 124.32 0.962 . . . . 0.0 111.19 177.945 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 35.6 mt-30 -55.99 -38.26 70.2 Favored 'General case' 0 C--N 1.34 0.155 0 CA-C-N 117.502 0.651 . . . . 0.0 111.39 -177.176 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -117.59 42.76 2.53 Favored 'General case' 0 CA--C 1.532 0.286 0 CA-C-O 121.838 0.828 . . . . 0.0 109.825 170.852 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 58.72 -148.1 39.28 Favored Glycine 0 CA--C 1.53 0.979 0 N-CA-C 110.199 -1.16 . . . . 0.0 110.199 -173.822 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 99.7 mtt180 -102.6 115.18 30.06 Favored 'General case' 0 N--CA 1.451 -0.409 0 C-N-CA 123.809 0.844 . . . . 0.0 109.623 -178.793 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.3 mp -110.62 137.0 48.86 Favored 'General case' 0 N--CA 1.458 -0.046 0 N-CA-C 108.966 -0.753 . . . . 0.0 108.966 170.072 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 63.2 m -86.07 131.47 34.26 Favored 'General case' 0 C--O 1.226 -0.156 0 N-CA-C 107.745 -1.206 . . . . 0.0 107.745 177.546 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 34.3 t80 -60.04 135.51 57.73 Favored 'General case' 0 CA--C 1.523 -0.095 0 N-CA-C 109.494 -0.558 . . . . 0.0 109.494 173.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.1 m-20 -105.76 -64.01 1.19 Allowed 'General case' 0 CA--C 1.52 -0.19 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 172.402 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -165.41 161.32 18.8 Favored 'General case' 0 N--CA 1.451 -0.377 0 C-N-CA 123.19 0.596 . . . . 0.0 109.637 -173.474 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.1 p -101.93 144.41 13.33 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.365 0 C-N-CA 125.429 1.491 . . . . 0.0 107.594 172.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 0.2 OUTLIER -147.16 159.99 9.01 Favored 'Isoleucine or valine' 0 C--N 1.333 -0.148 0 C-N-CA 123.011 0.524 . . . . 0.0 110.187 -176.26 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 8.2 ptp180 -61.39 152.89 71.61 Favored Pre-proline 0 CA--C 1.539 0.524 0 CA-C-N 115.545 -0.752 . . . . 0.0 110.831 -177.529 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 93.1 Cg_endo -75.43 153.79 98.71 Favored 'Cis proline' 0 N--CA 1.457 -0.637 0 CA-C-N 119.294 0.783 . . . . 0.0 111.08 -4.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 74.9 m -141.13 100.6 3.85 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 106.399 -1.704 . . . . 0.0 106.399 177.8 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 2.3 mtt -113.24 155.0 25.85 Favored 'General case' 0 C--N 1.333 -0.111 0 C-N-CA 124.28 1.032 . . . . 0.0 110.704 -174.709 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 45.7 pttt -138.38 154.7 48.92 Favored 'General case' 0 C--O 1.236 0.348 0 N-CA-C 112.753 0.649 . . . . 0.0 112.753 167.998 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 14.0 tmtt? -150.15 160.05 43.96 Favored 'General case' 0 CA--C 1.543 0.687 0 C-N-CA 124.396 1.079 . . . . 0.0 110.981 176.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 31.9 m -84.06 139.55 32.41 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.741 1.216 . . . . 0.0 112.851 -176.127 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -110.07 137.05 44.09 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 C-N-CA 125.756 1.622 . . . . 0.0 109.712 175.394 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 31.1 p90 -169.54 174.48 5.87 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 123.23 0.612 . . . . 0.0 111.737 -167.246 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -110.59 -159.38 0.68 Allowed 'General case' 0 CA--C 1.536 0.415 0 C-N-CA 124.96 1.304 . . . . 0.0 110.564 -178.923 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 28.6 t-20 -164.06 -46.94 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.184 0 C-N-CA 125.625 1.57 . . . . 0.0 109.812 173.44 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 43.6 mt-10 -68.47 72.83 0.22 Allowed 'General case' 0 CA--C 1.534 0.333 0 C-N-CA 125.031 1.332 . . . . 0.0 111.84 -176.023 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 161.57 -82.57 0.13 Allowed Glycine 0 N--CA 1.449 -0.452 0 N-CA-C 107.604 -2.199 . . . . 0.0 107.604 176.409 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 79.8 m-85 -141.07 140.37 34.21 Favored 'General case' 0 N--CA 1.453 -0.301 0 N-CA-C 107.482 -1.303 . . . . 0.0 107.482 172.281 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 31.6 ptt180 -64.82 100.61 0.41 Allowed 'General case' 0 N--CA 1.452 -0.325 0 N-CA-C 109.136 -0.69 . . . . 0.0 109.136 175.837 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 33.8 tt0 -138.81 125.38 20.65 Favored 'General case' 0 N--CA 1.445 -0.682 0 C-N-CA 124.489 1.115 . . . . 0.0 108.581 -179.495 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.5 mt -63.84 132.67 29.73 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.3 0 N-CA-C 109.204 -0.665 . . . . 0.0 109.204 170.276 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.6 mtpp -112.69 -27.51 8.15 Favored 'General case' 0 N--CA 1.461 0.109 0 C-N-CA 123.352 0.661 . . . . 0.0 111.458 -174.872 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.11 -160.48 24.57 Favored Glycine 0 N--CA 1.447 -0.571 0 N-CA-C 110.898 -0.881 . . . . 0.0 110.898 -174.669 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.1 m-85 -144.08 163.57 33.17 Favored 'General case' 0 N--CA 1.45 -0.432 0 C-N-CA 124.795 1.238 . . . . 0.0 108.356 178.61 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 17.1 pt-20 -122.57 145.76 48.05 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 125.492 1.517 . . . . 0.0 107.972 168.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.5 m-85 -121.3 140.37 52.16 Favored 'General case' 0 N--CA 1.447 -0.607 0 N-CA-C 104.563 -2.384 . . . . 0.0 104.563 172.3 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 57.2 tt0 -136.78 114.2 10.91 Favored 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 106.876 -1.527 . . . . 0.0 106.876 177.56 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -150.66 163.17 39.18 Favored 'General case' 0 N--CA 1.456 -0.139 0 C-N-CA 122.289 0.236 . . . . 0.0 110.711 -169.378 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -103.16 139.21 38.96 Favored 'General case' 0 N--CA 1.442 -0.854 0 C-N-CA 123.728 0.811 . . . . 0.0 110.345 177.45 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 46.7 t -126.48 137.4 57.91 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.346 0 C-N-CA 125.421 1.488 . . . . 0.0 108.037 -179.125 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -94.38 124.17 38.24 Favored 'General case' 0 N--CA 1.447 -0.591 0 N-CA-C 107.151 -1.426 . . . . 0.0 107.151 168.325 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.45 121.08 23.95 Favored 'General case' 0 N--CA 1.454 -0.248 0 C-N-CA 124.476 1.11 . . . . 0.0 109.554 -179.631 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 5.6 t 71.87 -63.31 0.43 Allowed 'General case' 0 N--CA 1.455 -0.215 0 C-N-CA 129.318 3.047 . . . . 0.0 108.588 -173.482 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 12.2 m-20 -173.22 10.8 0.01 OUTLIER 'General case' 0 CA--C 1.54 0.594 0 C-N-CA 128.965 2.906 . . . . 0.0 111.064 178.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 31.8 mmtp -113.77 130.75 56.4 Favored 'General case' 0 N--CA 1.455 -0.175 0 CA-C-N 119.432 1.014 . . . . 0.0 108.828 -176.488 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 6.7 tt -87.96 123.49 32.74 Favored 'General case' 0 N--CA 1.453 -0.325 0 C-N-CA 124.775 1.23 . . . . 0.0 108.116 177.536 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 17.0 p90 -133.3 159.23 40.85 Favored 'General case' 0 C--O 1.231 0.105 0 C-N-CA 123.81 0.844 . . . . 0.0 110.035 175.907 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 53.0 ttp180 -91.35 136.59 33.0 Favored 'General case' 0 N--CA 1.456 -0.156 0 C-N-CA 123.692 0.797 . . . . 0.0 108.957 174.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -123.57 135.26 53.89 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.044 -1.095 . . . . 0.0 108.044 169.663 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -116.94 130.5 56.74 Favored 'General case' 0 N--CA 1.454 -0.26 0 N-CA-C 106.832 -1.544 . . . . 0.0 106.832 169.785 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.5 mp -129.81 136.73 58.37 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.199 0 C-N-CA 125.513 1.525 . . . . 0.0 106.89 -173.558 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 5.3 p -103.4 151.32 22.91 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 123.437 0.695 . . . . 0.0 109.295 171.676 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 46.6 tt0 -126.62 119.6 27.45 Favored 'General case' 0 CA--C 1.523 -0.079 0 C-N-CA 126.802 2.041 . . . . 0.0 106.857 173.861 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 19.0 t70 -91.45 118.82 30.89 Favored 'General case' 0 CA--C 1.528 0.106 0 N-CA-C 108.615 -0.883 . . . . 0.0 108.615 176.243 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 49.4 t80 -60.57 -46.47 90.1 Favored 'General case' 0 CA--C 1.531 0.235 0 C-N-CA 124.081 0.953 . . . . 0.0 111.446 -171.916 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 32.3 mttp -63.74 -49.5 72.81 Favored 'General case' 0 CA--C 1.531 0.226 0 C-N-CA 122.902 0.481 . . . . 0.0 111.542 -177.056 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 14.8 m -71.27 -30.25 66.06 Favored 'General case' 0 N--CA 1.452 -0.343 0 N-CA-C 108.935 -0.765 . . . . 0.0 108.935 -179.377 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 13.8 ttm-85 58.04 41.9 23.43 Favored 'General case' 0 N--CA 1.449 -0.496 0 C-N-CA 124.538 1.135 . . . . 0.0 109.056 -170.576 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -131.23 150.76 19.5 Favored Glycine 0 N--CA 1.449 -0.48 0 N-CA-C 107.09 -2.404 . . . . 0.0 107.09 -179.939 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 42.9 mtt180 -120.35 167.72 12.03 Favored 'General case' 0 N--CA 1.446 -0.643 0 C-N-CA 123.539 0.735 . . . . 0.0 109.705 -175.756 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -158.09 147.68 19.79 Favored 'General case' 0 N--CA 1.45 -0.447 0 N-CA-C 112.712 0.634 . . . . 0.0 112.712 169.999 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 50.0 tp -57.33 109.9 0.76 Allowed 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.295 1.438 . . . . 0.0 108.147 170.96 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -72.92 -54.53 8.46 Favored 'General case' 0 N--CA 1.452 -0.332 0 N-CA-C 107.749 -1.204 . . . . 0.0 107.749 176.188 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.7 OUTLIER -149.78 156.78 42.42 Favored 'General case' 0 C--N 1.339 0.127 0 C-N-CA 123.598 0.759 . . . . 0.0 109.541 174.211 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 24.5 t80 -120.98 127.36 51.72 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 103.978 -2.601 . . . . 0.0 103.978 168.737 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 36.4 m120 -137.19 155.43 49.56 Favored 'General case' 0 N--CA 1.449 -0.517 0 N-CA-C 108.242 -1.021 . . . . 0.0 108.242 -178.747 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 96.91 -159.57 21.5 Favored Glycine 0 CA--C 1.531 1.054 0 N-CA-C 109.379 -1.489 . . . . 0.0 109.379 -169.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 64.8 Cg_endo -66.09 159.62 76.66 Favored 'Cis proline' 0 N--CA 1.457 -0.674 0 CA-C-N 119.099 1.45 . . . . 0.0 112.07 2.99 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 26.5 m -136.13 136.99 23.67 Favored Pre-proline 0 CA--C 1.532 0.288 0 N-CA-C 107.699 -1.223 . . . . 0.0 107.699 175.606 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 86.7 Cg_endo -75.4 157.55 41.03 Favored 'Trans proline' 0 N--CA 1.453 -0.906 0 C-N-CA 121.998 1.798 . . . . 0.0 109.646 176.987 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 82.1 Cg_endo -67.92 154.14 73.6 Favored 'Trans proline' 0 N--CA 1.453 -0.905 0 C-N-CA 121.827 1.685 . . . . 0.0 109.229 169.36 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo . . . . . 0 C--O 1.251 1.173 0 C-N-CA 122.493 2.129 . . . . 0.0 110.839 177.822 . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.295 0 N-CA-C 111.482 -0.647 . . . . 0.0 111.482 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 14.7 pt-20 -163.28 157.35 20.13 Favored 'General case' 0 N--CA 1.451 -0.406 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 177.332 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 3.8 m95 37.37 56.64 1.37 Allowed 'General case' 0 CA--C 1.53 0.207 0 C-N-CA 125.103 1.361 . . . . 0.0 111.748 -169.369 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -103.72 143.22 33.08 Favored 'General case' 0 N--CA 1.447 -0.592 0 CA-C-N 115.08 -0.964 . . . . 0.0 108.455 -178.307 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.8 mp -78.26 140.26 17.24 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.332 0 N-CA-C 107.455 -1.313 . . . . 0.0 107.455 179.433 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 44.9 pt -113.82 156.24 14.84 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.348 0 C-N-CA 124.072 0.949 . . . . 0.0 109.673 172.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 6.9 m-20 -70.3 167.44 18.04 Favored 'General case' 0 N--CA 1.451 -0.392 0 CA-C-O 121.807 0.813 . . . . 0.0 109.773 176.14 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.6 pp -100.44 164.21 2.8 Favored 'Isoleucine or valine' 0 N--CA 1.435 -1.223 0 N-CA-C 106.933 -1.506 . . . . 0.0 106.933 164.89 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 142.46 -174.12 23.54 Favored Glycine 0 CA--C 1.532 1.134 0 N-CA-C 109.754 -1.338 . . . . 0.0 109.754 -169.109 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -58.05 -43.19 50.34 Favored 'Trans proline' 0 N--CA 1.458 -0.59 0 C-N-CA 123.847 3.031 . . . . 0.0 112.382 -173.097 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 67.5 t80 -51.22 -58.11 7.02 Favored 'General case' 0 CA--C 1.533 0.311 0 CA-C-O 122.019 0.914 . . . . 0.0 110.871 174.596 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.3 OUTLIER -67.14 -41.18 86.52 Favored 'General case' 0 N--CA 1.445 -0.691 0 CA-C-N 115.949 -0.569 . . . . 0.0 109.665 -171.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 78.5 mt-30 -53.71 -53.79 47.15 Favored 'General case' 0 N--CA 1.445 -0.702 0 CA-C-O 118.547 -0.74 . . . . 0.0 109.643 171.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 48.6 t30 -51.68 -50.31 60.68 Favored 'General case' 0 CA--C 1.53 0.193 0 CA-C-N 118.771 0.714 . . . . 0.0 110.712 -179.887 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 70.6 mt -57.22 -49.92 74.48 Favored 'General case' 0 CA--C 1.531 0.236 0 O-C-N 122.032 -0.418 . . . . 0.0 110.877 176.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.0 -34.23 71.7 Favored Glycine 0 CA--C 1.534 1.274 0 O-C-N 122.142 -0.349 . . . . 0.0 112.257 176.819 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.2 tmtt? -73.06 -48.18 38.28 Favored 'General case' 0 N--CA 1.444 -0.758 0 N-CA-C 107.053 -1.462 . . . . 0.0 107.053 -174.336 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 1.9 t80 -51.58 -47.19 63.6 Favored 'General case' 0 N--CA 1.452 -0.348 0 C-N-CA 124.279 1.031 . . . . 0.0 110.554 169.569 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.97 -53.33 59.3 Favored 'General case' 0 N--CA 1.455 -0.191 0 CA-C-O 121.093 0.473 . . . . 0.0 110.052 -179.37 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 79.6 t -62.36 -40.08 86.59 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.281 0 CA-C-N 116.131 -0.486 . . . . 0.0 110.771 178.156 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.1 t70 -60.72 -48.11 83.27 Favored 'General case' 0 N--CA 1.45 -0.426 0 O-C-N 121.436 -0.79 . . . . 0.0 109.666 -178.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 11.4 tp10 -58.81 -50.27 74.59 Favored 'General case' 0 N--CA 1.453 -0.292 0 C-N-CA 124.282 1.033 . . . . 0.0 109.516 175.693 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 69.5 tt0 -53.78 -44.94 70.51 Favored 'General case' 0 N--CA 1.452 -0.347 0 C-N-CA 123.278 0.631 . . . . 0.0 110.778 179.519 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 74.2 m-20 -69.98 -39.69 75.81 Favored 'General case' 0 N--CA 1.448 -0.541 0 C-N-CA 125.554 1.542 . . . . 0.0 110.589 179.527 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 22.1 tptm -58.33 -46.03 86.99 Favored 'General case' 0 CA--C 1.53 0.193 0 N-CA-C 108.933 -0.766 . . . . 0.0 108.933 177.742 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 82.9 mt -64.86 -43.77 96.32 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.411 0 N-CA-C 109.341 -0.614 . . . . 0.0 109.341 171.366 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 88.41 24.59 33.3 Favored Glycine 0 CA--C 1.525 0.687 0 C-N-CA 125.243 1.401 . . . . 0.0 110.282 -173.287 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 47.5 tt0 -57.85 -35.33 70.78 Favored 'General case' 0 CA--C 1.531 0.246 0 C-N-CA 123.519 0.728 . . . . 0.0 111.47 -169.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 43.4 m-85 -129.27 45.43 2.8 Favored 'General case' 0 CA--C 1.533 0.294 0 N-CA-C 108.588 -0.893 . . . . 0.0 108.588 170.013 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.17 -140.11 46.44 Favored Glycine 0 CA--C 1.53 1.014 0 N-CA-C 111.161 -0.776 . . . . 0.0 111.161 -178.557 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -101.37 86.33 2.97 Favored 'General case' 0 CA--C 1.532 0.257 0 C-N-CA 125.066 1.346 . . . . 0.0 109.219 -178.559 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 96.0 mt -79.94 138.1 37.02 Favored 'General case' 0 CA--C 1.529 0.153 0 O-C-N 121.494 -0.754 . . . . 0.0 110.124 175.582 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 59.3 m -96.61 95.55 8.04 Favored 'General case' 0 C--N 1.331 -0.203 0 N-CA-C 107.976 -1.12 . . . . 0.0 107.976 177.597 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 24.3 t80 -45.67 131.45 8.96 Favored 'General case' 0 N--CA 1.461 0.084 0 C-N-CA 123.245 0.618 . . . . 0.0 110.234 173.113 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -102.0 -66.12 0.94 Allowed 'General case' 0 N--CA 1.455 -0.207 0 N-CA-C 108.23 -1.026 . . . . 0.0 108.23 175.035 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 18.8 pttm -173.36 154.16 2.57 Favored 'General case' 0 C--O 1.232 0.157 0 C-N-CA 123.93 0.892 . . . . 0.0 110.546 178.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 7.5 p -80.79 144.05 11.27 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.209 0 N-CA-C 108.18 -1.044 . . . . 0.0 108.18 168.439 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.8 pp -137.97 156.92 31.94 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.195 0 C-N-CA 123.815 0.846 . . . . 0.0 110.144 178.436 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 26.9 ptt85 -63.42 153.01 83.96 Favored Pre-proline 0 CA--C 1.538 0.489 0 C-N-CA 124.708 1.203 . . . . 0.0 111.226 -179.471 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 96.8 Cg_endo -76.11 154.72 98.36 Favored 'Cis proline' 0 N--CA 1.46 -0.494 0 CA-C-N 119.443 0.837 . . . . 0.0 111.268 -5.335 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 89.9 m -137.66 131.04 30.9 Favored 'General case' 0 CA--C 1.515 -0.4 0 N-CA-C 106.902 -1.518 . . . . 0.0 106.902 176.49 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 27.8 mtp -135.82 158.08 45.26 Favored 'General case' 0 C--N 1.33 -0.271 0 C-N-CA 123.44 0.696 . . . . 0.0 110.965 -169.965 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 18.8 pttp -145.07 154.58 42.64 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 123.251 0.621 . . . . 0.0 111.059 173.03 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 1.9 tmmt? -144.47 142.09 30.03 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.054 0.942 . . . . 0.0 111.381 -176.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 3.3 m -73.95 123.36 24.15 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 127.753 2.421 . . . . 0.0 111.395 -174.448 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.4 mp -97.61 100.91 11.51 Favored 'Isoleucine or valine' 0 CA--C 1.536 0.441 0 CA-C-O 122.387 1.089 . . . . 0.0 108.17 175.94 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 90.4 m-85 -81.09 166.48 20.69 Favored 'General case' 0 N--CA 1.453 -0.31 0 C-N-CA 124.517 1.127 . . . . 0.0 110.348 174.339 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 4.8 tt0 -148.04 162.23 39.78 Favored 'General case' 0 N--CA 1.442 -0.855 0 N-CA-C 107.447 -1.316 . . . . 0.0 107.447 166.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 8.6 t-20 -58.12 -52.99 63.24 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 113.763 -1.562 . . . . 0.0 109.794 173.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 2.8 tp10 45.86 -151.36 0.07 Allowed 'General case' 0 CA--C 1.539 0.528 0 C-N-CA 125.957 1.703 . . . . 0.0 112.366 172.528 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -79.15 64.34 3.75 Favored Glycine 0 CA--C 1.525 0.675 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 169.306 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 35.4 t80 73.01 163.24 0.27 Allowed 'General case' 0 CA--C 1.534 0.363 0 C-N-CA 126.165 1.786 . . . . 0.0 110.43 -167.532 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 92.9 mtt180 -33.2 112.29 0.12 Allowed 'General case' 0 C--N 1.34 0.193 0 C-N-CA 126.107 1.763 . . . . 0.0 112.338 -174.54 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 83.3 tt0 -142.92 145.63 33.23 Favored 'General case' 0 N--CA 1.448 -0.559 0 C-N-CA 122.935 0.494 . . . . 0.0 109.742 176.773 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 90.9 mt -80.64 101.95 6.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.298 0 N-CA-C 106.595 -1.631 . . . . 0.0 106.595 172.432 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.27 -19.44 33.85 Favored 'General case' 0 C--O 1.231 0.095 0 C-N-CA 120.762 -0.375 . . . . 0.0 110.612 178.85 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -170.71 -167.1 30.61 Favored Glycine 0 C--N 1.338 0.649 0 C-N-CA 121.046 -0.597 . . . . 0.0 112.464 -178.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 28.5 m-85 -142.29 164.63 29.61 Favored 'General case' 0 N--CA 1.451 -0.399 0 C-N-CA 125.313 1.445 . . . . 0.0 108.157 174.901 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 43.5 tt0 -122.49 146.22 47.58 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 126.902 2.081 . . . . 0.0 106.725 171.025 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 97.2 m-85 -127.42 138.85 53.08 Favored 'General case' 0 N--CA 1.451 -0.41 0 N-CA-C 105.517 -2.031 . . . . 0.0 105.517 176.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 45.8 tt0 -136.86 117.64 14.07 Favored 'General case' 0 N--CA 1.451 -0.424 0 N-CA-C 106.552 -1.647 . . . . 0.0 106.552 -179.393 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.1 pp -150.87 146.27 26.22 Favored 'General case' 0 N--CA 1.46 0.061 0 CA-C-N 118.438 0.563 . . . . 0.0 111.573 -169.15 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 25.6 m-85 -89.98 130.62 36.15 Favored 'General case' 0 N--CA 1.448 -0.554 0 C-N-CA 124.022 0.929 . . . . 0.0 109.446 -179.664 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 14.9 p -134.08 135.06 55.16 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.6 0 C-N-CA 124.336 1.054 . . . . 0.0 110.424 -176.151 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -89.22 128.81 35.85 Favored 'General case' 0 N--CA 1.442 -0.834 0 N-CA-C 107.37 -1.344 . . . . 0.0 107.37 169.592 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -135.72 125.49 25.56 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 172.416 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.5 t 52.34 40.0 28.43 Favored 'General case' 0 CA--C 1.54 0.586 0 C-N-CA 123.961 0.905 . . . . 0.0 111.105 -177.977 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 26.1 t70 57.54 23.0 8.71 Favored 'General case' 0 CA--C 1.54 0.566 0 C-N-CA 125.012 1.325 . . . . 0.0 113.359 -176.873 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 75.1 mmtt -110.78 132.08 54.5 Favored 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.389 -1.337 . . . . 0.0 107.389 169.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 3.4 tm? -91.2 124.52 35.47 Favored 'General case' 0 N--CA 1.454 -0.256 0 C-N-CA 123.818 0.847 . . . . 0.0 108.725 -178.484 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 47.4 m-85 -131.05 159.29 37.98 Favored 'General case' 0 C--O 1.231 0.111 0 C-N-CA 125.176 1.39 . . . . 0.0 109.215 179.475 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 2.9 tpp180 -101.08 123.11 44.74 Favored 'General case' 0 N--CA 1.456 -0.155 0 N-CA-C 107.764 -1.199 . . . . 0.0 107.764 167.623 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -97.83 133.85 41.78 Favored 'General case' 0 N--CA 1.451 -0.386 0 N-CA-C 108.253 -1.017 . . . . 0.0 108.253 171.134 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 12.7 t70 -122.77 124.8 44.17 Favored 'General case' 0 C--O 1.235 0.3 0 C-N-CA 124.359 1.063 . . . . 0.0 108.37 172.121 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.1 mp -129.46 155.02 41.01 Favored 'Isoleucine or valine' 0 C--N 1.332 -0.191 0 C-N-CA 126.557 1.943 . . . . 0.0 106.684 -172.088 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 69.9 m -127.79 164.94 21.08 Favored 'General case' 0 N--CA 1.452 -0.33 0 CA-C-N 118.424 0.556 . . . . 0.0 109.813 168.645 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -131.97 133.37 44.41 Favored 'General case' 0 N--CA 1.452 -0.342 0 C-N-CA 126.431 1.892 . . . . 0.0 107.595 175.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -105.21 109.11 20.97 Favored 'General case' 0 N--CA 1.452 -0.338 0 C-N-CA 125.256 1.422 . . . . 0.0 107.911 176.867 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 71.5 t80 -56.89 -31.95 65.39 Favored 'General case' 0 N--CA 1.453 -0.314 0 C-N-CA 125.394 1.477 . . . . 0.0 111.092 -173.327 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 65.3 mttt -48.86 -26.91 2.69 Favored 'General case' 0 N--CA 1.454 -0.271 0 C-N-CA 125.416 1.486 . . . . 0.0 112.928 176.489 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.1 m -144.22 17.54 1.72 Allowed 'General case' 0 CA--C 1.533 0.293 0 CA-C-N 118.64 0.654 . . . . 0.0 111.151 169.908 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.2 ttm180 49.07 30.86 3.08 Favored 'General case' 0 CA--C 1.539 0.544 0 C-N-CA 123.896 0.878 . . . . 0.0 110.442 -169.841 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -91.36 125.8 8.17 Favored Glycine 0 C--N 1.336 0.546 0 N-CA-C 109.2 -1.56 . . . . 0.0 109.2 -168.554 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 40.3 mtt85 -98.03 167.14 11.08 Favored 'General case' 0 N--CA 1.452 -0.335 0 CA-C-O 121.855 0.836 . . . . 0.0 112.433 -176.93 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 7.5 ptmm? -164.53 128.22 2.5 Favored 'General case' 0 N--CA 1.453 -0.322 0 CA-C-N 114.15 -1.386 . . . . 0.0 111.035 -170.877 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 58.8 tp -66.28 121.97 16.44 Favored 'General case' 0 N--CA 1.453 -0.295 0 N-CA-C 108.156 -1.053 . . . . 0.0 108.156 171.059 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.5 mp -84.33 -50.58 7.7 Favored 'General case' 0 CA--C 1.52 -0.178 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 170.096 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.2 ttm180 -161.88 161.42 28.86 Favored 'General case' 0 N--CA 1.456 -0.166 0 CA-C-O 120.724 0.297 . . . . 0.0 110.649 179.181 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -127.79 82.34 2.08 Favored 'General case' 0 N--CA 1.451 -0.391 0 N-CA-C 106.858 -1.534 . . . . 0.0 106.858 174.024 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -83.33 137.85 33.79 Favored 'General case' 0 N--CA 1.452 -0.326 0 N-CA-C 108.711 -0.848 . . . . 0.0 108.711 -169.498 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.18 -166.61 25.69 Favored Glycine 0 CA--C 1.531 1.05 0 N-CA-C 110.339 -1.105 . . . . 0.0 110.339 -179.482 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 70.9 Cg_endo -68.68 154.32 90.16 Favored 'Cis proline' 0 N--CA 1.457 -0.649 0 CA-C-N 118.175 0.988 . . . . 0.0 110.726 1.643 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 1.3 m -142.6 149.21 49.75 Favored Pre-proline 0 C--O 1.227 -0.108 0 N-CA-C 107.524 -1.287 . . . . 0.0 107.524 173.77 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.3 Cg_endo -73.1 155.88 52.04 Favored 'Trans proline' 0 N--CA 1.451 -1.014 0 C-N-CA 121.505 1.47 . . . . 0.0 109.076 172.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.2 Cg_endo -67.03 145.29 73.17 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 121.632 1.555 . . . . 0.0 108.782 169.56 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.25 1.11 0 C-N-CA 122.465 2.11 . . . . 0.0 110.763 179.101 . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 1.216 0 N-CA-C 111.309 -0.716 . . . . 0.0 111.309 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.8 mp0 -74.79 70.08 1.87 Allowed 'General case' 0 CA--C 1.532 0.252 0 C-N-CA 122.97 0.508 . . . . 0.0 111.621 -175.661 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 7.2 t-105 -163.88 82.87 0.44 Allowed 'General case' 0 CA--C 1.522 -0.117 0 C-N-CA 125.225 1.41 . . . . 0.0 107.783 168.358 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 39.5 tt0 -147.13 156.71 43.22 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 107.62 -1.252 . . . . 0.0 107.62 -176.077 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . 0.488 HD12 ' H ' ' A' ' 5' ' ' ILE . 3.4 mp -76.08 131.34 35.09 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.489 0 N-CA-C 106.763 -1.569 . . . . 0.0 106.763 178.666 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.8 pt -92.1 153.46 3.27 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.301 0 C-N-CA 123.54 0.736 . . . . 0.0 109.626 -179.954 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -69.49 122.65 19.43 Favored 'General case' 0 N--CA 1.45 -0.474 0 N-CA-C 109.201 -0.666 . . . . 0.0 109.201 -179.678 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 48.5 pt -64.44 146.34 13.21 Favored 'Isoleucine or valine' 0 N--CA 1.436 -1.137 0 N-CA-C 107.301 -1.37 . . . . 0.0 107.301 165.222 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 155.2 -177.59 32.33 Favored Glycine 0 CA--C 1.533 1.177 0 N-CA-C 108.139 -1.984 . . . . 0.0 108.139 -166.936 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -54.95 -47.27 27.53 Favored 'Trans proline' 0 N--CA 1.459 -0.534 0 C-N-CA 124.041 3.161 . . . . 0.0 113.352 -169.089 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 85.1 t80 -54.22 -54.19 43.33 Favored 'General case' 0 CA--C 1.537 0.449 0 CA-C-O 122.217 1.008 . . . . 0.0 111.101 177.109 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 18.3 m -65.92 -41.48 91.34 Favored 'General case' 0 N--CA 1.449 -0.482 0 C-N-CA 123.438 0.695 . . . . 0.0 110.239 -174.166 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 36.8 mt-30 -54.15 -54.69 36.2 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-O 118.628 -0.701 . . . . 0.0 109.45 169.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 28.5 t-20 -50.02 -49.39 50.97 Favored 'General case' 0 CA--C 1.528 0.114 0 CA-C-N 118.898 0.772 . . . . 0.0 111.004 -178.753 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 87.1 mt -61.79 -49.42 76.4 Favored 'General case' 0 CA--C 1.534 0.333 0 CA-C-O 120.816 0.341 . . . . 0.0 111.074 177.725 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.78 -27.93 62.39 Favored Glycine 0 CA--C 1.534 1.237 0 O-C-N 121.945 -0.472 . . . . 0.0 112.762 176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.2 tmtp? -79.7 -52.82 7.47 Favored 'General case' 0 N--CA 1.443 -0.781 0 N-CA-C 106.158 -1.793 . . . . 0.0 106.158 -175.794 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 14.1 t80 -46.26 -45.15 17.02 Favored 'General case' 0 N--CA 1.451 -0.392 0 C-N-CA 125.386 1.475 . . . . 0.0 110.802 172.165 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -54.46 -55.64 26.91 Favored 'General case' 0 C--O 1.232 0.18 0 CA-C-O 121.517 0.675 . . . . 0.0 110.523 177.25 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 69.6 t -62.32 -39.93 86.0 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 CA-C-N 115.584 -0.735 . . . . 0.0 110.754 179.566 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 24.7 t70 -61.58 -48.9 78.85 Favored 'General case' 0 N--CA 1.449 -0.5 0 C-N-CA 123.615 0.766 . . . . 0.0 109.701 -178.764 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 26.1 tt0 -59.94 -49.55 77.26 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 124.216 1.007 . . . . 0.0 109.24 177.36 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 67.7 tt0 -54.93 -47.0 75.01 Favored 'General case' 0 CA--C 1.531 0.25 0 C-N-CA 122.96 0.504 . . . . 0.0 110.732 178.749 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 59.8 m-20 -65.78 -40.53 92.06 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 125.315 1.446 . . . . 0.0 110.298 179.278 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 40.3 tptt -58.07 -45.16 87.54 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 109.215 -0.661 . . . . 0.0 109.215 179.818 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 66.4 mt -69.1 -42.72 81.96 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.505 0 N-CA-C 109.486 -0.561 . . . . 0.0 109.486 174.088 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 93.97 18.29 37.75 Favored Glycine 0 CA--C 1.527 0.782 0 C-N-CA 125.276 1.417 . . . . 0.0 112.167 175.619 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 54.4 mt-30 -58.69 -39.45 80.75 Favored 'General case' 0 N--CA 1.463 0.194 0 CA-C-N 117.978 0.889 . . . . 0.0 111.581 -172.151 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 11.7 m-85 -110.84 34.83 3.77 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.108 0.963 . . . . 0.0 109.794 175.068 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.08 -130.42 44.63 Favored Glycine 0 CA--C 1.527 0.784 0 N-CA-C 109.945 -1.262 . . . . 0.0 109.945 -176.302 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 76.9 ttt180 -119.92 84.73 2.26 Favored 'General case' 0 CA--C 1.531 0.241 0 C-N-CA 124.923 1.289 . . . . 0.0 109.305 -173.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 83.3 mt -77.01 139.82 40.19 Favored 'General case' 0 N--CA 1.456 -0.136 0 O-C-N 121.95 -0.469 . . . . 0.0 109.946 179.575 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 62.4 m -97.39 94.57 7.13 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 108.199 -1.037 . . . . 0.0 108.199 178.008 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 28.7 t80 -48.33 135.31 13.86 Favored 'General case' 0 N--CA 1.461 0.111 0 C-N-CA 122.756 0.422 . . . . 0.0 110.204 173.758 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -108.86 -62.47 1.47 Allowed 'General case' 0 C--N 1.332 -0.192 0 C-N-CA 124.089 0.956 . . . . 0.0 109.097 176.668 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -169.15 178.3 4.46 Favored 'General case' 0 CA--C 1.528 0.097 0 C-N-CA 124.551 1.14 . . . . 0.0 108.959 177.844 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -114.48 142.88 25.58 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.216 0 C-N-CA 124.838 1.255 . . . . 0.0 109.348 172.104 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -138.6 171.56 14.97 Favored 'Isoleucine or valine' 0 CA--C 1.533 0.322 0 C-N-CA 123.873 0.869 . . . . 0.0 109.37 175.699 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -71.41 151.4 94.1 Favored Pre-proline 0 CA--C 1.542 0.659 0 CA-C-O 118.821 -0.609 . . . . 0.0 111.532 -175.225 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.5 Cg_endo -69.33 160.97 85.88 Favored 'Cis proline' 0 C--N 1.348 0.519 0 CA-C-N 120.098 1.071 . . . . 0.0 111.649 0.049 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 19.9 p -177.0 77.52 0.02 OUTLIER 'General case' 0 N--CA 1.439 -1.0 0 N-CA-C 104.058 -2.571 . . . . 0.0 104.058 -163.935 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 7.5 ttt -122.01 134.25 54.8 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 124.42 1.088 . . . . 0.0 109.225 -165.596 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 51.5 pttt -103.47 138.44 40.19 Favored 'General case' 0 N--CA 1.472 0.673 0 CA-C-O 117.991 -1.004 . . . . 0.0 111.027 -178.784 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 50.9 tttm -134.62 145.59 48.77 Favored 'General case' 0 C--N 1.34 0.189 0 CA-C-N 118.944 0.793 . . . . 0.0 111.471 176.145 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 54.6 m -74.46 139.02 43.62 Favored 'General case' 0 N--CA 1.461 0.099 0 C-N-CA 122.884 0.473 . . . . 0.0 109.925 173.822 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.62 126.06 71.01 Favored 'Isoleucine or valine' 0 C--O 1.236 0.373 0 C-N-CA 124.905 1.282 . . . . 0.0 109.257 175.296 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.7 p90 -139.65 150.72 45.27 Favored 'General case' 0 N--CA 1.448 -0.573 0 C-N-CA 124.009 0.924 . . . . 0.0 109.946 -178.356 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.9 tt0 -176.51 173.24 2.07 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 125.996 1.718 . . . . 0.0 107.23 176.543 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 27.1 t-20 -150.05 -65.23 0.21 Allowed 'General case' 0 C--N 1.319 -0.718 0 C-N-CA 125.048 1.339 . . . . 0.0 108.663 169.336 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 10.1 tp10 -175.07 77.21 0.03 OUTLIER 'General case' 0 C--O 1.247 0.966 0 N-CA-C 105.802 -1.925 . . . . 0.0 105.802 -175.656 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 74.38 -60.58 2.36 Favored Glycine 0 CA--C 1.531 1.036 0 N-CA-C 108.478 -1.849 . . . . 0.0 108.478 -165.434 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 95.6 m-85 -57.57 165.5 1.58 Allowed 'General case' 0 C--O 1.239 0.509 0 C-N-CA 125.331 1.452 . . . . 0.0 110.843 167.721 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 21.2 ptt-85 -109.31 160.48 16.11 Favored 'General case' 0 C--N 1.328 -0.368 0 C-N-CA 126.45 1.9 . . . . 0.0 110.609 -170.576 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -174.47 139.19 0.56 Allowed 'General case' 0 CA--C 1.535 0.403 0 C-N-CA 127.16 2.184 . . . . 0.0 105.898 167.555 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.4 mt -62.28 125.48 18.73 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.243 0 CA-C-N 119.427 1.012 . . . . 0.0 109.158 178.209 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 60.4 mtpt -122.44 -34.19 3.31 Favored 'General case' 0 C--O 1.234 0.24 0 C-N-CA 123.235 0.614 . . . . 0.0 111.482 -178.578 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -172.35 -160.1 20.21 Favored Glycine 0 C--N 1.333 0.402 0 C-N-CA 120.505 -0.855 . . . . 0.0 111.507 -176.091 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 19.5 m-85 -135.67 163.9 29.09 Favored 'General case' 0 N--CA 1.451 -0.383 0 C-N-CA 124.675 1.19 . . . . 0.0 108.244 174.468 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 83.9 mt-10 -124.59 143.54 50.64 Favored 'General case' 0 C--N 1.329 -0.284 0 C-N-CA 125.664 1.585 . . . . 0.0 108.043 169.778 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 8.0 m-85 -124.13 111.91 16.47 Favored 'General case' 0 N--CA 1.447 -0.623 0 N-CA-C 105.548 -2.019 . . . . 0.0 105.548 178.303 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 1.2 tm0? -106.62 110.72 22.99 Favored 'General case' 0 C--N 1.333 -0.146 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -179.251 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -140.87 141.72 34.6 Favored 'General case' 0 C--N 1.341 0.2 0 CA-C-N 119.028 0.831 . . . . 0.0 112.46 -172.432 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -87.91 101.99 14.27 Favored 'General case' 0 CA--C 1.537 0.466 0 C-N-CA 123.896 0.879 . . . . 0.0 109.464 -179.254 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 61.3 t -91.83 125.68 44.49 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.282 0 C-N-CA 125.509 1.524 . . . . 0.0 109.301 -179.045 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.2 OUTLIER -85.8 117.79 24.89 Favored 'General case' 0 N--CA 1.451 -0.424 0 C-N-CA 124.889 1.276 . . . . 0.0 107.988 169.982 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -132.2 127.98 36.98 Favored 'General case' 0 N--CA 1.452 -0.34 0 C-N-CA 124.581 1.152 . . . . 0.0 108.17 174.483 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 t 51.27 39.4 23.81 Favored 'General case' 0 CA--C 1.54 0.58 0 C-N-CA 124.104 0.962 . . . . 0.0 111.322 -177.024 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.0 t0 55.26 22.79 5.0 Favored 'General case' 0 CA--C 1.54 0.577 0 C-N-CA 125.087 1.355 . . . . 0.0 113.707 -176.242 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.6 mptt -111.76 135.87 51.79 Favored 'General case' 0 N--CA 1.456 -0.132 0 N-CA-C 105.994 -1.854 . . . . 0.0 105.994 167.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 31.4 tp -100.11 126.39 46.34 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.467 -0.938 . . . . 0.0 108.467 -174.599 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 27.8 m-85 -131.63 142.8 49.95 Favored 'General case' 0 N--CA 1.461 0.083 0 C-N-CA 124.604 1.162 . . . . 0.0 109.674 -176.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 35.8 ttp180 -82.69 106.9 14.92 Favored 'General case' 0 N--CA 1.452 -0.366 0 C-N-CA 124.13 0.972 . . . . 0.0 108.707 174.293 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -89.43 124.64 34.66 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 107.584 -1.265 . . . . 0.0 107.584 172.577 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 19.0 t0 -110.62 108.9 18.99 Favored 'General case' 0 N--CA 1.452 -0.33 0 N-CA-C 107.246 -1.39 . . . . 0.0 107.246 170.27 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.0 mp -104.64 152.72 6.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 N-CA-C 106.563 -1.643 . . . . 0.0 106.563 177.245 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 33.5 t -125.48 152.61 44.72 Favored 'General case' 0 CA--C 1.518 -0.277 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 170.796 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -121.57 131.81 54.33 Favored 'General case' 0 C--N 1.34 0.156 0 C-N-CA 125.718 1.607 . . . . 0.0 107.779 173.538 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -92.04 124.03 35.83 Favored 'General case' 0 CA--C 1.532 0.278 0 C-N-CA 123.768 0.827 . . . . 0.0 109.519 179.519 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 40.3 t80 -66.92 -29.41 69.28 Favored 'General case' 0 CA--C 1.533 0.318 0 O-C-N 121.197 -0.939 . . . . 0.0 111.979 -172.861 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -58.92 -58.41 8.78 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 123.45 0.7 . . . . 0.0 111.329 -179.064 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -96.24 -14.72 22.46 Favored 'General case' 0 CA--C 1.532 0.265 0 C-N-CA 123.324 0.65 . . . . 0.0 110.827 -173.567 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 65.3 mtm-85 54.53 41.75 31.76 Favored 'General case' 0 CA--C 1.532 0.25 0 C-N-CA 124.462 1.105 . . . . 0.0 110.737 -174.26 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -115.91 158.2 14.56 Favored Glycine 0 CA--C 1.525 0.686 0 N-CA-C 108.055 -2.018 . . . . 0.0 108.055 173.774 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -115.12 165.92 12.39 Favored 'General case' 0 N--CA 1.45 -0.457 0 CA-C-N 117.673 0.736 . . . . 0.0 111.548 -176.228 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 1.8 pptp? -157.92 148.74 20.93 Favored 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 124.875 1.27 . . . . 0.0 110.985 174.144 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 tp -69.57 127.4 32.86 Favored 'General case' 0 N--CA 1.453 -0.279 0 C-N-CA 123.936 0.894 . . . . 0.0 109.091 175.512 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 38.0 mt -86.4 -51.43 6.22 Favored 'General case' 0 C--O 1.228 -0.039 0 N-CA-C 108.314 -0.995 . . . . 0.0 108.314 167.288 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.3 167.55 25.68 Favored 'General case' 0 N--CA 1.456 -0.141 0 CA-C-N 117.909 0.322 . . . . 0.0 111.502 175.861 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 46.9 t80 -133.59 86.06 2.26 Favored 'General case' 0 N--CA 1.455 -0.188 0 C-N-CA 125.678 1.591 . . . . 0.0 107.264 176.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 31.2 m120 -87.7 146.65 25.59 Favored 'General case' 0 CA--C 1.52 -0.188 0 N-CA-C 109.004 -0.739 . . . . 0.0 109.004 -174.923 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 147.25 -164.77 28.66 Favored Glycine 0 CA--C 1.528 0.85 0 CA-C-O 119.052 -0.86 . . . . 0.0 111.101 174.873 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 56.3 Cg_endo -64.09 146.85 64.48 Favored 'Cis proline' 0 N--CA 1.458 -0.599 0 CA-C-N 118.155 0.978 . . . . 0.0 110.744 -0.572 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -135.5 126.46 17.17 Favored Pre-proline 0 CA--C 1.532 0.265 0 C-N-CA 124.91 1.284 . . . . 0.0 108.168 177.433 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 89.7 Cg_endo -72.66 162.6 40.83 Favored 'Trans proline' 0 N--CA 1.452 -0.932 0 C-N-CA 122.426 2.084 . . . . 0.0 108.936 177.792 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 62.7 Cg_endo -67.55 119.0 6.01 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 121.634 1.556 . . . . 0.0 108.575 175.48 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.9 Cg_endo . . . . . 0 C--O 1.251 1.138 0 C-N-CA 121.969 1.78 . . . . 0.0 110.874 -176.587 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.274 0 N-CA-C 111.33 -0.708 . . . . 0.0 111.33 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 35.3 tt0 -97.88 139.34 33.88 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 108.478 -0.934 . . . . 0.0 108.478 172.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER 87.08 115.52 0.04 OUTLIER 'General case' 0 N--CA 1.472 0.639 0 C-N-CA 129.443 3.097 . . . . 0.0 108.384 167.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.0 tp10 -160.99 158.78 28.56 Favored 'General case' 0 C--O 1.235 0.302 0 CA-C-N 118.761 0.71 . . . . 0.0 110.694 -177.997 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 14.6 mm -64.93 148.34 12.04 Favored 'Isoleucine or valine' 0 CA--C 1.534 0.334 0 C-N-CA 124.906 1.282 . . . . 0.0 108.801 171.435 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 43.7 pt -114.08 152.06 15.8 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.445 0 C-N-CA 125.145 1.378 . . . . 0.0 108.852 170.875 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -82.12 125.62 31.07 Favored 'General case' 0 N--CA 1.452 -0.367 0 N-CA-C 109.269 -0.641 . . . . 0.0 109.269 -175.364 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 35.7 pt -60.19 132.79 25.69 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.977 0 N-CA-C 108.272 -1.01 . . . . 0.0 108.272 166.871 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 170.61 -176.22 44.2 Favored Glycine 0 CA--C 1.529 0.919 0 N-CA-C 106.848 -2.501 . . . . 0.0 106.848 -169.635 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 14.1 Cg_endo -52.1 -49.04 18.68 Favored 'Trans proline' 0 N--CA 1.459 -0.54 0 C-N-CA 123.71 2.94 . . . . 0.0 113.237 -169.773 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 57.4 t80 -54.31 -56.06 22.21 Favored 'General case' 0 CA--C 1.537 0.477 0 CA-C-O 122.153 0.978 . . . . 0.0 110.849 178.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 3.2 m -64.94 -39.27 93.25 Favored 'General case' 0 N--CA 1.45 -0.439 0 C-N-CA 124.383 1.073 . . . . 0.0 110.497 -175.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 41.8 mt-30 -59.28 -46.73 87.74 Favored 'General case' 0 N--CA 1.444 -0.733 0 C-N-CA 123.437 0.695 . . . . 0.0 109.813 173.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 44.2 t30 -57.0 -46.7 82.11 Favored 'General case' 0 C--O 1.226 -0.135 0 CA-C-N 118.592 0.633 . . . . 0.0 110.633 176.622 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 95.0 mt -57.27 -46.07 83.45 Favored 'General case' 0 CA--C 1.535 0.37 0 O-C-N 122.209 -0.307 . . . . 0.0 110.64 174.926 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.49 -51.84 53.89 Favored Glycine 0 CA--C 1.531 1.071 0 N-CA-C 111.596 -0.601 . . . . 0.0 111.596 176.788 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.5 tmtp? -57.4 -48.02 80.19 Favored 'General case' 0 N--CA 1.441 -0.908 0 C-N-CA 125.539 1.535 . . . . 0.0 109.063 179.879 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.6 t80 -55.21 -47.44 75.28 Favored 'General case' 0 C--N 1.33 -0.278 0 C-N-CA 124.705 1.202 . . . . 0.0 110.702 175.718 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -56.19 -53.4 57.64 Favored 'General case' 0 C--O 1.232 0.175 0 CA-C-O 121.672 0.749 . . . . 0.0 110.274 177.142 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.2 t -61.55 -39.81 84.33 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.252 0 CA-C-N 115.323 -0.853 . . . . 0.0 110.125 -179.535 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 19.3 t70 -63.62 -48.86 75.6 Favored 'General case' 0 N--CA 1.449 -0.483 0 C-N-CA 124.817 1.247 . . . . 0.0 109.494 -178.544 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 7.9 tp10 -55.99 -51.73 66.72 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 175.105 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 38.8 tt0 -58.71 -46.08 88.12 Favored 'General case' 0 N--CA 1.453 -0.298 0 C-N-CA 120.653 -0.419 . . . . 0.0 111.111 -178.45 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 5.3 m-80 -59.26 -45.63 90.69 Favored 'General case' 0 N--CA 1.453 -0.286 0 C-N-CA 124.182 0.993 . . . . 0.0 109.495 177.395 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 86.6 tttt -61.35 -45.29 95.01 Favored 'General case' 0 N--CA 1.454 -0.235 0 C-N-CA 123.446 0.698 . . . . 0.0 110.351 -175.944 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 74.5 mt -70.39 -43.27 78.39 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.474 0 N-CA-C 109.666 -0.494 . . . . 0.0 109.666 176.024 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 92.78 14.18 55.53 Favored Glycine 0 CA--C 1.529 0.953 0 C-N-CA 124.726 1.155 . . . . 0.0 112.863 174.708 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 44.8 mm-40 -50.32 -44.43 54.21 Favored 'General case' 0 N--CA 1.465 0.287 0 CA-C-N 118.232 1.016 . . . . 0.0 111.995 -177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.8 m-85 -113.09 34.79 4.25 Favored 'General case' 0 CA--C 1.534 0.349 0 CA-C-O 121.75 0.786 . . . . 0.0 110.099 176.895 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 61.93 -143.43 48.64 Favored Glycine 0 CA--C 1.53 1.009 0 N-CA-C 110.914 -0.874 . . . . 0.0 110.914 -179.267 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 37.0 ttm105 -100.19 124.23 45.37 Favored 'General case' 0 CA--C 1.53 0.191 0 C-N-CA 124.292 1.037 . . . . 0.0 108.961 -177.172 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 1.9 mp -126.53 134.9 50.76 Favored 'General case' 0 C--N 1.339 0.144 0 C-N-CA 124.111 0.964 . . . . 0.0 110.289 -178.525 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 16.0 m -95.59 99.02 10.94 Favored 'General case' 0 N--CA 1.453 -0.3 0 C-N-CA 125.032 1.333 . . . . 0.0 108.994 -174.901 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 66.1 t80 -45.41 122.83 3.73 Favored 'General case' 0 N--CA 1.461 0.121 0 C-N-CA 122.892 0.477 . . . . 0.0 110.712 173.891 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -95.15 -61.0 1.56 Allowed 'General case' 0 C--N 1.331 -0.229 0 N-CA-C 106.938 -1.504 . . . . 0.0 106.938 175.309 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.7 ttmt -169.52 -165.63 0.53 Allowed 'General case' 0 CA--C 1.531 0.215 0 N-CA-C 108.917 -0.771 . . . . 0.0 108.917 175.752 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 12.4 p -121.19 149.85 24.2 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.559 0 C-N-CA 126.342 1.857 . . . . 0.0 107.327 169.032 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 5.0 pt -142.55 160.33 19.11 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.316 0 N-CA-C 109.451 -0.574 . . . . 0.0 109.451 178.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 60.5 mtp180 -66.72 154.42 91.67 Favored Pre-proline 0 CA--C 1.537 0.474 0 CA-C-N 115.73 -0.668 . . . . 0.0 110.515 178.838 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 61.2 Cg_endo -72.65 141.85 72.59 Favored 'Cis proline' 0 N--CA 1.455 -0.76 0 CA-C-N 118.89 0.639 . . . . 0.0 111.322 0.176 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 73.9 m -132.91 108.87 9.21 Favored 'General case' 0 CA--C 1.509 -0.628 0 N-CA-C 103.515 -2.772 . . . . 0.0 103.515 174.36 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 8.4 ttt -133.57 143.46 48.69 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 119.148 0.885 . . . . 0.0 109.529 -167.83 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 55.5 pttt -119.48 144.44 46.99 Favored 'General case' 0 N--CA 1.464 0.228 0 CA-C-N 118.057 0.39 . . . . 0.0 111.95 -177.737 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 20.5 ttpp -121.37 149.53 42.83 Favored 'General case' 0 N--CA 1.457 -0.101 0 N-CA-C 108.868 -0.79 . . . . 0.0 108.868 170.351 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 57.2 m -80.77 137.97 36.27 Favored 'General case' 0 CA--C 1.532 0.252 0 N-CA-C 108.93 -0.767 . . . . 0.0 108.93 173.13 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -111.62 132.02 61.35 Favored 'Isoleucine or valine' 0 C--O 1.235 0.318 0 C-N-CA 125.205 1.402 . . . . 0.0 108.211 178.683 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 49.0 p90 -168.2 176.78 5.8 Favored 'General case' 0 N--CA 1.45 -0.445 0 O-C-N 121.448 -0.782 . . . . 0.0 110.217 -167.58 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.8 tm-20 -159.53 170.92 20.63 Favored 'General case' 0 N--CA 1.444 -0.729 0 N-CA-C 106.4 -1.704 . . . . 0.0 106.4 179.399 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 52.9 m-20 -79.08 -59.3 2.83 Favored 'General case' 0 N--CA 1.452 -0.358 0 C-N-CA 124.152 0.981 . . . . 0.0 109.384 179.597 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.3 tp10 45.72 55.51 6.75 Favored 'General case' 0 CA--C 1.534 0.349 0 C-N-CA 124.594 1.158 . . . . 0.0 109.796 -174.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 73.96 -71.33 1.42 Allowed Glycine 0 CA--C 1.527 0.829 0 N-CA-C 110.795 -0.922 . . . . 0.0 110.795 -171.197 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -115.47 103.18 10.51 Favored 'General case' 0 CA--C 1.532 0.253 0 C-N-CA 124.205 1.002 . . . . 0.0 110.414 -174.668 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 22.1 ptt-85 -28.72 126.24 0.1 Allowed 'General case' 0 CA--C 1.533 0.322 0 C-N-CA 127.283 2.233 . . . . 0.0 114.238 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 40.1 tt0 -151.95 134.63 15.48 Favored 'General case' 0 N--CA 1.449 -0.52 0 N-CA-C 108.81 -0.811 . . . . 0.0 108.81 175.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 23.4 mm -64.5 127.14 24.7 Favored 'Isoleucine or valine' 0 CA--C 1.53 0.201 0 N-CA-C 109.481 -0.563 . . . . 0.0 109.481 172.715 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 14.4 ptpt -100.44 -25.16 14.3 Favored 'General case' 0 C--N 1.34 0.195 0 CA-C-N 118.227 0.467 . . . . 0.0 111.431 179.975 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -179.73 -164.49 32.17 Favored Glycine 0 C--N 1.337 0.591 0 CA-C-N 118.649 0.659 . . . . 0.0 111.461 -173.761 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 24.4 m-85 -144.22 164.77 29.75 Favored 'General case' 0 N--CA 1.449 -0.484 0 C-N-CA 125.038 1.335 . . . . 0.0 107.561 174.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 23.4 pt-20 -127.4 145.19 50.9 Favored 'General case' 0 N--CA 1.444 -0.732 0 C-N-CA 124.063 0.945 . . . . 0.0 108.816 167.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 17.5 m-85 -120.2 119.12 32.32 Favored 'General case' 0 N--CA 1.447 -0.601 0 N-CA-C 105.233 -2.136 . . . . 0.0 105.233 -179.106 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 31.5 tt0 -114.84 105.36 12.92 Favored 'General case' 0 N--CA 1.451 -0.409 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 -176.592 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -134.12 143.41 47.95 Favored 'General case' 0 N--CA 1.457 -0.12 0 C-N-CA 123.819 0.848 . . . . 0.0 111.191 -168.974 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 35.5 m-85 -87.71 110.12 20.2 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 109.516 -0.55 . . . . 0.0 109.516 174.108 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 8.1 p -95.24 139.43 18.8 Favored 'Isoleucine or valine' 0 N--CA 1.448 -0.541 0 C-N-CA 124.502 1.121 . . . . 0.0 108.824 178.326 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 6.4 t80 -108.38 120.81 43.48 Favored 'General case' 0 N--CA 1.448 -0.568 0 N-CA-C 106.91 -1.515 . . . . 0.0 106.91 178.612 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -143.94 132.88 22.72 Favored 'General case' 0 N--CA 1.453 -0.29 0 N-CA-C 108.184 -1.043 . . . . 0.0 108.184 -177.043 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 60.1 m 46.81 45.08 14.81 Favored 'General case' 0 CA--C 1.535 0.39 0 C-N-CA 124.117 0.967 . . . . 0.0 111.309 -175.358 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 5.8 t70 63.57 10.89 5.26 Favored 'General case' 0 CA--C 1.541 0.625 0 C-N-CA 125.105 1.362 . . . . 0.0 113.656 178.919 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 12.7 mptt -110.52 140.22 45.02 Favored 'General case' 0 N--CA 1.456 -0.16 0 C-N-CA 125.227 1.411 . . . . 0.0 107.94 -179.129 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 11.1 tp -98.69 120.47 39.18 Favored 'General case' 0 N--CA 1.454 -0.267 0 C-N-CA 124.135 0.974 . . . . 0.0 109.018 178.611 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 83.4 m-85 -123.18 154.28 38.92 Favored 'General case' 0 N--CA 1.457 -0.084 0 C-N-CA 124.961 1.304 . . . . 0.0 108.638 176.056 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 21.7 ttt180 -96.45 128.79 43.71 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 108.614 -0.884 . . . . 0.0 108.614 172.647 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -113.11 126.92 55.99 Favored 'General case' 0 N--CA 1.453 -0.287 0 C-N-CA 124.809 1.244 . . . . 0.0 107.903 172.14 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 50.0 t0 -112.64 100.92 9.09 Favored 'General case' 0 N--CA 1.45 -0.445 0 N-CA-C 106.224 -1.769 . . . . 0.0 106.224 173.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 29.7 mm -96.21 147.34 6.17 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 C-N-CA 125.727 1.611 . . . . 0.0 107.51 178.829 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 58.2 m -121.44 148.43 44.43 Favored 'General case' 0 CA--C 1.518 -0.257 0 N-CA-C 109.654 -0.499 . . . . 0.0 109.654 170.244 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -122.9 120.83 34.61 Favored 'General case' 0 N--CA 1.453 -0.305 0 C-N-CA 127.714 2.406 . . . . 0.0 106.194 174.054 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 8.8 m-20 -97.27 115.72 28.16 Favored 'General case' 0 N--CA 1.452 -0.354 0 N-CA-C 106.995 -1.483 . . . . 0.0 106.995 177.585 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 12.4 t80 -63.48 -45.9 88.64 Favored 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 125.9 1.68 . . . . 0.0 110.701 -169.861 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 11.8 tppt? -64.68 -50.21 67.89 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 122.83 0.452 . . . . 0.0 110.082 -176.693 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 1.3 m -62.9 -35.18 79.2 Favored 'General case' 0 N--CA 1.453 -0.289 0 C-N-CA 124.063 0.945 . . . . 0.0 110.15 175.171 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 5.2 ttm-85 55.31 48.07 20.02 Favored 'General case' 0 N--CA 1.445 -0.724 0 C-N-CA 126.782 2.033 . . . . 0.0 110.141 -168.702 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -137.02 155.13 22.58 Favored Glycine 0 C--N 1.334 0.433 0 N-CA-C 108.426 -1.87 . . . . 0.0 108.426 177.404 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 57.3 mtt85 -115.61 170.23 8.59 Favored 'General case' 0 N--CA 1.45 -0.449 0 C-N-CA 123.447 0.699 . . . . 0.0 111.124 179.006 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 6.3 pttm -165.29 149.08 8.41 Favored 'General case' 0 N--CA 1.448 -0.553 0 C-N-CA 124.544 1.138 . . . . 0.0 111.183 -179.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 56.9 tp -63.73 117.2 6.54 Favored 'General case' 0 N--CA 1.449 -0.492 0 N-CA-C 107.981 -1.118 . . . . 0.0 107.981 168.567 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 10.2 tp -85.0 -54.72 4.46 Favored 'General case' 0 N--CA 1.454 -0.249 0 N-CA-C 108.366 -0.976 . . . . 0.0 108.366 174.173 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.6 mpp_? -142.79 155.33 44.8 Favored 'General case' 0 C--N 1.339 0.13 0 N-CA-C 109.177 -0.675 . . . . 0.0 109.177 174.541 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 14.7 t80 -133.05 134.2 44.05 Favored 'General case' 0 N--CA 1.452 -0.349 0 N-CA-C 104.829 -2.286 . . . . 0.0 104.829 167.43 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 28.6 m120 -141.68 155.42 45.68 Favored 'General case' 0 N--CA 1.448 -0.532 0 N-CA-C 108.343 -0.984 . . . . 0.0 108.343 -174.748 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 123.28 -164.99 16.08 Favored Glycine 0 CA--C 1.531 1.067 0 N-CA-C 110.955 -0.858 . . . . 0.0 110.955 177.942 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 72.7 Cg_endo -69.11 154.68 91.6 Favored 'Cis proline' 0 N--CA 1.455 -0.739 0 CA-C-N 118.249 1.025 . . . . 0.0 110.275 1.318 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 2.1 m -138.61 133.47 16.84 Favored Pre-proline 0 CA--C 1.531 0.222 0 N-CA-C 108.718 -0.845 . . . . 0.0 108.718 174.423 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 90.6 Cg_endo -72.69 154.18 54.3 Favored 'Trans proline' 0 N--CA 1.454 -0.851 0 C-N-CA 121.696 1.597 . . . . 0.0 109.355 175.778 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 94.4 Cg_endo -68.81 155.21 69.41 Favored 'Trans proline' 0 N--CA 1.452 -0.925 0 C-N-CA 122.097 1.865 . . . . 0.0 109.374 171.186 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 71.3 Cg_endo . . . . . 0 C--O 1.25 1.087 0 C-N-CA 122.566 2.177 . . . . 0.0 110.736 176.901 . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 1.117 0 N-CA-C 110.98 -0.848 . . . . 0.0 110.98 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 50.1 mt-10 -138.29 90.49 2.47 Favored 'General case' 0 CA--C 1.529 0.157 0 C-N-CA 124.155 0.982 . . . . 0.0 109.153 -176.085 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 32.5 t-105 -159.32 110.7 2.06 Favored 'General case' 0 N--CA 1.456 -0.148 0 C-N-CA 125.94 1.696 . . . . 0.0 107.034 170.828 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 3.7 tp10 -164.37 166.67 20.5 Favored 'General case' 0 N--CA 1.452 -0.34 0 N-CA-C 108.259 -1.015 . . . . 0.0 108.259 -179.903 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 2.2 mp -68.25 141.69 17.28 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.349 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 170.833 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 2.8 pp -122.74 157.95 27.47 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.476 0 C-N-CA 123.837 0.855 . . . . 0.0 109.902 177.283 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.6 m-20 -69.99 148.56 48.73 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 123.385 0.674 . . . . 0.0 109.709 -177.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.1 pp -84.11 137.63 20.57 Favored 'Isoleucine or valine' 0 N--CA 1.441 -0.909 0 N-CA-C 107.576 -1.268 . . . . 0.0 107.576 167.061 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 173.31 -171.24 44.33 Favored Glycine 0 CA--C 1.528 0.898 0 N-CA-C 107.901 -2.08 . . . . 0.0 107.901 -170.18 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -54.03 -42.72 64.54 Favored 'Trans proline' 0 N--CA 1.458 -0.596 0 C-N-CA 123.635 2.89 . . . . 0.0 113.006 -172.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 82.0 t80 -58.25 -52.88 63.74 Favored 'General case' 0 CA--C 1.536 0.407 0 CA-C-O 122.087 0.946 . . . . 0.0 111.053 177.198 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -66.75 -41.38 87.87 Favored 'General case' 0 C--N 1.329 -0.286 0 C-N-CA 123.74 0.816 . . . . 0.0 109.63 -175.829 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 92.1 mt-30 -57.38 -50.77 71.92 Favored 'General case' 0 N--CA 1.444 -0.773 0 C-N-CA 123.577 0.751 . . . . 0.0 109.875 172.788 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 9.4 t-20 -48.96 -54.9 13.59 Favored 'General case' 0 N--CA 1.465 0.291 0 C-N-CA 124.262 1.025 . . . . 0.0 109.828 175.558 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 25.4 mt -55.37 -44.34 75.94 Favored 'General case' 0 CA--C 1.531 0.221 0 CA-C-N 117.517 0.144 . . . . 0.0 111.157 177.079 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -58.27 -53.63 44.21 Favored Glycine 0 CA--C 1.534 1.227 0 C-N-CA 123.283 0.468 . . . . 0.0 112.31 177.982 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 2.9 mptm? -55.88 -47.84 76.65 Favored 'General case' 0 N--CA 1.443 -0.807 0 C-N-CA 124.457 1.103 . . . . 0.0 109.286 177.559 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 8.3 t80 -56.85 -48.32 78.37 Favored 'General case' 0 N--CA 1.448 -0.57 0 C-N-CA 123.604 0.762 . . . . 0.0 110.412 179.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -58.13 -51.19 70.73 Favored 'General case' 0 N--CA 1.451 -0.378 0 N-CA-C 110.056 -0.35 . . . . 0.0 110.056 179.156 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 78.5 t -63.99 -37.74 80.6 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.219 0 CA-C-N 116.421 -0.354 . . . . 0.0 110.66 -179.422 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 16.2 t70 -61.73 -49.7 75.37 Favored 'General case' 0 N--CA 1.453 -0.322 0 C-N-CA 124.238 1.015 . . . . 0.0 109.843 179.147 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 1.3 tt0 -59.3 -49.52 77.5 Favored 'General case' 0 N--CA 1.453 -0.299 0 C-N-CA 123.471 0.708 . . . . 0.0 109.328 177.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 3.1 tm-20 -53.38 -50.32 65.37 Favored 'General case' 0 C--O 1.225 -0.233 0 N-CA-C 109.739 -0.467 . . . . 0.0 109.739 177.852 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 2.4 m-80 -57.65 -48.32 79.81 Favored 'General case' 0 N--CA 1.454 -0.252 0 C-N-CA 124.301 1.04 . . . . 0.0 109.945 178.543 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 80.6 tttt -60.95 -38.95 87.7 Favored 'General case' 0 N--CA 1.452 -0.349 0 C-N-CA 122.528 0.331 . . . . 0.0 110.632 -174.431 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 75.7 mt -73.87 -52.83 19.35 Favored 'Isoleucine or valine' 0 CA--C 1.538 0.484 0 N-CA-C 109.783 -0.451 . . . . 0.0 109.783 174.692 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 97.07 13.18 46.91 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 125.46 1.505 . . . . 0.0 113.701 173.257 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 74.3 mt-30 -53.05 -43.68 66.85 Favored 'General case' 0 N--CA 1.465 0.276 0 CA-C-N 118.594 1.197 . . . . 0.0 112.041 -177.494 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 73.7 m-85 -108.24 36.42 2.81 Favored 'General case' 0 CA--C 1.532 0.258 0 C-N-CA 123.598 0.759 . . . . 0.0 110.005 175.206 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 63.97 -149.63 50.59 Favored Glycine 0 CA--C 1.527 0.825 0 N-CA-C 110.896 -0.882 . . . . 0.0 110.896 -177.375 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 78.7 mtt180 -111.16 76.99 1.01 Allowed 'General case' 0 N--CA 1.454 -0.253 0 C-N-CA 124.557 1.143 . . . . 0.0 108.802 -169.317 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 58.8 mt -73.7 139.51 45.39 Favored 'General case' 0 CA--C 1.531 0.217 0 C-N-CA 122.776 0.43 . . . . 0.0 111.448 -172.364 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 17.2 m -93.42 104.3 16.46 Favored 'General case' 0 N--CA 1.455 -0.218 0 N-CA-C 108.39 -0.967 . . . . 0.0 108.39 -179.133 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 27.8 t80 -48.98 133.53 18.02 Favored 'General case' 0 N--CA 1.462 0.161 0 N-CA-C 109.892 -0.41 . . . . 0.0 109.892 173.42 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 3.6 t-20 -106.79 -65.39 1.09 Allowed 'General case' 0 C--N 1.33 -0.245 0 C-N-CA 123.57 0.748 . . . . 0.0 109.058 176.351 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 10.9 ptpp? -167.11 164.43 15.77 Favored 'General case' 0 C--O 1.226 -0.153 0 C-N-CA 124.689 1.196 . . . . 0.0 109.017 178.587 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 8.9 p -109.43 141.42 24.77 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.173 0 C-N-CA 124.354 1.062 . . . . 0.0 108.958 172.077 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -141.24 168.49 15.79 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.256 0 C-N-CA 123.369 0.668 . . . . 0.0 110.67 -176.639 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.59 154.66 79.11 Favored Pre-proline 0 CA--C 1.537 0.461 0 C-N-CA 124.11 0.964 . . . . 0.0 110.864 -176.767 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 72.4 Cg_endo -76.03 137.67 50.79 Favored 'Cis proline' 0 N--CA 1.459 -0.523 0 CA-C-N 119.539 0.871 . . . . 0.0 111.746 -3.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 68.9 m -126.77 121.18 31.23 Favored 'General case' 0 CA--C 1.517 -0.316 0 N-CA-C 107.286 -1.375 . . . . 0.0 107.286 176.797 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 5.2 ttm -138.77 138.71 37.86 Favored 'General case' 0 C--N 1.333 -0.149 0 C-N-CA 123.199 0.6 . . . . 0.0 109.75 -167.577 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 17.9 ptmt -121.29 142.95 49.46 Favored 'General case' 0 CA--C 1.52 -0.204 0 CA-C-O 117.995 -1.002 . . . . 0.0 109.999 177.836 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 46.4 tttm -132.14 141.55 49.17 Favored 'General case' 0 CA--C 1.528 0.113 0 C-N-CA 123.927 0.891 . . . . 0.0 110.153 173.491 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 98.4 m -76.23 141.21 41.81 Favored 'General case' 0 CA--C 1.532 0.251 0 C-N-CA 122.362 0.265 . . . . 0.0 110.989 176.044 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.1 mp -110.56 123.72 66.71 Favored 'Isoleucine or valine' 0 C--O 1.235 0.34 0 C-N-CA 125.772 1.629 . . . . 0.0 109.19 -179.752 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 59.2 m-85 -103.82 168.03 9.4 Favored 'General case' 0 N--CA 1.455 -0.2 0 C-N-CA 125.305 1.442 . . . . 0.0 110.693 -176.393 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 1.2 mm-40 -123.19 155.86 36.26 Favored 'General case' 0 N--CA 1.442 -0.827 0 C-N-CA 125.147 1.379 . . . . 0.0 108.233 168.027 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 49.5 t-20 -113.44 -36.6 4.91 Favored 'General case' 0 C--N 1.325 -0.496 0 C-N-CA 128.949 2.9 . . . . 0.0 109.094 -177.075 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 37.2 tt0 -68.55 77.29 0.28 Allowed 'General case' 0 CA--C 1.535 0.378 0 C-N-CA 124.082 0.953 . . . . 0.0 110.58 -178.912 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 167.67 -69.07 0.18 Allowed Glycine 0 CA--C 1.52 0.4 0 N-CA-C 108.512 -1.835 . . . . 0.0 108.512 176.748 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -167.03 -59.14 0.03 OUTLIER 'General case' 0 CA--C 1.53 0.185 0 C-N-CA 124.684 1.193 . . . . 0.0 108.597 173.551 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 29.9 ttm180 -179.82 121.61 0.07 Allowed 'General case' 0 N--CA 1.455 -0.176 0 C-N-CA 126.782 2.033 . . . . 0.0 105.594 179.275 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 5.7 tt0 -163.97 161.53 22.84 Favored 'General case' 0 N--CA 1.455 -0.219 0 CA-C-N 119.203 0.91 . . . . 0.0 110.079 171.506 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.7 mt -75.56 131.27 35.26 Favored 'Isoleucine or valine' 0 CA--C 1.531 0.224 0 N-CA-C 107.731 -1.211 . . . . 0.0 107.731 170.286 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 27.8 tttp -99.43 -34.62 10.2 Favored 'General case' 0 CA--C 1.532 0.271 0 C-N-CA 123.354 0.661 . . . . 0.0 109.936 173.427 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -178.6 -157.64 19.61 Favored Glycine 0 N--CA 1.448 -0.52 0 N-CA-C 109.969 -1.253 . . . . 0.0 109.969 -172.452 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -142.96 160.0 41.18 Favored 'General case' 0 N--CA 1.449 -0.483 0 N-CA-C 108.341 -0.985 . . . . 0.0 108.341 -179.348 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 67.7 mt-10 -123.14 150.28 43.47 Favored 'General case' 0 N--CA 1.453 -0.324 0 C-N-CA 125.354 1.461 . . . . 0.0 109.05 170.739 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 83.0 m-85 -133.81 123.59 25.08 Favored 'General case' 0 N--CA 1.446 -0.638 0 N-CA-C 105.402 -2.073 . . . . 0.0 105.402 -178.663 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 30.6 tt0 -122.21 127.9 50.54 Favored 'General case' 0 N--CA 1.45 -0.439 0 N-CA-C 107.861 -1.162 . . . . 0.0 107.861 178.621 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -154.77 158.08 38.96 Favored 'General case' 0 N--CA 1.451 -0.398 0 CA-C-O 120.94 0.4 . . . . 0.0 110.839 -174.415 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 3.6 m-85 -96.63 112.74 24.37 Favored 'General case' 0 N--CA 1.448 -0.532 0 C-N-CA 123.998 0.919 . . . . 0.0 109.355 176.88 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 9.3 p -103.28 132.45 49.53 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.275 0 C-N-CA 124.091 0.956 . . . . 0.0 109.543 178.985 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 0.5 OUTLIER -87.72 119.95 28.56 Favored 'General case' 0 N--CA 1.447 -0.59 0 N-CA-C 107.458 -1.312 . . . . 0.0 107.458 169.655 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -131.84 127.6 36.93 Favored 'General case' 0 N--CA 1.452 -0.345 0 N-CA-C 107.493 -1.299 . . . . 0.0 107.493 174.549 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.7 t 53.06 39.81 30.15 Favored 'General case' 0 CA--C 1.54 0.568 0 C-N-CA 123.58 0.752 . . . . 0.0 111.001 -177.801 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 24.8 t0 53.45 28.1 7.2 Favored 'General case' 0 CA--C 1.54 0.592 0 C-N-CA 125.064 1.345 . . . . 0.0 113.245 -175.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 73.2 mmtt -118.61 134.88 54.77 Favored 'General case' 0 N--CA 1.453 -0.289 0 N-CA-C 107.48 -1.304 . . . . 0.0 107.48 169.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 9.2 tp -89.73 128.37 36.1 Favored 'General case' 0 N--CA 1.453 -0.284 0 N-CA-C 108.798 -0.815 . . . . 0.0 108.798 -178.493 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 50.1 m-85 -129.32 139.87 51.6 Favored 'General case' 0 CA--C 1.529 0.14 0 C-N-CA 124.992 1.317 . . . . 0.0 109.711 -179.303 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 19.8 tpt180 -88.19 108.2 19.16 Favored 'General case' 0 C--O 1.238 0.475 0 C-N-CA 124.868 1.267 . . . . 0.0 108.566 177.47 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -105.57 134.6 48.42 Favored 'General case' 0 N--CA 1.452 -0.339 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 -179.878 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 9.9 t70 -123.63 125.24 44.47 Favored 'General case' 0 C--O 1.233 0.228 0 C-N-CA 125.517 1.527 . . . . 0.0 107.608 176.099 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 5.1 mp -126.09 146.74 31.37 Favored 'Isoleucine or valine' 0 N--CA 1.452 -0.342 0 C-N-CA 126.004 1.721 . . . . 0.0 108.132 -173.225 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -110.5 161.16 15.96 Favored 'General case' 0 N--CA 1.454 -0.233 0 C-N-CA 123.912 0.885 . . . . 0.0 108.744 173.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -142.66 119.33 11.1 Favored 'General case' 0 CA--C 1.537 0.466 0 N-CA-C 105.817 -1.919 . . . . 0.0 105.817 174.392 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 11.9 t0 -97.32 122.06 39.92 Favored 'General case' 0 C--O 1.232 0.155 0 C-N-CA 124.729 1.212 . . . . 0.0 109.837 -174.883 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 73.1 t80 -58.04 -39.38 78.25 Favored 'General case' 0 N--CA 1.454 -0.265 0 C-N-CA 123.27 0.628 . . . . 0.0 112.423 -175.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 26.9 mtpp -56.48 -51.62 67.77 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.153 0.581 . . . . 0.0 111.039 -171.187 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 11.6 p -107.31 4.81 26.89 Favored 'General case' 0 N--CA 1.449 -0.48 0 C-N-CA 124.547 1.139 . . . . 0.0 111.555 -173.481 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 47.9 ptt85 46.78 40.72 9.28 Favored 'General case' 0 CA--C 1.535 0.379 0 C-N-CA 124.809 1.244 . . . . 0.0 110.185 -168.618 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -95.88 125.31 8.36 Favored Glycine 0 C--N 1.338 0.691 0 CA-C-N 115.678 -0.692 . . . . 0.0 111.6 -167.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 26.0 mmt85 -78.66 175.07 10.75 Favored 'General case' 0 CA--C 1.53 0.196 0 C-N-CA 124.617 1.167 . . . . 0.0 109.952 171.555 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER 165.67 118.85 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.534 0 C-N-CA 126.994 2.117 . . . . 0.0 113.512 -167.891 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 19.1 tp -65.82 132.1 47.88 Favored 'General case' 0 N--CA 1.456 -0.167 0 N-CA-C 107.955 -1.128 . . . . 0.0 107.955 169.486 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 7.7 mt -87.89 -62.58 1.46 Allowed 'General case' 0 N--CA 1.455 -0.22 0 N-CA-C 107.8 -1.185 . . . . 0.0 107.8 167.751 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.3 mtm180 -145.65 151.95 38.87 Favored 'General case' 0 CA--C 1.528 0.099 0 C-N-CA 123.322 0.649 . . . . 0.0 109.699 -175.217 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 67.8 t80 -135.46 115.12 12.8 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 105.904 -1.887 . . . . 0.0 105.904 176.345 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -127.39 143.12 51.26 Favored 'General case' 0 N--CA 1.453 -0.281 0 C-N-CA 123.662 0.785 . . . . 0.0 108.893 -167.809 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 140.0 -157.69 25.49 Favored Glycine 0 CA--C 1.529 0.948 0 N-CA-C 109.871 -1.291 . . . . 0.0 109.871 177.232 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 74.0 Cg_endo -66.79 156.75 82.75 Favored 'Cis proline' 0 N--CA 1.457 -0.624 0 CA-C-N 118.757 1.279 . . . . 0.0 110.123 -1.973 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 18.7 m -120.46 135.98 24.94 Favored Pre-proline 0 CA--C 1.535 0.395 0 N-CA-C 108.292 -1.003 . . . . 0.0 108.292 169.638 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 94.1 Cg_endo -77.16 152.85 31.47 Favored 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.034 1.823 . . . . 0.0 108.772 171.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 97.8 Cg_endo -70.51 151.08 64.55 Favored 'Trans proline' 0 N--CA 1.452 -0.927 0 C-N-CA 121.824 1.682 . . . . 0.0 109.171 170.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 73.8 Cg_endo . . . . . 0 C--O 1.25 1.096 0 C-N-CA 122.479 2.119 . . . . 0.0 110.674 176.398 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 1.356 0 N-CA-C 111.316 -0.713 . . . . 0.0 111.316 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -135.01 59.38 1.74 Allowed 'General case' 0 CA--C 1.53 0.198 0 N-CA-C 107.012 -1.477 . . . . 0.0 107.012 172.519 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 1.0 OUTLIER 61.35 96.91 0.03 OUTLIER 'General case' 0 CA--C 1.532 0.254 0 C-N-CA 125.351 1.46 . . . . 0.0 110.737 -176.302 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 9.3 tp10 -149.38 154.92 39.66 Favored 'General case' 0 C--O 1.232 0.183 0 O-C-N 121.377 -0.827 . . . . 0.0 110.367 177.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 35.0 mt -72.65 132.57 33.22 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.48 0 N-CA-C 107.192 -1.41 . . . . 0.0 107.192 174.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 25.4 pt -99.14 153.79 4.18 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.319 0 C-N-CA 123.299 0.64 . . . . 0.0 110.7 -178.511 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -61.92 124.45 20.82 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 123.754 0.821 . . . . 0.0 108.791 177.449 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 0.8 OUTLIER -77.29 122.12 31.24 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 107.769 -1.197 . . . . 0.0 107.769 168.653 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 177.79 -160.47 26.98 Favored Glycine 0 CA--C 1.532 1.154 0 N-CA-C 108.585 -1.806 . . . . 0.0 108.585 -169.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 20.6 Cg_endo -58.44 -46.24 25.6 Favored 'Trans proline' 0 N--CA 1.458 -0.579 0 C-N-CA 122.865 2.377 . . . . 0.0 112.974 -170.908 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 83.6 t80 -53.07 -54.72 31.3 Favored 'General case' 0 CA--C 1.535 0.403 0 CA-C-O 122.31 1.052 . . . . 0.0 111.076 177.419 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -62.75 -47.46 83.47 Favored 'General case' 0 N--CA 1.448 -0.561 0 C-N-CA 124.963 1.305 . . . . 0.0 109.416 -177.231 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 60.3 mt-30 -53.74 -49.24 68.59 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 123.636 0.774 . . . . 0.0 110.025 175.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 51.1 t30 -55.94 -49.2 74.16 Favored 'General case' 0 CA--C 1.531 0.213 0 C-N-CA 123.315 0.646 . . . . 0.0 110.859 178.166 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 75.5 mt -60.27 -44.41 95.36 Favored 'General case' 0 CA--C 1.532 0.281 0 O-C-N 121.779 -0.576 . . . . 0.0 111.218 178.006 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -57.73 -47.53 87.98 Favored Glycine 0 CA--C 1.53 0.997 0 N-CA-C 111.084 -0.807 . . . . 0.0 111.084 176.033 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.4 mttm -52.84 -54.02 40.3 Favored 'General case' 0 N--CA 1.449 -0.49 0 C-N-CA 124.929 1.292 . . . . 0.0 109.793 175.868 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 50.3 t80 -55.95 -46.22 78.6 Favored 'General case' 0 N--CA 1.449 -0.514 0 C-N-CA 124.472 1.109 . . . . 0.0 110.623 179.462 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.02 -51.69 68.24 Favored 'General case' 0 N--CA 1.454 -0.247 0 CA-C-O 120.924 0.392 . . . . 0.0 110.467 177.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.91 -39.41 85.32 Favored 'Isoleucine or valine' 0 C--O 1.226 -0.167 0 CA-C-N 116.449 -0.341 . . . . 0.0 110.443 -179.46 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 21.0 t70 -61.57 -50.86 70.94 Favored 'General case' 0 N--CA 1.45 -0.427 0 C-N-CA 123.976 0.91 . . . . 0.0 109.479 -179.533 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 8.2 tp10 -56.15 -51.04 69.42 Favored 'General case' 0 N--CA 1.453 -0.311 0 C-N-CA 124.13 0.972 . . . . 0.0 109.286 176.907 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 4.7 tm-20 -57.04 -51.24 70.05 Favored 'General case' 0 N--CA 1.451 -0.379 0 N-CA-C 109.87 -0.418 . . . . 0.0 109.87 -179.02 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 7.0 m-20 -55.32 -44.22 75.64 Favored 'General case' 0 N--CA 1.451 -0.384 0 C-N-CA 124.759 1.224 . . . . 0.0 109.999 177.004 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 42.4 tttp -58.07 -42.63 85.93 Favored 'General case' 0 CA--C 1.532 0.273 0 C-N-CA 122.894 0.478 . . . . 0.0 110.414 -177.18 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 62.1 mt -73.41 -46.69 48.54 Favored 'Isoleucine or valine' 0 CA--C 1.537 0.473 0 N-CA-C 109.655 -0.498 . . . . 0.0 109.655 175.718 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 91.42 18.83 43.93 Favored Glycine 0 CA--C 1.527 0.821 0 C-N-CA 125.386 1.47 . . . . 0.0 112.716 174.435 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 96.3 mt-30 -54.42 -43.09 71.24 Favored 'General case' 0 N--CA 1.463 0.184 0 CA-C-N 118.378 1.089 . . . . 0.0 111.256 -178.079 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 1.2 m-85 -107.74 30.69 6.08 Favored 'General case' 0 CA--C 1.538 0.496 0 C-N-CA 123.938 0.895 . . . . 0.0 110.473 176.076 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 67.57 -152.15 52.49 Favored Glycine 0 CA--C 1.528 0.893 0 N-CA-C 111.184 -0.766 . . . . 0.0 111.184 179.935 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 1.8 mpt_? -100.01 118.24 35.98 Favored 'General case' 0 N--CA 1.454 -0.247 0 C-N-CA 124.118 0.967 . . . . 0.0 109.227 178.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 2.7 mp -109.28 -171.89 1.93 Allowed 'General case' 0 N--CA 1.454 -0.254 0 N-CA-C 108.159 -1.052 . . . . 0.0 108.159 167.721 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 85.0 m -141.36 125.4 17.24 Favored 'General case' 0 N--CA 1.446 -0.644 0 N-CA-C 106.259 -1.756 . . . . 0.0 106.259 173.327 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 41.5 t80 -55.03 132.6 47.51 Favored 'General case' 0 N--CA 1.453 -0.308 0 N-CA-C 109.639 -0.504 . . . . 0.0 109.639 179.273 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -107.66 -65.31 1.12 Allowed 'General case' 0 N--CA 1.456 -0.141 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.812 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -164.48 -175.78 4.05 Favored 'General case' 0 N--CA 1.464 0.248 0 C-N-CA 123.363 0.665 . . . . 0.0 110.842 173.107 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 34.1 t -120.72 141.19 42.21 Favored 'Isoleucine or valine' 0 C--O 1.231 0.087 0 N-CA-C 106.502 -1.666 . . . . 0.0 106.502 172.888 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.6 pp -140.43 168.25 17.24 Favored 'Isoleucine or valine' 0 CA--C 1.528 0.114 0 CA-C-N 118.477 0.581 . . . . 0.0 110.254 175.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -58.88 147.91 71.11 Favored Pre-proline 0 CA--C 1.54 0.595 0 C-N-CA 123.682 0.793 . . . . 0.0 111.658 -175.836 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 92.5 Cg_endo -78.31 153.31 91.93 Favored 'Cis proline' 0 N--CA 1.455 -0.787 0 CA-C-N 119.085 0.709 . . . . 0.0 111.058 -1.317 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 63.8 m -142.4 87.69 2.03 Favored 'General case' 0 N--CA 1.451 -0.416 0 N-CA-C 106.639 -1.615 . . . . 0.0 106.639 179.077 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 4.8 ttt -112.43 123.5 50.43 Favored 'General case' 0 CA--C 1.534 0.35 0 C-N-CA 123.149 0.58 . . . . 0.0 110.938 -167.606 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 56.4 tttp -100.23 136.37 40.24 Favored 'General case' 0 N--CA 1.464 0.231 0 CA-C-O 118.329 -0.843 . . . . 0.0 111.09 178.269 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 45.2 tttm -122.85 153.91 38.98 Favored 'General case' 0 CA--C 1.537 0.47 0 C-N-CA 126.227 1.811 . . . . 0.0 109.379 171.361 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 86.1 m -89.65 138.99 30.99 Favored 'General case' 0 CA--C 1.533 0.323 0 C-N-CA 124.417 1.087 . . . . 0.0 110.124 169.845 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 0.9 OUTLIER -107.64 122.71 62.3 Favored 'Isoleucine or valine' 0 C--O 1.237 0.416 0 C-N-CA 124.944 1.297 . . . . 0.0 109.31 178.624 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 45.2 p90 -140.16 161.44 37.63 Favored 'General case' 0 N--CA 1.449 -0.511 0 C-N-CA 123.848 0.859 . . . . 0.0 111.227 -177.764 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 30.4 mm-40 -106.19 162.24 13.82 Favored 'General case' 0 N--CA 1.443 -0.777 0 C-N-CA 125.675 1.59 . . . . 0.0 106.799 169.885 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 67.7 m-80 -55.68 -69.57 0.14 Allowed 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 125.326 1.45 . . . . 0.0 111.761 -170.997 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 8.9 tp10 57.15 -171.19 0.09 Allowed 'General case' 0 CA--C 1.542 0.66 0 C-N-CA 122.972 0.509 . . . . 0.0 109.758 -174.761 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . -76.27 9.28 20.89 Favored Glycine 0 CA--C 1.532 1.131 0 O-C-N 120.86 -1.15 . . . . 0.0 113.454 174.002 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 0.7 OUTLIER -163.69 -72.44 0.04 OUTLIER 'General case' 0 CA--C 1.53 0.188 0 CA-C-N 118.985 1.392 . . . . 0.0 108.126 174.343 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 3.9 mpt_? -163.0 138.74 6.94 Favored 'General case' 0 N--CA 1.455 -0.208 0 C-N-CA 126.703 2.001 . . . . 0.0 106.334 171.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 31.6 tt0 -114.33 95.37 5.24 Favored 'General case' 0 N--CA 1.447 -0.587 0 C-N-CA 126.061 1.744 . . . . 0.0 106.839 170.115 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 98.5 mt -64.47 115.08 2.64 Favored 'Isoleucine or valine' 0 N--CA 1.456 -0.142 0 N-CA-C 108.528 -0.916 . . . . 0.0 108.528 175.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 33.1 ttmt -91.17 -33.03 15.58 Favored 'General case' 0 N--CA 1.454 -0.246 0 N-CA-C 108.797 -0.816 . . . . 0.0 108.797 174.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . 177.54 -148.93 9.01 Favored Glycine 0 N--CA 1.445 -0.717 0 N-CA-C 111.335 -0.706 . . . . 0.0 111.335 -169.232 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 13.8 m-85 -147.54 169.06 20.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 C-N-CA 124.376 1.07 . . . . 0.0 109.531 -175.977 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 26.1 pt-20 -136.89 155.22 50.05 Favored 'General case' 0 N--CA 1.444 -0.757 0 C-N-CA 124.126 0.97 . . . . 0.0 110.203 167.381 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 32.7 m-85 -133.42 118.07 17.98 Favored 'General case' 0 N--CA 1.447 -0.583 0 N-CA-C 105.746 -1.946 . . . . 0.0 105.746 -175.395 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -112.59 107.95 16.86 Favored 'General case' 0 N--CA 1.453 -0.316 0 N-CA-C 106.204 -1.776 . . . . 0.0 106.204 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 1.2 pt? -150.34 152.63 34.71 Favored 'General case' 0 C--N 1.339 0.117 0 N-CA-C 112.768 0.655 . . . . 0.0 112.768 -169.286 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 18.6 m-85 -99.3 116.74 32.17 Favored 'General case' 0 N--CA 1.45 -0.444 0 C-N-CA 124.272 1.029 . . . . 0.0 110.552 -173.561 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 41.7 t -109.48 127.8 65.97 Favored 'Isoleucine or valine' 0 N--CA 1.454 -0.234 0 C-N-CA 126.06 1.744 . . . . 0.0 109.123 -172.731 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -84.66 114.97 22.4 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 108.357 -0.979 . . . . 0.0 108.357 170.278 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -119.42 121.81 40.33 Favored 'General case' 0 N--CA 1.453 -0.297 0 C-N-CA 124.9 1.28 . . . . 0.0 109.016 178.703 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 18.9 t 71.15 -67.93 0.24 Allowed 'General case' 0 N--CA 1.455 -0.218 0 C-N-CA 128.969 2.907 . . . . 0.0 107.058 -169.97 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -178.13 26.6 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.545 0 C-N-CA 128.295 2.638 . . . . 0.0 110.047 170.72 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 14.7 mptt -111.71 135.75 51.89 Favored 'General case' 0 C--O 1.232 0.16 0 N-CA-C 106.089 -1.819 . . . . 0.0 106.089 173.754 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 14.4 tp -86.9 124.44 33.11 Favored 'General case' 0 N--CA 1.449 -0.511 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 79.3 m-85 -120.5 145.19 47.52 Favored 'General case' 0 N--CA 1.456 -0.135 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 175.2 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 8.3 tmm_? -86.28 131.11 34.3 Favored 'General case' 0 N--CA 1.45 -0.446 0 N-CA-C 107.418 -1.327 . . . . 0.0 107.418 171.644 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -120.27 138.95 53.39 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.821 -0.807 . . . . 0.0 108.821 175.76 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 29.4 t0 -118.45 121.84 41.28 Favored 'General case' 0 N--CA 1.454 -0.256 0 N-CA-C 106.482 -1.673 . . . . 0.0 106.482 171.643 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 6.9 mm -120.84 150.44 23.72 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 C-N-CA 126.487 1.915 . . . . 0.0 106.255 -173.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 23.3 t -124.48 158.16 33.52 Favored 'General case' 0 N--CA 1.456 -0.128 0 CA-C-N 119.153 0.888 . . . . 0.0 109.612 168.045 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -130.77 133.55 46.09 Favored 'General case' 0 N--CA 1.454 -0.265 0 N-CA-C 106.876 -1.528 . . . . 0.0 106.876 170.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 13.9 t0 -103.15 118.98 38.0 Favored 'General case' 0 C--O 1.233 0.221 0 O-C-N 124.155 0.909 . . . . 0.0 108.818 175.477 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 52.8 t80 -64.7 -24.02 67.44 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 123.965 0.906 . . . . 0.0 112.304 -171.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 95.7 mttt -56.97 -40.92 77.4 Favored 'General case' 0 N--CA 1.452 -0.366 0 CA-C-N 118.586 0.63 . . . . 0.0 111.018 178.476 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 25.0 m -103.87 -16.88 15.25 Favored 'General case' 0 CA--C 1.535 0.388 0 C-N-CA 123.576 0.751 . . . . 0.0 110.652 176.565 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 98.0 mtt180 55.2 36.25 26.61 Favored 'General case' 0 N--CA 1.452 -0.337 0 C-N-CA 124.944 1.298 . . . . 0.0 109.646 -167.313 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -113.53 137.99 14.59 Favored Glycine 0 C--N 1.338 0.659 0 N-CA-C 109.145 -1.582 . . . . 0.0 109.145 -174.203 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -93.54 164.69 13.08 Favored 'General case' 0 N--CA 1.448 -0.538 0 C-N-CA 123.296 0.638 . . . . 0.0 111.852 -176.089 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -155.77 140.09 16.66 Favored 'General case' 0 N--CA 1.451 -0.412 0 C-N-CA 125.004 1.321 . . . . 0.0 110.56 174.799 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 2.0 tp -62.3 125.07 22.64 Favored 'General case' 0 N--CA 1.455 -0.219 0 N-CA-C 107.659 -1.237 . . . . 0.0 107.659 170.03 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -87.54 -56.76 3.22 Favored 'General case' 0 N--CA 1.453 -0.309 0 N-CA-C 108.021 -1.103 . . . . 0.0 108.021 174.878 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 59.6 mtm180 -148.12 157.78 43.7 Favored 'General case' 0 C--O 1.232 0.177 0 C-N-CA 124.926 1.29 . . . . 0.0 109.292 178.007 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 65.1 t80 -138.07 125.15 21.44 Favored 'General case' 0 N--CA 1.452 -0.334 0 N-CA-C 105.807 -1.923 . . . . 0.0 105.807 174.276 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 10.4 m120 -137.65 149.49 46.63 Favored 'General case' 0 N--CA 1.448 -0.544 0 N-CA-C 108.397 -0.964 . . . . 0.0 108.397 -174.555 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 135.77 -166.25 24.62 Favored Glycine 0 CA--C 1.528 0.871 0 N-CA-C 111.024 -0.831 . . . . 0.0 111.024 178.767 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 55.9 Cg_endo -64.45 146.11 64.08 Favored 'Cis proline' 0 N--CA 1.456 -0.685 0 CA-C-N 118.23 1.015 . . . . 0.0 110.954 2.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -142.31 130.64 11.7 Favored Pre-proline 0 CA--C 1.531 0.23 0 C-N-CA 124.396 1.078 . . . . 0.0 108.585 178.56 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 88.8 Cg_endo -71.68 161.91 43.74 Favored 'Trans proline' 0 N--CA 1.451 -1.009 0 C-N-CA 121.867 1.711 . . . . 0.0 108.799 173.356 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 87.9 Cg_endo -68.75 147.27 68.91 Favored 'Trans proline' 0 N--CA 1.451 -0.972 0 C-N-CA 121.553 1.502 . . . . 0.0 108.969 172.451 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 74.4 Cg_endo . . . . . 0 C--O 1.251 1.139 0 C-N-CA 122.403 2.069 . . . . 0.0 110.797 178.131 . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' GLY . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.475 1.272 0 N-CA-C 111.744 -0.542 . . . . 0.0 111.744 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' GLU . . . . . . . . . . . . . 1.4 pm0 -75.61 66.56 1.98 Allowed 'General case' 0 CA--C 1.535 0.371 0 C-N-CA 124.169 0.987 . . . . 0.0 111.83 -172.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' TRP . . . . . . . . . . . . . 2.4 t-105 -59.68 123.82 18.15 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 109.007 -0.738 . . . . 0.0 109.007 169.359 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' GLU . . . . . . . . . . . . . 8.7 tp10 -169.02 163.5 11.3 Favored 'General case' 0 C--N 1.34 0.177 0 N-CA-C 108.661 -0.866 . . . . 0.0 108.661 -179.766 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' ILE . . . . . . . . . . . . . 25.6 mm -76.1 135.22 27.38 Favored 'Isoleucine or valine' 0 N--CA 1.455 -0.212 0 N-CA-C 107.72 -1.215 . . . . 0.0 107.72 169.269 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' ILE . . . . . . . . . . . . . 30.1 pt -107.44 163.98 5.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 C-N-CA 123.92 0.888 . . . . 0.0 109.759 174.126 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' ASP . . . . . . . . . . . . . 8.4 m-20 -73.01 154.85 40.33 Favored 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.788 0.804 . . . . 0.0 110.446 -179.165 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' ILE . . . . . . . . . . . . . 1.2 pp -94.41 138.24 21.13 Favored 'Isoleucine or valine' 0 N--CA 1.439 -0.993 0 N-CA-C 107.183 -1.414 . . . . 0.0 107.183 167.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' GLY . . . . . . . . . . . . . . . 174.58 -170.53 43.66 Favored Glycine 0 CA--C 1.528 0.888 0 N-CA-C 108.727 -1.749 . . . . 0.0 108.727 -170.608 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' PRO . . . . . . . . . . . . . 21.6 Cg_endo -55.91 -45.5 38.25 Favored 'Trans proline' 0 N--CA 1.46 -0.496 0 C-N-CA 123.298 2.666 . . . . 0.0 111.907 -177.018 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' PHE . . . . . . . . . . . . . 47.3 t80 -53.59 -52.33 60.15 Favored 'General case' 0 CA--C 1.535 0.39 0 CA-C-O 122.043 0.925 . . . . 0.0 110.732 176.525 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -65.58 -42.67 91.46 Favored 'General case' 0 N--CA 1.447 -0.578 0 C-N-CA 123.794 0.838 . . . . 0.0 110.083 -176.313 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 39.4 mt-30 -54.1 -51.98 62.46 Favored 'General case' 0 N--CA 1.447 -0.587 0 CA-C-O 118.478 -0.773 . . . . 0.0 109.752 172.686 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 12.4 t30 -50.48 -50.96 51.18 Favored 'General case' 0 CA--C 1.529 0.153 0 CA-C-N 118.915 0.779 . . . . 0.0 110.865 179.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LEU . . . . . . . . . . . . . 90.3 mt -58.42 -49.09 78.51 Favored 'General case' 0 CA--C 1.533 0.296 0 CA-C-O 120.792 0.329 . . . . 0.0 110.96 177.369 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' GLY . . . . . . . . . . . . . . . -56.91 -37.01 75.92 Favored Glycine 0 CA--C 1.532 1.126 0 O-C-N 122.108 -0.37 . . . . 0.0 112.238 176.696 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' LYS . . . . . . . . . . . . . 4.1 tmtt? -73.96 -45.37 50.64 Favored 'General case' 0 N--CA 1.443 -0.808 0 N-CA-C 106.872 -1.529 . . . . 0.0 106.872 -173.147 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -52.24 -48.32 65.26 Favored 'General case' 0 N--CA 1.452 -0.332 0 C-N-CA 124.03 0.932 . . . . 0.0 110.876 169.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ALA . . . . . . . . . . . . . . . -57.26 -53.44 58.12 Favored 'General case' 0 C--O 1.233 0.187 0 CA-C-O 121.574 0.702 . . . . 0.0 110.369 179.588 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' VAL . . . . . . . . . . . . . 72.0 t -61.42 -38.47 80.11 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.258 0 CA-C-N 115.597 -0.729 . . . . 0.0 110.632 179.001 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' ASP . . . . . . . . . . . . . 20.9 t70 -63.55 -48.63 76.69 Favored 'General case' 0 N--CA 1.453 -0.307 0 C-N-CA 123.924 0.89 . . . . 0.0 109.974 -179.743 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' GLU . . . . . . . . . . . . . 10.6 tp10 -55.77 -49.82 72.13 Favored 'General case' 0 N--CA 1.455 -0.185 0 C-N-CA 123.996 0.918 . . . . 0.0 108.727 175.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' GLU . . . . . . . . . . . . . 36.2 tt0 -60.22 -44.29 95.3 Favored 'General case' 0 N--CA 1.449 -0.517 0 CA-C-N 116.046 -0.524 . . . . 0.0 111.376 -177.572 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' ASN . . . . . . . . . . . . . 9.9 m-80 -62.42 -44.7 95.81 Favored 'General case' 0 N--CA 1.454 -0.239 0 C-N-CA 124.228 1.011 . . . . 0.0 109.795 175.232 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LYS . . . . . . . . . . . . . 88.1 tttt -58.62 -47.81 83.11 Favored 'General case' 0 CA--C 1.529 0.155 0 C-N-CA 123.486 0.714 . . . . 0.0 109.892 -178.249 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' ILE . . . . . . . . . . . . . 96.3 mt -67.01 -39.53 83.57 Favored 'Isoleucine or valine' 0 CA--C 1.535 0.4 0 N-CA-C 109.578 -0.527 . . . . 0.0 109.578 174.547 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' GLY . . . . . . . . . . . . . . . 80.58 22.83 61.39 Favored Glycine 0 CA--C 1.527 0.784 0 C-N-CA 124.73 1.157 . . . . 0.0 110.474 -174.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLN . . . . . . . . . . . . . 16.4 tp60 -60.79 -33.64 73.29 Favored 'General case' 0 CA--C 1.531 0.219 0 CA-C-N 117.651 0.726 . . . . 0.0 111.312 -171.343 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -116.01 32.03 6.35 Favored 'General case' 0 CA--C 1.535 0.402 0 C-N-CA 124.446 1.098 . . . . 0.0 109.591 174.427 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' GLY . . . . . . . . . . . . . . . 62.7 -151.96 46.2 Favored Glycine 0 CA--C 1.53 0.987 0 N-CA-C 109.801 -1.32 . . . . 0.0 109.801 -169.856 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' ARG . . . . . . . . . . . . . 93.3 mtt180 -87.56 135.0 33.53 Favored 'General case' 0 N--CA 1.454 -0.261 0 C-N-CA 123.136 0.575 . . . . 0.0 109.636 175.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' LEU . . . . . . . . . . . . . 84.6 mt -127.99 133.42 49.17 Favored 'General case' 0 C--O 1.231 0.122 0 C-N-CA 124.132 0.973 . . . . 0.0 109.319 177.945 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' THR . . . . . . . . . . . . . 55.2 m -99.68 97.6 8.54 Favored 'General case' 0 N--CA 1.457 -0.101 0 C-N-CA 124.523 1.129 . . . . 0.0 108.321 -179.905 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' PHE . . . . . . . . . . . . . 49.6 t80 -50.21 132.94 24.06 Favored 'General case' 0 N--CA 1.46 0.059 0 C-N-CA 123.466 0.706 . . . . 0.0 111.074 175.23 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' ASN . . . . . . . . . . . . . 32.3 m120 -98.94 -65.11 0.98 Allowed 'General case' 0 N--CA 1.455 -0.185 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 168.701 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' LYS . . . . . . . . . . . . . 12.6 mttt -172.26 167.63 5.79 Favored 'General case' 0 C--O 1.227 -0.116 0 C-N-CA 123.451 0.7 . . . . 0.0 110.11 -177.337 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' VAL . . . . . . . . . . . . . 11.8 p -100.24 142.48 15.42 Favored 'Isoleucine or valine' 0 N--CA 1.457 -0.099 0 C-N-CA 124.432 1.093 . . . . 0.0 109.09 170.932 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' ILE . . . . . . . . . . . . . 2.3 pp -138.98 177.0 5.36 Favored 'Isoleucine or valine' 0 CA--C 1.532 0.27 0 C-N-CA 123.281 0.632 . . . . 0.0 110.251 177.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' ARG . . . . . . . . . . . . . 12.2 ptp180 -63.13 153.26 81.96 Favored Pre-proline 0 CA--C 1.541 0.603 0 C-N-CA 123.654 0.782 . . . . 0.0 112.716 -172.374 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' PRO . . . . . . . . . . . . . 44.4 Cg_endo -83.12 169.63 57.53 Favored 'Cis proline' 0 N--CA 1.45 -1.047 0 N-CA-C 108.809 -1.266 . . . . 0.0 108.809 -7.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' CYS . . . . . . . . . . . . . 51.9 t -132.97 97.8 4.12 Favored 'General case' 0 N--CA 1.451 -0.387 0 N-CA-C 107.841 -1.17 . . . . 0.0 107.841 168.179 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -84.55 126.78 33.61 Favored 'General case' 0 N--CA 1.45 -0.441 0 C-N-CA 125.47 1.508 . . . . 0.0 107.765 -174.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' LYS . . . . . . . . . . . . . 39.3 ttpt -114.01 113.77 25.24 Favored 'General case' 0 C--N 1.341 0.229 0 CA-C-O 118.093 -0.956 . . . . 0.0 108.652 168.539 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -114.37 141.47 47.59 Favored 'General case' 0 C--N 1.342 0.257 0 C-N-CA 124.606 1.162 . . . . 0.0 111.158 173.864 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -73.5 142.25 46.76 Favored 'General case' 0 CA--C 1.532 0.277 0 N-CA-C 108.228 -1.027 . . . . 0.0 108.228 169.778 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -113.69 120.18 62.89 Favored 'Isoleucine or valine' 0 C--O 1.234 0.277 0 CA-C-O 122.392 1.091 . . . . 0.0 109.251 177.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' TYR . . . . . . . . . . . . . 5.7 p90 -151.59 178.04 9.73 Favored 'General case' 0 N--CA 1.444 -0.764 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 -176.362 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' GLU . . . . . . . . . . . . . 3.5 tm-20 -87.99 -128.12 0.06 Allowed 'General case' 0 CA--C 1.532 0.26 0 N-CA-C 106.275 -1.75 . . . . 0.0 106.275 171.191 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' ASN . . . . . . . . . . . . . 41.4 t30 -159.68 -41.8 0.05 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 118.708 0.686 . . . . 0.0 112.254 168.801 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' GLU . . . . . . . . . . . . . 9.1 tp10 -23.57 97.49 0.01 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 C-N-CA 127.755 2.422 . . . . 0.0 113.884 -175.771 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 55.41 43.21 84.97 Favored Glycine 0 CA--C 1.53 0.971 0 C-N-CA 123.355 0.502 . . . . 0.0 113.221 175.87 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' PHE . . . . . . . . . . . . . 22.8 t80 73.04 60.18 0.1 Allowed 'General case' 0 CA--C 1.531 0.214 0 C-N-CA 125.663 1.585 . . . . 0.0 109.904 -179.503 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' ARG . . . . . . . . . . . . . 8.8 mmt180 -59.9 149.55 31.3 Favored 'General case' 0 CA--C 1.529 0.16 0 CA-C-N 115.69 -0.686 . . . . 0.0 112.582 176.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' GLU . . . . . . . . . . . . . 46.3 mt-10 -66.31 148.12 52.32 Favored 'General case' 0 N--CA 1.446 -0.661 0 C-N-CA 124.138 0.975 . . . . 0.0 110.063 177.522 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 96.6 mt -70.41 128.73 34.09 Favored 'Isoleucine or valine' 0 N--CA 1.453 -0.299 0 N-CA-C 108.722 -0.844 . . . . 0.0 108.722 173.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -91.16 -35.38 14.58 Favored 'General case' 0 N--CA 1.455 -0.206 0 N-CA-C 109.107 -0.701 . . . . 0.0 109.107 178.628 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' GLY . . . . . . . . . . . . . . . -175.31 -152.25 9.21 Favored Glycine 0 N--CA 1.446 -0.685 0 N-CA-C 111.283 -0.727 . . . . 0.0 111.283 -172.821 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' TYR . . . . . . . . . . . . . 10.3 m-85 -148.42 159.72 43.75 Favored 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 125.584 1.554 . . . . 0.0 107.818 -178.974 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -126.93 142.74 51.47 Favored 'General case' 0 N--CA 1.452 -0.351 0 C-N-CA 126.147 1.779 . . . . 0.0 108.358 170.871 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' TYR . . . . . . . . . . . . . 45.0 m-85 -126.9 105.63 8.76 Favored 'General case' 0 N--CA 1.444 -0.743 0 N-CA-C 105.489 -2.041 . . . . 0.0 105.489 -179.786 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' GLN . . . . . . . . . . . . . 19.6 tt0 -106.16 117.77 34.88 Favored 'General case' 0 N--CA 1.464 0.247 0 N-CA-C 107.865 -1.161 . . . . 0.0 107.865 -175.384 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' LEU . . . . . . . . . . . . . 2.2 pp -149.64 146.44 27.29 Favored 'General case' 0 C--N 1.339 0.143 0 CA-C-N 118.897 0.771 . . . . 0.0 111.974 -166.818 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -88.51 112.69 23.28 Favored 'General case' 0 N--CA 1.452 -0.347 0 N-CA-C 109.643 -0.503 . . . . 0.0 109.643 179.333 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' VAL . . . . . . . . . . . . . 12.1 p -106.39 138.6 31.15 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.403 0 C-N-CA 124.101 0.961 . . . . 0.0 109.523 175.646 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' TYR . . . . . . . . . . . . . 9.3 t80 -103.54 123.12 46.34 Favored 'General case' 0 N--CA 1.446 -0.633 0 C-N-CA 126.133 1.773 . . . . 0.0 106.966 -179.294 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' ALA . . . . . . . . . . . . . . . -141.45 132.09 25.57 Favored 'General case' 0 N--CA 1.454 -0.236 0 N-CA-C 108.434 -0.951 . . . . 0.0 108.434 -178.953 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' SER . . . . . . . . . . . . . 1.9 t 46.77 41.48 10.4 Favored 'General case' 0 CA--C 1.538 0.514 0 C-N-CA 124.447 1.099 . . . . 0.0 111.331 -173.54 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' ASP . . . . . . . . . . . . . 21.4 t70 62.45 19.47 11.18 Favored 'General case' 0 CA--C 1.539 0.547 0 C-N-CA 125.11 1.364 . . . . 0.0 113.343 -179.807 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' LYS . . . . . . . . . . . . . 74.5 mmtt -113.94 135.15 54.31 Favored 'General case' 0 C--O 1.233 0.189 0 C-N-CA 124.809 1.243 . . . . 0.0 107.873 175.378 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LEU . . . . . . . . . . . . . 12.3 tp -92.51 126.81 37.76 Favored 'General case' 0 N--CA 1.455 -0.209 0 N-CA-C 109.059 -0.719 . . . . 0.0 109.059 177.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' PHE . . . . . . . . . . . . . 49.0 m-85 -131.4 143.39 50.43 Favored 'General case' 0 N--CA 1.454 -0.23 0 C-N-CA 124.934 1.294 . . . . 0.0 108.748 177.889 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' ARG . . . . . . . . . . . . . 26.5 ttt180 -85.32 110.48 19.12 Favored 'General case' 0 N--CA 1.446 -0.629 0 N-CA-C 107.975 -1.12 . . . . 0.0 107.975 175.041 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ALA . . . . . . . . . . . . . . . -93.55 126.69 38.85 Favored 'General case' 0 N--CA 1.447 -0.595 0 N-CA-C 106.628 -1.619 . . . . 0.0 106.628 173.474 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' ASP . . . . . . . . . . . . . 33.5 t0 -108.0 111.23 23.19 Favored 'General case' 0 N--CA 1.453 -0.302 0 N-CA-C 106.72 -1.585 . . . . 0.0 106.72 168.973 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' ILE . . . . . . . . . . . . . 4.9 mp -100.59 150.74 5.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 N-CA-C 106.499 -1.667 . . . . 0.0 106.499 175.351 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' SER . . . . . . . . . . . . . 56.9 p -127.62 154.27 45.45 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.47 0.708 . . . . 0.0 109.198 176.83 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' GLU . . . . . . . . . . . . . 85.2 tt0 -123.33 135.97 54.44 Favored 'General case' 0 N--CA 1.453 -0.325 0 N-CA-C 106.759 -1.571 . . . . 0.0 106.759 168.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -100.92 120.98 40.95 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.425 -1.324 . . . . 0.0 107.425 171.161 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 41.3 t80 -67.31 -33.49 75.39 Favored 'General case' 0 CA--C 1.529 0.158 0 O-C-N 121.7 -0.625 . . . . 0.0 110.703 -172.947 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LYS . . . . . . . . . . . . . 78.9 tttt -60.0 -48.05 83.31 Favored 'General case' 0 N--CA 1.453 -0.318 0 C-N-CA 124.062 0.945 . . . . 0.0 111.209 -173.033 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' THR . . . . . . . . . . . . . 2.0 m -90.61 -22.95 20.97 Favored 'General case' 0 CA--C 1.533 0.315 0 C-N-CA 123.084 0.554 . . . . 0.0 110.243 175.783 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' ARG . . . . . . . . . . . . . 17.2 ttt180 65.17 33.73 9.13 Favored 'General case' 0 CA--C 1.533 0.293 0 C-N-CA 124.782 1.233 . . . . 0.0 110.233 -173.344 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' GLY . . . . . . . . . . . . . . . -111.18 155.74 15.95 Favored Glycine 0 C--N 1.336 0.534 0 N-CA-C 108.482 -1.847 . . . . 0.0 108.482 178.511 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' ARG . . . . . . . . . . . . . 35.3 mtt85 -115.13 163.74 15.2 Favored 'General case' 0 N--CA 1.45 -0.44 0 CA-C-N 117.446 0.623 . . . . 0.0 111.285 175.471 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -162.56 152.39 16.09 Favored 'General case' 0 N--CA 1.45 -0.46 0 C-N-CA 125.275 1.43 . . . . 0.0 111.331 177.528 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' LEU . . . . . . . . . . . . . 44.6 tp -69.63 127.56 33.38 Favored 'General case' 0 CA--C 1.534 0.329 0 C-N-CA 124.634 1.174 . . . . 0.0 109.845 175.619 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.69 -54.78 5.33 Favored 'General case' 0 C--N 1.337 0.041 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 168.315 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ARG . . . . . . . . . . . . . 1.4 mtm180 -170.44 169.05 7.63 Favored 'General case' 0 C--O 1.234 0.273 0 CA-C-O 120.898 0.38 . . . . 0.0 111.197 -177.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' PHE . . . . . . . . . . . . . 40.6 t80 -131.87 88.44 2.56 Favored 'General case' 0 N--CA 1.453 -0.293 0 C-N-CA 126.288 1.835 . . . . 0.0 108.166 -174.479 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' ASN . . . . . . . . . . . . . 4.4 m120 -84.65 145.7 27.86 Favored 'General case' 0 C--N 1.332 -0.185 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -174.92 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' GLY . . . . . . . . . . . . . . . 136.65 -159.85 24.63 Favored Glycine 0 CA--C 1.528 0.905 0 N-CA-C 110.401 -1.08 . . . . 0.0 110.401 176.132 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' PRO . . . . . . . . . . . . . 62.5 Cg_endo -65.42 157.05 77.35 Favored 'Cis proline' 0 N--CA 1.458 -0.559 0 CA-C-N 118.808 1.304 . . . . 0.0 110.071 -1.993 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' VAL . . . . . . . . . . . . . 16.5 m -127.97 148.72 68.5 Favored Pre-proline 0 CA--C 1.532 0.267 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 170.459 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PRO . . . . . . . . . . . . . 95.9 Cg_endo -74.74 162.95 36.72 Favored 'Trans proline' 0 N--CA 1.453 -0.86 0 C-N-CA 122.361 2.041 . . . . 0.0 108.722 168.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' PRO . . . . . . . . . . . . . 72.0 Cg_endo -67.4 153.96 75.29 Favored 'Trans proline' 0 N--CA 1.452 -0.928 0 C-N-CA 121.689 1.593 . . . . 0.0 109.181 169.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' PRO . . . . . . . . . . . . . 72.6 Cg_endo . . . . . 0 C--O 1.25 1.098 0 C-N-CA 122.529 2.153 . . . . 0.0 110.851 177.205 . . . . . . . . 0 0 . 1 stop_ save_